13908	HMR136_D81166_16_tr0_r1_1_gPRT		Comparison report between D81166_P16 and Q96M35unique head   	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81166_P16, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 13908 x Q96M35   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                     Quality: 2362.00                      Escore:       0                                               
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	             Matching length:     258                Total length:     284                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:   98.84   Matching Percent Identity:   97.29                                               
						1 - 175 of D81166_P16, a second amino acid sequence being at 	    Total Percent Similarity:   89.79      Total Percent Identity:   88.38                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	                        Gaps:       1                        
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 	                                                            
						PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDT 	Alignment:                                                   
						ADL                                                          	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 11 -   	     170 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 219                                                          
						193 of Q96M35, which also corresponds to amino acids 176 -   	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						358 of D81166_P16, a third amino acid sequence being at least	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     220 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 269                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding to amino acids 359 -	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						384 of D81166_P16, a fourth amino acid sequence being at     	                  .         .         .         .         .  
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	     270 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 319                                                          
						YVYKNS                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 194 -  	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						259 of Q96M35, which also corresponds to amino acids 385 -   	                  .         .         .         .         .  
						450 of D81166_P16, and a fifth amino acid sequence being at  	     320 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVP 369                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         |||||||||||||||||||||||||||||||||||||||             
						more preferably at least 90% and most preferably at least 95%	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL........... 193                                                          
						IKHAPGVLPDAGTSTTMAHQPSGLCEKCHYPQIAPSHLVSIPSLCPEPNLIVLVLSSATH 	                  .         .         .         .         .  
						PLPQQT                                                       	     370 KRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 419                                                          
						homologous to a polypeptide having the sequence corresponding	                        |||||||||||||||||||||||||||||||||||  
						to amino acids 451 - 516 of D81166_P16, wherein said first   	     194 ...............EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 228                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .                      
						acid sequence, fourth amino acid sequence and fifth amino    	     420 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKH                 453                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         |||||||||||||||||||||||||||||||:::                  
						isolated polypeptide encoding for a head of D81166_P16,      	     229 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSMRQ                 262                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	                                                            
						about 95% homologous to the sequence of D81166_P16.3.An      	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81166_P16, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to D81166_P16.4.An 	                                                            
						isolated polypeptide encoding for a tail of D81166_P16,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IKHAPGVLPDAGTSTTMAHQPSGLCEKCHYPQIAPSHLVSIPSLCPEPNLIVLVLSSATH 	                                                            
						PLPQQT                                                       	                                                            
						about 95% homologous to the sequence in D81166_P16.          	                                                            

						Comparison report between D81166_P16 and Q96E63unique head   	Sequence name: Q96E63                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						D81166_P16, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13908 x Q96E63   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENW                                    	                     Quality: 3018.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     307                Total length:     307                                               
						to amino acids 1 - 145 of D81166_P16, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	                        Gaps:       0                        
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                                                            
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	Alignment:                                                   
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	                  .         .         .         .         .  
						VYKNSIK                                                      	     146 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 195                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 307 of Q96E63, which also corresponds to     	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						amino acids 146 - 452 of D81166_P16, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     196 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 245                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						HAPGVLPDAGTSTTMAHQPSGLCEKCHYPQIAPSHLVSIPSLCPEPNLIVLVLSSATHPL 	                  .         .         .         .         .  
						PQQT                                                         	     246 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 295                                                          
						having the sequence corresponding to amino acids 453 - 516 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P16, wherein said first amino acid sequence, second   	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     296 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 345                                                          
						polypeptide encoding for a head of D81166_P16, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     346 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 395                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						LDHSKHCLSVETEADSGQAGPYENW                                    	                  .         .         .         .         .  
						to the sequence of D81166_P16.3.An isolated polypeptide      	     396 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 445                                                          
						encoding for a tail of D81166_P16, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						at least about 85%, more preferably at least about 90% and   	                                                             
						HAPGVLPDAGTSTTMAHQPSGLCEKCHYPQIAPSHLVSIPSLCPEPNLIVLVLSSATHPL 	     446 VYKNSIK                                            452                                                          
						PQQT                                                         	         |||||||                                             
						most preferably at least about 95% homologous to the sequence	     301 VYKNSIK                                            307                                                          
						in D81166_P16.                                               	                                                            

13892	HMR136_D81166_17_tr0_r1_1_gPRT		Comparison report between D81166_P17 and Q96M35unique head   	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						D81166_P17, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13892 x Q96M35   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	                     Quality: 1837.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     190                Total length:     190                                               
						to amino acids 1 - 175 of D81166_P17, a second amino acid    	 Matching Percent Similarity:   98.42   Matching Percent Identity:   97.89                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	    Total Percent Similarity:   98.42      Total Percent Identity:   97.89                                               
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 	                        Gaps:       0                        
						PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDT 	                                                            
						ADLE                                                         	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 11 - 194 of Q96M35, which also corresponds to    	     170 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 219                                                          
						amino acids 176 - 359 of D81166_P17, and a third amino acid  	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     220 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 269                                                          
						having the sequence QAVEVMCFVPKRCNDMMTLGRLRGFEVRR            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 360 - 388 of D81166_P17, wherein	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	     270 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 319                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of D81166_P17, comprising a polypeptide being at least  	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .            
						85%, more preferably at least about 90% and most preferably  	     320 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLE           359                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	         ||||||||||||||||||||||||||||||||||||||||            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLE           194                                                          
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						D81166_P17.3.An isolated polypeptide encoding for a tail of  	                                                            
						D81166_P17, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						QAVEVMCFVPKRCNDMMTLGRLRGFEVRR in D81166_P17.                 	                                                            

						Comparison report between D81166_P17 and AAH47559unique head 	Sequence name: AAH47559                                      
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a short unique tail.1.An isolated chimeric polypeptide       	Sequence documentation:                                      
						encoding for D81166_P17, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 13892 x AAH47559   ..                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQP                                                  	                     Quality: 3087.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 71 of   	             Matching length:     314                Total length:     314                                               
						D81166_P17, a second amino acid sequence being at least 90 % 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						ESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVE 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						TEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEE 	                        Gaps:       0                        
						QKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQ 	                                                            
						IYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVY                     	Alignment:                                                   
						homologous to corresponding to amino acids 33 - 252 of       	                  .         .         .         .         .  
						AAH47559, which also corresponds to amino acids 72 - 291 of  	      72 ESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWL 121                                                          
						D81166_P17, a bridging amino acid C corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 292 of D81166_P17, a third amino acid sequence being at 	      33 ESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWL 82                                                           
						QNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAG 	                  .         .         .         .         .  
						MDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE                            	     122 DHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPG 171                                                          
						least 90 % homologous to corresponding to amino acids 254 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						346 of AAH47559, which also corresponds to amino acids 293 - 	      83 DHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPG 132                                                          
						385 of D81166_P17, and a fourth amino acid sequence being at 	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     172 DKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQI 221                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence VRR          	     133 DKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQI 182                                                          
						corresponding to amino acids 386 - 388 of D81166_P17, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     222 VEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDP 271                                                          
						bridging amino acid, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     183 VEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDP 232                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						D81166_P17, comprising a polypeptide being at least 70%,     	     272 DWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRL 321                                                          
						optionally at least about 80%, preferably at least about 85%,	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     233 DWLAQLFIKHERRLHMYVVYYQNKPKSEHVVSEFGDSYFEELRQQLGHRL 282                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                  .         .         .         .         .  
						EHEVLAGALQP                                                  	     322 QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 371                                                          
						least about 95% homologous to the sequence of D81166_P17.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     283 QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 332                                                          
						                                                            	                  .                                          
						                                                            	     372 CNDMMTLGRLRGFE                                     385                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     333 CNDMMTLGRLRGFE                                     346                                                          

						Comparison report between D81166_P17 and Q96E63unique head   	Sequence name: Q96E63                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						D81166_P17, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13892 x Q96E63   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENW                                    	                     Quality: 2380.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     240                Total length:     240                                               
						to amino acids 1 - 145 of D81166_P17, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	                        Gaps:       0                        
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                                                            
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 240 of Q96E63, which also corresponds to     	     146 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 195                                                          
						amino acids 146 - 385 of D81166_P17, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     196 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 245                                                          
						having the sequence VRR corresponding to amino acids 386 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						388 of D81166_P17, wherein said first amino acid sequence,   	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     246 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 295                                                          
						polypeptide encoding for a head of D81166_P17, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     296 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 345                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						LDHSKHCLSVETEADSGQAGPYENW                                    	                  .         .         .         .            
						to the sequence of D81166_P17.                               	     346 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE           385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE           240                                                          

						Comparison report between D81166_P17 and AAO49463unique head 	Sequence name: AAO49463                                      
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a short unique tail.1.An isolated chimeric polypeptide       	Sequence documentation:                                      
						encoding for D81166_P17, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 13892 x AAO49463   ..                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQP                                                  	                     Quality: 3087.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 71 of   	             Matching length:     314                Total length:     314                                               
						D81166_P17, a second amino acid sequence being at least 90 % 	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						ESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVE 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						TEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEE 	                        Gaps:       0                        
						QKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQ 	                                                            
						IYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVY                     	Alignment:                                                   
						homologous to corresponding to amino acids 33 - 252 of       	                  .         .         .         .         .  
						AAO49463, which also corresponds to amino acids 72 - 291 of  	      72 ESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWL 121                                                          
						D81166_P17, a bridging amino acid C corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 292 of D81166_P17, a third amino acid sequence being at 	      33 ESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWL 82                                                           
						QNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAG 	                  .         .         .         .         .  
						MDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE                            	     122 DHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPG 171                                                          
						least 90 % homologous to corresponding to amino acids 254 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						346 of AAO49463, which also corresponds to amino acids 293 - 	      83 DHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPG 132                                                          
						385 of D81166_P17, and a fourth amino acid sequence being at 	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     172 DKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQI 221                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence VRR          	     133 DKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQI 182                                                          
						corresponding to amino acids 386 - 388 of D81166_P17, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     222 VEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDP 271                                                          
						bridging amino acid, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     183 VEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDP 232                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						D81166_P17, comprising a polypeptide being at least 70%,     	     272 DWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRL 321                                                          
						optionally at least about 80%, preferably at least about 85%,	         |||||||||||||||||||| |||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     233 DWLAQLFIKHERRLHMYVVYYQNKPKSEHVVSEFGDSYFEELRQQLGHRL 282                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                  .         .         .         .         .  
						EHEVLAGALQP                                                  	     322 QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 371                                                          
						least about 95% homologous to the sequence of D81166_P17.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     283 QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 332                                                          
						                                                            	                  .                                          
						                                                            	     372 CNDMMTLGRLRGFE                                     385                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     333 CNDMMTLGRLRGFE                                     346                                                          

13874	HMR136_D81166_18_tr0_r1_1_gPRT		Comparison report between D81166_P18 and AAH47559unique head 	Sequence name: AAH47559                                      
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for D81166_P18, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13874 x AAH47559   ..                          
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence SVPLFAP corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 7 of D81166_P18, a second amino acid sequence	                                                            
						being at least 90 % homologous to                            	                     Quality: 1033.00                      Escore:       0                                               
						ALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI corresponding to amino acids	             Matching length:     110                Total length:     110                                               
						474 - 505 of AAH47559, which also corresponds to amino acids 	 Matching Percent Similarity:   98.18   Matching Percent Identity:   97.27                                               
						8 - 39 of D81166_P18, a bridging amino acid Q corresponding  	    Total Percent Similarity:   98.18      Total Percent Identity:   97.27                                               
						to amino acid 40 of D81166_P18, and a third amino acid       	                        Gaps:       0                        
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	                                                            
						PCQARLAKLDEDEL                                               	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 507 - 580 of AAH47559, which also corresponds to 	       5 FAPALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPIN 54                                                           
						amino acids 41 - 114 of D81166_P18, wherein said first amino 	         |  ||||||||||||||||||||||||||||||||:||||||||||||||  
						acid sequence, second amino acid sequence, bridging amino    	     471 FLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIRLGDQAQGSTHTPIN 520                                                          
						acid and third amino acid sequence are contiguous and in a   	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      55 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 104                                                          
						head of D81166_P18, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     521 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 570                                                          
						85%, more preferably at least about 90% and most preferably  	                  .                                          
						at least about 95% homologous to the sequence SVPLFAP of     	     105 RLAKLDEDEL                                         114                                                          
						D81166_P18.                                                  	         ||||||||||                                          
						                                                            	     571 RLAKLDEDEL                                         580                                                          

						Comparison report between D81166_P18 and Q96E63unique head   	Sequence name: Q96E63                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for D81166_P18, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13874 x Q96E63   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence SVPLFAP corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 7 of D81166_P18, a second amino acid sequence	                                                            
						being at least 90 % homologous to                            	                     Quality: 1033.00                      Escore:       0                                               
						ALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI corresponding to amino acids	             Matching length:     110                Total length:     110                                               
						368 - 399 of Q96E63, which also corresponds to amino acids 8 	 Matching Percent Similarity:   98.18   Matching Percent Identity:   97.27                                               
						- 39 of D81166_P18, a bridging amino acid Q corresponding to 	    Total Percent Similarity:   98.18      Total Percent Identity:   97.27                                               
						amino acid 40 of D81166_P18, and a third amino acid sequence 	                        Gaps:       0                        
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	                                                            
						PCQARLAKLDEDEL                                               	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 401 - 474 of Q96E63, which also corresponds to amino   	       5 FAPALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPIN 54                                                           
						acids 41 - 114 of D81166_P18, wherein said first amino acid  	         |  ||||||||||||||||||||||||||||||||:||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid and	     365 FLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIRLGDQAQGSTHTPIN 414                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      55 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 104                                                          
						D81166_P18, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     415 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 464                                                          
						more preferably at least about 90% and most preferably at    	                  .                                          
						least about 95% homologous to the sequence SVPLFAP of        	     105 RLAKLDEDEL                                         114                                                          
						D81166_P18.                                                  	         ||||||||||                                          
						                                                            	     465 RLAKLDEDEL                                         474                                                          

						Comparison report between D81166_P18 and AAO49463unique head 	Sequence name: AAO49463                                      
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for D81166_P18, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13874 x AAO49463   ..                          
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence SVPLFAP corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 7 of D81166_P18, a second amino acid sequence	                                                            
						being at least 90 % homologous to                            	                     Quality: 1033.00                      Escore:       0                                               
						ALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI corresponding to amino acids	             Matching length:     110                Total length:     110                                               
						474 - 505 of AAO49463, which also corresponds to amino acids 	 Matching Percent Similarity:   98.18   Matching Percent Identity:   97.27                                               
						8 - 39 of D81166_P18, a bridging amino acid Q corresponding  	    Total Percent Similarity:   98.18      Total Percent Identity:   97.27                                               
						to amino acid 40 of D81166_P18, and a third amino acid       	                        Gaps:       0                        
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	                                                            
						PCQARLAKLDEDEL                                               	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 507 - 580 of AAO49463, which also corresponds to 	       5 FAPALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPIN 54                                                           
						amino acids 41 - 114 of D81166_P18, wherein said first amino 	         |  ||||||||||||||||||||||||||||||||:||||||||||||||  
						acid sequence, second amino acid sequence, bridging amino    	     471 FLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIRLGDQAQGSTHTPIN 520                                                          
						acid and third amino acid sequence are contiguous and in a   	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      55 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 104                                                          
						head of D81166_P18, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     521 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 570                                                          
						85%, more preferably at least about 90% and most preferably  	                  .                                          
						at least about 95% homologous to the sequence SVPLFAP of     	     105 RLAKLDEDEL                                         114                                                          
						D81166_P18.                                                  	         ||||||||||                                          
						                                                            	     571 RLAKLDEDEL                                         580                                                          

						Comparison report between D81166_P18 and Q8WV84unique head   	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P18, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13874 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence SVPLFAP corresponding to amino acids 1 - 	Alignment segment 1/1:                                       
						7 of D81166_P18, and a second amino acid sequence being at   	                                                            
						ALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGE 	                     Quality: 1044.00                      Escore:       0                                               
						VARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL              	             Matching length:     110                Total length:     110                                               
						least 90 % homologous to corresponding to amino acids 40 -   	 Matching Percent Similarity:   98.18   Matching Percent Identity:   98.18                                               
						146 of Q8WV84, which also corresponds to amino acids 8 - 114 	    Total Percent Similarity:   98.18      Total Percent Identity:   98.18                                               
						of D81166_P18, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a head of       	Alignment:                                                   
						D81166_P18, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	       5 FAPALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPIN 54                                                           
						more preferably at least about 90% and most preferably at    	         |  |||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence SVPLFAP of        	      37 FLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPIN 86                                                           
						D81166_P18.                                                  	                  .         .         .         .         .  
						                                                            	      55 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 104                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      87 GSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQA 136                                                          
						                                                            	                  .                                          
						                                                            	     105 RLAKLDEDEL                                         114                                                          
						                                                            	         ||||||||||                                          
						                                                            	     137 RLAKLDEDEL                                         146                                                          

13886	HMR136_D81166_2_tr0_r1_1_gPRT		Comparison report between D81166_P2 and Q96M35unique head    	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81166_P2, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 13886 x Q96M35   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                     Quality: 2361.00                      Escore:       0                                               
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	             Matching length:     257                Total length:     283                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:   98.83   Matching Percent Identity:   97.67                                               
						1 - 175 of D81166_P2, a second amino acid sequence being at  	    Total Percent Similarity:   89.75      Total Percent Identity:   88.69                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	                        Gaps:       1                        
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 	                                                            
						PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDT 	Alignment:                                                   
						ADL                                                          	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 11 -   	     170 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 219                                                          
						193 of Q96M35, which also corresponds to amino acids 176 -   	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						358 of D81166_P2, a third amino acid sequence being at least 	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     220 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 269                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding to amino acids 359 -	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						384 of D81166_P2, a fourth amino acid sequence being at least	                  .         .         .         .         .  
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	     270 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 319                                                          
						YVYKNS                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 194 - 259 of 	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						Q96M35, which also corresponds to amino acids 385 - 450 of   	                  .         .         .         .         .  
						D81166_P2, and a fifth amino acid sequence being at least    	     320 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVP 369                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         |||||||||||||||||||||||||||||||||||||||             
						preferably at least 90% and most preferably at least 95%     	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL........... 193                                                          
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                  .         .         .         .         .  
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	     370 KRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 419                                                          
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                        |||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     194 ...............EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 228                                                          
						to amino acids 451 - 619 of D81166_P2, wherein said first    	                  .         .         .                      
						amino acid sequence, second amino acid sequence, third amino 	     420 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIK                  452                                                          
						acid sequence, fourth amino acid sequence and fifth amino    	         |||||||||||||||||||||||||||||||::                   
						acid sequence are contiguous and in a sequential order.2.An  	     229 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSMR                  261                                                          
						isolated polypeptide encoding for a head of D81166_P2,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	                                                            
						about 95% homologous to the sequence of D81166_P2.3.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81166_P2, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to D81166_P2.4.An  	                                                            
						isolated polypeptide encoding for a tail of D81166_P2,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                            
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                                                            
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                                                            
						about 95% homologous to the sequence in D81166_P2.           	                                                            

						Comparison report between D81166_P2 and Q96E63unique head    	Sequence name: Q96E63                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for D81166_P2, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13886 x Q96E63   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENW                                    	                     Quality: 4634.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     474                Total length:     474                                               
						1 - 145 of D81166_P2, a second amino acid sequence being at  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	                        Gaps:       0                        
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                                                            
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	Alignment:                                                   
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	                  .         .         .         .         .  
						VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILE 	     146 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 195                                                          
						SQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 399	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						of Q96E63, which also corresponds to amino acids 146 - 544 of	                  .         .         .         .         .  
						D81166_P2, a bridging amino acid Q corresponding to amino    	     196 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 245                                                          
						acid 545 of D81166_P2, and a third amino acid sequence being 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						PCQARLAKLDEDEL                                               	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 401 	     246 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 295                                                          
						- 474 of Q96E63, which also corresponds to amino acids 546 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						619 of D81166_P2, wherein said first amino acid sequence,    	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						second amino acid sequence, bridging amino acid and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     296 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 345                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P2, comprising a polypeptide being at least 70%,      	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     346 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 395                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						LDHSKHCLSVETEADSGQAGPYENW                                    	                  .         .         .         .         .  
						least about 95% homologous to the sequence of D81166_P2.     	     396 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 445                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     446 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 495                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     496 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQ 545                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     351 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     546 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 595                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 450                                                          
						                                                            	                  .         .                                
						                                                            	     596 PPVSPTPKTPPCQARLAKLDEDEL                           619                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     451 PPVSPTPKTPPCQARLAKLDEDEL                           474                                                          

						Comparison report between D81166_P2 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13886 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEE 	                     Quality: 1422.00                      Escore:       0                                               
						TLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRG 	             Matching length:     146                Total length:     146                                               
						RDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRV 	                        Gaps:       0                        
						FLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTS        	                                                            
						having the sequence corresponding to amino acids 1 - 473 of  	Alignment:                                                   
						D81166_P2, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	     474 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 523                                                          
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						% homologous to corresponding to amino acids 1 - 146 of      	                  .         .         .         .         .  
						Q8WV84, which also corresponds to amino acids 474 - 619 of   	     524 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 573                                                          
						D81166_P2, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .            
						D81166_P2, comprising a polypeptide being at least 70%,      	     574 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     619                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||      
						more preferably at least about 90% and most preferably at    	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEE 	                                                            
						TLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRG 	                                                            
						RDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEH 	                                                            
						VVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQ 	                                                            
						AVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRV 	                                                            
						FLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTS        	                                                            
						least about 95% homologous to the sequence of D81166_P2.     	                                                            

13880	HMR136_D81166_3_tr0_r1_1_gPRT		Comparison report between D81166_P3 and Q96E63partial WT     	Sequence name: Q96E63                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for D81166_P3, comprising a first amino 	Sequence documentation:                                      
						MYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLK 	                                                            
						YYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPE 	Alignment of: 13880 x Q96E63   ..                            
						AGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDP 	                                                            
						CRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQ 	Alignment segment 1/1:                                       
						TNSLGRPRGPGVGSPGRI                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 3246.00                      Escore:       0                                               
						to amino acids 142 - 399 of Q96E63, which also corresponds to	             Matching length:     333                Total length:     333                                               
						amino acids 1 - 258 of D81166_P3, a bridging amino acid Q    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.70                                               
						corresponding to amino acid 259 of D81166_P3, and a second   	    Total Percent Similarity:  100.00      Total Percent Identity:   99.70                                               
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	                        Gaps:       0                        
						PCQARLAKLDEDEL                                               	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 401 - 474 of Q96E63, which also 	                  .         .         .         .         .  
						corresponds to amino acids 260 - 333 of D81166_P3, wherein   	       1 MYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMK 50                                                           
						said first amino acid sequence, bridging amino acid and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     142 MYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMK 191                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	      51 YQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 YQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEG 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 KLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGG 291                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 VRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQ 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 AADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGP 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALG 300                                                          
						                                                            	         ||||||||:|||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 GVGSPGRIRLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALG 441                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 DIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL                  333                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     442 DIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL                  474                                                          

						Comparison report between D81166_P3 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13880 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLK 	Alignment segment 1/1:                                       
						YYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPE 	                                                            
						AGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDP 	                     Quality: 1422.00                      Escore:       0                                               
						CRFALTS                                                      	             Matching length:     146                Total length:     146                                               
						having the sequence corresponding to amino acids 1 - 187 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						D81166_P3, and a second amino acid sequence being at least 90	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	                        Gaps:       0                        
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	                                                            
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	Alignment:                                                   
						% homologous to corresponding to amino acids 1 - 146 of      	                  .         .         .         .         .  
						Q8WV84, which also corresponds to amino acids 188 - 333 of   	     188 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 237                                                          
						D81166_P3, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						D81166_P3, comprising a polypeptide being at least 70%,      	     238 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 287                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						MYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLK 	                  .         .         .         .            
						YYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPE 	     288 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     333                                                          
						AGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDP 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						CRFALTS                                                      	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						least about 95% homologous to the sequence of D81166_P3.     	                                                            

13906	HMR136_D81166_4_tr0_r1_1_gPRT		Comparison report between D81166_P4 and Q96M35unique head    	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81166_P4, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 13906 x Q96M35   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                     Quality: 2261.00                      Escore:       0                                               
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	             Matching length:     257                Total length:     307                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:   98.83   Matching Percent Identity:   97.67                                               
						1 - 175 of D81166_P4, a second amino acid sequence being at  	    Total Percent Similarity:   82.74      Total Percent Identity:   81.76                                               
						least 90 % homologous to PPEEETLSQAPESEEEQKKKALERSM          	                        Gaps:       2                        
						corresponding to amino acids 11 - 36 of Q96M35, which also   	                                                            
						corresponds to amino acids 176 - 201 of D81166_P4, a third   	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     170 PGDKTQPPEEETLSQAPESEEEQKKKALERSMREERAEPRMSSDAEVGAS 219                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||  : ||||||||||||||||||||||||||                    
						having the sequence REERAEPRMSSDAEVGASSCFHPR corresponding to	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSM.................. 36                                                           
						amino acids 202 - 225 of D81166_P4, a fourth amino acid      	                  .         .         .         .         .  
						YVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFL 	     220 SCFHPRYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 269                                                          
						QELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRL 	               ||||||||||||||||||||||||||||||||||||||||||||  
						QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL                        	      37 ......YVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 80                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 37 - 193 of Q96M35, which also corresponds to    	     270 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 319                                                          
						amino acids 226 - 382 of D81166_P4, a fifth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      81 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 130                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     320 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 369                                                          
						having the sequence EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 383 - 408 of D81166_P4, a sixth amino acid    	     131 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 180                                                          
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	                  .         .         .         .         .  
						YVYKNS                                                       	     370 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 419                                                          
						sequence being at least 90 % homologous to corresponding to  	         |||||||||||||                          |||||||||||  
						amino acids 194 - 259 of Q96M35, which also corresponds to   	     181 KYYNRAGMDTADL..........................EGKLTAQGKLL 204                                                          
						amino acids 409 - 474 of D81166_P4, and a seventh amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     420 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 469                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     205 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 254                                                          
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                             
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	     470 VYKNSIK                                            476                                                          
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	         |||||::                                             
						having the sequence corresponding to amino acids 475 - 643 of	     255 VYKNSMR                                            261                                                          
						D81166_P4, wherein said first amino acid sequence, second    	                                                            
						amino acid sequence, third amino acid sequence, fourth amino 	                                                            
						acid sequence, fifth amino acid sequence, sixth amino acid   	                                                            
						sequence and seventh amino acid sequence are contiguous and  	                                                            
						in a sequential order.2.An isolated polypeptide encoding for 	                                                            
						a head of D81166_P4, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						D81166_P4.3.An isolated polypeptide encoding for an edge     	                                                            
						portion of D81166_P4, comprising an amino acid sequence being	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for REERAEPRMSSDAEVGASSCFHPR, corresponding to      	                                                            
						D81166_P4.4.An isolated polypeptide encoding for an edge     	                                                            
						portion of D81166_P4, comprising an amino acid sequence being	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to    	                                                            
						D81166_P4.5.An isolated polypeptide encoding for a tail of   	                                                            
						D81166_P4, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                            
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                                                            
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                                                            
						least about 95% homologous to the sequence in D81166_P4.     	                                                            

						Comparison report between D81166_P4 and Q96E63unique head    	Sequence name: Q96E63                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a mismatch.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for D81166_P4, comprising a first amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 13906 x Q96E63   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                     Quality: 4534.00                      Escore:       0                                               
						LDHSKHCLSVETEADSGQAGPYENW                                    	             Matching length:     474                Total length:     498                                               
						having the sequence corresponding to amino acids 1 - 145 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						D81166_P4, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   95.18      Total Percent Identity:   94.98                                               
						homologous to                                                	                        Gaps:       1                        
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSM     	                                                            
						corresponding to amino acids 1 - 56 of Q96E63, which also    	Alignment:                                                   
						corresponds to amino acids 146 - 201 of D81166_P4, a third   	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     146 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 195                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						having the sequence REERAEPRMSSDAEVGASSCFHPR corresponding to	                  .         .         .         .         .  
						amino acids 202 - 225 of D81166_P4, a fourth amino acid      	     196 ALERSMREERAEPRMSSDAEVGASSCFHPRYVLSELVETEKMYVDDLGQI 245                                                          
						YVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFL 	         ||||||                        ||||||||||||||||||||  
						QELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRL 	      51 ALERSM........................YVLSELVETEKMYVDDLGQI 76                                                           
						QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRL 	                  .         .         .         .         .  
						RGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGT 	     246 VEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDP 295                                                          
						QPGYVYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI                  	      77 VEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDP 126                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 57 - 399 of Q96E63, which also corresponds to    	     296 DWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRL 345                                                          
						amino acids 226 - 568 of D81166_P4, a bridging amino acid Q  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 569 of D81166_P4, and a fifth    	     127 DWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRL 176                                                          
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	                  .         .         .         .         .  
						PCQARLAKLDEDEL                                               	     346 QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 395                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 401 - 474 of Q96E63, which also 	     177 QLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 226                                                          
						corresponds to amino acids 570 - 643 of D81166_P4, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     396 CNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVF 445                                                          
						third amino acid sequence, fourth amino acid sequence,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid and fifth amino acid sequence are        	     227 CNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVF 276                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of D81166_P4, comprising a   	     446 LFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFAL 495                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     277 LFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFAL 326                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	     496 TSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQ 545                                                          
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDHSKHCLSVETEADSGQAGPYENW                                    	     327 TSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQ 376                                                          
						to the sequence of D81166_P4.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for an edge portion of D81166_P4, comprising an     	     546 RRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKG 595                                                          
						amino acid sequence being at least 70%, optionally at least  	         |||||||||||||||||||||||:||||||||||||||||||||||||||  
						about 80%, preferably at least about 85%, more preferably at 	     377 RRESQTNSLGRPRGPGVGSPGRIRLGDQAQGSTHTPINGSLPSLLLSPKG 426                                                          
						least about 90% and most preferably at least about 95%       	                  .         .         .         .            
						homologous to the sequence encoding for                      	     596 EVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL   643                                                          
						REERAEPRMSSDAEVGASSCFHPR, corresponding to D81166_P4.        	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     427 EVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL   474                                                          

						Comparison report between D81166_P4 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13906 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEE 	                     Quality: 1422.00                      Escore:       0                                               
						TLSQAPESEEEQKKKALERSMREERAEPRMSSDAEVGASSCFHPRYVLSELVETEKMYVD 	             Matching length:     146                Total length:     146                                               
						DLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						YQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLG 	                        Gaps:       0                        
						QDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCL 	                                                            
						GLEGNLQGDPCRFALTS                                            	Alignment:                                                   
						having the sequence corresponding to amino acids 1 - 497 of  	                  .         .         .         .         .  
						D81166_P4, and a second amino acid sequence being at least 90	     498 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 547                                                          
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 146 of      	     548 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 597                                                          
						Q8WV84, which also corresponds to amino acids 498 - 643 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P4, wherein said first amino acid sequence and second 	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .            
						order.2.An isolated polypeptide encoding for a head of       	     598 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     643                                                          
						D81166_P4, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||      
						optionally at least about 80%, preferably at least about 85%,	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEE 	                                                            
						TLSQAPESEEEQKKKALERSMREERAEPRMSSDAEVGASSCFHPRYVLSELVETEKMYVD 	                                                            
						DLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQ 	                                                            
						LFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMK 	                                                            
						YQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLG 	                                                            
						QDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCL 	                                                            
						GLEGNLQGDPCRFALTS                                            	                                                            
						least about 95% homologous to the sequence of D81166_P4.     	                                                            

13888	HMR136_D81166_5_tr0_r1_1_gPRT		Comparison report between D81166_P5 and Q96M35unique head    	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81166_P5, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 13888 x Q96M35   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						RFLTVVLSPQPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSEGSI 	                                                            
						SASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYE 	                     Quality: 2361.00                      Escore:       0                                               
						NWMLEPALATGEELPELTLLTTLLEGPGDKTQ                             	             Matching length:     257                Total length:     283                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:   98.83   Matching Percent Identity:   97.67                                               
						1 - 152 of D81166_P5, a second amino acid sequence being at  	    Total Percent Similarity:   89.75      Total Percent Identity:   88.69                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	                        Gaps:       1                        
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 	                                                            
						PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDT 	Alignment:                                                   
						ADL                                                          	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 11 -   	     147 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 196                                                          
						193 of Q96M35, which also corresponds to amino acids 153 -   	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						335 of D81166_P5, a third amino acid sequence being at least 	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     197 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 246                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding to amino acids 336 -	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						361 of D81166_P5, a fourth amino acid sequence being at least	                  .         .         .         .         .  
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	     247 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 296                                                          
						YVYKNS                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 194 - 259 of 	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						Q96M35, which also corresponds to amino acids 362 - 427 of   	                  .         .         .         .         .  
						D81166_P5, and a fifth amino acid sequence being at least    	     297 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVP 346                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         |||||||||||||||||||||||||||||||||||||||             
						preferably at least 90% and most preferably at least 95%     	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL........... 193                                                          
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                  .         .         .         .         .  
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	     347 KRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 396                                                          
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                        |||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     194 ...............EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 228                                                          
						to amino acids 428 - 596 of D81166_P5, wherein said first    	                  .         .         .                      
						amino acid sequence, second amino acid sequence, third amino 	     397 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIK                  429                                                          
						acid sequence, fourth amino acid sequence and fifth amino    	         |||||||||||||||||||||||||||||||::                   
						acid sequence are contiguous and in a sequential order.2.An  	     229 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSMR                  261                                                          
						isolated polypeptide encoding for a head of D81166_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						RFLTVVLSPQPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSEGSI 	                                                            
						SASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYE 	                                                            
						NWMLEPALATGEELPELTLLTTLLEGPGDKTQ                             	                                                            
						about 95% homologous to the sequence of D81166_P5.3.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81166_P5, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to D81166_P5.4.An  	                                                            
						isolated polypeptide encoding for a tail of D81166_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                            
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                                                            
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                                                            
						about 95% homologous to the sequence in D81166_P5.           	                                                            

						Comparison report between D81166_P5 and Q96E63unique head    	Sequence name: Q96E63                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for D81166_P5, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13888 x Q96E63   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						RFLTVVLSPQPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSEGSI 	Alignment segment 1/1:                                       
						SASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYE 	                                                            
						NW                                                           	                     Quality: 4634.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     474                Total length:     474                                               
						1 - 122 of D81166_P5, a second amino acid sequence being at  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	                        Gaps:       0                        
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                                                            
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	Alignment:                                                   
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	                  .         .         .         .         .  
						VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILE 	     123 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 172                                                          
						SQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 399	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						of Q96E63, which also corresponds to amino acids 123 - 521 of	                  .         .         .         .         .  
						D81166_P5, a bridging amino acid Q corresponding to amino    	     173 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 222                                                          
						acid 522 of D81166_P5, and a third amino acid sequence being 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						PCQARLAKLDEDEL                                               	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 401 	     223 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 272                                                          
						- 474 of Q96E63, which also corresponds to amino acids 523 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						596 of D81166_P5, wherein said first amino acid sequence,    	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						second amino acid sequence, bridging amino acid and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     273 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 322                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P5, comprising a polypeptide being at least 70%,      	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     323 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 372                                                          
						RFLTVVLSPQPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSEGSI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYE 	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						NW                                                           	                  .         .         .         .         .  
						least about 95% homologous to the sequence of D81166_P5.     	     373 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     473 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQ 522                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     351 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     523 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 572                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 450                                                          
						                                                            	                  .         .                                
						                                                            	     573 PPVSPTPKTPPCQARLAKLDEDEL                           596                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     451 PPVSPTPKTPPCQARLAKLDEDEL                           474                                                          

						Comparison report between D81166_P5 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13888 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						RFLTVVLSPQPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSEGSI 	Alignment segment 1/1:                                       
						SASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYE 	                                                            
						NWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYV 	                     Quality: 1422.00                      Escore:       0                                               
						LSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQE 	             Matching length:     146                Total length:     146                                               
						LQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQP 	                        Gaps:       0                        
						GYVYKNSIKVSCLGLEGNLQGDPCRFALTS                               	                                                            
						having the sequence corresponding to amino acids 1 - 450 of  	Alignment:                                                   
						D81166_P5, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	     451 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 500                                                          
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						% homologous to corresponding to amino acids 1 - 146 of      	                  .         .         .         .         .  
						Q8WV84, which also corresponds to amino acids 451 - 596 of   	     501 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 550                                                          
						D81166_P5, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .            
						D81166_P5, comprising a polypeptide being at least 70%,      	     551 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     596                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||      
						more preferably at least about 90% and most preferably at    	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						RFLTVVLSPQPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSEGSI 	                                                            
						SASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYE 	                                                            
						NWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYV 	                                                            
						LSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQE 	                                                            
						LQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQL 	                                                            
						NDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRG 	                                                            
						FEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQP 	                                                            
						GYVYKNSIKVSCLGLEGNLQGDPCRFALTS                               	                                                            
						least about 95% homologous to the sequence of D81166_P5.     	                                                            

13884	HMR136_D81166_6_tr0_r1_1_gPRT		Comparison report between D81166_P6 and Q96M35unique head    	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81166_P6, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 13884 x Q96M35   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						MLEPALATGEELPELTLLTTLLEGPGDKTQ corresponding to amino acids 1	                     Quality: 2361.00                      Escore:       0                                               
						- 30 of D81166_P6, a second amino acid sequence being at     	             Matching length:     257                Total length:     283                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	 Matching Percent Similarity:   98.83   Matching Percent Identity:   97.67                                               
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 	    Total Percent Similarity:   89.75      Total Percent Identity:   88.69                                               
						PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDT 	                        Gaps:       1                        
						ADL                                                          	                                                            
						least 90 % homologous to corresponding to amino acids 11 -   	Alignment:                                                   
						193 of Q96M35, which also corresponds to amino acids 31 - 213	                  .         .         .         .         .  
						of D81166_P6, a third amino acid sequence being at least 70%,	      25 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 74                                                           
						optionally at least 80%, preferably at least 85%, more       	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding to amino acids 214 -	      75 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 124                                                          
						239 of D81166_P6, a fourth amino acid sequence being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						YVYKNS                                                       	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 194 - 259 of 	     125 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 174                                                          
						Q96M35, which also corresponds to amino acids 240 - 305 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P6, and a fifth amino acid sequence being at least    	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     175 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVP 224                                                          
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	         |||||||||||||||||||||||||||||||||||||||             
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL........... 193                                                          
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     225 KRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 274                                                          
						to amino acids 306 - 474 of D81166_P6, wherein said first    	                        |||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence, third amino 	     194 ...............EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 228                                                          
						acid sequence, fourth amino acid sequence and fifth amino    	                  .         .         .                      
						acid sequence are contiguous and in a sequential order.2.An  	     275 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIK                  307                                                          
						isolated polypeptide encoding for a head of D81166_P6,       	         |||||||||||||||||||||||||||||||::                   
						comprising a polypeptide being at least 70%, optionally at   	     229 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSMR                  261                                                          
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						MLEPALATGEELPELTLLTTLLEGPGDKTQ of D81166_P6.3.An isolated    	                                                            
						polypeptide encoding for an edge portion of D81166_P6,       	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to D81166_P6.4.An  	                                                            
						isolated polypeptide encoding for a tail of D81166_P6,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                            
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                                                            
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                                                            
						about 95% homologous to the sequence in D81166_P6.           	                                                            

						Comparison report between D81166_P6 and Q96E63partial WT     	Sequence name: Q96E63                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for D81166_P6, comprising a first amino 	Sequence documentation:                                      
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	                                                            
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	Alignment of: 13884 x Q96E63   ..                            
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                                                            
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	Alignment segment 1/1:                                       
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	                                                            
						VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILE 	                     Quality: 4634.00                      Escore:       0                                               
						SQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI                      	             Matching length:     474                Total length:     474                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						to amino acids 1 - 399 of Q96E63, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						amino acids 1 - 399 of D81166_P6, a bridging amino acid Q    	                        Gaps:       0                        
						corresponding to amino acid 400 of D81166_P6, and a second   	                                                            
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	Alignment:                                                   
						PCQARLAKLDEDEL                                               	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						corresponding to amino acids 401 - 474 of Q96E63, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 401 - 474 of D81166_P6, wherein   	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQ 400                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     351 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 450                                                          
						                                                            	                  .         .                                
						                                                            	     451 PPVSPTPKTPPCQARLAKLDEDEL                           474                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     451 PPVSPTPKTPPCQARLAKLDEDEL                           474                                                          

						Comparison report between D81166_P6 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13884 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	Alignment segment 1/1:                                       
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	                                                            
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                     Quality: 1422.00                      Escore:       0                                               
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	             Matching length:     146                Total length:     146                                               
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VYKNSIKVSCLGLEGNLQGDPCRFALTS                                 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 328 of  	                        Gaps:       0                        
						D81166_P6, and a second amino acid sequence being at least 90	                                                            
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	Alignment:                                                   
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	                  .         .         .         .         .  
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	     329 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 378                                                          
						% homologous to corresponding to amino acids 1 - 146 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8WV84, which also corresponds to amino acids 329 - 474 of   	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						D81166_P6, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     379 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 428                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P6, comprising a polypeptide being at least 70%,      	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .            
						more preferably at least about 90% and most preferably at    	     429 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     474                                                          
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                                                            
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	                                                            
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	                                                            
						VYKNSIKVSCLGLEGNLQGDPCRFALTS                                 	                                                            
						least about 95% homologous to the sequence of D81166_P6.     	                                                            

13898	HMR136_D81166_7_tr0_r1_1_gPRT		Comparison report between D81166_P7 and Q96E63partial WT     	Sequence name: Q96E63                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for D81166_P7, comprising a first amino 	Sequence documentation:                                      
						MKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKL 	                                                            
						LGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVS 	Alignment of: 13898 x Q96E63   ..                            
						CLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNAL 	                                                            
						QSPIEYQRRESQTNSLGRPRGPGVGSPGRI                               	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 190 - 399 of Q96E63, which also corresponds to	                     Quality: 2766.00                      Escore:       0                                               
						amino acids 1 - 210 of D81166_P7, a bridging amino acid Q    	             Matching length:     285                Total length:     285                                               
						corresponding to amino acid 211 of D81166_P7, and a second   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.65                                               
						PCQARLAKLDEDEL                                               	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 401 - 474 of Q96E63, which also 	Alignment:                                                   
						corresponds to amino acids 212 - 285 of D81166_P7, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	       1 MKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGF 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	     190 MKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGF 239                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     240 EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALG 289                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     290 GGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYV 339                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     340 LQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPR 389                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQA 250                                                          
						                                                            	         ||||||||||:|||||||||||||||||||||||||||||||||||||||  
						                                                            	     390 GPGVGSPGRIRLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQA 439                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 LGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL                285                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     440 LGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL                474                                                          

						Comparison report between D81166_P7 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13898 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKL 	Alignment segment 1/1:                                       
						LGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVS 	                                                            
						CLGLEGNLQGDPCRFALTS                                          	                     Quality: 1422.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 139 of  	             Matching length:     146                Total length:     146                                               
						D81166_P7, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	                        Gaps:       0                        
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	                                                            
						% homologous to corresponding to amino acids 1 - 146 of      	Alignment:                                                   
						Q8WV84, which also corresponds to amino acids 140 - 285 of   	                  .         .         .         .         .  
						D81166_P7, wherein said first amino acid sequence and second 	     140 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 189                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						D81166_P7, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     190 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 239                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKL 	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						LGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVS 	                  .         .         .         .            
						CLGLEGNLQGDPCRFALTS                                          	     240 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     285                                                          
						least about 95% homologous to the sequence of D81166_P7.     	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          

13894	HMR136_D81166_8_tr0_r1_1_gPRT		Comparison report between D81166_P8 and Q96M35unique head    	Sequence name: Q96M35                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81166_P8, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 13894 x Q96M35   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MRPPWAGGESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDH 	                                                            
						SKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ         	                     Quality: 2361.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     257                Total length:     283                                               
						1 - 112 of D81166_P8, a second amino acid sequence being at  	 Matching Percent Similarity:   98.83   Matching Percent Identity:   97.67                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	    Total Percent Similarity:   89.75      Total Percent Identity:   88.69                                               
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 	                        Gaps:       1                        
						PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDT 	                                                            
						ADL                                                          	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 11 -   	                  .         .         .         .         .  
						193 of Q96M35, which also corresponds to amino acids 113 -   	     107 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 156                                                          
						295 of D81166_P8, a third amino acid sequence being at least 	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     157 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 206                                                          
						EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding to amino acids 296 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						321 of D81166_P8, a fourth amino acid sequence being at least	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	                  .         .         .         .         .  
						YVYKNS                                                       	     207 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 256                                                          
						90 % homologous to corresponding to amino acids 194 - 259 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q96M35, which also corresponds to amino acids 322 - 387 of   	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						D81166_P8, and a fifth amino acid sequence being at least    	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     257 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVP 306                                                          
						preferably at least 90% and most preferably at least 95%     	         |||||||||||||||||||||||||||||||||||||||             
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL........... 193                                                          
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                  .         .         .         .         .  
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	     307 KRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 356                                                          
						homologous to a polypeptide having the sequence corresponding	                        |||||||||||||||||||||||||||||||||||  
						to amino acids 388 - 556 of D81166_P8, wherein said first    	     194 ...............EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 228                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .                      
						acid sequence, fourth amino acid sequence and fifth amino    	     357 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIK                  389                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         |||||||||||||||||||||||||||||||::                   
						isolated polypeptide encoding for a head of D81166_P8,       	     229 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSMR                  261                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MRPPWAGGESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDH 	                                                            
						SKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ         	                                                            
						about 95% homologous to the sequence of D81166_P8.3.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81166_P8, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to D81166_P8.4.An  	                                                            
						isolated polypeptide encoding for a tail of D81166_P8,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                            
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                                                            
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                                                            
						about 95% homologous to the sequence in D81166_P8.           	                                                            

						Comparison report between D81166_P8 and Q96E63unique head    	Sequence name: Q96E63                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for D81166_P8, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13894 x Q96E63   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MRPPWAGGESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDH 	Alignment segment 1/1:                                       
						SKHCLSVETEADSGQAGPYENW                                       	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 4634.00                      Escore:       0                                               
						1 - 82 of D81166_P8, a second amino acid sequence being at   	             Matching length:     474                Total length:     474                                               
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						RCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGHRLQLND 	                        Gaps:       0                        
						LLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFE 	                                                            
						GKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 	Alignment:                                                   
						VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILE 	                  .         .         .         .         .  
						SQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI                      	      83 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 132                                                          
						least 90 % homologous to corresponding to amino acids 1 - 399	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q96E63, which also corresponds to amino acids 83 - 481 of 	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						D81166_P8, a bridging amino acid Q corresponding to amino    	                  .         .         .         .         .  
						acid 482 of D81166_P8, and a third amino acid sequence being 	     133 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 182                                                          
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PCQARLAKLDEDEL                                               	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						at least 90 % homologous to corresponding to amino acids 401 	                  .         .         .         .         .  
						- 474 of Q96E63, which also corresponds to amino acids 483 - 	     183 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 232                                                          
						556 of D81166_P8, wherein said first amino acid sequence,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, bridging amino acid and third    	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     233 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 282                                                          
						D81166_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MRPPWAGGESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDH 	     283 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 332                                                          
						SKHCLSVETEADSGQAGPYENW                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of D81166_P8.     	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     333 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 382                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     383 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 432                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     433 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQ 482                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     351 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     483 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 532                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 450                                                          
						                                                            	                  .         .                                
						                                                            	     533 PPVSPTPKTPPCQARLAKLDEDEL                           556                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     451 PPVSPTPKTPPCQARLAKLDEDEL                           474                                                          

						Comparison report between D81166_P8 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13894 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MRPPWAGGESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDH 	Alignment segment 1/1:                                       
						SKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLS 	                                                            
						QAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDR 	                     Quality: 1422.00                      Escore:       0                                               
						IVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVS 	             Matching length:     146                Total length:     146                                               
						EFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTS           	                        Gaps:       0                        
						having the sequence corresponding to amino acids 1 - 410 of  	                                                            
						D81166_P8, and a second amino acid sequence being at least 90	Alignment:                                                   
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	                  .         .         .         .         .  
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	     411 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 460                                                          
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 146 of      	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						Q8WV84, which also corresponds to amino acids 411 - 556 of   	                  .         .         .         .         .  
						D81166_P8, wherein said first amino acid sequence and second 	     461 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 510                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						D81166_P8, comprising a polypeptide being at least 70%,      	                  .         .         .         .            
						optionally at least about 80%, preferably at least about 85%,	     511 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     556                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||      
						MRPPWAGGESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDH 	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						SKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLS 	                                                            
						QAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDR 	                                                            
						IVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVS 	                                                            
						EFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVE 	                                                            
						VMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLF 	                                                            
						EQIIIFSEALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTS           	                                                            
						least about 95% homologous to the sequence of D81166_P8.     	                                                            

13896	HMR136_D81166_9_tr0_r1_1_gPRT		Comparison report between D81166_P9 and Q96M35unique head    	Sequence name: Q96M35                                        
						followed by partial WT sequence featuring a skipped exon,    	                                                            
						followed by a unique insertion and a followed by a unique    	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						D81166_P9, comprising a first amino acid sequence being at   	Alignment of: 13896 x Q96M35   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                     Quality: 1951.00                      Escore:       0                                               
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	             Matching length:     227                Total length:     283                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:   98.68   Matching Percent Identity:   97.36                                               
						to amino acids 1 - 175 of D81166_P9, a second amino acid     	    Total Percent Similarity:   79.15      Total Percent Identity:   78.09                                               
						PPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVP 	                        Gaps:       2                        
						ESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKH               	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 11 - 116 of Q96M35, which also corresponds to    	                  .         .         .         .         .  
						amino acids 176 - 281 of D81166_P9, a third amino acid       	     170 PGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 219                                                          
						sequence being at least 90 % homologous to                   	         ||  : ||||||||||||||||||||||||||||||||||||||||||||  
						ELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL corresponding	       5 PGLCSPPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLG 54                                                           
						to amino acids 147 - 193 of Q96M35, which also corresponds to	                  .         .         .         .         .  
						amino acids 282 - 328 of D81166_P9, a fourth amino acid      	     220 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 269                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      55 QIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLK 104                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence EQAVEVMCFVPKRCNDMMTLGRLRGF corresponding 	     270 DPDWLAQLFIKH..............................ELRQQLGH 289                                                          
						to amino acids 329 - 354 of D81166_P9, a fifth amino acid    	         ||||||||||||                              ||||||||  
						EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPG 	     105 DPDWLAQLFIKHERRLHMYVVYCQNKPKSEHVVSEFGDSYFEELRQQLGH 154                                                          
						YVYKNS                                                       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     290 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVP 339                                                          
						amino acids 194 - 259 of Q96M35, which also corresponds to   	         |||||||||||||||||||||||||||||||||||||||             
						amino acids 355 - 420 of D81166_P9, and a sixth amino acid   	     155 RLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADL........... 193                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     340 KRCNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 389                                                          
						most preferably at least 95% homologous to a polypeptide     	                        |||||||||||||||||||||||||||||||||||  
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	     194 ...............EGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERR 228                                                          
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                  .         .         .                      
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	     390 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIK                  422                                                          
						having the sequence corresponding to amino acids 421 - 589 of	         |||||||||||||||||||||||||||||||::                   
						D81166_P9, wherein said first amino acid sequence, second    	     229 VFLFEQIIIFSEALGGGVRGGTQPGYVYKNSMR                  261                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                                                            
						acid sequence, fifth amino acid sequence and sixth amino acid	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of D81166_P9,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQ      	                                                            
						about 95% homologous to the sequence of D81166_P9.3.An       	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						D81166_P9, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise HE, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						281-x to 282; and ending at any of amino acid numbers 282+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						polypeptide encoding for an edge portion of D81166_P9,       	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						EQAVEVMCFVPKRCNDMMTLGRLRGF, corresponding to D81166_P9.5.An  	                                                            
						isolated polypeptide encoding for a tail of D81166_P9,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						IKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDF 	                                                            
						LNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPK 	                                                            
						GEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL            	                                                            
						about 95% homologous to the sequence in D81166_P9.           	                                                            

						Comparison report between D81166_P9 and Q96E63unique head    	Sequence name: Q96E63                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a mismatch.1.An isolated chimeric polypeptide encoding for   	Sequence documentation:                                      
						D81166_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13896 x Q96E63   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENW                                    	                     Quality: 4224.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     444                Total length:     474                                               
						to amino acids 1 - 145 of D81166_P9, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVLS 	    Total Percent Similarity:   93.67      Total Percent Identity:   93.46                                               
						ELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQ 	                        Gaps:       1                        
						RCLKDPDWLAQLFIKH                                             	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 136 of Q96E63, which also corresponds to     	                  .         .         .         .         .  
						amino acids 146 - 281 of D81166_P9, a third amino acid       	     146 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 195                                                          
						ELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CNDMMTLGRLRGFEGKLTAQGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSE 	       1 MLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKK 50                                                           
						ALGGGVRGGTQPGYVYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPA 	                  .         .         .         .         .  
						ISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRI        	     196 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 245                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 167 - 399 of Q96E63, which also corresponds to   	      51 ALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIV 100                                                          
						amino acids 282 - 514 of D81166_P9, a bridging amino acid Q  	                  .         .         .         .         .  
						corresponding to amino acid 515 of D81166_P9, and a fourth   	     246 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKH.............. 281                                                          
						LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDSPPVSPTPKTP 	         ||||||||||||||||||||||||||||||||||||                
						PCQARLAKLDEDEL                                               	     101 FGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHERRLHMYVVYCQNK 150                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 401 - 474 of Q96E63, which also 	     282 ................ELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 315                                                          
						corresponds to amino acids 516 - 589 of D81166_P9, wherein   	                         ||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     151 PKSEHVVSEFGDSYFEELRQQLGHRLQLNDLLIKPVQRIMKYQLLLKDFL 200                                                          
						third amino acid sequence, bridging amino acid and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     316 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 365                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P9, comprising a polypeptide being at least 70%,      	     201 KYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTAQGKLL 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     366 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 415                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	     251 GQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGY 300                                                          
						LDHSKHCLSVETEADSGQAGPYENW                                    	                  .         .         .         .         .  
						least about 95% homologous to the sequence of D81166_P9.3.An 	     416 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 465                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81166_P9, comprising a polypeptide having a length "n",     	     301 VYKNSIKVSCLGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADPAISQA 350                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     466 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIQ 515                                                          
						preferably at least about 30 amino acids in length, more     	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						preferably at least about 40 amino acids in length and most  	     351 WIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRPRGPGVGSPGRIR 400                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise HE, having a structure as  	     516 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 565                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						281-x to 282; and ending at any of amino acid numbers 282+   	     401 LGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPHDS 450                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .                                
						                                                            	     566 PPVSPTPKTPPCQARLAKLDEDEL                           589                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     451 PPVSPTPKTPPCQARLAKLDEDEL                           474                                                          

						Comparison report between D81166_P9 and Q8WV84unique head    	Sequence name: Q8WV84                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81166_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13896 x Q8WV84   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	Alignment segment 1/1:                                       
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEE 	                     Quality: 1422.00                      Escore:       0                                               
						TLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRG 	             Matching length:     146                Total length:     146                                               
						RDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHELRQQLGHRLQLNDLLIKP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNS 	                        Gaps:       0                        
						IKVSCLGLEGNLQGDPCRFALTS                                      	                                                            
						having the sequence corresponding to amino acids 1 - 443 of  	Alignment:                                                   
						D81166_P9, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRRESQTNSLGRP 	     444 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 493                                                          
						RGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEVARALLPLDKQALGDIPQAPH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSPPVSPTPKTPPCQARLAKLDEDEL                                   	       1 RGPEGGIQRYVLQAADPAISQAWIKHVAQILESQRDFLNALQSPIEYQRR 50                                                           
						% homologous to corresponding to amino acids 1 - 146 of      	                  .         .         .         .         .  
						Q8WV84, which also corresponds to amino acids 444 - 589 of   	     494 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 543                                                          
						D81166_P9, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 ESQTNSLGRPRGPGVGSPGRIQLGDQAQGSTHTPINGSLPSLLLSPKGEV 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .            
						D81166_P9, comprising a polypeptide being at least 70%,      	     544 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     589                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||      
						more preferably at least about 90% and most preferably at    	     101 ARALLPLDKQALGDIPQAPHDSPPVSPTPKTPPCQARLAKLDEDEL     146                                                          
						MKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDR 	                                                            
						EHEVLAGALQPESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRW 	                                                            
						LDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEE 	                                                            
						TLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRG 	                                                            
						RDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHELRQQLGHRLQLNDLLIKP 	                                                            
						VQRIMKYQLLLKDFLKYYNRAGMDTADLEQAVEVMCFVPKRCNDMMTLGRLRGFEGKLTA 	                                                            
						QGKLLGQDTFWVTEPEAGGLLSSRGRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNS 	                                                            
						IKVSCLGLEGNLQGDPCRFALTS                                      	                                                            
						least about 95% homologous to the sequence of D81166_P9.     	                                                            

14747	HMR136_D81444_0_tr0_r1_1_gPRT		Comparison report between D81444_P0 and Q96L14unique head    	Sequence name: Q96L14                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81444_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 14747 x Q96L14   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						NKTDEGPDTPSYKRDNSISPESDVDTASTISLVTGETERKSTQKRKSFTSLYKDRCSTGS 	Alignment segment 1/1:                                       
						PSKDVTKSSSSGAREKMEKKTKSRSTDVGSRADGHKFVQSSGRIRQPSVDLTDDDQTSSV 	                                                            
						PHSAISDIMSSDQETYSCKPHGRTPLTSADEHVHSKLEGSKVTKSKTSPVVSGSSSKSTT 	                     Quality: 1684.00                      Escore:       0                                               
						LPRPRPTRTSLLRRARRGEASDSELADADKASVASEVSTTSSTSKPPTGRRNISRIDLLA 	             Matching length:     173                Total length:     173                                               
						QPRRTRLGSLSARSDSEATISRSSASSRTAEAIIRSGARLVPSDKFSPRIRANSISRLSD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SKVKSMTSAHGSASVNSRWRRFPTGYASTSEDEFGSDHNSPKHTRLCTSPALKTTRLQSA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GSAMPTSSSFKHRIKEQEDYIRDWTAHREEIARISQDLALIAREINDVAGEIDSVTSSGT 	                        Gaps:       0                        
						APSTTVSTAATTPGSAIDTREELVDRVFDESLNFQKIPPLVHSKTPEGNNGRSGDPRPQA 	                                                            
						AEPPDHLTITRRRTWSRDEV                                         	Alignment:                                                   
						having the sequence corresponding to amino acids 1 - 500 of  	                  .         .         .         .         .  
						D81444_P0, and a second amino acid sequence being at least 90	     501 MGDNLLLSSVFQFSKKIRQSIDKTAGKIRILFKDKDRNWDDIESKLRAES 550                                                          
						MGDNLLLSSVFQFSKKIRQSIDKTAGKIRILFKDKDRNWDDIESKLRAESEVPIVKTSSM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EISSILQELKRVEKQLQAINAMIDPDGTLEALNNMGFPSAMLPSPPKQKSSPVNNHHSPG 	       1 MGDNLLLSSVFQFSKKIRQSIDKTAGKIRILFKDKDRNWDDIESKLRAES 50                                                           
						QTPTLGQPEARALHPAAVSAAAEFENAESEADFSIHFNRVNPDGEEEDVTVHK        	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 173 of      	     551 EVPIVKTSSMEISSILQELKRVEKQLQAINAMIDPDGTLEALNNMGFPSA 600                                                          
						Q96L14, which also corresponds to amino acids 501 - 673 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D81444_P0, wherein said first amino acid sequence and second 	      51 EVPIVKTSSMEISSILQELKRVEKQLQAINAMIDPDGTLEALNNMGFPSA 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     601 MLPSPPKQKSSPVNNHHSPGQTPTLGQPEARALHPAAVSAAAEFENAESE 650                                                          
						D81444_P0, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 MLPSPPKQKSSPVNNHHSPGQTPTLGQPEARALHPAAVSAAAEFENAESE 150                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						NKTDEGPDTPSYKRDNSISPESDVDTASTISLVTGETERKSTQKRKSFTSLYKDRCSTGS 	     651 ADFSIHFNRVNPDGEEEDVTVHK                            673                                                          
						PSKDVTKSSSSGAREKMEKKTKSRSTDVGSRADGHKFVQSSGRIRQPSVDLTDDDQTSSV 	         |||||||||||||||||||||||                             
						PHSAISDIMSSDQETYSCKPHGRTPLTSADEHVHSKLEGSKVTKSKTSPVVSGSSSKSTT 	     151 ADFSIHFNRVNPDGEEEDVTVHK                            173                                                          
						LPRPRPTRTSLLRRARRGEASDSELADADKASVASEVSTTSSTSKPPTGRRNISRIDLLA 	                                                            
						QPRRTRLGSLSARSDSEATISRSSASSRTAEAIIRSGARLVPSDKFSPRIRANSISRLSD 	                                                            
						SKVKSMTSAHGSASVNSRWRRFPTGYASTSEDEFGSDHNSPKHTRLCTSPALKTTRLQSA 	                                                            
						GSAMPTSSSFKHRIKEQEDYIRDWTAHREEIARISQDLALIAREINDVAGEIDSVTSSGT 	                                                            
						APSTTVSTAATTPGSAIDTREELVDRVFDESLNFQKIPPLVHSKTPEGNNGRSGDPRPQA 	                                                            
						AEPPDHLTITRRRTWSRDEV                                         	                                                            
						least about 95% homologous to the sequence of D81444_P0.     	                                                            

14749	HMR136_D81444_4_tr0_r1_1_gPRT		Comparison report between D81444_P4 and Q96L14unique head    	Sequence name: Q96L14                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81444_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 14749 x Q96L14   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MPTSSSFKHRIKEQEDYIRDWTAHREEIARISQDLALIAREINDVAGEIDSVTSSGTAPS 	Alignment segment 1/1:                                       
						TTVSTAATTPGSAIDTREELVDRVFDESLNFQKIPPLVHSKTPEGNNGRSGDPRPQAAEP 	                                                            
						PDHLTITRRRTWSRDEV                                            	                     Quality: 1684.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 137 of  	             Matching length:     173                Total length:     173                                               
						D81444_P4, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MGDNLLLSSVFQFSKKIRQSIDKTAGKIRILFKDKDRNWDDIESKLRAESEVPIVKTSSM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EISSILQELKRVEKQLQAINAMIDPDGTLEALNNMGFPSAMLPSPPKQKSSPVNNHHSPG 	                        Gaps:       0                        
						QTPTLGQPEARALHPAAVSAAAEFENAESEADFSIHFNRVNPDGEEEDVTVHK        	                                                            
						% homologous to corresponding to amino acids 1 - 173 of      	Alignment:                                                   
						Q96L14, which also corresponds to amino acids 138 - 310 of   	                  .         .         .         .         .  
						D81444_P4, wherein said first amino acid sequence and second 	     138 MGDNLLLSSVFQFSKKIRQSIDKTAGKIRILFKDKDRNWDDIESKLRAES 187                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       1 MGDNLLLSSVFQFSKKIRQSIDKTAGKIRILFKDKDRNWDDIESKLRAES 50                                                           
						D81444_P4, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     188 EVPIVKTSSMEISSILQELKRVEKQLQAINAMIDPDGTLEALNNMGFPSA 237                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPTSSSFKHRIKEQEDYIRDWTAHREEIARISQDLALIAREINDVAGEIDSVTSSGTAPS 	      51 EVPIVKTSSMEISSILQELKRVEKQLQAINAMIDPDGTLEALNNMGFPSA 100                                                          
						TTVSTAATTPGSAIDTREELVDRVFDESLNFQKIPPLVHSKTPEGNNGRSGDPRPQAAEP 	                  .         .         .         .         .  
						PDHLTITRRRTWSRDEV                                            	     238 MLPSPPKQKSSPVNNHHSPGQTPTLGQPEARALHPAAVSAAAEFENAESE 287                                                          
						least about 95% homologous to the sequence of D81444_P4.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MLPSPPKQKSSPVNNHHSPGQTPTLGQPEARALHPAAVSAAAEFENAESE 150                                                          
						                                                            	                  .         .                                
						                                                            	     288 ADFSIHFNRVNPDGEEEDVTVHK                            310                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     151 ADFSIHFNRVNPDGEEEDVTVHK                            173                                                          

14905	HMR136_D81449_8_tr0_r1_1_gPRT		Comparison report between D81449_P8 and XPF_HUMANunique head 	Sequence name: XPF_HUMAN                                     
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for D81449_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 14905 x XPF_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLFFQPKSSVLTC corresponding to amino     	Alignment segment 1/1:                                       
						acids 1 - 13 of D81449_P8, and a second amino acid sequence  	                                                            
						RVYFLIYGGSTEEQRYLTALRKEKEAFEKLIREKASMVVPEEREGRDETNLDLVRGTASA 	                     Quality: 3023.00                      Escore:       0                                               
						DVSTDTRKAGGQEQNGTQQSIVVDMREFRSELPSLIHRRGIDIEPVTLEVGDYILTPEMC 	             Matching length:     313                Total length:     313                                               
						VERKSISDLIGSLNNGRLYSQCISMSRYYKRPVLLIEFDPSKPFSLTSRGALFQEISSND 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISSKLTLLTLHFPRLRILWCPSPHATAELFEELKQSKPQPDAATALAITADSETLPESEK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						YNPGPQDFLLKMPGVNAKNCRSLMHHVKNIAELAALSQDELTSILGNAANAKQLYDFIHT 	                        Gaps:       0                        
						SFAEVVSKGKGKK                                                	                                                            
						being at least 90 % homologous to corresponding to amino     	Alignment:                                                   
						acids 593 - 905 of XPF_HUMAN, which also corresponds to amino	                  .         .         .         .         .  
						acids 14 - 326 of D81449_P8, wherein said first amino acid   	      14 RVYFLIYGGSTEEQRYLTALRKEKEAFEKLIREKASMVVPEEREGRDETN 63                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     593 RVYFLIYGGSTEEQRYLTALRKEKEAFEKLIREKASMVVPEEREGRDETN 642                                                          
						head of D81449_P8, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      64 LDLVRGTASADVSTDTRKAGGQEQNGTQQSIVVDMREFRSELPSLIHRRG 113                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence MLFFQPKSSVLTC  	     643 LDLVRGTASADVSTDTRKAGGQEQNGTQQSIVVDMREFRSELPSLIHRRG 692                                                          
						of D81449_P8.                                                	                  .         .         .         .         .  
						                                                            	     114 IDIEPVTLEVGDYILTPEMCVERKSISDLIGSLNNGRLYSQCISMSRYYK 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     693 IDIEPVTLEVGDYILTPEMCVERKSISDLIGSLNNGRLYSQCISMSRYYK 742                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 RPVLLIEFDPSKPFSLTSRGALFQEISSNDISSKLTLLTLHFPRLRILWC 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     743 RPVLLIEFDPSKPFSLTSRGALFQEISSNDISSKLTLLTLHFPRLRILWC 792                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 PSPHATAELFEELKQSKPQPDAATALAITADSETLPESEKYNPGPQDFLL 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     793 PSPHATAELFEELKQSKPQPDAATALAITADSETLPESEKYNPGPQDFLL 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 KMPGVNAKNCRSLMHHVKNIAELAALSQDELTSILGNAANAKQLYDFIHT 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 KMPGVNAKNCRSLMHHVKNIAELAALSQDELTSILGNAANAKQLYDFIHT 892                                                          
						                                                            	                  .                                          
						                                                            	     314 SFAEVVSKGKGKK                                      326                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     893 SFAEVVSKGKGKK                                      905                                                          

15423	HMR136_D81586_11_tr0_r1_1_gPRT		Comparison report between D81586_P11 and Q9NP82unique head   	Sequence name: Q9NP82                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						D81586_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15423 x Q9NP82   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MQISPADSGSSAPSASGRARAPQTPRARSSGPAA corresponding to amino    	                                                            
						acids 1 - 34 of D81586_P11, a second amino acid sequence     	                     Quality: 1888.00                      Escore:       0                                               
						MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADK 	             Matching length:     201                Total length:     211                                               
						VASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTSPLLKYHHCVGEKYRWVEQHL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GPQFVERIILTRDKTVVLGDLLIDDKDTVR                               	    Total Percent Similarity:   95.26      Total Percent Identity:   95.26                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       1                        
						acids 1 - 150 of Q9NP82, which also corresponds to amino     	                                                            
						acids 35 - 184 of D81586_P11, a third amino acid sequence    	Alignment:                                                   
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	      35 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 84                                                           
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGSALSFTVL corresponding to amino acids 185 - 194 of         	       1 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 50                                                           
						D81586_P11, and a fourth amino acid sequence being at least  	                  .         .         .         .         .  
						90 % homologous to                                           	      85 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 134                                                          
						GQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREILDSKRGAAQRE          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 151 - 201 of Q9NP82, which also 	      51 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 100                                                          
						corresponds to amino acids 195 - 245 of D81586_P11, wherein  	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     135 PLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVR 184                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 PLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVR 150                                                          
						polypeptide encoding for a head of D81586_P11, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     185 DGSALSFTVLGQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREI 234                                                          
						80%, preferably at least about 85%, more preferably at least 	                   ||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 ..........GQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREI 190                                                          
						to the sequence MQISPADSGSSAPSASGRARAPQTPRARSSGPAA of        	                  .                                          
						D81586_P11.3.An isolated polypeptide encoding for an edge    	     235 LDSKRGAAQRE                                        245                                                          
						portion of D81586_P11, comprising an amino acid sequence     	         |||||||||||                                         
						being at least 70%, optionally at least about 80%, preferably	     191 LDSKRGAAQRE                                        201                                                          
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for DGSALSFTVL, corresponding to D81586_P11.        	                                                            

						Comparison report between D81586_P11 and Q9BUL3unique head   	Sequence name: Q9BUL3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81586_P11, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 15423 x Q9BUL3   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						MQISPADSGSSAPSASGRARAPQTPRARSSGPAA corresponding to amino    	                     Quality: 1589.00                      Escore:       0                                               
						acids 1 - 34 of D81586_P11, a second amino acid sequence     	             Matching length:     171                Total length:     181                                               
						MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTSPLLKYHHCVGEKYRWVEQHL 	    Total Percent Similarity:   94.48      Total Percent Identity:   94.48                                               
						GPQFVERIILTRDKTVVLGDLLIDDKDTVR                               	                        Gaps:       1                        
						being at least 90 % homologous to corresponding to amino     	                                                            
						acids 1 - 150 of Q9BUL3, which also corresponds to amino     	Alignment:                                                   
						acids 35 - 184 of D81586_P11, a third amino acid sequence    	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	      35 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 84                                                           
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	       1 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 50                                                           
						DGSALSFTVL corresponding to amino acids 185 - 194 of         	                  .         .         .         .         .  
						D81586_P11, a fourth amino acid sequence being at least 90 % 	      85 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 134                                                          
						homologous to GQEETPSWEHILFTCCHNRHL corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 151 - 171 of Q9BUL3, which also corresponds to amino   	      51 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 100                                                          
						acids 195 - 215 of D81586_P11, and a fifth amino acid        	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     135 PLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVR 184                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     101 PLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVR 150                                                          
						having the sequence VLPPTRRRLLSWSDNWREILDSKRGAAQRE           	                  .         .         .                      
						corresponding to amino acids 216 - 245 of D81586_P11, wherein	     185 DGSALSFTVLGQEETPSWEHILFTCCHNRHL                    215                                                          
						said first amino acid sequence, second amino acid sequence,  	                   |||||||||||||||||||||                     
						third amino acid sequence, fourth amino acid sequence and    	     151 ..........GQEETPSWEHILFTCCHNRHL                    171                                                          
						fifth amino acid sequence are contiguous and in a sequential 	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						D81586_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						MQISPADSGSSAPSASGRARAPQTPRARSSGPAA of D81586_P11.3.An        	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81586_P11, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						DGSALSFTVL, corresponding to D81586_P11.4.An isolated        	                                                            
						polypeptide encoding for a tail of D81586_P11, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VLPPTRRRLLSWSDNWREILDSKRGAAQRE in D81586_P11.	                                                            

						Comparison report between D81586_P11 and Q96HS6unique head   	Sequence name: Q96HS6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for D81586_P11, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 15423 x Q96HS6   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						MQISPADSGSSAPSASGRARAPQTPRARSSGPAA corresponding to amino    	                     Quality:  915.00                      Escore:       0                                               
						acids 1 - 34 of D81586_P11, a second amino acid sequence     	             Matching length:     104                Total length:     112                                               
						MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VASVYEAPGFFLDLEPIPGALDAVREMNDLPD                             	    Total Percent Similarity:   92.86      Total Percent Identity:   92.86                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       1                        
						acids 1 - 92 of Q96HS6, which also corresponds to amino acids	                                                            
						35 - 126 of D81586_P11, a third amino acid sequence being at 	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      35 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 84                                                           
						homologous to a polypeptide having the sequence TQVFICTS     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 127 - 134 of D81586_P11, a      	       1 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 50                                                           
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						PLLKYHHCVGEK corresponding to amino acids 93 - 104 of Q96HS6,	      85 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 134                                                          
						which also corresponds to amino acids 135 - 146 of           	         ||||||||||||||||||||||||||||||||||||||||||          
						D81586_P11, and a fifth amino acid sequence being at least   	      51 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPD........ 92                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .                                          
						preferably at least 90% and most preferably at least 95%     	     135 PLLKYHHCVGEK                                       146                                                          
						YRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVRDGSALSFTVLGQEETPSWEHIL 	         ||||||||||||                                        
						FTCCHNRHLVLPPTRRRLLSWSDNWREILDSKRGAAQRE                      	      93 PLLKYHHCVGEK                                       104                                                          
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 147 - 245 of D81586_P11, wherein said first   	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence, fourth amino acid sequence and fifth amino    	                                                            
						acid sequence are contiguous and in a sequential order.2.An  	                                                            
						isolated polypeptide encoding for a head of D81586_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						MQISPADSGSSAPSASGRARAPQTPRARSSGPAA of D81586_P11.3.An        	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81586_P11, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						TQVFICTS, corresponding to D81586_P11.4.An isolated          	                                                            
						polypeptide encoding for a tail of D81586_P11, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						YRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVRDGSALSFTVLGQEETPSWEHIL 	                                                            
						FTCCHNRHLVLPPTRRRLLSWSDNWREILDSKRGAAQRE                      	                                                            
						to the sequence in D81586_P11.                               	                                                            

						Comparison report between D81586_P11 and Q8TCD5unique head   	Sequence name: Q8TCD5                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique insertion.1.An isolated chimeric polypeptide        	Sequence documentation:                                      
						encoding for D81586_P11, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 15423 x Q8TCD5   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MQISPADSGSSAPSASGRARAPQTPRARSSGPAA       	                                                            
						corresponding to amino acids 1 - 34 of D81586_P11, a second  	                     Quality: 1869.00                      Escore:       0                                               
						MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADK 	             Matching length:     201                Total length:     211                                               
						VASVYEA                                                      	 Matching Percent Similarity:   99.50   Matching Percent Identity:   99.50                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   94.79      Total Percent Identity:   94.79                                               
						corresponding to amino acids 1 - 67 of Q8TCD5, which also    	                        Gaps:       1                        
						corresponds to amino acids 35 - 101 of D81586_P11, a bridging	                                                            
						amino acid P corresponding to amino acid 102 of D81586_P11, a	Alignment:                                                   
						GFFLDLEPIPGALDAVREMNDLPDTQVFICTSPLLKYHHCVGEKYRWVEQHLGPQFVERI 	                  .         .         .         .         .  
						ILTRDKTVVLGDLLIDDKDTVR                                       	      35 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 84                                                           
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 69 - 150 of Q8TCD5, which also  	       1 MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY 50                                                           
						corresponds to amino acids 103 - 184 of D81586_P11, a fourth 	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	      85 RALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 134                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	      51 RALRPDLADKVASVYEALGFFLDLEPIPGALDAVREMNDLPDTQVFICTS 100                                                          
						having the sequence DGSALSFTVL corresponding to amino acids  	                  .         .         .         .         .  
						185 - 194 of D81586_P11, and a fifth amino acid sequence     	     135 PLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVR 184                                                          
						being at least 90 % homologous to                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREILDSKRGAAQRE          	     101 PLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVR 150                                                          
						corresponding to amino acids 151 - 201 of Q8TCD5, which also 	                  .         .         .         .         .  
						corresponds to amino acids 195 - 245 of D81586_P11, wherein  	     185 DGSALSFTVLGQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREI 234                                                          
						said first amino acid sequence, second amino acid sequence,  	                   ||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid, third amino acid sequence, fourth amino 	     151 ..........GQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREI 190                                                          
						acid sequence and fifth amino acid sequence are contiguous   	                  .                                          
						and in a sequential order.2.An isolated polypeptide encoding 	     235 LDSKRGAAQRE                                        245                                                          
						for a head of D81586_P11, comprising a polypeptide being at  	         |||||||||||                                         
						least 70%, optionally at least about 80%, preferably at least	     191 LDSKRGAAQRE                                        201                                                          
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						MQISPADSGSSAPSASGRARAPQTPRARSSGPAA of D81586_P11.3.An        	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						D81586_P11, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						DGSALSFTVL, corresponding to D81586_P11.                     	                                                            

17963	HMR136_F00201_1_tr0_r1_1_gPRT		Comparison report between F00201_P1 and CAQ1_HUMANunique     	Sequence name: CAQ1_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F00201_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17963 x CAQ1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MSATDR       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 6 of F00201_P1, a second    	                                                            
						MGPRAVPGLRLALLLLLVLGTPKSGVQGQEGLDFPEYDGVDRVINVNAKNYKNVFKKYEV 	                     Quality: 3119.00                      Escore:       0                                               
						LALLYHEPPEDDKASQRQFEMEELILE                                  	             Matching length:     328                Total length:     390                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 87 of CAQ1_HUMAN, which also	    Total Percent Similarity:   84.10      Total Percent Identity:   84.10                                               
						corresponds to amino acids 7 - 93 of F00201_P1, and a third  	                        Gaps:       1                        
						VLEDPVELIEGERELQAFENIEDEIKLIGYFKSKDSEHYKAFEDAAEEFHPYIPFFATFD 	                                                            
						SKVAKKLTLKLNEIDFYEAFMEEPVTIPDKPNSEEEIVNFVEEHRRSTLRKLKPESMYET 	Alignment:                                                   
						WEDDMDGIHIVAFAEEADPDGFEFLETLKAVAQDNTENPDLSIIWIDPDDFPLLVPYWEK 	                  .         .         .         .         .  
						TFDIDLSAPQIGVVNVTDADSVWMEMDDEEDLPSAEELEDWLEDVLEGEINTEDDDDDDD 	       7 MGPRAVPGLRLALLLLLVLGTPKSGVQGQEGLDFPEYDGVDRVINVNAKN 56                                                           
						D                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MGPRAVPGLRLALLLLLVLGTPKSGVQGQEGLDFPEYDGVDRVINVNAKN 50                                                           
						corresponding to amino acids 150 - 390 of CAQ1_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 94 - 334 of F00201_P1,       	      57 YKNVFKKYEVLALLYHEPPEDDKASQRQFEMEELILE............. 93                                                           
						wherein said first amino acid sequence, second amino acid    	         |||||||||||||||||||||||||||||||||||||               
						sequence and third amino acid sequence are contiguous and in 	      51 YKNVFKKYEVLALLYHEPPEDDKASQRQFEMEELILELAAQVLEDKGVGF 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of F00201_P1, comprising a polypeptide being at least   	      94 .................................................V 94                                                           
						70%, optionally at least about 80%, preferably at least about	                                                          |  
						85%, more preferably at least about 90% and most preferably  	     101 GLVDSEKDAAVAKKLGLTEVDSMYVFKGDEVIEYDGEFSADTIVEFLLDV 150                                                          
						at least about 95% homologous to the sequence MSATDR of      	                  .         .         .         .         .  
						F00201_P1.3.An isolated chimeric polypeptide encoding for an 	      95 LEDPVELIEGERELQAFENIEDEIKLIGYFKSKDSEHYKAFEDAAEEFHP 144                                                          
						edge portion of F00201_P1, comprising a polypeptide having a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     151 LEDPVELIEGERELQAFENIEDEIKLIGYFKSKDSEHYKAFEDAAEEFHP 200                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     145 YIPFFATFDSKVAKKLTLKLNEIDFYEAFMEEPVTIPDKPNSEEEIVNFV 194                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     201 YIPFFATFDSKVAKKLTLKLNEIDFYEAFMEEPVTIPDKPNSEEEIVNFV 250                                                          
						at least two amino acids comprise EV, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     195 EEHRRSTLRKLKPESMYETWEDDMDGIHIVAFAEEADPDGFEFLETLKAV 244                                                          
						93-x to 94; and ending at any of amino acid numbers 94+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     251 EEHRRSTLRKLKPESMYETWEDDMDGIHIVAFAEEADPDGFEFLETLKAV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     245 AQDNTENPDLSIIWIDPDDFPLLVPYWEKTFDIDLSAPQIGVVNVTDADS 294                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AQDNTENPDLSIIWIDPDDFPLLVPYWEKTFDIDLSAPQIGVVNVTDADS 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     295 VWMEMDDEEDLPSAEELEDWLEDVLEGEINTEDDDDDDDD           334                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     351 VWMEMDDEEDLPSAEELEDWLEDVLEGEINTEDDDDDDDD           390                                                          

18218	HMR136_F00220_2_tr0_r1_1_gPRT		Comparison report between F00220_P2 and MO25_HUMANpartial WT 	Sequence name: MO25_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F00220_P2, comprising a first amino acid        	                                                            
						MLRECIRHEPLAKIILWSEQFYDFFRYVEMSTFDIASDAFATFKDLLTRHKLLSAEFLEQ 	Alignment of: 18218 x MO25_HUMAN   ..                        
						HYDRFFSEYEKLLHSENYVTKRQSLKLLGELLLDRHNFTIMTKYISKPENLKLMMNLLRD 	                                                            
						KSRNIQFEAFHVFKVFVANPNKTQPILDILLKNQAKLIEFLSKFQNDRTEDEQFNDEKTY 	Alignment segment 1/1:                                       
						LVKQIRDLKRPAQQEA                                             	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1933.00                      Escore:       0                                               
						amino acids 146 - 341 of MO25_HUMAN, which also corresponds  	             Matching length:     196                Total length:     196                                               
						to amino acids 1 - 196 of F00220_P2.                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLRECIRHEPLAKIILWSEQFYDFFRYVEMSTFDIASDAFATFKDLLTRH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     146 MLRECIRHEPLAKIILWSEQFYDFFRYVEMSTFDIASDAFATFKDLLTRH 195                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KLLSAEFLEQHYDRFFSEYEKLLHSENYVTKRQSLKLLGELLLDRHNFTI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     196 KLLSAEFLEQHYDRFFSEYEKLLHSENYVTKRQSLKLLGELLLDRHNFTI 245                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MTKYISKPENLKLMMNLLRDKSRNIQFEAFHVFKVFVANPNKTQPILDIL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     246 MTKYISKPENLKLMMNLLRDKSRNIQFEAFHVFKVFVANPNKTQPILDIL 295                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 LKNQAKLIEFLSKFQNDRTEDEQFNDEKTYLVKQIRDLKRPAQQEA     196                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     296 LKNQAKLIEFLSKFQNDRTEDEQFNDEKTYLVKQIRDLKRPAQQEA     341                                                          

19092	HMR136_F00379_5_tr0_r1_1_gPRT		Comparison report between F00379_P5 and CAH3_HUMAN_V2unique  	Sequence name: CAH3_HUMAN_V2                                 
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F00379_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19092 x CAH3_HUMAN_V2   ..                     
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MDCFKATYKHQLST corresponding to amino acids 1 - 14 of        	                                                            
						F00379_P5, a second amino acid sequence being at least 90 %  	                     Quality: 2115.00                      Escore:       0                                               
						GPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILNNGKTCRVVFD 	             Matching length:     218                Total length:     249                                               
						DTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDGVKYAAE               	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to corresponding to amino acids 12 - 117 of       	    Total Percent Similarity:   87.55      Total Percent Identity:   87.55                                               
						CAH3_HUMAN_V2, which also corresponds to amino acids 15 - 120	                        Gaps:       1                        
						of F00379_P5, and a third amino acid sequence being at least 	                                                            
						IGHENGEFQIFLDALDKIKTKGKEAPFTKFDPSCLFPACRDYWTYQGSFTTPPCEECIVW 	Alignment:                                                   
						LLLKEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK         	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 149 - 260 of 	      15 GPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILN 64                                                           
						CAH3_HUMAN_V2, which also corresponds to amino acids 121 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						232 of F00379_P5, wherein said first amino acid sequence,    	      12 GPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILN 61                                                           
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      65 NGKTCRVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDG 114                                                          
						polypeptide encoding for a head of F00379_P5, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	      62 NGKTCRVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDG 111                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     115 VKYAAE...............................IGHENGEFQIFLD 133                                                          
						to the sequence MDCFKATYKHQLST of F00379_P5.3.An isolated    	         ||||||                               |||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     112 VKYAAELHLVHWNPKYNTFKEALKQRDGIAVIGIFLKIGHENGEFQIFLD 161                                                          
						F00379_P5, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     134 ALDKIKTKGKEAPFTKFDPSCLFPACRDYWTYQGSFTTPPCEECIVWLLL 183                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     162 ALDKIKTKGKEAPFTKFDPSCLFPACRDYWTYQGSFTTPPCEECIVWLLL 211                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .            
						preferably at least about 50 amino acids in length, wherein  	     184 KEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK  232                                                          
						at least two amino acids comprise EI, having a structure as  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						follows: a sequence starting from any of amino acid numbers  	     212 KEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK  260                                                          
						120-x to 121; and ending at any of amino acid numbers 121+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

19090	HMR136_F00379_8_tr0_r1_1_gPRT		Comparison report between F00379_P8 and CAH3_HUMAN_V2unique  	Sequence name: CAH3_HUMAN_V2                                 
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F00379_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19090 x CAH3_HUMAN_V2   ..                     
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MDCFKATYKHQLST corresponding to amino acids 1 - 14 of        	                                                            
						F00379_P8, a second amino acid sequence being at least 90 %  	                     Quality:  938.00                      Escore:       0                                               
						GPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILNNGKTCRVVFD 	             Matching length:      93                Total length:      93                                               
						DTYDRSMLRGGPLPGPYRLRQFHLHWGSSDD                              	 Matching Percent Similarity:   98.92   Matching Percent Identity:   98.92                                               
						homologous to corresponding to amino acids 12 - 102 of       	    Total Percent Similarity:   98.92      Total Percent Identity:   98.92                                               
						CAH3_HUMAN_V2, which also corresponds to amino acids 15 - 105	                        Gaps:       0                        
						of F00379_P8, and a third amino acid sequence being at least 	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      15 GPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILN 64                                                           
						PGLIHHAALRGMHCVAAAEGAHDREL corresponding to amino acids 106 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						131 of F00379_P8, wherein said first amino acid sequence,    	      12 GPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILN 61                                                           
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .            
						contiguous and in a sequential order.2.An isolated           	      65 NGKTCRVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDPG        107                                                          
						polypeptide encoding for a head of F00379_P8, comprising a   	         ||||||||||||||||||||||||||||||||||||||||| |         
						polypeptide being at least 70%, optionally at least about    	      62 NGKTCRVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHG        104                                                          
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MDCFKATYKHQLST of F00379_P8.3.An isolated    	                                                            
						polypeptide encoding for a tail of F00379_P8, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence PGLIHHAALRGMHCVAAAEGAHDREL in F00379_P8.     	                                                            

19193	HMR136_F00388_10_tr0_r1_1_gPRT		Comparison report between F00388_P10 and Q9H6S8unique head   	Sequence name: Q9H6S8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F00388_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19193 x Q9H6S8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDPGSRWRNLPSGPSLKHLTDPSYGIPREQQKAALQELTRAHVESFNYAVHEGLGLAVQA 	Alignment segment 1/1:                                       
						IPPFEFAFKDERISFTILDAVISPPTVPKGTICKEANVYPAECRGRRSTYRGKLTADINW 	                                                            
						AVNGISKGIIKQFLGYVPIMVKSKLCNLRNLPPQALIEHHEEAEEMGGYFIINGIEKVIR 	                     Quality: 3486.00                      Escore:       0                                               
						MLIMPRRNFPIAMIRPKWKTRGPGYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIY 	             Matching length:     353                Total length:     353                                               
						RKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQMLRIVMEEGCSTQKQV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LNYLGECFRVKLNVPDWYPNEQAAEFLFNQCICIHLKSNTEKFYMLCLMTRKLFALAKGE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						CMEDNPDSLVNQEVLTPGQLFLMFLKEKLEGWLVSIKIAFDKKAQKTSVSMNTDNLMRIF 	                        Gaps:       0                        
						TMGIDLTKPFEYLFATGNLRSKTGLGLLQDSGLCVVADKLNFIRYLSHFRCVHRGADFAK 	                                                            
						MRTTTVRRLLPESWGFLCPVHTPDGEPCGLMNHLTAVCEVVTQFVYTASIPALLCNLGVT 	Alignment:                                                   
						PIDGAPHRSYSECYPVLLDGVMVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPM 	                  .         .         .         .         .  
						TGKPSLYPGLFLFTTPCRLVRPVQNLALGKEELIGTME                       	     639 QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERG 688                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 638 of F00388_P10, a second amino acid    	      77 QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERG 126                                                          
						QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERGFAHGSVYKSE 	                  .         .         .         .         .  
						FIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGAKLQYGDPYYSYLNLNTGESF 	     689 FAHGSVYKSEFIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGA 738                                                          
						VMYYKSKENCVVDNIKVCSNDTGSGKFKCVCITMRVPRNPTIGDKFASRHGQKGILSRLW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PAEDMPFTESGMVPDILFNPHGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENS 	     127 FAHGSVYKSEFIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGA 176                                                          
						ALEYFGEMLKAAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 	                  .         .         .         .         .  
						RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVAHVC        	     739 KLQYGDPYYSYLNLNTGESFVMYYKSKENCVVDNIKVCSNDTGSGKFKCV 788                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 77 - 429 of Q9H6S8, which also corresponds to    	     177 KLQYGDPYYSYLNLNTGESFVMYYKSKENCVVDNIKVCSNDTGSGKFKCV 226                                                          
						amino acids 639 - 991 of F00388_P10, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     789 CITMRVPRNPTIGDKFASRHGQKGILSRLWPAEDMPFTESGMVPDILFNP 838                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     227 CITMRVPRNPTIGDKFASRHGQKGILSRLWPAEDMPFTESGMVPDILFNP 276                                                          
						VKCGSLLSPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVSVPYVFRYFVAELAAMNIKV 	                  .         .         .         .         .  
						KLDVV                                                        	     839 HGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENSALEYFGEMLK 888                                                          
						having the sequence corresponding to amino acids 992 - 1056  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F00388_P10, wherein said first amino acid sequence, second	     277 HGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENSALEYFGEMLK 326                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     889 AAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 938                                                          
						polypeptide encoding for a head of F00388_P10, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     327 AAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 376                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     939 RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVA 988                                                          
						MDPGSRWRNLPSGPSLKHLTDPSYGIPREQQKAALQELTRAHVESFNYAVHEGLGLAVQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IPPFEFAFKDERISFTILDAVISPPTVPKGTICKEANVYPAECRGRRSTYRGKLTADINW 	     377 RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVA 426                                                          
						AVNGISKGIIKQFLGYVPIMVKSKLCNLRNLPPQALIEHHEEAEEMGGYFIINGIEKVIR 	                                                             
						MLIMPRRNFPIAMIRPKWKTRGPGYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIY 	     989 HVC                                                991                                                          
						RKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQMLRIVMEEGCSTQKQV 	         |||                                                 
						LNYLGECFRVKLNVPDWYPNEQAAEFLFNQCICIHLKSNTEKFYMLCLMTRKLFALAKGE 	     427 HVC                                                429                                                          
						CMEDNPDSLVNQEVLTPGQLFLMFLKEKLEGWLVSIKIAFDKKAQKTSVSMNTDNLMRIF 	                                                            
						TMGIDLTKPFEYLFATGNLRSKTGLGLLQDSGLCVVADKLNFIRYLSHFRCVHRGADFAK 	                                                            
						MRTTTVRRLLPESWGFLCPVHTPDGEPCGLMNHLTAVCEVVTQFVYTASIPALLCNLGVT 	                                                            
						PIDGAPHRSYSECYPVLLDGVMVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPM 	                                                            
						TGKPSLYPGLFLFTTPCRLVRPVQNLALGKEELIGTME                       	                                                            
						to the sequence of F00388_P10.3.An isolated polypeptide      	                                                            
						encoding for a tail of F00388_P10, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						VKCGSLLSPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVSVPYVFRYFVAELAAMNIKV 	                                                            
						KLDVV                                                        	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F00388_P10.                                               	                                                            

						Comparison report between F00388_P10 and Q9BSR4unique head   	Sequence name: Q9BSR4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F00388_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 19193 x Q9BSR4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MDPGSRWRNLPSGPSLKHLTDPSYGIPREQQKAALQELTRAHVESFNYAVHEGLGLAVQA 	Alignment segment 1/1:                                       
						IPPFEFAFKDERISFTILDAVISPPTVPKGTICKEANVYPAECRGRRSTYRGKLTADINW 	                                                            
						AVNGISKGIIKQFLGYVPIMVKSKLCNLRNLPPQALIEHHEEAEEMGGYFIINGIEKVIR 	                     Quality: 4127.00                      Escore:       0                                               
						MLIMPRRNFPIAMIRPKWKTRGPGYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIY 	             Matching length:     418                Total length:     418                                               
						RKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQMLRIVMEEGCSTQKQV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LNYLGECFRVKLNVPDWYPNEQAAEFLFNQCICIHLKSNTEKFYMLCLMTRKLFALAKGE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						CMEDNPDSLVNQEVLTPGQLFLMFLKEKLEGWLVSIKIAFDKKAQKTSVSMNTDNLMRIF 	                        Gaps:       0                        
						TMGIDLTKPFEYLFATGNLRSKTGLGLLQDSGLCVVADKLNFIRYLSHFRCVHRGADFAK 	                                                            
						MRTTTVRRLLPESWGFLCPVHTPDGEPCGLMNHLTAVCEVVTQFVYTASIPALLCNLGVT 	Alignment:                                                   
						PIDGAPHRSYSECYPVLLDGVMVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPM 	                  .         .         .         .         .  
						TGKPSLYPGLFLFTTPCRLVRPVQNLALGKEELIGTME                       	     639 QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERG 688                                                          
						having the sequence corresponding to amino acids 1 - 638 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F00388_P10, and a second amino acid sequence being at least  	      77 QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERG 126                                                          
						QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERGFAHGSVYKSE 	                  .         .         .         .         .  
						FIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGAKLQYGDPYYSYLNLNTGESF 	     689 FAHGSVYKSEFIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGA 738                                                          
						VMYYKSKENCVVDNIKVCSNDTGSGKFKCVCITMRVPRNPTIGDKFASRHGQKGILSRLW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PAEDMPFTESGMVPDILFNPHGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENS 	     127 FAHGSVYKSEFIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGA 176                                                          
						ALEYFGEMLKAAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 	                  .         .         .         .         .  
						RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVAHVCVKCGSLL 	     739 KLQYGDPYYSYLNLNTGESFVMYYKSKENCVVDNIKVCSNDTGSGKFKCV 788                                                          
						SPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVSVPYVFRYFVAELAAMNIKVKLDVV   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 77 - 494 of  	     177 KLQYGDPYYSYLNLNTGESFVMYYKSKENCVVDNIKVCSNDTGSGKFKCV 226                                                          
						Q9BSR4, which also corresponds to amino acids 639 - 1056 of  	                  .         .         .         .         .  
						F00388_P10, wherein said first amino acid sequence and second	     789 CITMRVPRNPTIGDKFASRHGQKGILSRLWPAEDMPFTESGMVPDILFNP 838                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     227 CITMRVPRNPTIGDKFASRHGQKGILSRLWPAEDMPFTESGMVPDILFNP 276                                                          
						F00388_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     839 HGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENSALEYFGEMLK 888                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDPGSRWRNLPSGPSLKHLTDPSYGIPREQQKAALQELTRAHVESFNYAVHEGLGLAVQA 	     277 HGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENSALEYFGEMLK 326                                                          
						IPPFEFAFKDERISFTILDAVISPPTVPKGTICKEANVYPAECRGRRSTYRGKLTADINW 	                  .         .         .         .         .  
						AVNGISKGIIKQFLGYVPIMVKSKLCNLRNLPPQALIEHHEEAEEMGGYFIINGIEKVIR 	     889 AAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 938                                                          
						MLIMPRRNFPIAMIRPKWKTRGPGYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQMLRIVMEEGCSTQKQV 	     327 AAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 376                                                          
						LNYLGECFRVKLNVPDWYPNEQAAEFLFNQCICIHLKSNTEKFYMLCLMTRKLFALAKGE 	                  .         .         .         .         .  
						CMEDNPDSLVNQEVLTPGQLFLMFLKEKLEGWLVSIKIAFDKKAQKTSVSMNTDNLMRIF 	     939 RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVA 988                                                          
						TMGIDLTKPFEYLFATGNLRSKTGLGLLQDSGLCVVADKLNFIRYLSHFRCVHRGADFAK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MRTTTVRRLLPESWGFLCPVHTPDGEPCGLMNHLTAVCEVVTQFVYTASIPALLCNLGVT 	     377 RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVA 426                                                          
						PIDGAPHRSYSECYPVLLDGVMVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPM 	                  .         .         .         .         .  
						TGKPSLYPGLFLFTTPCRLVRPVQNLALGKEELIGTME                       	     989 HVCVKCGSLLSPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVSVPYVFR 1038                                                         
						least about 95% homologous to the sequence of F00388_P10.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     427 HVCVKCGSLLSPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVSVPYVFR 476                                                          
						                                                            	                  .                                          
						                                                            	    1039 YFVAELAAMNIKVKLDVV                                 1056                                                         
						                                                            	         ||||||||||||||||||                                  
						                                                            	     477 YFVAELAAMNIKVKLDVV                                 494                                                          

						Comparison report between F00388_P10 and AAH04882unique head 	Sequence name: AAH04882                                      
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F00388_P10,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 19193 x AAH04882   ..                          
						preferably at least 90% and most preferably at least 95%     	                                                            
						MDPGSRWRNLPSGPSLKHLTDPSYGIPREQQKAALQELTRAHVESFNYAVHEGLGLAVQA 	Alignment segment 1/1:                                       
						IPPFEFAFKDERISFTILDAVISPPTVPKGTICKEANVYPAECRGRRSTYRGKLTADINW 	                                                            
						AVNGISKGIIKQFLGYVPIMVKSKLCNLRNLPPQALIEHHEEAEEMGGYFIINGIEKVIR 	                     Quality: 4787.00                      Escore:       0                                               
						MLIMPRRNFPIAMIRPKWKTRGPGYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIY 	             Matching length:     495                Total length:     574                                               
						RKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQMLRIVMEEGCSTQKQV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LNYLGECFRVKLNVPDWYPNEQAAEFLFNQCICIHLKSNTEKFYMLCLMTRKLFALAKGE 	    Total Percent Similarity:   86.24      Total Percent Identity:   86.24                                               
						CMEDNPDSLVNQEVLTPGQLFLMFLKEKLEGWLVSIKIAFDKKAQKTSVSMNTDNLMRIF 	                        Gaps:       1                        
						TMGIDLTKPFEYLFATGNLRSKTGLGLLQDSGLCVVADKLNFIRYLSHFRCVHRGADFAK 	                                                            
						MRTTTVRRLLPESWGFLCPVHTPDGEPCGLMNHLTAVCEVVTQFVYTASIPALLCNLGVT 	Alignment:                                                   
						PIDGAPHRSYSECYPVLLDGV                                        	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     562 MVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPMTGKPSLYPGLF 611                                                          
						to amino acids 1 - 561 of F00388_P10, a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPMTGKPSLYPGLFLFTTPCRLVR 	       1 MVGWVDKDLAPGIADSLRHFKVLREKRIPPWMEVVLIPMTGKPSLYPGLF 50                                                           
						PVQNLALGKEELIGTME                                            	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     612 LFTTPCRLVRPVQNLALGKEELIGTME....................... 638                                                          
						amino acids 1 - 77 of AAH04882, which also corresponds to    	         |||||||||||||||||||||||||||                         
						amino acids 562 - 638 of F00388_P10, and a third amino acid  	      51 LFTTPCRLVRPVQNLALGKEELIGTMEQIFMNVAIFEDEVFAGVTTHQEL 100                                                          
						QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNKASWERGFAHGSVYKSE 	                  .         .         .         .         .  
						FIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDGLPFIGAKLQYGDPYYSYLNLNTGESF 	     638 .................................................. 638                                                          
						VMYYKSKENCVVDNIKVCSNDTGSGKFKCVCITMRVPRNPTIGDKFASRHGQKGILSRLW 	                                                            
						PAEDMPFTESGMVPDILFNPHGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENS 	     101 FPHSLLSVIANFIPFSDHNQSPRNMYQCQMGKQTMGFPLLTYQDRSDNKL 150                                                          
						ALEYFGEMLKAAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQVRTTGA 	                  .         .         .         .         .  
						RDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNCSDRSVAHVCVKCGSLL 	     639 ......QSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNK 682                                                          
						SPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVSVPYVFRYFVAELAAMNIKVKLDVV   	               ||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 YRLQTPQSPLVRPSMYDYYDMDNYPIGTNAIVAVISYTGYDMEDAMIVNK 200                                                          
						amino acids 157 - 574 of AAH04882, which also corresponds to 	                  .         .         .         .         .  
						amino acids 639 - 1056 of F00388_P10, wherein said first     	     683 ASWERGFAHGSVYKSEFIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDG 732                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 ASWERGFAHGSVYKSEFIDLSEKIKQGDSSLVFGIKPGDPRVLQKLDDDG 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F00388_P10, comprising a polypeptide being at least 70%,     	     733 LPFIGAKLQYGDPYYSYLNLNTGESFVMYYKSKENCVVDNIKVCSNDTGS 782                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 LPFIGAKLQYGDPYYSYLNLNTGESFVMYYKSKENCVVDNIKVCSNDTGS 300                                                          
						MDPGSRWRNLPSGPSLKHLTDPSYGIPREQQKAALQELTRAHVESFNYAVHEGLGLAVQA 	                  .         .         .         .         .  
						IPPFEFAFKDERISFTILDAVISPPTVPKGTICKEANVYPAECRGRRSTYRGKLTADINW 	     783 GKFKCVCITMRVPRNPTIGDKFASRHGQKGILSRLWPAEDMPFTESGMVP 832                                                          
						AVNGISKGIIKQFLGYVPIMVKSKLCNLRNLPPQALIEHHEEAEEMGGYFIINGIEKVIR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MLIMPRRNFPIAMIRPKWKTRGPGYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIY 	     301 GKFKCVCITMRVPRNPTIGDKFASRHGQKGILSRLWPAEDMPFTESGMVP 350                                                          
						RKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQMLRIVMEEGCSTQKQV 	                  .         .         .         .         .  
						LNYLGECFRVKLNVPDWYPNEQAAEFLFNQCICIHLKSNTEKFYMLCLMTRKLFALAKGE 	     833 DILFNPHGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENSALEY 882                                                          
						CMEDNPDSLVNQEVLTPGQLFLMFLKEKLEGWLVSIKIAFDKKAQKTSVSMNTDNLMRIF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TMGIDLTKPFEYLFATGNLRSKTGLGLLQDSGLCVVADKLNFIRYLSHFRCVHRGADFAK 	     351 DILFNPHGFPSRMTIGMLIESMAGKSAALHGLCHDATPFIFSEENSALEY 400                                                          
						MRTTTVRRLLPESWGFLCPVHTPDGEPCGLMNHLTAVCEVVTQFVYTASIPALLCNLGVT 	                  .         .         .         .         .  
						PIDGAPHRSYSECYPVLLDGV                                        	     883 FGEMLKAAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQ 932                                                          
						least about 95% homologous to the sequence of F00388_P10.3.An	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     401 FGEMLKAAGYNFYGTERLYSGISGLELEADIFIGVVYYQRLRHMVSDKFQ 450                                                          
						F00388_P10, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     933 VRTTGARDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNC 982                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     451 VRTTGARDRVTNQPIGGRNVQGGIRFGEMERDALLAHGTSFLLHDRLFNC 500                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     983 SDRSVAHVCVKCGSLLSPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVS 1032                                                         
						at least two amino acids comprise EQ, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     501 SDRSVAHVCVKCGSLLSPLLEKPPPSWSAMRNRKYNCTLCSRSDTIDTVS 550                                                          
						638-x to 639; and ending at any of amino acid numbers 639+   	                  .         .                                
						((n-2) - x), in which x varies from 0 to n-2.                	    1033 VPYVFRYFVAELAAMNIKVKLDVV                           1056                                                         
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     551 VPYVFRYFVAELAAMNIKVKLDVV                           574                                                          

21189	HMR136_F00757_1_tr0_r1_1_gPRT		Comparison report between F00757_P1 and KPB1_HUMANpartial WT 	Sequence name: KPB1_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F00757_P1, comprising a first amino acid sequence being at   	                                                            
						MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYSILAVWGLGLA 	Alignment of: 21189 x KPB1_HUMAN   ..                        
						YRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVESFKYSQSTKDSLHAKYNTKT 	                                                            
						CATVVGDDQWGHLQLDATSVYLLFLAQMTASGLHIIHSLDEVNFIQNLVFYIEAAYKTAD 	Alignment segment 1/1:                                       
						FGIWERGDKTNQGISELNASSVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQS 	                                                            
						ILNSLLPRASTSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 	                     Quality: 11829.00                      Escore:       0                                              
						YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQEYKEALEAVLI 	             Matching length:    1223                Total length:    1240                                               
						KGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPHMWGQSLYILGSLMAEGFLAP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.92                                               
						GEIDPLNRRFSTVPKPDVVVQVSILAETEEIKTILKDKGIYVETIAEVYPIRVQPARILS 	    Total Percent Similarity:   98.63      Total Percent Identity:   98.55                                               
						HIYSSLGCNNRMKLSGRPYRHMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIV 	                        Gaps:       1                        
						EMLRTDLSYLCSRWRMTGQPTITFPIS                                  	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 567	Alignment:                                                   
						of KPB1_HUMAN, which also corresponds to amino acids 1 - 567 	                  .         .         .         .         .  
						of F00757_P1, a bridging amino acid H corresponding to amino 	       1 MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYS 50                                                           
						acid 568 of F00757_P1, a second amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGKLSEFLTTSCCTHLSFMDPGPEGKLY 	       1 MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYS 50                                                           
						SEDYDDNYDYLESGNWMNDYDSTSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDR 	                  .         .         .         .         .  
						FQAAVQTTCDLMSLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVR 	      51 ILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVE 100                                                          
						VEIHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYNERSATVRE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSHQKHLTVGLPPEPREKTIS 	      51 ILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVE 100                                                          
						APLPYEALTQLIDEASEGDMSISILTQEIMVYLAMYMRTQPGLFAEMFRLRIGLIIQVMA 	                  .         .         .         .         .  
						TELAHSLRCSAEEATEGLMNLSPSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHE 	     101 SFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTA 150                                                          
						IGAVGATKTERTGIMQLKSEIKQVEFRRLSISAESQ                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 569 -  	     101 SFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTA 150                                                          
						1024 of KPB1_HUMAN, which also corresponds to amino acids 569	                  .         .         .         .         .  
						- 1024 of F00757_P1, a third amino acid sequence being at    	     151 SGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNAS 200                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     151 SGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNAS 200                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						SNGGHPLGIDLMSPSFM corresponding to amino acids 1025 - 1041 of	     201 SVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRAS 250                                                          
						F00757_P1, and a fourth amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPGTSMTPSSGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCHG 	     201 SVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRAS 250                                                          
						LSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILVLTMLADIEIHS 	                  .         .         .         .         .  
						IGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASGICTLLYDSAPSGRFGTMTYLS 	     251 TSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 300                                                          
						KAAATYVQEFLPHSICAMQ                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1025 - 1223 of  	     251 TSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 300                                                          
						KPB1_HUMAN, which also corresponds to amino acids 1042 - 1240	                  .         .         .         .         .  
						of F00757_P1, wherein said first amino acid sequence,        	     301 YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQE 350                                                          
						bridging amino acid, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and fourth amino acid sequence are contiguous  	     301 YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQE 350                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of F00757_P1, comprising an amino acid   	     351 YKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPH 400                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     351 YKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPH 400                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for SNGGHPLGIDLMSPSFM, corresponding to    	     401 MWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEE 450                                                          
						F00757_P1.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 MWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 HMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 HMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CSRWRMTGQPTITFPISHSMLDEDGTSLNSSILAALRKMQDGYFGGARVQ 600                                                          
						                                                            	         |||||||||||||||||:||||||||||||||||||||||||||||||||  
						                                                            	     551 CSRWRMTGQPTITFPISYSMLDEDGTSLNSSILAALRKMQDGYFGGARVQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 TSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 TSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 SLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVE 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 IHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYN 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 IHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYN 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ERSATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSH 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ERSATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSH 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 QKHLTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVY 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 QKHLTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVY 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 LAMYMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLS 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 LAMYMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLS 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 PSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERT 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 PSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERT 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 GIMQLKSEIKQVEFRRLSISAESQSNGGHPLGIDLMSPSFMSPGTSMTPS 1050                                                         
						                                                            	         ||||||||||||||||||||||||                 |||||||||  
						                                                            	    1001 GIMQLKSEIKQVEFRRLSISAESQ.................SPGTSMTPS 1033                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 SGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCH 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1034 SGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCH 1083                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 GLSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILV 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1084 GLSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILV 1133                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 LTMLADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASG 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1134 LTMLADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASG 1183                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1201 ICTLLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ           1240                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	    1184 ICTLLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ           1223                                                         

21185	HMR136_F00757_2_tr0_r1_1_gPRT		Comparison report between F00757_P2 and KPB1_HUMANpartial WT 	Sequence name: KPB1_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F00757_P2, comprising a first amino acid sequence being at   	                                                            
						MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYSILAVWGLGLA 	Alignment of: 21185 x KPB1_HUMAN   ..                        
						YRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVESFKYSQSTKDSLHAKYNTKT 	                                                            
						CATVVGDDQWGHLQLDATSVYLLFLAQMTASGLHIIHSLDEVNFIQNLVFYIEAAYKTAD 	Alignment segment 1/1:                                       
						FGIWERGDKTNQGISELNASSVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQS 	                                                            
						ILNSLLPRASTSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 	                     Quality: 11829.00                      Escore:       0                                              
						YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQEYKEALEAVLI 	             Matching length:    1223                Total length:    1240                                               
						KGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPHMWGQSLYILGSLMAEGFLAP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.92                                               
						GEIDPLNRRFSTVPKPDVVVQVSILAETEEIKTILKDKGIYVETIAEVYPIRVQPARILS 	    Total Percent Similarity:   98.63      Total Percent Identity:   98.55                                               
						HIYSSLGCNNRMKLSGRPYRHMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIV 	                        Gaps:       1                        
						EMLRTDLSYLCSRWRMTGQPTITFPIS                                  	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 567	Alignment:                                                   
						of KPB1_HUMAN, which also corresponds to amino acids 1 - 567 	                  .         .         .         .         .  
						of F00757_P2, a bridging amino acid H corresponding to amino 	       1 MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYS 50                                                           
						acid 568 of F00757_P2, a second amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGKLSEFLTTSCCTHLSFMDPGPEGKLY 	       1 MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYS 50                                                           
						SEDYDDNYDYLESGNWMNDYDSTSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDR 	                  .         .         .         .         .  
						FQAAVQTTCDLMSLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVR 	      51 ILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVE 100                                                          
						VEIHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYNERSATVRE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSHQKHLTVGLPPEPREKTIS 	      51 ILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVE 100                                                          
						APLPYEALTQLIDEASEGDMSISILTQEIMVYLAMYMRTQPGLFAEMFRLRIGLIIQVMA 	                  .         .         .         .         .  
						TELAHSLRCSAEEATEGLMNLSPSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHE 	     101 SFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTA 150                                                          
						IGAVGATKTERTGIMQLKSEIKQVEFRRLSISAESQ                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 569 -  	     101 SFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTA 150                                                          
						1024 of KPB1_HUMAN, which also corresponds to amino acids 569	                  .         .         .         .         .  
						- 1024 of F00757_P2, a third amino acid sequence being at    	     151 SGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNAS 200                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     151 SGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNAS 200                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						SNGGHPLGIDLMSPSFM corresponding to amino acids 1025 - 1041 of	     201 SVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRAS 250                                                          
						F00757_P2, and a fourth amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPGTSMTPSSGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCHG 	     201 SVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRAS 250                                                          
						LSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILVLTMLADIEIHS 	                  .         .         .         .         .  
						IGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASGICTLLYDSAPSGRFGTMTYLS 	     251 TSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 300                                                          
						KAAATYVQEFLPHSICAMQ                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1025 - 1223 of  	     251 TSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 300                                                          
						KPB1_HUMAN, which also corresponds to amino acids 1042 - 1240	                  .         .         .         .         .  
						of F00757_P2, wherein said first amino acid sequence,        	     301 YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQE 350                                                          
						bridging amino acid, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and fourth amino acid sequence are contiguous  	     301 YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQE 350                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of F00757_P2, comprising an amino acid   	     351 YKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPH 400                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     351 YKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPH 400                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for SNGGHPLGIDLMSPSFM, corresponding to    	     401 MWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEE 450                                                          
						F00757_P2.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 MWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 HMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 HMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CSRWRMTGQPTITFPISHSMLDEDGTSLNSSILAALRKMQDGYFGGARVQ 600                                                          
						                                                            	         |||||||||||||||||:||||||||||||||||||||||||||||||||  
						                                                            	     551 CSRWRMTGQPTITFPISYSMLDEDGTSLNSSILAALRKMQDGYFGGARVQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 TSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 TSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 SLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVE 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 IHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYN 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 IHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYN 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ERSATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSH 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ERSATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSH 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 QKHLTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVY 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 QKHLTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVY 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 LAMYMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLS 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 LAMYMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLS 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 PSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERT 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 PSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERT 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 GIMQLKSEIKQVEFRRLSISAESQSNGGHPLGIDLMSPSFMSPGTSMTPS 1050                                                         
						                                                            	         ||||||||||||||||||||||||                 |||||||||  
						                                                            	    1001 GIMQLKSEIKQVEFRRLSISAESQ.................SPGTSMTPS 1033                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 SGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCH 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1034 SGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCH 1083                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 GLSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILV 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1084 GLSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILV 1133                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 LTMLADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASG 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1134 LTMLADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASG 1183                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1201 ICTLLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ           1240                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	    1184 ICTLLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ           1223                                                         

21187	HMR136_F00757_4_tr0_r1_1_gPRT		Comparison report between F00757_P4 and KPB1_HUMANpartial WT 	Sequence name: KPB1_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F00757_P4, comprising a first amino acid sequence being at   	                                                            
						MAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRASTSKEVDASLLSVV 	Alignment of: 21187 x KPB1_HUMAN   ..                        
						SFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDGYKTPKEDPNRLYYEPAELKLFEN 	                                                            
						IECEWPLFWTYFILDGVFSGNAEQVQEYKEALEAVLIKGKNGVPLLPELYSVPPDRVDEE 	Alignment segment 1/1:                                       
						YQNPHTVDRVPMGKLPHMWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVS 	                                                            
						ILAETEEIKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYRHMG 	                     Quality: 9850.00                      Escore:       0                                               
						VLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYLCSRWRMTGQPTIT 	             Matching length:    1020                Total length:    1037                                               
						FPIS                                                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.90                                               
						least 90 % homologous to corresponding to amino acids 204 -  	    Total Percent Similarity:   98.36      Total Percent Identity:   98.26                                               
						567 of KPB1_HUMAN, which also corresponds to amino acids 1 - 	                        Gaps:       1                        
						364 of F00757_P4, a bridging amino acid H corresponding to   	                                                            
						amino acid 365 of F00757_P4, a second amino acid sequence    	Alignment:                                                   
						SMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGKLSEFLTTSCCTHLSFMDPGPEGKLY 	                  .         .         .         .         .  
						SEDYDDNYDYLESGNWMNDYDSTSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDR 	       1 MAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRASTSK 50                                                           
						FQAAVQTTCDLMSLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEIHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYNERSATVRE 	     204 MAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRASTSK 253                                                          
						LLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSHQKHLTVGLPPEPREKTIS 	                  .         .         .         .         .  
						APLPYEALTQLIDEASEGDMSISILTQEIMVYLAMYMRTQPGLFAEMFRLRIGLIIQVMA 	      51 EVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDGYKT 100                                                          
						TELAHSLRCSAEEATEGLMNLSPSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IGAVGATKTERTGIMQLKSEIKQVEFRRLSISAESQ                         	     254 EVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDGYKT 303                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 569 - 1024 of KPB1_HUMAN, which also corresponds to    	     101 PKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQEYKE 150                                                          
						amino acids 366 - 821 of F00757_P4, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     304 PKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQEYKE 353                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     151 ALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPHMWG 200                                                          
						having the sequence SNGGHPLGIDLMSPSFM corresponding to amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 822 - 838 of F00757_P4, and a fourth amino acid        	     354 ALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPHMWG 403                                                          
						SPGTSMTPSSGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCHG 	                  .         .         .         .         .  
						LSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILVLTMLADIEIHS 	     201 QSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEEIKT 250                                                          
						IGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASGICTLLYDSAPSGRFGTMTYLS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KAAATYVQEFLPHSICAMQ                                          	     404 QSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEEIKT 453                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1025 - 1223 of KPB1_HUMAN, which also corresponds	     251 ILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYRHMG 300                                                          
						to amino acids 839 - 1037 of F00757_P4, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid, second amino acid  	     454 ILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYRHMG 503                                                          
						sequence, third amino acid sequence and fourth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     301 VLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYLCSR 350                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F00757_P4, comprising an amino acid sequence being at least  	     504 VLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYLCSR 553                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     351 WRMTGQPTITFPISHSMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGK 400                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||:|||||||||||||||||||||||||||||||||||  
						SNGGHPLGIDLMSPSFM, corresponding to F00757_P4.               	     554 WRMTGQPTITFPISYSMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGK 603                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDSTSH 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     604 LSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDSTSH 653                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLMSLV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     654 ARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLMSLV 703                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVEIHL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     704 TKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVEIHL 753                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 PRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYNERS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     754 PRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYNERS 803                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSHQKH 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     804 ATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSHQKH 853                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 LTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVYLAM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     854 LTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVYLAM 903                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 YMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLSPSA 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     904 YMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLSPSA 953                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 MKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERTGIM 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     954 MKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERTGIM 1003                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 QLKSEIKQVEFRRLSISAESQSNGGHPLGIDLMSPSFMSPGTSMTPSSGS 850                                                          
						                                                            	         |||||||||||||||||||||                 ||||||||||||  
						                                                            	    1004 QLKSEIKQVEFRRLSISAESQ.................SPGTSMTPSSGS 1036                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCHGLS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1037 FPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCHGLS 1086                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 VEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILVLTM 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1087 VEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILVLTM 1136                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 LADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASGICT 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1137 LADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASGICT 1186                                                         
						                                                            	                  .         .         .                      
						                                                            	    1001 LLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ              1037                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1187 LLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ              1223                                                         

21183	HMR136_F00757_5_tr0_r1_1_gPRT		Comparison report between F00757_P5 and KPB1_HUMANpartial WT 	Sequence name: KPB1_HUMAN                                    
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F00757_P5, comprising a first amino 	Sequence documentation:                                      
						MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYSILAVWGLGLA 	                                                            
						YRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVESFKYSQSTKDSLHAKYNTKT 	Alignment of: 21183 x KPB1_HUMAN   ..                        
						CATVVGDDQWGHLQLDATSVYLLFLAQMTASGLHIIHSLDEVNFIQNLVFYIEAAYKTAD 	                                                            
						FGIWERGDKTNQGISELNASSVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQS 	Alignment segment 1/1:                                       
						ILNSLLPRASTSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 	                                                            
						YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQEYKEALEAVLI 	                     Quality: 7743.00                      Escore:       0                                               
						KGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPHMWGQSLYILGSLMAEGFLAP 	             Matching length:     790                Total length:     790                                               
						GEIDPLNRRFSTVPKPDVVVQVSILAETEEIKTILKDKGIYVETIAEVYPIRVQPARILS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.87                                               
						HIYSSLGCNNRMKLSGRPYRHMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.87                                               
						EMLRTDLSYLCSRWRMTGQPTITFPIS                                  	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 567 of KPB1_HUMAN, which also corresponds 	Alignment:                                                   
						to amino acids 1 - 567 of F00757_P5, a bridging amino acid H 	                  .         .         .         .         .  
						corresponding to amino acid 568 of F00757_P5, and a second   	       1 MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYS 50                                                           
						SMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGKLSEFLTTSCCTHLSFMDPGPEGKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEDYDDNYDYLESGNWMNDYDSTSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDR 	       1 MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYS 50                                                           
						FQAAVQTTCDLMSLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVR 	                  .         .         .         .         .  
						VEIHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMK                   	      51 ILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVE 100                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 569 - 790 of KPB1_HUMAN, which  	      51 ILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVE 100                                                          
						also corresponds to amino acids 569 - 790 of F00757_P5,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, bridging amino acid  	     101 SFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTA 150                                                          
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.                                            	     101 SFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNAS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNAS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRAS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRAS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 TSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 YKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPH 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 YKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPH 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 MWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 MWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 HMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 HMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CSRWRMTGQPTITFPISHSMLDEDGTSLNSSILAALRKMQDGYFGGARVQ 600                                                          
						                                                            	         |||||||||||||||||:||||||||||||||||||||||||||||||||  
						                                                            	     551 CSRWRMTGQPTITFPISYSMLDEDGTSLNSSILAALRKMQDGYFGGARVQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 TSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLM 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 TSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLM 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 SLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 SLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVE 750                                                          
						                                                            	                  .         .         .         .            
						                                                            	     751 IHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMK           790                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     751 IHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMK           790                                                          

2367	HMR136_F01478_25_tr0_r1_1_gPRT		Comparison report between F01478_P25 and T2D5_HUMANpartial   	Sequence name: T2D5_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for F01478_P25, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MAEEKKLKLSNTVLPSESM corresponding to amino acids 1 - 19 of   	Alignment of: 2367 x T2D5_HUMAN   ..                         
						T2D5_HUMAN, which also corresponds to amino acids 1 - 19 of  	                                                            
						F01478_P25, and a second amino acid sequence being at least  	Alignment segment 1/1:                                       
						KFIVMSSSSSAPSTQQVLSLSTSAPGSGSTTTSPVTTTVPSVQPIVKLVSTATTAPPSTA 	                                                            
						PSGPGSVQKYIVVSLPPTGEGKGGPTSHPSPVPPPASSPSPLSGSALCGGKQEAGDSPPP 	                     Quality: 1449.00                      Escore:       0                                               
						APGTPKANGSQPNSGSPQPAP                                        	             Matching length:     160                Total length:     677                                               
						90 % homologous to corresponding to amino acids 537 - 677 of 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T2D5_HUMAN, which also corresponds to amino acids 20 - 160 of	    Total Percent Similarity:   23.63      Total Percent Identity:   23.63                                               
						F01478_P25, wherein said first amino acid sequence and second	                        Gaps:       1                        
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated chimeric polypeptide encoding for an edge	Alignment:                                                   
						portion of F01478_P25, comprising a polypeptide having a     	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	       1 MAEEKKLKLSNTVLPSESM............................... 19                                                           
						length, optionally at least about 20 amino acids in length,  	         |||||||||||||||||||                                 
						preferably at least about 30 amino acids in length, more     	       1 MAEEKKLKLSNTVLPSESMKVVAESMGIAQIQEETCQLLTDEVSYRIKEI 50                                                           
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      19 .................................................. 19                                                           
						at least two amino acids comprise MK, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	      51 AQDALKFMHMGKRQKLTTSDIDYALKLKNVEPLYGFHAQEFIPFRFASGG 100                                                          
						19-x to 20; and ending at any of amino acid numbers 20+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     101 GRELYFYEEKEVDLSDIINTPLPRVPLDVCLKAHWLSIEGCQPAIPENPP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     151 PAPKEQQKAEATEPLKSAKPGQEEDGPLKGKGQGATTADGKGKEKKAPPL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     201 LEGAPLRLKPRSIHELSVEQQLYYKEITEACVGSCEAKRAEALQSIATDP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     251 GLYQMLPRFSTFISEGVRVNVVQNNLALLIYLMRMVKALMDNPTLYLEKY 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     301 VHELIPAVMTCIVSRQLCLRPDVDNHWALRDFAARLVAQICKHFSTTTNN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     351 IQSRITKTFTKSWVDEKTPWTTRYGSIAGLAELGHDVIKTLILPRLQQEG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     401 ERIRSVLDGPVLSNIDRIGADHVQSLLLKHCAPVLAKLRPPPDNQDAYRA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      19 .................................................. 19                                                           
						                                                            	                                                            
						                                                            	     451 EFGSLGPLLCSQVVKARAQAALQAQQVNRTTLTITQPRPTLTLSQAPQPG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      20 ....................................KFIVMSSSSSAPST 33                                                           
						                                                            	                                             ||||||||||||||  
						                                                            	     501 PRTPGLLKVPGSIALPVQTLVSARAAAPPQPSPPPTKFIVMSSSSSAPST 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      34 QQVLSLSTSAPGSGSTTTSPVTTTVPSVQPIVKLVSTATTAPPSTAPSGP 83                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 QQVLSLSTSAPGSGSTTTSPVTTTVPSVQPIVKLVSTATTAPPSTAPSGP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      84 GSVQKYIVVSLPPTGEGKGGPTSHPSPVPPPASSPSPLSGSALCGGKQEA 133                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GSVQKYIVVSLPPTGEGKGGPTSHPSPVPPPASSPSPLSGSALCGGKQEA 650                                                          
						                                                            	                  .         .                                
						                                                            	     134 GDSPPPAPGTPKANGSQPNSGSPQPAP                        160                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     651 GDSPPPAPGTPKANGSQPNSGSPQPAP                        677                                                          

24316	HMR136_F01701_14_tr0_r1_1_gPRT		Comparison report between F01701_P14 and O14784unique head   	Sequence name: O14784                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01701_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24316 x O14784   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPDSPVDVKTQSRLTPPTMPPPP 	Alignment segment 1/1:                                       
						TTQGAPRTSSFTPTTLTNGTSHSPTALNGAPSPPNGFSNGPSSSSSSSLANQQLPPACGA 	                                                            
						RQLSKLKRFLTTLQQFGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPF 	                     Quality: 1271.00                      Escore:       0                                               
						VIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTSPVDSSELLLDVNENG 	             Matching length:     125                Total length:     125                                               
						KRRTPDRTKENGFDREPLHSEHPSKRPCTISPGQRYSPNNGLSYQPNGLPHPTPPPPQHY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						R                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 301 of F01701_P14, a second amino acid    	                                                            
						LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWAEEWKHLDHLL 	Alignment:                                                   
						NCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAEDLKKGGGSSSSHSRQQSPVNP 	                  .         .         .         .         .  
						DPVAL                                                        	     302 LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWA 351                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 125 of O14784, which also corresponds to     	       1 LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWA 50                                                           
						amino acids 302 - 426 of F01701_P14, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     352 EEWKHLDHLLNCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAED 401                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 EEWKHLDHLLNCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAED 100                                                          
						DAHREFLHRPASGYVPEEIWKKAEEAVNEVKRQAMTELQKAVSEAERKAHDMITTERAKM 	                  .         .                                
						ERTVAEAKRQAAEDALAVINQQEDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEK 	     402 LKKGGGSSSSHSRQQSPVNPDPVAL                          426                                                          
						HHHICGQTLQAQQQGDTPAVSSSVTPNSGAGSPMDTPPAATPRSTTPGTPSTIETTPR   	         |||||||||||||||||||||||||                           
						having the sequence corresponding to amino acids 427 - 604 of	     101 LKKGGGSSSSHSRQQSPVNPDPVAL                          125                                                          
						F01701_P14, wherein said first amino acid sequence, second   	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of F01701_P14, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPDSPVDVKTQSRLTPPTMPPPP 	                                                            
						TTQGAPRTSSFTPTTLTNGTSHSPTALNGAPSPPNGFSNGPSSSSSSSLANQQLPPACGA 	                                                            
						RQLSKLKRFLTTLQQFGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPF 	                                                            
						VIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTSPVDSSELLLDVNENG 	                                                            
						KRRTPDRTKENGFDREPLHSEHPSKRPCTISPGQRYSPNNGLSYQPNGLPHPTPPPPQHY 	                                                            
						R                                                            	                                                            
						to the sequence of F01701_P14.3.An isolated polypeptide      	                                                            
						encoding for a tail of F01701_P14, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						DAHREFLHRPASGYVPEEIWKKAEEAVNEVKRQAMTELQKAVSEAERKAHDMITTERAKM 	                                                            
						ERTVAEAKRQAAEDALAVINQQEDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEK 	                                                            
						HHHICGQTLQAQQQGDTPAVSSSVTPNSGAGSPMDTPPAATPRSTTPGTPSTIETTPR   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F01701_P14.                                               	                                                            

24314	HMR136_F01701_2_tr0_r1_1_gPRT		Comparison report between F01701_P2 and O14784unique head    	Sequence name: O14784                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01701_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24314 x O14784   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPDSPVDVKTQSRLTPPTMPPPP 	Alignment segment 1/1:                                       
						TTQGAPRTSSFTPTTLTNGTSHSPTALNGAPSPPNGFSNGPSSSSSSSLANQQLPPACGA 	                                                            
						RQLSKLKRFLTTLQQFGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPF 	                     Quality: 1271.00                      Escore:       0                                               
						VIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTSPVDSSELLLDVNENG 	             Matching length:     125                Total length:     125                                               
						KRRTPDRTKENGFDREPLHSEHPSKRPCTISPGQRYSPNNGLSYQPNGLPHPTPPPPQHY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						R                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 301 of F01701_P2, a second amino acid     	                                                            
						LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWAEEWKHLDHLL 	Alignment:                                                   
						NCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAEDLKKGGGSSSSHSRQQSPVNP 	                  .         .         .         .         .  
						DPVAL                                                        	     302 LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWA 351                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 125 of O14784, which also corresponds to     	       1 LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWA 50                                                           
						amino acids 302 - 426 of F01701_P2, and a third amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     352 EEWKHLDHLLNCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAED 401                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 EEWKHLDHLLNCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAED 100                                                          
						DAHREFLHRPASGYVPEEIWKKAEEAVNEVKRQAMTELQKAVSEAERKAHDMITTERAKM 	                  .         .                                
						ERTVAEAKRQAAEDALAVINQQEDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEK 	     402 LKKGGGSSSSHSRQQSPVNPDPVAL                          426                                                          
						HHHICGQTLQAQQQGDTPAVSSSVTPNSGAGSPMDTPPAATPRSTTPGTPSTIETTPR   	         |||||||||||||||||||||||||                           
						having the sequence corresponding to amino acids 427 - 604 of	     101 LKKGGGSSSSHSRQQSPVNPDPVAL                          125                                                          
						F01701_P2, wherein said first amino acid sequence, second    	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of F01701_P2, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPDSPVDVKTQSRLTPPTMPPPP 	                                                            
						TTQGAPRTSSFTPTTLTNGTSHSPTALNGAPSPPNGFSNGPSSSSSSSLANQQLPPACGA 	                                                            
						RQLSKLKRFLTTLQQFGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPF 	                                                            
						VIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTSPVDSSELLLDVNENG 	                                                            
						KRRTPDRTKENGFDREPLHSEHPSKRPCTISPGQRYSPNNGLSYQPNGLPHPTPPPPQHY 	                                                            
						R                                                            	                                                            
						to the sequence of F01701_P2.3.An isolated polypeptide       	                                                            
						encoding for a tail of F01701_P2, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						DAHREFLHRPASGYVPEEIWKKAEEAVNEVKRQAMTELQKAVSEAERKAHDMITTERAKM 	                                                            
						ERTVAEAKRQAAEDALAVINQQEDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEK 	                                                            
						HHHICGQTLQAQQQGDTPAVSSSVTPNSGAGSPMDTPPAATPRSTTPGTPSTIETTPR   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F01701_P2.                                                	                                                            

24318	HMR136_F01701_4_tr0_r1_1_gPRT		Comparison report between F01701_P4 and O14784unique head    	Sequence name: O14784                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01701_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24318 x O14784   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPDSPVDVKTQSRLTPPTMPPPP 	Alignment segment 1/1:                                       
						TTQGAPRTSSFTPTTLTNGTSHSPTALNGAPSPPNGFSNGPSSSSSSSLANQQLPPACGA 	                                                            
						RQLSKLKRFLTTLQQFGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPF 	                     Quality: 1271.00                      Escore:       0                                               
						VIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTSPVDSSELLLDVNENG 	             Matching length:     125                Total length:     125                                               
						KRRTPDRTKENGFDREPLHSEHPSKRPCTISPGQRYSPNNGLSYQPNGLPHPTPPPPQHY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						R                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 301 of F01701_P4, a second amino acid     	                                                            
						LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWAEEWKHLDHLL 	Alignment:                                                   
						NCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAEDLKKGGGSSSSHSRQQSPVNP 	                  .         .         .         .         .  
						DPVAL                                                        	     302 LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWA 351                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 125 of O14784, which also corresponds to     	       1 LDDMAIAHHYRDSYRHPSHRDLRDRNRPMGLHGTRQEEMIDHRLTDREWA 50                                                           
						amino acids 302 - 426 of F01701_P4, and a third amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     352 EEWKHLDHLLNCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAED 401                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 EEWKHLDHLLNCIMDMVEKTRRSLTVLRRCQEADREELNYWIRRYSDAED 100                                                          
						DAHREFLHRPASGYVPEEIWKKAEEAVNEVKRQAMTELQKAVSEAERKAHDMITTERAKM 	                  .         .                                
						ERTVAEAKRQAAEDALAVINQQEDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEK 	     402 LKKGGGSSSSHSRQQSPVNPDPVAL                          426                                                          
						HHHICGQTLQAQQQGDTPAVSSSVTPNSGAGSPMDTPPAATPRSTTPGTPSTIETTPR   	         |||||||||||||||||||||||||                           
						having the sequence corresponding to amino acids 427 - 604 of	     101 LKKGGGSSSSHSRQQSPVNPDPVAL                          125                                                          
						F01701_P4, wherein said first amino acid sequence, second    	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of F01701_P4, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPDSPVDVKTQSRLTPPTMPPPP 	                                                            
						TTQGAPRTSSFTPTTLTNGTSHSPTALNGAPSPPNGFSNGPSSSSSSSLANQQLPPACGA 	                                                            
						RQLSKLKRFLTTLQQFGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPF 	                                                            
						VIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTSPVDSSELLLDVNENG 	                                                            
						KRRTPDRTKENGFDREPLHSEHPSKRPCTISPGQRYSPNNGLSYQPNGLPHPTPPPPQHY 	                                                            
						R                                                            	                                                            
						to the sequence of F01701_P4.3.An isolated polypeptide       	                                                            
						encoding for a tail of F01701_P4, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						DAHREFLHRPASGYVPEEIWKKAEEAVNEVKRQAMTELQKAVSEAERKAHDMITTERAKM 	                                                            
						ERTVAEAKRQAAEDALAVINQQEDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEK 	                                                            
						HHHICGQTLQAQQQGDTPAVSSSVTPNSGAGSPMDTPPAATPRSTTPGTPSTIETTPR   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F01701_P4.                                                	                                                            

25005	HMR136_F01811_5_tr0_r1_1_gPRT		Comparison report between F01811_P5 and Q8N1V9partial WT     	Sequence name: Q8N1V9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F01811_P5, comprising a first amino 	Sequence documentation:                                      
						MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTAGDKLQPSPPP 	                                                            
						LSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGREFFFDRHPGVFAYVLNYYRT 	Alignment of: 25005 x Q8N1V9   ..                            
						GKLHCPADVCGPLFEEELAFWGIDETDVEPCCWMTYRQHRDAEEALDIFETPDLIGGDPG 	                                                            
						DDEDLAAKRLGIEDAAGLGGPDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFIL 	Alignment segment 1/1:                                       
						VSITTFCLETHEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 	                                                            
						IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVVRFVRILRIFK 	                     Quality: 5283.00                      Escore:       0                                               
						LTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMIYYAERVGAQPNDPSASEHTQ 	             Matching length:     538                Total length:     538                                               
						FKNIPIGFWWAVVTMTTLGYGDMYPQTWSGMLVGALCALAGVLTIAMPVPVIVNNFGMYY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SLAMAKQKLPRKRKKHIPPAPQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRS   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 538 of Q8N1V9, which also corresponds to  	                                                            
						amino acids 1 - 538 of F01811_P5, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLPLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDAL 	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						VPETKTEEGKHVSY                                               	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 539 - 612 of	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						F01811_P5, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F01811_P5, comprising a polypeptide being at least 70%,      	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						VLPLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDAL 	                  .         .         .         .         .  
						VPETKTEEGKHVSY                                               	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						least about 95% homologous to the sequence in F01811_P5.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRS             538                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRS             538                                                          

						Comparison report between F01811_P5 and AAO89503partial WT   	Sequence name: AAO89503                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F01811_P5, comprising a first amino 	Sequence documentation:                                      
						MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTAGDKLQPSPPP 	                                                            
						LSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGREFFFDRHPGVFAYVLNYYRT 	Alignment of: 25005 x AAO89503   ..                          
						GKLHCPADVCGPLFEEELAFWGIDETDVEPCCWMTYRQHRDAEEALDIFETPDLIGGDPG 	                                                            
						DDEDLAAKRLGIEDAAGLGGPDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFIL 	Alignment segment 1/1:                                       
						VSITTFCLETHEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 	                                                            
						IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVVRFVRILRIFK 	                     Quality: 5299.00                      Escore:       0                                               
						LTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMIYYAERVGAQPNDPSASEHTQ 	             Matching length:     540                Total length:     540                                               
						FKNIPIGFWWAVVTMTTLGYGDMYPQTWSGMLVGALCALAGVLTIAMPVPVIVNNFGMYY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SLAMAKQKLPRKRKKHIPPAPQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 540 of AAO89503, which also corresponds to	                                                            
						amino acids 1 - 540 of F01811_P5, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDALVP 	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						ETKTEEGKHVSY                                                 	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 541 - 612 of	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						F01811_P5, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F01811_P5, comprising a polypeptide being at least 70%,      	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						PLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDALVP 	                  .         .         .         .         .  
						ETKTEEGKHVSY                                                 	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						least about 95% homologous to the sequence in F01811_P5.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL           540                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL           540                                                          

						Comparison report between F01811_P5 and Q96PR1partial WT     	Sequence name: Q96PR1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F01811_P5, comprising a first amino 	Sequence documentation:                                      
						MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTAGDKLQPSPPP 	                                                            
						LSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGREFFFDRHPGVFAYVLNYYRT 	Alignment of: 25005 x Q96PR1   ..                            
						GKLHCPADVCGPLFEEELAFWGIDETDVEPCCWMTYRQHRDAEEALDIFETPDLIGGDPG 	                                                            
						DDEDLAAKRLGIEDAAGLGGPDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFIL 	Alignment segment 1/1:                                       
						VSITTFCLETHEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 	                                                            
						IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVVRFVRILRIFK 	                     Quality: 5299.00                      Escore:       0                                               
						LTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMIYYAERVGAQPNDPSASEHTQ 	             Matching length:     540                Total length:     540                                               
						FKNIPIGFWWAVVTMTTLGYGDMYPQTWSGMLVGALCALAGVLTIAMPVPVIVNNFGMYY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SLAMAKQKLPRKRKKHIPPAPQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 540 of Q96PR1, which also corresponds to  	                                                            
						amino acids 1 - 540 of F01811_P5, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDALVP 	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						ETKTEEGKHVSY                                                 	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 541 - 612 of	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						F01811_P5, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F01811_P5, comprising a polypeptide being at least 70%,      	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						PLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDALVP 	                  .         .         .         .         .  
						ETKTEEGKHVSY                                                 	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						least about 95% homologous to the sequence in F01811_P5.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL           540                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL           540                                                          

						Comparison report between F01811_P5 and Q96PR0partial WT     	Sequence name: Q96PR0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F01811_P5, comprising a first amino 	Sequence documentation:                                      
						MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTAGDKLQPSPPP 	                                                            
						LSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGREFFFDRHPGVFAYVLNYYRT 	Alignment of: 25005 x Q96PR0   ..                            
						GKLHCPADVCGPLFEEELAFWGIDETDVEPCCWMTYRQHRDAEEALDIFETPDLIGGDPG 	                                                            
						DDEDLAAKRLGIEDAAGLGGPDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFIL 	Alignment segment 1/1:                                       
						VSITTFCLETHEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 	                                                            
						IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVVRFVRILRIFK 	                     Quality: 5299.00                      Escore:       0                                               
						LTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMIYYAERVGAQPNDPSASEHTQ 	             Matching length:     540                Total length:     540                                               
						FKNIPIGFWWAVVTMTTLGYGDMYPQTWSGMLVGALCALAGVLTIAMPVPVIVNNFGMYY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SLAMAKQKLPRKRKKHIPPAPQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 540 of Q96PR0, which also corresponds to  	                                                            
						amino acids 1 - 540 of F01811_P5, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDALVP 	       1 MGKIENNERVILNVGGTRHETYRSTLKTLPGTRLALLASSEPPGDCLTTA 50                                                           
						ETKTEEGKHVSY                                                 	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 541 - 612 of	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						F01811_P5, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 GDKLQPSPPPLSPPPRAPPLSPGPGGCFEGGAGNCSSRGGRASDHPGGGR 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F01811_P5, comprising a polypeptide being at least 70%,      	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 EFFFDRHPGVFAYVLNYYRTGKLHCPADVCGPLFEEELAFWGIDETDVEP 150                                                          
						PLPHGAMHLNLIHKKQLFKKNGCLHFKGLNSKQCYQVTTVQEVSRHYHPQKGSPSDALVP 	                  .         .         .         .         .  
						ETKTEEGKHVSY                                                 	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						least about 95% homologous to the sequence in F01811_P5.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 CCWMTYRQHRDAEEALDIFETPDLIGGDPGDDEDLAAKRLGIEDAAGLGG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PDGKSGRWRRLQPRMWALFEDPYSSRAARFIAFASLFFILVSITTFCLET 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HEAFNIVKNKTEPVINGTSVVLQYEIETDPALTYVEGVCVVWFTFEFLVR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IVFSPNKLEFIKNLLNIIDFVAILPFYLEVGLSGLSSKAAKDVLGFLRVV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RFVRILRIFKLTRHFVGLRVLGHTLRASTNEFLLLIIFLALGVLIFATMI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YYAERVGAQPNDPSASEHTQFKNIPIGFWWAVVTMTTLGYGDMYPQTWSG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQKLPRKRKKHIPPA 500                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL           540                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     501 PQASSPTFCKTELNMACNSTQSDTCLGKDNRLLEHNRSVL           540                                                          

25084	HMR136_F01885_4_tr0_r1_1_gPRT		Comparison report between F01885_P4 and GABC_HUMANpartial WT 	Sequence name: GABC_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01885_P4, comprising a first amino acid sequence being at   	                                                            
						MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHYSTTEVLLRA 	Alignment of: 25084 x GABC_HUMAN   ..                        
						GVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVV 	                                                            
						ELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEILQIAMQNQINTNPESPDTVTIHAAT 	Alignment segment 1/1:                                       
						PQFIIGPGGVVNL                                                	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 193	                     Quality: 3121.00                      Escore:       0                                               
						of GABC_HUMAN, which also corresponds to amino acids 1 - 193 	             Matching length:     340                Total length:     352                                               
						of F01885_P4, a second amino acid sequence being at least 90 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEEVVTAESVDGAIQQVV 	    Total Percent Similarity:   96.59      Total Percent Identity:   96.59                                               
						SSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVTMPDGQQVLTVPATDIAEETVISEEP 	                        Gaps:       1                        
						PAKRQCIEIIENRVESAEIEVRSLLPG                                  	                                                            
						% homologous to corresponding to amino acids 206 - 352 of    	Alignment:                                                   
						GABC_HUMAN, which also corresponds to amino acids 194 - 340  	                  .         .         .         .         .  
						of F01885_P4, and a third amino acid sequence being at least 	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						homologous to a polypeptide having the sequence ERSSSETAG    	                  .         .         .         .         .  
						corresponding to amino acids 341 - 349 of F01885_P4, wherein 	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						said first amino acid sequence, second amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and third amino acid sequence are contiguous and in a        	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						sequential order.2.An isolated chimeric polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of F01885_P4, comprising a polypeptide   	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						length, preferably at least about 30 amino acids in length,  	                  .         .         .         .         .  
						more preferably at least about 40 amino acids in length and  	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNL....... 193                                                          
						most preferably at least about 50 amino acids in length,     	         |||||||||||||||||||||||||||||||||||||||||||         
						wherein at least two amino acids comprise LT, having a       	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNLTGLVSSE 200                                                          
						structure as follows: a sequence starting from any of amino  	                  .         .         .         .         .  
						acid numbers 193-x to 194; and ending at any of amino acid   	     194 .....TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 238                                                          
						numbers 194+ ((n-2) - x), in which x varies from 0 to        	              |||||||||||||||||||||||||||||||||||||||||||||  
						n-2.3.An isolated polypeptide encoding for a tail of         	     201 NSSKATDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 250                                                          
						F01885_P4, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     239 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 288                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence ERSSSETAG in      	     251 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 300                                                          
						F01885_P4.                                                   	                  .         .         .         .         .  
						                                                            	     289 MPDGQQVLTVPATDIAEETVISEEPPAKRQCIEIIENRVESAEIEVRSLL 338                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 MPDGQQVLTVPATDIAEETVISEEPPAKRQCIEIIENRVESAEIEVRSLL 350                                                          
						                                                            	                                                             
						                                                            	     339 PG                                                 340                                                          
						                                                            	         ||                                                  
						                                                            	     351 PG                                                 352                                                          

25082	HMR136_F01885_5_tr0_r1_1_gPRT		Comparison report between F01885_P5 and GABB_HUMANpartial WT 	Sequence name: GABB_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01885_P5, comprising a first amino acid sequence being at   	                                                            
						MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHYSTTEVLLRA 	Alignment of: 25082 x GABB_HUMAN   ..                        
						GVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVV 	                                                            
						ELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEILQIAMQNQINTNPESPDTVTIHAAT 	Alignment segment 1/1:                                       
						PQFIIGPGGVVNL                                                	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 193	                     Quality: 2690.00                      Escore:       0                                               
						of GABB_HUMAN, which also corresponds to amino acids 1 - 193 	             Matching length:     294                Total length:     306                                               
						of F01885_P5, a second amino acid sequence being at least 90 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEEVVTAESVDGAIQQVV 	    Total Percent Similarity:   96.08      Total Percent Identity:   96.08                                               
						SSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVTMPDGQQ                    	                        Gaps:       1                        
						% homologous to corresponding to amino acids 206 - 306 of    	                                                            
						GABB_HUMAN, which also corresponds to amino acids 194 - 294  	Alignment:                                                   
						of F01885_P5, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence GERSSSETAG   	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						corresponding to amino acids 295 - 304 of F01885_P5, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated chimeric polypeptide encoding 	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						for an edge portion of F01885_P5, comprising a polypeptide   	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNL....... 193                                                          
						wherein at least two amino acids comprise LT, having a       	         |||||||||||||||||||||||||||||||||||||||||||         
						structure as follows: a sequence starting from any of amino  	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNLTGLVSSE 200                                                          
						acid numbers 193-x to 194; and ending at any of amino acid   	                  .         .         .         .         .  
						numbers 194+ ((n-2) - x), in which x varies from 0 to        	     194 .....TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 238                                                          
						n-2.3.An isolated polypeptide encoding for a tail of         	              |||||||||||||||||||||||||||||||||||||||||||||  
						F01885_P5, comprising a polypeptide being at least 70%,      	     201 NSSKATDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     239 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 288                                                          
						least about 95% homologous to the sequence GERSSSETAG in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F01885_P5.                                                   	     251 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 300                                                          
						                                                            	                                                             
						                                                            	     289 MPDGQQ                                             294                                                          
						                                                            	         ||||||                                              
						                                                            	     301 MPDGQQ                                             306                                                          

						Comparison report between F01885_P5 and GABC_HUMANpartial WT 	Sequence name: GABC_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01885_P5, comprising a first amino acid sequence being at   	                                                            
						MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHYSTTEVLLRA 	Alignment of: 25082 x GABC_HUMAN   ..                        
						GVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVV 	                                                            
						ELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEILQIAMQNQINTNPESPDTVTIHAAT 	Alignment segment 1/1:                                       
						PQFIIGPGGVVNL                                                	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 193	                     Quality: 2690.00                      Escore:       0                                               
						of GABC_HUMAN, which also corresponds to amino acids 1 - 193 	             Matching length:     294                Total length:     306                                               
						of F01885_P5, a second amino acid sequence being at least 90 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEEVVTAESVDGAIQQVV 	    Total Percent Similarity:   96.08      Total Percent Identity:   96.08                                               
						SSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVTMPDGQQ                    	                        Gaps:       1                        
						% homologous to corresponding to amino acids 206 - 306 of    	                                                            
						GABC_HUMAN, which also corresponds to amino acids 194 - 294  	Alignment:                                                   
						of F01885_P5, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence GERSSSETAG   	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						corresponding to amino acids 295 - 304 of F01885_P5, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated chimeric polypeptide encoding 	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						for an edge portion of F01885_P5, comprising a polypeptide   	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNL....... 193                                                          
						wherein at least two amino acids comprise LT, having a       	         |||||||||||||||||||||||||||||||||||||||||||         
						structure as follows: a sequence starting from any of amino  	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNLTGLVSSE 200                                                          
						acid numbers 193-x to 194; and ending at any of amino acid   	                  .         .         .         .         .  
						numbers 194+ ((n-2) - x), in which x varies from 0 to        	     194 .....TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 238                                                          
						n-2.3.An isolated polypeptide encoding for a tail of         	              |||||||||||||||||||||||||||||||||||||||||||||  
						F01885_P5, comprising a polypeptide being at least 70%,      	     201 NSSKATDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     239 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 288                                                          
						least about 95% homologous to the sequence GERSSSETAG in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F01885_P5.                                                   	     251 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 300                                                          
						                                                            	                                                             
						                                                            	     289 MPDGQQ                                             294                                                          
						                                                            	         ||||||                                              
						                                                            	     301 MPDGQQ                                             306                                                          

25080	HMR136_F01885_9_tr0_r1_1_gPRT		Comparison report between F01885_P9 and GABB_HUMANunique     	Sequence name: GABB_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F01885_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25080 x GABB_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						VGPCYHRMWKLISSL corresponding to amino acids 1 - 15 of       	                                                            
						F01885_P9, a second amino acid sequence being at least 90 %  	                     Quality: 3543.00                      Escore:       0                                               
						MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHYSTTEVLLRA 	             Matching length:     383                Total length:     395                                               
						GVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEILQIAMQNQINTNPESPDTVTIHAAT 	    Total Percent Similarity:   96.96      Total Percent Identity:   96.96                                               
						PQFIIGPGGVVNL                                                	                        Gaps:       1                        
						homologous to corresponding to amino acids 1 - 193 of        	                                                            
						GABB_HUMAN, which also corresponds to amino acids 16 - 208 of	Alignment:                                                   
						F01885_P9, and a third amino acid sequence being at least 90 	                  .         .         .         .         .  
						TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEEVVTAESVDGAIQQVV 	      16 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 65                                                           
						SSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVTMPDGQQVLTVPATDIAEETVISEEP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PAKRQCIEIIENRVESAEIEEREALQKQLDEANREAQKYRQQLLKKEQEAEAYRQKLEAM 	       1 MSLVDLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGH 50                                                           
						TRLQTNKEAV                                                   	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 206 - 395 of    	      66 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 115                                                          
						GABB_HUMAN, which also corresponds to amino acids 209 - 398  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F01885_P9, wherein said first amino acid sequence, second 	      51 YSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHASIVEVLLKHGADVNAK 100                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     116 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 165                                                          
						polypeptide encoding for a head of F01885_P9, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 DMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     166 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNL....... 208                                                          
						to the sequence VGPCYHRMWKLISSL of F01885_P9.3.An isolated   	         |||||||||||||||||||||||||||||||||||||||||||         
						chimeric polypeptide encoding for an edge portion of         	     151 DLAEILQIAMQNQINTNPESPDTVTIHAATPQFIIGPGGVVNLTGLVSSE 200                                                          
						F01885_P9, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     209 .....TDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 253                                                          
						optionally at least about 20 amino acids in length,          	              |||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     201 NSSKATDETGVSAVQFGNSSTSVLATLAALAEASAPLSNSSETPVVATEE 250                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     254 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 303                                                          
						at least two amino acids comprise LT, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     251 VVTAESVDGAIQQVVSSGGQQVITIVTDGIQLGNLHSIPTSGIGQPIIVT 300                                                          
						208-x to 209; and ending at any of amino acid numbers 209+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     304 MPDGQQVLTVPATDIAEETVISEEPPAKRQCIEIIENRVESAEIEEREAL 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 MPDGQQVLTVPATDIAEETVISEEPPAKRQCIEIIENRVESAEIEEREAL 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     354 QKQLDEANREAQKYRQQLLKKEQEAEAYRQKLEAMTRLQTNKEAV      398                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     351 QKQLDEANREAQKYRQQLLKKEQEAEAYRQKLEAMTRLQTNKEAV      395                                                          

25417	HMR136_F01909_4_tr0_r1_1_gPRT		Comparison report between F01909_P4 and PGTA_HUMANpartial WT 	Sequence name: PGTA_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for F01909_P4, comprising a first amino 	Sequence documentation:                                      
						MHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLELTSQILGANP 	                                                            
						DFATLWNCRREVLQQLETQKSPEELAALVKAELGFLESCLRVNPKSYGTWHHRCWLLGRL 	Alignment of: 25417 x PGTA_HUMAN   ..                        
						PEPNWTRELELCARFLEVDERNFHCWDYRRFVATQAAVPPAEELAFTDSLITRNFSNYSS 	                                                            
						WHYRSCLLPQLHPQPDSGPQGRLPEDVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRAD 	Alignment segment 1/1:                                       
						PQDALRCLHVSRDEACLTVSFSRPLLVGSRMEILLLMVDDSPLIVEWRTPDGRNRPSHVW 	                                                            
						LCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDSTTDEQLFRCELSVEK 	                     Quality: 5496.00                      Escore:       0                                               
						STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFQTLK         	             Matching length:     567                Total length:     598                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 412 of PGTA_HUMAN, which also corresponds 	    Total Percent Similarity:   94.82      Total Percent Identity:   94.82                                               
						to amino acids 1 - 412 of F01909_P4, a second amino acid     	                        Gaps:       1                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence ASSVCRTDQGEAQQAGGRQLTCIPCPPHPLQ          	       1 MHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLE 50                                                           
						corresponding to amino acids 413 - 443 of F01909_P4, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDPMRATYLDDLRSKFLLENSVLKMEYAEVRVLHLAHKDLTVLCHLEQLLLVTHLDLSH 	       1 MHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLE 50                                                           
						NRLRTLPPALAALRCLEVLQASDNAIESLDGVTNLPRLQELLLCNNRLQQPAVLQPLASC 	                  .         .         .         .         .  
						PRLVLLNLQGNPLCQAVGILEQLAELLPSVSSVLT                          	      51 LTSQILGANPDFATLWNCRREVLQQLETQKSPEELAALVKAELGFLESCL 100                                                          
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 413 - 567 of PGTA_HUMAN, which  	      51 LTSQILGANPDFATLWNCRREVLQQLETQKSPEELAALVKAELGFLESCL 100                                                          
						also corresponds to amino acids 444 - 598 of F01909_P4,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     101 RVNPKSYGTWHHRCWLLGRLPEPNWTRELELCARFLEVDERNFHCWDYRR 150                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for an 	     101 RVNPKSYGTWHHRCWLLGRLPEPNWTRELELCARFLEVDERNFHCWDYRR 150                                                          
						edge portion of F01909_P4, comprising an amino acid sequence 	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     151 FVATQAAVPPAEELAFTDSLITRNFSNYSSWHYRSCLLPQLHPQPDSGPQ 200                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     151 FVATQAAVPPAEELAFTDSLITRNFSNYSSWHYRSCLLPQLHPQPDSGPQ 200                                                          
						encoding for ASSVCRTDQGEAQQAGGRQLTCIPCPPHPLQ, corresponding  	                  .         .         .         .         .  
						to F01909_P4.                                                	     201 GRLPEDVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRADPQDALRCLHV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GRLPEDVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRADPQDALRCLHV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SRDEACLTVSFSRPLLVGSRMEILLLMVDDSPLIVEWRTPDGRNRPSHVW 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SRDEACLTVSFSRPLLVGSRMEILLLMVDDSPLIVEWRTPDGRNRPSHVW 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDSTTDEQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDSTTDEQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EKETLQYFQTLKASSVCRTDQGEAQQAGGRQLTCIPCPPHPLQAVDPMRA 450                                                          
						                                                            	         ||||||||||||                               |||||||  
						                                                            	     401 EKETLQYFQTLK...............................AVDPMRA 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TYLDDLRSKFLLENSVLKMEYAEVRVLHLAHKDLTVLCHLEQLLLVTHLD 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 TYLDDLRSKFLLENSVLKMEYAEVRVLHLAHKDLTVLCHLEQLLLVTHLD 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LSHNRLRTLPPALAALRCLEVLQASDNAIESLDGVTNLPRLQELLLCNNR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 LSHNRLRTLPPALAALRCLEVLQASDNAIESLDGVTNLPRLQELLLCNNR 519                                                          
						                                                            	                  .         .         .         .            
						                                                            	     551 LQQPAVLQPLASCPRLVLLNLQGNPLCQAVGILEQLAELLPSVSSVLT   598                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     520 LQQPAVLQPLASCPRLVLLNLQGNPLCQAVGILEQLAELLPSVSSVLT   567                                                          

25415	HMR136_F01909_7_tr0_r1_1_gPRT		Comparison report between F01909_P7 and PGTA_HUMANpartial WT 	Sequence name: PGTA_HUMAN                                    
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for F01909_P7, comprising a first amino 	Sequence documentation:                                      
						MHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLELTSQILGANP 	                                                            
						DFATLWNCRREVLQQLETQKSPEELAALVKAELGFLESCLRVNPKSYGTWHHRCWLLGRL 	Alignment of: 25415 x PGTA_HUMAN   ..                        
						PEPNWTRELELCARFLEVDERNFHCWDYRRFVATQAAVPPAEELAFTDSLITRNFSNYSS 	                                                            
						WHYRSCLLPQLHPQPDSGPQGRLPEDVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRAD 	Alignment segment 1/1:                                       
						PQDALRCLHVSRDEACLTVSFSRPLLVGSRMEILLLMVDDSPLIVEWRTPDGRNRPSHVW 	                                                            
						LCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDSTTDEQLFR        	                     Quality: 3542.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     353                Total length:     353                                               
						to amino acids 1 - 353 of PGTA_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 353 of F01909_P7, and a second amino acid 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence W corresponding to amino acids 354 - 354 	                  .         .         .         .         .  
						of F01909_P7, wherein said first amino acid sequence and     	       1 MHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLE 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	       1 MHGRLKVKTSEEQAEAKRLEREQKLKLYQSATQAVFQKRQAGELDESVLE 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LTSQILGANPDFATLWNCRREVLQQLETQKSPEELAALVKAELGFLESCL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 LTSQILGANPDFATLWNCRREVLQQLETQKSPEELAALVKAELGFLESCL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RVNPKSYGTWHHRCWLLGRLPEPNWTRELELCARFLEVDERNFHCWDYRR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RVNPKSYGTWHHRCWLLGRLPEPNWTRELELCARFLEVDERNFHCWDYRR 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FVATQAAVPPAEELAFTDSLITRNFSNYSSWHYRSCLLPQLHPQPDSGPQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FVATQAAVPPAEELAFTDSLITRNFSNYSSWHYRSCLLPQLHPQPDSGPQ 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GRLPEDVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRADPQDALRCLHV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GRLPEDVLLKELELVQNAFFTDPNDQSAWFYHRWLLGRADPQDALRCLHV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SRDEACLTVSFSRPLLVGSRMEILLLMVDDSPLIVEWRTPDGRNRPSHVW 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SRDEACLTVSFSRPLLVGSRMEILLLMVDDSPLIVEWRTPDGRNRPSHVW 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDSTTDEQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDSTTDEQ 350                                                          
						                                                            	                                                             
						                                                            	     351 LFR                                                353                                                          
						                                                            	         |||                                                 
						                                                            	     351 LFR                                                353                                                          

26012	HMR136_F02024_5_tr0_r1_1_gPRT		Comparison report between F02024_P5 and NUGL_HUMANpartial WT 	Sequence name: NUGL_HUMAN                                    
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F02024_P5, comprising a first amino 	Sequence documentation:                                      
						MAETFYLSNIVPQDFDNNSGYWNRIEMYCRELTERFEDVWVVSGPLTLPQTRGDGKKIVS 	                                                            
						YQVIGEDNVAVPSHLYKVILARRSSVSTEPLALGAFVVPNEAIGFQPQLTEFQVSLQDLE 	Alignment of: 26012 x NUGL_HUMAN   ..                        
						KLS                                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 154 - 276 of NUGL_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 123 of F02024_P5, a bridging  	                     Quality: 2081.00                      Escore:       0                                               
						amino acid G corresponding to amino acid 124 of F02024_P5,   	             Matching length:     215                Total length:     215                                               
						and a second amino acid sequence being at least 90 %         	 Matching Percent Similarity:   99.53   Matching Percent Identity:   99.53                                               
						LVFFPHLDRTSDIRNICSVDTCKLLDFQEFTLYLSTRKIEGARSVLRLEKIMENLKNAEI 	    Total Percent Similarity:   99.53      Total Percent Identity:   99.53                                               
						EPDDYFMSRYEKKLEELKAKEQSGTQIRKPS                              	                        Gaps:       0                        
						homologous to corresponding to amino acids 278 - 368 of      	                                                            
						NUGL_HUMAN, which also corresponds to amino acids 125 - 215  	Alignment:                                                   
						of F02024_P5, wherein said first amino acid sequence,        	                  .         .         .         .         .  
						bridging amino acid and second amino acid sequence are       	       1 MAETFYLSNIVPQDFDNNSGYWNRIEMYCRELTERFEDVWVVSGPLTLPQ 50                                                           
						contiguous and in a sequential order.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     154 MAETFYLSNIVPQDFDNNSGYWNRIEMYCRELTERFEDVWVVSGPLTLPQ 203                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TRGDGKKIVSYQVIGEDNVAVPSHLYKVILARRSSVSTEPLALGAFVVPN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 TRGDGKKIVSYQVIGEDNVAVPSHLYKVILARRSSVSTEPLALGAFVVPN 253                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EAIGFQPQLTEFQVSLQDLEKLSGLVFFPHLDRTSDIRNICSVDTCKLLD 150                                                          
						                                                            	         ||||||||||||||||||||||| ||||||||||||||||||||||||||  
						                                                            	     254 EAIGFQPQLTEFQVSLQDLEKLSVLVFFPHLDRTSDIRNICSVDTCKLLD 303                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FQEFTLYLSTRKIEGARSVLRLEKIMENLKNAEIEPDDYFMSRYEKKLEE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 FQEFTLYLSTRKIEGARSVLRLEKIMENLKNAEIEPDDYFMSRYEKKLEE 353                                                          
						                                                            	                  .                                          
						                                                            	     201 LKAKEQSGTQIRKPS                                    215                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     354 LKAKEQSGTQIRKPS                                    368                                                          

26465	HMR136_F02050_14_tr0_r1_1_gPRT		Comparison report between F02050_P14 and Q96NM0unique head   	Sequence name: Q96NM0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F02050_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 26465 x Q96NM0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						LGSCCRVAGGRAAALRGPGAGGPAARPRLGGDGGGRRHLGQGQPRELAGCGSRADGGFRP 	Alignment segment 1/1:                                       
						SRVVVVAKTTRYEFEQQRYRYAELSEEDLKQLLALKGSSYSGLLERHHIHTKNVEHIIDS 	                                                            
						LRNEGIEVRLVKRREYDEETVRWADAVIAAGGDGT                          	                     Quality: 1524.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     155                Total length:     155                                               
						to amino acids 1 - 155 of F02050_P14, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLLAASKVLDRLKPVIGVNTDPERSEGHLCLPVRYTHSFPEALQKFYRGEFRWLWRQRIR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSEASGPQLLPVRALNEVFIGES 	                        Gaps:       0                        
						LSSRASYYEISVDDGPWEKQKSSGLNLCTGTGSKA                          	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 155 of Q96NM0, which also corresponds to     	                  .         .         .         .         .  
						amino acids 156 - 310 of F02050_P14, and a third amino acid  	     156 MLLAASKVLDRLKPVIGVNTDPERSEGHLCLPVRYTHSFPEALQKFYRGE 205                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MLLAASKVLDRLKPVIGVNTDPERSEGHLCLPVRYTHSFPEALQKFYRGE 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence CKTTRKFESSIEQRIGRESNK corresponding to   	     206 FRWLWRQRIRLYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSE 255                                                          
						amino acids 311 - 331 of F02050_P14, wherein said first amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	      51 FRWLWRQRIRLYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSE 100                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of F02050_P14,      	     256 ASGPQLLPVRALNEVFIGESLSSRASYYEISVDDGPWEKQKSSGLNLCTG 305                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     101 ASGPQLLPVRALNEVFIGESLSSRASYYEISVDDGPWEKQKSSGLNLCTG 150                                                          
						preferably at least about 90% and most preferably at least   	                                                             
						LGSCCRVAGGRAAALRGPGAGGPAARPRLGGDGGGRRHLGQGQPRELAGCGSRADGGFRP 	     306 TGSKA                                              310                                                          
						SRVVVVAKTTRYEFEQQRYRYAELSEEDLKQLLALKGSSYSGLLERHHIHTKNVEHIIDS 	         |||||                                               
						LRNEGIEVRLVKRREYDEETVRWADAVIAAGGDGT                          	     151 TGSKA                                              155                                                          
						about 95% homologous to the sequence of F02050_P14.3.An      	                                                            
						isolated polypeptide encoding for a tail of F02050_P14,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence CKTTRKFESSIEQRIGRESNK in	                                                            
						F02050_P14.                                                  	                                                            

26467	HMR136_F02050_7_tr0_r1_1_gPRT		Comparison report between F02050_P7 and Q96NM0unique head    	Sequence name: Q96NM0                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F02050_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 26467 x Q96NM0   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						LGSCCRVAGGRAAALRGPGAGGPAARPRLGGDGGGRRHLGQGQPRELAGCGSRADGGFRP 	Alignment segment 1/1:                                       
						SRVVVVAKTTRYEFEQQRYRYAELSEEDLKQLLALKGSSYSGLLERHHIHTKNVEHIIDS 	                                                            
						LRNEGIEVRLVKRREYDEETVRWADAVIAAGGDGT                          	                     Quality: 2352.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     251                Total length:     279                                               
						to amino acids 1 - 155 of F02050_P7, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to                   	    Total Percent Similarity:   89.96      Total Percent Identity:   89.96                                               
						MLLAASKVLDRLKPVIGVNTDPE corresponding to amino acids 1 - 23  	                        Gaps:       1                        
						of Q96NM0, which also corresponds to amino acids 156 - 178 of	                                                            
						F02050_P7, and a third amino acid sequence being at least 90 	Alignment:                                                   
						RWLWRQRIRLYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSEASGPQLLPVRA 	                  .         .         .         .         .  
						LNEVFIGESLSSRASYYEISVDDGPWEKQKSSGLNLCTGTGSKAWSFNINRVATQAVEDV 	     156 MLLAASKVLDRLKPVIGVNTDPE........................... 178                                                          
						LNIAKRQGNLSLPLNRELVEKVTNEYNESLLYSPEEPKILFSIREPIANRVFSSSRQRCF 	         |||||||||||||||||||||||                             
						SSKVCVRSRCWDACMVVDGGTSFEFNDGAIASMMINKEDELRTVLLEQ             	       1 MLLAASKVLDRLKPVIGVNTDPERSEGHLCLPVRYTHSFPEALQKFYRGE 50                                                           
						% homologous to corresponding to amino acids 52 - 279 of     	                  .         .         .         .         .  
						Q96NM0, which also corresponds to amino acids 179 - 406 of   	     179 .RWLWRQRIRLYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSE 227                                                          
						F02050_P7, wherein said first amino acid sequence, second    	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      51 FRWLWRQRIRLYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSE 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of F02050_P7, comprising a   	     228 ASGPQLLPVRALNEVFIGESLSSRASYYEISVDDGPWEKQKSSGLNLCTG 277                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 ASGPQLLPVRALNEVFIGESLSSRASYYEISVDDGPWEKQKSSGLNLCTG 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						LGSCCRVAGGRAAALRGPGAGGPAARPRLGGDGGGRRHLGQGQPRELAGCGSRADGGFRP 	     278 TGSKAWSFNINRVATQAVEDVLNIAKRQGNLSLPLNRELVEKVTNEYNES 327                                                          
						SRVVVVAKTTRYEFEQQRYRYAELSEEDLKQLLALKGSSYSGLLERHHIHTKNVEHIIDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRNEGIEVRLVKRREYDEETVRWADAVIAAGGDGT                          	     151 TGSKAWSFNINRVATQAVEDVLNIAKRQGNLSLPLNRELVEKVTNEYNES 200                                                          
						to the sequence of F02050_P7.3.An isolated chimeric          	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of F02050_P7,       	     328 LLYSPEEPKILFSIREPIANRVFSSSRQRCFSSKVCVRSRCWDACMVVDG 377                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     201 LLYSPEEPKILFSIREPIANRVFSSSRQRCFSSKVCVRSRCWDACMVVDG 250                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .                                
						amino acids in length, more preferably at least about 40     	     378 GTSFEFNDGAIASMMINKEDELRTVLLEQ                      406                                                          
						amino acids in length and most preferably at least about 50  	         |||||||||||||||||||||||||||||                       
						amino acids in length, wherein at least two amino acids      	     251 GTSFEFNDGAIASMMINKEDELRTVLLEQ                      279                                                          
						comprise ER, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 178-x to 179; and    	                                                            
						ending at any of amino acid numbers 179+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.                                	                                                            

26912	HMR136_F02206_5_tr0_r1_1_gPRT		Comparison report between F02206_P5 and KCH7_HUMANpartial WT 	Sequence name: KCH7_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F02206_P5, comprising a first amino 	Sequence documentation:                                      
						MPVRRGHVAPQNTFLGTIIRKFEGQNKKFIIANARVQNCAIIYCNDGFCEMTGFSRPDVM 	                                                            
						QKPCTCDFLHGPETKRHDIAQIAQALLGSEERKVEVTYYHKNG                  	Alignment of: 26912 x KCH7_HUMAN   ..                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 103 of KCH7_HUMAN, which also corresponds 	Alignment segment 1/1:                                       
						to amino acids 1 - 103 of F02206_P5, and a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1036.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     103                Total length:     103                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence KIPLFRIPSI corresponding to amino acids  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						104 - 113 of F02206_P5, wherein said first amino acid        	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of F02206_P5, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MPVRRGHVAPQNTFLGTIIRKFEGQNKKFIIANARVQNCAIIYCNDGFCE 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence KIPLFRIPSI in  	       1 MPVRRGHVAPQNTFLGTIIRKFEGQNKKFIIANARVQNCAIIYCNDGFCE 50                                                           
						F02206_P5.                                                   	                  .         .         .         .         .  
						                                                            	      51 MTGFSRPDVMQKPCTCDFLHGPETKRHDIAQIAQALLGSEERKVEVTYYH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 MTGFSRPDVMQKPCTCDFLHGPETKRHDIAQIAQALLGSEERKVEVTYYH 100                                                          
						                                                            	                                                             
						                                                            	     101 KNG                                                103                                                          
						                                                            	         |||                                                 
						                                                            	     101 KNG                                                103                                                          

27049	HMR136_F02253_14_tr0_r1_1_gPRT		Comparison report between F02253_P14 and Z131_HUMANunique    	Sequence name: Z131_HUMAN                                    
						head followed by partial WT sequence with a short unique     	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for F02253_P14,       	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 27049 x Z131_HUMAN   ..                        
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						MEAEETMECLQEFPEHHKMILDRLNEQREQDRFTDITLIVDGHHFKAHKAVLAACSKFFY 	                                                            
						KFFQEFTQEPLVEIEGVSKMAFRHLIEFTYTAKLMIQGEEEANDVWKAAEFLQMLEAIKA 	                     Quality: 1883.00                      Escore:       0                                               
						LEVRNKENSAPLEENTTGKNEAKKRKIAETS                              	             Matching length:     201                Total length:     202                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:   99.50   Matching Percent Identity:   99.00                                               
						to amino acids 1 - 151 of F02253_P14, a second amino acid    	    Total Percent Similarity:   99.01      Total Percent Identity:   98.51                                               
						sequence being at least 90 % homologous to                   	                        Gaps:       1                        
						NVITESLPSAESEPVEIEVEIAE corresponding to amino acids 5 - 27  	                                                            
						of Z131_HUMAN, which also corresponds to amino acids 152 -   	Alignment:                                                   
						174 of F02253_P14, a third amino acid sequence being at least	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     151 SNVITESLPSAESEPVEIEVEIAEGTIEVEDEGIETLEEVASAKQSVKYI 200                                                          
						preferably at least 90% and most preferably at least 95%     	         :|||||||||||||||||||||||  ||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence G            	       4 ANVITESLPSAESEPVEIEVEIAE.AIEVEDEGIETLEEVASAKQSVKYI 52                                                           
						corresponding to amino acids 175 - 175 of F02253_P14, a      	                  .         .         .         .         .  
						bridging amino acid T corresponding to amino acid 176 of     	     201 QSTGSSDDSALALLADITSKYRQGDRKGQIKEDGCPSDPTSKQVEGIEIV 250                                                          
						F02253_P14, a fourth amino acid sequence being at least 90 % 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEVEDEGIETLEEVASAKQSVKYIQSTGSSDDSALALLADITSKYRQGDRKGQIKEDGCP 	      53 QSTGSSDDSALALLADITSKYRQGDRKGQIKEDGCPSDPTSKQVEGIEIV 102                                                          
						SDPTSKQVEGIEIVELQLSHVKDLFHCEKCNRSFKLFYHFKEHMKSHSTESFKCEICNKR 	                  .         .         .         .         .  
						YLRESAWKQHLNCYHLEEGGVSKKQRTGKKIHVCQYCEKQFDHFGHFKEHLRKHTG     	     251 ELQLSHVKDLFHCEKCNRSFKLFYHFKEHMKSHSTESFKCEICNKRYLRE 300                                                          
						homologous to corresponding to amino acids 29 - 204 of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Z131_HUMAN, which also corresponds to amino acids 177 - 352  	     103 ELQLSHVKDLFHCEKCNRSFKLFYHFKEHMKSHSTESFKCEICNKRYLRE 152                                                          
						of F02253_P14, and a fifth amino acid sequence being at least	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     301 SAWKQHLNCYHLEEGGVSKKQRTGKKIHVCQYCEKQFDHFGHFKEHLRKH 350                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence NEQILC       	     153 SAWKQHLNCYHLEEGGVSKKQRTGKKIHVCQYCEKQFDHFGHFKEHLRKH 202                                                          
						corresponding to amino acids 353 - 358 of F02253_P14, wherein	                                                             
						said first amino acid sequence, second amino acid sequence,  	     351 TG                                                 352                                                          
						third amino acid sequence, bridging amino acid, fourth amino 	         ||                                                  
						acid sequence and fifth amino acid sequence are contiguous   	     203 TG                                                 204                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of F02253_P14, comprising a polypeptide being at  	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MEAEETMECLQEFPEHHKMILDRLNEQREQDRFTDITLIVDGHHFKAHKAVLAACSKFFY 	                                                            
						KFFQEFTQEPLVEIEGVSKMAFRHLIEFTYTAKLMIQGEEEANDVWKAAEFLQMLEAIKA 	                                                            
						LEVRNKENSAPLEENTTGKNEAKKRKIAETS                              	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						F02253_P14.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of F02253_P14, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for G, corresponding to F02253_P14.4.An isolated    	                                                            
						polypeptide encoding for a tail of F02253_P14, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence NEQILC in F02253_P14.                        	                                                            

27047	HMR136_F02253_6_tr0_r1_1_gPRT		Comparison report between F02253_P6 and Z131_HUMANpartial WT 	Sequence name: Z131_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02253_P6, comprising a first amino acid        	                                                            
						MKSHSTESFKCEICNKRYLRESAWKQHLNCYHLEEGGVSKKQRTGKKIHVCQYCEKQFDH 	Alignment of: 27047 x Z131_HUMAN   ..                        
						FGHFKEHLRKHTGEKPFECPNCHERFARNSTLKCHLTACQTGVGAKKGRKKLYECQVCNS 	                                                            
						VFNSWDQFKDHLVIHTGDKPNHCTLCDLWFMQGNELRRHLSDAHNISERLVTEEVLSVET 	Alignment segment 1/1:                                       
						RVQTEPVTSMTIIEQVGKVHVLPLLQVQVDSAQVTVEQVHPDLLQDSQVHDSHMSELPEQ 	                                                            
						VQVSYLEVGRIQTEEGTEVHVEELHVERVNQMPVEVQTELLEADLDHVTPEIMNQEERES 	                     Quality: 3448.00                      Escore:       0                                               
						SQADAAEAAREDHEDAEDLETKPTVDSEAEKAENEDRTALPVLE                 	             Matching length:     344                Total length:     344                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 132 - 475 of Z131_HUMAN, which also corresponds  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 344 of F02253_P6.                         	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKSHSTESFKCEICNKRYLRESAWKQHLNCYHLEEGGVSKKQRTGKKIHV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     132 MKSHSTESFKCEICNKRYLRESAWKQHLNCYHLEEGGVSKKQRTGKKIHV 181                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CQYCEKQFDHFGHFKEHLRKHTGEKPFECPNCHERFARNSTLKCHLTACQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     182 CQYCEKQFDHFGHFKEHLRKHTGEKPFECPNCHERFARNSTLKCHLTACQ 231                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TGVGAKKGRKKLYECQVCNSVFNSWDQFKDHLVIHTGDKPNHCTLCDLWF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     232 TGVGAKKGRKKLYECQVCNSVFNSWDQFKDHLVIHTGDKPNHCTLCDLWF 281                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MQGNELRRHLSDAHNISERLVTEEVLSVETRVQTEPVTSMTIIEQVGKVH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     282 MQGNELRRHLSDAHNISERLVTEEVLSVETRVQTEPVTSMTIIEQVGKVH 331                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VLPLLQVQVDSAQVTVEQVHPDLLQDSQVHDSHMSELPEQVQVSYLEVGR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     332 VLPLLQVQVDSAQVTVEQVHPDLLQDSQVHDSHMSELPEQVQVSYLEVGR 381                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IQTEEGTEVHVEELHVERVNQMPVEVQTELLEADLDHVTPEIMNQEERES 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     382 IQTEEGTEVHVEELHVERVNQMPVEVQTELLEADLDHVTPEIMNQEERES 431                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 SQADAAEAAREDHEDAEDLETKPTVDSEAEKAENEDRTALPVLE       344                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     432 SQADAAEAAREDHEDAEDLETKPTVDSEAEKAENEDRTALPVLE       475                                                          

27884	HMR136_F02311_14_tr0_r1_1_gPRT		Comparison report between F02311_P14 and DJB2_HUMANunique    	Sequence name: DJB2_HUMAN                                    
						head followed by partial WT sequence followed by a short     	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						F02311_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27884 x DJB2_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MIWSLFAE     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of F02311_P14, a second   	                                                            
						HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDD 	                     Quality: 2084.00                      Escore:       0                                               
						LGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRI 	             Matching length:     215                Total length:     215                                               
						TTRRIMENGQERVEVEEDGQLKSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 60 - 274 of DJB2_HUMAN, which   	                                                            
						also corresponds to amino acids 9 - 223 of F02311_P14, and a 	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	       9 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 58                                                           
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence DVF corresponding to amino   	      60 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 109                                                          
						acids 224 - 226 of F02311_P14, wherein said first amino acid 	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	      59 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 108                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F02311_P14,      	     110 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 159                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     109 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 158                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence MIWSLFAE of F02311_P14. 	     160 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 209                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 259                                                          
						                                                            	                  .                                          
						                                                            	     209 AYSLSEMEAAGKKPA                                    223                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     260 AYSLSEMEAAGKKPA                                    274                                                          

						Comparison report between F02311_P14 and AAH47056unique head 	Sequence name: AAH47056                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F02311_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27884 x AAH47056   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MIWSLFAE corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F02311_P14, and a second amino acid sequence being at   	                                                            
						HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDD 	                     Quality: 2113.00                      Escore:       0                                               
						LGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRI 	             Matching length:     218                Total length:     218                                               
						TTRRIMENGQERVEVEEDGQLKSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPADVF                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 60 -   	                        Gaps:       0                        
						277 of AAH47056, which also corresponds to amino acids 9 -   	                                                            
						226 of F02311_P14, wherein said first amino acid sequence and	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	       9 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 58                                                           
						F02311_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      60 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 109                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence MIWSLFAE of       	      59 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 108                                                          
						F02311_P14.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     110 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 159                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     109 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     160 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 209                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 259                                                          
						                                                            	                  .                                          
						                                                            	     209 AYSLSEMEAAGKKPADVF                                 226                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     260 AYSLSEMEAAGKKPADVF                                 277                                                          

						Comparison report between F02311_P14 and AAP35751unique head 	Sequence name: AAP35751                                      
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F02311_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27884 x AAP35751   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MIWSLFAE     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of F02311_P14, a second   	                                                            
						HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDD 	                     Quality: 2084.00                      Escore:       0                                               
						LGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRI 	             Matching length:     215                Total length:     215                                               
						TTRRIMENGQERVEVEEDGQLKSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 60 - 274 of AAP35751, which also	                                                            
						corresponds to amino acids 9 - 223 of F02311_P14, and a third	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       9 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 58                                                           
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence DVF corresponding to amino acids 224 -   	      60 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 109                                                          
						226 of F02311_P14, wherein said first amino acid sequence,   	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	      59 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 108                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F02311_P14, comprising a  	     110 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 159                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     109 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 158                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MIWSLFAE of F02311_P14.                      	     160 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 209                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 259                                                          
						                                                            	                  .                                          
						                                                            	     209 AYSLSEMEAAGKKPA                                    223                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     260 AYSLSEMEAAGKKPA                                    274                                                          

						Comparison report between F02311_P14 and Q8IUK2unique head   	Sequence name: Q8IUK2                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a short unique tail.1.An isolated chimeric polypeptide       	Sequence documentation:                                      
						encoding for F02311_P14, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 27884 x Q8IUK2   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MIWSLFAE corresponding to amino acids 1 -	                                                            
						8 of F02311_P14, a second amino acid sequence being at least 	                     Quality: 2070.00                      Escore:       0                                               
						HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDD 	             Matching length:     215                Total length:     215                                               
						LGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRI 	 Matching Percent Similarity:   99.53   Matching Percent Identity:   99.53                                               
						TTRRIMENGQERVEVEEDGQLKSVTINGVPDDLA                           	    Total Percent Similarity:   99.53      Total Percent Identity:   99.53                                               
						90 % homologous to corresponding to amino acids 60 - 213 of  	                        Gaps:       0                        
						Q8IUK2, which also corresponds to amino acids 9 - 162 of     	                                                            
						F02311_P14, a bridging amino acid L corresponding to amino   	Alignment:                                                   
						acid 163 of F02311_P14, a third amino acid sequence being at 	                  .         .         .         .         .  
						least 90 % homologous to GLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                                    	       9 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 58                                                           
						corresponding to amino acids 215 - 274 of Q8IUK2, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 164 - 223 of F02311_P14, and a    	      60 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 109                                                          
						fourth amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      59 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 108                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence DVF corresponding to amino   	     110 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 159                                                          
						acids 224 - 226 of F02311_P14, wherein said first amino acid 	                  .         .         .         .         .  
						sequence, second amino acid sequence, bridging amino acid,   	     109 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 158                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     160 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 209                                                          
						polypeptide encoding for a head of F02311_P14, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     159 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 208                                                          
						80%, preferably at least about 85%, more preferably at least 	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     210 DDLARGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 259                                                          
						to the sequence MIWSLFAE of F02311_P14.                      	                  .                                          
						                                                            	     209 AYSLSEMEAAGKKPA                                    223                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     260 AYSLSEMEAAGKKPA                                    274                                                          

						Comparison report between F02311_P14 and Q8IUK1unique head   	Sequence name: Q8IUK1                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F02311_P14, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 27884 x Q8IUK1   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MIWSLFAE corresponding to    	Alignment segment 1/1:                                       
						amino acids 1 - 8 of F02311_P14, a second amino acid sequence	                                                            
						HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDD 	                     Quality: 2099.00                      Escore:       0                                               
						LGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRI 	             Matching length:     218                Total length:     218                                               
						TTRRIMENGQERVEVEEDGQLKSVTINGVPDDLA                           	 Matching Percent Similarity:   99.54   Matching Percent Identity:   99.54                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:   99.54      Total Percent Identity:   99.54                                               
						acids 60 - 213 of Q8IUK1, which also corresponds to amino    	                        Gaps:       0                        
						acids 9 - 162 of F02311_P14, a bridging amino acid L         	                                                            
						corresponding to amino acid 163 of F02311_P14, and a third   	Alignment:                                                   
						GLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA 	                  .         .         .         .         .  
						DVF                                                          	       9 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 58                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 215 - 277 of Q8IUK1, which also 	      60 HKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGS 109                                                          
						corresponds to amino acids 164 - 226 of F02311_P14, wherein  	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	      59 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 108                                                          
						bridging amino acid and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     110 GDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSP 159                                                          
						polypeptide encoding for a head of F02311_P14, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     109 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 158                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     160 GAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQLKSVTINGVP 209                                                          
						to the sequence MIWSLFAE of F02311_P14.                      	                  .         .         .         .         .  
						                                                            	     159 DDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 208                                                          
						                                                            	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 DDLARGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAM 259                                                          
						                                                            	                  .                                          
						                                                            	     209 AYSLSEMEAAGKKPADVF                                 226                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     260 AYSLSEMEAAGKKPADVF                                 277                                                          

27886	HMR136_F02311_3_tr0_r1_1_gPRT		Comparison report between F02311_P3 and DJB2_HUMANpartial WT 	Sequence name: DJB2_HUMAN                                    
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for F02311_P3, comprising a first amino 	Sequence documentation:                                      
						MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVAEAYEVLSDKH 	                                                            
						KREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDDL 	Alignment of: 27886 x DJB2_HUMAN   ..                        
						GPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRIT 	                                                            
						TRRIMENGQERVEVEEDGQLKSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTP 	Alignment segment 1/1:                                       
						ASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2669.00                      Escore:       0                                               
						to amino acids 1 - 274 of DJB2_HUMAN, which also corresponds 	             Matching length:     274                Total length:     274                                               
						to amino acids 1 - 274 of F02311_P3, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DVF corresponding to amino acids 275 -   	Alignment:                                                   
						277 of F02311_P3, wherein said first amino acid sequence and 	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          

						Comparison report between F02311_P3 and AAP35751partial WT   	Sequence name: AAP35751                                      
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for F02311_P3, comprising a first amino 	Sequence documentation:                                      
						MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVAEAYEVLSDKH 	                                                            
						KREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDDL 	Alignment of: 27886 x AAP35751   ..                          
						GPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRIT 	                                                            
						TRRIMENGQERVEVEEDGQLKSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTP 	Alignment segment 1/1:                                       
						ASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2669.00                      Escore:       0                                               
						to amino acids 1 - 274 of AAP35751, which also corresponds to	             Matching length:     274                Total length:     274                                               
						amino acids 1 - 274 of F02311_P3, and a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DVF corresponding to amino acids 275 -   	Alignment:                                                   
						277 of F02311_P3, wherein said first amino acid sequence and 	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          

						Comparison report between F02311_P3 and Q8IUK2partial WT     	Sequence name: Q8IUK2                                        
						sequence followed by mismatch and a followed by a short      	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						F02311_P3, comprising a first amino acid sequence being at   	                                                            
						MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVAEAYEVLSDKH 	Alignment of: 27886 x Q8IUK2   ..                            
						KREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDDL 	                                                            
						GPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRIT 	Alignment segment 1/1:                                       
						TRRIMENGQERVEVEEDGQLKSVTINGVPDDLA                            	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 213	                     Quality: 2655.00                      Escore:       0                                               
						of Q8IUK2, which also corresponds to amino acids 1 - 213 of  	             Matching length:     274                Total length:     274                                               
						F02311_P3, a bridging amino acid L corresponding to amino    	 Matching Percent Similarity:   99.64   Matching Percent Identity:   99.64                                               
						acid 214 of F02311_P3, a second amino acid sequence being at 	    Total Percent Similarity:   99.64      Total Percent Identity:   99.64                                               
						least 90 % homologous to GLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                                    	                        Gaps:       0                        
						corresponding to amino acids 215 - 274 of Q8IUK2, which also 	                                                            
						corresponds to amino acids 215 - 274 of F02311_P3, and a     	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence DVF corresponding to amino   	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						acids 275 - 277 of F02311_P3, wherein said first amino acid  	                  .         .         .         .         .  
						sequence, bridging amino acid, second amino acid sequence and	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						third amino acid sequence are contiguous and in a sequential 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KSVTINGVPDDLARGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          

						Comparison report between F02311_P3 and Q8IUK1partial WT     	Sequence name: Q8IUK1                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F02311_P3, comprising a first amino 	Sequence documentation:                                      
						MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVAEAYEVLSDKH 	                                                            
						KREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDDL 	Alignment of: 27886 x Q8IUK1   ..                            
						GPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRIT 	                                                            
						TRRIMENGQERVEVEEDGQLKSVTINGVPDDLA                            	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 213 of Q8IUK1, which also corresponds to  	                     Quality: 2684.00                      Escore:       0                                               
						amino acids 1 - 213 of F02311_P3, a bridging amino acid L    	             Matching length:     277                Total length:     277                                               
						corresponding to amino acid 214 of F02311_P3, and a second   	 Matching Percent Similarity:   99.64   Matching Percent Identity:   99.64                                               
						GLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA 	    Total Percent Similarity:   99.64      Total Percent Identity:   99.64                                               
						DVF                                                          	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 215 - 277 of Q8IUK1, which also 	Alignment:                                                   
						corresponds to amino acids 215 - 277 of F02311_P3, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KSVTINGVPDDLARGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPADVF                        277                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPADVF                        277                                                          

27882	HMR136_F02311_8_tr0_r1_1_gPRT		Comparison report between F02311_P8 and DJB2_HUMANpartial WT 	Sequence name: DJB2_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F02311_P8, comprising a first amino 	Sequence documentation:                                      
						MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVAEAYEVLSDKH 	                                                            
						KREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPEEVFREFFGSGDPFAELFDDL 	Alignment of: 27882 x DJB2_HUMAN   ..                        
						GPFSELQNRGSRHSGPFFTFSSSFPGHSDFSSSSFSFSPGAGAFRSVSTSTTFVQGRRIT 	                                                            
						TRRIMENGQERVEVEEDGQLKSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTP 	Alignment segment 1/1:                                       
						ASCPLDSDLSEDEDLQLAMAYSLSEMEAAGKKPA                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2669.00                      Escore:       0                                               
						to amino acids 1 - 274 of DJB2_HUMAN, which also corresponds 	             Matching length:     274                Total length:     274                                               
						to amino acids 1 - 274 of F02311_P8, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence ACPHPQD corresponding to amino acids 275 	Alignment:                                                   
						- 281 of F02311_P8, wherein said first amino acid sequence   	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of F02311_P8, comprising a polypeptide being at least   	       1 MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVA 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						at least about 95% homologous to the sequence ACPHPQD in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F02311_P8.                                                   	      51 EAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGFTFTFRSPE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVFREFFGSGDPFAELFDDLGPFSELQNRGSRHSGPFFTFSSSFPGHSDF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSSSFSFSPGAGAFRSVSTSTTFVQGRRITTRRIMENGQERVEVEEDGQL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KSVTINGVPDDLALGLELSRREQQPSVTSRSGGTQVQQTPASCPLDSDLS 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     251 EDEDLQLAMAYSLSEMEAAGKKPA                           274                                                          

28014	HMR136_F02366_12_tr0_r1_1_gPRT		Comparison report between F02366_P12 and CDK7_HUMANpartial   	Sequence name: CDK7_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F02366_P12, comprising a first amino	                                                            
						MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 	Alignment of: 28014 x CDK7_HUMAN   ..                        
						FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 	                                                            
						RPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF                       	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 189 - 346 of CDK7_HUMAN, which also           	                     Quality: 1566.00                      Escore:       0                                               
						corresponds to amino acids 1 - 158 of F02366_P12.            	             Matching length:     158                Total length:     158                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 ALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQG 338                                                          
						                                                            	                                                             
						                                                            	     151 GLPKKLIF                                           158                                                          
						                                                            	         ||||||||                                            
						                                                            	     339 GLPKKLIF                                           346                                                          

28016	HMR136_F02366_9_tr0_r1_1_gPRT		Comparison report between F02366_P9 and CDK7_HUMANpartial WT 	Sequence name: CDK7_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F02366_P9, comprising a first amino 	Sequence documentation:                                      
						MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 	                                                            
						REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE                      	Alignment of: 28016 x CDK7_HUMAN   ..                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 99 of CDK7_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 99 of F02366_P9, and a second amino acid  	                                                            
						DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 	                     Quality: 2915.00                      Escore:       0                                               
						WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 	             Matching length:     309                Total length:     346                                               
						LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVET 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LKEQSNPALAIKRKRTEALEQGGLPKKLIF                               	    Total Percent Similarity:   89.31      Total Percent Identity:   89.31                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 137 - 346 of CDK7_HUMAN, which also corresponds  	                                                            
						to amino acids 100 - 309 of F02366_P9, wherein said first    	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE 50                                                           
						polypeptide encoding for an edge portion of F02366_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	       1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      51 AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE. 99                                                           
						amino acids in length, more preferably at least about 40     	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						amino acids in length and most preferably at least about 50  	      51 AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise ED, having a structure as follows: a sequence       	     100 ....................................DLKPNNLLLDENGV 113                                                          
						starting from any of amino acid numbers 99-x to 100; and     	                                             ||||||||||||||  
						ending at any of amino acid numbers 100+ ((n-2) - x), in     	     101 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV 150                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     114 LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     264 PTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF     309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     301 PTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF     346                                                          

28159	HMR136_F02383_12_tr0_r1_1_gPRT		Comparison report between F02383_P12 and B3G3_HUMANpartial   	Sequence name: B3G3_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F02383_P12, comprising a first amino	Sequence documentation:                                      
						MKLKLKNVFLAYFLVSIAGLLYALVQLGQPCDCLPPLRAAAEQLRQKDLRISQLQAELRR 	                                                            
						PPPAPAQPPEPEALPTIYVVTPTYAR                                   	Alignment of: 28159 x B3G3_HUMAN   ..                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 86 of B3G3_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 86 of F02383_P12, and a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  837.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      86                Total length:      86                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence YGLWCTQEVCVVQEVGVDDEEFGEALG corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 87 - 113 of F02383_P12, wherein said first    	                        Gaps:       0                        
						amino acid sequence and second amino acid sequence are       	                                                            
						contiguous and in a sequential order.2.An isolated           	Alignment:                                                   
						polypeptide encoding for a tail of F02383_P12, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	       1 MKLKLKNVFLAYFLVSIAGLLYALVQLGQPCDCLPPLRAAAEQLRQKDLR 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	       1 MKLKLKNVFLAYFLVSIAGLLYALVQLGQPCDCLPPLRAAAEQLRQKDLR 50                                                           
						to the sequence YGLWCTQEVCVVQEVGVDDEEFGEALG in F02383_P12.   	                  .         .         .                      
						                                                            	      51 ISQLQAELRRPPPAPAQPPEPEALPTIYVVTPTYAR               86                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	      51 ISQLQAELRRPPPAPAQPPEPEALPTIYVVTPTYAR               86                                                           

28157	HMR136_F02383_7_tr0_r1_1_gPRT		Comparison report between F02383_P7 and B3G3_HUMAN_V1unique  	Sequence name: B3G3_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F02383_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28157 x B3G3_HUMAN_V1   ..                     
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLLPPPMP corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F02383_P7, and a second amino acid sequence being at    	                                                            
						AQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVYFADDDNTYSR 	                     Quality: 1933.00                      Escore:       0                                               
						ELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHTAWEPSRPFPVDMAGFAVALP 	             Matching length:     194                Total length:     194                                               
						LLLDKPNAQFDSTAPRGHLESSLLSHLVDPKDLEPRAANCTRVLVWHTRTEKPKMKQEEQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQRQGRGSDPAIEV                                               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 142 -  	                        Gaps:       0                        
						335 of B3G3_HUMAN_V1, which also corresponds to amino acids 9	                                                            
						- 202 of F02383_P7, wherein said first amino acid sequence   	Alignment:                                                   
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	       9 AQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVY 58                                                           
						head of F02383_P7, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     142 AQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVY 191                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MLLPPPMP of    	      59 FADDDNTYSRELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHT 108                                                          
						F02383_P7.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 FADDDNTYSRELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHT 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     109 AWEPSRPFPVDMAGFAVALPLLLDKPNAQFDSTAPRGHLESSLLSHLVDP 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 AWEPSRPFPVDMAGFAVALPLLLDKPNAQFDSTAPRGHLESSLLSHLVDP 291                                                          
						                                                            	                  .         .         .         .            
						                                                            	     159 KDLEPRAANCTRVLVWHTRTEKPKMKQEEQLQRQGRGSDPAIEV       202                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     292 KDLEPRAANCTRVLVWHTRTEKPKMKQEEQLQRQGRGSDPAIEV       335                                                          

28780	HMR136_F02560_3_tr0_r1_1_gPRT		Comparison report between F02560_P3 and PTPN_HUMANpartial WT 	Sequence name: PTPN_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F02560_P3, comprising a first amino 	Sequence documentation:                                      
						MRRPRRPGGLGGSGGLRLLLCLLLLSSRPGGCSAVSAHGCLFDRRLCSHLEVCIQDGLFG 	                                                            
						QCQVGVGQARPLLQVTSPVLQRLQGVLRQLMSQGLSWHDDLTQYVISQEMERIPRLRPPE 	Alignment of: 28780 x PTPN_HUMAN   ..                        
						PRPRDRSGLAPKRPGPAGELLLQDIPTGSAPAAQHRLPQPPVGKGGAGASSSLSPLQAEL 	                                                            
						LPPLLEHLLLPPQPPHPSLSYEPALLQPYLFHQFGSRDGSRVSEGSPGMVSVGPLPKAEA 	Alignment segment 1/1:                                       
						PALFSRTASKGIFGDHPGHSYGDLPGPSPAQLFQDSGLLYLAQELPAPSRARVPRLPEQG 	                                                            
						SSSRAEDSPEGYEKEGLGDRGEKPASPAVQPDAALQRLAAVLAGYGVELRQLTPEQLSTL 	                     Quality: 6733.00                      Escore:       0                                               
						LTLLQLLPKGAGRNPGGVVNVGADIKKTMEGPVEGRDTAELPARTSPMPGHPTASPTSSE 	             Matching length:     696                Total length:     696                                               
						VQQVPSPVSSEPPKAARPPVTPVLLEKKSPLGQSQPTVAGQPSARPAAEEYGYIVTDQKP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LSLAAGVKLLEILAEHVHMSSGSFINISVVGPALTFRIRHNEQNLSLADVTQQAGLVKSE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEAQTGLQILQTGVGQREEAAAVLPQTAHSTSPMRSVLLTLVALAGVAGLLVALAVALCV 	                        Gaps:       0                        
						RQHARQQDKERLAALGPEGAHGDTTFEYQDLCRQHMATKSLFNRAEGPPEPSRVSSVSSQ 	                                                            
						FSDAAQASPSSHSSTPSWCEEPAQANMDISTGHMIL                         	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 696 of PTPN_HUMAN, which also corresponds 	       1 MRRPRRPGGLGGSGGLRLLLCLLLLSSRPGGCSAVSAHGCLFDRRLCSHL 50                                                           
						to amino acids 1 - 696 of F02560_P3, and a second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MRRPRRPGGLGGSGGLRLLLCLLLLSSRPGGCSAVSAHGCLFDRRLCSHL 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 EVCIQDGLFGQCQVGVGQARPLLQVTSPVLQRLQGVLRQLMSQGLSWHDD 100                                                          
						having the sequence VRTGPGPRVGEGMGW corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 697 - 711 of F02560_P3, wherein said first amino acid  	      51 EVCIQDGLFGQCQVGVGQARPLLQVTSPVLQRLQGVLRQLMSQGLSWHDD 100                                                          
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 LTQYVISQEMERIPRLRPPEPRPRDRSGLAPKRPGPAGELLLQDIPTGSA 150                                                          
						tail of F02560_P3, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 LTQYVISQEMERIPRLRPPEPRPRDRSGLAPKRPGPAGELLLQDIPTGSA 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence VRTGPGPRVGEGMGW	     151 PAAQHRLPQPPVGKGGAGASSSLSPLQAELLPPLLEHLLLPPQPPHPSLS 200                                                          
						in F02560_P3.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PAAQHRLPQPPVGKGGAGASSSLSPLQAELLPPLLEHLLLPPQPPHPSLS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YEPALLQPYLFHQFGSRDGSRVSEGSPGMVSVGPLPKAEAPALFSRTASK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 YEPALLQPYLFHQFGSRDGSRVSEGSPGMVSVGPLPKAEAPALFSRTASK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GIFGDHPGHSYGDLPGPSPAQLFQDSGLLYLAQELPAPSRARVPRLPEQG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GIFGDHPGHSYGDLPGPSPAQLFQDSGLLYLAQELPAPSRARVPRLPEQG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SSSRAEDSPEGYEKEGLGDRGEKPASPAVQPDAALQRLAAVLAGYGVELR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SSSRAEDSPEGYEKEGLGDRGEKPASPAVQPDAALQRLAAVLAGYGVELR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QLTPEQLSTLLTLLQLLPKGAGRNPGGVVNVGADIKKTMEGPVEGRDTAE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QLTPEQLSTLLTLLQLLPKGAGRNPGGVVNVGADIKKTMEGPVEGRDTAE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LPARTSPMPGHPTASPTSSEVQQVPSPVSSEPPKAARPPVTPVLLEKKSP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LPARTSPMPGHPTASPTSSEVQQVPSPVSSEPPKAARPPVTPVLLEKKSP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 LGQSQPTVAGQPSARPAAEEYGYIVTDQKPLSLAAGVKLLEILAEHVHMS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LGQSQPTVAGQPSARPAAEEYGYIVTDQKPLSLAAGVKLLEILAEHVHMS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SGSFINISVVGPALTFRIRHNEQNLSLADVTQQAGLVKSELEAQTGLQIL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SGSFINISVVGPALTFRIRHNEQNLSLADVTQQAGLVKSELEAQTGLQIL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 QTGVGQREEAAAVLPQTAHSTSPMRSVLLTLVALAGVAGLLVALAVALCV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 QTGVGQREEAAAVLPQTAHSTSPMRSVLLTLVALAGVAGLLVALAVALCV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RQHARQQDKERLAALGPEGAHGDTTFEYQDLCRQHMATKSLFNRAEGPPE 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RQHARQQDKERLAALGPEGAHGDTTFEYQDLCRQHMATKSLFNRAEGPPE 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	     651 PSRVSSVSSQFSDAAQASPSSHSSTPSWCEEPAQANMDISTGHMIL     696                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     651 PSRVSSVSSQFSDAAQASPSSHSSTPSWCEEPAQANMDISTGHMIL     696                                                          

4161	HMR136_F02596_7_tr0_r1_1_gPRT		Comparison report between F02596_P7 and HSS2_HUMANpartial WT 	Sequence name: HSS2_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F02596_P7, comprising a first amino 	Sequence documentation:                                      
						MLQLWKVVRPARQLELHRLILLLIAFSLGSMGFLAYYVSTSPKAKEPLPLPLGDCSSGGA 	                                                            
						AGPGPARPPVPPRPPRPPETARTEPVVLVFVESAYSQLGQEIVAILESSRFRYSTELAPG 	Alignment of: 4161 x HSS2_HUMAN   ..                         
						RGDMPTLTDNTHGRYVLVIYENLLKYVNLDAWSRELLDRYCVEYGVGIIGFFRAHEHSLL 	                                                            
						SAQLKGFPLFLHSNLGLRDYQVNPSAPLLHLTRPSRLEPGPLPGDDWTIFQSNHSTYEPV 	Alignment segment 1/1:                                       
						LLASLRPAEPAVPGPVLRRARLPTVVQDLGLHDGIQRVLFGHGLSFWLHKLIFVDAVAYL 	                                                            
						TGKRLCLDLDRYILVDIDDIFVGKEGTRMKVADVEALLTTQNKLRTLVPNFTFNLGFSGK 	                     Quality: 5763.00                      Escore:       0                                               
						FYHTGTEEEDAGDDMLLKHRKEFWWFPHMWSHMQPHLFHNRSVLADQMRLNKQFALEHGI 	             Matching length:     582                Total length:     582                                               
						PTDLGYAVAPHHSGVYPIHTQLYEAWKSVWGIQVTSTEEYPHLRPARYRRGFIHNGIMVL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PRQTCGLFTHTIFYNEYPGGSRELDRSIRGGELFLTVLLNPISIFMTHLSNYGNDRLGLY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TFESLVRFLQCWTRLRLQTLPPVPLAQKYFELFPQERSPLWQ                   	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 582 of HSS2_HUMAN, which also corresponds 	Alignment:                                                   
						to amino acids 1 - 582 of F02596_P7, and a second amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MLQLWKVVRPARQLELHRLILLLIAFSLGSMGFLAYYVSTSPKAKEPLPL 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MLQLWKVVRPARQLELHRLILLLIAFSLGSMGFLAYYVSTSPKAKEPLPL 50                                                           
						having the sequence VKVELSLMRDMIGVGKKK corresponding to amino	                  .         .         .         .         .  
						acids 583 - 600 of F02596_P7, wherein said first amino acid  	      51 PLGDCSSGGAAGPGPARPPVPPRPPRPPETARTEPVVLVFVESAYSQLGQ 100                                                          
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 PLGDCSSGGAAGPGPARPPVPPRPPRPPETARTEPVVLVFVESAYSQLGQ 100                                                          
						tail of F02596_P7, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     101 EIVAILESSRFRYSTELAPGRGDMPTLTDNTHGRYVLVIYENLLKYVNLD 150                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     101 EIVAILESSRFRYSTELAPGRGDMPTLTDNTHGRYVLVIYENLLKYVNLD 150                                                          
						VKVELSLMRDMIGVGKKK in F02596_P7.                             	                  .         .         .         .         .  
						                                                            	     151 AWSRELLDRYCVEYGVGIIGFFRAHEHSLLSAQLKGFPLFLHSNLGLRDY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 AWSRELLDRYCVEYGVGIIGFFRAHEHSLLSAQLKGFPLFLHSNLGLRDY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QVNPSAPLLHLTRPSRLEPGPLPGDDWTIFQSNHSTYEPVLLASLRPAEP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 QVNPSAPLLHLTRPSRLEPGPLPGDDWTIFQSNHSTYEPVLLASLRPAEP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AVPGPVLRRARLPTVVQDLGLHDGIQRVLFGHGLSFWLHKLIFVDAVAYL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AVPGPVLRRARLPTVVQDLGLHDGIQRVLFGHGLSFWLHKLIFVDAVAYL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TGKRLCLDLDRYILVDIDDIFVGKEGTRMKVADVEALLTTQNKLRTLVPN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 TGKRLCLDLDRYILVDIDDIFVGKEGTRMKVADVEALLTTQNKLRTLVPN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FTFNLGFSGKFYHTGTEEEDAGDDMLLKHRKEFWWFPHMWSHMQPHLFHN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTFNLGFSGKFYHTGTEEEDAGDDMLLKHRKEFWWFPHMWSHMQPHLFHN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 RSVLADQMRLNKQFALEHGIPTDLGYAVAPHHSGVYPIHTQLYEAWKSVW 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RSVLADQMRLNKQFALEHGIPTDLGYAVAPHHSGVYPIHTQLYEAWKSVW 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GIQVTSTEEYPHLRPARYRRGFIHNGIMVLPRQTCGLFTHTIFYNEYPGG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIQVTSTEEYPHLRPARYRRGFIHNGIMVLPRQTCGLFTHTIFYNEYPGG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SRELDRSIRGGELFLTVLLNPISIFMTHLSNYGNDRLGLYTFESLVRFLQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SRELDRSIRGGELFLTVLLNPISIFMTHLSNYGNDRLGLYTFESLVRFLQ 550                                                          
						                                                            	                  .         .         .                      
						                                                            	     551 CWTRLRLQTLPPVPLAQKYFELFPQERSPLWQ                   582                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     551 CWTRLRLQTLPPVPLAQKYFELFPQERSPLWQ                   582                                                          

8844	HMR136_F02664_3_tr0_r1_1_gPRT		Comparison report between F02664_P3 and PSS1_HUMANpartial WT 	Sequence name: PSS1_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02664_P3, comprising a first amino acid        	                                                            
						MVFGLSVLYFLFLVFLLFLNFEQVKSLMYWLDPNLRYATREADVMEYAVNCHVITWERII 	Alignment of: 8844 x PSS1_HUMAN   ..                         
						SHFDIFAFGHFWGWAMKALLIRSYGLCWTISITWELTELFFMHLLPNFAECWWDQVILDI 	                                                            
						LLCNGGGIWLGMVVCRFLEMRTYHWASFKDIHTTTGKIKRAVLQFTPASWTYVRWFDPKS 	Alignment segment 1/1:                                       
						SFQRVAGVYLFMIIWQLTELNTFFLKHIFVFQASHPLSWGRILFIGGITAPTVRQYYAYL 	                                                            
						TDTQCKRVGTQCWVFGVIGFLEAIVCIKFGQDLFSKTQILYVVLWLLCVAFTTFLCLYGM 	                     Quality: 3764.00                      Escore:       0                                               
						IWYAEHYGHREKTYSECEDGTYSPEISWHHRKGTKGSEDSPPKHAGNNESHSSRRRNRHS 	             Matching length:     371                Total length:     371                                               
						KSKVTNGVGKK                                                  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 103 - 473 of PSS1_HUMAN, which also corresponds  	                        Gaps:       0                        
						to amino acids 1 - 371 of F02664_P3.                         	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVFGLSVLYFLFLVFLLFLNFEQVKSLMYWLDPNLRYATREADVMEYAVN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 MVFGLSVLYFLFLVFLLFLNFEQVKSLMYWLDPNLRYATREADVMEYAVN 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CHVITWERIISHFDIFAFGHFWGWAMKALLIRSYGLCWTISITWELTELF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 CHVITWERIISHFDIFAFGHFWGWAMKALLIRSYGLCWTISITWELTELF 202                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FMHLLPNFAECWWDQVILDILLCNGGGIWLGMVVCRFLEMRTYHWASFKD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 FMHLLPNFAECWWDQVILDILLCNGGGIWLGMVVCRFLEMRTYHWASFKD 252                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IHTTTGKIKRAVLQFTPASWTYVRWFDPKSSFQRVAGVYLFMIIWQLTEL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     253 IHTTTGKIKRAVLQFTPASWTYVRWFDPKSSFQRVAGVYLFMIIWQLTEL 302                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NTFFLKHIFVFQASHPLSWGRILFIGGITAPTVRQYYAYLTDTQCKRVGT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     303 NTFFLKHIFVFQASHPLSWGRILFIGGITAPTVRQYYAYLTDTQCKRVGT 352                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QCWVFGVIGFLEAIVCIKFGQDLFSKTQILYVVLWLLCVAFTTFLCLYGM 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     353 QCWVFGVIGFLEAIVCIKFGQDLFSKTQILYVVLWLLCVAFTTFLCLYGM 402                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IWYAEHYGHREKTYSECEDGTYSPEISWHHRKGTKGSEDSPPKHAGNNES 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     403 IWYAEHYGHREKTYSECEDGTYSPEISWHHRKGTKGSEDSPPKHAGNNES 452                                                          
						                                                            	                  .         .                                
						                                                            	     351 HSSRRRNRHSKSKVTNGVGKK                              371                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     453 HSSRRRNRHSKSKVTNGVGKK                              473                                                          

9045	HMR136_F02670_11_tr0_r1_1_gPRT		Comparison report between F02670_P11 and KAD5_HUMANunique    	Sequence name: KAD5_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F02670_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 9045 x KAD5_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LTTLALLQ corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F02670_P11, and a second amino acid sequence being at   	                                                            
						GIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMDCSADTMTNRL 	                     Quality: 1207.00                      Escore:       0                                               
						LQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQLHKINAEGTPEDVFLQLCTA 	             Matching length:     126                Total length:     126                                               
						IDSIIF                                                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 73 -   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						198 of KAD5_HUMAN, which also corresponds to amino acids 9 - 	                        Gaps:       0                        
						134 of F02670_P11, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F02670_P11, comprising a polypeptide being at least 70%,     	       9 GIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMD 58                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      73 GIVLELLKEAMVASLGDTRGFLIDGYPREVKQGEEFGRRIGDPQLVICMD 122                                                          
						least about 95% homologous to the sequence LTTLALLQ of       	                  .         .         .         .         .  
						F02670_P11.                                                  	      59 CSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQ 108                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     123 CSADTMTNRLLQRSRSSLPVDDTTKTIAKRLEAYYRASIPVIAYYETKTQ 172                                                          
						                                                            	                  .         .                                
						                                                            	     109 LHKINAEGTPEDVFLQLCTAIDSIIF                         134                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     173 LHKINAEGTPEDVFLQLCTAIDSIIF                         198                                                          

9461	HMR136_F02693_6_tr0_r1_1_gPRT		Comparison report between F02693_P6 and APOD_HUMANunique     	Sequence name: APOD_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F02693_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 9461 x APOD_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence PFCLASPGQGSASARQWGRSCRSPENHRVLLCLLSLQ    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 37 of F02693_P6, and a      	                                                            
						YLGRWYEIEKIPTTFENGRCIQANYSLMENGKIKVLNQELRADGTVNQIEGEATPVNLTE 	                     Quality: 1479.00                      Escore:       0                                               
						PAKLEVKFSWFMPSAPYWILATDYENYALVYSCTCIIQLFHVDFAWILARNPNLPPETVD 	             Matching length:     149                Total length:     149                                               
						SLKNILTSNNIDVKKMTVTDQVNCPKLS                                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.33                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.33                                               
						corresponding to amino acids 42 - 189 of APOD_HUMAN, which   	                        Gaps:       0                        
						also corresponds to amino acids 38 - 185 of F02693_P6,       	                                                            
						wherein said first amino acid sequence and second amino acid 	Alignment:                                                   
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of F02693_P6,       	      37 QYLGRWYEIEKIPTTFENGRCIQANYSLMENGKIKVLNQELRADGTVNQI 86                                                           
						comprising a polypeptide being at least 70%, optionally at   	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	      41 KYLGRWYEIEKIPTTFENGRCIQANYSLMENGKIKVLNQELRADGTVNQI 90                                                           
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	      87 EGEATPVNLTEPAKLEVKFSWFMPSAPYWILATDYENYALVYSCTCIIQL 136                                                          
						PFCLASPGQGSASARQWGRSCRSPENHRVLLCLLSLQ of F02693_P6.          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      91 EGEATPVNLTEPAKLEVKFSWFMPSAPYWILATDYENYALVYSCTCIIQL 140                                                          
						                                                            	                  .         .         .         .            
						                                                            	     137 FHVDFAWILARNPNLPPETVDSLKNILTSNNIDVKKMTVTDQVNCPKLS  185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     141 FHVDFAWILARNPNLPPETVDSLKNILTSNNIDVKKMTVTDQVNCPKLS  189                                                          

4962	HMR136_F02712_10_tr0_r1_1_gPRT		Comparison report between F02712_P10 and                     	Sequence name: XRC1_HUMAN_V1                                 
						XRC1_HUMAN_V1partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for F02712_P10, comprising a   	                                                            
						MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLEKEEQIHSVDI 	Alignment of: 4962 x XRC1_HUMAN_V1   ..                      
						GNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESRSGSNPNRVRMFGPDKLVRAA 	                                                            
						AEKRWDRVKIVCSQPYSKDSPFGLSFVRFHSPPDKDEAEAPSQKVTVTKLGQFRVKEEDE 	Alignment segment 1/1:                                       
						SANSLRPGALFFSRINKTSPVTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQE 	                                                            
						SPKGKRKLDLNQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 	                     Quality: 4809.00                      Escore:       0                                               
						GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYRPDWTRDSTHL 	             Matching length:     494                Total length:     494                                               
						ICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQRYLMAGPGSSSEEDEASHSGG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SGDEAPKLPQKQPQTKTKPTQAAGPSSPQKPPTPEETKAASPVLQEDIDIEGVQSEGQDN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GAEDSGDTEDELRR                                               	                        Gaps:       0                        
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 1 - 494 of XRC1_HUMAN_V1, which 	Alignment:                                                   
						also corresponds to amino acids 1 - 494 of F02712_P10.       	                  .         .         .         .         .  
						                                                            	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLE 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KEEQIHSVDIGNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 KEEQIHSVDIGNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESR 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SGSNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFH 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SGSNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFH 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPPDKDEAEAPSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SPPDKDEAEAPSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQESPKGKRKLDL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQESPKGKRKLDL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQK 450                                                          
						                                                            	                  .         .         .         .            
						                                                            	     451 PPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRR       494                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     451 PPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRR       494                                                          

4972	HMR136_F02712_11_tr0_r1_1_gPRT		Comparison report between F02712_P11 and                     	Sequence name: XRC1_HUMAN_V2                                 
						XRC1_HUMAN_V2partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for F02712_P11, comprising a   	                                                            
						MRRRLPSQRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQKP 	Alignment of: 4972 x XRC1_HUMAN_V2   ..                      
						PTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRRVAEQKEHRLPPGQEENG 	                                                            
						EDPYAGSTDENTDSEEHQEPPDLPVPELPDFFQGKHFFLYGEFPGDERRKLIRYVTAFNG 	Alignment segment 1/1:                                       
						ELEDNMSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVP 	                                                            
						QA                                                           	                     Quality: 2421.00                      Escore:       0                                               
						first amino acid sequence being at least 90 % homologous to  	             Matching length:     242                Total length:     242                                               
						corresponding to amino acids 392 - 633 of XRC1_HUMAN_V2,     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						which also corresponds to amino acids 1 - 242 of F02712_P11. 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRRRLPSQRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQ 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 MRRRLPSQRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQ 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AAGPSSPQKPPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 AAGPSSPQKPPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDE 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LRRVAEQKEHRLPPGQEENGEDPYAGSTDENTDSEEHQEPPDLPVPELPD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 LRRVAEQKEHRLPPGQEENGEDPYAGSTDENTDSEEHQEPPDLPVPELPD 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FFQGKHFFLYGEFPGDERRKLIRYVTAFNGELEDNMSDRVQFVITAQEWD 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 FFQGKHFFLYGEFPGDERRKLIRYVTAFNGELEDNMSDRVQFVITAQEWD 591                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 PSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVPQA         242                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     592 PSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVPQA         633                                                          

4968	HMR136_F02712_12_tr0_r1_1_gPRT		Comparison report between F02712_P12 and                     	Sequence name: XRC1_HUMAN_V2                                 
						XRC1_HUMAN_V2partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for F02712_P12, comprising a   	                                                            
						MRRRLPSQRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQKP 	Alignment of: 4968 x XRC1_HUMAN_V2   ..                      
						PTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRRVAEQKEHRLPPGQEENG 	                                                            
						EDPYAGSTDENTDSEEHQEPPDLPVPELPDFFQGKHFFLYGEFPGDERRKLIRYVTAFNG 	Alignment segment 1/1:                                       
						ELEDNMSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVP 	                                                            
						QA                                                           	                     Quality: 2421.00                      Escore:       0                                               
						first amino acid sequence being at least 90 % homologous to  	             Matching length:     242                Total length:     242                                               
						corresponding to amino acids 392 - 633 of XRC1_HUMAN_V2,     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						which also corresponds to amino acids 1 - 242 of F02712_P12. 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRRRLPSQRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQ 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 MRRRLPSQRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQ 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AAGPSSPQKPPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 AAGPSSPQKPPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDE 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LRRVAEQKEHRLPPGQEENGEDPYAGSTDENTDSEEHQEPPDLPVPELPD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 LRRVAEQKEHRLPPGQEENGEDPYAGSTDENTDSEEHQEPPDLPVPELPD 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FFQGKHFFLYGEFPGDERRKLIRYVTAFNGELEDNMSDRVQFVITAQEWD 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 FFQGKHFFLYGEFPGDERRKLIRYVTAFNGELEDNMSDRVQFVITAQEWD 591                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 PSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVPQA         242                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     592 PSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVPQA         633                                                          

4966	HMR136_F02712_19_tr0_r1_1_gPRT		Comparison report between F02712_P19 and XRC1_HUMANpartial   	Sequence name: XRC1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F02712_P19, comprising a first amino	                                                            
						acid sequence being at least 90 % homologous to              	Alignment of: 4966 x XRC1_HUMAN   ..                         
						MSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVPQA    	                                                            
						corresponding to amino acids 577 - 633 of XRC1_HUMAN, which  	Alignment segment 1/1:                                       
						also corresponds to amino acids 1 - 57 of F02712_P19.        	                                                            
						                                                            	                     Quality:  581.00                      Escore:       0                                               
						                                                            	             Matching length:      57                Total length:      57                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     577 MSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQL 626                                                          
						                                                            	                                                             
						                                                            	      51 YGVVPQA                                            57                                                           
						                                                            	         |||||||                                             
						                                                            	     627 YGVVPQA                                            633                                                          

4970	HMR136_F02712_22_tr0_r1_1_gPRT		Comparison report between F02712_P22 and XRC1_HUMANpartial   	Sequence name: XRC1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F02712_P22, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQ             	Alignment of: 4970 x XRC1_HUMAN   ..                         
						corresponding to amino acids 1 - 48 of XRC1_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 48 of F02712_P22, and a second	Alignment segment 1/1:                                       
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	                     Quality:  471.00                      Escore:       0                                               
						and most preferably at least 95% homologous to a polypeptide 	             Matching length:      48                Total length:      48                                               
						having the sequence VILPPHLL corresponding to amino acids 49 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						- 56 of F02712_P22, wherein said first amino acid sequence   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						and second amino acid sequence are contiguous and in a       	                        Gaps:       0                        
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						tail of F02712_P22, comprising a polypeptide being at least  	Alignment:                                                   
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .            
						85%, more preferably at least about 90% and most preferably  	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQ   48                                                           
						at least about 95% homologous to the sequence VILPPHLL in    	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						F02712_P22.                                                  	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQ   48                                                           

4964	HMR136_F02712_4_tr0_r1_1_gPRT		Comparison report between F02712_P4 and XRC1_HUMAN_V1partial 	Sequence name: XRC1_HUMAN_V1                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F02712_P4, comprising a first amino 	Sequence documentation:                                      
						MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLEKEEQIHSVDI 	                                                            
						GNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESRSGSNPNRVRMFGPDKLVRAA 	Alignment of: 4964 x XRC1_HUMAN_V1   ..                      
						AEKRWDRVKIVCSQPYSKDSPFGLSFVRFHSPPDKDEAEAPSQKVTVTKLGQFRVKEEDE 	                                                            
						SANSLRPGALFFSRINKTSPVTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQE 	Alignment segment 1/1:                                       
						SPKGKRKLDLNQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 	                                                            
						GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYRPDWTRDSTHL 	                     Quality: 4193.00                      Escore:       0                                               
						ICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQRYLMAGPGSSSEEDEASHSGG 	             Matching length:     431                Total length:     431                                               
						SGDEAPKLPQK                                                  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 431 of XRC1_HUMAN_V1, which also          	                        Gaps:       0                        
						corresponds to amino acids 1 - 431 of F02712_P4, and a second	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLE 50                                                           
						having the sequence ILGTQRMS corresponding to amino acids 432	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 439 of F02712_P4, wherein said first amino acid sequence   	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLE 50                                                           
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      51 KEEQIHSVDIGNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESR 100                                                          
						tail of F02712_P4, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 KEEQIHSVDIGNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESR 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence ILGTQRMS in    	     101 SGSNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFH 150                                                          
						F02712_P4.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SGSNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFH 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPPDKDEAEAPSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SPPDKDEAEAPSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQESPKGKRKLDL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQESPKGKRKLDL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQR 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 YLMAGPGSSSEEDEASHSGGSGDEAPKLPQK                    431                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     401 YLMAGPGSSSEEDEASHSGGSGDEAPKLPQK                    431                                                          

4960	HMR136_F02712_8_tr0_r1_1_gPRT		Comparison report between F02712_P8 and XRC1_HUMAN_V1partial 	Sequence name: XRC1_HUMAN_V1                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F02712_P8, comprising a first amino 	Sequence documentation:                                      
						MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLEKEEQIHSVDI 	                                                            
						GNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESRSGSNPNRVRMFGPDKLVRAA 	Alignment of: 4960 x XRC1_HUMAN_V1   ..                      
						AEKRWDRVKIVCSQPYSKDSPFGLSFVRFHSPPDKDEAEAPSQKVTVTKLGQFRVKEEDE 	                                                            
						SANSLRPGALFFSRINKTSPVTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQE 	Alignment segment 1/1:                                       
						SPKGKRKLDLNQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 	                                                            
						GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYRPDWTRDSTHL 	                     Quality: 4809.00                      Escore:       0                                               
						ICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQRYLMAGPGSSSEEDEASHSGG 	             Matching length:     494                Total length:     494                                               
						SGDEAPKLPQKQPQTKTKPTQAAGPSSPQKPPTPEETKAASPVLQEDIDIEGVQSEGQDN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GAEDSGDTEDELRR                                               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 494 of XRC1_HUMAN_V1, which also          	                                                            
						corresponds to amino acids 1 - 494 of F02712_P8, and a second	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLE 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence FLPGQALLSLRGVPWGRAAETHPIRHSLQWGARGQYE    	       1 MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTISVVLQLE 50                                                           
						corresponding to amino acids 495 - 531 of F02712_P8, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      51 KEEQIHSVDIGNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESR 100                                                          
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of F02712_P8, comprising a   	      51 KEEQIHSVDIGNDGSAFVEVLVGSSAGGAGEQDYEVLLVTSSFMSPSESR 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     101 SGSNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFH 150                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence FLPGQALLSLRGVPWGRAAETHPIRHSLQWGARGQYE in     	     101 SGSNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFH 150                                                          
						F02712_P8.                                                   	                  .         .         .         .         .  
						                                                            	     151 SPPDKDEAEAPSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SPPDKDEAEAPSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQESPKGKRKLDL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VTASDPAGPSYAAATLQASSAASSASPVSRAIGSTSKPQESPKGKRKLDL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NQEEKKTPSKPPAQLSPSVPKRPKLPAPTRTPATAPVPARAQGAVTGKPR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPFRSELRDKALELGAKYR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRMRRRLPSQR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQK 450                                                          
						                                                            	                  .         .         .         .            
						                                                            	     451 PPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRR       494                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     451 PPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRR       494                                                          

5116	HMR136_F02841_11_tr0_r1_1_gPRT		Comparison report between F02841_P11 and Q8NDH9partial WT    	Sequence name: Q8NDH9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02841_P11, comprising a first amino acid       	                                                            
						MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLGHVAVGIGDTN 	Alignment of: 5116 x Q8NDH9   ..                             
						LAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALLQTASSLAPHMYEPHFNFATI 	                                                            
						SDKIGDLQRSYVAAQKSEAAFPDHVDTQHLIKQLRQHFAML                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 321 - 481 of Q8NDH9, which also corresponds to   	                     Quality: 1591.00                      Escore:       0                                               
						amino acids 1 - 161 of F02841_P11.                           	             Matching length:     161                Total length:     161                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 370                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 420                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 470                                                          
						                                                            	                  .                                          
						                                                            	     151 IKQLRQHFAML                                        161                                                          
						                                                            	         |||||||||||                                         
						                                                            	     471 IKQLRQHFAML                                        481                                                          

						Comparison report between F02841_P11 and Q96DG8partial WT    	Sequence name: Q96DG8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02841_P11, comprising a first amino acid       	                                                            
						MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLGHVAVGIGDTN 	Alignment of: 5116 x Q96DG8   ..                             
						LAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALLQTASSLAPHMYEPHFNFATI 	                                                            
						SDKIGDLQRSYVAAQKSEAAFPDHVDTQHLIKQLRQHFAML                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 193 - 353 of Q96DG8, which also corresponds to   	                     Quality: 1591.00                      Escore:       0                                               
						amino acids 1 - 161 of F02841_P11.                           	             Matching length:     161                Total length:     161                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     193 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 242                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 342                                                          
						                                                            	                  .                                          
						                                                            	     151 IKQLRQHFAML                                        161                                                          
						                                                            	         |||||||||||                                         
						                                                            	     343 IKQLRQHFAML                                        353                                                          

						Comparison report between F02841_P11 and Q8TAM2partial WT    	Sequence name: Q8TAM2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02841_P11, comprising a first amino acid       	                                                            
						MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLGHVAVGIGDTN 	Alignment of: 5116 x Q8TAM2   ..                             
						LAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALLQTASSLAPHMYEPHFNFATI 	                                                            
						SDKIGDLQRSYVAAQKSEAAFPDHVDTQHLIKQLRQHFAML                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 371 - 531 of Q8TAM2, which also corresponds to   	                     Quality: 1591.00                      Escore:       0                                               
						amino acids 1 - 161 of F02841_P11.                           	             Matching length:     161                Total length:     161                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 420                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 470                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     471 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 520                                                          
						                                                            	                  .                                          
						                                                            	     151 IKQLRQHFAML                                        161                                                          
						                                                            	         |||||||||||                                         
						                                                            	     521 IKQLRQHFAML                                        531                                                          

						Comparison report between F02841_P11 and CAD61928partial WT  	Sequence name: CAD61928                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02841_P11, comprising a first amino acid       	                                                            
						MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLGHVAVGIGDTN 	Alignment of: 5116 x CAD61928   ..                           
						LAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALLQTASSLAPHMYEPHFNFATI 	                                                            
						SDKIGDLQRSYVAAQKSEAAFPDHVDTQHLIKQLRQHFAML                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 157 - 317 of CAD61928, which also corresponds to 	                     Quality: 1591.00                      Escore:       0                                               
						amino acids 1 - 161 of F02841_P11.                           	             Matching length:     161                Total length:     161                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 306                                                          
						                                                            	                  .                                          
						                                                            	     151 IKQLRQHFAML                                        161                                                          
						                                                            	         |||||||||||                                         
						                                                            	     307 IKQLRQHFAML                                        317                                                          

						Comparison report between F02841_P11 and CAD62360partial WT  	Sequence name: CAD62360                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02841_P11, comprising a first amino acid       	                                                            
						MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLGHVAVGIGDTN 	Alignment of: 5116 x CAD62360   ..                           
						LAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALLQTASSLAPHMYEPHFNFATI 	                                                            
						SDKIGDLQRSYVAAQKSEAAFPDHVDTQHLIKQLRQHFAML                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 106 - 266 of CAD62360, which also corresponds to 	                     Quality: 1591.00                      Escore:       0                                               
						amino acids 1 - 161 of F02841_P11.                           	             Matching length:     161                Total length:     161                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     106 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 155                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     156 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 255                                                          
						                                                            	                  .                                          
						                                                            	     151 IKQLRQHFAML                                        161                                                          
						                                                            	         |||||||||||                                         
						                                                            	     256 IKQLRQHFAML                                        266                                                          

						Comparison report between F02841_P11 and CAD62576partial WT  	Sequence name: CAD62576                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F02841_P11, comprising a first amino acid       	                                                            
						MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLGHVAVGIGDTN 	Alignment of: 5116 x CAD62576   ..                           
						LAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALLQTASSLAPHMYEPHFNFATI 	                                                            
						SDKIGDLQRSYVAAQKSEAAFPDHVDTQHLIKQLRQHFAML                    	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 224 - 384 of CAD62576, which also corresponds to 	                     Quality: 1591.00                      Escore:       0                                               
						amino acids 1 - 161 of F02841_P11.                           	             Matching length:     161                Total length:     161                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     224 MGIYNGQLFNNLGLCCFYAQQYDMTLTSFERALSLAENEEEAADVWYNLG 273                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     274 HVAVGIGDTNLAHQCFRLALVNNNNHAEAYNNLAVLEMRKGHVEQARALL 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 QTASSLAPHMYEPHFNFATISDKIGDLQRSYVAAQKSEAAFPDHVDTQHL 373                                                          
						                                                            	                  .                                          
						                                                            	     151 IKQLRQHFAML                                        161                                                          
						                                                            	         |||||||||||                                         
						                                                            	     374 IKQLRQHFAML                                        384                                                          

10469	HMR136_F02926_4_tr0_r1_1_gPRT		Comparison report between F02926_P4 and CADA_HUMAN_V3partial 	Sequence name: CADA_HUMAN_V3                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F02926_P4, comprising a first amino 	Sequence documentation:                                      
						MTIHQFLLLFLFWVCLPHFCSPEIMFRRTPVPQQRILSSRVPRSDGKILHRQKRGWMWNQ 	                                                            
						FFLLEEYTGSDYQYVGKLHSDQDKGDGSLKYILSGDGAGTLFIIDEKTGDIHATRRIDRE 	Alignment of: 10469 x CADA_HUMAN_V3   ..                     
						EKAFYTLRAQAINRRTLRPVEPESEFVIKIHDINDNEPTFPEEIYTASVPEMSVVGTSVV 	                                                            
						QVTATDADDPSYGNSARVIYSILQGQPYFSVEPETGIIRTALPNMNRENREQYQVVIQAK 	Alignment segment 1/1:                                       
						DMGGQMGGLSGTTTVNITLTDVNDNPPRFPQ                              	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2673.00                      Escore:       0                                               
						to amino acids 1 - 271 of CADA_HUMAN_V3, which also          	             Matching length:     271                Total length:     271                                               
						corresponds to amino acids 1 - 271 of F02926_P4, and a second	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 70%, optionally at least  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						80%, preferably at least 85%, more preferably at least 90%   	                        Gaps:       0                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence SKHPLMVILPGKRFRVK corresponding to amino 	Alignment:                                                   
						acids 272 - 288 of F02926_P4, wherein said first amino acid  	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MTIHQFLLLFLFWVCLPHFCSPEIMFRRTPVPQQRILSSRVPRSDGKILH 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of F02926_P4, comprising a polypeptide being at least   	       1 MTIHQFLLLFLFWVCLPHFCSPEIMFRRTPVPQQRILSSRVPRSDGKILH 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 RQKRGWMWNQFFLLEEYTGSDYQYVGKLHSDQDKGDGSLKYILSGDGAGT 100                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKHPLMVILPGKRFRVK in F02926_P4.                              	      51 RQKRGWMWNQFFLLEEYTGSDYQYVGKLHSDQDKGDGSLKYILSGDGAGT 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LFIIDEKTGDIHATRRIDREEKAFYTLRAQAINRRTLRPVEPESEFVIKI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LFIIDEKTGDIHATRRIDREEKAFYTLRAQAINRRTLRPVEPESEFVIKI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 HDINDNEPTFPEEIYTASVPEMSVVGTSVVQVTATDADDPSYGNSARVIY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 HDINDNEPTFPEEIYTASVPEMSVVGTSVVQVTATDADDPSYGNSARVIY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SILQGQPYFSVEPETGIIRTALPNMNRENREQYQVVIQAKDMGGQMGGLS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SILQGQPYFSVEPETGIIRTALPNMNRENREQYQVVIQAKDMGGQMGGLS 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 GTTTVNITLTDVNDNPPRFPQ                              271                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     251 GTTTVNITLTDVNDNPPRFPQ                              271                                                          

10825	HMR136_F02956_10_tr0_r1_1_gPRT		Comparison report between F02956_P10 and Q9Y2S7unique head   	Sequence name: Q9Y2S7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F02956_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10825 x Q9Y2S7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MRAGTPRGAVWDWGGTPPGRGSGSVSAAGRALGRD corresponding to amino   	                                                            
						acids 1 - 35 of F02956_P10, a second amino acid sequence     	                     Quality: 1119.00                      Escore:       0                                               
						MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRHLSSRNRPEGK 	             Matching length:     114                Total length:     114                                               
						VLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQARLYDRDVASAAPEK       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 1 - 114 of Q9Y2S7, which also corresponds to amino     	                        Gaps:       0                        
						acids 36 - 149 of F02956_P10, and a third amino acid sequence	                                                            
						being at least 70%, optionally at least 80%, preferably at   	Alignment:                                                   
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	      36 MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRH 85                                                           
						GIHTVR corresponding to amino acids 150 - 155 of F02956_P10, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	       1 MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRH 50                                                           
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      86 LSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQA 135                                                          
						head of F02956_P10, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 LSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQA 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .                                          
						at least about 95% homologous to the sequence                	     136 RLYDRDVASAAPEK                                     149                                                          
						MRAGTPRGAVWDWGGTPPGRGSGSVSAAGRALGRD of F02956_P10.3.An       	         ||||||||||||||                                      
						isolated polypeptide encoding for a tail of F02956_P10,      	     101 RLYDRDVASAAPEK                                     114                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence GIHTVR in F02956_P10.   	                                                            

10829	HMR136_F02956_16_tr0_r1_1_gPRT		Comparison report between F02956_P16 and Q9Y2S7unique head   	Sequence name: Q9Y2S7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F02956_P16, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10829 x Q9Y2S7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MRAGTPRGAVWDWGGTPPGRGSGSVSAAGRALGRD corresponding to amino   	                                                            
						acids 1 - 35 of F02956_P16, a second amino acid sequence     	                     Quality: 2506.00                      Escore:       0                                               
						MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRHLSSRNRPEGK 	             Matching length:     253                Total length:     253                                               
						VLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQARLYDRDVASAAPEKAENPAG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HGSKEVKGKTHTYYQVLIDARDCPHISQRSQTEAVTFLANHDDSRALYAIPGLDYVSHED 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ILPYTSTDQVPIQHELFERFLLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTEN 	                        Gaps:       0                        
						IRVTVIPFYMGMR                                                	                                                            
						being at least 90 % homologous to corresponding to amino     	Alignment:                                                   
						acids 1 - 253 of Q9Y2S7, which also corresponds to amino     	                  .         .         .         .         .  
						acids 36 - 288 of F02956_P16, and a third amino acid sequence	      36 MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRH 85                                                           
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	       1 MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRH 50                                                           
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						VCGQPGPLLAGVGP corresponding to amino acids 289 - 302 of     	      86 LSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQA 135                                                          
						F02956_P16, wherein said first amino acid sequence, second   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	      51 LSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQA 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of F02956_P16, comprising a  	     136 RLYDRDVASAAPEKAENPAGHGSKEVKGKTHTYYQVLIDARDCPHISQRS 185                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 RLYDRDVASAAPEKAENPAGHGSKEVKGKTHTYYQVLIDARDCPHISQRS 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MRAGTPRGAVWDWGGTPPGRGSGSVSAAGRALGRD of       	     186 QTEAVTFLANHDDSRALYAIPGLDYVSHEDILPYTSTDQVPIQHELFERF 235                                                          
						F02956_P16.3.An isolated polypeptide encoding for a tail of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F02956_P16, comprising a polypeptide being at least 70%,     	     151 QTEAVTFLANHDDSRALYAIPGLDYVSHEDILPYTSTDQVPIQHELFERF 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     236 LLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTENIRVTVIPFYM 285                                                          
						least about 95% homologous to the sequence VCGQPGPLLAGVGP in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F02956_P16.                                                  	     201 LLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTENIRVTVIPFYM 250                                                          
						                                                            	                                                             
						                                                            	     286 GMR                                                288                                                          
						                                                            	         |||                                                 
						                                                            	     251 GMR                                                253                                                          

10827	HMR136_F02956_9_tr0_r1_1_gPRT		Comparison report between F02956_P9 and Q9Y2S7unique head    	Sequence name: Q9Y2S7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F02956_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10827 x Q9Y2S7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MRAGTPRGAVWDWGGTPPGRGSGSVSAAGRALGRD corresponding to amino   	                                                            
						acids 1 - 35 of F02956_P9, a second amino acid sequence being	                     Quality: 3022.00                      Escore:       0                                               
						MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRHLSSRNRPEGK 	             Matching length:     308                Total length:     308                                               
						VLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQARLYDRDVASAAPEKAENPAG 	 Matching Percent Similarity:   99.35   Matching Percent Identity:   99.03                                               
						HGSKEVKGKTHTYYQVLIDARDCPHISQRSQTEAVTFLANHDDSRALYAIPGLDYVSHED 	    Total Percent Similarity:   99.35      Total Percent Identity:   99.03                                               
						ILPYTSTDQVPIQHELFERFLLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTEN 	                        Gaps:       0                        
						IRVTVIPFYMGMREAQNSHVYWWRYCIRLENLDSDVVQLRERHWRIFSLSGTLETVRGRG 	                                                            
						VVGR                                                         	Alignment:                                                   
						at least 90 % homologous to corresponding to amino acids 1 - 	                  .         .         .         .         .  
						304 of Q9Y2S7, which also corresponds to amino acids 36 - 339	      36 MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRH 85                                                           
						of F02956_P9, and a third amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MAACTARRALAVGSRWWSRSLTGARWPRPLCAAAGAGAFSPASTTTTRRH 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						VSILGLVILVLCGKPGGLANQCYPRSSLRSSIAATSRCRLPVGTCGARSALKDLMAPTLM 	      86 LSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQA 135                                                          
						FGFLPSPWKAIKMRRHHPQAFTGRPAEAPSAQAWSPGRTTLIPQLLQNSSLPIMGHSGSL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NLIVGFFLWGGVV                                                	      51 LSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQA 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 340 - 472 of F02956_P9, wherein said first    	     136 RLYDRDVASAAPEKAENPAGHGSKEVKGKTHTYYQVLIDARDCPHISQRS 185                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     101 RLYDRDVASAAPEKAENPAGHGSKEVKGKTHTYYQVLIDARDCPHISQRS 150                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F02956_P9, comprising a polypeptide being at least 70%,      	     186 QTEAVTFLANHDDSRALYAIPGLDYVSHEDILPYTSTDQVPIQHELFERF 235                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     151 QTEAVTFLANHDDSRALYAIPGLDYVSHEDILPYTSTDQVPIQHELFERF 200                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						MRAGTPRGAVWDWGGTPPGRGSGSVSAAGRALGRD of F02956_P9.3.An        	     236 LLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTENIRVTVIPFYM 285                                                          
						isolated polypeptide encoding for a tail of F02956_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     201 LLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTENIRVTVIPFYM 250                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     286 GMREAQNSHVYWWRYCIRLENLDSDVVQLRERHWRIFSLSGTLETVRGRG 335                                                          
						VSILGLVILVLCGKPGGLANQCYPRSSLRSSIAATSRCRLPVGTCGARSALKDLMAPTLM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FGFLPSPWKAIKMRRHHPQAFTGRPAEAPSAQAWSPGRTTLIPQLLQNSSLPIMGHSGSL 	     251 GMREAQNSHVYWWRYCIRLENLDSDVVQLRERHWRIFSLSGTLETVRGRG 300                                                          
						NLIVGFFLWGGVV                                                	                                                             
						about 95% homologous to the sequence in F02956_P9.           	     336 VVGRVSIL                                           343                                                          
						                                                            	         ||||  :|                                            
						                                                            	     301 VVGREPVL                                           308                                                          

11051	HMR136_F02994_4_tr0_r1_1_gPRT		Comparison report between F02994_P4 and CLB2_HUMANunique     	Sequence name: CLB2_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for F02994_P4, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 11051 x CLB2_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment segment 1/1:                                       
						MIKTQMGKSRWQSWRRSCQPKRTSFCASGSTWAPAPSLWRLTFLLLQ corresponding	                                                            
						to amino acids 1 - 47 of F02994_P4, a second amino acid      	                     Quality: 1538.00                      Escore:       0                                               
						AWRKYDTDRSGYIEANELKGFLSDLLKKANRPYDEPKLQEYTQTILRMFDLNGDGKLGLS 	             Matching length:     159                Total length:     159                                               
						EMSRLLPVQENFLLKFQGMKLTSEEFNAIFTFYDKDRSGYIDEHELDALLKDLYEKNKKE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.11                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:   98.11                                               
						amino acids 115 - 234 of CLB2_HUMAN, which also corresponds  	                        Gaps:       0                        
						to amino acids 48 - 167 of F02994_P4, a bridging amino acid M	                                                            
						corresponding to amino acid 168 of F02994_P4, and a third    	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						NIQQLTNYRKSVMSLAEAGKLYRKDLEIVLCSEPPM corresponding to amino  	      46 LQAWRKYDTDRSGYIEANELKGFLSDLLKKANRPYDEPKLQEYTQTILRM 95                                                           
						acids 236 - 271 of CLB2_HUMAN, which also corresponds to     	         ::||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 169 - 204 of F02994_P4, wherein said first amino 	     113 MEAWRKYDTDRSGYIEANELKGFLSDLLKKANRPYDEPKLQEYTQTILRM 162                                                          
						acid sequence, second amino acid sequence, bridging amino    	                  .         .         .         .         .  
						acid and third amino acid sequence are contiguous and in a   	      96 FDLNGDGKLGLSEMSRLLPVQENFLLKFQGMKLTSEEFNAIFTFYDKDRS 145                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of F02994_P4, comprising a polypeptide being at least   	     163 FDLNGDGKLGLSEMSRLLPVQENFLLKFQGMKLTSEEFNAIFTFYDKDRS 212                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     146 GYIDEHELDALLKDLYEKNKKEMNIQQLTNYRKSVMSLAEAGKLYRKDLE 195                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||:|||||||||||||||||||||||||||  
						MIKTQMGKSRWQSWRRSCQPKRTSFCASGSTWAPAPSLWRLTFLLLQ of F02994_P4.	     213 GYIDEHELDALLKDLYEKNKKEINIQQLTNYRKSVMSLAEAGKLYRKDLE 262                                                          
						                                                            	                                                             
						                                                            	     196 IVLCSEPPM                                          204                                                          
						                                                            	         |||||||||                                           
						                                                            	     263 IVLCSEPPM                                          271                                                          

11205	HMR136_F02996_8_tr0_r1_1_gPRT		Comparison report between F02996_P8 and Q8NBC5partial WT     	Sequence name: Q8NBC5                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F02996_P8, comprising a first amino 	Sequence documentation:                                      
						MDFKIEHTWDGFPVKHEPVFIRLNPGDRGVMMDISAPFFRDPPAPLGEPGKPFNELWDYE 	                                                            
						VVEAFFLNDITEQYLEVELCPH                                       	Alignment of: 11205 x Q8NBC5   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 82 of Q8NBC5, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 82 of F02996_P8, and a second amino acid     	                                                            
						sequence being at least 90 % homologous to                   	                     Quality: 1087.00                      Escore:       0                                               
						CLEYFKSFNFNTLLGEEWKQPESDLWLIEKCDI corresponding to amino     	             Matching length:     115                Total length:     199                                               
						acids 167 - 199 of Q8NBC5, which also corresponds to amino   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acids 83 - 115 of F02996_P8, wherein said first amino acid   	    Total Percent Similarity:   57.79      Total Percent Identity:   57.79                                               
						sequence and second amino acid sequence are contiguous and in	                        Gaps:       1                        
						a sequential order.2.An isolated chimeric polypeptide        	                                                            
						encoding for an edge portion of F02996_P8, comprising a      	Alignment:                                                   
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	       1 MDFKIEHTWDGFPVKHEPVFIRLNPGDRGVMMDISAPFFRDPPAPLGEPG 50                                                           
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	       1 MDFKIEHTWDGFPVKHEPVFIRLNPGDRGVMMDISAPFFRDPPAPLGEPG 50                                                           
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise HC, having 	      51 KPFNELWDYEVVEAFFLNDITEQYLEVELCPH.................. 82                                                           
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||                    
						acid numbers 82-x to 83; and ending at any of amino acid     	      51 KPFNELWDYEVVEAFFLNDITEQYLEVELCPHGQHLVLLLSGRRNVWKQE 100                                                          
						numbers 83+ ((n-2) - x), in which x varies from 0 to n-2.    	                  .         .         .         .         .  
						                                                            	      82 .................................................. 82                                                           
						                                                            	                                                            
						                                                            	     101 LPLSFRVSRGETKWEGKAYLPWSYFPPNVAKFNSFAIHGSKDKRSYEALY 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	      83 ................CLEYFKSFNFNTLLGEEWKQPESDLWLIEKCDI  115                                                          
						                                                            	                         |||||||||||||||||||||||||||||||||   
						                                                            	     151 PVPQHELQQGQKPDFRCLEYFKSFNFNTLLGEEWKQPESDLWLIEKCDI  199                                                          

						Comparison report between F02996_P8 and Q8N1A6partial WT     	Sequence name: Q8N1A6                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F02996_P8, comprising a first amino 	Sequence documentation:                                      
						MDFKIEHTWDGFPVKHEPVFIRLNPGDRGVMMDISAPFFRDPPAPLGEPGKPFNELWDYE 	                                                            
						VVEAFFLNDITEQYLEVELCP                                        	Alignment of: 11205 x Q8N1A6   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 81 of Q8N1A6, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 81 of F02996_P8, and a second amino acid     	                                                            
						sequence being at least 90 % homologous to                   	                     Quality: 1087.00                      Escore:       0                                               
						HCLEYFKSFNFNTLLGEEWKQPESDLWLIEKCDI corresponding to amino    	             Matching length:     115                Total length:     199                                               
						acids 166 - 199 of Q8N1A6, which also corresponds to amino   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acids 82 - 115 of F02996_P8, wherein said first amino acid   	    Total Percent Similarity:   57.79      Total Percent Identity:   57.79                                               
						sequence and second amino acid sequence are contiguous and in	                        Gaps:       1                        
						a sequential order.2.An isolated chimeric polypeptide        	                                                            
						encoding for an edge portion of F02996_P8, comprising a      	Alignment:                                                   
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	       1 MDFKIEHTWDGFPVKHEPVFIRLNPGDRGVMMDISAPFFRDPPAPLGEPG 50                                                           
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	       1 MDFKIEHTWDGFPVKHEPVFIRLNPGDRGVMMDISAPFFRDPPAPLGEPG 50                                                           
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise PH, having 	      51 KPFNELWDYEVVEAFFLNDITEQYLEVELCP................... 81                                                           
						a structure as follows: a sequence starting from any of amino	         |||||||||||||||||||||||||||||||                     
						acid numbers 81-x to 82; and ending at any of amino acid     	      51 KPFNELWDYEVVEAFFLNDITEQYLEVELCPHGQHLVLLLSGRRNVWKQE 100                                                          
						numbers 82+ ((n-2) - x), in which x varies from 0 to n-2.    	                  .         .         .         .         .  
						                                                            	      81 .................................................. 81                                                           
						                                                            	                                                            
						                                                            	     101 LPLSFRVSRGETKWEGKAYLPWSYFPPNVTKFNSFAIHGSKDKRSYEALY 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	      82 ...............HCLEYFKSFNFNTLLGEEWKQPESDLWLIEKCDI  115                                                          
						                                                            	                        ||||||||||||||||||||||||||||||||||   
						                                                            	     151 PVPQHELQQGQKPDFHCLEYFKSFNFNTLLGEEWKQPESDLWLIEKCDI  199                                                          

11291	HMR136_F03035_16_tr0_r1_1_gPRT		Comparison report between F03035_P16 and Q9UL40partial WT    	Sequence name: Q9UL40                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F03035_P16, comprising a first amino	Sequence documentation:                                      
						MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSGAQPVGREEVE 	                                                            
						HMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANKVKRYLAIHGMETLKGETKKL 	Alignment of: 11291 x Q9UL40   ..                            
						DSDQ                                                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 124 of Q9UL40, which also corresponds to  	                                                            
						amino acids 1 - 124 of F03035_P16, and a second amino acid   	                     Quality: 1225.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     124                Total length:     124                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VIQLPY corresponding to amino acids 125 -	                        Gaps:       0                        
						130 of F03035_P16, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F03035_P16, comprising a polypeptide being at least 70%,     	       1 MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSG 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       1 MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSG 50                                                           
						least about 95% homologous to the sequence VIQLPY in         	                  .         .         .         .         .  
						F03035_P16.                                                  	      51 AQPVGREEVEHMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AQPVGREEVEHMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANK 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 VKRYLAIHGMETLKGETKKLDSDQ                           124                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     101 VKRYLAIHGMETLKGETKKLDSDQ                           124                                                          

11293	HMR136_F03035_3_tr0_r1_1_gPRT		Comparison report between F03035_P3 and Q9UL40partial WT     	Sequence name: Q9UL40                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for F03035_P3, comprising a first amino 	Sequence documentation:                                      
						MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSGAQPVGREEVE 	                                                            
						HMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANKVKRYLAIHGMETLKGETKKL 	Alignment of: 11293 x Q9UL40   ..                            
						DSDQKSSRSKDKNQCCPICNMTFSSPVVAQSHYLGKTHAKNLKLKQQSTKVE         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 172 of Q9UL40, which also corresponds to  	                                                            
						amino acids 1 - 172 of F03035_P3, a second amino acid        	                     Quality: 2839.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     294                Total length:     310                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   94.84      Total Percent Identity:   94.84                                               
						having the sequence ALSKRLTNPFLVASTL corresponding to amino  	                        Gaps:       1                        
						acids 173 - 188 of F03035_P3, and a third amino acid sequence	                                                            
						ALHQNREMIDPDKFCSLCHATFNDPVMAQQHYVGKKHRKQETKLKLMARYGRLADPAVTD 	Alignment:                                                   
						FPAGKGYPCKTCKIVLNSIEQYQAHVSGFKHKNQSPKTVASSLGQIPMQRQPIQKDSTTL 	                  .         .         .         .         .  
						ED                                                           	       1 MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSG 50                                                           
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 173 - 294 of Q9UL40, which also corresponds to amino   	       1 MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSG 50                                                           
						acids 189 - 310 of F03035_P3, wherein said first amino acid  	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	      51 AQPVGREEVEHMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANK 100                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	      51 AQPVGREEVEHMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANK 100                                                          
						F03035_P3, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     101 VKRYLAIHGMETLKGETKKLDSDQKSSRSKDKNQCCPICNMTFSSPVVAQ 150                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     101 VKRYLAIHGMETLKGETKKLDSDQKSSRSKDKNQCCPICNMTFSSPVVAQ 150                                                          
						ALSKRLTNPFLVASTL, corresponding to F03035_P3.                	                  .         .         .         .         .  
						                                                            	     151 SHYLGKTHAKNLKLKQQSTKVEALSKRLTNPFLVASTLALHQNREMIDPD 200                                                          
						                                                            	         ||||||||||||||||||||||                ||||||||||||  
						                                                            	     151 SHYLGKTHAKNLKLKQQSTKVE................ALHQNREMIDPD 184                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KFCSLCHATFNDPVMAQQHYVGKKHRKQETKLKLMARYGRLADPAVTDFP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     185 KFCSLCHATFNDPVMAQQHYVGKKHRKQETKLKLMARYGRLADPAVTDFP 234                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AGKGYPCKTCKIVLNSIEQYQAHVSGFKHKNQSPKTVASSLGQIPMQRQP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     235 AGKGYPCKTCKIVLNSIEQYQAHVSGFKHKNQSPKTVASSLGQIPMQRQP 284                                                          
						                                                            	                  .                                          
						                                                            	     301 IQKDSTTLED                                         310                                                          
						                                                            	         ||||||||||                                          
						                                                            	     285 IQKDSTTLED                                         294                                                          

11289	HMR136_F03035_4_tr0_r1_1_gPRT		Comparison report between F03035_P4 and Q9UL40partial WT     	Sequence name: Q9UL40                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F03035_P4, comprising a first amino 	Sequence documentation:                                      
						MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSGAQPVGREEVE 	                                                            
						HMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANKVKRYLAIHGMETLKGETKKL 	Alignment of: 11289 x Q9UL40   ..                            
						DSDQ                                                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 124 of Q9UL40, which also corresponds to  	                                                            
						amino acids 1 - 124 of F03035_P4, and a second amino acid    	                     Quality: 1231.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     128                Total length:     128                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:   98.44   Matching Percent Identity:   97.66                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   98.44      Total Percent Identity:   97.66                                               
						having the sequence PCTRIER corresponding to amino acids 125 	                        Gaps:       0                        
						- 131 of F03035_P4, wherein said first amino acid sequence   	                                                            
						and second amino acid sequence are contiguous and in a       	Alignment:                                                   
						sequential order.2.An isolated polypeptide encoding for a    	                  .         .         .         .         .  
						tail of F03035_P4, comprising a polypeptide being at least   	       1 MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSG 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MEYPAPATVQAADGGAAGPYSSSELLEGQEPDGVRFDRERARRLWEAVSG 50                                                           
						at least about 95% homologous to the sequence PCTRIER in     	                  .         .         .         .         .  
						F03035_P4.                                                   	      51 AQPVGREEVEHMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 AQPVGREEVEHMIQKNQCLFTNTQCKVCCALLISESQKLAHYQSKKHANK 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 VKRYLAIHGMETLKGETKKLDSDQPCTR                       128                                                          
						                                                            	         ||||||||||||||||||||||||  :|                        
						                                                            	     101 VKRYLAIHGMETLKGETKKLDSDQKSSR                       128                                                          

5710	HMR136_F03076_17_tr0_r1_1_gPRT		Comparison report between F03076_P17 and MAON_HUMANpartial   	Sequence name: MAON_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F03076_P17, comprising a first amino	Sequence documentation:                                      
						MGAALGTGTRLAPWPGRACGALPRWTPTAPAQGCHSKPGPARPVPLKKRGYDVTRNPHLN 	                                                            
						K                                                            	Alignment of: 5710 x MAON_HUMAN   ..                         
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 61 of MAON_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 61 of F03076_P17, and a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  621.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      61                Total length:      61                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence TWITVSFKNLHFDV corresponding to amino    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 62 - 75 of F03076_P17, wherein said first amino acid   	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of F03076_P17, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MGAALGTGTRLAPWPGRACGALPRWTPTAPAQGCHSKPGPARPVPLKKRG 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence TWITVSFKNLHFDV 	       1 MGAALGTGTRLAPWPGRACGALPRWTPTAPAQGCHSKPGPARPVPLKKRG 50                                                           
						in F03076_P17.                                               	                  .                                          
						                                                            	      51 YDVTRNPHLNK                                        61                                                           
						                                                            	         |||||||||||                                         
						                                                            	      51 YDVTRNPHLNK                                        61                                                           

12417	HMR136_F03192_4_tr0_r1_1_gPRT		Comparison report between F03192_P4 and Q9NQ80partial WT     	Sequence name: Q9NQ80                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F03192_P4, comprising a first amino 	Sequence documentation:                                      
						MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAV 	                                                            
						TDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTAC 	Alignment of: 12417 x Q9NQ80   ..                            
						DIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSV 	                                                            
						ACVDRKGSGRYSIYIANYAYGNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGG 	Alignment segment 1/1:                                       
						RGVSVGPILSSSASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADF 	                                                            
						NRDGKVDIVYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELE 	                     Quality: 5950.00                      Escore:       0                                               
						IFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTDFDGDGMLDL 	             Matching length:     607                Total length:     607                                               
						ILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARGAKVVLYTKKSGAHLRIIDGG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SGYLCEMEPVAHFGLGKDEASSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						APLECGQGFSQQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNE 	                        Gaps:       0                        
						DGTACVG                                                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 607 of Q9NQ80, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 607 of F03192_P4, and a second amino acid    	       1 MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSN 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSN 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence LGLCLQLYAL corresponding to amino acids  	      51 PTQLNYGVAVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDER 100                                                          
						608 - 617 of F03192_P4, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      51 PTQLNYGVAVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDER 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F03192_P4, comprising a polypeptide being at least   	     101 SSPYYALRDRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLF 150                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     101 SSPYYALRDRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLF 150                                                          
						at least about 95% homologous to the sequence LGLCLQLYAL in  	                  .         .         .         .         .  
						F03192_P4.                                                   	     151 KFRNNRWEDILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 KFRNNRWEDILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SSASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SSASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NRDGKVDIVYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVIT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NRDGKVDIVYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVIT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ADFDNDQELEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ADFDNDQELEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EGRGTGGVVTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EGRGTGGVVTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 RTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFS 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 QQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNE 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 QQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNE 600                                                          
						                                                            	                                                             
						                                                            	     601 DGTACVG                                            607                                                          
						                                                            	         |||||||                                             
						                                                            	     601 DGTACVG                                            607                                                          

						Comparison report between F03192_P4 and Q8N4H6unique head    	Sequence name: Q8N4H6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03192_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12417 x Q8N4H6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAV 	Alignment segment 1/1:                                       
						TDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTAC 	                                                            
						DIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSV 	                     Quality: 3912.00                      Escore:       0                                               
						ACVDRKGSGRYSIYIANYAYGNVGPDALIE                               	             Matching length:     397                Total length:     397                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 210 of F03192_P4, a second amino acid     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDNENGPNFLFHN 	                        Gaps:       0                        
						RGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVYGNWNGPHRLYLQMSTHGKVR 	                                                            
						FRDIASPKFSMPSPVRTVITADFDNDQELEIFFNNIAYRSSSANRLFRVIRREHGDPLIE 	Alignment:                                                   
						ELNPGDALEPEGRGTGGVVTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVP 	                  .         .         .         .         .  
						RTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDG 	     211 MDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDN 260                                                          
						KMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCMDTNECIQFPFVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG                        	       1 MDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDN 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 397 of Q8N4H6, which also corresponds to     	     261 ENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVY 310                                                          
						amino acids 211 - 607 of F03192_P4, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 ENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVY 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     311 GNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELE 360                                                          
						having the sequence LGLCLQLYAL corresponding to amino acids  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						608 - 617 of F03192_P4, wherein said first amino acid        	     101 GNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELE 150                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     361 IFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVT 410                                                          
						isolated polypeptide encoding for a head of F03192_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     151 IFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVT 200                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     411 DFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARG 460                                                          
						MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTAC 	     201 DFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARG 250                                                          
						DIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSV 	                  .         .         .         .         .  
						ACVDRKGSGRYSIYIANYAYGNVGPDALIE                               	     461 AKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDG 510                                                          
						about 95% homologous to the sequence of F03192_P4.3.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of F03192_P4,       	     251 AKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDG 300                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     511 KMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCMDT 560                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence LGLCLQLYAL in F03192_P4.	     301 KMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCMDT 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     561 NECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG    607                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     351 NECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG    397                                                          

						Comparison report between F03192_P4 and Q9NW46unique head    	Sequence name: Q9NW46                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F03192_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12417 x Q9NW46   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAV 	Alignment segment 1/1:                                       
						TDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTAC 	                                                            
						DIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSV 	                     Quality: 3231.00                      Escore:       0                                               
						ACVDRKGSGRYSIYIANYAYGNVGPDALIE                               	             Matching length:     334                Total length:     334                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:   99.70   Matching Percent Identity:   99.70                                               
						to amino acids 1 - 210 of F03192_P4, a second amino acid     	    Total Percent Similarity:   99.70      Total Percent Identity:   99.70                                               
						MDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDNENGPNFLFHN 	                        Gaps:       0                        
						RGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVYGNWNGPHRLYLQMSTHGKVR 	                                                            
						FRDIASPKFSMPSPVRTVITADFDNDQELEIFFNNIAYRSSSANRLFRVIRREHGDPLIE 	Alignment:                                                   
						ELNPGDALEPEGRGTGGVVTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVP 	                  .         .         .         .         .  
						RTR                                                          	     211 MDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDN 260                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 243 of Q9NW46, which also corresponds to     	       1 MDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDN 50                                                           
						amino acids 211 - 453 of F03192_P4, a bridging amino acid F  	                  .         .         .         .         .  
						corresponding to amino acid 454 of F03192_P4, a third amino  	     261 ENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVY 310                                                          
						GAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDGKMVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RNVASGEMNSVLEILYPRDEDTLQDPAPLE                               	      51 ENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVY 100                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 245 - 334 of Q9NW46, which also corresponds to	     311 GNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELE 360                                                          
						amino acids 455 - 544 of F03192_P4, and a fourth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     101 GNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELE 150                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     361 IFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVT 410                                                          
						CGQGFSQQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CVGLGLCLQLYAL                                                	     151 IFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVT 200                                                          
						having the sequence corresponding to amino acids 545 - 617 of	                  .         .         .         .         .  
						F03192_P4, wherein said first amino acid sequence, second    	     411 DFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARG 460                                                          
						amino acid sequence, bridging amino acid, third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||| ||||||  
						sequence and fourth amino acid sequence are contiguous and in	     201 DFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRVGAFARG 250                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of F03192_P4, comprising a polypeptide being at least   	     461 AKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDG 510                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     251 AKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDG 300                                                          
						MAPSADPGMSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAV 	                  .         .         .                      
						TDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTAC 	     511 KMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLE                 544                                                          
						DIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSV 	         ||||||||||||||||||||||||||||||||||                  
						ACVDRKGSGRYSIYIANYAYGNVGPDALIE                               	     301 KMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLE                 334                                                          
						at least about 95% homologous to the sequence of             	                                                            
						F03192_P4.3.An isolated polypeptide encoding for a tail of   	                                                            
						F03192_P4, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						CGQGFSQQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTA 	                                                            
						CVGLGLCLQLYAL                                                	                                                            
						least about 95% homologous to the sequence in F03192_P4.     	                                                            

						Comparison report between F03192_P4 and Q8TE52unique head    	Sequence name: Q8TE52                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F03192_P4,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 12417 x Q8TE52   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence MAPSADPG     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of F03192_P4, a second    	                                                            
						MSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAVTDVDHDGD 	                     Quality: 5864.00                      Escore:       0                                               
						FEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTACDIDGDGRE 	             Matching length:     609                Total length:     637                                               
						EIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSVACVDRKGS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GRYSIYIANYAYGNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPI 	    Total Percent Similarity:   95.60      Total Percent Identity:   95.60                                               
						LSSSASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDI 	                        Gaps:       1                        
						VYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELEIFFNNIAY 	                                                            
						RSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTDFDGDGMLDLILSHGESM 	Alignment:                                                   
						AQPLSVFRGNQGFNNNWLRVVPRTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEME 	                  .         .         .         .         .  
						PVAHFGLGKDEASSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQG 	       9 MSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGV 58                                                           
						FSQQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACV   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGV 50                                                           
						corresponding to amino acids 1 - 598 of Q8TE52, which also   	                  .         .         .         .         .  
						corresponds to amino acids 9 - 606 of F03192_P4, and a third 	      59 AVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALR 108                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GLGLCLQLYAL corresponding to amino acids 627 - 637 of Q8TE52,	      51 AVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALR 100                                                          
						which also corresponds to amino acids 607 - 617 of F03192_P4,	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     109 DRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWE 158                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 DRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWE 150                                                          
						head of F03192_P4, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     159 DILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDAL 208                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence MAPSADPG of    	     151 DILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDAL 200                                                          
						F03192_P4.3.An isolated chimeric polypeptide encoding for an 	                  .         .         .         .         .  
						edge portion of F03192_P4, comprising a polypeptide having a 	     209 IEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFC 258                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     201 IEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFC 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     259 DNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDI 308                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise VG, having a structure as  	     251 DNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDI 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						606-x to 607; and ending at any of amino acid numbers 607+   	     309 VYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQE 358                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 LEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGV 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     409 VTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFA 458                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     459 RGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWP 508                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWP 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     509 DGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCM 558                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCM 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     559 DTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACV.. 606                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     551 DTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVAQ 600                                                          
						                                                            	                  .         .         .                      
						                                                            	     607 ..........................GLGLCLQLYAL              617                                                          
						                                                            	                                   |||||||||||               
						                                                            	     601 VAFLGGYSSAASRISEPLSRASYLSLGLGLCLQLYAL              637                                                          

						Comparison report between F03192_P4 and Q9NQ78unique head    	Sequence name: Q9NQ78                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03192_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12417 x Q9NQ78   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAPSADPGMSR  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of F03192_P4, a second   	                                                            
						MLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAVTDVDHDGDFEI 	                     Quality: 5839.00                      Escore:       0                                               
						VVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTACDIDGDGREEIY 	             Matching length:     596                Total length:     596                                               
						FLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSVACVDRKGSGRY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SIYIANYAYGNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVYG 	                        Gaps:       0                        
						NWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELEIFFNNIAYRSS 	                                                            
						SANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTDFDGDGMLDLILSHGESMAQP 	Alignment:                                                   
						LSVFRGNQGFNNNWLRVVPRTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVA 	                  .         .         .         .         .  
						HFGLGKDEASSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQ 	      12 MLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAVT 61                                                           
						QENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAVT 50                                                           
						corresponding to amino acids 1 - 596 of Q9NQ78, which also   	                  .         .         .         .         .  
						corresponds to amino acids 12 - 607 of F03192_P4, and a third	      62 DVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQ 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	      51 DVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQ 100                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence LGLCLQLYAL corresponding to amino acids  	     112 GNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDIL 161                                                          
						608 - 617 of F03192_P4, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     101 GNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWEDIL 150                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of F03192_P4,       	     162 SDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDALIEM 211                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 SDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDALIEM 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence MAPSADPGMSR of          	     212 DPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDNE 261                                                          
						F03192_P4.3.An isolated polypeptide encoding for a tail of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F03192_P4, comprising a polypeptide being at least 70%,      	     201 DPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFCDNE 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     262 NGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVYG 311                                                          
						least about 95% homologous to the sequence LGLCLQLYAL in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F03192_P4.                                                   	     251 NGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDIVYG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     312 NWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELEI 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELEI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     362 FFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTD 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 FDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARGA 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 FDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFARGA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     462 KVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDGK 511                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWPDGK 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     512 MVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCMDTN 561                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 MVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCMDTN 550                                                          
						                                                            	                  .         .         .         .            
						                                                            	     562 ECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG     607                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     551 ECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG     596                                                          

						Comparison report between F03192_P4 and Q9NQ79unique head    	Sequence name: Q9NQ79                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03192_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12417 x Q9NQ79   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAPSADPG     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of F03192_P4, a second    	                                                            
						MSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGVAVTDVDHDGD 	                     Quality: 5870.00                      Escore:       0                                               
						FEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALRDRQGNAIGVTACDIDGDGRE 	             Matching length:     599                Total length:     599                                               
						EIYFLNTNNAFSGVATYTDKLFKFRNNRWEDILSDEVNVARGVASLFAGRSVACVDRKGS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GRYSIYIANYAYGNVGPDALIEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LSSSASDIFCDNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDI 	                        Gaps:       0                        
						VYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQELEIFFNNIAY 	                                                            
						RSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGVVTDFDGDGMLDLILSHGESM 	Alignment:                                                   
						AQPLSVFRGNQGFNNNWLRVVPRTRFGAFARGAKVVLYTKKSGAHLRIIDGGSGYLCEME 	                  .         .         .         .         .  
						PVAHFGLGKDEASSVEVTWPDGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQG 	       9 MSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGV 58                                                           
						FSQQENGHCMDTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MSRMLPFLLLLWFLPITEGSQRAEPMFTAVTNSVLPPDYDSNPTQLNYGV 50                                                           
						corresponding to amino acids 1 - 599 of Q9NQ79, which also   	                  .         .         .         .         .  
						corresponds to amino acids 9 - 607 of F03192_P4, and a third 	      59 AVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALR 108                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	      51 AVTDVDHDGDFEIVVAGYNGPNLVLKYDRAQKRLVNIAVDERSSPYYALR 100                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence LGLCLQLYAL corresponding to amino acids  	     109 DRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWE 158                                                          
						608 - 617 of F03192_P4, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     101 DRQGNAIGVTACDIDGDGREEIYFLNTNNAFSGVATYTDKLFKFRNNRWE 150                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of F03192_P4,       	     159 DILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDAL 208                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 DILSDEVNVARGVASLFAGRSVACVDRKGSGRYSIYIANYAYGNVGPDAL 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence MAPSADPG of             	     209 IEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFC 258                                                          
						F03192_P4.3.An isolated polypeptide encoding for a tail of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F03192_P4, comprising a polypeptide being at least 70%,      	     201 IEMDPEASDLSRGILALRDVAAEAGVSKYTGGRGVSVGPILSSSASDIFC 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     259 DNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDI 308                                                          
						least about 95% homologous to the sequence LGLCLQLYAL in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F03192_P4.                                                   	     251 DNENGPNFLFHNRGDGTFVDAAASAGVDDPHQHGRGVALADFNRDGKVDI 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 VYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQE 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYGNWNGPHRLYLQMSTHGKVRFRDIASPKFSMPSPVRTVITADFDNDQE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 LEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGV 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LEIFFNNIAYRSSSANRLFRVIRREHGDPLIEELNPGDALEPEGRGTGGV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     409 VTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFA 458                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VTDFDGDGMLDLILSHGESMAQPLSVFRGNQGFNNNWLRVVPRTRFGAFA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     459 RGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWP 508                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RGAKVVLYTKKSGAHLRIIDGGSGYLCEMEPVAHFGLGKDEASSVEVTWP 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     509 DGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCM 558                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DGKMVSRNVASGEMNSVLEILYPRDEDTLQDPAPLECGQGFSQQENGHCM 550                                                          
						                                                            	                  .         .         .         .            
						                                                            	     559 DTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG  607                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     551 DTNECIQFPFVCPRDKPVCVNTYGSYRCRTNKKCSRGYEPNEDGTACVG  599                                                          

12562	HMR136_F03245_11_tr0_r1_1_gPRT		Comparison report between F03245_P11 and BAC77379unique head 	Sequence name: BAC77379                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F03245_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 12562 x BAC77379   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MDSHRSSQDKTLTPVCFSA corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 19 of F03245_P11, and a second amino acid    	                                                            
						PQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSVFTFVA 	                     Quality: 2349.00                      Escore:       0                                               
						EVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVALSVLTASLSYMVGMIAS 	             Matching length:     245                Total length:     245                                               
						FYNTEAVIMAVGITTAVCFTVVIFSMQTRYDFTSCMGVLLVSMVVLFIFAILCIFIRNRI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						LEIVYASLGALLFTCFLAVDTQLLLGNKQLSLSPEEYVFAALNLYTDIINIFLYILTIIG 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.59                                               
						RAKE                                                         	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 128 - 371 of BAC77379, which also corresponds to 	Alignment:                                                   
						amino acids 20 - 263 of F03245_P11, wherein said first amino 	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      19 APQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVT 68                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of F03245_P11, comprising a polypeptide being at  	     127 SPQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVT 176                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      69 LSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPW 118                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDSHRSSQDKTLTPVCFSA of F03245_P11.                           	     177 LSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPW 226                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     119 NLVALSVLTASLSYMVGMIASFYNTEAVIMAVGITTAVCFTVVIFSMQTR 168                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     227 NLVALSVLTASLSYMVGMIASFYNTEAVIMAVGITTAVCFTVVIFSMQTR 276                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     169 YDFTSCMGVLLVSMVVLFIFAILCIFIRNRILEIVYASLGALLFTCFLAV 218                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     277 YDFTSCMGVLLVSMVVLFIFAILCIFIRNRILEIVYASLGALLFTCFLAV 326                                                          
						                                                            	                  .         .         .         .            
						                                                            	     219 DTQLLLGNKQLSLSPEEYVFAALNLYTDIINIFLYILTIIGRAKE      263                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     327 DTQLLLGNKQLSLSPEEYVFAALNLYTDIINIFLYILTIIGRAKE      371                                                          

						Comparison report between F03245_P11 and Q8IVW7unique head   	Sequence name: Q8IVW7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F03245_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 12562 x Q8IVW7   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MDSHRSSQDKTLTPVCFSA corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 19 of F03245_P11, and a second amino acid    	                                                            
						PQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSVFTFVA 	                     Quality: 2349.00                      Escore:       0                                               
						EVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVALSVLTASLSYMVGMIAS 	             Matching length:     245                Total length:     245                                               
						FYNTEAVIMAVGITTAVCFTVVIFSMQTRYDFTSCMGVLLVSMVVLFIFAILCIFIRNRI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.59                                               
						LEIVYASLGALLFTCFLAVDTQLLLGNKQLSLSPEEYVFAALNLYTDIINIFLYILTIIG 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.59                                               
						RAKE                                                         	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 100 - 343 of Q8IVW7, which also corresponds to   	Alignment:                                                   
						amino acids 20 - 263 of F03245_P11, wherein said first amino 	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      19 APQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVT 68                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of F03245_P11, comprising a polypeptide being at  	      99 SPQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVT 148                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      69 LSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPW 118                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDSHRSSQDKTLTPVCFSA of F03245_P11.                           	     149 LSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPW 198                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     119 NLVALSVLTASLSYMVGMIASFYNTEAVIMAVGITTAVCFTVVIFSMQTR 168                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     199 NLVALSVLTASLSYMVGMIASFYNTEAVIMAVGITTAVCFTVVIFSMQTR 248                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     169 YDFTSCMGVLLVSMVVLFIFAILCIFIRNRILEIVYASLGALLFTCFLAV 218                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     249 YDFTSCMGVLLVSMVVLFIFAILCIFIRNRILEIVYASLGALLFTCFLAV 298                                                          
						                                                            	                  .         .         .         .            
						                                                            	     219 DTQLLLGNKQLSLSPEEYVFAALNLYTDIINIFLYILTIIGRAKE      263                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     299 DTQLLLGNKQLSLSPEEYVFAALNLYTDIINIFLYILTIIGRAKE      343                                                          

12560	HMR136_F03245_20_tr0_r1_1_gPRT		Comparison report between F03245_P20 and BAC77379unique head 	Sequence name: BAC77379                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03245_P20, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12560 x BAC77379   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKRVFWCLGTTILPPTLDIRGGPSHPCPPMLSLPTLGPLTHSPLSSPPPTVSQGTPMAPA 	Alignment segment 1/1:                                       
						PTPKGATHR                                                    	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1431.00                      Escore:       0                                               
						to amino acids 1 - 69 of F03245_P20, a second amino acid     	             Matching length:     149                Total length:     149                                               
						GPYPQGGYPQGPYPQSPFPPNPYGQPQVFPGQDPDSPQHGNYQEEGPPSYYDNQDFPATN 	 Matching Percent Similarity:   96.64   Matching Percent Identity:   95.30                                               
						WDDKSIRQAFIRKVFLVLTLQLSVTLSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISL 	    Total Percent Similarity:   96.64      Total Percent Identity:   95.30                                               
						IVLSCCGDFRRKHPWNLVAL                                         	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 92 - 231 of BAC77379, which also corresponds to  	Alignment:                                                   
						amino acids 70 - 209 of F03245_P20, and a third amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      61 PTPKGATHRGPYPQGGYPQGPYPQSPFPPNPYGQPQVFPGQDPDSPQHGN 110                                                          
						preferably at least 85%, more preferably at least 90% and    	         | |:    :|||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      83 PYPQEGYPQGPYPQGGYPQGPYPQSPFPPNPYGQPQVFPGQDPDSPQHGN 132                                                          
						having the sequence VTPKPEPLC corresponding to amino acids   	                  .         .         .         .         .  
						210 - 218 of F03245_P20, wherein said first amino acid       	     111 YQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSV 160                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     133 YQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSV 182                                                          
						isolated polypeptide encoding for a head of F03245_P20,      	                  .         .         .         .            
						comprising a polypeptide being at least 70%, optionally at   	     161 FTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVAL  209                                                          
						least about 80%, preferably at least about 85%, more         	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						preferably at least about 90% and most preferably at least   	     183 FTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVAL  231                                                          
						MKRVFWCLGTTILPPTLDIRGGPSHPCPPMLSLPTLGPLTHSPLSSPPPTVSQGTPMAPA 	                                                            
						PTPKGATHR                                                    	                                                            
						about 95% homologous to the sequence of F03245_P20.3.An      	                                                            
						isolated polypeptide encoding for a tail of F03245_P20,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VTPKPEPLC in F03245_P20.	                                                            

						Comparison report between F03245_P20 and Q8IVW7unique head   	Sequence name: Q8IVW7                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F03245_P20, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12560 x Q8IVW7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKRVFWCLGTTILPPTLDIRGGPSHPCPPMLSLPTLGPLTHSPLSSPPPTVSQGTPMAPA 	Alignment segment 1/1:                                       
						PTPKGATHR                                                    	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1422.00                      Escore:       0                                               
						to amino acids 1 - 69 of F03245_P20, a second amino acid     	             Matching length:     149                Total length:     149                                               
						sequence being at least 90 % homologous to GPYPQGGYPQGPYPQ   	 Matching Percent Similarity:   96.64   Matching Percent Identity:   94.63                                               
						corresponding to amino acids 64 - 78 of Q8IVW7, which also   	    Total Percent Similarity:   96.64      Total Percent Identity:   94.63                                               
						corresponds to amino acids 70 - 84 of F03245_P20, a bridging 	                        Gaps:       0                        
						amino acid S corresponding to amino acid 85 of F03245_P20, a 	                                                            
						PFPPNPYGQPQVFPGQDPDSPQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFL 	Alignment:                                                   
						VLTLQLSVTLSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWN 	                  .         .         .         .         .  
						LVAL                                                         	      61 PTPKGATHRGPYPQGGYPQGPYPQSPFPPNPYGQPQVFPGQDPDSPQHGN 110                                                          
						third amino acid sequence being at least 90 % homologous to  	         | |:    :|||||||||||||||:|||||||||||||||||||||||||  
						corresponding to amino acids 80 - 203 of Q8IVW7, which also  	      55 PYPQEGYPQGPYPQGGYPQGPYPQNPFPPNPYGQPQVFPGQDPDSPQHGN 104                                                          
						corresponds to amino acids 86 - 209 of F03245_P20, and a     	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	     111 YQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSV 160                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     105 YQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSV 154                                                          
						polypeptide having the sequence VTPKPEPLC corresponding to   	                  .         .         .         .            
						amino acids 210 - 218 of F03245_P20, wherein said first amino	     161 FTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVAL  209                                                          
						acid sequence, second amino acid sequence, bridging amino    	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						acid, third amino acid sequence and fourth amino acid        	     155 FTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVAL  203                                                          
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of F03245_P20,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MKRVFWCLGTTILPPTLDIRGGPSHPCPPMLSLPTLGPLTHSPLSSPPPTVSQGTPMAPA 	                                                            
						PTPKGATHR                                                    	                                                            
						about 95% homologous to the sequence of F03245_P20.3.An      	                                                            
						isolated polypeptide encoding for a tail of F03245_P20,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VTPKPEPLC in F03245_P20.	                                                            

12558	HMR136_F03245_21_tr0_r1_1_gPRT		Comparison report between F03245_P21 and BAC77379partial WT  	Sequence name: BAC77379                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F03245_P21, comprising a first amino	Sequence documentation:                                      
						MSHEKSFLVSGDNYPPPNPGYPGGPQPPMPPYAQPPYPGAPYPQPPFQPSPYGQPGYPHG 	                                                            
						PSPYPQGGYPQGPYPQGGYPQGPYPQEGYPQGPYPQGGYPQGPYPQSPFPPNPYGQPQVF 	Alignment of: 12558 x BAC77379   ..                          
						PGQDPDSPQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLSTV 	                                                            
						SVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNLVAL          	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 231 of BAC77379, which also corresponds to	                     Quality: 2422.00                      Escore:       0                                               
						amino acids 1 - 231 of F03245_P21, and a second amino acid   	             Matching length:     231                Total length:     231                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence VTPKPEPLC corresponding to amino acids   	                                                            
						232 - 240 of F03245_P21, wherein said first amino acid       	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MSHEKSFLVSGDNYPPPNPGYPGGPQPPMPPYAQPPYPGAPYPQPPFQPS 50                                                           
						tail of F03245_P21, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MSHEKSFLVSGDNYPPPNPGYPGGPQPPMPPYAQPPYPGAPYPQPPFQPS 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence VTPKPEPLC in   	      51 PYGQPGYPHGPSPYPQGGYPQGPYPQGGYPQGPYPQEGYPQGPYPQGGYP 100                                                          
						F03245_P21.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PYGQPGYPHGPSPYPQGGYPQGPYPQGGYPQGPYPQEGYPQGPYPQGGYP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QGPYPQSPFPPNPYGQPQVFPGQDPDSPQHGNYQEEGPPSYYDNQDFPAT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QGPYPQSPFPPNPYGQPQVFPGQDPDSPQHGNYQEEGPPSYYDNQDFPAT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSVFTFVAEVKGFVRENVWTY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NWDDKSIRQAFIRKVFLVLTLQLSVTLSTVSVFTFVAEVKGFVRENVWTY 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 YVSYAVFFISLIVLSCCGDFRRKHPWNLVAL                    231                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     201 YVSYAVFFISLIVLSCCGDFRRKHPWNLVAL                    231                                                          

						Comparison report between F03245_P21 and Q8IVW7unique head   	Sequence name: Q8IVW7                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F03245_P21, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12558 x Q8IVW7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSHEKSFLVSGDNYPPPNPGYPGGPQPP corresponding to amino acids 1 -	                                                            
						28 of F03245_P21, a second amino acid sequence being at least	                     Quality: 2115.00                      Escore:       0                                               
						MPPYAQPPYPGAPYPQPPFQPSPYGQPGYPHGPSPYPQGGYPQGPYPQGGYPQGPYPQEG 	             Matching length:     203                Total length:     203                                               
						YPQGPYPQGGYPQGPYPQ                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.51                                               
						90 % homologous to corresponding to amino acids 1 - 78 of    	    Total Percent Similarity:  100.00      Total Percent Identity:   99.51                                               
						Q8IVW7, which also corresponds to amino acids 29 - 106 of    	                        Gaps:       0                        
						F03245_P21, a bridging amino acid S corresponding to amino   	                                                            
						acid 107 of F03245_P21, a third amino acid sequence being at 	Alignment:                                                   
						PFPPNPYGQPQVFPGQDPDSPQHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFL 	                  .         .         .         .         .  
						VLTLQLSVTLSTVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWN 	      29 MPPYAQPPYPGAPYPQPPFQPSPYGQPGYPHGPSPYPQGGYPQGPYPQGG 78                                                           
						LVAL                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 80 -   	       1 MPPYAQPPYPGAPYPQPPFQPSPYGQPGYPHGPSPYPQGGYPQGPYPQGG 50                                                           
						203 of Q8IVW7, which also corresponds to amino acids 108 -   	                  .         .         .         .         .  
						231 of F03245_P21, and a fourth amino acid sequence being at 	      79 YPQGPYPQEGYPQGPYPQGGYPQGPYPQSPFPPNPYGQPQVFPGQDPDSP 128                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||:|||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	      51 YPQGPYPQEGYPQGPYPQGGYPQGPYPQNPFPPNPYGQPQVFPGQDPDSP 100                                                          
						homologous to a polypeptide having the sequence VTPKPEPLC    	                  .         .         .         .         .  
						corresponding to amino acids 232 - 240 of F03245_P21, wherein	     129 QHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLS 178                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid, third amino acid sequence and fourth    	     101 QHGNYQEEGPPSYYDNQDFPATNWDDKSIRQAFIRKVFLVLTLQLSVTLS 150                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     179 TVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNL 228                                                          
						F03245_P21, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 TVSVFTFVAEVKGFVRENVWTYYVSYAVFFISLIVLSCCGDFRRKHPWNL 200                                                          
						more preferably at least about 90% and most preferably at    	                                                             
						least about 95% homologous to the sequence                   	     229 VAL                                                231                                                          
						MSHEKSFLVSGDNYPPPNPGYPGGPQPP of F03245_P21.3.An isolated     	         |||                                                 
						polypeptide encoding for a tail of F03245_P21, comprising a  	     201 VAL                                                203                                                          
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VTPKPEPLC in F03245_P21.                     	                                                            

12666	HMR136_F03316_4_tr0_r1_1_gPRT		Comparison report between F03316_P4 and IFR1_HUMANpartial WT 	Sequence name: IFR1_HUMAN                                    
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03316_P4, comprising a first amino acid sequence being at   	                                                            
						MPKNKKRNTPHRGSSAGGGGSGAAAATAATAGGQHRNVQPFSDEDASIETMSHCSGYSDP 	Alignment of: 12666 x IFR1_HUMAN   ..                        
						SSFAEDGPEVLDEEGTQEDLEYK                                      	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 83 	Alignment segment 1/1:                                       
						of IFR1_HUMAN, which also corresponds to amino acids 1 - 83  	                                                            
						of F03316_P4, a bridging amino acid L corresponding to amino 	                     Quality: 3822.00                      Escore:       0                                               
						acid 84 of F03316_P4, a second amino acid sequence being at  	             Matching length:     408                Total length:     451                                               
						KGLIDLTLDKSAKTRQAALEGIKNALASKMLYEFILERRMTLTDSIERCLKKGKSDEQRA 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						AAALASVLCIQLGPGIESEEILKTLGPILKKIICDGSASMQARQTCATCFGVCCFIATDD 	    Total Percent Similarity:   90.24      Total Percent Identity:   90.24                                               
						ITELYSTLECLENIFTKSYLKEKDTTVICSTPNTVLHISSLLAWTLLLTICPINEVKKKL 	                        Gaps:       1                        
						EMHFHKLPSLLSCDDVNMRIAAGESLALLFELARGIESDFFYEDMESLTQMLRALATDGN 	                                                            
						KHRAKVDKRKQRSVFRDVLRAVE                                      	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 85 -   	                  .         .         .         .         .  
						347 of IFR1_HUMAN, which also corresponds to amino acids 85 -	       1 MPKNKKRNTPHRGSSAGGGGSGAAAATAATAGGQHRNVQPFSDEDASIET 50                                                           
						347 of F03316_P4, and a third amino acid sequence being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNEFLRNVFELGPPVMLDAATLKTMKISRFERHLYNSAAFKARTKARSKCRDKRADVGEF 	       1 MPKNKKRNTPHRGSSAGGGGSGAAAATAATAGGQHRNVQPFSDEDASIET 50                                                           
						F                                                            	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 391 -  	      51 MSHCSGYSDPSSFAEDGPEVLDEEGTQEDLEYKLKGLIDLTLDKSAKTRQ 100                                                          
						451 of IFR1_HUMAN, which also corresponds to amino acids 348 	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						- 408 of F03316_P4, wherein said first amino acid sequence,  	      51 MSHCSGYSDPSSFAEDGPEVLDEEGTQEDLEYKRKGLIDLTLDKSAKTRQ 100                                                          
						bridging amino acid, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     101 AALEGIKNALASKMLYEFILERRMTLTDSIERCLKKGKSDEQRAAAALAS 150                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of F03316_P4, comprising a polypeptide having a      	     101 AALEGIKNALASKMLYEFILERRMTLTDSIERCLKKGKSDEQRAAAALAS 150                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     151 VLCIQLGPGIESEEILKTLGPILKKIICDGSASMQARQTCATCFGVCCFI 200                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     151 VLCIQLGPGIESEEILKTLGPILKKIICDGSASMQARQTCATCFGVCCFI 200                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise ES, having a structure as  	     201 ATDDITELYSTLECLENIFTKSYLKEKDTTVICSTPNTVLHISSLLAWTL 250                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						347-x to 348; and ending at any of amino acid numbers 348+   	     201 ATDDITELYSTLECLENIFTKSYLKEKDTTVICSTPNTVLHISSLLAWTL 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     251 LLTICPINEVKKKLEMHFHKLPSLLSCDDVNMRIAAGESLALLFELARGI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LLTICPINEVKKKLEMHFHKLPSLLSCDDVNMRIAAGESLALLFELARGI 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ESDFFYEDMESLTQMLRALATDGNKHRAKVDKRKQRSVFRDVLRAVE... 347                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     301 ESDFFYEDMESLTQMLRALATDGNKHRAKVDKRKQRSVFRDVLRAVEERD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     348 ........................................SNEFLRNVFE 357                                                          
						                                                            	                                                 ||||||||||  
						                                                            	     351 FPTETIKFGPERMYIDCWVKKHTYDTFKEVLGSGMQYHLQSNEFLRNVFE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     358 LGPPVMLDAATLKTMKISRFERHLYNSAAFKARTKARSKCRDKRADVGEF 407                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LGPPVMLDAATLKTMKISRFERHLYNSAAFKARTKARSKCRDKRADVGEF 450                                                          
						                                                            	                                                             
						                                                            	     408 F                                                  408                                                          
						                                                            	         |                                                   
						                                                            	     451 F                                                  451                                                          

12905	HMR136_F03435_5_tr0_r1_1_gPRT		Comparison report between F03435_P5 and SRD1_HUMAN_V2partial 	Sequence name: SRD1_HUMAN_V2                                 
						WT sequence with short unique insertion.1.An isolated        	                                                            
						chimeric polypeptide encoding for F03435_P5, comprising a    	Sequence documentation:                                      
						MDGAIAAALLMFGDAGGGPRKRKLSSSSEPYEEDEFNDDQSIKKTRLDHGEESNESAESS 	                                                            
						SNWEKQESIVLKLQKEFPNFDKQELREVLKEHEWMYTEALESLKVFAEDQDMQYVSQSEV 	Alignment of: 12905 x SRD1_HUMAN_V2   ..                     
						PNGKEVSSRSQNYPKNATKTKLKQKFSMKAQNGFNKKRKKNVFNPKRVVEDSEYDSGSDV 	                                                            
						GSSLDEDYSSGEEVMEDGYKGKILHFLQDASIGELTLIPQCSQKKAQKITELRPFNSWEA 	Alignment segment 1/1:                                       
						LFTKMSKTNGLSEDLIWHCKTLIQERDVVIRLMNKCEDISNKLTKQVTMLTGNGGGWNIE 	                                                            
						QPSILNQSLSLKPYQKVGLNWLALVHKHGLNGILADEMGLGKTIQAIAFLAYLYQEGNNG 	                     Quality: 8175.00                      Escore:       0                                               
						PHLIVVPASTIDNWLREVNLWCPTLKVLCYYGSQEERKQIRFNIHSRYEDYNVIVTTYNC 	             Matching length:     840                Total length:     842                                               
						AISSSDDRSLFRRLKLNYAIFDEGHMLKNMGSIRYQHLMTINANNRLLLTGTPVQNNLLE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LMSLLNFVMPHMFSSSTSEIRRMFSSKTKSADEQSIYEKERIAHAKQIIKPFILRRVKEE 	    Total Percent Similarity:   99.76      Total Percent Identity:   99.76                                               
						VLKQLPPKKDRIELCAMSEKQEQLYLGLFNRLKKSINNL                      	                        Gaps:       1                        
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 187 - 765 of SRD1_HUMAN_V2,     	Alignment:                                                   
						which also corresponds to amino acids 1 - 579 of F03435_P5, a	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	       1 MDGAIAAALLMFGDAGGGPRKRKLSSSSEPYEEDEFNDDQSIKKTRLDHG 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     187 MDGAIAAALLMFGDAGGGPRKRKLSSSSEPYEEDEFNDDQSIKKTRLDHG 236                                                          
						polypeptide having the sequence VT corresponding to amino    	                  .         .         .         .         .  
						acids 580 - 581 of F03435_P5, and a third amino acid sequence	      51 EESNESAESSSNWEKQESIVLKLQKEFPNFDKQELREVLKEHEWMYTEAL 100                                                          
						EKNTEMCNVMMQLRKMANHPLLHRQYYTAEKLKEMSQLMLKEPTHCEANPDLIFEDMEVM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDFELHVLCKQYRHINNFQLDMDLILDSGKFRVLGCILSELKQKGDRVVLFSQFTMMLDI 	     237 EESNESAESSSNWEKQESIVLKLQKEFPNFDKQELREVLKEHEWMYTEAL 286                                                          
						LEVLLKHHQHRYLRLDGKTQISERIHLIDEFNTDMDIFVFLLSTKAGGLGINLTSANVVI 	                  .         .         .         .         .  
						LHDIDCNPYNDKQAEDRCHRVGQTKEVLVIKLISQGTIEESMLKINQQKLKLEQDMTTVD 	     101 ESLKVFAEDQDMQYVSQSEVPNGKEVSSRSQNYPKNATKTKLKQKFSMKA 150                                                          
						EGDEGSMPADIATLLKTSMGL                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     287 ESLKVFAEDQDMQYVSQSEVPNGKEVSSRSQNYPKNATKTKLKQKFSMKA 336                                                          
						acids 766 - 1026 of SRD1_HUMAN_V2, which also corresponds to 	                  .         .         .         .         .  
						amino acids 582 - 842 of F03435_P5, wherein said first amino 	     151 QNGFNKKRKKNVFNPKRVVEDSEYDSGSDVGSSLDEDYSSGEEVMEDGYK 200                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	     337 QNGFNKKRKKNVFNPKRVVEDSEYDSGSDVGSSLDEDYSSGEEVMEDGYK 386                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						F03435_P5, comprising an amino acid sequence being at least  	     201 GKILHFLQDASIGELTLIPQCSQKKAQKITELRPFNSWEALFTKMSKTNG 250                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     387 GKILHFLQDASIGELTLIPQCSQKKAQKITELRPFNSWEALFTKMSKTNG 436                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						VT, corresponding to F03435_P5.                              	     251 LSEDLIWHCKTLIQERDVVIRLMNKCEDISNKLTKQVTMLTGNGGGWNIE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     437 LSEDLIWHCKTLIQERDVVIRLMNKCEDISNKLTKQVTMLTGNGGGWNIE 486                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QPSILNQSLSLKPYQKVGLNWLALVHKHGLNGILADEMGLGKTIQAIAFL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     487 QPSILNQSLSLKPYQKVGLNWLALVHKHGLNGILADEMGLGKTIQAIAFL 536                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 AYLYQEGNNGPHLIVVPASTIDNWLREVNLWCPTLKVLCYYGSQEERKQI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     537 AYLYQEGNNGPHLIVVPASTIDNWLREVNLWCPTLKVLCYYGSQEERKQI 586                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 RFNIHSRYEDYNVIVTTYNCAISSSDDRSLFRRLKLNYAIFDEGHMLKNM 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     587 RFNIHSRYEDYNVIVTTYNCAISSSDDRSLFRRLKLNYAIFDEGHMLKNM 636                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GSIRYQHLMTINANNRLLLTGTPVQNNLLELMSLLNFVMPHMFSSSTSEI 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     637 GSIRYQHLMTINANNRLLLTGTPVQNNLLELMSLLNFVMPHMFSSSTSEI 686                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RRMFSSKTKSADEQSIYEKERIAHAKQIIKPFILRRVKEEVLKQLPPKKD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     687 RRMFSSKTKSADEQSIYEKERIAHAKQIIKPFILRRVKEEVLKQLPPKKD 736                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 RIELCAMSEKQEQLYLGLFNRLKKSINNLVTEKNTEMCNVMMQLRKMANH 600                                                          
						                                                            	         |||||||||||||||||||||||||||||  |||||||||||||||||||  
						                                                            	     737 RIELCAMSEKQEQLYLGLFNRLKKSINNL..EKNTEMCNVMMQLRKMANH 784                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PLLHRQYYTAEKLKEMSQLMLKEPTHCEANPDLIFEDMEVMTDFELHVLC 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     785 PLLHRQYYTAEKLKEMSQLMLKEPTHCEANPDLIFEDMEVMTDFELHVLC 834                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 KQYRHINNFQLDMDLILDSGKFRVLGCILSELKQKGDRVVLFSQFTMMLD 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     835 KQYRHINNFQLDMDLILDSGKFRVLGCILSELKQKGDRVVLFSQFTMMLD 884                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 ILEVLLKHHQHRYLRLDGKTQISERIHLIDEFNTDMDIFVFLLSTKAGGL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     885 ILEVLLKHHQHRYLRLDGKTQISERIHLIDEFNTDMDIFVFLLSTKAGGL 934                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GINLTSANVVILHDIDCNPYNDKQAEDRCHRVGQTKEVLVIKLISQGTIE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     935 GINLTSANVVILHDIDCNPYNDKQAEDRCHRVGQTKEVLVIKLISQGTIE 984                                                          
						                                                            	                  .         .         .         .            
						                                                            	     801 ESMLKINQQKLKLEQDMTTVDEGDEGSMPADIATLLKTSMGL         842                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     985 ESMLKINQQKLKLEQDMTTVDEGDEGSMPADIATLLKTSMGL         1026                                                         

13167	HMR136_F03465_2_tr0_r1_1_gPRT		Comparison report between F03465_P2 and Q9H6Q0unique head    	Sequence name: Q9H6Q0                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F03465_P2, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13167 x Q9H6Q0   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                     Quality: 1478.00                      Escore:       0                                               
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	             Matching length:     151                Total length:     151                                               
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	 Matching Percent Similarity:   99.34   Matching Percent Identity:   99.34                                               
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	    Total Percent Similarity:   99.34      Total Percent Identity:   99.34                                               
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	                        Gaps:       0                        
						STEFRPNAPVPLVID                                              	                                                            
						polypeptide having the sequence corresponding to amino acids 	Alignment:                                                   
						1 - 435 of F03465_P2, a second amino acid sequence being at  	                  .         .         .         .         .  
						MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQN 	     436 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 485                                                          
						DLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQGCK                                                        	       1 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 125	                  .         .         .         .         .  
						of Q9H6Q0, which also corresponds to amino acids 436 - 560 of	     486 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 535                                                          
						F03465_P2, a bridging amino acid L corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 561 of F03465_P2, and a third amino acid sequence being 	      51 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 100                                                          
						at least 90 % homologous to SSSDRYSDASDDSFSEPRIAELEIS        	                  .         .         .         .         .  
						corresponding to amino acids 127 - 151 of Q9H6Q0, which also 	     536 PSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEI 585                                                          
						corresponds to amino acids 562 - 586 of F03465_P2, wherein   	         ||||||||||||||||||||||||| ||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     101 PSPPYLGLLLAATGNLNAYLQQGCKPSSSDRYSDASDDSFSEPRIAELEI 150                                                          
						bridging amino acid and third amino acid sequence are        	                                                             
						contiguous and in a sequential order.2.An isolated           	     586 S                                                  586                                                          
						polypeptide encoding for a head of F03465_P2, comprising a   	         |                                                   
						polypeptide being at least 70%, optionally at least about    	     151 S                                                  151                                                          
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	                                                            
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	                                                            
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	                                                            
						STEFRPNAPVPLVID                                              	                                                            
						to the sequence of F03465_P2.                                	                                                            

						Comparison report between F03465_P2 and Q9BRI0unique head    	Sequence name: Q9BRI0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F03465_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13167 x Q9BRI0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	                                                            
						having the sequence corresponding to amino acids 1 - 87 of   	                     Quality: 4899.00                      Escore:       0                                               
						F03465_P2, and a second amino acid sequence being at least 90	             Matching length:     499                Total length:     499                                               
						ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFK 	                        Gaps:       0                        
						ERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALA 	                                                            
						INHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 	Alignment:                                                   
						ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGT 	                  .         .         .         .         .  
						MRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGD 	      88 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 137                                                          
						RMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDASDDSFSEPRIAELEIS                                          	       4 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 53                                                           
						% homologous to corresponding to amino acids 4 - 502 of      	                  .         .         .         .         .  
						Q9BRI0, which also corresponds to amino acids 88 - 586 of    	     138 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 187                                                          
						F03465_P2, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      54 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 103                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F03465_P2, comprising a polypeptide being at least 70%,      	     188 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 237                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     104 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 153                                                          
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                  .         .         .         .         .  
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	     238 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 287                                                          
						least about 95% homologous to the sequence of F03465_P2.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     154 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 203                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     288 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 337                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 253                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     338 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     254 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 303                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     388 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 353                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     488 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 537                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 453                                                          
						                                                            	                  .         .         .         .            
						                                                            	     538 PPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS  586                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     454 PPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS  502                                                          

						Comparison report between F03465_P2 and Q9H809partial WT     	Sequence name: Q9H809                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F03465_P2, comprising a first amino 	Sequence documentation:                                      
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	Alignment of: 13167 x Q9H809   ..                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSS                      	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 219 of Q9H809, which also corresponds to  	                     Quality: 5715.00                      Escore:       0                                               
						amino acids 1 - 219 of F03465_P2, a bridging amino acid T    	             Matching length:     586                Total length:     586                                               
						corresponding to amino acid 220 of F03465_P2, and a second   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						PIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASN 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						LLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSI 	                        Gaps:       0                        
						DLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 	                                                            
						GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTE 	Alignment:                                                   
						NSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYF 	                  .         .         .         .         .  
						VGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRI 	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						AELEIS                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						corresponding to amino acids 221 - 586 of Q9H809, which also 	                  .         .         .         .         .  
						corresponds to amino acids 221 - 586 of F03465_P2, wherein   	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						said first amino acid sequence, bridging amino acid and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSSPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	                  .         .         .                      
						                                                            	     551 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               586                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     551 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               586                                                          

13169	HMR136_F03465_4_tr0_r1_1_gPRT		Comparison report between F03465_P4 and Q9H6Q0unique head    	Sequence name: Q9H6Q0                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F03465_P4, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13169 x Q9H6Q0   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                     Quality: 1478.00                      Escore:       0                                               
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	             Matching length:     151                Total length:     151                                               
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	 Matching Percent Similarity:   99.34   Matching Percent Identity:   99.34                                               
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	    Total Percent Similarity:   99.34      Total Percent Identity:   99.34                                               
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	                        Gaps:       0                        
						STEFRPNAPVPLVID                                              	                                                            
						polypeptide having the sequence corresponding to amino acids 	Alignment:                                                   
						1 - 435 of F03465_P4, a second amino acid sequence being at  	                  .         .         .         .         .  
						MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQN 	     436 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 485                                                          
						DLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQGCK                                                        	       1 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 125	                  .         .         .         .         .  
						of Q9H6Q0, which also corresponds to amino acids 436 - 560 of	     486 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 535                                                          
						F03465_P4, a bridging amino acid L corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 561 of F03465_P4, and a third amino acid sequence being 	      51 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 100                                                          
						at least 90 % homologous to SSSDRYSDASDDSFSEPRIAELEIS        	                  .         .         .         .         .  
						corresponding to amino acids 127 - 151 of Q9H6Q0, which also 	     536 PSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEI 585                                                          
						corresponds to amino acids 562 - 586 of F03465_P4, wherein   	         ||||||||||||||||||||||||| ||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     101 PSPPYLGLLLAATGNLNAYLQQGCKPSSSDRYSDASDDSFSEPRIAELEI 150                                                          
						bridging amino acid and third amino acid sequence are        	                                                             
						contiguous and in a sequential order.2.An isolated           	     586 S                                                  586                                                          
						polypeptide encoding for a head of F03465_P4, comprising a   	         |                                                   
						polypeptide being at least 70%, optionally at least about    	     151 S                                                  151                                                          
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	                                                            
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	                                                            
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	                                                            
						STEFRPNAPVPLVID                                              	                                                            
						to the sequence of F03465_P4.                                	                                                            

						Comparison report between F03465_P4 and Q9BRI0unique head    	Sequence name: Q9BRI0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F03465_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13169 x Q9BRI0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	                                                            
						having the sequence corresponding to amino acids 1 - 87 of   	                     Quality: 4899.00                      Escore:       0                                               
						F03465_P4, and a second amino acid sequence being at least 90	             Matching length:     499                Total length:     499                                               
						ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFK 	                        Gaps:       0                        
						ERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALA 	                                                            
						INHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 	Alignment:                                                   
						ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGT 	                  .         .         .         .         .  
						MRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGD 	      88 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 137                                                          
						RMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDASDDSFSEPRIAELEIS                                          	       4 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 53                                                           
						% homologous to corresponding to amino acids 4 - 502 of      	                  .         .         .         .         .  
						Q9BRI0, which also corresponds to amino acids 88 - 586 of    	     138 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 187                                                          
						F03465_P4, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      54 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 103                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F03465_P4, comprising a polypeptide being at least 70%,      	     188 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 237                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     104 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 153                                                          
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                  .         .         .         .         .  
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	     238 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 287                                                          
						least about 95% homologous to the sequence of F03465_P4.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     154 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 203                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     288 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 337                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     204 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 253                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     338 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     254 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 303                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     388 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 353                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     488 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 537                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 453                                                          
						                                                            	                  .         .         .         .            
						                                                            	     538 PPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS  586                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     454 PPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS  502                                                          

						Comparison report between F03465_P4 and Q9H809partial WT     	Sequence name: Q9H809                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F03465_P4, comprising a first amino 	Sequence documentation:                                      
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	Alignment of: 13169 x Q9H809   ..                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSS                      	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 219 of Q9H809, which also corresponds to  	                     Quality: 5715.00                      Escore:       0                                               
						amino acids 1 - 219 of F03465_P4, a bridging amino acid T    	             Matching length:     586                Total length:     586                                               
						corresponding to amino acid 220 of F03465_P4, and a second   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						PIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASN 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						LLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSI 	                        Gaps:       0                        
						DLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 	                                                            
						GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTE 	Alignment:                                                   
						NSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYF 	                  .         .         .         .         .  
						VGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRI 	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						AELEIS                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						corresponding to amino acids 221 - 586 of Q9H809, which also 	                  .         .         .         .         .  
						corresponds to amino acids 221 - 586 of F03465_P4, wherein   	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						said first amino acid sequence, bridging amino acid and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						order.                                                       	                  .         .         .         .         .  
						                                                            	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSSPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	                  .         .         .                      
						                                                            	     551 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               586                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     551 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               586                                                          

13171	HMR136_F03465_5_tr0_r1_1_gPRT		Comparison report between F03465_P5 and Q9H6Q0unique head    	Sequence name: Q9H6Q0                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F03465_P5, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13171 x Q9H6Q0   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVC 	Alignment segment 1/1:                                       
						RSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGD 	                                                            
						SASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMY 	                     Quality: 1478.00                      Escore:       0                                               
						IDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFL 	             Matching length:     151                Total length:     151                                               
						GVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVID                      	 Matching Percent Similarity:   99.34   Matching Percent Identity:   99.34                                               
						polypeptide having the sequence corresponding to amino acids 	    Total Percent Similarity:   99.34      Total Percent Identity:   99.34                                               
						1 - 279 of F03465_P5, a second amino acid sequence being at  	                        Gaps:       0                        
						MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQN 	                                                            
						DLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYL 	Alignment:                                                   
						QQGCK                                                        	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 125	     280 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 329                                                          
						of Q9H6Q0, which also corresponds to amino acids 280 - 404 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F03465_P5, a bridging amino acid L corresponding to amino    	       1 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 50                                                           
						acid 405 of F03465_P5, and a third amino acid sequence being 	                  .         .         .         .         .  
						at least 90 % homologous to SSSDRYSDASDDSFSEPRIAELEIS        	     330 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 379                                                          
						corresponding to amino acids 127 - 151 of Q9H6Q0, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 406 - 430 of F03465_P5, wherein   	      51 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 100                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						bridging amino acid and third amino acid sequence are        	     380 PSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEI 429                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||| ||||||||||||||||||||||||  
						polypeptide encoding for a head of F03465_P5, comprising a   	     101 PSPPYLGLLLAATGNLNAYLQQGCKPSSSDRYSDASDDSFSEPRIAELEI 150                                                          
						polypeptide being at least 70%, optionally at least about    	                                                             
						80%, preferably at least about 85%, more preferably at least 	     430 S                                                  430                                                          
						about 90% and most preferably at least about 95% homologous  	         |                                                   
						MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVC 	     151 S                                                  151                                                          
						RSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGD 	                                                            
						SASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMY 	                                                            
						IDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFL 	                                                            
						GVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVID                      	                                                            
						to the sequence of F03465_P5.                                	                                                            

						Comparison report between F03465_P5 and Q9BRI0partial WT     	Sequence name: Q9BRI0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F03465_P5, comprising a first amino acid        	                                                            
						MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVC 	Alignment of: 13171 x Q9BRI0   ..                            
						RSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGD 	                                                            
						SASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMY 	Alignment segment 1/1:                                       
						IDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFL 	                                                            
						GVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 	                     Quality: 4227.00                      Escore:       0                                               
						FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELAN 	             Matching length:     430                Total length:     430                                               
						HPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EPRIAELEIS                                                   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 73 - 502 of Q9BRI0, which also corresponds to    	                                                            
						amino acids 1 - 430 of F03465_P5.                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      73 MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRG 122                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     123 LGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVL 172                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     173 LEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGK 222                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     223 YTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHE 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 AWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAV 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 IEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDG 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 DRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQ 472                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 QGCKLSSSDRYSDASDDSFSEPRIAELEIS                     430                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     473 QGCKLSSSDRYSDASDDSFSEPRIAELEIS                     502                                                          

						Comparison report between F03465_P5 and Q9H809partial WT     	Sequence name: Q9H809                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F03465_P5, comprising a first amino 	Sequence documentation:                                      
						MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVC 	                                                            
						RSS                                                          	Alignment of: 13171 x Q9H809   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 157 - 219 of Q9H809, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 63 of F03465_P5, a bridging amino acid T     	                                                            
						corresponding to amino acid 64 of F03465_P5, and a second    	                     Quality: 4220.00                      Escore:       0                                               
						PIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASN 	             Matching length:     430                Total length:     430                                               
						LLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						DLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTE 	                        Gaps:       0                        
						NSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYF 	                                                            
						VGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRI 	Alignment:                                                   
						AELEIS                                                       	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRG 50                                                           
						corresponding to amino acids 221 - 586 of Q9H809, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 65 - 430 of F03465_P5, wherein    	     157 MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRG 206                                                          
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 LGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVL 100                                                          
						order.                                                       	         |||||||||||||:||||||||||||||||||||||||||||||||||||  
						                                                            	     207 LGLSPDLIVCRSSSPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVL 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 LEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGK 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 YTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHE 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 AWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAV 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 IEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDG 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 DRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQ 556                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 QGCKLSSSDRYSDASDDSFSEPRIAELEIS                     430                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     557 QGCKLSSSDRYSDASDDSFSEPRIAELEIS                     586                                                          

						Comparison report between F03465_P5 and Q9NRF8partial WT     	Sequence name: Q9NRF8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F03465_P5, comprising a first amino acid        	                                                            
						MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVC 	Alignment of: 13171 x Q9NRF8   ..                            
						RSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGD 	                                                            
						SASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMY 	Alignment segment 1/1:                                       
						IDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFL 	                                                            
						GVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 	                     Quality: 4227.00                      Escore:       0                                               
						FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELAN 	             Matching length:     430                Total length:     430                                               
						HPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EPRIAELEIS                                                   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 157 - 586 of Q9NRF8, which also corresponds to   	                                                            
						amino acids 1 - 430 of F03465_P5.                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 MPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRG 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 LGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVL 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 LEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGK 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 YTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHE 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 AWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAV 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 IEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTV 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 FKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDG 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 DRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQ 556                                                          
						                                                            	                  .         .         .                      
						                                                            	     401 QGCKLSSSDRYSDASDDSFSEPRIAELEIS                     430                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     557 QGCKLSSSDRYSDASDDSFSEPRIAELEIS                     586                                                          

13165	HMR136_F03465_6_tr0_r1_1_gPRT		Comparison report between F03465_P6 and Q9H6Q0unique head    	Sequence name: Q9H6Q0                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F03465_P6, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13165 x Q9H6Q0   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                     Quality: 1478.00                      Escore:       0                                               
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	             Matching length:     151                Total length:     151                                               
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	 Matching Percent Similarity:   99.34   Matching Percent Identity:   99.34                                               
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMVID                       	    Total Percent Similarity:   99.34      Total Percent Identity:   99.34                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       0                        
						1 - 338 of F03465_P6, a second amino acid sequence being at  	                                                            
						MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQN 	Alignment:                                                   
						DLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYL 	                  .         .         .         .         .  
						QQGCK                                                        	     339 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 388                                                          
						least 90 % homologous to corresponding to amino acids 1 - 125	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q9H6Q0, which also corresponds to amino acids 339 - 463 of	       1 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 50                                                           
						F03465_P6, a bridging amino acid L corresponding to amino    	                  .         .         .         .         .  
						acid 464 of F03465_P6, and a third amino acid sequence being 	     389 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 438                                                          
						at least 90 % homologous to SSSDRYSDASDDSFSEPRIAELEIS        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 127 - 151 of Q9H6Q0, which also 	      51 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 100                                                          
						corresponds to amino acids 465 - 489 of F03465_P6, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     439 PSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEI 488                                                          
						bridging amino acid and third amino acid sequence are        	         ||||||||||||||||||||||||| ||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 PSPPYLGLLLAATGNLNAYLQQGCKPSSSDRYSDASDDSFSEPRIAELEI 150                                                          
						polypeptide encoding for a head of F03465_P6, comprising a   	                                                             
						polypeptide being at least 70%, optionally at least about    	     489 S                                                  489                                                          
						80%, preferably at least about 85%, more preferably at least 	         |                                                   
						about 90% and most preferably at least about 95% homologous  	     151 S                                                  151                                                          
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	                                                            
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMVID                       	                                                            
						to the sequence of F03465_P6.                                	                                                            

						Comparison report between F03465_P6 and Q9BRI0unique head    	Sequence name: Q9BRI0                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F03465_P6,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 13165 x Q9BRI0   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 3853.00                      Escore:       0                                               
						to amino acids 1 - 87 of F03465_P6, a second amino acid      	             Matching length:     402                Total length:     499                                               
						ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGL 	    Total Percent Similarity:   80.56      Total Percent Identity:   80.56                                               
						GLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFK 	                        Gaps:       1                        
						ERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALA 	                                                            
						INHKLNLM                                                     	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 4 - 251 of Q9BRI0, which also corresponds to     	      88 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 137                                                          
						amino acids 88 - 335 of F03465_P6, and a third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQF 	       4 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 53                                                           
						EQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLN 	                  .         .         .         .         .  
						AYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS                           	     138 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 187                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 349 - 502 of Q9BRI0, which also corresponds to   	      54 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 103                                                          
						amino acids 336 - 489 of F03465_P6, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, second amino acid sequence and third amino    	     188 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 237                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F03465_P6,       	     104 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 153                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     238 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 287                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	     154 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 203                                                          
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	                  .         .         .         .         .  
						about 95% homologous to the sequence of F03465_P6.3.An       	     288 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLM.. 335                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						F03465_P6, comprising a polypeptide having a length "n",     	     204 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 253                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     335 .................................................. 335                                                          
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	     254 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 303                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise MV, having a structure as  	     336 .............................................VIDMP 340                                                          
						follows: a sequence starting from any of amino acid numbers  	                                                      |||||  
						335-x to 336; and ending at any of amino acid numbers 336+   	     304 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 353                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     341 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 390                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     391 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 440                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 453                                                          
						                                                            	                  .         .         .         .            
						                                                            	     441 PPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS  489                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     454 PPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS  502                                                          

						Comparison report between F03465_P6 and Q9H809partial WT     	Sequence name: Q9H809                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03465_P6, comprising a first amino acid sequence being at   	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment of: 13165 x Q9H809   ..                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	Alignment segment 1/1:                                       
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSS                      	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 219	                     Quality: 4669.00                      Escore:       0                                               
						of Q9H809, which also corresponds to amino acids 1 - 219 of  	             Matching length:     489                Total length:     586                                               
						F03465_P6, a bridging amino acid T corresponding to amino    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						acid 220 of F03465_P6, a second amino acid sequence being at 	    Total Percent Similarity:   83.45      Total Percent Identity:   83.28                                               
						PIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASN 	                        Gaps:       1                        
						LLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLM      	                                                            
						least 90 % homologous to corresponding to amino acids 221 -  	Alignment:                                                   
						335 of Q9H809, which also corresponds to amino acids 221 -   	                  .         .         .         .         .  
						335 of F03465_P6, and a third amino acid sequence being at   	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						VIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLN 	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						AYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS                           	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 433 -  	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						586 of Q9H809, which also corresponds to amino acids 336 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						489 of F03465_P6, wherein said first amino acid sequence,    	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						bridging amino acid, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of F03465_P6, comprising a polypeptide having a      	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise MV, having a structure as  	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						follows: a sequence starting from any of amino acid numbers  	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						335-x to 336; and ending at any of amino acid numbers 336+   	     201 VRALRGLGLSPDLIVCRSSSPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLM............... 335                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     335 .................................................. 335                                                          
						                                                            	                                                            
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     336 ................................VIDMPEHNPGNLGGTMRL 353                                                          
						                                                            	                                         ||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     354 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 403                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     404 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 453                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	                  .         .         .                      
						                                                            	     454 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               489                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     551 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               586                                                          

						Comparison report between F03465_P6 and Q9NRF8partial WT     	Sequence name: Q9NRF8                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F03465_P6, comprising a first amino 	Sequence documentation:                                      
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	Alignment of: 13165 x Q9NRF8   ..                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	Alignment segment 1/1:                                       
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLM                          	                     Quality: 4676.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     489                Total length:     586                                               
						to amino acids 1 - 335 of Q9NRF8, which also corresponds to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 335 of F03465_P6, and a second amino acid    	    Total Percent Similarity:   83.45      Total Percent Identity:   83.45                                               
						VIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQF 	                        Gaps:       1                        
						EQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLN 	                                                            
						AYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS                           	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 433 - 586 of Q9NRF8, which also corresponds to   	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						amino acids 336 - 489 of F03465_P6, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						and in a sequential order.2.An isolated chimeric polypeptide 	                  .         .         .         .         .  
						encoding for an edge portion of F03465_P6, comprising a      	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise MV, having 	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 335-x to 336; and ending at any of amino acid   	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						numbers 336+ ((n-2) - x), in which x varies from 0 to n-2.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLM............... 335                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     335 .................................................. 335                                                          
						                                                            	                                                            
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     336 ................................VIDMPEHNPGNLGGTMRL 353                                                          
						                                                            	                                         ||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     354 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 403                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     404 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 453                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	                  .         .         .                      
						                                                            	     454 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               489                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     551 LNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS               586                                                          

13163	HMR136_F03465_7_tr0_r1_1_gPRT		Comparison report between F03465_P7 and Q9H6Q0unique head    	Sequence name: Q9H6Q0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03465_P7, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13163 x Q9H6Q0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                     Quality: 1259.00                      Escore:       0                                               
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	             Matching length:     128                Total length:     128                                               
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	 Matching Percent Similarity:   99.22   Matching Percent Identity:   99.22                                               
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	    Total Percent Similarity:   99.22      Total Percent Identity:   99.22                                               
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	                        Gaps:       0                        
						STEFRPNAPVPLVID                                              	                                                            
						homologous to a polypeptide having the sequence corresponding	Alignment:                                                   
						to amino acids 1 - 435 of F03465_P7, a second amino acid     	                  .         .         .         .         .  
						MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQN 	     436 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 485                                                          
						DLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQGCK                                                        	       1 MPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVN 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 125 of Q9H6Q0, which also corresponds to     	     486 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 535                                                          
						amino acids 436 - 560 of F03465_P7, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 PNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMK 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .                                
						most preferably at least 95% homologous to a polypeptide     	     536 PSPPYLGLLLAATGNLNAYLQQGCKLSS                       563                                                          
						having the sequence LSSRSLSPSLHVYIQMA corresponding to amino 	         ||||||||||||||||||||||||| ||                        
						acids 561 - 577 of F03465_P7, wherein said first amino acid  	     101 PSPPYLGLLLAATGNLNAYLQQGCKPSS                       128                                                          
						sequence, second amino acid sequence and third amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of F03465_P7,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	                                                            
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	                                                            
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	                                                            
						STEFRPNAPVPLVID                                              	                                                            
						about 95% homologous to the sequence of F03465_P7.3.An       	                                                            
						isolated polypeptide encoding for a tail of F03465_P7,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence LSSRSLSPSLHVYIQMA in    	                                                            
						F03465_P7.                                                   	                                                            

						Comparison report between F03465_P7 and Q9BRI0unique head    	Sequence name: Q9BRI0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03465_P7, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13163 x Q9BRI0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 4680.00                      Escore:       0                                               
						to amino acids 1 - 87 of F03465_P7, a second amino acid      	             Matching length:     476                Total length:     476                                               
						ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFK 	                        Gaps:       0                        
						ERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALA 	                                                            
						INHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 	Alignment:                                                   
						ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGT 	                  .         .         .         .         .  
						MRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGD 	      88 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 137                                                          
						RMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSS     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       4 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 53                                                           
						amino acids 4 - 479 of Q9BRI0, which also corresponds to     	                  .         .         .         .         .  
						amino acids 88 - 563 of F03465_P7, and a third amino acid    	     138 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 187                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      54 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 103                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence RSLSPSLHVYIQMA corresponding to amino    	     188 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 237                                                          
						acids 564 - 577 of F03465_P7, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     104 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 153                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of F03465_P7,       	     238 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 287                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     154 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 203                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	     288 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 337                                                          
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of F03465_P7.3.An       	     204 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 253                                                          
						isolated polypeptide encoding for a tail of F03465_P7,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     338 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 387                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     254 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 303                                                          
						about 95% homologous to the sequence RSLSPSLHVYIQMA in       	                  .         .         .         .         .  
						F03465_P7.                                                   	     388 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 353                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 EHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPN 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     488 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 537                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 LIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPS 453                                                          
						                                                            	                  .         .                                
						                                                            	     538 PPYLGLLLAATGNLNAYLQQGCKLSS                         563                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     454 PPYLGLLLAATGNLNAYLQQGCKLSS                         479                                                          

						Comparison report between F03465_P7 and Q9H809partial WT     	Sequence name: Q9H809                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03465_P7, comprising a first amino acid sequence being at   	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment of: 13163 x Q9H809   ..                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	Alignment segment 1/1:                                       
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSS                      	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 219	                     Quality: 5496.00                      Escore:       0                                               
						of Q9H809, which also corresponds to amino acids 1 - 219 of  	             Matching length:     563                Total length:     563                                               
						F03465_P7, a bridging amino acid T corresponding to amino    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						acid 220 of F03465_P7, a second amino acid sequence being at 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						PIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASN 	                        Gaps:       0                        
						LLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSI 	                                                            
						DLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 	Alignment:                                                   
						GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTE 	                  .         .         .         .         .  
						NSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYF 	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						VGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSS                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 221 -  	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						563 of Q9H809, which also corresponds to amino acids 221 -   	                  .         .         .         .         .  
						563 of F03465_P7, and a third amino acid sequence being at   	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						RSLSPSLHVYIQMA corresponding to amino acids 564 - 577 of     	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						F03465_P7, wherein said first amino acid sequence, bridging  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid, second amino acid sequence and third amino acid  	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of F03465_P7,       	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence RSLSPSLHVYIQMA in       	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						F03465_P7.                                                   	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSSPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	                  .                                          
						                                                            	     551 LNAYLQQGCKLSS                                      563                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     551 LNAYLQQGCKLSS                                      563                                                          

						Comparison report between F03465_P7 and Q9NRF8partial WT     	Sequence name: Q9NRF8                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F03465_P7, comprising a first amino 	Sequence documentation:                                      
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	Alignment of: 13163 x Q9NRF8   ..                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	Alignment segment 1/1:                                       
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	                     Quality: 5503.00                      Escore:       0                                               
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	             Matching length:     563                Total length:     563                                               
						STEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LGLLLAATGNLNAYLQQGCKLSS                                      	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 563 of Q9NRF8, which also corresponds to  	Alignment:                                                   
						amino acids 1 - 563 of F03465_P7, and a second amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						having the sequence RSLSPSLHVYIQMA corresponding to amino    	                  .         .         .         .         .  
						acids 564 - 577 of F03465_P7, wherein said first amino acid  	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						tail of F03465_P7, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence RSLSPSLHVYIQMA 	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						in F03465_P7.                                                	                  .         .         .         .         .  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGN 550                                                          
						                                                            	                  .                                          
						                                                            	     551 LNAYLQQGCKLSS                                      563                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     551 LNAYLQQGCKLSS                                      563                                                          

13161	HMR136_F03465_8_tr0_r1_1_gPRT		Comparison report between F03465_P8 and Q9BRI0unique head    	Sequence name: Q9BRI0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03465_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13161 x Q9BRI0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment segment 1/1:                                       
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 3691.00                      Escore:       0                                               
						to amino acids 1 - 87 of F03465_P8, a second amino acid      	             Matching length:     377                Total length:     377                                               
						ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFK 	                        Gaps:       0                        
						ERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALA 	                                                            
						INHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 	Alignment:                                                   
						ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGT 	                  .         .         .         .         .  
						MRLGIRRTVFKTENSIL                                            	      88 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 137                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 4 - 380 of Q9BRI0, which also corresponds to     	       4 ITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNK 53                                                           
						amino acids 88 - 464 of F03465_P8, and a third amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     138 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 187                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      54 EEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLS 103                                                          
						having the sequence                                          	                  .         .         .         .         .  
						ISLSLGLASVEHTECPSAFDLRDSLFIGLFCELPMLLEMNLDWDLD corresponding 	     188 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 237                                                          
						to amino acids 465 - 510 of F03465_P8, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     104 ATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVN 153                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     238 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 287                                                          
						F03465_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     154 PEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRN 203                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	     288 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 337                                                          
						LNDGGEVDLDLGNYERFLDINLYKDNN                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F03465_P8.3.An 	     204 MADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYI 253                                                          
						isolated polypeptide encoding for a tail of F03465_P8,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     338 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 387                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     254 DSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISW 303                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						ISLSLGLASVEHTECPSAFDLRDSLFIGLFCELPMLLEMNLDWDLD in F03465_P8. 	     388 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     304 ARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMP 353                                                          
						                                                            	                  .         .                                
						                                                            	     438 EHNPGNLGGTMRLGIRRTVFKTENSIL                        464                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     354 EHNPGNLGGTMRLGIRRTVFKTENSIL                        380                                                          

						Comparison report between F03465_P8 and Q9H809partial WT     	Sequence name: Q9H809                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F03465_P8, comprising a first amino acid sequence being at   	                                                            
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	Alignment of: 13161 x Q9H809   ..                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	                                                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	Alignment segment 1/1:                                       
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSS                      	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 219	                     Quality: 4507.00                      Escore:       0                                               
						of Q9H809, which also corresponds to amino acids 1 - 219 of  	             Matching length:     464                Total length:     464                                               
						F03465_P8, a bridging amino acid T corresponding to amino    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						acid 220 of F03465_P8, a second amino acid sequence being at 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.78                                               
						PIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASN 	                        Gaps:       0                        
						LLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSI 	                                                            
						DLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 	Alignment:                                                   
						GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTE 	                  .         .         .         .         .  
						NSIL                                                         	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						least 90 % homologous to corresponding to amino acids 221 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						464 of Q9H809, which also corresponds to amino acids 221 -   	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						464 of F03465_P8, and a third amino acid sequence being at   	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						ISLSLGLASVEHTECPSAFDLRDSLFIGLFCELPMLLEMNLDWDLD corresponding 	                  .         .         .         .         .  
						to amino acids 465 - 510 of F03465_P8, wherein said first    	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F03465_P8, comprising a polypeptide being at least   	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						ISLSLGLASVEHTECPSAFDLRDSLFIGLFCELPMLLEMNLDWDLD in F03465_P8. 	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSSPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .                                          
						                                                            	     451 GIRRTVFKTENSIL                                     464                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     451 GIRRTVFKTENSIL                                     464                                                          

						Comparison report between F03465_P8 and Q9NRF8partial WT     	Sequence name: Q9NRF8                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F03465_P8, comprising a first amino 	Sequence documentation:                                      
						MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV 	                                                            
						LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA 	Alignment of: 13161 x Q9NRF8   ..                            
						VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV 	                                                            
						SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ 	Alignment segment 1/1:                                       
						VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 	                                                            
						IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK 	                     Quality: 4514.00                      Escore:       0                                               
						LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD 	             Matching length:     464                Total length:     464                                               
						STEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSIL                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 464 of Q9NRF8, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 464 of F03465_P8, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISLSLGLASVEHTECPSAFDLRDSLFIGLFCELPMLLEMNLDWDLD corresponding 	       1 MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTF 50                                                           
						to amino acids 465 - 510 of F03465_P8, wherein said first    	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of F03465_P8, comprising a   	      51 SPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINK 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	     101 ERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGT 150                                                          
						ISLSLGLASVEHTECPSAFDLRDSLFIGLFCELPMLLEMNLDWDLD in F03465_P8. 	                  .         .         .         .         .  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSST 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETED 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRL 450                                                          
						                                                            	                  .                                          
						                                                            	     451 GIRRTVFKTENSIL                                     464                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     451 GIRRTVFKTENSIL                                     464                                                          

13912	HMR136_F03940_5_tr0_r1_1_gPRT		Comparison report between F03940_P5 and Q9H819partial WT     	Sequence name: Q9H819                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F03940_P5, comprising a first amino acid        	                                                            
						MKAQKEKKSENEWTQTRQGEGNSTYSEEQLLGVQRIKKCRNYYEILGVSRDASDEELKKA 	Alignment of: 13912 x Q9H819   ..                            
						YRKLALKFHPDKNCAPGATDAFKAIGNAFAVLSNPDKRLRYDEYGDEQVTFTAPRARPYN 	                                                            
						YYRDFEADITPEELFNVFFGGHFPTGNIHMFSNVTDDTYYYRRRHRHERTQTQKEEEEEK 	Alignment segment 1/1:                                       
						PQTTYSAFIQLLPVLVIVIISVITQLLATNPPYSLFYKSTLGYTISRETQNLQVPYFVDK 	                                                            
						NFDKAYRGASLHDLEKTIEKDYIDYIQTSCWKEKQQKSELTNLAGLYRDERLKQKAESLK 	                     Quality: 3131.00                      Escore:       0                                               
						LENCEKLSKLIGLRRGG                                            	             Matching length:     317                Total length:     317                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 42 - 358 of Q9H819, which also corresponds to    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 317 of F03940_P5.                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKAQKEKKSENEWTQTRQGEGNSTYSEEQLLGVQRIKKCRNYYEILGVSR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      42 MKAQKEKKSENEWTQTRQGEGNSTYSEEQLLGVQRIKKCRNYYEILGVSR 91                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DASDEELKKAYRKLALKFHPDKNCAPGATDAFKAIGNAFAVLSNPDKRLR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      92 DASDEELKKAYRKLALKFHPDKNCAPGATDAFKAIGNAFAVLSNPDKRLR 141                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YDEYGDEQVTFTAPRARPYNYYRDFEADITPEELFNVFFGGHFPTGNIHM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     142 YDEYGDEQVTFTAPRARPYNYYRDFEADITPEELFNVFFGGHFPTGNIHM 191                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FSNVTDDTYYYRRRHRHERTQTQKEEEEEKPQTTYSAFIQLLPVLVIVII 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 FSNVTDDTYYYRRRHRHERTQTQKEEEEEKPQTTYSAFIQLLPVLVIVII 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SVITQLLATNPPYSLFYKSTLGYTISRETQNLQVPYFVDKNFDKAYRGAS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 SVITQLLATNPPYSLFYKSTLGYTISRETQNLQVPYFVDKNFDKAYRGAS 291                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LHDLEKTIEKDYIDYIQTSCWKEKQQKSELTNLAGLYRDERLKQKAESLK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 LHDLEKTIEKDYIDYIQTSCWKEKQQKSELTNLAGLYRDERLKQKAESLK 341                                                          
						                                                            	                  .                                          
						                                                            	     301 LENCEKLSKLIGLRRGG                                  317                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     342 LENCEKLSKLIGLRRGG                                  358                                                          

14131	HMR136_F04058_5_tr0_r1_1_gPRT		Comparison report between F04058_P5 and CLC2_HUMAN_V1partial 	Sequence name: CLC2_HUMAN_V1                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F04058_P5, comprising a first amino 	Sequence documentation:                                      
						MAAAAAEEGMEPRALQYEQTLMYGRYTQDLGAFAKEEAARIRLGGPEPWKGPPSSRAAPE 	                                                            
						LLEYGRSRCARCRVCSVRCHKFLVSRVGEDWIFLVLLGLLMALVSWVMDYAIAACLQAQQ 	Alignment of: 14131 x CLC2_HUMAN_V1   ..                     
						WMSRGLNTSILLQYLAWVTYPVVLITFSAGFTQILAPQAVGSGIPEMKTILRGVVLKEYL 	                                                            
						TLKTFIAKVIGLTCALGSGMPLGKEGPFVHIASMCAALLSKFLSLFGGIYENESRNTEML 	Alignment segment 1/1:                                       
						AAACAVGVGCCFAAPIGGVLFSIEVTSTFFAVRNYWRGFFAATFSAFIFRVLAVWNRDEE 	                                                            
						TITALFKTRFRLDFPFDLQELPAFAVIGIASGFGGALFVYLNRKIVQ              	                     Quality: 3357.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     347                Total length:     347                                               
						to amino acids 1 - 347 of CLC2_HUMAN_V1, which also          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 347 of F04058_P5, and a second	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 70%, optionally at least  	                        Gaps:       0                        
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment:                                                   
						having the sequence TPALPGSGDPAHLHADLPPWLWTVHGWTALTERDAGHPV  	                  .         .         .         .         .  
						corresponding to amino acids 348 - 386 of F04058_P5, wherein 	       1 MAAAAAEEGMEPRALQYEQTLMYGRYTQDLGAFAKEEAARIRLGGPEPWK 50                                                           
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	       1 MAAAAAEEGMEPRALQYEQTLMYGRYTQDLGAFAKEEAARIRLGGPEPWK 50                                                           
						polypeptide encoding for a tail of F04058_P5, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 GPPSSRAAPELLEYGRSRCARCRVCSVRCHKFLVSRVGEDWIFLVLLGLL 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 GPPSSRAAPELLEYGRSRCARCRVCSVRCHKFLVSRVGEDWIFLVLLGLL 100                                                          
						to the sequence TPALPGSGDPAHLHADLPPWLWTVHGWTALTERDAGHPV in   	                  .         .         .         .         .  
						F04058_P5.                                                   	     101 MALVSWVMDYAIAACLQAQQWMSRGLNTSILLQYLAWVTYPVVLITFSAG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MALVSWVMDYAIAACLQAQQWMSRGLNTSILLQYLAWVTYPVVLITFSAG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FTQILAPQAVGSGIPEMKTILRGVVLKEYLTLKTFIAKVIGLTCALGSGM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FTQILAPQAVGSGIPEMKTILRGVVLKEYLTLKTFIAKVIGLTCALGSGM 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PLGKEGPFVHIASMCAALLSKFLSLFGGIYENESRNTEMLAAACAVGVGC 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PLGKEGPFVHIASMCAALLSKFLSLFGGIYENESRNTEMLAAACAVGVGC 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 CFAAPIGGVLFSIEVTSTFFAVRNYWRGFFAATFSAFIFRVLAVWNRDEE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 CFAAPIGGVLFSIEVTSTFFAVRNYWRGFFAATFSAFIFRVLAVWNRDEE 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 TITALFKTRFRLDFPFDLQELPAFAVIGIASGFGGALFVYLNRKIVQ    347                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     301 TITALFKTRFRLDFPFDLQELPAFAVIGIASGFGGALFVYLNRKIVQ    347                                                          

14129	HMR136_F04058_7_tr0_r1_1_gPRT		Comparison report between F04058_P7 and CLC2_HUMAN_V2partial 	Sequence name: CLC2_HUMAN_V2                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F04058_P7, comprising a first amino 	Sequence documentation:                                      
						MLAAACAVGVGCCFAAPIGGVLFSIEVTSTFFAVRNYWRGFFAATFSAFIFRVLAVWNRD 	                                                            
						EETITALFKTRFRLDFPFDLQELPAFAVIGIASGFGGALFVYLNRKIVQVMRKQKTINRF 	Alignment of: 14129 x CLC2_HUMAN_V2   ..                     
						LMRKRLLFPALVTLLISTLTFPPGFGQFMAGQLSQKETLVTLFDNRTWVRQGLVEELEPP 	                                                            
						STSQAWNPPRANVFLTLVIFILMKFWMSALATTIPVPCGAFMPVFVIGAAFGRLVGESMA 	Alignment segment 1/1:                                       
						AWFPDGIHTDSSTYRIVPGGYAVVGAAALAGAVTHTVSTAVIVFELTGQIAHILPVMIAV 	                                                            
						ILANAVAQSLQPSLYDSIIRIKKLPYLPELGWGRHQQYRVRVEDIMVRDVPHVALSCTFR 	                     Quality: 4839.00                      Escore:       0                                               
						DLRLALHRTKGRMLALVESPESMILLGSIERSQVVALLGAQLSPARRRQHMQERRATQTS 	             Matching length:     502                Total length:     502                                               
						PLSDQEGPPTPEASVCFQVNTEDSAFPAARGETHKPLKPALKRGPSVTRNLGESPTGSAE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SAGIALRSLFCGSPPPEAASEK                                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 239 - 740 of CLC2_HUMAN_V2, which also        	                                                            
						corresponds to amino acids 1 - 502 of F04058_P7, and a second	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MLAAACAVGVGCCFAAPIGGVLFSIEVTSTFFAVRNYWRGFFAATFSAFI 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VGIL corresponding to amino acids 503 -  	     239 MLAAACAVGVGCCFAAPIGGVLFSIEVTSTFFAVRNYWRGFFAATFSAFI 288                                                          
						506 of F04058_P7, wherein said first amino acid sequence and 	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 FRVLAVWNRDEETITALFKTRFRLDFPFDLQELPAFAVIGIASGFGGALF 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04058_P7, comprising a polypeptide being at least 70%,      	     289 FRVLAVWNRDEETITALFKTRFRLDFPFDLQELPAFAVIGIASGFGGALF 338                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 VYLNRKIVQVMRKQKTINRFLMRKRLLFPALVTLLISTLTFPPGFGQFMA 150                                                          
						least about 95% homologous to the sequence VGIL in F04058_P7.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 VYLNRKIVQVMRKQKTINRFLMRKRLLFPALVTLLISTLTFPPGFGQFMA 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GQLSQKETLVTLFDNRTWVRQGLVEELEPPSTSQAWNPPRANVFLTLVIF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 GQLSQKETLVTLFDNRTWVRQGLVEELEPPSTSQAWNPPRANVFLTLVIF 438                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ILMKFWMSALATTIPVPCGAFMPVFVIGAAFGRLVGESMAAWFPDGIHTD 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     439 ILMKFWMSALATTIPVPCGAFMPVFVIGAAFGRLVGESMAAWFPDGIHTD 488                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SSTYRIVPGGYAVVGAAALAGAVTHTVSTAVIVFELTGQIAHILPVMIAV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     489 SSTYRIVPGGYAVVGAAALAGAVTHTVSTAVIVFELTGQIAHILPVMIAV 538                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ILANAVAQSLQPSLYDSIIRIKKLPYLPELGWGRHQQYRVRVEDIMVRDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     539 ILANAVAQSLQPSLYDSIIRIKKLPYLPELGWGRHQQYRVRVEDIMVRDV 588                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PHVALSCTFRDLRLALHRTKGRMLALVESPESMILLGSIERSQVVALLGA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     589 PHVALSCTFRDLRLALHRTKGRMLALVESPESMILLGSIERSQVVALLGA 638                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 QLSPARRRQHMQERRATQTSPLSDQEGPPTPEASVCFQVNTEDSAFPAAR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     639 QLSPARRRQHMQERRATQTSPLSDQEGPPTPEASVCFQVNTEDSAFPAAR 688                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GETHKPLKPALKRGPSVTRNLGESPTGSAESAGIALRSLFCGSPPPEAAS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     689 GETHKPLKPALKRGPSVTRNLGESPTGSAESAGIALRSLFCGSPPPEAAS 738                                                          
						                                                            	                                                             
						                                                            	     501 EK                                                 502                                                          
						                                                            	         ||                                                  
						                                                            	     739 EK                                                 740                                                          

14753	HMR136_F04219_20_tr0_r1_1_gPRT		Comparison report between F04219_P20 and Q9BV79unique head   	Sequence name: Q9BV79                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04219_P20, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 14753 x Q9BV79   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence QMRKLKFQGAACPGRHSK corresponding to amino	Alignment segment 1/1:                                       
						acids 1 - 18 of F04219_P20, and a second amino acid sequence 	                                                            
						PDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGKSSTELLRQLAR 	                     Quality: 1519.00                      Escore:       0                                               
						GGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKKDHSPDQFKELILTLCDLIRRG 	             Matching length:     156                Total length:     156                                               
						QLTAPACSQVPLQDYQSALEASMKPFISSKQILTM                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.36                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.36                                               
						acids 219 - 373 of Q9BV79, which also corresponds to amino   	                        Gaps:       0                        
						acids 19 - 173 of F04219_P20, wherein said first amino acid  	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of F04219_P20, comprising a polypeptide being at least  	      18 KPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGK 67                                                           
						70%, optionally at least about 80%, preferably at least about	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     218 RPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGK 267                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						QMRKLKFQGAACPGRHSK of F04219_P20.                            	      68 SSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKK 117                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     268 SSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKK 317                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     118 DHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISS 167                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     318 DHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISS 367                                                          
						                                                            	                                                             
						                                                            	     168 KQILTM                                             173                                                          
						                                                            	         ||||||                                              
						                                                            	     368 KQILTM                                             373                                                          

						Comparison report between F04219_P20 and Q9Y373unique head   	Sequence name: Q9Y373                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04219_P20, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 14753 x Q9Y373   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence QMRKLKFQGAACPGRHSK corresponding to amino	Alignment segment 1/1:                                       
						acids 1 - 18 of F04219_P20, and a second amino acid sequence 	                                                            
						PDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGKSSTELLRQLAR 	                     Quality: 1519.00                      Escore:       0                                               
						GGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKKDHSPDQFKELILTLCDLIRRG 	             Matching length:     156                Total length:     156                                               
						QLTAPACSQVPLQDYQSALEASMKPFISSKQILTM                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.36                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.36                                               
						acids 219 - 373 of Q9Y373, which also corresponds to amino   	                        Gaps:       0                        
						acids 19 - 173 of F04219_P20, wherein said first amino acid  	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of F04219_P20, comprising a polypeptide being at least  	      18 KPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGK 67                                                           
						70%, optionally at least about 80%, preferably at least about	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     218 RPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGK 267                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						QMRKLKFQGAACPGRHSK of F04219_P20.                            	      68 SSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKK 117                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     268 SSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKK 317                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     118 DHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISS 167                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     318 DHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISS 367                                                          
						                                                            	                                                             
						                                                            	     168 KQILTM                                             173                                                          
						                                                            	         ||||||                                              
						                                                            	     368 KQILTM                                             373                                                          

14751	HMR136_F04219_24_tr0_r1_1_gPRT		Comparison report between F04219_P24 and Q9BV79unique head   	Sequence name: Q9BV79                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04219_P24, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 14751 x Q9BV79   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence AGASGSVLVGAS 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 12 of F04219_P24, a second  	                                                            
						MWVCSTLWRVRTPARQWRGLLPASGCHGPAASSYSASAEPARVRALVYGHHGDPAKVVEL 	                     Quality: 1792.00                      Escore:       0                                               
						KNLELAAVRGSDVRVKMLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVT 	             Matching length:     184                Total length:     184                                               
						GLKPGDWVIPANAGLGTWRTEAVFSEEALIQVPSDIPLQSAATLGVNPCTAYRMLMDFEQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQPG                                                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 1 - 184 of Q9BV79, which also   	                                                            
						corresponds to amino acids 13 - 196 of F04219_P24, and a     	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      13 MWVCSTLWRVRTPARQWRGLLPASGCHGPAASSYSASAEPARVRALVYGH 62                                                           
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence RNPQVGGAGQGLATRV             	       1 MWVCSTLWRVRTPARQWRGLLPASGCHGPAASSYSASAEPARVRALVYGH 50                                                           
						corresponding to amino acids 197 - 212 of F04219_P24, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	      63 HGDPAKVVELKNLELAAVRGSDVRVKMLAAPINPSDINMIQGNYGLLPEL 112                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	      51 HGDPAKVVELKNLELAAVRGSDVRVKMLAAPINPSDINMIQGNYGLLPEL 100                                                          
						head of F04219_P24, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     113 PAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLGTWRTEAVFSEEALI 162                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence AGASGSVLVGAS of	     101 PAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLGTWRTEAVFSEEALI 150                                                          
						F04219_P24.3.An isolated polypeptide encoding for a tail of  	                  .         .         .                      
						F04219_P24, comprising a polypeptide being at least 70%,     	     163 QVPSDIPLQSAATLGVNPCTAYRMLMDFEQLQPG                 196                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||                  
						more preferably at least about 90% and most preferably at    	     151 QVPSDIPLQSAATLGVNPCTAYRMLMDFEQLQPG                 184                                                          
						least about 95% homologous to the sequence RNPQVGGAGQGLATRV  	                                                            
						in F04219_P24.                                               	                                                            

14755	HMR136_F04219_27_tr0_r1_1_gPRT		Comparison report between F04219_P27 and Q9BV79partial WT    	Sequence name: Q9BV79                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04219_P27, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLG             	                                                            
						corresponding to amino acids 77 - 136 of Q9BV79, which also  	Alignment of: 14755 x Q9BV79   ..                            
						corresponds to amino acids 1 - 60 of F04219_P27, and a second	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment segment 1/1:                                       
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	                     Quality:  572.00                      Escore:       0                                               
						having the sequence EFLQVSAA corresponding to amino acids 61 	             Matching length:      60                Total length:      60                                               
						- 68 of F04219_P27, wherein said first amino acid sequence   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						and second amino acid sequence are contiguous and in a       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequential order.2.An isolated polypeptide encoding for a    	                        Gaps:       0                        
						tail of F04219_P27, comprising a polypeptide being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	Alignment:                                                   
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence EFLQVSAA in    	       1 MLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGD 50                                                           
						F04219_P27.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      77 MLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGD 126                                                          
						                                                            	                  .                                          
						                                                            	      51 WVIPANAGLG                                         60                                                           
						                                                            	         ||||||||||                                          
						                                                            	     127 WVIPANAGLG                                         136                                                          

						Comparison report between F04219_P27 and Q9Y373partial WT    	Sequence name: Q9Y373                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04219_P27, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLG             	                                                            
						corresponding to amino acids 77 - 136 of Q9Y373, which also  	Alignment of: 14755 x Q9Y373   ..                            
						corresponds to amino acids 1 - 60 of F04219_P27, and a second	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment segment 1/1:                                       
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	                     Quality:  572.00                      Escore:       0                                               
						having the sequence EFLQVSAA corresponding to amino acids 61 	             Matching length:      60                Total length:      60                                               
						- 68 of F04219_P27, wherein said first amino acid sequence   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						and second amino acid sequence are contiguous and in a       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequential order.2.An isolated polypeptide encoding for a    	                        Gaps:       0                        
						tail of F04219_P27, comprising a polypeptide being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	Alignment:                                                   
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence EFLQVSAA in    	       1 MLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGD 50                                                           
						F04219_P27.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      77 MLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGD 126                                                          
						                                                            	                  .                                          
						                                                            	      51 WVIPANAGLG                                         60                                                           
						                                                            	         ||||||||||                                          
						                                                            	     127 WVIPANAGLG                                         136                                                          

14907	HMR136_F04230_9_tr0_r1_1_gPRT		Comparison report between F04230_P9 and GCST_HUMANpartial WT 	Sequence name: GCST_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for F04230_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MTSAVMEVFGVSGCRVTRCGYTGEDGVE corresponding to amino acids 205	Alignment of: 14907 x GCST_HUMAN   ..                        
						- 232 of GCST_HUMAN, which also corresponds to amino acids 1 	                                                            
						- 28 of F04230_P9, a second amino acid sequence being at     	Alignment segment 1/1:                                       
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	                     Quality: 1833.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence              	             Matching length:     199                Total length:     235                                               
						VCQEVVWGQYRAQDACEGLGVCGTGSFPSALWCFIQ corresponding to amino  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acids 29 - 64 of F04230_P9, and a third amino acid sequence  	    Total Percent Similarity:   84.68      Total Percent Identity:   84.68                                               
						ISVPVAGAVHLATAILKNPEVKLAGLAARDSLRLEAGLCLYGNDIDEHTTPVEGSLSWTL 	                        Gaps:       1                        
						GKRRRAAMDFPGAKVIVPQLKGRVQRRRVGLMCEGAPMRAHSPILNMEGTKIGTVTSGCP 	                                                            
						SPSLKKNVAMGYVPCEYSRPGTMLLVEVRRKQQMAVVSKMPFVPTNYYTLK          	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 233 - 403 of GCST_HUMAN, which also corresponds to     	       1 MTSAVMEVFGVSGCRVTRCGYTGEDGVEVCQEVVWGQYRAQDACEGLGVC 50                                                           
						amino acids 65 - 235 of F04230_P9, wherein said first amino  	         ||||||||||||||||||||||||||||                        
						acid sequence, second amino acid sequence and third amino    	     205 MTSAVMEVFGVSGCRVTRCGYTGEDGVE...................... 232                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	      51 GTGSFPSALWCFIQISVPVAGAVHLATAILKNPEVKLAGLAARDSLRLEA 100                                                          
						F04230_P9, comprising an amino acid sequence being at least  	                       ||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     233 ..............ISVPVAGAVHLATAILKNPEVKLAGLAARDSLRLEA 268                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     101 GLCLYGNDIDEHTTPVEGSLSWTLGKRRRAAMDFPGAKVIVPQLKGRVQR 150                                                          
						VCQEVVWGQYRAQDACEGLGVCGTGSFPSALWCFIQ, corresponding to       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04230_P9.                                                   	     269 GLCLYGNDIDEHTTPVEGSLSWTLGKRRRAAMDFPGAKVIVPQLKGRVQR 318                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RRVGLMCEGAPMRAHSPILNMEGTKIGTVTSGCPSPSLKKNVAMGYVPCE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     319 RRVGLMCEGAPMRAHSPILNMEGTKIGTVTSGCPSPSLKKNVAMGYVPCE 368                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 YSRPGTMLLVEVRRKQQMAVVSKMPFVPTNYYTLK                235                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     369 YSRPGTMLLVEVRRKQQMAVVSKMPFVPTNYYTLK                403                                                          

15027	HMR136_F04291_11_tr0_r1_1_gPRT		Comparison report between F04291_P11 and Q9NW00unique head   	Sequence name: Q9NW00                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04291_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15027 x Q9NW00   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPKLVKNLLGEMPLWVCQSCRKSMEEDERQTGREHAVAISLSHTSCKSQSCGDDSHSSSS 	Alignment segment 1/1:                                       
						SSSSSSSSSSSSCPGNSGDWDPSSFLSAHKLSGLWNSPHSSGAMPGSSLGSPPTIPGEAF 	                                                            
						PVSEHHQHSDLTAPPNSPTGHHPQPASLIPSHPSSFGSPPHPHLLPTTPAAPFPAQASEC 	                     Quality: 2246.00                      Escore:       0                                               
						PVAAATAPHTPGPCQSSHLPSTSMPLLKMPPPFSGCSHPCSGHCGGHCSGPLLPPPSSQP 	             Matching length:     228                Total length:     228                                               
						LPSTHRDPGCKGHKFAHSGLACQLPQPCEADEGLGEEEDSSSERSSCTSSSTHQRDGKFC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DCCYCEFFGHNAPPAAPTSRNYTEIREKLRSRLTRRKEELP                    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 341 of F04291_P11, a second amino acid    	                                                            
						MKGGTLGGIPGEPAVDHRDVDELLEFINSTEPKVPNSARAAKRARHKLKKKEKEKAQLAA 	Alignment:                                                   
						EALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSRLQEIKNTVKDSIRASFSVCE 	                  .         .         .         .         .  
						LSMDSNGFSKEGAAEPEPQSLPPSNLSGSSEQQPDINLDLSPLTLGSPQNHTLQAPGEPA 	     342 MKGGTLGGIPGEPAVDHRDVDELLEFINSTEPKVPNSARAAKRARHKLKK 391                                                          
						PPWAEMRGPHPPWTEVRGPPPGIVPENGLVRRLNTVPNLSRVIWVKTP             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MKGGTLGGIPGEPAVDHRDVDELLEFINSTEPKVPNSARAAKRARHKLKK 50                                                           
						amino acids 1 - 228 of Q9NW00, which also corresponds to     	                  .         .         .         .         .  
						amino acids 342 - 569 of F04291_P11, and a third amino acid  	     392 KEKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSR 441                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 KEKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSR 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence NQPRGSQCQGPGRWPQAARQGPRASQSRQLC          	     442 LQEIKNTVKDSIRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSS 491                                                          
						corresponding to amino acids 570 - 600 of F04291_P11, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	     101 LQEIKNTVKDSIRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSS 150                                                          
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     492 EQQPDINLDLSPLTLGSPQNHTLQAPGEPAPPWAEMRGPHPPWTEVRGPP 541                                                          
						head of F04291_P11, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     151 EQQPDINLDLSPLTLGSPQNHTLQAPGEPAPPWAEMRGPHPPWTEVRGPP 200                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .                                
						MPKLVKNLLGEMPLWVCQSCRKSMEEDERQTGREHAVAISLSHTSCKSQSCGDDSHSSSS 	     542 PGIVPENGLVRRLNTVPNLSRVIWVKTP                       569                                                          
						SSSSSSSSSSSSCPGNSGDWDPSSFLSAHKLSGLWNSPHSSGAMPGSSLGSPPTIPGEAF 	         ||||||||||||||||||||||||||||                        
						PVSEHHQHSDLTAPPNSPTGHHPQPASLIPSHPSSFGSPPHPHLLPTTPAAPFPAQASEC 	     201 PGIVPENGLVRRLNTVPNLSRVIWVKTP                       228                                                          
						PVAAATAPHTPGPCQSSHLPSTSMPLLKMPPPFSGCSHPCSGHCGGHCSGPLLPPPSSQP 	                                                            
						LPSTHRDPGCKGHKFAHSGLACQLPQPCEADEGLGEEEDSSSERSSCTSSSTHQRDGKFC 	                                                            
						DCCYCEFFGHNAPPAAPTSRNYTEIREKLRSRLTRRKEELP                    	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F04291_P11.3.An isolated polypeptide encoding for a tail of  	                                                            
						F04291_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						NQPRGSQCQGPGRWPQAARQGPRASQSRQLC in F04291_P11.               	                                                            

15033	HMR136_F04291_13_tr0_r1_1_gPRT		Comparison report between F04291_P13 and Q9NW00partial WT    	Sequence name: Q9NW00                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F04291_P13, comprising a first amino	Sequence documentation:                                      
						MDSNGFSKEGAAEPEPQSLPPSNLSGSSEQQPDINLDLSPLTLGSPQNHTLQAPGEPAPP 	                                                            
						WAEMRGPHPPWTEVRGPPPGIVPENGLVRRLNTVPNLSRVIWVKTPKPGYPSSEEPSSKE 	Alignment of: 15033 x Q9NW00   ..                            
						VPSCKQELPEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAKGQVAGPKQPGR 	                                                            
						VLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAKARPQEQESVQP  	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 123 - 361 of Q9NW00, which also corresponds to	                     Quality: 3255.00                      Escore:       0                                               
						amino acids 1 - 239 of F04291_P13, a bridging amino acid S   	             Matching length:     326                Total length:     326                                               
						corresponding to amino acid 240 of F04291_P13, and a second  	 Matching Percent Similarity:   99.69   Matching Percent Identity:   99.69                                               
						GPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDMDGVEMDETDREVEYFKRFCLDS 	    Total Percent Similarity:   99.69      Total Percent Identity:   99.69                                               
						AKQTRQKVAVNWTNFSLKKTTPSTAQ                                   	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 363 - 448 of Q9NW00, which also 	Alignment:                                                   
						corresponds to amino acids 241 - 326 of F04291_P13, wherein  	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	       1 MDSNGFSKEGAAEPEPQSLPPSNLSGSSEQQPDINLDLSPLTLGSPQNHT 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	     123 MDSNGFSKEGAAEPEPQSLPPSNLSGSSEQQPDINLDLSPLTLGSPQNHT 172                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LQAPGEPAPPWAEMRGPHPPWTEVRGPPPGIVPENGLVRRLNTVPNLSRV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     173 LQAPGEPAPPWAEMRGPHPPWTEVRGPPPGIVPENGLVRRLNTVPNLSRV 222                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IWVKTPKPGYPSSEEPSSKEVPSCKQELPEPVSSGGKPQKGKRQGSQAKK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     223 IWVKTPKPGYPSSEEPSSKEVPSCKQELPEPVSSGGKPQKGKRQGSQAKK 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SEASPAPRPPASLEVPSAKGQVAGPKQPGRVLELPKVGSCAEAGEGSRGS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 SEASPAPRPPASLEVPSAKGQVAGPKQPGRVLELPKVGSCAEAGEGSRGS 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RPGPGWAGSPKTEKEKGSSWRNWPGEAKARPQEQESVQPSGPARPQSLPQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||| ||||||||||  
						                                                            	     323 RPGPGWAGSPKTEKEKGSSWRNWPGEAKARPQEQESVQPPGPARPQSLPQ 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GKGRSRRSRNKQEKPASSLDDVFLPKDMDGVEMDETDREVEYFKRFCLDS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 GKGRSRRSRNKQEKPASSLDDVFLPKDMDGVEMDETDREVEYFKRFCLDS 422                                                          
						                                                            	                  .         .                                
						                                                            	     301 AKQTRQKVAVNWTNFSLKKTTPSTAQ                         326                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     423 AKQTRQKVAVNWTNFSLKKTTPSTAQ                         448                                                          

15031	HMR136_F04291_14_tr0_r1_1_gPRT		Comparison report between F04291_P14 and Q9NW00unique head   	Sequence name: Q9NW00                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F04291_P14, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15031 x Q9NW00   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MTRRRSRPSGGAGRRERARAAGPQKPQAPEPPPPPSLEAGAGAGPPEAPAEPDHDGPRED 	Alignment segment 1/1:                                       
						DEPNLVPGPQ                                                   	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 3939.00                      Escore:       0                                               
						1 - 70 of F04291_P14, a second amino acid sequence being at  	             Matching length:     398                Total length:     398                                               
						EKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSRLQEIKNTVKDS 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.50                                               
						IRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSSEQQPDINLDLSPLTLGSPQNH 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.50                                               
						TLQAPGEPAPPWAEMRGPHPPWTEVRGPPPGIVPENGLVRRLNTVPNLSRVIWVKTPKPG 	                        Gaps:       0                        
						YPSSEEPSSKEVPSCKQELPEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAK 	                                                            
						GQVAGPKQPGRVLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAKA 	Alignment:                                                   
						RPQEQESVQP                                                   	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 52 -   	      70 QEKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSR 119                                                          
						361 of Q9NW00, which also corresponds to amino acids 71 - 380	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						of F04291_P14, a bridging amino acid S corresponding to amino	      51 KEKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSR 100                                                          
						acid 381 of F04291_P14, and a third amino acid sequence being	                  .         .         .         .         .  
						GPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDMDGVEMDETDREVEYFKRFCLDS 	     120 LQEIKNTVKDSIRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSS 169                                                          
						AKQTRQKVAVNWTNFSLKKTTPSTAQ                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 363 	     101 LQEIKNTVKDSIRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSS 150                                                          
						- 448 of Q9NW00, which also corresponds to amino acids 382 - 	                  .         .         .         .         .  
						467 of F04291_P14, wherein said first amino acid sequence,   	     170 EQQPDINLDLSPLTLGSPQNHTLQAPGEPAPPWAEMRGPHPPWTEVRGPP 219                                                          
						second amino acid sequence, bridging amino acid and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     151 EQQPDINLDLSPLTLGSPQNHTLQAPGEPAPPWAEMRGPHPPWTEVRGPP 200                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F04291_P14, comprising a polypeptide being at least 70%,     	     220 PGIVPENGLVRRLNTVPNLSRVIWVKTPKPGYPSSEEPSSKEVPSCKQEL 269                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     201 PGIVPENGLVRRLNTVPNLSRVIWVKTPKPGYPSSEEPSSKEVPSCKQEL 250                                                          
						MTRRRSRPSGGAGRRERARAAGPQKPQAPEPPPPPSLEAGAGAGPPEAPAEPDHDGPRED 	                  .         .         .         .         .  
						DEPNLVPGPQ                                                   	     270 PEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAKGQVAGPKQP 319                                                          
						least about 95% homologous to the sequence of F04291_P14.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAKGQVAGPKQP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     320 GRVLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAK 369                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GRVLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     370 ARPQEQESVQPSGPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDM 419                                                          
						                                                            	         ||||||||||| ||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ARPQEQESVQPPGPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDM 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     420 DGVEMDETDREVEYFKRFCLDSAKQTRQKVAVNWTNFSLKKTTPSTAQ   467                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     401 DGVEMDETDREVEYFKRFCLDSAKQTRQKVAVNWTNFSLKKTTPSTAQ   448                                                          

15035	HMR136_F04291_6_tr0_r1_1_gPRT		Comparison report between F04291_P6 and Q9NW00unique head    	Sequence name: Q9NW00                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F04291_P6, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15035 x Q9NW00   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MDWCCRISLSHTSCKSQSCGDDSHSSSSSSSSSSSSSSSSCPGNSGDWDPSSFLSAHKLS 	Alignment segment 1/1:                                       
						GLWNSPHSSGAMPGSSLGSPPTIPGEAFPVSEHHQHSDLTAPPNSPTGHHPQPASLIPSH 	                                                            
						PSSFGSPPHPHLLPTTPAAPFPAQASECPVAAATAPHTPGPCQSSHLPSTSMPLLKMPPP 	                     Quality: 4429.00                      Escore:       0                                               
						FSGCSHPCSGHCGGHCSGPLLPPPSSQPLPSTHRDPGCKGHKFAHSGLACQLPQPCEADE 	             Matching length:     448                Total length:     448                                               
						GLGEEEDSSSERSSCTSSSTHQRDGKFCDCCYCEFFGHNAPPAAPTSRNYTEIREKLRSR 	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						LTRRKEELP                                                    	    Total Percent Similarity:   99.78      Total Percent Identity:   99.78                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       0                        
						1 - 309 of F04291_P6, a second amino acid sequence being at  	                                                            
						MKGGTLGGIPGEPAVDHRDVDELLEFINSTEPKVPNSARAAKRARHKLKKKEKEKAQLAA 	Alignment:                                                   
						EALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSRLQEIKNTVKDSIRASFSVCE 	                  .         .         .         .         .  
						LSMDSNGFSKEGAAEPEPQSLPPSNLSGSSEQQPDINLDLSPLTLGSPQNHTLQAPGEPA 	     310 MKGGTLGGIPGEPAVDHRDVDELLEFINSTEPKVPNSARAAKRARHKLKK 359                                                          
						PPWAEMRGPHPPWTEVRGPPPGIVPENGLVRRLNTVPNLSRVIWVKTPKPGYPSSEEPSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEVPSCKQELPEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAKGQVAGPKQP 	       1 MKGGTLGGIPGEPAVDHRDVDELLEFINSTEPKVPNSARAAKRARHKLKK 50                                                           
						GRVLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAKARPQEQESVQ 	                  .         .         .         .         .  
						P                                                            	     360 KEKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSR 409                                                          
						least 90 % homologous to corresponding to amino acids 1 - 361	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q9NW00, which also corresponds to amino acids 310 - 670 of	      51 KEKEKAQLAAEALKQANRVSGSREPRPARERLLEWPDRELDRVNSFLSSR 100                                                          
						F04291_P6, a bridging amino acid S corresponding to amino    	                  .         .         .         .         .  
						acid 671 of F04291_P6, and a third amino acid sequence being 	     410 LQEIKNTVKDSIRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSS 459                                                          
						GPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDMDGVEMDETDREVEYFKRFCLDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKQTRQKVAVNWTNFSLKKTTPSTAQ                                   	     101 LQEIKNTVKDSIRASFSVCELSMDSNGFSKEGAAEPEPQSLPPSNLSGSS 150                                                          
						at least 90 % homologous to corresponding to amino acids 363 	                  .         .         .         .         .  
						- 448 of Q9NW00, which also corresponds to amino acids 672 - 	     460 EQQPDINLDLSPLTLGSPQNHTLQAPGEPAPPWAEMRGPHPPWTEVRGPP 509                                                          
						757 of F04291_P6, wherein said first amino acid sequence,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, bridging amino acid and third    	     151 EQQPDINLDLSPLTLGSPQNHTLQAPGEPAPPWAEMRGPHPPWTEVRGPP 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     510 PGIVPENGLVRRLNTVPNLSRVIWVKTPKPGYPSSEEPSSKEVPSCKQEL 559                                                          
						F04291_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 PGIVPENGLVRRLNTVPNLSRVIWVKTPKPGYPSSEEPSSKEVPSCKQEL 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MDWCCRISLSHTSCKSQSCGDDSHSSSSSSSSSSSSSSSSCPGNSGDWDPSSFLSAHKLS 	     560 PEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAKGQVAGPKQP 609                                                          
						GLWNSPHSSGAMPGSSLGSPPTIPGEAFPVSEHHQHSDLTAPPNSPTGHHPQPASLIPSH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSSFGSPPHPHLLPTTPAAPFPAQASECPVAAATAPHTPGPCQSSHLPSTSMPLLKMPPP 	     251 PEPVSSGGKPQKGKRQGSQAKKSEASPAPRPPASLEVPSAKGQVAGPKQP 300                                                          
						FSGCSHPCSGHCGGHCSGPLLPPPSSQPLPSTHRDPGCKGHKFAHSGLACQLPQPCEADE 	                  .         .         .         .         .  
						GLGEEEDSSSERSSCTSSSTHQRDGKFCDCCYCEFFGHNAPPAAPTSRNYTEIREKLRSR 	     610 GRVLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAK 659                                                          
						LTRRKEELP                                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F04291_P6.     	     301 GRVLELPKVGSCAEAGEGSRGSRPGPGWAGSPKTEKEKGSSWRNWPGEAK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     660 ARPQEQESVQPSGPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDM 709                                                          
						                                                            	         ||||||||||| ||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ARPQEQESVQPPGPARPQSLPQGKGRSRRSRNKQEKPASSLDDVFLPKDM 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     710 DGVEMDETDREVEYFKRFCLDSAKQTRQKVAVNWTNFSLKKTTPSTAQ   757                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     401 DGVEMDETDREVEYFKRFCLDSAKQTRQKVAVNWTNFSLKKTTPSTAQ   448                                                          

15624	HMR136_F04341_14_tr0_r1_1_gPRT		Comparison report between F04341_P14 and Q8TC72unique head   	Sequence name: Q8TC72                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F04341_P14, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15624 x Q8TC72   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence RDHVAGKRCTERTPMHSCWKMKL      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 23 of F04341_P14, a second  	                                                            
						QNEKTLGHFMSHSSNISKAGSPPSASAPAPVSSFSRTSITPSSQDICRICHCEGDDESPL 	                     Quality: 2601.00                      Escore:       0                                               
						ITPCHCTGSLHFVHQACLQQWIKSSDTRCCELCKYEFIMETKLKPLRKWEKLQMTSSERR 	             Matching length:     258                Total length:     258                                               
						KIMCSVTFHVIAITCVVWSLYVLIDRTAEEIKQGQATGILEWPFWTKLVVVAIGFTGGLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.61                                               
						FMYVQCKVYVQLWKRLKAYNRVIYVQNCPETSKKNIFEKSPLTEPNFENKHG         	    Total Percent Similarity:  100.00      Total Percent Identity:   99.61                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 34 - 265 of Q8TC72, which also  	                                                            
						corresponds to amino acids 24 - 255 of F04341_P14, a bridging	Alignment:                                                   
						amino acid Y corresponding to amino acid 256 of F04341_P14,  	                  .         .         .         .         .  
						and a third amino acid sequence being at least 90 %          	      24 QNEKTLGHFMSHSSNISKAGSPPSASAPAPVSSFSRTSITPSSQDICRIC 73                                                           
						homologous to GICHSDTNSSCCTEPEDTGAEIIHV corresponding to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 267 - 291 of Q8TC72, which also corresponds to   	      34 QNEKTLGHFMSHSSNISKAGSPPSASAPAPVSSFSRTSITPSSQDICRIC 83                                                           
						amino acids 257 - 281 of F04341_P14, wherein said first amino	                  .         .         .         .         .  
						acid sequence, second amino acid sequence, bridging amino    	      74 HCEGDDESPLITPCHCTGSLHFVHQACLQQWIKSSDTRCCELCKYEFIME 123                                                          
						acid and third amino acid sequence are contiguous and in a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	      84 HCEGDDESPLITPCHCTGSLHFVHQACLQQWIKSSDTRCCELCKYEFIME 133                                                          
						head of F04341_P14, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     124 TKLKPLRKWEKLQMTSSERRKIMCSVTFHVIAITCVVWSLYVLIDRTAEE 173                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     134 TKLKPLRKWEKLQMTSSERRKIMCSVTFHVIAITCVVWSLYVLIDRTAEE 183                                                          
						RDHVAGKRCTERTPMHSCWKMKL of F04341_P14.                       	                  .         .         .         .         .  
						                                                            	     174 IKQGQATGILEWPFWTKLVVVAIGFTGGLLFMYVQCKVYVQLWKRLKAYN 223                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 IKQGQATGILEWPFWTKLVVVAIGFTGGLLFMYVQCKVYVQLWKRLKAYN 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     224 RVIYVQNCPETSKKNIFEKSPLTEPNFENKHGYGICHSDTNSSCCTEPED 273                                                          
						                                                            	         ||||||||||||||||||||||||||||||||:|||||||||||||||||  
						                                                            	     234 RVIYVQNCPETSKKNIFEKSPLTEPNFENKHGHGICHSDTNSSCCTEPED 283                                                          
						                                                            	                                                             
						                                                            	     274 TGAEIIHV                                           281                                                          
						                                                            	         ||||||||                                            
						                                                            	     284 TGAEIIHV                                           291                                                          

15909	HMR136_F04442_4_tr0_r1_1_gPRT		Comparison report between F04442_P4 and WN1B_HUMANpartial WT 	Sequence name: WN1B_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F04442_P4, comprising a first amino 	Sequence documentation:                                      
						MLEEPRPRPPPSGLAGLLFLALCSRALSNEILGLKLPGEPPLTANTVCLTLSGLSKRQLG 	                                                            
						LCLRNPDVTASALQGLHIAVHECQHQLRDQRWNCSALEGGGRLPHHSAILKRGFRESAFS 	Alignment of: 15909 x WN1B_HUMAN   ..                        
						FSMLAAGVMHAVATACSLGKL                                        	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 141 of WN1B_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 141 of F04442_P4, and a second amino acid 	                     Quality: 2832.00                      Escore:       0                                               
						VVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHNRNSGAFQP 	             Matching length:     293                Total length:     389                                               
						RLRPRRLSGELVYFEKSPDFCERDPTMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QTRVERCHCRFHWCCYVLCDECKVTEWVNVCK                             	    Total Percent Similarity:   75.32      Total Percent Identity:   75.32                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 238 - 389 of WN1B_HUMAN, which also corresponds  	                                                            
						to amino acids 142 - 293 of F04442_P4, wherein said first    	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MLEEPRPRPPPSGLAGLLFLALCSRALSNEILGLKLPGEPPLTANTVCLT 50                                                           
						polypeptide encoding for an edge portion of F04442_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	       1 MLEEPRPRPPPSGLAGLLFLALCSRALSNEILGLKLPGEPPLTANTVCLT 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      51 LSGLSKRQLGLCLRNPDVTASALQGLHIAVHECQHQLRDQRWNCSALEGG 100                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	      51 LSGLSKRQLGLCLRNPDVTASALQGLHIAVHECQHQLRDQRWNCSALEGG 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise LV, having a structure as follows: a sequence       	     101 GRLPHHSAILKRGFRESAFSFSMLAAGVMHAVATACSLGKL......... 141                                                          
						starting from any of amino acid numbers 141-x to 142; and    	         |||||||||||||||||||||||||||||||||||||||||           
						ending at any of amino acid numbers 142+ ((n-2) - x), in     	     101 GRLPHHSAILKRGFRESAFSFSMLAAGVMHAVATACSLGKLVSCGCGWKG 150                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     141 .................................................. 141                                                          
						                                                            	                                                            
						                                                            	     151 SGEQDRLRAKLLQLQALSRGKSFPHSLPSPGPGSSPSPGPQDTWEWGGCN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     142 .....................................VVTENLKRKCKCH 154                                                          
						                                                            	                                              |||||||||||||  
						                                                            	     201 HDMDFGEKFSRDFLDSREAPRDIQARMRIHNNRVGRQVVTENLKRKCKCH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     155 GTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHNRNSGAFQPRLR 204                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHNRNSGAFQPRLR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     205 PRRLSGELVYFEKSPDFCERDPTMGSPGTRGRACNKTSRLLDGCGSLCCG 254                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PRRLSGELVYFEKSPDFCERDPTMGSPGTRGRACNKTSRLLDGCGSLCCG 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     255 RGHNVLRQTRVERCHCRFHWCCYVLCDECKVTEWVNVCK            293                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     351 RGHNVLRQTRVERCHCRFHWCCYVLCDECKVTEWVNVCK            389                                                          

15911	HMR136_F04442_5_tr0_r1_1_gPRT		Comparison report between F04442_P5 and WN1B_HUMANpartial WT 	Sequence name: WN1B_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F04442_P5, comprising a first amino acid        	                                                            
						MLAAGVMHAVATACSLGKLVSCGCGWKGSGEQDRLRAKLLQLQALSRGKSFPHSLPSPGP 	Alignment of: 15911 x WN1B_HUMAN   ..                        
						GSSPSPGPQDTWEWGGCNHDMDFGEKFSRDFLDSREAPRDIQARMRIHNNRVGRQVVTEN 	                                                            
						LKRKCKCHGTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHNRNSGAFQPRLRPR 	Alignment segment 1/1:                                       
						RLSGELVYFEKSPDFCERDPTMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLRQTRVE 	                                                            
						RCHCRFHWCCYVLCDECKVTEWVNVCK                                  	                     Quality: 2720.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     267                Total length:     267                                               
						amino acids 123 - 389 of WN1B_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 267 of F04442_P5.                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLAAGVMHAVATACSLGKLVSCGCGWKGSGEQDRLRAKLLQLQALSRGKS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     123 MLAAGVMHAVATACSLGKLVSCGCGWKGSGEQDRLRAKLLQLQALSRGKS 172                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FPHSLPSPGPGSSPSPGPQDTWEWGGCNHDMDFGEKFSRDFLDSREAPRD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     173 FPHSLPSPGPGSSPSPGPQDTWEWGGCNHDMDFGEKFSRDFLDSREAPRD 222                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IQARMRIHNNRVGRQVVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     223 IQARMRIHNNRVGRQVVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVG 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AALRERLGRAIFIDTHNRNSGAFQPRLRPRRLSGELVYFEKSPDFCERDP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 AALRERLGRAIFIDTHNRNSGAFQPRLRPRRLSGELVYFEKSPDFCERDP 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLRQTRVERCHCRFHWCC 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 TMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLRQTRVERCHCRFHWCC 372                                                          
						                                                            	                  .                                          
						                                                            	     251 YVLCDECKVTEWVNVCK                                  267                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     373 YVLCDECKVTEWVNVCK                                  389                                                          

15907	HMR136_F04442_7_tr0_r1_1_gPRT		Comparison report between F04442_P7 and WN1B_HUMANpartial WT 	Sequence name: WN1B_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F04442_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MLAAGVMHAVATACSLGKL corresponding to amino acids 123 - 141 of	Alignment of: 15907 x WN1B_HUMAN   ..                        
						WN1B_HUMAN, which also corresponds to amino acids 1 - 19 of  	                                                            
						F04442_P7, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						VVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHNRNSGAFQP 	                                                            
						RLRPRRLSGELVYFEKSPDFCERDPTMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLR 	                     Quality: 1639.00                      Escore:       0                                               
						QTRVERCHCRFHWCCYVLCDECKVTEWVNVCK                             	             Matching length:     171                Total length:     267                                               
						% homologous to corresponding to amino acids 238 - 389 of    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WN1B_HUMAN, which also corresponds to amino acids 20 - 171 of	    Total Percent Similarity:   64.04      Total Percent Identity:   64.04                                               
						F04442_P7, wherein said first amino acid sequence and second 	                        Gaps:       1                        
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated chimeric polypeptide encoding for an edge	Alignment:                                                   
						portion of F04442_P7, comprising a polypeptide having a      	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	       1 MLAAGVMHAVATACSLGKL............................... 19                                                           
						length, optionally at least about 20 amino acids in length,  	         |||||||||||||||||||                                 
						preferably at least about 30 amino acids in length, more     	     123 MLAAGVMHAVATACSLGKLVSCGCGWKGSGEQDRLRAKLLQLQALSRGKS 172                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      19 .................................................. 19                                                           
						at least two amino acids comprise LV, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	     173 FPHSLPSPGPGSSPSPGPQDTWEWGGCNHDMDFGEKFSRDFLDSREAPRD 222                                                          
						19-x to 20; and ending at any of amino acid numbers 20+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      20 ...............VVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVG 54                                                           
						                                                            	                        |||||||||||||||||||||||||||||||||||  
						                                                            	     223 IQARMRIHNNRVGRQVVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVG 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      55 AALRERLGRAIFIDTHNRNSGAFQPRLRPRRLSGELVYFEKSPDFCERDP 104                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 AALRERLGRAIFIDTHNRNSGAFQPRLRPRRLSGELVYFEKSPDFCERDP 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     105 TMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLRQTRVERCHCRFHWCC 154                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 TMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLRQTRVERCHCRFHWCC 372                                                          
						                                                            	                  .                                          
						                                                            	     155 YVLCDECKVTEWVNVCK                                  171                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     373 YVLCDECKVTEWVNVCK                                  389                                                          

7447	HMR136_F04482_2_tr0_r1_1_gPRT		Comparison report between F04482_P2 and FXJ2_HUMANpartial WT 	Sequence name: FXJ2_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F04482_P2, comprising a first amino acid        	                                                            
						MSLQSPTSIASYSQGTGSVDGGAVAAGASGRESAEGPPPLYNTNHDFKFSYSEINFQDLS 	Alignment of: 7447 x FXJ2_HUMAN   ..                         
						WSFRNLYKSMLEKSSSSSQHGFSSLLGDIPPSNNYYMYQQQQPPPPQQQQQQQQPPQPPP 	                                                            
						QQSQPQQQQAPAQGPSAVGGAPPLHTPSTDGCTPPGGKQAGAEGYGPPPVMAMHPPPLQH 	Alignment segment 1/1:                                       
						GGYHPHQHHPHSHPAQQPPPPQPQAQGQAPINNTGFAFPSDWCSNIDSLKESFKMVNRLN 	                                                            
						WSSIEQSQFSELMESLRQAEQKNWTLDQHHIANLCDSLNHFLTQTGHVPPQGGTHRPPAP 	                     Quality: 3943.00                      Escore:       0                                               
						ARIADSCALTSGKQESAMSQVNSYGHPQAPHLYPGPSPMYPIPTQDSAGYNRPAHHMVPR 	             Matching length:     382                Total length:     382                                               
						PSVPPPGANEEIPDDFDWDLIT                                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 193 - 574 of FXJ2_HUMAN, which also corresponds  	                        Gaps:       0                        
						to amino acids 1 - 382 of F04482_P2.                         	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSLQSPTSIASYSQGTGSVDGGAVAAGASGRESAEGPPPLYNTNHDFKFS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     193 MSLQSPTSIASYSQGTGSVDGGAVAAGASGRESAEGPPPLYNTNHDFKFS 242                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YSEINFQDLSWSFRNLYKSMLEKSSSSSQHGFSSLLGDIPPSNNYYMYQQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     243 YSEINFQDLSWSFRNLYKSMLEKSSSSSQHGFSSLLGDIPPSNNYYMYQQ 292                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QQPPPPQQQQQQQQPPQPPPQQSQPQQQQAPAQGPSAVGGAPPLHTPSTD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     293 QQPPPPQQQQQQQQPPQPPPQQSQPQQQQAPAQGPSAVGGAPPLHTPSTD 342                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GCTPPGGKQAGAEGYGPPPVMAMHPPPLQHGGYHPHQHHPHSHPAQQPPP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     343 GCTPPGGKQAGAEGYGPPPVMAMHPPPLQHGGYHPHQHHPHSHPAQQPPP 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PQPQAQGQAPINNTGFAFPSDWCSNIDSLKESFKMVNRLNWSSIEQSQFS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 PQPQAQGQAPINNTGFAFPSDWCSNIDSLKESFKMVNRLNWSSIEQSQFS 442                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ELMESLRQAEQKNWTLDQHHIANLCDSLNHFLTQTGHVPPQGGTHRPPAP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     443 ELMESLRQAEQKNWTLDQHHIANLCDSLNHFLTQTGHVPPQGGTHRPPAP 492                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ARIADSCALTSGKQESAMSQVNSYGHPQAPHLYPGPSPMYPIPTQDSAGY 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     493 ARIADSCALTSGKQESAMSQVNSYGHPQAPHLYPGPSPMYPIPTQDSAGY 542                                                          
						                                                            	                  .         .         .                      
						                                                            	     351 NRPAHHMVPRPSVPPPGANEEIPDDFDWDLIT                   382                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     543 NRPAHHMVPRPSVPPPGANEEIPDDFDWDLIT                   574                                                          

16340	HMR136_F04487_23_tr0_r1_1_gPRT		Comparison report between F04487_P23 and DNM1_HUMANpartial   	Sequence name: DNM1_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for F04487_P23, comprising a   	Sequence documentation:                                      
						MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLHEFLQTEIKNQ 	                                                            
						LCDLETKLRKEELSEEGYLAKVKSLLNKDLSLENGAHAYNREVNGRLENGNQARSEARRV 	Alignment of: 16340 x DNM1_HUMAN   ..                        
						GMADANSPPKPLSKPRTPRRSKSDGEAKPEPSPSPRITRKSTRQTTITSHFAKGPAKRKP 	                                                            
						QEESERAKSDESIKEEDKDQDEKRRRVTSRERVARPLPAEEPERAKSGTRTEKEEERDEK 	Alignment segment 1/1:                                       
						EEKRLRSQTKEPTPKQKLKEEPDREARAGVQADEDEDGDEKDEKKHRSQPKDLAAKRRPE 	                                                            
						EKEPEKVNPQISDEKDEDEKEEKRRKTTPKEPTEKKMARAKTVMNSKTHPPKCIQCGQYL 	                     Quality: 9404.00                      Escore:       0                                               
						DDPDLKYGQHPPDAVDEPQMLTNEKLSIFDANESGFESYEALPQHKLTCFSVYCKHGHLC 	             Matching length:     948                Total length:     948                                               
						PIDTGLIEKNIELFFSGSAKPIYDDDPSLEGGVNGKNLGPINEWWITGFDGGEKALIGFS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TSFAEYILMDPSPEYAPIFGLMQEKIYISKIVVEFLQSNSDSTYEDLINKIETTVPPSGL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						NLNRFTEDSLLRHAQFVVEQVESYDEAGDSDEQPIFLTPCMRDLIKLAGVTLGQRRAQAR 	                        Gaps:       0                        
						RQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKRRRCGVCEVCQ 	                                                            
						QPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEADDDEEVDDNIPEMPSPKKMHQ 	Alignment:                                                   
						GKKKKQNKNRISWVGEAVKTDGKKSYYKKVCIDAETLEVGDCVSVIPDDSSKPLYLARVT 	                  .         .         .         .         .  
						ALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPS 	       1 MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLH 50                                                           
						ENWAMEGGMDPESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTF             	       1 MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLH 50                                                           
						first amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 1 - 948 of DNM1_HUMAN, which    	      51 EFLQTEIKNQLCDLETKLRKEELSEEGYLAKVKSLLNKDLSLENGAHAYN 100                                                          
						also corresponds to amino acids 1 - 948 of F04487_P23, and a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 70%, optionally at 	      51 EFLQTEIKNQLCDLETKLRKEELSEEGYLAKVKSLLNKDLSLENGAHAYN 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     101 REVNGRLENGNQARSEARRVGMADANSPPKPLSKPRTPRRSKSDGEAKPE 150                                                          
						polypeptide having the sequence KT corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 949 - 950 of F04487_P23, wherein said first amino acid 	     101 REVNGRLENGNQARSEARRVGMADANSPPKPLSKPRTPRRSKSDGEAKPE 150                                                          
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.                                          	     151 PSPSPRITRKSTRQTTITSHFAKGPAKRKPQEESERAKSDESIKEEDKDQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PSPSPRITRKSTRQTTITSHFAKGPAKRKPQEESERAKSDESIKEEDKDQ 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DEKRRRVTSRERVARPLPAEEPERAKSGTRTEKEEERDEKEEKRLRSQTK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DEKRRRVTSRERVARPLPAEEPERAKSGTRTEKEEERDEKEEKRLRSQTK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EPTPKQKLKEEPDREARAGVQADEDEDGDEKDEKKHRSQPKDLAAKRRPE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EPTPKQKLKEEPDREARAGVQADEDEDGDEKDEKKHRSQPKDLAAKRRPE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EKEPEKVNPQISDEKDEDEKEEKRRKTTPKEPTEKKMARAKTVMNSKTHP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EKEPEKVNPQISDEKDEDEKEEKRRKTTPKEPTEKKMARAKTVMNSKTHP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PKCIQCGQYLDDPDLKYGQHPPDAVDEPQMLTNEKLSIFDANESGFESYE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PKCIQCGQYLDDPDLKYGQHPPDAVDEPQMLTNEKLSIFDANESGFESYE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ALPQHKLTCFSVYCKHGHLCPIDTGLIEKNIELFFSGSAKPIYDDDPSLE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ALPQHKLTCFSVYCKHGHLCPIDTGLIEKNIELFFSGSAKPIYDDDPSLE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GGVNGKNLGPINEWWITGFDGGEKALIGFSTSFAEYILMDPSPEYAPIFG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GGVNGKNLGPINEWWITGFDGGEKALIGFSTSFAEYILMDPSPEYAPIFG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LMQEKIYISKIVVEFLQSNSDSTYEDLINKIETTVPPSGLNLNRFTEDSL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LMQEKIYISKIVVEFLQSNSDSTYEDLINKIETTVPPSGLNLNRFTEDSL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LRHAQFVVEQVESYDEAGDSDEQPIFLTPCMRDLIKLAGVTLGQRRAQAR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LRHAQFVVEQVESYDEAGDSDEQPIFLTPCMRDLIKLAGVTLGQRRAQAR 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKR 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKR 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEAD 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 RRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEAD 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 DDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 DDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKV 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 CIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAG 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 CIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAG 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 TDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMD 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMD 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 PESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLA 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 PESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLA 900                                                          
						                                                            	                  .         .         .         .            
						                                                            	     901 EMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTF   948                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     901 EMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTF   948                                                          

16716	HMR136_F04751_3_tr0_r1_1_gPRT		Comparison report between F04751_P3 and AAO27355unique head  	Sequence name: AAO27355                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04751_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16716 x AAO27355   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	Alignment segment 1/1:                                       
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	                                                            
						DPGAFWGLSSLKRL                                               	                     Quality: 4636.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     469                Total length:     469                                               
						to amino acids 1 - 134 of F04751_P3, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSHRQVV 	                        Gaps:       0                        
						FEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIHNCSLIASALTISNI 	                                                            
						QAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYL 	Alignment:                                                   
						QCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNL 	                  .         .         .         .         .  
						TNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIM 	     135 DLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEF 184                                                          
						LADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKSTGFTG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSLALK            	      10 DLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEF 59                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 10 - 478 of AAO27355, which also corresponds to  	     185 QTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLT 234                                                          
						amino acids 135 - 603 of F04751_P3, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      60 QTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLT 109                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     235 CDPPLELPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIV 284                                                          
						having the sequence PPASCGLYYRYHSPLMSLSRHCQLHIPSQFD          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 604 - 634 of F04751_P3, wherein 	     110 CDPPLELPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIV 159                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	     285 ETDESQGIFVEKNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNT 334                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of F04751_P3, comprising a polypeptide being at least   	     160 ETDESQGIFVEKNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNT 209                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     335 RTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSG 384                                                          
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	     210 RTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSG 259                                                          
						DPGAFWGLSSLKRL                                               	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of             	     385 IYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNL 434                                                          
						F04751_P3.3.An isolated polypeptide encoding for a tail of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04751_P3, comprising a polypeptide being at least 70%,      	     260 IYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNL 309                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     435 TNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGD 484                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPASCGLYYRYHSPLMSLSRHCQLHIPSQFD in F04751_P3.                	     310 TNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGD 359                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     485 VMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYS 534                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     360 VMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYS 409                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     535 TYSPNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLD 584                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     410 TYSPNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLD 459                                                          
						                                                            	                  .                                          
						                                                            	     585 KQLSFKCNVSNTFSSLALK                                603                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     460 KQLSFKCNVSNTFSSLALK                                478                                                          

						Comparison report between F04751_P3 and Q8TC55unique head    	Sequence name: Q8TC55                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F04751_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16716 x Q8TC55   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	Alignment segment 1/1:                                       
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	                                                            
						DPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLR 	                     Quality: 3524.00                      Escore:       0                                               
						SLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLE 	             Matching length:     358                Total length:     358                                               
						LPSFY                                                        	 Matching Percent Similarity:   99.72   Matching Percent Identity:   99.72                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.72      Total Percent Identity:   99.72                                               
						to amino acids 1 - 245 of F04751_P3, a second amino acid     	                        Gaps:       0                        
						MTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIHNCSLI 	                                                            
						ASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGDFRWPR 	Alignment:                                                   
						TLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLY 	                  .         .         .         .         .  
						MFNQMPLNLTNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDV 	     246 MTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVE 295                                                          
						MVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTY          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVE 50                                                           
						amino acids 1 - 291 of Q8TC55, which also corresponds to     	                  .         .         .         .         .  
						amino acids 246 - 536 of F04751_P3, a bridging amino acid S  	     296 KNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESS 345                                                          
						corresponding to amino acid 537 of F04751_P3, a third amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTF 	      51 KNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESS 100                                                          
						SSLALK                                                       	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     346 AQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERK 395                                                          
						to amino acids 293 - 358 of Q8TC55, which also corresponds to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 538 - 603 of F04751_P3, and a fourth amino acid  	     101 AQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERK 150                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     396 AWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLL 445                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence PPASCGLYYRYHSPLMSLSRHCQLHIPSQFD          	     151 AWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLL 200                                                          
						corresponding to amino acids 604 - 634 of F04751_P3, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     446 AYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIML 495                                                          
						bridging amino acid, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 AYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIML 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F04751_P3, comprising a polypeptide being at least 70%,      	     496 ADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAY 545                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||| ||||||||  
						more preferably at least about 90% and most preferably at    	     251 ADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYPPNIALEAY 300                                                          
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	                  .         .         .         .         .  
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	     546 VIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSN 595                                                          
						DPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLE 	     301 VIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSN 350                                                          
						LPSFY                                                        	                                                             
						least about 95% homologous to the sequence of F04751_P3.3.An 	     596 TFSSLALK                                           603                                                          
						isolated polypeptide encoding for a tail of F04751_P3,       	         ||||||||                                            
						comprising a polypeptide being at least 70%, optionally at   	     351 TFSSLALK                                           358                                                          
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PPASCGLYYRYHSPLMSLSRHCQLHIPSQFD in F04751_P3.                	                                                            

						Comparison report between F04751_P3 and Q8IWK6partial WT     	Sequence name: Q8IWK6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04751_P3, comprising a first amino 	Sequence documentation:                                      
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	                                                            
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	Alignment of: 16716 x Q8IWK6   ..                            
						DPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLR 	                                                            
						SLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLE 	Alignment segment 1/1:                                       
						LPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH 	                                                            
						NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGD 	                     Quality: 5896.00                      Escore:       0                                               
						FRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDV 	             Matching length:     603                Total length:     603                                               
						TRVLYMFNQMPLNLTNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ELGDVMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL 	                        Gaps:       0                        
						ALK                                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 603 of Q8IWK6, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 603 of F04751_P3, and a second amino acid    	       1 MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPR 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPR 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PPASCGLYYRYHSPLMSLSRHCQLHIPSQFD          	      51 GAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGS 100                                                          
						corresponding to amino acids 604 - 634 of F04751_P3, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	      51 GAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGS 100                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F04751_P3, comprising a   	     101 FSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFR 150                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 FSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFR 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence PPASCGLYYRYHSPLMSLSRHCQLHIPSQFD in F04751_P3.	     151 GLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 WVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 WVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRC 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRC 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLLAYTVE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLLAYTVE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKST 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKST 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL 600                                                          
						                                                            	                                                             
						                                                            	     601 ALK                                                603                                                          
						                                                            	         |||                                                 
						                                                            	     601 ALK                                                603                                                          

16718	HMR136_F04751_8_tr0_r1_1_gPRT		Comparison report between F04751_P8 and AAO27355unique head  	Sequence name: AAO27355                                      
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for F04751_P8, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 16718 x AAO27355   ..                          
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	                                                            
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	                     Quality: 5730.00                      Escore:       0                                               
						DPGAFWGLSSLKRL                                               	             Matching length:     592                Total length:     610                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						1 - 134 of F04751_P8, a second amino acid sequence being at  	    Total Percent Similarity:   97.05      Total Percent Identity:   97.05                                               
						DLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCN 	                        Gaps:       1                        
						ILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSHRQVV 	                                                            
						FEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIHNCSLIASALTISNI 	Alignment:                                                   
						QAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYL 	                  .         .         .         .         .  
						QCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNL 	     135 DLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEF 184                                                          
						TNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKSTGFTG 	      10 DLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEF 59                                                           
						MTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSLAL             	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 10 -   	     185 QTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLT 234                                                          
						477 of AAO27355, which also corresponds to amino acids 135 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						602 of F04751_P8, a third amino acid sequence being at least 	      60 QTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLT 109                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     235 CDPPLELPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIV 284                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KNTIVEASIQLPPSLFSP corresponding to amino acids 603 - 620 of 	     110 CDPPLELPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIV 159                                                          
						F04751_P8, a fourth amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						KQKRELRPTDDSLYKLQLIAFRNGKLFPATGNSTNLADDGKRRTVVTPVILTKIDGVNVD 	     285 ETDESQGIFVEKNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNT 334                                                          
						THHIPVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGCHILYSDENITTIQCYSLSNY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVLM                                                         	     160 ETDESQGIFVEKNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNT 209                                                          
						homologous to corresponding to amino acids 478 - 601 of      	                  .         .         .         .         .  
						AAO27355, which also corresponds to amino acids 621 - 744 of 	     335 RTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSG 384                                                          
						F04751_P8, and a fifth amino acid sequence being at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     210 RTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSG 259                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     385 IYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNL 434                                                          
						VWQLLTLCINTILHFCYA corresponding to amino acids 745 - 762 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04751_P8, wherein said first amino acid sequence, second    	     260 IYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNL 309                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .         .         .         .  
						acid sequence and fifth amino acid sequence are contiguous   	     435 TNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGD 484                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of F04751_P8, comprising a polypeptide being at   	     310 TNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGD 359                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     485 VMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYS 534                                                          
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	     360 VMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYS 409                                                          
						DPGAFWGLSSLKRL                                               	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence of  	     535 TYSPNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLD 584                                                          
						F04751_P8.3.An isolated polypeptide encoding for an edge     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of F04751_P8, comprising an amino acid sequence being	     410 TYSPNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLD 459                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     585 KQLSFKCNVSNTFSSLALKNTIVEASIQLPPSLFSPKQKRELRPTDDSLY 634                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||                  ||||||||||||||  
						encoding for KNTIVEASIQLPPSLFSP, corresponding to            	     460 KQLSFKCNVSNTFSSLAL..................KQKRELRPTDDSLY 491                                                          
						F04751_P8.4.An isolated polypeptide encoding for a tail of   	                  .         .         .         .         .  
						F04751_P8, comprising a polypeptide being at least 70%,      	     635 KLQLIAFRNGKLFPATGNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHI 684                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     492 KLQLIAFRNGKLFPATGNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHI 541                                                          
						least about 95% homologous to the sequence VWQLLTLCINTILHFCYA	                  .         .         .         .         .  
						in F04751_P8.                                                	     685 PVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGCHILYSDENITTIQC 734                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 PVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGCHILYSDENITTIQC 591                                                          
						                                                            	                  .                                          
						                                                            	     735 YSLSNYAVLM                                         744                                                          
						                                                            	         ||||||||||                                          
						                                                            	     592 YSLSNYAVLM                                         601                                                          

						Comparison report between F04751_P8 and Q8TC55unique head    	Sequence name: Q8TC55                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F04751_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16718 x Q8TC55   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	Alignment segment 1/1:                                       
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	                                                            
						DPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLR 	                     Quality: 3524.00                      Escore:       0                                               
						SLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLE 	             Matching length:     358                Total length:     358                                               
						LPSFY                                                        	 Matching Percent Similarity:   99.72   Matching Percent Identity:   99.72                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.72      Total Percent Identity:   99.72                                               
						to amino acids 1 - 245 of F04751_P8, a second amino acid     	                        Gaps:       0                        
						MTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIHNCSLI 	                                                            
						ASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGDFRWPR 	Alignment:                                                   
						TLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLY 	                  .         .         .         .         .  
						MFNQMPLNLTNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDV 	     246 MTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVE 295                                                          
						MVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTY          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVE 50                                                           
						amino acids 1 - 291 of Q8TC55, which also corresponds to     	                  .         .         .         .         .  
						amino acids 246 - 536 of F04751_P8, a bridging amino acid S  	     296 KNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESS 345                                                          
						corresponding to amino acid 537 of F04751_P8, a third amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTF 	      51 KNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESS 100                                                          
						SSLALK                                                       	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     346 AQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERK 395                                                          
						to amino acids 293 - 358 of Q8TC55, which also corresponds to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 538 - 603 of F04751_P8, and a fourth amino acid  	     101 AQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERK 150                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     396 AWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLL 445                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPATGNSTNLADDGKRR 	     151 AWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLL 200                                                          
						TVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGCHIL 	                  .         .         .         .         .  
						YSDENITTIQCYSLSNYAVLMVWQLLTLCINTILHFCYA                      	     446 AYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIML 495                                                          
						having the sequence corresponding to amino acids 604 - 762 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04751_P8, wherein said first amino acid sequence, second    	     201 AYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIML 250                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     496 ADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAY 545                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||| ||||||||  
						head of F04751_P8, comprising a polypeptide being at least   	     251 ADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYPPNIALEAY 300                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     546 VIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSN 595                                                          
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	     301 VIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSN 350                                                          
						DPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLR 	                                                             
						SLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLE 	     596 TFSSLALK                                           603                                                          
						LPSFY                                                        	         ||||||||                                            
						at least about 95% homologous to the sequence of             	     351 TFSSLALK                                           358                                                          
						F04751_P8.3.An isolated polypeptide encoding for a tail of   	                                                            
						F04751_P8, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						NTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPATGNSTNLADDGKRR 	                                                            
						TVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGCHIL 	                                                            
						YSDENITTIQCYSLSNYAVLMVWQLLTLCINTILHFCYA                      	                                                            
						least about 95% homologous to the sequence in F04751_P8.     	                                                            

						Comparison report between F04751_P8 and Q8IWK6partial WT     	Sequence name: Q8IWK6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04751_P8, comprising a first amino 	Sequence documentation:                                      
						MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAE 	                                                            
						GKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSI 	Alignment of: 16718 x Q8IWK6   ..                            
						DPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLR 	                                                            
						SLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLE 	Alignment segment 1/1:                                       
						LPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH 	                                                            
						NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGD 	                     Quality: 7263.00                      Escore:       0                                               
						FRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDV 	             Matching length:     744                Total length:     744                                               
						TRVLYMFNQMPLNLTNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ELGDVMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL 	                        Gaps:       0                        
						ALKNTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPATGNSTNLADDG 	                                                            
						KRRTVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGC 	Alignment:                                                   
						HILYSDENITTIQCYSLSNYAVLM                                     	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPR 50                                                           
						to amino acids 1 - 744 of Q8IWK6, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 744 of F04751_P8, and a second amino acid    	       1 MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPR 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      51 GAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGS 100                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VWQLLTLCINTILHFCYA corresponding to amino	      51 GAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGS 100                                                          
						acids 745 - 762 of F04751_P8, wherein said first amino acid  	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	     101 FSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFR 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of F04751_P8, comprising a polypeptide being at least   	     101 FSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFR 150                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     151 GLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHR 200                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VWQLLTLCINTILHFCYA in F04751_P8.                             	     151 GLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 WVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 WVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRC 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRC 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLLAYTVE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLLAYTVE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKST 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKST 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ALKNTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPAT 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 ALKNTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPAT 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 GNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAV 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 GNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAV 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     701 AARWDFDLLNGQGGWKSDGCHILYSDENITTIQCYSLSNYAVLM       744                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     701 AARWDFDLLNGQGGWKSDGCHILYSDENITTIQCYSLSNYAVLM       744                                                          

27718	HMR136_F04983_0_tr0_r1_1_gPRT		Comparison report between F04983_P0 and Q9Y4U0unique head    	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27718 x Q9Y4U0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 2531.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     248                Total length:     248                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                        Gaps:       0                        
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	Alignment:                                                   
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                  .         .         .         .         .  
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	     656 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 705                                                          
						having the sequence corresponding to amino acids 1 - 655 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P0, and a second amino acid sequence being at least 90	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPG 	                  .         .         .         .         .  
						RTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVED 	     706 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 755                                                          
						ASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLD 	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						PNYFPANR                                                     	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 2 - 249 of      	     756 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 805                                                          
						Q9Y4U0, which also corresponds to amino acids 656 - 903 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P0, wherein said first amino acid sequence and second 	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     806 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 855                                                          
						F04983_P0, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     856 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   903                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	                                                            
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                                                            
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                                                            
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	                                                            
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                                                            
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	                                                            
						least about 95% homologous to the sequence of F04983_P0.     	                                                            

						Comparison report between F04983_P0 and Q8TEK4unique head    	Sequence name: Q8TEK4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04983_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27718 x Q8TEK4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 4936.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     500                Total length:     500                                               
						to amino acids 1 - 160 of F04983_P0, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQA 	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						VQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFERE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRG 	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						RLCDDTKPETFNQLWTVEEQ                                         	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						amino acids 1 - 500 of Q8TEK4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 161 - 660 of F04983_P0, and a third amino acid   	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDE 	                  .         .         .         .         .  
						SIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQD 	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						CPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANR                                                          	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						having the sequence corresponding to amino acids 661 - 903 of	                  .         .         .         .         .  
						F04983_P0, wherein said first amino acid sequence, second    	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						polypeptide encoding for a head of F04983_P0, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                  .         .         .         .         .  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 510                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of F04983_P0.3.An isolated polypeptide       	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 350                                                          
						encoding for a tail of F04983_P0, comprising a polypeptide   	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     511 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 560                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 	     351 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 400                                                          
						YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDE 	                  .         .         .         .         .  
						SIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQD 	     561 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 610                                                          
						CPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANR                                                          	     401 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 450                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						in F04983_P0.                                                	     611 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 660                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 500                                                          

						Comparison report between F04983_P0 and Q8IYP0unique head    	Sequence name: Q8IYP0                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F04983_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27718 x Q8IYP0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 6093.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     617                Total length:     618                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						to amino acids 1 - 285 of F04983_P0, a second amino acid     	                        Gaps:       1                        
						CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLES 	                                                            
						MPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQF 	Alignment:                                                   
						EENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGH 	                  .         .         .         .         .  
						LPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLE 	     286 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 335                                                          
						SLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHTRRVKLVFDK                                                 	       1 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 312 of Q8IYP0, which also corresponds to     	     336 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 385                                                          
						amino acids 286 - 597 of F04983_P0, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     386 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 435                                                          
						having the sequence V corresponding to amino acids 598 - 598 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F04983_P0, and a fourth amino acid sequence being at least	     101 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 150                                                          
						GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVE 	                  .         .         .         .         .  
						EQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTP 	     436 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 485                                                          
						NLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHC 	     151 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 200                                                          
						QDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNY 	                  .         .         .         .         .  
						FPANR                                                        	     486 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 535                                                          
						90 % homologous to corresponding to amino acids 313 - 617 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8IYP0, which also corresponds to amino acids 599 - 903 of   	     201 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 250                                                          
						F04983_P0, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     536 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 585                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     251 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 300                                                          
						F04983_P0, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     586 RHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 635                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     301 RHTRRVKLVFDK.GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 349                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                  .         .         .         .         .  
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     636 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 685                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	     350 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 399                                                          
						least about 95% homologous to the sequence of F04983_P0.3.An 	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     686 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 735                                                          
						F04983_P0, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     400 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 449                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for V,	     736 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 785                                                          
						corresponding to F04983_P0.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 499                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     786 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 835                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     500 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 549                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     836 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 885                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     550 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 599                                                          
						                                                            	                  .                                          
						                                                            	     886 SQGTSYNYLDPNYFPANR                                 903                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     600 SQGTSYNYLDPNYFPANR                                 617                                                          

27714	HMR136_F04983_1_tr0_r1_1_gPRT		Comparison report between F04983_P1 and Q9Y4U0unique head    	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27714 x Q9Y4U0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 2531.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     248                Total length:     248                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                        Gaps:       0                        
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	Alignment:                                                   
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                  .         .         .         .         .  
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	     656 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 705                                                          
						having the sequence corresponding to amino acids 1 - 655 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P1, and a second amino acid sequence being at least 90	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPG 	                  .         .         .         .         .  
						RTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVED 	     706 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 755                                                          
						ASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLD 	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						PNYFPANR                                                     	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 2 - 249 of      	     756 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 805                                                          
						Q9Y4U0, which also corresponds to amino acids 656 - 903 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P1, wherein said first amino acid sequence and second 	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     806 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 855                                                          
						F04983_P1, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     856 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   903                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	                                                            
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                                                            
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                                                            
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	                                                            
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                                                            
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	                                                            
						least about 95% homologous to the sequence of F04983_P1.     	                                                            

						Comparison report between F04983_P1 and Q8TEK4unique head    	Sequence name: Q8TEK4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04983_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27714 x Q8TEK4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 4936.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     500                Total length:     500                                               
						to amino acids 1 - 160 of F04983_P1, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQA 	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						VQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFERE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRG 	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						RLCDDTKPETFNQLWTVEEQ                                         	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						amino acids 1 - 500 of Q8TEK4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 161 - 660 of F04983_P1, and a third amino acid   	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDE 	                  .         .         .         .         .  
						SIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQD 	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						CPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANR                                                          	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						having the sequence corresponding to amino acids 661 - 903 of	                  .         .         .         .         .  
						F04983_P1, wherein said first amino acid sequence, second    	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						polypeptide encoding for a head of F04983_P1, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                  .         .         .         .         .  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 510                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of F04983_P1.3.An isolated polypeptide       	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 350                                                          
						encoding for a tail of F04983_P1, comprising a polypeptide   	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     511 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 560                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 	     351 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 400                                                          
						YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDE 	                  .         .         .         .         .  
						SIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQD 	     561 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 610                                                          
						CPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANR                                                          	     401 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 450                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						in F04983_P1.                                                	     611 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 660                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 500                                                          

						Comparison report between F04983_P1 and Q8IYP0unique head    	Sequence name: Q8IYP0                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F04983_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27714 x Q8IYP0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 6093.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     617                Total length:     618                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						to amino acids 1 - 285 of F04983_P1, a second amino acid     	                        Gaps:       1                        
						CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLES 	                                                            
						MPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQF 	Alignment:                                                   
						EENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGH 	                  .         .         .         .         .  
						LPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLE 	     286 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 335                                                          
						SLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHTRRVKLVFDK                                                 	       1 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 312 of Q8IYP0, which also corresponds to     	     336 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 385                                                          
						amino acids 286 - 597 of F04983_P1, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     386 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 435                                                          
						having the sequence V corresponding to amino acids 598 - 598 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F04983_P1, and a fourth amino acid sequence being at least	     101 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 150                                                          
						GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVE 	                  .         .         .         .         .  
						EQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTP 	     436 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 485                                                          
						NLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHC 	     151 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 200                                                          
						QDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNY 	                  .         .         .         .         .  
						FPANR                                                        	     486 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 535                                                          
						90 % homologous to corresponding to amino acids 313 - 617 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8IYP0, which also corresponds to amino acids 599 - 903 of   	     201 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 250                                                          
						F04983_P1, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     536 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 585                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     251 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 300                                                          
						F04983_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     586 RHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 635                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     301 RHTRRVKLVFDK.GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 349                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                  .         .         .         .         .  
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     636 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 685                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	     350 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 399                                                          
						least about 95% homologous to the sequence of F04983_P1.3.An 	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     686 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 735                                                          
						F04983_P1, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     400 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 449                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for V,	     736 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 785                                                          
						corresponding to F04983_P1.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 499                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     786 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 835                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     500 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 549                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     836 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 885                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     550 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 599                                                          
						                                                            	                  .                                          
						                                                            	     886 SQGTSYNYLDPNYFPANR                                 903                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     600 SQGTSYNYLDPNYFPANR                                 617                                                          

27706	HMR136_F04983_10_tr0_r1_1_gPRT		Comparison report between F04983_P10 and Q9Y4U0unique head   	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27706 x Q9Y4U0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 35 of F04983_P10, and a     	                                                            
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPG 	                     Quality: 2531.00                      Escore:       0                                               
						RTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVED 	             Matching length:     248                Total length:     248                                               
						ASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLD 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PNYFPANR                                                     	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 2 - 249 of Q9Y4U0, which also   	Alignment:                                                   
						corresponds to amino acids 36 - 283 of F04983_P10, wherein   	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      36 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 85                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F04983_P10, comprising a  	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      86 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 135                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW of       	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						F04983_P10.                                                  	                  .         .         .         .         .  
						                                                            	     136 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 185                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     186 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 235                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						                                                            	                  .         .         .         .            
						                                                            	     236 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   283                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          

						Comparison report between F04983_P10 and Q8IYP0partial WT    	Sequence name: Q8IYP0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F04983_P10, comprising a first amino acid       	                                                            
						MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRW 	Alignment of: 27706 x Q8IYP0   ..                            
						QKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHL 	                                                            
						FKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKK 	Alignment segment 1/1:                                       
						LKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHET 	                                                            
						DIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  	                     Quality: 2889.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     283                Total length:     283                                               
						amino acids 335 - 617 of Q8IYP0, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 283 of F04983_P10.                           	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 384                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 434                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     435 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 484                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     485 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 534                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     535 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 584                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  283                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     585 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  617                                                          

						Comparison report between F04983_P10 and Q8IYH5partial WT    	Sequence name: Q8IYH5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F04983_P10, comprising a first amino acid       	                                                            
						MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRW 	Alignment of: 27706 x Q8IYH5   ..                            
						QKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHL 	                                                            
						FKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKK 	Alignment segment 1/1:                                       
						LKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHET 	                                                            
						DIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  	                     Quality: 2889.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     283                Total length:     283                                               
						amino acids 621 - 903 of Q8IYH5, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 283 of F04983_P10.                           	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     621 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 670                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     671 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 720                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     721 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 770                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     771 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 820                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     821 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 870                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  283                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     871 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  903                                                          

27708	HMR136_F04983_11_tr0_r1_1_gPRT		Comparison report between F04983_P11 and Q9Y4U0unique head   	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F04983_P11,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 27708 x Q9Y4U0   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 2122.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     216                Total length:     248                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	    Total Percent Similarity:   87.10      Total Percent Identity:   87.10                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                        Gaps:       1                        
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	Alignment:                                                   
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                  .         .         .         .         .  
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	     656 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ........... 694                                                          
						homologous to a polypeptide having the sequence corresponding	         |||||||||||||||||||||||||||||||||||||||             
						to amino acids 1 - 655 of F04983_P11, a second amino acid    	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ corresponding to     	     695 .....................SSTSRRQHPLNKHLFKPSTFMTSHEPPVY 723                                                          
						amino acids 2 - 40 of Q9Y4U0, which also corresponds to amino	                              |||||||||||||||||||||||||||||  
						acids 656 - 694 of F04983_P11, and a third amino acid        	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						SSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMY 	                  .         .         .         .         .  
						RNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMS 	     724 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 773                                                          
						LDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						amino acids 73 - 249 of Q9Y4U0, which also corresponds to    	                  .         .         .         .         .  
						amino acids 695 - 871 of F04983_P11, wherein said first amino	     774 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 823                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						isolated polypeptide encoding for a head of F04983_P11,      	                  .         .         .         .            
						comprising a polypeptide being at least 70%, optionally at   	     824 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   871                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						preferably at least about 90% and most preferably at least   	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                                                            
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	                                                            
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                                                            
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                                                            
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	                                                            
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                                                            
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	                                                            
						about 95% homologous to the sequence of F04983_P11.3.An      	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						F04983_P11, comprising a polypeptide having a length "n",    	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise QS, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						694-x to 695; and ending at any of amino acid numbers 695+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between F04983_P11 and Q8TEK4unique head   	Sequence name: Q8TEK4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04983_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27708 x Q8TEK4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 4936.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     500                Total length:     500                                               
						to amino acids 1 - 160 of F04983_P11, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQA 	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						VQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFERE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRG 	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						RLCDDTKPETFNQLWTVEEQ                                         	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						amino acids 1 - 500 of Q8TEK4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 161 - 660 of F04983_P11, and a third amino acid  	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQSSTSRRQHPLNKHLFKPSTFMTSHEP 	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAE 	                  .         .         .         .         .  
						SGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPI 	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						YRSETFLDRDYCVSQGTSYNYLDPNYFPANR                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 661 - 871 of	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						F04983_P11, wherein said first amino acid sequence, second   	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F04983_P11, comprising a  	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                  .         .         .         .         .  
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 510                                                          
						to the sequence of F04983_P11.3.An isolated polypeptide      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of F04983_P11, comprising a polypeptide  	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 350                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     511 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 560                                                          
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQSSTSRRQHPLNKHLFKPSTFMTSHEP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAE 	     351 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 400                                                          
						SGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPI 	                  .         .         .         .         .  
						YRSETFLDRDYCVSQGTSYNYLDPNYFPANR                              	     561 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 610                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in F04983_P11.                                               	     401 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     611 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 660                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 500                                                          

						Comparison report between F04983_P11 and Q8IYR1unique head   	Sequence name: Q8IYR1                                        
						followed by partial WT sequence a mismatch and a featuring a 	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						F04983_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27708 x Q8IYR1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 3621.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     369                Total length:     401                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	    Total Percent Similarity:   91.77      Total Percent Identity:   91.77                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                        Gaps:       1                        
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKD                                       	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 502 of F04983_P11, a second amino acid    	     503 YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIG 552                                                          
						YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVF                            	       9 YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIG 58                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 9 - 101 of Q8IYR1, which also corresponds to     	     553 LPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPA 602                                                          
						amino acids 503 - 595 of F04983_P11, a bridging amino acid D 	         ||||||||||||||||||||||||||||||||||||||||||| ||||||  
						corresponding to amino acid 596 of F04983_P11, a third amino 	      59 LPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFGKVGLPA 108                                                          
						KVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWT 	                  .         .         .         .         .  
						VEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ                       	     603 RPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFN 652                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 103 - 200 of Q8IYR1, which also corresponds to	     109 RPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFN 158                                                          
						amino acids 597 - 694 of F04983_P11, and a fourth amino acid 	                  .         .         .         .         .  
						SSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMY 	     653 QLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ........ 694                                                          
						RNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMS 	         ||||||||||||||||||||||||||||||||||||||||||          
						LDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR    	     159 QLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASQVQKY 208                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 233 - 409 of Q8IYR1, which also corresponds to   	     695 ........................SSTSRRQHPLNKHLFKPSTFMTSHEP 720                                                          
						amino acids 695 - 871 of F04983_P11, wherein said first amino	                                 ||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, bridging amino    	     209 FIKLTKAGIPVPGRTPNLCIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEP 258                                                          
						acid, third amino acid sequence and fourth amino acid        	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     721 PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 770                                                          
						isolated polypeptide encoding for a head of F04983_P11,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     259 PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 308                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     771 KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDS 820                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     309 KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDS 358                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                  .         .         .         .         .  
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	     821 CSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPAN 870                                                          
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	     359 CSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPAN 408                                                          
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                                                             
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	     871 R                                                  871                                                          
						EDDDPDVYYFESDHVALKHNKD                                       	         |                                                   
						about 95% homologous to the sequence of F04983_P11.3.An      	     409 R                                                  409                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						F04983_P11, comprising a polypeptide having a length "n",    	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise QS, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						694-x to 695; and ending at any of amino acid numbers 695+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between F04983_P11 and Q8IYP0unique head   	Sequence name: Q8IYP0                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a featuring a skipped exon.1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F04983_P11, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 27708 x Q8IYP0   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                     Quality: 5684.00                      Escore:       0                                               
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	             Matching length:     585                Total length:     618                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	    Total Percent Similarity:   94.66      Total Percent Identity:   94.66                                               
						having the sequence corresponding to amino acids 1 - 285 of  	                        Gaps:       2                        
						F04983_P11, a second amino acid sequence being at least 90 % 	                                                            
						CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLES 	Alignment:                                                   
						MPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQF 	                  .         .         .         .         .  
						EENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGH 	     286 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 335                                                          
						LPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 	       1 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 50                                                           
						RHTRRVKLVFDK                                                 	                  .         .         .         .         .  
						homologous to corresponding to amino acids 1 - 312 of Q8IYP0,	     336 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 385                                                          
						which also corresponds to amino acids 286 - 597 of           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P11, a third amino acid sequence being at least 70%,  	      51 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 100                                                          
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     386 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 435                                                          
						homologous to a polypeptide having the sequence V            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 598 - 598 of F04983_P11, a      	     101 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 150                                                          
						GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVE 	                  .         .         .         .         .  
						EQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ                         	     436 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 485                                                          
						fourth amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 313 - 408 of Q8IYP0, which also 	     151 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 200                                                          
						corresponds to amino acids 599 - 694 of F04983_P11, and a    	                  .         .         .         .         .  
						SSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMY 	     486 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 535                                                          
						RNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR    	     201 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 250                                                          
						fifth amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 441 - 617 of Q8IYP0, which also 	     536 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 585                                                          
						corresponds to amino acids 695 - 871 of F04983_P11, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     251 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 300                                                          
						third amino acid sequence, fourth amino acid sequence and    	                  .         .         .         .         .  
						fifth amino acid sequence are contiguous and in a sequential 	     586 RHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 635                                                          
						order.2.An isolated polypeptide encoding for a head of       	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						F04983_P11, comprising a polypeptide being at least 70%,     	     301 RHTRRVKLVFDK.GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 349                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     636 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 685                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     350 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 399                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                  .         .         .         .         .  
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	     686 ELGNRTAKQ................................SSTSRRQHP 703                                                          
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	         |||||||||                                |||||||||  
						least about 95% homologous to the sequence of F04983_P11.3.An	     400 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 449                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						F04983_P11, comprising an amino acid sequence being at least 	     704 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 753                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     450 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 499                                                          
						at least about 95% homologous to the sequence encoding for V,	                  .         .         .         .         .  
						corresponding to F04983_P11.4.An isolated chimeric           	     754 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 803                                                          
						polypeptide encoding for an edge portion of F04983_P11,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     500 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 549                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     804 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 853                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     550 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 599                                                          
						amino acids in length, wherein at least two amino acids      	                  .                                          
						comprise QS, having a structure as follows: a sequence       	     854 SQGTSYNYLDPNYFPANR                                 871                                                          
						starting from any of amino acid numbers 694-x to 695; and    	         ||||||||||||||||||                                  
						ending at any of amino acid numbers 695+ ((n-2) - x), in     	     600 SQGTSYNYLDPNYFPANR                                 617                                                          
						which x varies from 0 to n-2.                                	                                                            

						Comparison report between F04983_P11 and Q8IYH5partial WT    	Sequence name: Q8IYH5                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F04983_P11, comprising a first amino	Sequence documentation:                                      
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	Alignment of: 27708 x Q8IYH5   ..                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                                                            
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	Alignment segment 1/1:                                       
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                     Quality: 8573.00                      Escore:       0                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	             Matching length:     871                Total length:     903                                               
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	    Total Percent Similarity:   96.46      Total Percent Identity:   96.46                                               
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                        Gaps:       1                        
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 	                                                            
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ                           	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 694 of Q8IYH5, which also corresponds to  	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						amino acids 1 - 694 of F04983_P11, and a second amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMY 	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						RNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMS 	                  .         .         .         .         .  
						LDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR    	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 727 - 903 of Q8IYH5, which also corresponds to   	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						amino acids 695 - 871 of F04983_P11, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						and in a sequential order.2.An isolated chimeric polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of F04983_P11, comprising a     	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise QS, having 	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 694-x to 695; and ending at any of amino acid   	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						numbers 695+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 KDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKAD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKAD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 IGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 IGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPET 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPET 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 FNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQ...... 694                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     651 FNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQ 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     695 ..........................SSTSRRQHPLNKHLFKPSTFMTSH 718                                                          
						                                                            	                                   ||||||||||||||||||||||||  
						                                                            	     701 KYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSH 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     719 EPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKK 768                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKK 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     769 LKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFC 818                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 LKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFC 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     819 DSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 868                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 DSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 900                                                          
						                                                            	                                                             
						                                                            	     869 ANR                                                871                                                          
						                                                            	         |||                                                 
						                                                            	     901 ANR                                                903                                                          

27720	HMR136_F04983_12_tr0_r1_1_gPRT		Comparison report between F04983_P12 and Q9Y4U0unique head   	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P12, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27720 x Q9Y4U0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 2531.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     248                Total length:     248                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                        Gaps:       0                        
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	Alignment:                                                   
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                  .         .         .         .         .  
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	     656 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 705                                                          
						having the sequence corresponding to amino acids 1 - 655 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P12, and a second amino acid sequence being at least  	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPG 	                  .         .         .         .         .  
						RTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVED 	     706 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 755                                                          
						ASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLD 	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						PNYFPANR                                                     	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 2 - 249 of   	     756 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 805                                                          
						Q9Y4U0, which also corresponds to amino acids 656 - 903 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P12, wherein said first amino acid sequence and second	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     806 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 855                                                          
						F04983_P12, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     856 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   903                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	                                                            
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                                                            
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	                                                            
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	                                                            
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	                                                            
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                                                            
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	                                                            
						least about 95% homologous to the sequence of F04983_P12.    	                                                            

						Comparison report between F04983_P12 and Q8TEK4unique head   	Sequence name: Q8TEK4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04983_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27720 x Q8TEK4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 4936.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     500                Total length:     500                                               
						to amino acids 1 - 160 of F04983_P12, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQA 	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						VQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFERE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRG 	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						RLCDDTKPETFNQLWTVEEQ                                         	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						amino acids 1 - 500 of Q8TEK4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 161 - 660 of F04983_P12, and a third amino acid  	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDE 	                  .         .         .         .         .  
						SIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQD 	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						CPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANR                                                          	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						having the sequence corresponding to amino acids 661 - 903 of	                  .         .         .         .         .  
						F04983_P12, wherein said first amino acid sequence, second   	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						polypeptide encoding for a head of F04983_P12, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                  .         .         .         .         .  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 510                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of F04983_P12.3.An isolated polypeptide      	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 350                                                          
						encoding for a tail of F04983_P12, comprising a polypeptide  	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     511 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 560                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 	     351 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 400                                                          
						YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDE 	                  .         .         .         .         .  
						SIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQD 	     561 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 610                                                          
						CPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANR                                                          	     401 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 450                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						in F04983_P12.                                               	     611 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 660                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 500                                                          

						Comparison report between F04983_P12 and Q8IYP0unique head   	Sequence name: Q8IYP0                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F04983_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27720 x Q8IYP0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                     Quality: 6093.00                      Escore:       0                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	             Matching length:     617                Total length:     618                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						to amino acids 1 - 285 of F04983_P12, a second amino acid    	                        Gaps:       1                        
						CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLES 	                                                            
						MPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQF 	Alignment:                                                   
						EENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGH 	                  .         .         .         .         .  
						LPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLE 	     286 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 335                                                          
						SLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHTRRVKLVFDK                                                 	       1 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 312 of Q8IYP0, which also corresponds to     	     336 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 385                                                          
						amino acids 286 - 597 of F04983_P12, a third amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     386 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 435                                                          
						having the sequence V corresponding to amino acids 598 - 598 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F04983_P12, and a fourth amino acid sequence being at     	     101 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 150                                                          
						GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVE 	                  .         .         .         .         .  
						EQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTP 	     436 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 485                                                          
						NLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHC 	     151 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 200                                                          
						QDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNY 	                  .         .         .         .         .  
						FPANR                                                        	     486 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 535                                                          
						least 90 % homologous to corresponding to amino acids 313 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						617 of Q8IYP0, which also corresponds to amino acids 599 -   	     201 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 250                                                          
						903 of F04983_P12, wherein said first amino acid sequence,   	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence and    	     536 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 585                                                          
						fourth amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     251 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 300                                                          
						F04983_P12, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     586 RHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 635                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     301 RHTRRVKLVFDK.GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 349                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                  .         .         .         .         .  
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     636 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 685                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	     350 QMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQKIAD 399                                                          
						least about 95% homologous to the sequence of F04983_P12.3.An	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     686 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 735                                                          
						F04983_P12, comprising an amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     400 ELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHP 449                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for V,	     736 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 785                                                          
						corresponding to F04983_P12.                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 LNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIM 499                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     786 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 835                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     500 YRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 549                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     836 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 885                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     550 WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCV 599                                                          
						                                                            	                  .                                          
						                                                            	     886 SQGTSYNYLDPNYFPANR                                 903                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     600 SQGTSYNYLDPNYFPANR                                 617                                                          

27716	HMR136_F04983_14_tr0_r1_1_gPRT		Comparison report between F04983_P14 and Q8TEK4unique head   	Sequence name: Q8TEK4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04983_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27716 x Q8TEK4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 3379.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     343                Total length:     343                                               
						to amino acids 1 - 160 of F04983_P14, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.71                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.71                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNK                    	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 341 of Q8TEK4, which also corresponds to     	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						amino acids 161 - 501 of F04983_P14, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						having the sequence EYV corresponding to amino acids 502 -   	                  .         .         .         .         .  
						504 of F04983_P14, wherein said first amino acid sequence,   	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						second amino acid sequence and third amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						polypeptide encoding for a head of F04983_P14, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                  .         .         .         .         .  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of F04983_P14.3.An isolated polypeptide      	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						encoding for a tail of F04983_P14, comprising a polypeptide  	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						EYV in F04983_P14.                                           	                  .         .         .         .            
						                                                            	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKEY        503                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||:|         
						                                                            	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDY        343                                                          

						Comparison report between F04983_P14 and Q8IYH5partial WT    	Sequence name: Q8IYH5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04983_P14, comprising a first amino	Sequence documentation:                                      
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	Alignment of: 27716 x Q8IYH5   ..                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                                                            
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	Alignment segment 1/1:                                       
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                     Quality: 4942.00                      Escore:       0                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	             Matching length:     503                Total length:     503                                               
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						EDDDPDVYYFESDHVALKHNK                                        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 501 of Q8IYH5, which also corresponds to  	                                                            
						amino acids 1 - 501 of F04983_P14, and a second amino acid   	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence EYV corresponding to amino acids 502 -   	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						504 of F04983_P14, wherein said first amino acid sequence and	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P14, comprising a polypeptide being at least 70%,     	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						least about 95% homologous to the sequence EYV in F04983_P14.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	                                                             
						                                                            	     501 KEY                                                503                                                          
						                                                            	         |:|                                                 
						                                                            	     501 KDY                                                503                                                          

27702	HMR136_F04983_4_tr0_r1_1_gPRT		Comparison report between F04983_P4 and Q8TEK4unique head    	Sequence name: Q8TEK4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27702 x Q8TEK4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 5151.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 160 of  	             Matching length:     523                Total length:     523                                               
						F04983_P4, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQA 	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						VQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFERE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRG 	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						RLCDDTKPETFNQLWTVEEQVINISKSCRLKKTSKQLTSESVL                  	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 523 of      	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						Q8TEK4, which also corresponds to amino acids 161 - 683 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P4, wherein said first amino acid sequence and second 	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						F04983_P4, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						least about 95% homologous to the sequence of F04983_P4.     	                  .         .         .         .         .  
						                                                            	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 510                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     511 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 560                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     561 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 610                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 QLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     611 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 660                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 500                                                          
						                                                            	                  .         .                                
						                                                            	     661 VINISKSCRLKKTSKQLTSESVL                            683                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     501 VINISKSCRLKKTSKQLTSESVL                            523                                                          

						Comparison report between F04983_P4 and Q8IYP0unique head    	Sequence name: Q8IYP0                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for F04983_P4, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 27702 x Q8IYP0   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                     Quality: 3610.00                      Escore:       0                                               
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	             Matching length:     374                Total length:     375                                               
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						having the sequence corresponding to amino acids 1 - 285 of  	                        Gaps:       1                        
						F04983_P4, a second amino acid sequence being at least 90 %  	                                                            
						CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLES 	Alignment:                                                   
						MPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQF 	                  .         .         .         .         .  
						EENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGH 	     286 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 335                                                          
						LPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 	       1 CLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENT 50                                                           
						RHTRRVKLVFDK                                                 	                  .         .         .         .         .  
						homologous to corresponding to amino acids 1 - 312 of Q8IYP0,	     336 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 385                                                          
						which also corresponds to amino acids 286 - 597 of F04983_P4,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	      51 NNELDTSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRA 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     386 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 435                                                          
						polypeptide having the sequence V corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 598 - 598 of F04983_P4, a fourth amino acid sequence   	     101 APTRGSPTKNSSPYRENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQ 150                                                          
						GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVE 	                  .         .         .         .         .  
						EQ                                                           	     436 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 485                                                          
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 313 - 374 of Q8IYP0, which also corresponds to amino   	     151 NEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEEEDDDP 200                                                          
						acids 599 - 660 of F04983_P4, and a fifth amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     486 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 535                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	     201 DVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREAL 250                                                          
						VINISKSCRLKKTSKQLTSESVL corresponding to amino acids 661 -   	                  .         .         .         .         .  
						683 of F04983_P4, wherein said first amino acid sequence,    	     536 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 585                                                          
						second amino acid sequence, third amino acid sequence, fourth	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and fifth amino acid sequence are        	     251 KNPIGFVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRK 300                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of F04983_P4, comprising a   	     586 RHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 635                                                          
						polypeptide being at least 70%, optionally at least about    	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     301 RHTRRVKLVFDK.GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRP 349                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .                                
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	     636 QMIRGRLCDDTKPETFNQLWTVEEQ                          660                                                          
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	         |||||||||||||||||||||||||                           
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	     350 QMIRGRLCDDTKPETFNQLWTVEEQ                          374                                                          
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	                                                            
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTA                	                                                            
						to the sequence of F04983_P4.3.An isolated polypeptide       	                                                            
						encoding for an edge portion of F04983_P4, comprising an     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for V, corresponding to  	                                                            
						F04983_P4.4.An isolated polypeptide encoding for a tail of   	                                                            
						F04983_P4, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VINISKSCRLKKTSKQLTSESVL in F04983_P4.                        	                                                            

						Comparison report between F04983_P4 and Q8IYH5partial WT     	Sequence name: Q8IYH5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04983_P4, comprising a first amino 	Sequence documentation:                                      
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	Alignment of: 27702 x Q8IYH5   ..                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                                                            
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	Alignment segment 1/1:                                       
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                     Quality: 6499.00                      Escore:       0                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	             Matching length:     660                Total length:     660                                               
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EDDDPDVYYFESDHVALKHNKDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FVEKLQKKADIGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 	                        Gaps:       0                        
						PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQ 	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 660 of Q8IYH5, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 660 of F04983_P4, and a second amino acid    	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VINISKSCRLKKTSKQLTSESVL corresponding to 	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						amino acids 661 - 683 of F04983_P4, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a tail of F04983_P4, comprising a polypeptide being at   	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						VINISKSCRLKKTSKQLTSESVL in F04983_P4.                        	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 KDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKAD 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 KDYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKAD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 IGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 IGLPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPET 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPET 650                                                          
						                                                            	                  .                                          
						                                                            	     651 FNQLWTVEEQ                                         660                                                          
						                                                            	         ||||||||||                                          
						                                                            	     651 FNQLWTVEEQ                                         660                                                          

27712	HMR136_F04983_6_tr0_r1_1_gPRT		Comparison report between F04983_P6 and Q8TEK4unique head    	Sequence name: Q8TEK4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F04983_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27712 x Q8TEK4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	Alignment segment 1/1:                                       
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	                                                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	                     Quality: 3379.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     343                Total length:     343                                               
						to amino acids 1 - 160 of F04983_P6, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.71                                               
						KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQP 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.71                                               
						DGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDH 	                        Gaps:       0                        
						KIVTACLPVEHVNQLTTEPATGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELD 	                                                            
						TSLESMPASGEPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 	Alignment:                                                   
						ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 	                  .         .         .         .         .  
						LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNK                    	     161 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 210                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 341 of Q8TEK4, which also corresponds to     	       1 KRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYLAVNGVDDSDS 50                                                           
						amino acids 161 - 501 of F04983_P6, and a third amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     211 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 260                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 AVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTSMFLDSRKEDS 100                                                          
						having the sequence EYV corresponding to amino acids 502 -   	                  .         .         .         .         .  
						504 of F04983_P6, wherein said first amino acid sequence,    	     261 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 310                                                          
						second amino acid sequence and third amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 YIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPATGPFSETQSS 150                                                          
						polypeptide encoding for a head of F04983_P6, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     311 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 360                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 LRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 200                                                          
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                  .         .         .         .         .  
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	     361 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 410                                                          
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGT                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of F04983_P6.3.An isolated polypeptide       	     201 VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNL 250                                                          
						encoding for a tail of F04983_P6, comprising a polypeptide   	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     411 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 460                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     251 SPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEAR 300                                                          
						EYV in F04983_P6.                                            	                  .         .         .         .            
						                                                            	     461 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKEY        503                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||:|         
						                                                            	     301 LNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHNKDY        343                                                          

						Comparison report between F04983_P6 and Q8IYH5partial WT     	Sequence name: Q8IYH5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F04983_P6, comprising a first amino 	Sequence documentation:                                      
						MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSPKKRPEPVPIQ 	                                                            
						KGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQAIENCERRQTEPVSPVLKRIK 	Alignment of: 27712 x Q8IYH5   ..                            
						RCLRSEAPNSSEEDSPIKSDKESVEQRSTVVDNDADFQGTKRACRCLILDDCEKREIKKV 	                                                            
						NVSEEGPLNSAVVEEITGYLAVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVA 	Alignment segment 1/1:                                       
						ENGDTDTQTSMFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 	                                                            
						TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASGEPEPSPVLDC 	                     Quality: 4942.00                      Escore:       0                                               
						VSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYRENGQFEENNLSPNETNATVS 	             Matching length:     503                Total length:     503                                               
						DNVSQSPTNPGEISQNEKGICCDSQNNGSEGVSKPPSEARLNIGHLPSAKESASQHITEE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						EDDDPDVYYFESDHVALKHNK                                        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 501 of Q8IYH5, which also corresponds to  	                                                            
						amino acids 1 - 501 of F04983_P6, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence EYV corresponding to amino acids 502 -   	       1 MAASRSTRVTRSTVGLNGLDESFCGRTLRNRSIAHPEEISSNSQVRSRSP 50                                                           
						504 of F04983_P6, wherein said first amino acid sequence and 	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P6, comprising a polypeptide being at least 70%,      	      51 KKRPEPVPIQKGNNNGRTTDLKQQSTRESWVSPRKRGLSSSEKDNIERQA 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						least about 95% homologous to the sequence EYV in F04983_P6. 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IENCERRQTEPVSPVLKRIKRCLRSEAPNSSEEDSPIKSDKESVEQRSTV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VDNDADFQGTKRACRCLILDDCEKREIKKVNVSEEGPLNSAVVEEITGYL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AVNGVDDSDSAVINCDDCQPDGNTKQNSIGSYVLQEKSVAENGDTDTQTS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MFLDSRKEDSYIDHKVPCTDSQVQVKLEDHKIVTACLPVEHVNQLTTEPA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 TGPFSETQSSLRDSEEEVDVVGDSSASKEQCKENTNNELDTSLESMPASG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EPEPSPVLDCVSAQMMSLSEPQEHRYTLRTSPRRAAPTRGSPTKNSSPYR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ENGQFEENNLSPNETNATVSDNVSQSPTNPGEISQNEKGICCDSQNNGSE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GVSKPPSEARLNIGHLPSAKESASQHITEEEDDDPDVYYFESDHVALKHN 500                                                          
						                                                            	                                                             
						                                                            	     501 KEY                                                503                                                          
						                                                            	         |:|                                                 
						                                                            	     501 KDY                                                503                                                          

27704	HMR136_F04983_8_tr0_r1_1_gPRT		Comparison report between F04983_P8 and Q9Y4U0unique head    	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27704 x Q9Y4U0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 35 of F04983_P8, and a      	                                                            
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPG 	                     Quality: 2531.00                      Escore:       0                                               
						RTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVED 	             Matching length:     248                Total length:     248                                               
						ASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLD 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PNYFPANR                                                     	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 2 - 249 of Q9Y4U0, which also   	Alignment:                                                   
						corresponds to amino acids 36 - 283 of F04983_P8, wherein    	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      36 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 85                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F04983_P8, comprising a   	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      86 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 135                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW of       	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						F04983_P8.                                                   	                  .         .         .         .         .  
						                                                            	     136 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 185                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     186 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 235                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						                                                            	                  .         .         .         .            
						                                                            	     236 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   283                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          

						Comparison report between F04983_P8 and Q8IYP0partial WT     	Sequence name: Q8IYP0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F04983_P8, comprising a first amino acid        	                                                            
						MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRW 	Alignment of: 27704 x Q8IYP0   ..                            
						QKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHL 	                                                            
						FKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKK 	Alignment segment 1/1:                                       
						LKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHET 	                                                            
						DIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  	                     Quality: 2889.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     283                Total length:     283                                               
						amino acids 335 - 617 of Q8IYP0, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 283 of F04983_P8.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 384                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 434                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     435 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 484                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     485 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 534                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     535 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 584                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  283                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     585 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  617                                                          

						Comparison report between F04983_P8 and Q8IYH5partial WT     	Sequence name: Q8IYH5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F04983_P8, comprising a first amino acid        	                                                            
						MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRW 	Alignment of: 27704 x Q8IYH5   ..                            
						QKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHL 	                                                            
						FKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKK 	Alignment segment 1/1:                                       
						LKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHET 	                                                            
						DIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  	                     Quality: 2889.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     283                Total length:     283                                               
						amino acids 621 - 903 of Q8IYH5, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 283 of F04983_P8.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     621 MLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKY 670                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     671 PPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNL 720                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     721 YIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMN 770                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     771 TAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVG 820                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     821 FKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLE 870                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  283                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     871 PIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                  903                                                          

27710	HMR136_F04983_9_tr0_r1_1_gPRT		Comparison report between F04983_P9 and Q9Y4U0unique head    	Sequence name: Q9Y4U0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27710 x Q9Y4U0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MIDLWLYSYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLP 	Alignment segment 1/1:                                       
						YPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDG 	                                                            
						ESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW                    	                     Quality: 2531.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 161 of  	             Matching length:     248                Total length:     248                                               
						F04983_P9, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVED 	                        Gaps:       0                        
						ASDDESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVR 	                                                            
						WHCQDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLD 	Alignment:                                                   
						PNYFPANR                                                     	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 2 - 249 of      	     162 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 211                                                          
						Q9Y4U0, which also corresponds to amino acids 162 - 409 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P9, wherein said first amino acid sequence and second 	       2 TVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIK 51                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     212 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 261                                                          
						F04983_P9, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      52 LTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVY 101                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MIDLWLYSYQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLP 	     262 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 311                                                          
						YPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLW                    	     102 MDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLKKQK 151                                                          
						least about 95% homologous to the sequence of F04983_P9.     	                  .         .         .         .         .  
						                                                            	     312 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     152 LQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSD 201                                                          
						                                                            	                  .         .         .         .            
						                                                            	     362 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   409                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     202 CLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR   249                                                          

						Comparison report between F04983_P9 and Q8IYP0unique head    	Sequence name: Q8IYP0                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F04983_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27710 x Q8IYP0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MIDLWLYS     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of F04983_P9, a second    	                                                            
						YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQL 	                     Quality: 3936.00                      Escore:       0                                               
						PEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDK                          	             Matching length:     400                Total length:     401                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 218 - 312 of Q8IYP0, which also 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						corresponds to amino acids 9 - 103 of F04983_P9, a third     	                        Gaps:       1                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence V corresponding to amino acids 104 - 104 	       9 YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIG 58                                                           
						of F04983_P9, and a fourth amino acid sequence being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GLPARPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVE 	     218 YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIG 267                                                          
						EQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTP 	                  .         .         .         .         .  
						NLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASD 	      59 LPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPA 108                                                          
						DESIPIMYRNLPEYKELLQFKKLKKQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHC 	         ||||||||||||||||||||||||||||||||||||||||||||| ||||  
						QDCPPEMSLDFCDSCSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNY 	     268 LPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDK.GLPA 316                                                          
						FPANR                                                        	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 313 - 617 of 	     109 RPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFN 158                                                          
						Q8IYP0, which also corresponds to amino acids 105 - 409 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P9, wherein said first amino acid sequence, second    	     317 RPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFN 366                                                          
						amino acid sequence, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     159 QLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKY 208                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P9, comprising a polypeptide being at least 70%,      	     367 QLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKY 416                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     209 FIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEP 258                                                          
						least about 95% homologous to the sequence MIDLWLYS of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F04983_P9.3.An isolated polypeptide encoding for an edge     	     417 FIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEP 466                                                          
						portion of F04983_P9, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     259 PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 308                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     467 PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 516                                                          
						encoding for V, corresponding to F04983_P9.                  	                  .         .         .         .         .  
						                                                            	     309 KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDS 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDS 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 CSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPAN 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 CSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPAN 616                                                          
						                                                            	                                                             
						                                                            	     409 R                                                  409                                                          
						                                                            	         |                                                   
						                                                            	     617 R                                                  617                                                          

						Comparison report between F04983_P9 and Q8IYH5unique head    	Sequence name: Q8IYH5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F04983_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27710 x Q8IYH5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MIDLWLYS corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F04983_P9, and a second amino acid sequence being at    	                                                            
						YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIGLPYPQRVVQL 	                     Quality: 4044.00                      Escore:       0                                               
						PEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPARPKSPLDPKKDGESLSYSML 	             Matching length:     401                Total length:     401                                               
						PLSDGPEGSSSRPQMIRGRLCDDTKPETFNQLWTVEEQKKLEQLLIKYPPEEVESRRWQK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IADELGNRTAKQVASRVQKYFIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PSTFMTSHEPPVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 	                        Gaps:       0                        
						KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDSCSDCLHETDI 	                                                            
						HKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPANR                    	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 503 -  	                  .         .         .         .         .  
						903 of Q8IYH5, which also corresponds to amino acids 9 - 409 	       9 YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIG 58                                                           
						of F04983_P9, wherein said first amino acid sequence and     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     503 YQRLLQTIAVLEAQRSQAVQDLESLGRHQREALKNPIGFVEKLQKKADIG 552                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F04983_P9, comprising a polypeptide being at least 70%,      	      59 LPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPA 108                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     553 LPYPQRVVQLPEIVWDQYTHSLGNFEREFKNRKRHTRRVKLVFDKVGLPA 602                                                          
						least about 95% homologous to the sequence MIDLWLYS of       	                  .         .         .         .         .  
						F04983_P9.                                                   	     109 RPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFN 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     603 RPKSPLDPKKDGESLSYSMLPLSDGPEGSSSRPQMIRGRLCDDTKPETFN 652                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 QLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKY 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     653 QLWTVEEQKKLEQLLIKYPPEEVESRRWQKIADELGNRTAKQVASRVQKY 702                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 FIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEP 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     703 FIKLTKAGIPVPGRTPNLYIYSKKSSTSRRQHPLNKHLFKPSTFMTSHEP 752                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     753 PVYMDEDDDRSCFHSHMNTAVEDASDDESIPIMYRNLPEYKELLQFKKLK 802                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDS 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     803 KQKLQQMQAESGFVQHVGFKCDNCGIEPIQGVRWHCQDCPPEMSLDFCDS 852                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 CSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPAN 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     853 CSDCLHETDIHKEDHQLEPIYRSETFLDRDYCVSQGTSYNYLDPNYFPAN 902                                                          
						                                                            	                                                             
						                                                            	     409 R                                                  409                                                          
						                                                            	         |                                                   
						                                                            	     903 R                                                  903                                                          

12216	HMR136_F05349_5_tr0_r1_1_gPRT		Comparison report between F05349_P5 and PIB1_HUMANpartial WT 	Sequence name: PIB1_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05349_P5, comprising a first amino 	Sequence documentation:                                      
						MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDDSTIVTPIILRTDPQGFFFYWTDQNKE 	                                                            
						TELLDLSLVKDARCGRHAKAPKDPKLRELLDVGNIGRLEQRMITVVYGPDLVNISHLNLV 	Alignment of: 12216 x PIB1_HUMAN   ..                        
						AFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKLQVTPEGRIPLKNIYRLFSA 	                                                            
						DRKRVETALEACSLPSSRNDSIPQEDFTPEVYRVFLNNLCPRPEIDNIFSEFGAKSKPYL 	Alignment segment 1/1:                                       
						TVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPNNSLARKGQISVDGFMRYLS 	                                                            
						GEENGVVSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYRQVLLSGCRCV 	                     Quality: 11216.00                      Escore:       0                                              
						ELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAFKTSPFPILLSFENHVDSPKQ 	             Matching length:    1141                Total length:    1141                                               
						QAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYKILVKNKKKSHKSSEGSGKK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLSEQASNTYSDSSSMFEPSSPGAGEADTESDDDDDDDDCKKSSMDEGTAGSEAMATEEM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SNLVNYIQPVKFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPK 	                        Gaps:       0                        
						GTRVDSSNYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYEYNGKSGYRLKPEFMRRPDK 	                                                            
						HFDPFTEGIVDGIVANTLSVKIISGQFLSDKKVGTYVEVDMFGLPVDTRRKAFKTKTSQG 	Alignment:                                                   
						NAVNPVWEEEPIVFKKVVLPTLACLRIAVYEEGGKFIGHRILPVQAIRPGYHYICLRNER 	                  .         .         .         .         .  
						NQPLTLPAVFVYIEVKDYVPDTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKK 	       1 MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDDSTIVTPIILRTDPQGF 50                                                           
						EADPGETPSEAPSEARTTPAENGVNHTTTLTPKPPSQALHSQPAPGSVKAPAKTEDLIQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLTEVEAQTIEELKQQKSFVKLQKKHYKEMKDLVKRHHKKTTDLIKEHTTKYNEIQNDYL 	       1 MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDDSTIVTPIILRTDPQGF 50                                                           
						RRRAALEKSAKKDSKKKSEPSSPDHGSSTIEQDLAALDAEMTQKLIDLKDKQQQQLLNLR 	                  .         .         .         .         .  
						QEQYYSEKYQKREHIKLLIQKLTDVAEECQNNQLKKLKEICEKEKKELKKKMDKKRQEKI 	      51 FFYWTDQNKETELLDLSLVKDARCGRHAKAPKDPKLRELLDVGNIGRLEQ 100                                                          
						TEAKSKDKSQMEEEKTEMIRSYIQEVVQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						K                                                            	      51 FFYWTDQNKETELLDLSLVKDARCGRHAKAPKDPKLRELLDVGNIGRLEQ 100                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 1141 of PIB1_HUMAN, which also corresponds	     101 RMITVVYGPDLVNISHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDA 150                                                          
						to amino acids 1 - 1141 of F05349_P5, and a second amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     101 RMITVVYGPDLVNISHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDA 150                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     151 FLEKAYTKLKLQVTPEGRIPLKNIYRLFSADRKRVETALEACSLPSSRND 200                                                          
						having the sequence GEGSSSFLSETCHEDPSVSPNFTPPNPQALKW         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1142 - 1173 of F05349_P5,       	     151 FLEKAYTKLKLQVTPEGRIPLKNIYRLFSADRKRVETALEACSLPSSRND 200                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     201 SIPQEDFTPEVYRVFLNNLCPRPEIDNIFSEFGAKSKPYLTVDQMMDFIN 250                                                          
						isolated polypeptide encoding for a tail of F05349_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     201 SIPQEDFTPEVYRVFLNNLCPRPEIDNIFSEFGAKSKPYLTVDQMMDFIN 250                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     251 LKQRDPRLNEILYPPLKQEQVQVLIEKYEPNNSLARKGQISVDGFMRYLS 300                                                          
						about 95% homologous to the sequence                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GEGSSSFLSETCHEDPSVSPNFTPPNPQALKW in F05349_P5.               	     251 LKQRDPRLNEILYPPLKQEQVQVLIEKYEPNNSLARKGQISVDGFMRYLS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GEENGVVSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GEENGVVSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QVLLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAF 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QVLLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KTSPFPILLSFENHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KTSPFPILLSFENHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PLPSPMDLMYKILVKNKKKSHKSSEGSGKKKLSEQASNTYSDSSSMFEPS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PLPSPMDLMYKILVKNKKKSHKSSEGSGKKKLSEQASNTYSDSSSMFEPS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SPGAGEADTESDDDDDDDDCKKSSMDEGTAGSEAMATEEMSNLVNYIQPV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SPGAGEADTESDDDDDDDDCKKSSMDEGTAGSEAMATEEMSNLVNYIQPV 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 KFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPK 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 KFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPK 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GTRVDSSNYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYEYNGKSGYRL 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GTRVDSSNYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYEYNGKSGYRL 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 KPEFMRRPDKHFDPFTEGIVDGIVANTLSVKIISGQFLSDKKVGTYVEVD 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KPEFMRRPDKHFDPFTEGIVDGIVANTLSVKIISGQFLSDKKVGTYVEVD 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 MFGLPVDTRRKAFKTKTSQGNAVNPVWEEEPIVFKKVVLPTLACLRIAVY 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 MFGLPVDTRRKAFKTKTSQGNAVNPVWEEEPIVFKKVVLPTLACLRIAVY 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLTLPAVFVYIEVKDYVP 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLTLPAVFVYIEVKDYVP 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKKEADPGETPSE 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKKEADPGETPSE 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 APSEARTTPAENGVNHTTTLTPKPPSQALHSQPAPGSVKAPAKTEDLIQS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 APSEARTTPAENGVNHTTTLTPKPPSQALHSQPAPGSVKAPAKTEDLIQS 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 VLTEVEAQTIEELKQQKSFVKLQKKHYKEMKDLVKRHHKKTTDLIKEHTT 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 VLTEVEAQTIEELKQQKSFVKLQKKHYKEMKDLVKRHHKKTTDLIKEHTT 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 KYNEIQNDYLRRRAALEKSAKKDSKKKSEPSSPDHGSSTIEQDLAALDAE 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 KYNEIQNDYLRRRAALEKSAKKDSKKKSEPSSPDHGSSTIEQDLAALDAE 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 MTQKLIDLKDKQQQQLLNLRQEQYYSEKYQKREHIKLLIQKLTDVAEECQ 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 MTQKLIDLKDKQQQQLLNLRQEQYYSEKYQKREHIKLLIQKLTDVAEECQ 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 NNQLKKLKEICEKEKKELKKKMDKKRQEKITEAKSKDKSQMEEEKTEMIR 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 NNQLKKLKEICEKEKKELKKKMDKKRQEKITEAKSKDKSQMEEEKTEMIR 1100                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1101 SYIQEVVQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKPK          1141                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	    1101 SYIQEVVQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKPK          1141                                                         

6649	HMR136_F05440_10_tr0_r1_1_gPRT		Comparison report between F05440_P10 and GEPH_HUMANunique    	Sequence name: GEPH_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F05440_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6649 x GEPH_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence FPCVLISLSLFFSS corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 14 of F05440_P10, and a second amino acid sequence 	                                                            
						PDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQIHFGRVFMKPGLPTTFA 	                     Quality: 1821.00                      Escore:       0                                               
						TLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPR 	             Matching length:     195                Total length:     195                                               
						PEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDV 	 Matching Percent Similarity:   97.95   Matching Percent Identity:   96.41                                               
						MVIGRL                                                       	    Total Percent Similarity:   97.95      Total Percent Identity:   96.41                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       0                        
						acids 551 - 736 of GEPH_HUMAN, which also corresponds to     	                                                            
						amino acids 15 - 200 of F05440_P10, wherein said first amino 	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	       6 ISLSLFFSSPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLH 55                                                           
						for a head of F05440_P10, comprising a polypeptide being at  	         |:| :   :|||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     542 INLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLH 591                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	      56 AQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVP 105                                                          
						FPCVLISLSLFFSS of F05440_P10.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     592 AQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVP 641                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     106 ALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQS 155                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     642 ALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQS 691                                                          
						                                                            	                  .         .         .         .            
						                                                            	     156 TGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIGRL      200                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     692 TGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIGRL      736                                                          

6647	HMR136_F05440_2_tr0_r1_1_gPRT		Comparison report between F05440_P2 and GEPH_HUMANpartial WT 	Sequence name: GEPH_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for F05440_P2, comprising a first amino 	Sequence documentation:                                      
						MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVP 	                                                            
						DEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREAPGMALAMLMGSL 	Alignment of: 6647 x GEPH_HUMAN   ..                         
						NVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVH 	                                                            
						DELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAI 	Alignment segment 1/1:                                       
						AAK                                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 6900.00                      Escore:       0                                               
						to amino acids 1 - 243 of GEPH_HUMAN, which also corresponds 	             Matching length:     736                Total length:     802                                               
						to amino acids 1 - 243 of F05440_P2, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   91.77      Total Percent Identity:   91.77                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       2                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER        	Alignment:                                                   
						corresponding to amino acids 244 - 276 of F05440_P2, a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLG 50                                                           
						IPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPK corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 244 - 288 of GEPH_HUMAN, which also           	       1 MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLG 50                                                           
						corresponds to amino acids 277 - 321 of F05440_P2, a fourth  	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	      51 GTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEAT 100                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	      51 GTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEAT 100                                                          
						having the sequence QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE        	                  .         .         .         .         .  
						corresponding to amino acids 322 - 354 of F05440_P2, and a   	     101 KEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKG 150                                                          
						VQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQV 	     101 KEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKG 150                                                          
						MRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGE 	                  .         .         .         .         .  
						CVLAKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRS 	     151 SQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPPTTS 200                                                          
						TLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQG 	     151 SQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPPTTS 200                                                          
						ILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANG 	                  .         .         .         .         .  
						LLMLPPKTEQYVELHKGEVVDVMVIGRL                                 	     201 PHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAIAAKKHPFYTS 250                                                          
						fifth amino acid sequence being at least 90 % homologous to  	         |||||||||||||||||||||||||||||||||||||||||||         
						corresponding to amino acids 289 - 736 of GEPH_HUMAN, which  	     201 PHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAIAAK....... 243                                                          
						also corresponds to amino acids 355 - 802 of F05440_P2,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     251 PAVVMAHGEQPIPGLINYSHHSTDERIPDSIISRGVQVLPRDTASLSTTP 300                                                          
						sequence, third amino acid sequence, fourth amino acid       	                                   ||||||||||||||||||||||||  
						sequence and fifth amino acid sequence are contiguous and in 	     244 ..........................IPDSIISRGVQVLPRDTASLSTTP 267                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	                  .         .         .         .         .  
						edge portion of F05440_P2, comprising an amino acid sequence 	     301 SESPRAQATSRLSTASCPTPKQIRRPDESKGVASRVGSLKARLPSCSSTY 350                                                          
						being at least 70%, optionally at least about 80%, preferably	         |||||||||||||||||||||                               
						at least about 85%, more preferably at least about 90% and   	     268 SESPRAQATSRLSTASCPTPK............................. 288                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						encoding for KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER, corresponding	     351 SVSEVQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVL 400                                                          
						to F05440_P2.3.An isolated polypeptide encoding for an edge  	             ||||||||||||||||||||||||||||||||||||||||||||||  
						portion of F05440_P2, comprising an amino acid sequence being	     289 ....VQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVL 334                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     401 EMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGP 450                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE, corresponding	     335 EMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGP 384                                                          
						to F05440_P2.                                                	                  .         .         .         .         .  
						                                                            	     451 GDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 GDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIR 434                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     435 ESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGL 484                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     485 LATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATI 534                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 QEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQ 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     535 QEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQ 584                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     585 VLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVT 634                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 CNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     635 CNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQE 684                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 PLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIG 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     685 PLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIG 734                                                          
						                                                            	                                                             
						                                                            	     801 RL                                                 802                                                          
						                                                            	         ||                                                  
						                                                            	     735 RL                                                 736                                                          

6645	HMR136_F05440_3_tr0_r1_1_gPRT		Comparison report between F05440_P3 and GEPH_HUMANpartial WT 	Sequence name: GEPH_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for F05440_P3, comprising a first amino 	Sequence documentation:                                      
						MALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLR 	                                                            
						DAIVKVKEVHDELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDS 	Alignment of: 6645 x GEPH_HUMAN   ..                         
						SSSHITAAAIAAK                                                	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 111 - 243 of GEPH_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 133 of F05440_P3, a second    	                     Quality: 5847.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     626                Total length:     692                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   90.46      Total Percent Identity:   90.46                                               
						having the sequence KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER        	                        Gaps:       2                        
						corresponding to amino acids 134 - 166 of F05440_P3, a third 	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						IPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPK corresponding  	                  .         .         .         .         .  
						to amino acids 244 - 288 of GEPH_HUMAN, which also           	       1 MALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILP 50                                                           
						corresponds to amino acids 167 - 211 of F05440_P3, a fourth  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	     111 MALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILP 160                                                          
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	      51 ALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPPTTSPHKQTEDKGV 100                                                          
						having the sequence QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 212 - 244 of F05440_P3, and a   	     161 ALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPPTTSPHKQTEDKGV 210                                                          
						VQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYR 	                  .         .         .         .         .  
						DGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQV 	     101 QCEEEEEEKKDSGVASTEDSSSSHITAAAIAAKKHPFYTSPAVVMAHGEQ 150                                                          
						MRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGE 	         |||||||||||||||||||||||||||||||||                   
						CVLAKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRS 	     211 QCEEEEEEKKDSGVASTEDSSSSHITAAAIAAK................. 243                                                          
						TLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDI 	                  .         .         .         .         .  
						DLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQG 	     151 PIPGLINYSHHSTDERIPDSIISRGVQVLPRDTASLSTTPSESPRAQATS 200                                                          
						ILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANG 	                         ||||||||||||||||||||||||||||||||||  
						LLMLPPKTEQYVELHKGEVVDVMVIGRL                                 	     244 ................IPDSIISRGVQVLPRDTASLSTTPSESPRAQATS 277                                                          
						fifth amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 289 - 736 of GEPH_HUMAN, which  	     201 RLSTASCPTPKQIRRPDESKGVASRVGSLKARLPSCSSTYSVSEVQSRCS 250                                                          
						also corresponds to amino acids 245 - 692 of F05440_P3,      	         |||||||||||                                 ||||||  
						wherein said first amino acid sequence, second amino acid    	     278 RLSTASCPTPK.................................VQSRCS 294                                                          
						sequence, third amino acid sequence, fourth amino acid       	                  .         .         .         .         .  
						sequence and fifth amino acid sequence are contiguous and in 	     251 SKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEI 300                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of F05440_P3, comprising an amino acid sequence 	     295 SKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEI 344                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     301 INYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQ 350                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER, corresponding	     345 INYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQ 394                                                          
						to F05440_P3.3.An isolated polypeptide encoding for an edge  	                  .         .         .         .         .  
						portion of F05440_P3, comprising an amino acid sequence being	     351 AGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELE 400                                                          
						at least 70%, optionally at least about 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 85%, more preferably at least about 90% and most 	     395 AGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELE 444                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE, corresponding	     401 VRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVGVTEVE 450                                                          
						to F05440_P3.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     445 VRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVGVTEVE 494                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     495 VNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINL 544                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     545 GIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQI 594                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 HFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     595 HFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALR 644                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 KMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGN 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     645 KMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGN 694                                                          
						                                                            	                  .         .         .         .            
						                                                            	     651 QMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIGRL         692                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     695 QMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIGRL         736                                                          

6641	HMR136_F05440_4_tr0_r1_1_gPRT		Comparison report between F05440_P4 and GEPH_HUMANpartial WT 	Sequence name: GEPH_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for F05440_P4, comprising a first amino 	Sequence documentation:                                      
						MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVP 	                                                            
						DEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPE                       	Alignment of: 6641 x GEPH_HUMAN   ..                         
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 98 of GEPH_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 98 of F05440_P4, a second amino acid      	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 6800.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     736                Total length:     815                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence KFPTFPFCGLQKG corresponding to amino     	    Total Percent Similarity:   90.31      Total Percent Identity:   90.31                                               
						acids 99 - 111 of F05440_P4, a third amino acid sequence     	                        Gaps:       3                        
						ATKEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFI 	                                                            
						LPALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEE 	Alignment:                                                   
						KKDSGVASTEDSSSSHITAAAIAAK                                    	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	       1 MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLG 50                                                           
						acids 99 - 243 of GEPH_HUMAN, which also corresponds to amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 112 - 256 of F05440_P4, a fourth amino acid sequence   	       1 MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLG 50                                                           
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	      51 GTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEKF 100                                                          
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER corresponding to amino     	      51 GTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPE.. 98                                                           
						acids 257 - 289 of F05440_P4, a fifth amino acid sequence    	                  .         .         .         .         .  
						being at least 90 % homologous to                            	     101 PTFPFCGLQKGATKEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRG 150                                                          
						IPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPK corresponding  	                    |||||||||||||||||||||||||||||||||||||||  
						to amino acids 244 - 288 of GEPH_HUMAN, which also           	      99 ...........ATKEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRG 137                                                          
						corresponds to amino acids 290 - 334 of F05440_P4, a sixth   	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     151 KTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLP 200                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     138 KTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLP 187                                                          
						having the sequence QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE        	                  .         .         .         .         .  
						corresponding to amino acids 335 - 367 of F05440_P4, and a   	     201 SPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITA 250                                                          
						VQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQV 	     188 SPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITA 237                                                          
						MRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGE 	                  .         .         .         .         .  
						CVLAKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRS 	     251 AAIAAKKHPFYTSPAVVMAHGEQPIPGLINYSHHSTDERIPDSIISRGVQ 300                                                          
						TLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDI 	         ||||||                                 |||||||||||  
						DLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQG 	     238 AAIAAK.................................IPDSIISRGVQ 254                                                          
						ILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANG 	                  .         .         .         .         .  
						LLMLPPKTEQYVELHKGEVVDVMVIGRL                                 	     301 VLPRDTASLSTTPSESPRAQATSRLSTASCPTPKQIRRPDESKGVASRVG 350                                                          
						seventh amino acid sequence being at least 90 % homologous to	         ||||||||||||||||||||||||||||||||||                  
						corresponding to amino acids 289 - 736 of GEPH_HUMAN, which  	     255 VLPRDTASLSTTPSESPRAQATSRLSTASCPTPK................ 288                                                          
						also corresponds to amino acids 368 - 815 of F05440_P4,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     351 SLKARLPSCSSTYSVSEVQSRCSSKENILRASHSAVDITKVARRHRMSPF 400                                                          
						sequence, third amino acid sequence, fourth amino acid       	                          |||||||||||||||||||||||||||||||||  
						sequence, fifth amino acid sequence, sixth amino acid        	     289 .................VQSRCSSKENILRASHSAVDITKVARRHRMSPF 321                                                          
						sequence and seventh amino acid sequence are contiguous and  	                  .         .         .         .         .  
						in a sequential order.2.An isolated polypeptide encoding for 	     401 PLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPAS 450                                                          
						an edge portion of F05440_P4, comprising an amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least about 80%,  	     322 PLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPAS 371                                                          
						preferably at least about 85%, more preferably at least about	                  .         .         .         .         .  
						90% and most preferably at least about 95% homologous to the 	     451 VKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGA 500                                                          
						sequence encoding for KFPTFPFCGLQKG, corresponding to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05440_P4.3.An isolated polypeptide encoding for an edge     	     372 VKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGA 421                                                          
						portion of F05440_P4, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     501 DAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVL 550                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     422 DAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVL 471                                                          
						encoding for KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER, corresponding	                  .         .         .         .         .  
						to F05440_P4.4.An isolated polypeptide encoding for an edge  	     551 AKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGK 600                                                          
						portion of F05440_P4, comprising an amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     472 AKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGK 521                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     601 IRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITS 650                                                          
						encoding for QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE, corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to F05440_P4.                                                	     522 IRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITS 571                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 GGVSMGEKDYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKII 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     572 GGVSMGEKDYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKII 621                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 FALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     622 FALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP 671                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     672 EYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVE 721                                                          
						                                                            	                  .                                          
						                                                            	     801 LHKGEVVDVMVIGRL                                    815                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     722 LHKGEVVDVMVIGRL                                    736                                                          

6651	HMR136_F05440_7_tr0_r1_1_gPRT		Comparison report between F05440_P7 and GEPH_HUMANshort      	Sequence name: GEPH_HUMAN                                    
						unique head followed by partial WT sequence followed by a    	                                                            
						unique insertion.1.An isolated chimeric polypeptide encoding 	Sequence documentation:                                      
						for F05440_P7, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 6651 x GEPH_HUMAN   ..                         
						85%, more preferably at least 90% and most preferably at     	                                                            
						least 95% homologous to a polypeptide having the sequence M  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of F05440_P7, a second    	                                                            
						LGGTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREA 	                     Quality: 6441.00                      Escore:       0                                               
						PGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDL 	             Matching length:     689                Total length:     755                                               
						LRDAIVKVKEVHDELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						DSSSSHITAAAIAAK                                              	    Total Percent Similarity:   91.26      Total Percent Identity:   91.13                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       2                        
						corresponding to amino acids 49 - 243 of GEPH_HUMAN, which   	                                                            
						also corresponds to amino acids 2 - 196 of F05440_P7, a third	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MLGGTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTP 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER        	      48 LLGGTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTP 97                                                           
						corresponding to amino acids 197 - 229 of F05440_P7, a fourth	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      51 EATKEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGS 100                                                          
						IPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPK corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 244 - 288 of GEPH_HUMAN, which also           	      98 EATKEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGS 147                                                          
						corresponds to amino acids 230 - 274 of F05440_P7, a fifth   	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     101 KKGSQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPP 150                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     148 KKGSQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPP 197                                                          
						having the sequence QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE        	                  .         .         .         .         .  
						corresponding to amino acids 275 - 307 of F05440_P7, and a   	     151 TTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAIAAKKHPF 200                                                          
						VQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYR 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						DGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQV 	     198 TTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAIAAK.... 243                                                          
						MRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGE 	                  .         .         .         .         .  
						CVLAKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRS 	     201 YTSPAVVMAHGEQPIPGLINYSHHSTDERIPDSIISRGVQVLPRDTASLS 250                                                          
						TLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDI 	                                      |||||||||||||||||||||  
						DLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQG 	     244 .............................IPDSIISRGVQVLPRDTASLS 264                                                          
						ILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANG 	                  .         .         .         .         .  
						LLMLPPKTEQYVELHKGEVVDVMVIGRL                                 	     251 TTPSESPRAQATSRLSTASCPTPKQIRRPDESKGVASRVGSLKARLPSCS 300                                                          
						sixth amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||                            
						corresponding to amino acids 289 - 736 of GEPH_HUMAN, which  	     265 TTPSESPRAQATSRLSTASCPTPK.......................... 288                                                          
						also corresponds to amino acids 308 - 755 of F05440_P7,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     301 STYSVSEVQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFI 350                                                          
						sequence, third amino acid sequence, fourth amino acid       	                |||||||||||||||||||||||||||||||||||||||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     289 .......VQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFI 331                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     351 TVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAA 400                                                          
						F05440_P7, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     332 TVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAA 381                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     401 DGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTE 450                                                          
						KHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER, corresponding to          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05440_P7.3.An isolated polypeptide encoding for an edge     	     382 DGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTE 431                                                          
						portion of F05440_P7, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     451 LIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSE 500                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     432 LIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSE 481                                                          
						encoding for QIRRPDESKGVASRVGSLKARLPSCSSTYSVSE, corresponding	                  .         .         .         .         .  
						to F05440_P7.                                                	     501 IGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     482 IGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLL 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 ATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDY 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     532 ATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDY 581                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     582 LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSA 631                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWH 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     632 VVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWH 681                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVM 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     682 HQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVM 731                                                          
						                                                            	                                                             
						                                                            	     751 VIGRL                                              755                                                          
						                                                            	         |||||                                               
						                                                            	     732 VIGRL                                              736                                                          

17048	HMR136_F05564_4_tr0_r1_1_gPRT		Comparison report between F05564_P4 and ZIN_HUMANunique head 	Sequence name: ZIN_HUMAN                                     
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F05564_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17048 x ZIN_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						RGRAGARGTAGAQAGPGAS corresponding to amino acids 1 - 19 of   	                                                            
						F05564_P4, a second amino acid sequence being at least 90 %  	                     Quality: 3723.00                      Escore:       0                                               
						MMEERAAAAVAAAASSCRPLGSGAGPGPTGAAPVSAPAPGPGPAGKGGGGGGSPGPTAGP 	             Matching length:     384                Total length:     384                                               
						EPLSLPGILHFIQHEWARFEAEKARWEAERAELQAQVAFLQGERKGQENLKTDLVRRIKM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.74                                               
						LEYALKQERAKYHKLKFGTDLNQGEKKADVSEQVSNGPVESVTLENSPLVWKEGRQLLRQ 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.74                                               
						YLEEVGYTDTILDMRSKRVRSLLGRSLELNGAVEPSEGAPRAPPGPAGLSGGESLLVKQI 	                        Gaps:       0                        
						EEQIKRNAAGKDGKERLGGSVLGQIPFLQNCEDEDSDEDDELDSVQHKKQRVKLPSKALV 	                                                            
						PEMEDEDEEDDSEDAINEFDFLGSGEDGEGAPDPRRCTVDGSPHELESRRVKLQG      	Alignment:                                                   
						homologous to corresponding to amino acids 1 - 355 of        	                  .         .         .         .         .  
						ZIN_HUMAN, which also corresponds to amino acids 20 - 374 of 	      20 MMEERAAAAVAAAASSCRPLGSGAGPGPTGAAPVSAPAPGPGPAGKGGGG 69                                                           
						F05564_P4, a bridging amino acid I corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 375 of F05564_P4, a third amino acid sequence being at  	       1 MMEERAAAAVAAAASSCRPLGSGAGPGPTGAAPVSAPAPGPGPAGKGGGG 50                                                           
						least 90 % homologous to LADLRDVDGLPPKVTGPPPGTPQPRPHE        	                  .         .         .         .         .  
						corresponding to amino acids 357 - 384 of ZIN_HUMAN, which   	      70 GGSPGPTAGPEPLSLPGILHFIQHEWARFEAEKARWEAERAELQAQVAFL 119                                                          
						also corresponds to amino acids 376 - 403 of F05564_P4, and a	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 70%, optionally at 	      51 GGSPGPTAGPEPLSLPGILHFIQHEWARFEAEKARWEAERAELQAQVAFL 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     120 QGERKGQENLKTDLVRRIKMLEYALKQERAKYHKLKFGTDLNQGEKKADV 169                                                          
						GKRHPPPGPSPAGPWQREAAELSPGLLCLQGRGPASSLQPPCPKSSSVCLSPSLFVCPAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVSLSLSSCDSSSCPLPVSLSCSLSLSLPLSVILSLPGPLCPSLPSPYQVPLASPQTSSS 	     101 QGERKGQENLKTDLVRRIKMLEYALKQERAKYHKLKFGTDLNQGEKKADV 150                                                          
						WTLSGAGR                                                     	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     170 SEQVSNGPVESVTLENSPLVWKEGRQLLRQYLEEVGYTDTILDMRSKRVR 219                                                          
						404 - 531 of F05564_P4, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid,   	     151 SEQVSNGPVESVTLENSPLVWKEGRQLLRQYLEEVGYTDTILDMRSKRVR 200                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     220 SLLGRSLELNGAVEPSEGAPRAPPGPAGLSGGESLLVKQIEEQIKRNAAG 269                                                          
						polypeptide encoding for a head of F05564_P4, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     201 SLLGRSLELNGAVEPSEGAPRAPPGPAGLSGGESLLVKQIEEQIKRNAAG 250                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     270 KDGKERLGGSVLGQIPFLQNCEDEDSDEDDELDSVQHKKQRVKLPSKALV 319                                                          
						to the sequence RGRAGARGTAGAQAGPGAS of F05564_P4.3.An        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of F05564_P4,       	     251 KDGKERLGGSVLGQIPFLQNCEDEDSDEDDELDSVQHKKQRVKLPSKALV 300                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     320 PEMEDEDEEDDSEDAINEFDFLGSGEDGEGAPDPRRCTVDGSPHELESRR 369                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKRHPPPGPSPAGPWQREAAELSPGLLCLQGRGPASSLQPPCPKSSSVCLSPSLFVCPAL 	     301 PEMEDEDEEDDSEDAINEFDFLGSGEDGEGAPDPRRCTVDGSPHELESRR 350                                                          
						SVSLSLSSCDSSSCPLPVSLSCSLSLSLPLSVILSLPGPLCPSLPSPYQVPLASPQTSSS 	                  .         .         .                      
						WTLSGAGR                                                     	     370 VKLQGILADLRDVDGLPPKVTGPPPGTPQPRPHE                 403                                                          
						about 95% homologous to the sequence in F05564_P4.           	         |||||:||||||||||||||||||||||||||||                  
						                                                            	     351 VKLQGVLADLRDVDGLPPKVTGPPPGTPQPRPHE                 384                                                          

17341	HMR136_F05593_5_tr0_r1_1_gPRT		Comparison report between F05593_P5 and LCFE_HUMANunique     	Sequence name: LCFE_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F05593_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17341 x LCFE_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MDALKPPCLWRNHERGKKDRDSCGRKNSEPGSPHSLEALRDAAPSQGLNFLLLFTK     	                                                            
						corresponding to amino acids 1 - 56 of F05593_P5, and a      	                     Quality: 6676.00                      Escore:       0                                               
						MLFIFNFLFSPLPTPALICILTFGAAIFLWLITRPQPVLPLLDLNNQSVGIEGGARKGVS 	             Matching length:     683                Total length:     683                                               
						QKNNDLTSCCFSDAKTMYEVFQRGLAVSDNGPCLGYRKPNQPYRWLSYKQVSDRAEYLGS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CLLHKGYKSSPDQFVGIFAQNRPEWIISELACYTYSMVAVPLYDTLGPEAIVHIVNKADI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AMVICDTPQKALVLIGNVEKGFTPSLKVIILMDPFDDDLKQRGEKSGIEILSLYDAENLG 	                        Gaps:       0                        
						KEHFRKPVPPSPEDLSVICFTSGTTGDPKGAMITHQNIVSNAAAFLKCVEHAYEPTPDDV 	                                                            
						AISYLPLAHMFERIVQAVVYSCGARVGFFQGDIRLLADDMKTLKPTLFPAVPRLLNRIYD 	Alignment:                                                   
						KVQNEAKTPLKKFLLKLAVSSKFKELQKGIIRHDSFWDKLIFAKIQDSLGGRVRVIVTGA 	                  .         .         .         .         .  
						APMSTSVMTFFRAAMGCQVYEAYGQTECTGGCTFTLPGDWTSGHVGVPLACNYVKLEDVA 	      57 MLFIFNFLFSPLPTPALICILTFGAAIFLWLITRPQPVLPLLDLNNQSVG 106                                                          
						DMNYFTVNNEGEVCIKGTNVFKGYLKDPEKTQEALDSDGWLHTGDIGRWLPNGTLKIIDR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKNIFKLAQGEYIAPEKIENIYNRSQPVLQIFVHGESLRSSLVGVVVPDTDVLPSFAAKL 	       1 MLFIFNFLFSPLPTPALICILTFGAAIFLWLITRPQPVLPLLDLNNQSVG 50                                                           
						GVKGSFEELCQNQVVREAILEDLQKIGKESGLKTFEQVKAIFLHPEPFSIENGLLTPTLK 	                  .         .         .         .         .  
						AKRGELSKYFRTQIDSLYEHIQD                                      	     107 IEGGARKGVSQKNNDLTSCCFSDAKTMYEVFQRGLAVSDNGPCLGYRKPN 156                                                          
						second amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1 - 683 of LCFE_HUMAN, which    	      51 IEGGARKGVSQKNNDLTSCCFSDAKTMYEVFQRGLAVSDNGPCLGYRKPN 100                                                          
						also corresponds to amino acids 57 - 739 of F05593_P5,       	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	     157 QPYRWLSYKQVSDRAEYLGSCLLHKGYKSSPDQFVGIFAQNRPEWIISEL 206                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F05593_P5,       	     101 QPYRWLSYKQVSDRAEYLGSCLLHKGYKSSPDQFVGIFAQNRPEWIISEL 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     207 ACYTYSMVAVPLYDTLGPEAIVHIVNKADIAMVICDTPQKALVLIGNVEK 256                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     151 ACYTYSMVAVPLYDTLGPEAIVHIVNKADIAMVICDTPQKALVLIGNVEK 200                                                          
						MDALKPPCLWRNHERGKKDRDSCGRKNSEPGSPHSLEALRDAAPSQGLNFLLLFTK of  	                  .         .         .         .         .  
						F05593_P5.                                                   	     257 GFTPSLKVIILMDPFDDDLKQRGEKSGIEILSLYDAENLGKEHFRKPVPP 306                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GFTPSLKVIILMDPFDDDLKQRGEKSGIEILSLYDAENLGKEHFRKPVPP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     307 SPEDLSVICFTSGTTGDPKGAMITHQNIVSNAAAFLKCVEHAYEPTPDDV 356                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SPEDLSVICFTSGTTGDPKGAMITHQNIVSNAAAFLKCVEHAYEPTPDDV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     357 AISYLPLAHMFERIVQAVVYSCGARVGFFQGDIRLLADDMKTLKPTLFPA 406                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AISYLPLAHMFERIVQAVVYSCGARVGFFQGDIRLLADDMKTLKPTLFPA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     407 VPRLLNRIYDKVQNEAKTPLKKFLLKLAVSSKFKELQKGIIRHDSFWDKL 456                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VPRLLNRIYDKVQNEAKTPLKKFLLKLAVSSKFKELQKGIIRHDSFWDKL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     457 IFAKIQDSLGGRVRVIVTGAAPMSTSVMTFFRAAMGCQVYEAYGQTECTG 506                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 IFAKIQDSLGGRVRVIVTGAAPMSTSVMTFFRAAMGCQVYEAYGQTECTG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     507 GCTFTLPGDWTSGHVGVPLACNYVKLEDVADMNYFTVNNEGEVCIKGTNV 556                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GCTFTLPGDWTSGHVGVPLACNYVKLEDVADMNYFTVNNEGEVCIKGTNV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     557 FKGYLKDPEKTQEALDSDGWLHTGDIGRWLPNGTLKIIDRKKNIFKLAQG 606                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 FKGYLKDPEKTQEALDSDGWLHTGDIGRWLPNGTLKIIDRKKNIFKLAQG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     607 EYIAPEKIENIYNRSQPVLQIFVHGESLRSSLVGVVVPDTDVLPSFAAKL 656                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EYIAPEKIENIYNRSQPVLQIFVHGESLRSSLVGVVVPDTDVLPSFAAKL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     657 GVKGSFEELCQNQVVREAILEDLQKIGKESGLKTFEQVKAIFLHPEPFSI 706                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GVKGSFEELCQNQVVREAILEDLQKIGKESGLKTFEQVKAIFLHPEPFSI 650                                                          
						                                                            	                  .         .         .                      
						                                                            	     707 ENGLLTPTLKAKRGELSKYFRTQIDSLYEHIQD                  739                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     651 ENGLLTPTLKAKRGELSKYFRTQIDSLYEHIQD                  683                                                          

17497	HMR136_F05684_0_tr0_r1_1_gPRT		Comparison report between F05684_P0 and Q8TCJ4unique head    	Sequence name: Q8TCJ4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05684_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17497 x Q8TCJ4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                     Quality:  767.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:      82                Total length:      82                                               
						to amino acids 1 - 176 of F05684_P0, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SGTATNRPGKNLKAFVPAKRPI                                       	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 82 of Q8TCJ4, which also corresponds to amino	Alignment:                                                   
						acids 177 - 258 of F05684_P0, and a third amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     177 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 226                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	       1 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 50                                                           
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                  .         .         .                      
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	     227 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   258                                                          
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	         ||||||||||||||||||||||||||||||||                    
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	      51 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   82                                                           
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTH 	                                                            
						TANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLL 	                                                            
						TRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQ 	                                                            
						EGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLK 	                                                            
						GPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGG 	                                                            
						SKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYP 	                                                            
						QIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSI 	                                                            
						EMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQQLNDDSVGLAELP 	                                                            
						SSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDD 	                                                            
						FSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPTLH 	                                                            
						MKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAPIAAKVGSVGHKM 	                                                            
						NLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK                        	                                                            
						at least 95% homologous to a polypeptide having the sequence 	                                                            
						corresponding to amino acids 259 - 1795 of F05684_P0, wherein	                                                            
						said first amino acid sequence, second amino acid sequence   	                                                            
						and third amino acid sequence are contiguous and in a        	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						head of F05684_P0, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F05684_P0.3.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P0, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	                                                            
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                                                            
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	                                                            
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	                                                            
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	                                                            
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTH 	                                                            
						TANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLL 	                                                            
						TRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQ 	                                                            
						EGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLK 	                                                            
						GPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGG 	                                                            
						SKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYP 	                                                            
						QIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSI 	                                                            
						EMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQQLNDDSVGLAELP 	                                                            
						SSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDD 	                                                            
						FSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPTLH 	                                                            
						MKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAPIAAKVGSVGHKM 	                                                            
						NLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK                        	                                                            
						least about 95% homologous to the sequence in F05684_P0.     	                                                            

						Comparison report between F05684_P0 and Q9Y4E9unique head    	Sequence name: Q9Y4E9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17497 x Q9Y4E9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                     Quality: 6242.00                      Escore:       0                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	             Matching length:     650                Total length:     650                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                        Gaps:       0                        
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	Alignment:                                                   
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                  .         .         .         .         .  
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	    1146 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 1195                                                         
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	       1 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 50                                                           
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                  .         .         .         .         .  
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	    1196 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 1245                                                         
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	      51 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 100                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	    1246 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 1295                                                         
						SDKLQ                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 1145 of 	     101 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 150                                                          
						F05684_P0, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLT 	    1296 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 1345                                                         
						DQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSAN 	     151 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 200                                                          
						LVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVT 	                  .         .         .         .         .  
						SLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 	    1346 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 1395                                                         
						TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQ 	     201 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 250                                                          
						QLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESD 	                  .         .         .         .         .  
						SISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLP 	    1396 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 1445                                                         
						AEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK           	     251 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 300                                                          
						% homologous to corresponding to amino acids 1 - 650 of      	                  .         .         .         .         .  
						Q9Y4E9, which also corresponds to amino acids 1146 - 1795 of 	    1446 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 1495                                                         
						F05684_P0, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 350                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F05684_P0, comprising a polypeptide being at least 70%,      	    1496 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 1545                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     351 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 400                                                          
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                  .         .         .         .         .  
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	    1546 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 1595                                                         
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	     401 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 450                                                          
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                  .         .         .         .         .  
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    1596 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 1645                                                         
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	     451 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 500                                                          
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	    1646 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 1695                                                         
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	     501 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 550                                                          
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	                  .         .         .         .         .  
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	    1696 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 1745                                                         
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	     551 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 600                                                          
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	                  .         .         .         .         .  
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	    1746 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 1795                                                         
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDKLQ                                                        	     601 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 650                                                          
						least about 95% homologous to the sequence of F05684_P0.     	                                                            

						Comparison report between F05684_P0 and Q9UG69unique head    	Sequence name: Q9UG69                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17497 x Q9UG69   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                     Quality: 2388.00                      Escore:       0                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	             Matching length:     249                Total length:     249                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                        Gaps:       0                        
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	Alignment:                                                   
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                  .         .         .         .         .  
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	    1547 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 1596                                                         
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	       1 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 50                                                           
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                  .         .         .         .         .  
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	    1597 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 1646                                                         
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	      51 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 100                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	    1647 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 1696                                                         
						SDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRK 	     101 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 150                                                          
						KKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTP 	                  .         .         .         .         .  
						HTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPR 	    1697 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 1746                                                         
						IVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKS 	     151 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 200                                                          
						KDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDE               	                  .         .         .         .            
						having the sequence corresponding to amino acids 1 - 1546 of 	    1747 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  1795                                                         
						F05684_P0, and a second amino acid sequence being at least 90	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQ 	     201 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  249                                                          
						VEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKD 	                                                            
						SLLSNKKAIDGGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKV 	                                                            
						ANPSSDADGQSLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNS 	                                                            
						GASPSSAGK                                                    	                                                            
						% homologous to corresponding to amino acids 1 - 249 of      	                                                            
						Q9UG69, which also corresponds to amino acids 1547 - 1795 of 	                                                            
						F05684_P0, wherein said first amino acid sequence and second 	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						F05684_P0, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                                                            
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	                                                            
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                                                            
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                                                            
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                                                            
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	                                                            
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	                                                            
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	                                                            
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                                                            
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	                                                            
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	                                                            
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	                                                            
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                                                            
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	                                                            
						SDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSE 	                                                            
						IQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRK 	                                                            
						KKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTP 	                                                            
						HTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPR 	                                                            
						IVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGR 	                                                            
						VTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKS 	                                                            
						KDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDE               	                                                            
						least about 95% homologous to the sequence of F05684_P0.     	                                                            

						Comparison report between F05684_P0 and Q9H8R3unique head    	Sequence name: Q9H8R3                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for F05684_P0,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17497 x Q9H8R3   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                     Quality: 6642.00                      Escore:       0                                               
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	             Matching length:     696                Total length:     697                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	    Total Percent Similarity:   99.71      Total Percent Identity:   99.71                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                        Gaps:       1                        
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	Alignment:                                                   
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPV                                          	     560 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 609                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 559 of F05684_P0, a second amino acid     	       1 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 50                                                           
						MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSS 	                  .         .         .         .         .  
						GASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQL 	     610 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 659                                                          
						PGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEY 	      51 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 100                                                          
						GARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 	                  .         .         .         .         .  
						FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGA 	     660 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 709                                                          
						SQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     101 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 150                                                          
						amino acids 1 - 400 of Q9H8R3, which also corresponds to     	                  .         .         .         .         .  
						amino acids 560 - 959 of F05684_P0, a third amino acid       	     710 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 759                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     151 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 200                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence I corresponding to amino acids 960 - 960 	     760 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 809                                                          
						of F05684_P0, a fourth amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	     201 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 250                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINV                                               	     810 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 859                                                          
						% homologous to corresponding to amino acids 401 - 534 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9H8R3, which also corresponds to amino acids 961 - 1094 of  	     251 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 300                                                          
						F05684_P0, a bridging amino acid A corresponding to amino    	                  .         .         .         .         .  
						acid 1095 of F05684_P0, a fifth amino acid sequence being at 	     860 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 909                                                          
						HLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQK 	     301 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 350                                                          
						NLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA                    	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 536 -  	     910 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 959                                                          
						696 of Q9H8R3, which also corresponds to amino acids 1096 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1256 of F05684_P0, and a sixth amino acid sequence being at  	     351 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 400                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     960 ITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 1009                                                         
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	     401 .TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 449                                                          
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                  .         .         .         .         .  
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	    1010 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 1059                                                         
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	     450 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 499                                                          
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                  .         .         .         .         .  
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	    1060 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQ 1109                                                         
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     500 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVTHLKTTAAHTQSFKQ 549                                                          
						to amino acids 1257 - 1795 of F05684_P0, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	    1110 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 1159                                                         
						acid sequence, fourth amino acid sequence, bridging amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid, fifth amino acid sequence and sixth amino acid sequence	     550 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 599                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of F05684_P0, comprising a   	    1160 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 1209                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     600 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 649                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	    1210 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    1256                                                         
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	         |||||||||||||||||||||||||||||||||||||||||||||||     
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	     650 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    696                                                          
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	                                                            
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                                                            
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                                                            
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPV                                          	                                                            
						to the sequence of F05684_P0.3.An isolated polypeptide       	                                                            
						encoding for an edge portion of F05684_P0, comprising an     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for I, corresponding to  	                                                            
						F05684_P0.4.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P0, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	                                                            
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	                                                            
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                                                            
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	                                                            
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	                                                            
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	                                                            
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                                                            
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	                                                            
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	                                                            
						least about 95% homologous to the sequence in F05684_P0.     	                                                            

17499	HMR136_F05684_1_tr0_r1_1_gPRT		Comparison report between F05684_P1 and Q8TCJ4unique head    	Sequence name: Q8TCJ4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05684_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17499 x Q8TCJ4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                     Quality:  767.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:      82                Total length:      82                                               
						to amino acids 1 - 176 of F05684_P1, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SGTATNRPGKNLKAFVPAKRPI                                       	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 82 of Q8TCJ4, which also corresponds to amino	Alignment:                                                   
						acids 177 - 258 of F05684_P1, and a third amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     177 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 226                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	       1 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 50                                                           
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                  .         .         .                      
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	     227 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   258                                                          
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	         ||||||||||||||||||||||||||||||||                    
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	      51 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   82                                                           
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTH 	                                                            
						TANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLL 	                                                            
						TRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQ 	                                                            
						EGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLK 	                                                            
						GPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGG 	                                                            
						SKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYP 	                                                            
						QIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSI 	                                                            
						EMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQQLNDDSVGLAELP 	                                                            
						SSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDD 	                                                            
						FSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPTLH 	                                                            
						MKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAPIAAKVGSVGHKM 	                                                            
						NLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK                        	                                                            
						at least 95% homologous to a polypeptide having the sequence 	                                                            
						corresponding to amino acids 259 - 1795 of F05684_P1, wherein	                                                            
						said first amino acid sequence, second amino acid sequence   	                                                            
						and third amino acid sequence are contiguous and in a        	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						head of F05684_P1, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F05684_P1.3.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P1, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	                                                            
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                                                            
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	                                                            
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	                                                            
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	                                                            
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTH 	                                                            
						TANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLL 	                                                            
						TRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQ 	                                                            
						EGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLK 	                                                            
						GPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGG 	                                                            
						SKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYP 	                                                            
						QIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSI 	                                                            
						EMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQQLNDDSVGLAELP 	                                                            
						SSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDD 	                                                            
						FSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPTLH 	                                                            
						MKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAPIAAKVGSVGHKM 	                                                            
						NLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK                        	                                                            
						least about 95% homologous to the sequence in F05684_P1.     	                                                            

						Comparison report between F05684_P1 and Q9Y4E9unique head    	Sequence name: Q9Y4E9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17499 x Q9Y4E9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                     Quality: 6242.00                      Escore:       0                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	             Matching length:     650                Total length:     650                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                        Gaps:       0                        
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	Alignment:                                                   
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                  .         .         .         .         .  
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	    1146 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 1195                                                         
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	       1 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 50                                                           
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                  .         .         .         .         .  
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	    1196 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 1245                                                         
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	      51 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 100                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	    1246 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 1295                                                         
						SDKLQ                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 1145 of 	     101 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 150                                                          
						F05684_P1, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLT 	    1296 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 1345                                                         
						DQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSAN 	     151 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 200                                                          
						LVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVT 	                  .         .         .         .         .  
						SLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 	    1346 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 1395                                                         
						TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQ 	     201 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 250                                                          
						QLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESD 	                  .         .         .         .         .  
						SISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLP 	    1396 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 1445                                                         
						AEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK           	     251 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 300                                                          
						% homologous to corresponding to amino acids 1 - 650 of      	                  .         .         .         .         .  
						Q9Y4E9, which also corresponds to amino acids 1146 - 1795 of 	    1446 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 1495                                                         
						F05684_P1, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 350                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F05684_P1, comprising a polypeptide being at least 70%,      	    1496 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 1545                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     351 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 400                                                          
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                  .         .         .         .         .  
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	    1546 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 1595                                                         
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	     401 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 450                                                          
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                  .         .         .         .         .  
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    1596 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 1645                                                         
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	     451 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 500                                                          
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	    1646 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 1695                                                         
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	     501 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 550                                                          
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	                  .         .         .         .         .  
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	    1696 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 1745                                                         
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	     551 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 600                                                          
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	                  .         .         .         .         .  
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	    1746 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 1795                                                         
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDKLQ                                                        	     601 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 650                                                          
						least about 95% homologous to the sequence of F05684_P1.     	                                                            

						Comparison report between F05684_P1 and Q9UG69unique head    	Sequence name: Q9UG69                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17499 x Q9UG69   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                     Quality: 2388.00                      Escore:       0                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	             Matching length:     249                Total length:     249                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                        Gaps:       0                        
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	Alignment:                                                   
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                  .         .         .         .         .  
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	    1547 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 1596                                                         
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	       1 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 50                                                           
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                  .         .         .         .         .  
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	    1597 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 1646                                                         
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	      51 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 100                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	    1647 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 1696                                                         
						SDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRK 	     101 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 150                                                          
						KKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTP 	                  .         .         .         .         .  
						HTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPR 	    1697 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 1746                                                         
						IVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKS 	     151 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 200                                                          
						KDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDE               	                  .         .         .         .            
						having the sequence corresponding to amino acids 1 - 1546 of 	    1747 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  1795                                                         
						F05684_P1, and a second amino acid sequence being at least 90	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQ 	     201 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  249                                                          
						VEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKD 	                                                            
						SLLSNKKAIDGGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKV 	                                                            
						ANPSSDADGQSLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNS 	                                                            
						GASPSSAGK                                                    	                                                            
						% homologous to corresponding to amino acids 1 - 249 of      	                                                            
						Q9UG69, which also corresponds to amino acids 1547 - 1795 of 	                                                            
						F05684_P1, wherein said first amino acid sequence and second 	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						F05684_P1, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                                                            
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	                                                            
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                                                            
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                                                            
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                                                            
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	                                                            
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	                                                            
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	                                                            
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                                                            
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	                                                            
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	                                                            
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	                                                            
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                                                            
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	                                                            
						SDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSE 	                                                            
						IQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRK 	                                                            
						KKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTP 	                                                            
						HTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPR 	                                                            
						IVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGR 	                                                            
						VTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKS 	                                                            
						KDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDE               	                                                            
						least about 95% homologous to the sequence of F05684_P1.     	                                                            

						Comparison report between F05684_P1 and Q9H8R3unique head    	Sequence name: Q9H8R3                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for F05684_P1,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17499 x Q9H8R3   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                     Quality: 6642.00                      Escore:       0                                               
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	             Matching length:     696                Total length:     697                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	    Total Percent Similarity:   99.71      Total Percent Identity:   99.71                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                        Gaps:       1                        
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	Alignment:                                                   
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPV                                          	     560 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 609                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 559 of F05684_P1, a second amino acid     	       1 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 50                                                           
						MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSS 	                  .         .         .         .         .  
						GASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQL 	     610 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 659                                                          
						PGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEY 	      51 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 100                                                          
						GARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 	                  .         .         .         .         .  
						FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGA 	     660 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 709                                                          
						SQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     101 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 150                                                          
						amino acids 1 - 400 of Q9H8R3, which also corresponds to     	                  .         .         .         .         .  
						amino acids 560 - 959 of F05684_P1, a third amino acid       	     710 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 759                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     151 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 200                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence I corresponding to amino acids 960 - 960 	     760 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 809                                                          
						of F05684_P1, a fourth amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	     201 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 250                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINV                                               	     810 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 859                                                          
						% homologous to corresponding to amino acids 401 - 534 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9H8R3, which also corresponds to amino acids 961 - 1094 of  	     251 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 300                                                          
						F05684_P1, a bridging amino acid A corresponding to amino    	                  .         .         .         .         .  
						acid 1095 of F05684_P1, a fifth amino acid sequence being at 	     860 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 909                                                          
						HLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQK 	     301 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 350                                                          
						NLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA                    	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 536 -  	     910 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 959                                                          
						696 of Q9H8R3, which also corresponds to amino acids 1096 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1256 of F05684_P1, and a sixth amino acid sequence being at  	     351 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 400                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     960 ITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 1009                                                         
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	     401 .TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 449                                                          
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                  .         .         .         .         .  
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	    1010 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 1059                                                         
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	     450 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 499                                                          
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                  .         .         .         .         .  
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	    1060 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQ 1109                                                         
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     500 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVTHLKTTAAHTQSFKQ 549                                                          
						to amino acids 1257 - 1795 of F05684_P1, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	    1110 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 1159                                                         
						acid sequence, fourth amino acid sequence, bridging amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid, fifth amino acid sequence and sixth amino acid sequence	     550 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 599                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of F05684_P1, comprising a   	    1160 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 1209                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     600 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 649                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	    1210 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    1256                                                         
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	         |||||||||||||||||||||||||||||||||||||||||||||||     
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	     650 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    696                                                          
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	                                                            
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                                                            
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                                                            
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPV                                          	                                                            
						to the sequence of F05684_P1.3.An isolated polypeptide       	                                                            
						encoding for an edge portion of F05684_P1, comprising an     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for I, corresponding to  	                                                            
						F05684_P1.4.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P1, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	                                                            
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	                                                            
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                                                            
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	                                                            
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	                                                            
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	                                                            
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                                                            
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	                                                            
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	                                                            
						least about 95% homologous to the sequence in F05684_P1.     	                                                            

17501	HMR136_F05684_2_tr0_r1_1_gPRT		Comparison report between F05684_P2 and Q8TCJ4unique head    	Sequence name: Q8TCJ4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05684_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17501 x Q8TCJ4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                     Quality:  767.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:      82                Total length:      82                                               
						to amino acids 1 - 176 of F05684_P2, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SGTATNRPGKNLKAFVPAKRPI                                       	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 82 of Q8TCJ4, which also corresponds to amino	Alignment:                                                   
						acids 177 - 258 of F05684_P2, and a third amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     177 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 226                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	       1 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 50                                                           
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                  .         .         .                      
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	     227 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   258                                                          
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	         ||||||||||||||||||||||||||||||||                    
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	      51 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   82                                                           
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTH 	                                                            
						TANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLL 	                                                            
						TRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQ 	                                                            
						EGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLK 	                                                            
						GPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGG 	                                                            
						SKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYP 	                                                            
						QIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSI 	                                                            
						EMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQQLNDDSVGLAELP 	                                                            
						SSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDD 	                                                            
						FSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPTLH 	                                                            
						MKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAPIAAKVGSVGHKM 	                                                            
						NLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK                        	                                                            
						at least 95% homologous to a polypeptide having the sequence 	                                                            
						corresponding to amino acids 259 - 1795 of F05684_P2, wherein	                                                            
						said first amino acid sequence, second amino acid sequence   	                                                            
						and third amino acid sequence are contiguous and in a        	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						head of F05684_P2, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F05684_P2.3.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P2, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	                                                            
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                                                            
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	                                                            
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	                                                            
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	                                                            
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTH 	                                                            
						TANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLL 	                                                            
						TRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQ 	                                                            
						EGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLK 	                                                            
						GPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGG 	                                                            
						SKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYP 	                                                            
						QIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSI 	                                                            
						EMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQQLNDDSVGLAELP 	                                                            
						SSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDD 	                                                            
						FSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPTLH 	                                                            
						MKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAPIAAKVGSVGHKM 	                                                            
						NLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK                        	                                                            
						least about 95% homologous to the sequence in F05684_P2.     	                                                            

						Comparison report between F05684_P2 and Q9Y4E9unique head    	Sequence name: Q9Y4E9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17501 x Q9Y4E9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                     Quality: 6242.00                      Escore:       0                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	             Matching length:     650                Total length:     650                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                        Gaps:       0                        
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	Alignment:                                                   
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                  .         .         .         .         .  
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	    1146 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 1195                                                         
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	       1 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 50                                                           
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                  .         .         .         .         .  
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	    1196 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 1245                                                         
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	      51 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 100                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	    1246 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 1295                                                         
						SDKLQ                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 1145 of 	     101 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 150                                                          
						F05684_P2, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLT 	    1296 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 1345                                                         
						DQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSAN 	     151 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 200                                                          
						LVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVT 	                  .         .         .         .         .  
						SLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 	    1346 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 1395                                                         
						TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQ 	     201 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 250                                                          
						QLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESD 	                  .         .         .         .         .  
						SISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLP 	    1396 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 1445                                                         
						AEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK           	     251 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 300                                                          
						% homologous to corresponding to amino acids 1 - 650 of      	                  .         .         .         .         .  
						Q9Y4E9, which also corresponds to amino acids 1146 - 1795 of 	    1446 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 1495                                                         
						F05684_P2, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 350                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F05684_P2, comprising a polypeptide being at least 70%,      	    1496 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 1545                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     351 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 400                                                          
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                  .         .         .         .         .  
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	    1546 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 1595                                                         
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	     401 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 450                                                          
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                  .         .         .         .         .  
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    1596 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 1645                                                         
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	     451 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 500                                                          
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	    1646 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 1695                                                         
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	     501 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 550                                                          
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	                  .         .         .         .         .  
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	    1696 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 1745                                                         
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	     551 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 600                                                          
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	                  .         .         .         .         .  
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	    1746 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 1795                                                         
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDKLQ                                                        	     601 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 650                                                          
						least about 95% homologous to the sequence of F05684_P2.     	                                                            

						Comparison report between F05684_P2 and Q9UG69unique head    	Sequence name: Q9UG69                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17501 x Q9UG69   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                     Quality: 2388.00                      Escore:       0                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	             Matching length:     249                Total length:     249                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                        Gaps:       0                        
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	Alignment:                                                   
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                  .         .         .         .         .  
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	    1547 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 1596                                                         
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	       1 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 50                                                           
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                  .         .         .         .         .  
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	    1597 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 1646                                                         
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	      51 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 100                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	    1647 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 1696                                                         
						SDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRK 	     101 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 150                                                          
						KKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTP 	                  .         .         .         .         .  
						HTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPR 	    1697 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 1746                                                         
						IVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKS 	     151 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 200                                                          
						KDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDE               	                  .         .         .         .            
						having the sequence corresponding to amino acids 1 - 1546 of 	    1747 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  1795                                                         
						F05684_P2, and a second amino acid sequence being at least 90	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQ 	     201 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  249                                                          
						VEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKD 	                                                            
						SLLSNKKAIDGGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKV 	                                                            
						ANPSSDADGQSLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNS 	                                                            
						GASPSSAGK                                                    	                                                            
						% homologous to corresponding to amino acids 1 - 249 of      	                                                            
						Q9UG69, which also corresponds to amino acids 1547 - 1795 of 	                                                            
						F05684_P2, wherein said first amino acid sequence and second 	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						F05684_P2, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                                                            
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	                                                            
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                                                            
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                                                            
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQA 	                                                            
						VGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQP 	                                                            
						VGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQET 	                                                            
						KKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEH 	                                                            
						SCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLG 	                                                            
						DVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKD 	                                                            
						RERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGI 	                                                            
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	                                                            
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                                                            
						DIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYW 	                                                            
						SDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSE 	                                                            
						IQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRK 	                                                            
						KKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTP 	                                                            
						HTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPR 	                                                            
						IVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGR 	                                                            
						VTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKS 	                                                            
						KDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDE               	                                                            
						least about 95% homologous to the sequence of F05684_P2.     	                                                            

						Comparison report between F05684_P2 and Q9H8R3unique head    	Sequence name: Q9H8R3                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for F05684_P2,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17501 x Q9H8R3   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                     Quality: 6642.00                      Escore:       0                                               
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	             Matching length:     696                Total length:     697                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	    Total Percent Similarity:   99.71      Total Percent Identity:   99.71                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                        Gaps:       1                        
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	Alignment:                                                   
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPV                                          	     560 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 609                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 559 of F05684_P2, a second amino acid     	       1 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 50                                                           
						MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSS 	                  .         .         .         .         .  
						GASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQL 	     610 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 659                                                          
						PGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEY 	      51 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 100                                                          
						GARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 	                  .         .         .         .         .  
						FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGA 	     660 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 709                                                          
						SQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     101 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 150                                                          
						amino acids 1 - 400 of Q9H8R3, which also corresponds to     	                  .         .         .         .         .  
						amino acids 560 - 959 of F05684_P2, a third amino acid       	     710 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 759                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     151 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 200                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence I corresponding to amino acids 960 - 960 	     760 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 809                                                          
						of F05684_P2, a fourth amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	     201 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 250                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINV                                               	     810 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 859                                                          
						% homologous to corresponding to amino acids 401 - 534 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9H8R3, which also corresponds to amino acids 961 - 1094 of  	     251 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 300                                                          
						F05684_P2, a bridging amino acid A corresponding to amino    	                  .         .         .         .         .  
						acid 1095 of F05684_P2, a fifth amino acid sequence being at 	     860 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 909                                                          
						HLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQK 	     301 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 350                                                          
						NLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA                    	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 536 -  	     910 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 959                                                          
						696 of Q9H8R3, which also corresponds to amino acids 1096 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1256 of F05684_P2, and a sixth amino acid sequence being at  	     351 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 400                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     960 ITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 1009                                                         
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	     401 .TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 449                                                          
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                  .         .         .         .         .  
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	    1010 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 1059                                                         
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	     450 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 499                                                          
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                  .         .         .         .         .  
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	    1060 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQ 1109                                                         
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     500 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVTHLKTTAAHTQSFKQ 549                                                          
						to amino acids 1257 - 1795 of F05684_P2, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	    1110 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 1159                                                         
						acid sequence, fourth amino acid sequence, bridging amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid, fifth amino acid sequence and sixth amino acid sequence	     550 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 599                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of F05684_P2, comprising a   	    1160 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 1209                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     600 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 649                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	    1210 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    1256                                                         
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	         |||||||||||||||||||||||||||||||||||||||||||||||     
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	     650 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    696                                                          
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	                                                            
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	                                                            
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                                                            
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPV                                          	                                                            
						to the sequence of F05684_P2.3.An isolated polypeptide       	                                                            
						encoding for an edge portion of F05684_P2, comprising an     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for I, corresponding to  	                                                            
						F05684_P2.4.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P2, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	                                                            
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	                                                            
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                                                            
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	                                                            
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	                                                            
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	                                                            
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                                                            
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	                                                            
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	                                                            
						least about 95% homologous to the sequence in F05684_P2.     	                                                            

17491	HMR136_F05684_3_tr0_r1_1_gPRT		Comparison report between F05684_P3 and Q9Y4E9unique head    	Sequence name: Q9Y4E9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17491 x Q9Y4E9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVASNAKVAASRKPRTLLPSTS 	                     Quality: 6242.00                      Escore:       0                                               
						NSKMASSSGTATNRPGKNLKAFVPAKRPIVVVTAAASSSMVTTPTSSLGSVPIILSGING 	             Matching length:     650                Total length:     650                                               
						SPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEP 	                        Gaps:       0                        
						QSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMK 	                                                            
						RESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 	Alignment:                                                   
						DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTI 	                  .         .         .         .         .  
						SEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVME 	     927 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 976                                                          
						QQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGH 	       1 KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILT 50                                                           
						FQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 	                  .         .         .         .         .  
						EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADE 	     977 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 1026                                                         
						KAAERSRKAPPIPLKLKPDYWSDKLQ                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 926 of  	      51 RAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLE 100                                                          
						F05684_P3, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						KEAEAFAYYRRTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLT 	    1027 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 1076                                                         
						DQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEAQKRKKKMGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSPLNTPHTSAN 	     101 YIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINN 150                                                          
						LVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVT 	                  .         .         .         .         .  
						SLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 	    1077 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 1126                                                         
						TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGERVKSKDSSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSLLNEIAFLNQ 	     151 RRGKPLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGP 200                                                          
						QLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKELPDVQGESD 	                  .         .         .         .         .  
						SISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLP 	    1127 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 1176                                                         
						AEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK           	     201 VVAVSPDLLESDLKPQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVD 250                                                          
						% homologous to corresponding to amino acids 1 - 650 of      	                  .         .         .         .         .  
						Q9Y4E9, which also corresponds to amino acids 927 - 1576 of  	    1177 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 1226                                                         
						F05684_P3, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     251 MGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGNRDGRVTLGP 300                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F05684_P3, comprising a polypeptide being at least 70%,      	    1227 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 1276                                                         
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     301 TQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRG 350                                                          
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                  .         .         .         .         .  
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	    1277 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 1326                                                         
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVASNAKVAASRKPRTLLPSTS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSKMASSSGTATNRPGKNLKAFVPAKRPIVVVTAAASSSMVTTPTSSLGSVPIILSGING 	     351 ERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMED 400                                                          
						SPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVL 	                  .         .         .         .         .  
						QPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPS 	    1327 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 1376                                                         
						ETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMK 	     401 EDDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFIS 450                                                          
						RESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 	                  .         .         .         .         .  
						DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTI 	    1377 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 1426                                                         
						SEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVME 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQ 	     451 KVPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQ 500                                                          
						ENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGH 	                  .         .         .         .         .  
						FQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 	    1427 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 1476                                                         
						EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KAAERSRKAPPIPLKLKPDYWSDKLQ                                   	     501 LAEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPP 550                                                          
						least about 95% homologous to the sequence of F05684_P3.     	                  .         .         .         .         .  
						                                                            	    1477 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 1526                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLA 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1527 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 1576                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK 650                                                          

						Comparison report between F05684_P3 and Q9UG69unique head    	Sequence name: Q9UG69                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17491 x Q9UG69   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVASNAKVAASRKPRTLLPSTS 	                     Quality: 2388.00                      Escore:       0                                               
						NSKMASSSGTATNRPGKNLKAFVPAKRPIVVVTAAASSSMVTTPTSSLGSVPIILSGING 	             Matching length:     249                Total length:     249                                               
						SPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEP 	                        Gaps:       0                        
						QSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMK 	                                                            
						RESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 	Alignment:                                                   
						DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTI 	                  .         .         .         .         .  
						SEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVME 	    1328 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 1377                                                         
						QQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGH 	       1 DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISK 50                                                           
						FQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 	                  .         .         .         .         .  
						EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADE 	    1378 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 1427                                                         
						KAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKIT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEV 	      51 VPPGSRATFQVEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQL 100                                                          
						VLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGK 	                  .         .         .         .         .  
						PLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLK 	    1428 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 1477                                                         
						PQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISG 	     101 AEPASEPDVLKIVIDSEIKDSLLSNKKAIDGGKNTSGLPAEPESVSSPPT 150                                                          
						DMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSEL 	                  .         .         .         .         .  
						LTNMEDE                                                      	    1478 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 1527                                                         
						having the sequence corresponding to amino acids 1 - 1327 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05684_P3, and a second amino acid sequence being at least 90	     151 LHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQSLKVMPCLAP 200                                                          
						DDTDETLTSLLNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQ 	                  .         .         .         .            
						VEHLGTGLKELPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKD 	    1528 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  1576                                                         
						SLLSNKKAIDGGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKV 	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						ANPSSDADGQSLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNS 	     201 IAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  249                                                          
						GASPSSAGK                                                    	                                                            
						% homologous to corresponding to amino acids 1 - 249 of      	                                                            
						Q9UG69, which also corresponds to amino acids 1328 - 1576 of 	                                                            
						F05684_P3, wherein said first amino acid sequence and second 	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						F05684_P3, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVASNAKVAASRKPRTLLPSTS 	                                                            
						NSKMASSSGTATNRPGKNLKAFVPAKRPIVVVTAAASSSMVTTPTSSLGSVPIILSGING 	                                                            
						SPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVL 	                                                            
						QPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQPVMFRNPGSVMGIRLPAPSKPS 	                                                            
						ETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSSGASFVSQAGTLTLRISPPEP 	                                                            
						QSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMK 	                                                            
						RESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 	                                                            
						DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKEKVAVLEVRTI 	                                                            
						SEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSEFPVTFKEESKFELSGSKVME 	                                                            
						QQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGASQECKKEADEQLIKETKTCQ 	                                                            
						ENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGH 	                                                            
						FQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 	                                                            
						EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQPSCTHISADE 	                                                            
						KAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHTANERRRRGEMRDLFEKLKIT 	                                                            
						LGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQKNLLTRKRNILIRKVSSLSGKTEEV 	                                                            
						VLKKLEYIYAKQQALEAQKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGK 	                                                            
						PLILSRKKDQATENTSPLNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLK 	                                                            
						PQVAGSAVALPENDDLFMMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVR 	                                                            
						NEDNSLEDKGRISSRGNRDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISG 	                                                            
						DMRGIQYKWKESESRGERVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSEL 	                                                            
						LTNMEDE                                                      	                                                            
						least about 95% homologous to the sequence of F05684_P3.     	                                                            

						Comparison report between F05684_P3 and Q9H8R3unique head    	Sequence name: Q9H8R3                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for F05684_P3,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17491 x Q9H8R3   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                     Quality: 6642.00                      Escore:       0                                               
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVASNAKVAASRKPRTLLPSTS 	             Matching length:     696                Total length:     697                                               
						NSKMASSSGTATNRPGKNLKAFVPAKRPIVVVTAAASSSMVTTPTSSLGSVPIILSGING 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						SPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVL 	    Total Percent Similarity:   99.71      Total Percent Identity:   99.71                                               
						QPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQPV                     	                        Gaps:       1                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 340 of F05684_P3, a second amino acid     	Alignment:                                                   
						MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSS 	                  .         .         .         .         .  
						GASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQL 	     341 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 390                                                          
						PGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEY 	       1 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 50                                                           
						GARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 	                  .         .         .         .         .  
						FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGA 	     391 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 440                                                          
						SQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 100                                                          
						amino acids 1 - 400 of Q9H8R3, which also corresponds to     	                  .         .         .         .         .  
						amino acids 341 - 740 of F05684_P3, a third amino acid       	     441 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 490                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence I corresponding to amino acids 741 - 741 	     491 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 540                                                          
						of F05684_P3, a fourth amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	     151 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 200                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINV                                               	     541 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 590                                                          
						% homologous to corresponding to amino acids 401 - 534 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9H8R3, which also corresponds to amino acids 742 - 875 of   	     201 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 250                                                          
						F05684_P3, a bridging amino acid A corresponding to amino    	                  .         .         .         .         .  
						acid 876 of F05684_P3, a fifth amino acid sequence being at  	     591 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 640                                                          
						HLKTTAAHTQSFKQPSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RTHTANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQADKLIGQK 	     251 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 300                                                          
						NLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA                    	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 536 -  	     641 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 690                                                          
						696 of Q9H8R3, which also corresponds to amino acids 877 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1037 of F05684_P3, and a sixth amino acid sequence being at  	     301 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 350                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     691 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 740                                                          
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	     351 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 400                                                          
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                  .         .         .         .         .  
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	     741 ITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 790                                                          
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	     401 .TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 449                                                          
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                  .         .         .         .         .  
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	     791 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 840                                                          
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     450 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 499                                                          
						to amino acids 1038 - 1576 of F05684_P3, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	     841 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQ 890                                                          
						acid sequence, fourth amino acid sequence, bridging amino    	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						acid, fifth amino acid sequence and sixth amino acid sequence	     500 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVTHLKTTAAHTQSFKQ 549                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of F05684_P3, comprising a   	     891 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 940                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     550 PSCTHISADEKAAERSRKAPPIPLKLKPDYWSDKLQKEAEAFAYYRRTHT 599                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	     941 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 990                                                          
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVASNAKVAASRKPRTLLPSTS 	     600 ANERRRRGEMRDLFEKLKITLGLLHSSKVSKSLILTRAFSEIQGLTDQAD 649                                                          
						NSKMASSSGTATNRPGKNLKAFVPAKRPIVVVTAAASSSMVTTPTSSLGSVPIILSGING 	                  .         .         .         .            
						SPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVL 	     991 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    1037                                                         
						QPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQPV                     	         |||||||||||||||||||||||||||||||||||||||||||||||     
						to the sequence of F05684_P3.3.An isolated polypeptide       	     650 KLIGQKNLLTRKRNILIRKVSSLSGKTEEVVLKKLEYIYAKQQALEA    696                                                          
						encoding for an edge portion of F05684_P3, comprising an     	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for I, corresponding to  	                                                            
						F05684_P3.4.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P3, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						QKRKKKMGSDEFDISPRISKQQEGSSASSVDLGQMFINNRRGKPLILSRKKDQATENTSP 	                                                            
						LNTPHTSANLVMTPQGQLLTLKGPLFSGPVVAVSPDLLESDLKPQVAGSAVALPENDDLF 	                                                            
						MMPRIVNVTSLATEGGLVDMGGSKYPHEVPDSKPSDHLKDTVRNEDNSLEDKGRISSRGN 	                                                            
						RDGRVTLGPTQVFLANKDSGYPQIVDVSNMQKAQEFLPKKISGDMRGIQYKWKESESRGE 	                                                            
						RVKSKDSSFHKLKMKDLKDSSIEMELRKVTSAIEEAALDSSELLTNMEDEDDTDETLTSL 	                                                            
						LNEIAFLNQQLNDDSVGLAELPSSMDTEFPGDARRAFISKVPPGSRATFQVEHLGTGLKE 	                                                            
						LPDVQGESDSISPLLLHLEDDDFSENEKQLAEPASEPDVLKIVIDSEIKDSLLSNKKAID 	                                                            
						GGKNTSGLPAEPESVSSPPTLHMKTGLENSNSTDTLWRPMPKLAPLGLKVANPSSDADGQ 	                                                            
						SLKVMPCLAPIAAKVGSVGHKMNLTGNDQEGRESKVMPTLAPVVAKLGNSGASPSSAGK  	                                                            
						least about 95% homologous to the sequence in F05684_P3.     	                                                            

17495	HMR136_F05684_4_tr0_r1_1_gPRT		Comparison report between F05684_P4 and Q8TCJ4unique head    	Sequence name: Q8TCJ4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05684_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17495 x Q8TCJ4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                     Quality:  767.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:      82                Total length:      82                                               
						to amino acids 1 - 176 of F05684_P4, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SGTATNRPGKNLKAFVPAKRPI                                       	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 82 of Q8TCJ4, which also corresponds to amino	Alignment:                                                   
						acids 177 - 258 of F05684_P4, and a third amino acid sequence	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     177 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 226                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	       1 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 50                                                           
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                  .         .         .                      
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	     227 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   258                                                          
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	         ||||||||||||||||||||||||||||||||                    
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	      51 STSNSKMASSSGTATNRPGKNLKAFVPAKRPI                   82                                                           
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPLSYFSLDCCFCSFVTRNKMRCSVQELWVTHLVPSSSSFFSD        	                                                            
						at least 95% homologous to a polypeptide having the sequence 	                                                            
						corresponding to amino acids 259 - 1151 of F05684_P4, wherein	                                                            
						said first amino acid sequence, second amino acid sequence   	                                                            
						and third amino acid sequence are contiguous and in a        	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						head of F05684_P4, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F05684_P4.3.An isolated polypeptide encoding for a tail of   	                                                            
						F05684_P4, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						AARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSIRPSPVMVVTPVVSSEPVQ 	                                                            
						VCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSSGATTTGVVEVSETNTSTS 	                                                            
						VTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPVASTASTSLVVVTAAASSS 	                                                            
						MVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQVSPNTVKRAGPRLLLIPVQ 	                                                            
						QGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQLLPLHQLRGSNTQPNLQP 	                                                            
						VMFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLS 	                                                            
						SGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQ 	                                                            
						LPGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVI 	                                                            
						KQNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEE 	                                                            
						YGARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSS 	                                                            
						EFPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVG 	                                                            
						ASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSGITEDARVLKTECDSWSRIS 	                                                            
						NPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGGRSSADFTVLDLEEDDEDD 	                                                            
						NEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLK 	                                                            
						TTAAHTQSFKQPLSYFSLDCCFCSFVTRNKMRCSVQELWVTHLVPSSSSFFSD        	                                                            
						least about 95% homologous to the sequence in F05684_P4.     	                                                            

						Comparison report between F05684_P4 and Q9H8R3unique head    	Sequence name: Q9H8R3                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for F05684_P4,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17495 x Q9H8R3   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	                                                            
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                     Quality: 5245.00                      Escore:       0                                               
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	             Matching length:     550                Total length:     551                                               
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	 Matching Percent Similarity:   99.82   Matching Percent Identity:   99.82                                               
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	    Total Percent Similarity:   99.64      Total Percent Identity:   99.64                                               
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	                        Gaps:       1                        
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	Alignment:                                                   
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                  .         .         .         .         .  
						LLPLHQLRGSNTQPNLQPV                                          	     560 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 609                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 559 of F05684_P4, a second amino acid     	       1 MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNV 50                                                           
						MFRNPGSVMGIRLPAPSKPSETPPSSTSSSAFSVMNPVIQAVGSSSAVNVITQAPSLLSS 	                  .         .         .         .         .  
						GASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQPVGTASLIPLQSGSFALLQL 	     610 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 659                                                          
						PGQKPVPSSILQHVASLQMKRESQNPDQKDETNSIKREQETKKVLQSEGEAVDPEANVIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNSGAATSEETLNDSLEDRGDHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEY 	      51 ITQAPSLLSSGASFVSQAGTLTLRISPPEPQSFASKTGSETKITYSSGGQ 100                                                          
						GARNRKSSKEKVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 	                  .         .         .         .         .  
						FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLKGPLTRKCVGA 	     660 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 709                                                          
						SQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     101 PVGTASLIPLQSGSFALLQLPGQKPVPSSILQHVASLQMKRESQNPDQKD 150                                                          
						amino acids 1 - 400 of Q9H8R3, which also corresponds to     	                  .         .         .         .         .  
						amino acids 560 - 959 of F05684_P4, a third amino acid       	     710 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 759                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     151 ETNSIKREQETKKVLQSEGEAVDPEANVIKQNSGAATSEETLNDSLEDRG 200                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence I corresponding to amino acids 960 - 960 	     760 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 809                                                          
						of F05684_P4, a fourth amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGEQIQPKQEKKGG 	     201 DHLDEECLPEEGCATVKPSEHSCITGSHTDQDYKDVNEEYGARNRKSSKE 250                                                          
						RSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSEEVDDVEKNNCVEYIEDDEEHV 	                  .         .         .         .         .  
						DIETVEELSEEINV                                               	     810 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 859                                                          
						% homologous to corresponding to amino acids 401 - 534 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9H8R3, which also corresponds to amino acids 961 - 1094 of  	     251 KVAVLEVRTISEKASNKTVQNLSKVQHQKLGDVKVEQQKGFDNPEENSSE 300                                                          
						F05684_P4, a bridging amino acid A corresponding to amino    	                  .         .         .         .         .  
						acid 1095 of F05684_P4, a fifth amino acid sequence being at 	     860 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 909                                                          
						least 90 % homologous to HLKTTAAHTQSFKQP corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 536 - 550 of Q9H8R3, which also corresponds to   	     301 FPVTFKEESKFELSGSKVMEQQSNLQPEAKEKECGDSLEKDRERWRKHLK 350                                                          
						amino acids 1096 - 1110 of F05684_P4, and a sixth amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     910 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 959                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     351 GPLTRKCVGASQECKKEADEQLIKETKTCQENSDVFQQEQGISDLLGKSG 400                                                          
						having the sequence LSYFSLDCCFCSFVTRNKMRCSVQELWVTHLVPSSSSFFSD	                  .         .         .         .         .  
						corresponding to amino acids 1111 - 1151 of F05684_P4,       	     960 ITEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 1009                                                         
						wherein said first amino acid sequence, second amino acid    	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, fourth amino acid       	     401 .TEDARVLKTECDSWSRISNPSAFSIVPRRAAKSSRGNGHFQGHLLLPGE 449                                                          
						sequence, bridging amino acid, fifth amino acid sequence and 	                  .         .         .         .         .  
						sixth amino acid sequence are contiguous and in a sequential 	    1010 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 1059                                                         
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05684_P4, comprising a polypeptide being at least 70%,      	     450 QIQPKQEKKGGRSSADFTVLDLEEDDEDDNEKTDDSIDEIVDVVSDYQSE 499                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	    1060 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVAHLKTTAAHTQSFKQ 1109                                                         
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	     500 EVDDVEKNNCVEYIEDDEEHVDIETVEELSEEINVTHLKTTAAHTQSFKQ 549                                                          
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMGALHP 	                                                             
						ANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASSSGTA 	    1110 P                                                  1110                                                         
						TNRPGKNLKAFVPAKRPIAARPSPGGVFTQFVMSKVGALQQKIPGVSTPQTLAGTQKFSI 	         |                                                   
						RPSPVMVVTPVVSSEPVQVCSPVTAAVTTTTPQVFLENTTAVTPMTAISDVETKETTYSS 	     550 P                                                  550                                                          
						GATTTGVVEVSETNTSTSVTSTQSTATVNLTKTTGITTPVASVAFPKSLVASPSTITLPV 	                                                            
						ASTASTSLVVVTAAASSSMVTTPTSSLGSVPIILSGINGSPPVSQRPENAAQIPVATPQV 	                                                            
						SPNTVKRAGPRLLLIPVQQGSPTLRPVSNTQLQGHRMVLQPVRSPSGMNLFRHPNGQIVQ 	                                                            
						LLPLHQLRGSNTQPNLQPV                                          	                                                            
						least about 95% homologous to the sequence of F05684_P4.3.An 	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						F05684_P4, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for I,	                                                            
						corresponding to F05684_P4.4.An isolated polypeptide encoding	                                                            
						for a tail of F05684_P4, comprising a polypeptide being at   	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						LSYFSLDCCFCSFVTRNKMRCSVQELWVTHLVPSSSSFFSD in F05684_P4.      	                                                            

17493	HMR136_F05684_5_tr0_r1_1_gPRT		Comparison report between F05684_P5 and Q8TCJ4unique head    	Sequence name: Q8TCJ4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05684_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17493 x Q8TCJ4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	Alignment segment 1/1:                                       
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	                                                            
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                     Quality: 1077.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 176 of  	             Matching length:     110                Total length:     110                                               
						F05684_P5, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLPSTSNSKMASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SGTATNRPGKNLKAFVPAKRPIGKLGCMYGLERPMTWWWDSGYRYGGCKN           	                        Gaps:       0                        
						% homologous to corresponding to amino acids 1 - 110 of      	                                                            
						Q8TCJ4, which also corresponds to amino acids 177 - 286 of   	Alignment:                                                   
						F05684_P5, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     177 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 226                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05684_P5, comprising a polypeptide being at least 70%,      	       1 ALHPANRLAAYITGRLRPSVLDLSTLSTVISKVASNAKVAASRKPRTLLP 50                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     227 STSNSKMASSSGTATNRPGKNLKAFVPAKRPIGKLGCMYGLERPMTWWWD 276                                                          
						STSYMHQRSPGGPTKLIEIISDCNWEEDRNKILSILSQHINSNMPQSLKVGSFIIELASQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKSRGEKNPPVYSSRVKISMPSCQDQDDMAEKSGSETPDGPLSPGKMEDISPVQTDALDS 	      51 STSNSKMASSSGTATNRPGKNLKAFVPAKRPIGKLGCMYGLERPMTWWWD 100                                                          
						VRERLHGGKGLPFYAGLSPAGKLVAYKRKPSSSTSGLIQVNGKSYPQAKLLLGQMG     	                  .                                          
						least about 95% homologous to the sequence of F05684_P5.     	     277 SGYRYGGCKN                                         286                                                          
						                                                            	         ||||||||||                                          
						                                                            	     101 SGYRYGGCKN                                         110                                                          

17781	HMR136_F05701_3_tr0_r1_1_gPRT		Comparison report between F05701_P3 and Q96AF7partial WT     	Sequence name: Q96AF7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05701_P3, comprising a first amino 	Sequence documentation:                                      
						MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAY 	                                                            
						GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 	Alignment of: 17781 x Q96AF7   ..                            
						FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 	                                                            
						ENILLDSNGHVVLTDFGLSKEFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWS 	Alignment segment 1/1:                                       
						LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 	                                                            
						RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYS 	                     Quality: 5334.00                      Escore:       0                                               
						PAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPFY 	             Matching length:     548                Total length:     548                                               
						QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VHRDLKPE                                                     	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 548 of Q96AF7, which also corresponds to  	Alignment:                                                   
						amino acids 1 - 548 of F05701_P3, and a second amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE 50                                                           
						YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 	                  .         .         .         .         .  
						NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCL 	      51 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 100                                                          
						QNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADSNNPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLFQFSDSVA                                                   	      51 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 100                                                          
						having the sequence corresponding to amino acids 549 - 738 of	                  .         .         .         .         .  
						F05701_P3, wherein said first amino acid sequence and second 	     101 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT 150                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     101 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT 150                                                          
						F05701_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     151 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 200                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 	     151 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 200                                                          
						NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCL 	                  .         .         .         .         .  
						QNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADSNNPE 	     201 EFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 250                                                          
						TLFQFSDSVA                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in F05701_P3.     	     201 EFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 500                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE   548                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     501 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE   548                                                          

						Comparison report between F05701_P3 and O75582partial WT     	Sequence name: O75582                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F05701_P3, comprising a first amino 	Sequence documentation:                                      
						MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAY 	                                                            
						GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 	Alignment of: 17781 x O75582   ..                            
						FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 	                                                            
						ENILLDSNGHVVLTDFGLSKEFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWS 	Alignment segment 1/1:                                       
						LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 	                                                            
						RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYS 	                     Quality: 7107.00                      Escore:       0                                               
						PAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPFY 	             Matching length:     738                Total length:     802                                               
						QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 	    Total Percent Similarity:   92.02      Total Percent Identity:   92.02                                               
						VHRDLKPE                                                     	                        Gaps:       1                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 548 of O75582, which also corresponds to  	Alignment:                                                   
						amino acids 1 - 548 of F05701_P3, and a second amino acid    	                  .         .         .         .         .  
						YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 	       1 MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE 50                                                           
						NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADSNNPE 	       1 MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE 50                                                           
						TLFQFSDSVA                                                   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      51 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 100                                                          
						amino acids 613 - 802 of O75582, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 549 - 738 of F05701_P3, wherein said first amino 	      51 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 100                                                          
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	     101 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT 150                                                          
						encoding for an edge portion of F05701_P3, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     101 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT 150                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     151 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 200                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     151 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 200                                                          
						length, wherein at least two amino acids comprise EY, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     201 EFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 250                                                          
						acid numbers 548-x to 549; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 549+ ((n-2) - x), in which x varies from 0 to n-2.   	     201 EFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE.. 548                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     501 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     548 .................................................. 548                                                          
						                                                            	                                                            
						                                                            	     551 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     549 ............YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 586                                                          
						                                                            	                     ||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     587 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMT 636                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMT 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     637 PDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTS 686                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 PDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     687 TSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDS 736                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDS 800                                                          
						                                                            	                                                             
						                                                            	     737 VA                                                 738                                                          
						                                                            	         ||                                                  
						                                                            	     801 VA                                                 802                                                          

						Comparison report between F05701_P3 and Q9UG98unique head    	Sequence name: Q9UG98                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05701_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17781 x Q9UG98   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAY 	Alignment segment 1/1:                                       
						GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 	                                                            
						FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 	                     Quality: 1360.00                      Escore:       0                                               
						ENILLDSNGHVVLTDFGLSKEFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWS 	             Matching length:     138                Total length:     138                                               
						LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPFY 	                        Gaps:       0                        
						QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPN 	                                                            
						IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 	Alignment:                                                   
						VHRDLKPEYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 600 of  	     601 QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 650                                                          
						F05701_P3, and a second amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNK 	       1 QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 50                                                           
						YKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSN 	                  .         .         .         .         .  
						PADSNNPETLFQFSDSVA                                           	     651 VKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSH 700                                                          
						% homologous to corresponding to amino acids 1 - 138 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9UG98, which also corresponds to amino acids 601 - 738 of   	      51 VKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSH 100                                                          
						F05701_P3, wherein said first amino acid sequence and second 	                  .         .         .                      
						amino acid sequence are contiguous and in a sequential       	     701 SSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA             738                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||              
						F05701_P3, comprising a polypeptide being at least 70%,      	     101 SSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA             138                                                          
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						MEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAY 	                                                            
						GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 	                                                            
						FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 	                                                            
						ENILLDSNGHVVLTDFGLSKEFVADETERAYSFCGTIEYMAPDIVRGGDSGHDKAVDWWS 	                                                            
						LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 	                                                            
						RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYS 	                                                            
						PAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPFY 	                                                            
						QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPN 	                                                            
						IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 	                                                            
						VHRDLKPEYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 	                                                            
						least about 95% homologous to the sequence of F05701_P3.     	                                                            

17783	HMR136_F05701_4_tr0_r1_1_gPRT		Comparison report between F05701_P4 and Q96AF7partial WT     	Sequence name: Q96AF7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05701_P4, comprising a first amino 	Sequence documentation:                                      
						MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 	                                                            
						QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 	Alignment of: 17783 x Q96AF7   ..                            
						RDELDVSNFAEEFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMG 	                                                            
						VERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK 	Alignment segment 1/1:                                       
						RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 	                                                            
						EASYIMRKLVSAVSHMHDVGVVHRDLKPE                                	                     Quality: 3248.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     329                Total length:     329                                               
						to amino acids 220 - 548 of Q96AF7, which also corresponds to	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 329 of F05701_P4, and a second amino acid    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL 	                  .         .         .         .         .  
						GVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLL 	       1 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 50                                                           
						TVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKRE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADS 	     220 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 269                                                          
						NNPETLFQFSDSVA                                               	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 330 - 583 of	      51 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 100                                                          
						F05701_P4, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     270 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 319                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F05701_P4, comprising a polypeptide being at least 70%,      	     101 KINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAALPQSSE 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     320 KINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAALPQSSE 369                                                          
						NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL 	                  .         .         .         .         .  
						GVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLL 	     151 KLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPF 200                                                          
						TVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKRE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSNPADS 	     370 KLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPF 419                                                          
						NNPETLFQFSDSVA                                               	                  .         .         .         .         .  
						least about 95% homologous to the sequence in F05701_P4.     	     201 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 519                                                          
						                                                            	                  .         .                                
						                                                            	     301 EASYIMRKLVSAVSHMHDVGVVHRDLKPE                      329                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     520 EASYIMRKLVSAVSHMHDVGVVHRDLKPE                      548                                                          

						Comparison report between F05701_P4 and O75582partial WT     	Sequence name: O75582                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F05701_P4, comprising a first amino acid        	                                                            
						MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 	Alignment of: 17783 x O75582   ..                            
						QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 	                                                            
						RDELDVSNFAEEFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMG 	Alignment segment 1/1:                                       
						VERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK 	                                                            
						RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 	                     Quality: 5759.00                      Escore:       0                                               
						EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 	             Matching length:     583                Total length:     583                                               
						KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSS 	                        Gaps:       0                        
						SESSHSSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA                  	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 220 - 802 of O75582, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1 - 583 of F05701_P4.                            	       1 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     220 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 269                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     270 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 319                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAALPQSSE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     320 KINWDDLAAKKVPAPFKPVIRDELDVSNFAEEFTEMDPTYSPAALPQSSE 369                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     370 KLFQGYSFVAPSILFKRNAAVIDPLQFHMGVERPGVTNVARSAMMKDSPF 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     520 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 619                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     620 VPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT 669                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATF 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     670 VDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATF 719                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 HAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSH 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     720 HAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSH 769                                                          
						                                                            	                  .         .         .                      
						                                                            	     551 SHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA                  583                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     770 SHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA                  802                                                          

						Comparison report between F05701_P4 and Q9UG98unique head    	Sequence name: Q9UG98                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F05701_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17783 x Q9UG98   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 	Alignment segment 1/1:                                       
						QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 	                                                            
						RDELDVSNFAEEFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMG 	                     Quality: 1360.00                      Escore:       0                                               
						VERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK 	             Matching length:     138                Total length:     138                                               
						RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 	                        Gaps:       0                        
						KIKKGDFSFEGEAWKNVSQEAKDLI                                    	                                                            
						having the sequence corresponding to amino acids 1 - 445 of  	Alignment:                                                   
						F05701_P4, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNK 	     446 QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 495                                                          
						YKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSHSSSSHSHGKTTPTKTLQPSN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PADSNNPETLFQFSDSVA                                           	       1 QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 50                                                           
						% homologous to corresponding to amino acids 1 - 138 of      	                  .         .         .         .         .  
						Q9UG98, which also corresponds to amino acids 446 - 583 of   	     496 VKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSH 545                                                          
						F05701_P4, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 VKATFHAFNKYKREGFCLQNVDKAPLAKRRKMKKTSTSTETRSSSSESSH 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .                      
						F05701_P4, comprising a polypeptide being at least 70%,      	     546 SSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA             583                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||              
						more preferably at least about 90% and most preferably at    	     101 SSSSHSHGKTTPTKTLQPSNPADSNNPETLFQFSDSVA             138                                                          
						MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 	                                                            
						QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 	                                                            
						RDELDVSNFAEEFTEMDPTYSPAALPQSSEKLFQGYSFVAPSILFKRNAAVIDPLQFHMG 	                                                            
						VERPGVTNVARSAMMKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK 	                                                            
						RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 	                                                            
						EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 	                                                            
						KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 	                                                            
						KIKKGDFSFEGEAWKNVSQEAKDLI                                    	                                                            
						least about 95% homologous to the sequence of F05701_P4.     	                                                            

17965	HMR136_F05715_15_tr0_r1_1_gPRT		Comparison report between F05715_P15 and DTNB_HUMANpartial   	Sequence name: DTNB_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F05715_P15, comprising a first amino	Sequence documentation:                                      
						MIEESGNKRKTMAEKRQLFIEMRAQNFDVIRLSTYRTACKLRFVQKRCNLHLVDIWNMIE 	                                                            
						AFRDNGLNTLDHTTEISVSRLETVISSIYYQLNKRLPSTHQISVEQSISLLLNFMIAAYD 	Alignment of: 17965 x DTNB_HUMAN   ..                        
						SEGRGKLTVFSVKAMLATMCGGKMLDKLRYVFSQMSDSNGLMIFSKFDQFLKEVLKLPTA 	                                                            
						VFEGPSFGYTEHSVRTCFPQQRKIMLNMFLDTMMADPPPQCLVWLPLMHRLAHVENVFHP 	Alignment segment 1/1:                                       
						VECSYCRCESMMGFRYRCQQCHNYQLCQNCFWRGHAGGPHSNQHQMKEHSSW         	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2973.00                      Escore:       0                                               
						to amino acids 1 - 292 of DTNB_HUMAN, which also corresponds 	             Matching length:     294                Total length:     294                                               
						to amino acids 1 - 292 of F05715_P15, and a second amino acid	 Matching Percent Similarity:   99.66   Matching Percent Identity:   99.66                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:   99.66      Total Percent Identity:   99.66                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence SSSPSD corresponding to amino acids 293 -	Alignment:                                                   
						298 of F05715_P15, wherein said first amino acid sequence and	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MIEESGNKRKTMAEKRQLFIEMRAQNFDVIRLSTYRTACKLRFVQKRCNL 50                                                           
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05715_P15, comprising a polypeptide being at least 70%,     	       1 MIEESGNKRKTMAEKRQLFIEMRAQNFDVIRLSTYRTACKLRFVQKRCNL 50                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	      51 HLVDIWNMIEAFRDNGLNTLDHTTEISVSRLETVISSIYYQLNKRLPSTH 100                                                          
						least about 95% homologous to the sequence SSSPSD in         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05715_P15.                                                  	      51 HLVDIWNMIEAFRDNGLNTLDHTTEISVSRLETVISSIYYQLNKRLPSTH 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QISVEQSISLLLNFMIAAYDSEGRGKLTVFSVKAMLATMCGGKMLDKLRY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QISVEQSISLLLNFMIAAYDSEGRGKLTVFSVKAMLATMCGGKMLDKLRY 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VFSQMSDSNGLMIFSKFDQFLKEVLKLPTAVFEGPSFGYTEHSVRTCFPQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VFSQMSDSNGLMIFSKFDQFLKEVLKLPTAVFEGPSFGYTEHSVRTCFPQ 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QRKIMLNMFLDTMMADPPPQCLVWLPLMHRLAHVENVFHPVECSYCRCES 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 QRKIMLNMFLDTMMADPPPQCLVWLPLMHRLAHVENVFHPVECSYCRCES 250                                                          
						                                                            	                  .         .         .         .            
						                                                            	     251 MMGFRYRCQQCHNYQLCQNCFWRGHAGGPHSNQHQMKEHSSWSS       294                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||| |        
						                                                            	     251 MMGFRYRCQQCHNYQLCQNCFWRGHAGGPHSNQHQMKEHSSWKS       294                                                          

17967	HMR136_F05715_18_tr0_r1_1_gPRT		Comparison report between F05715_P18 and DTNB_HUMANpartial   	Sequence name: DTNB_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a short 	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						F05715_P18, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to MIEESGNKRKTMAEKRQLFIEM corresponding	Alignment of: 17967 x DTNB_HUMAN   ..                        
						to amino acids 1 - 22 of DTNB_HUMAN, which also corresponds  	                                                            
						to amino acids 1 - 22 of F05715_P18, a second amino acid     	Alignment segment 1/1:                                       
						LHLVDIWNMIEAFRDNGLNTLDHTTEISVSRLETVISSIYYQLNKRLPSTHQISVEQSIS 	                                                            
						LLLNFMIAAYDSEGRGKLTVFSVKAMLATMCGGKMLDKLRYVFSQMSDSNGLMIFSKFDQ 	                     Quality: 5521.00                      Escore:       0                                               
						FLKEVLKLPTAVFEGPSFGYTEHSVRTCFPQQRKIMLNMFLDTMMADPPPQCLVWLPLMH 	             Matching length:     574                Total length:     608                                               
						RLAHVENVFHPVECSYCRCESMMGFRYRCQQCHNYQLCQNCFWRGHAGGPHSNQHQMKEH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SSWKSPAKKLSHAISKSLGCVPTREPPHPVFPEQPEKPLDLAHIVPPRPLTNMNDTMVSH 	    Total Percent Similarity:   94.41      Total Percent Identity:   94.41                                               
						MSSGVPTPTKRLQYSQDIPSHLADEHALIASYVARLQHCARVLDSPSRLDEEHRLIARYA 	                        Gaps:       2                        
						ARLAAEAGNVTRPPTDLSFNFDANKQQRQLIAELENKNREILQEIQRLRLEHEQASQPTP 	                                                            
						EKAQQNPTLLAELRLLRQRKDELEQRMSALQESRRELMVQLEELMKLLK            	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 50 - 518 of DTNB_HUMAN, which also corresponds to	       1 MIEESGNKRKTMAEKRQLFIEM...........................L 23                                                           
						amino acids 23 - 491 of F05715_P18, a third amino acid       	         ||||||||||||||||||||||                           |  
						AQATGSPHTSPTHGGGRPMPMPVRSTSAGSTPTHCPQDSLSGVGGDVQEAFAQGTRRNLR 	       1 MIEESGNKRKTMAEKRQLFIEMRAQNFDVIRLSTYRTACKLRFVQKRCNL 50                                                           
						NDLLVAADSITNTMSSLVKELHS                                      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      24 HLVDIWNMIEAFRDNGLNTLDHTTEISVSRLETVISSIYYQLNKRLPSTH 73                                                           
						amino acids 526 - 608 of DTNB_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 492 - 574 of F05715_P18, and a fourth amino   	      51 HLVDIWNMIEAFRDNGLNTLDHTTEISVSRLETVISSIYYQLNKRLPSTH 100                                                          
						acid sequence being at least 70%, optionally at least 80%,   	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      74 QISVEQSISLLLNFMIAAYDSEGRGKLTVFSVKAMLATMCGGKMLDKLRY 123                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence G corresponding to amino acids 575 - 575 	     101 QISVEQSISLLLNFMIAAYDSEGRGKLTVFSVKAMLATMCGGKMLDKLRY 150                                                          
						of F05715_P18, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     124 VFSQMSDSNGLMIFSKFDQFLKEVLKLPTAVFEGPSFGYTEHSVRTCFPQ 173                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated chimeric polypeptide encoding for an edge	     151 VFSQMSDSNGLMIFSKFDQFLKEVLKLPTAVFEGPSFGYTEHSVRTCFPQ 200                                                          
						portion of F05715_P18, comprising a polypeptide having a     	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     174 QRKIMLNMFLDTMMADPPPQCLVWLPLMHRLAHVENVFHPVECSYCRCES 223                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     201 QRKIMLNMFLDTMMADPPPQCLVWLPLMHRLAHVENVFHPVECSYCRCES 250                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     224 MMGFRYRCQQCHNYQLCQNCFWRGHAGGPHSNQHQMKEHSSWKSPAKKLS 273                                                          
						at least two amino acids comprise ML, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     251 MMGFRYRCQQCHNYQLCQNCFWRGHAGGPHSNQHQMKEHSSWKSPAKKLS 300                                                          
						22-x to 23; and ending at any of amino acid numbers 23+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     274 HAISKSLGCVPTREPPHPVFPEQPEKPLDLAHIVPPRPLTNMNDTMVSHM 323                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05715_P18, comprising a polypeptide having a length "n",    	     301 HAISKSLGCVPTREPPHPVFPEQPEKPLDLAHIVPPRPLTNMNDTMVSHM 350                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     324 SSGVPTPTKRLQYSQDIPSHLADEHALIASYVARLQHCARVLDSPSRLDE 373                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     351 SSGVPTPTKRLQYSQDIPSHLADEHALIASYVARLQHCARVLDSPSRLDE 400                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KA, having a structure as  	     374 EHRLIARYAARLAAEAGNVTRPPTDLSFNFDANKQQRQLIAELENKNREI 423                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						491-x to 492; and ending at any of amino acid numbers 492+   	     401 EHRLIARYAARLAAEAGNVTRPPTDLSFNFDANKQQRQLIAELENKNREI 450                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     424 LQEIQRLRLEHEQASQPTPEKAQQNPTLLAELRLLRQRKDELEQRMSALQ 473                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LQEIQRLRLEHEQASQPTPEKAQQNPTLLAELRLLRQRKDELEQRMSALQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     474 ESRRELMVQLEELMKLLK.......AQATGSPHTSPTHGGGRPMPMPVRS 516                                                          
						                                                            	         ||||||||||||||||||       |||||||||||||||||||||||||  
						                                                            	     501 ESRRELMVQLEELMKLLKEEEQKQAAQATGSPHTSPTHGGGRPMPMPVRS 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     517 TSAGSTPTHCPQDSLSGVGGDVQEAFAQGTRRNLRNDLLVAADSITNTMS 566                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TSAGSTPTHCPQDSLSGVGGDVQEAFAQGTRRNLRNDLLVAADSITNTMS 600                                                          
						                                                            	                                                             
						                                                            	     567 SLVKELHS                                           574                                                          
						                                                            	         ||||||||                                            
						                                                            	     601 SLVKELHS                                           608                                                          

530	HMR136_F05816_16_tr0_r1_1_gPRT		Comparison report between F05816_P16 and MEI2_HUMANpartial   	Sequence name: MEI2_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05816_P16, comprising a first amino acid sequence being at  	                                                            
						MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSSKSDHEELSGS 	Alignment of: 530 x MEI2_HUMAN   ..                          
						STNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGDNSSEQGDGLDNSVASPGTGD 	                                                            
						DDDPDKDKKRQKKRGIFPKVATNIMRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNW 	Alignment segment 1/1:                                       
						FINARRRIVQPMIDQSNRA                                          	                                                            
						least 90 % homologous to corresponding to amino acids 147 -  	                     Quality: 2187.00                      Escore:       0                                               
						345 of MEI2_HUMAN, which also corresponds to amino acids 1 - 	             Matching length:     230                Total length:     237                                               
						199 of F05816_P16, a second amino acid sequence being at     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to VSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG     	    Total Percent Similarity:   97.05      Total Percent Identity:   97.05                                               
						corresponding to amino acids 353 - 383 of MEI2_HUMAN, which  	                        Gaps:       1                        
						also corresponds to amino acids 200 - 230 of F05816_P16, and 	                                                            
						a third amino acid sequence being at least 70%, optionally at	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSS 50                                                           
						polypeptide having the sequence PMSGMGMNMGMDGQWHYM           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 231 - 248 of F05816_P16, wherein	     147 MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSS 196                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      51 KSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGD 100                                                          
						sequential order.2.An isolated chimeric polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of F05816_P16, comprising a polypeptide  	     197 KSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGD 246                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     101 NSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLF 150                                                          
						length, preferably at least about 30 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 40 amino acids in length and  	     247 NSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLF 296                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise AV, having a       	     151 QHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRA. 199                                                          
						structure as follows: a sequence starting from any of amino  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						acid numbers 199-x to 200; and ending at any of amino acid   	     297 QHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAG 346                                                          
						numbers 200+ ((n-2) - x), in which x varies from 0 to        	                  .         .         .                      
						n-2.3.An isolated polypeptide encoding for a tail of         	     200 ......VSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG              230                                                          
						F05816_P16, comprising a polypeptide being at least 70%,     	               |||||||||||||||||||||||||||||||               
						optionally at least about 80%, preferably at least about 85%,	     347 FLLDPSVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG              383                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence PMSGMGMNMGMDGQWHYM	                                                            
						in F05816_P16.                                               	                                                            

						Comparison report between F05816_P16 and AAH50431partial WT  	Sequence name: AAH50431                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05816_P16, comprising a first amino	Sequence documentation:                                      
						MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSSKSDHEELSGS 	                                                            
						STNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGDNSSEQGDGLDNSVASPGTGD 	Alignment of: 530 x AAH50431   ..                            
						DDDPDKDKKRQKKRGIFPKVATNIMRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNW 	                                                            
						FINARRRIVQPMIDQSNRAVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG           	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 147 - 376 of AAH50431, which also corresponds 	                     Quality: 2287.00                      Escore:       0                                               
						to amino acids 1 - 230 of F05816_P16, and a second amino acid	             Matching length:     230                Total length:     230                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence PMSGMGMNMGMDGQWHYM corresponding to amino	                                                            
						acids 231 - 248 of F05816_P16, wherein said first amino acid 	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSS 50                                                           
						tail of F05816_P16, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     147 MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSS 196                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	      51 KSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGD 100                                                          
						PMSGMGMNMGMDGQWHYM in F05816_P16.                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     197 KSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGD 246                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     247 NSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLF 296                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     297 QHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAV 346                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 SQGAAYSPEGQPMGSFVLDGQQHMGIRPAG                     230                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     347 SQGAAYSPEGQPMGSFVLDGQQHMGIRPAG                     376                                                          

						Comparison report between F05816_P16 and Q96DI2partial WT    	Sequence name: Q96DI2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F05816_P16, comprising a first amino acid       	                                                            
						MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSSKSDHEELSGS 	Alignment of: 530 x Q96DI2   ..                              
						STNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGDNSSEQGDGLDNSVASPGTGD 	                                                            
						DDDPDKDKKRQKKRGIFPKVATNIMRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNW 	Alignment segment 1/1:                                       
						FINARRRIVQPMIDQSNRAVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAGPMSGMGMNMG 	                                                            
						MDGQWHYM                                                     	                     Quality: 2490.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     248                Total length:     248                                               
						amino acids 134 - 381 of Q96DI2, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 248 of F05816_P16.                           	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     134 MIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSS 183                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 KSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGD 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 NSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLF 283                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     284 QHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAV 333                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 SQGAAYSPEGQPMGSFVLDGQQHMGIRPAGPMSGMGMNMGMDGQWHYM   248                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     334 SQGAAYSPEGQPMGSFVLDGQQHMGIRPAGPMSGMGMNMGMDGQWHYM   381                                                          

532	HMR136_F05816_24_tr0_r1_1_gPRT		Comparison report between F05816_P24 and MEI2_HUMANpartial   	Sequence name: MEI2_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05816_P24, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to                                     	Alignment of: 532 x MEI2_HUMAN   ..                          
						MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRA      	                                                            
						corresponding to amino acids 291 - 345 of MEI2_HUMAN, which  	Alignment segment 1/1:                                       
						also corresponds to amino acids 1 - 55 of F05816_P24, a      	                                                            
						second amino acid sequence being at least 90 % homologous to 	                     Quality:  766.00                      Escore:       0                                               
						VSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG corresponding to amino acids 	             Matching length:      86                Total length:      93                                               
						353 - 383 of MEI2_HUMAN, which also corresponds to amino     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acids 56 - 86 of F05816_P24, and a third amino acid sequence 	    Total Percent Similarity:   92.47      Total Percent Identity:   92.47                                               
						being at least 70%, optionally at least 80%, preferably at   	                        Gaps:       1                        
						least 85%, more preferably at least 90% and most preferably  	                                                            
						at least 95% homologous to a polypeptide having the sequence 	Alignment:                                                   
						PMSGMGMNMGMDGQWHYM corresponding to amino acids 87 - 104 of  	                  .         .         .         .         .  
						F05816_P24, wherein said first amino acid sequence, second   	       1 MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMID 50                                                           
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     291 MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMID 340                                                          
						polypeptide encoding for an edge portion of F05816_P24,      	                  .         .         .         .            
						comprising a polypeptide having a length "n", wherein n is at	      51 QSNRA.......VSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG        86                                                           
						least about 10 amino acids in length, optionally at least    	         |||||       |||||||||||||||||||||||||||||||         
						about 20 amino acids in length, preferably at least about 30 	     341 QSNRAGFLLDPSVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG        383                                                          
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise AV, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 55-x to 56; and      	                                                            
						ending at any of amino acid numbers 56+ ((n-2) - x), in which	                                                            
						x varies from 0 to n-2.3.An isolated polypeptide encoding for	                                                            
						a tail of F05816_P24, comprising a polypeptide being at least	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						PMSGMGMNMGMDGQWHYM in F05816_P24.                            	                                                            

						Comparison report between F05816_P24 and AAH50431partial WT  	Sequence name: AAH50431                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05816_P24, comprising a first amino	Sequence documentation:                                      
						MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAVSQGA 	                                                            
						AYSPEGQPMGSFVLDGQQHMGIRPAG                                   	Alignment of: 532 x AAH50431   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 291 - 376 of AAH50431, which also corresponds 	Alignment segment 1/1:                                       
						to amino acids 1 - 86 of F05816_P24, and a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  866.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      86                Total length:      86                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence PMSGMGMNMGMDGQWHYM corresponding to amino	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 87 - 104 of F05816_P24, wherein said first amino acid  	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of F05816_P24, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMID 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     291 MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMID 340                                                          
						PMSGMGMNMGMDGQWHYM in F05816_P24.                            	                  .         .         .                      
						                                                            	      51 QSNRAVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG               86                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     341 QSNRAVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAG               376                                                          

						Comparison report between F05816_P24 and Q96DI2partial WT    	Sequence name: Q96DI2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F05816_P24, comprising a first amino acid       	                                                            
						MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAVSQGA 	Alignment of: 532 x Q96DI2   ..                              
						AYSPEGQPMGSFVLDGQQHMGIRPAGPMSGMGMNMGMDGQWHYM                 	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 278 - 381 of Q96DI2, which also corresponds to   	                                                            
						amino acids 1 - 104 of F05816_P24.                           	                     Quality: 1069.00                      Escore:       0                                               
						                                                            	             Matching length:     104                Total length:     104                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMID 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 MRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMID 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QSNRAVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAGPMSGMGMNMGMDGQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 QSNRAVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAGPMSGMGMNMGMDGQ 377                                                          
						                                                            	                                                             
						                                                            	     101 WHYM                                               104                                                          
						                                                            	         ||||                                                
						                                                            	     378 WHYM                                               381                                                          

606	HMR136_F05869_16_tr0_r1_1_gPRT		Comparison report between F05869_P16 and Q9NR85partial WT    	Sequence name: Q9NR85                                        
						sequence followed by short unique deletion and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F05869_P16, comprising a first amino acid sequence being at  	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	Alignment of: 606 x Q9NR85   ..                              
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	                                                            
						LPGMNRPIQVKPADSESRG                                          	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 139	                                                            
						of Q9NR85, which also corresponds to amino acids 1 - 139 of  	                     Quality: 2778.00                      Escore:       0                                               
						F05869_P16, a second amino acid sequence being at least 90 % 	             Matching length:     293                Total length:     294                                               
						DRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGAYGAYAQALMQ 	    Total Percent Similarity:   99.66      Total Percent Identity:   99.66                                               
						QQAALMASVAQGGYLNPMAAFAAAQMQQMAALNM                           	                        Gaps:       1                        
						homologous to corresponding to amino acids 141 - 294 of      	                                                            
						Q9NR85, which also corresponds to amino acids 140 - 293 of   	Alignment:                                                   
						F05869_P16, and a third amino acid sequence being at least   	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NGLAAAPMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHP 	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						YPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQISQAFPQPPPMIPQQQREGPEGCNLF 	                  .         .         .         .         .  
						IYHLPQEFGDAELMQMFLPFGRHPVPARCQAPSCQGG                        	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 294 - 450 of F05869_P16, wherein said first   	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     101 TYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRG.DRKLFVGMLN 149                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||| ||||||||||  
						portion of F05869_P16, comprising a polypeptide having a     	     101 TYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRGEDRKLFVGMLN 150                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     150 KQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 199                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     151 KQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 200                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise GD, having a structure as  	     200 ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGA 249                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						140-x to 140; and ending at any of amino acid numbers 140+   	     201 ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGA 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .            
						polypeptide encoding for a tail of F05869_P16, comprising a  	     250 YGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMAALNM       293                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||        
						80%, preferably at least about 85%, more preferably at least 	     251 YGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMAALNM       294                                                          
						about 90% and most preferably at least about 95% homologous  	                                                            
						NGLAAAPMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHP 	                                                            
						YPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQISQAFPQPPPMIPQQQREGPEGCNLF 	                                                            
						IYHLPQEFGDAELMQMFLPFGRHPVPARCQAPSCQGG                        	                                                            
						to the sequence in F05869_P16.                               	                                                            

						Comparison report between F05869_P16 and Q9BQ96unique head   	Sequence name: Q9BQ96                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids, a mismatch, with a short unique insertion 	Sequence documentation:                                      
						and a followed by a unique tail.1.An isolated chimeric       	                                                            
						polypeptide encoding for F05869_P16, comprising a first amino	Alignment of: 606 x Q9BQ96   ..                              
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment segment 1/1:                                       
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	                     Quality: 3594.00                      Escore:       0                                               
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIP corresponding	             Matching length:     386                Total length:     397                                               
						to amino acids 1 - 47 of F05869_P16, a second amino acid     	 Matching Percent Similarity:   99.48   Matching Percent Identity:   99.48                                               
						MKDHDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERES 	    Total Percent Similarity:   96.73      Total Percent Identity:   96.73                                               
						ALKAQSALHEQKTLPGMNRPIQVKPADSESRG                             	                        Gaps:       2                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 92 of Q9BQ96, which also corresponds to amino	Alignment:                                                   
						acids 48 - 139 of F05869_P16, a third amino acid sequence    	                  .         .         .         .         .  
						bridging amino acid sequence comprising of D, a fourth amino 	      48 MKDHDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGC 97                                                           
						RKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAINA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGAYGAYAQALMQQ 	       1 MKDHDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGC 50                                                           
						QAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAAPMTPTSGGSTPPGITAPAVPS 	                  .         .         .         .         .  
						IPSPIGVNGFTGLPPQANGQPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYA     	      98 AFLTYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRG........ 139                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||          
						to amino acids 104 - 339 of Q9BQ96, which also corresponds to	      51 AFLTYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRGGSSCLRQP 100                                                          
						amino acids 141 - 376 of F05869_P16, a bridging amino acid G 	                  .         .         .         .         .  
						corresponding to amino acid 377 of F05869_P16, a fifth amino 	     140 ..DRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVK 187                                                          
						acid sequence being at least 70%, optionally at least 80%,   	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 PSHRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence P corresponding to amino acids 378 - 378 	     188 YSSHAEAQAAINALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQM 237                                                          
						of F05869_P16, a sixth amino acid sequence being at least 90 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to                                              	     151 YSSHAEAQAAINALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQM 200                                                          
						AAYPAAYGQISQAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLPFG     	                  .         .         .         .         .  
						corresponding to amino acids 341 - 396 of Q9BQ96, which also 	     238 GMFNPMAIPFGAYGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQ 287                                                          
						corresponds to amino acids 379 - 434 of F05869_P16, and a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						seventh amino acid sequence being at least 70%, optionally at	     201 GMFNPMAIPFGAYGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQ 250                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     288 MAALNMNGLAAAPMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQA 337                                                          
						polypeptide having the sequence RHPVPARCQAPSCQGG             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 435 - 450 of F05869_P16, wherein	     251 MAALNMNGLAAAPMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQA 300                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						third amino acid sequence, fourth amino acid sequence,       	     338 NGQPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQ 387                                                          
						bridging amino acid, fifth amino acid sequence, sixth amino  	         |||||||||||||||||||||||||||||||||||||||  |||||||||  
						acid sequence and seventh amino acid sequence are contiguous 	     301 NGQPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYAA.AAYPAAYGQ 349                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .            
						for a head of F05869_P16, comprising a polypeptide being at  	     388 ISQAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLPFG    434                                                          
						least 70%, optionally at least about 80%, preferably at least	         |||||||||||||||||||||||||||||||||||||||||||||||     
						about 85%, more preferably at least about 90% and most       	     350 ISQAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLPFG    396                                                          
						preferably at least about 95% homologous to the sequence     	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIP of           	                                                            
						F05869_P16.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of F05869_P16, comprising a polypeptide having a     	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise GDR having a structure as  	                                                            
						follows (numbering according to F05869_P16): a sequence      	                                                            
						starting from any of amino acid numbers 139-x to 139; and    	                                                            
						ending at any of amino acid numbers 141 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for an edge portion of F05869_P16, comprising an    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for P, corresponding to  	                                                            
						F05869_P16.5.An isolated polypeptide encoding for a tail of  	                                                            
						F05869_P16, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence RHPVPARCQAPSCQGG  	                                                            
						in F05869_P16.                                               	                                                            

						Comparison report between F05869_P16 and Q9NR84unique head   	Sequence name: Q9NR84                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05869_P16, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 606 x Q9NR84   ..                              
						more preferably at least 90% and most preferably at least 95%	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	Alignment segment 1/1:                                       
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	                                                            
						LPGMNRPIQVKPADSESRGDRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNS 	                     Quality: 1225.00                      Escore:       0                                               
						KGCAFVKYSSHAEAQAAINALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMF 	             Matching length:     122                Total length:     122                                               
						NPMAIPFGAYGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAAP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MTPTSGGSTPPG                                                 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 312 of F05869_P16, a second amino acid    	                                                            
						ITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHPYPAQSPTAADPLQQAYAGV 	Alignment:                                                   
						QQYAGPAAYPAAYGQISQAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLP 	                  .         .         .         .         .  
						FG                                                           	     313 ITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHPYPAQSPTAA 362                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 122 of Q9NR84, which also corresponds to     	       1 ITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHPYPAQSPTAA 50                                                           
						amino acids 313 - 434 of F05869_P16, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     363 DPLQQAYAGVQQYAGPAAYPAAYGQISQAFPQPPPMIPQQQREGPEGCNL 412                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 DPLQQAYAGVQQYAGPAAYPAAYGQISQAFPQPPPMIPQQQREGPEGCNL 100                                                          
						having the sequence RHPVPARCQAPSCQGG corresponding to amino  	                  .         .                                
						acids 435 - 450 of F05869_P16, wherein said first amino acid 	     413 FIYHLPQEFGDAELMQMFLPFG                             434                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||                              
						sequence are contiguous and in a sequential order.2.An       	     101 FIYHLPQEFGDAELMQMFLPFG                             122                                                          
						isolated polypeptide encoding for a head of F05869_P16,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	                                                            
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	                                                            
						LPGMNRPIQVKPADSESRGDRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNS 	                                                            
						KGCAFVKYSSHAEAQAAINALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMF 	                                                            
						NPMAIPFGAYGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAAP 	                                                            
						MTPTSGGSTPPG                                                 	                                                            
						about 95% homologous to the sequence of F05869_P16.3.An      	                                                            
						isolated polypeptide encoding for a tail of F05869_P16,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence RHPVPARCQAPSCQGG in     	                                                            
						F05869_P16.                                                  	                                                            

						Comparison report between F05869_P16 and AAH45711partial WT  	Sequence name: AAH45711                                      
						sequence followed by short unique deletion and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F05869_P16, comprising a first amino acid sequence being at  	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	Alignment of: 606 x AAH45711   ..                            
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	                                                            
						LPGMNRPIQVKPADSESRG                                          	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 139	                                                            
						of AAH45711, which also corresponds to amino acids 1 - 139 of	                     Quality: 3896.00                      Escore:       0                                               
						F05869_P16, a second amino acid sequence being at least 90 % 	             Matching length:     406                Total length:     407                                               
						DRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGAYGAYAQALMQ 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						QQAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAAPMTPTSGGSTPPGITAPAVP 	                        Gaps:       1                        
						SIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYAGPA 	                                                            
						AYPAAYGQISQAFPQPPPMIPQQQREG                                  	Alignment:                                                   
						homologous to corresponding to amino acids 141 - 407 of      	                  .         .         .         .         .  
						AAH45711, which also corresponds to amino acids 140 - 406 of 	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						F05869_P16, and a third amino acid sequence being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						PEGCNLFIYHLPQEFGDAELMQMFLPFGRHPVPARCQAPSCQGG corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 407 - 450 of F05869_P16, wherein said first amino	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     101 TYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRG.DRKLFVGMLN 149                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||| ||||||||||  
						F05869_P16, comprising a polypeptide having a length "n",    	     101 TYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRGEDRKLFVGMLN 150                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     150 KQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 199                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     151 KQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 200                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise GD, having a structure as  	     200 ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGA 249                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						140-x to 140; and ending at any of amino acid numbers 140+   	     201 ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGA 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of F05869_P16, comprising a  	     250 YGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAA 299                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     251 YGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAA 300                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence PEGCNLFIYHLPQEFGDAELMQMFLPFGRHPVPARCQAPSCQGG 	     300 PMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFAN 349                                                          
						in F05869_P16.                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQANGQPAAEAVFAN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     350 GIHPYPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQISQAFPQPPPMI 399                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 GIHPYPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQISQAFPQPPPMI 400                                                          
						                                                            	                                                             
						                                                            	     400 PQQQREG                                            406                                                          
						                                                            	         |||||||                                             
						                                                            	     401 PQQQREG                                            407                                                          

						Comparison report between F05869_P16 and Q9BZC1partial WT    	Sequence name: Q9BZC1                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05869_P16, comprising a first amino acid sequence being at  	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	Alignment of: 606 x Q9BZC1   ..                              
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	                                                            
						LPGMNRPIQVKPADSESRG                                          	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 139	                                                            
						of Q9BZC1, which also corresponds to amino acids 1 - 139 of  	                     Quality: 4187.00                      Escore:       0                                               
						F05869_P16, a second amino acid sequence being at least 90 % 	             Matching length:     434                Total length:     445                                               
						DRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYSSHAEAQAAIN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGMFNPMAIPFGAYGAYAQALMQ 	    Total Percent Similarity:   97.53      Total Percent Identity:   97.53                                               
						QQAALMASVAQGGYLNPMAAFAAAQMQQMAALNMNGLAAAPMTPTSGGSTPPGITAPAVP 	                        Gaps:       1                        
						SIPSPIGVNGFTGLPPQANGQPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYAGPA 	                                                            
						AYPAAYGQISQAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLPFG      	Alignment:                                                   
						homologous to corresponding to amino acids 151 - 445 of      	                  .         .         .         .         .  
						Q9BZC1, which also corresponds to amino acids 140 - 434 of   	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						F05869_P16, and a third amino acid sequence being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						RHPVPARCQAPSCQGG corresponding to amino acids 435 - 450 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F05869_P16, wherein said first amino acid sequence, second   	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     101 TYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRG........... 139                                                          
						polypeptide encoding for an edge portion of F05869_P16,      	         |||||||||||||||||||||||||||||||||||||||             
						comprising a polypeptide having a length "n", wherein n is at	     101 TYCERESALKAQSALHEQKTLPGMNRPIQVKPADSESRGGSSCLRQPPSQ 150                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     140 DRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYS 189                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     151 DRKLFVGMLNKQQSEDDVRRLFEAFGNIEECTILRGPDGNSKGCAFVKYS 200                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise GD, having a structure as follows: a sequence       	     190 SHAEAQAAINALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGM 239                                                          
						starting from any of amino acid numbers 139-x to 140; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 140+ ((n-2) - x), in     	     201 SHAEAQAAINALHGSQTMPGASSSLVVKFADTDKERTMRRMQQMAGQMGM 250                                                          
						which x varies from 0 to n-2.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of F05869_P16, comprising a polypeptide  	     240 FNPMAIPFGAYGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMA 289                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     251 FNPMAIPFGAYGAYAQALMQQQAALMASVAQGGYLNPMAAFAAAQMQQMA 300                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						RHPVPARCQAPSCQGG in F05869_P16.                              	     290 ALNMNGLAAAPMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQANG 339                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ALNMNGLAAAPMTPTSGGSTPPGITAPAVPSIPSPIGVNGFTGLPPQANG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     340 QPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQIS 389                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QPAAEAVFANGIHPYPAQSPTAADPLQQAYAGVQQYAGPAAYPAAYGQIS 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     390 QAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLPFG      434                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     401 QAFPQPPPMIPQQQREGPEGCNLFIYHLPQEFGDAELMQMFLPFG      445                                                          

608	HMR136_F05869_20_tr0_r1_1_gPRT		Comparison report between F05869_P20 and Q9NR85partial WT    	Sequence name: Q9NR85                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05869_P20, comprising a first amino	Sequence documentation:                                      
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	                                                            
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	Alignment of: 608 x Q9NR85   ..                              
						LPG                                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 123 of Q9NR85, which also corresponds to  	                                                            
						amino acids 1 - 123 of F05869_P20, and a second amino acid   	                     Quality: 1207.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     123                Total length:     123                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VSGARRGASGRRADRGRLREAGRRRGARG            	                        Gaps:       0                        
						corresponding to amino acids 124 - 152 of F05869_P20, wherein	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F05869_P20, comprising a  	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSGARRGASGRRADRGRLREAGRRRGARG in F05869_P20. 	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          

						Comparison report between F05869_P20 and Q8N2M6partial WT    	Sequence name: Q8N2M6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05869_P20, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to                                     	Alignment of: 608 x Q8N2M6   ..                              
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIG  	                                                            
						corresponding to amino acids 1 - 59 of Q8N2M6, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 59 of F05869_P20, a bridging  	                                                            
						amino acid Q corresponding to amino acid 60 of F05869_P20, a 	                     Quality: 1196.00                      Escore:       0                                               
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	             Matching length:     123                Total length:     123                                               
						LPG                                                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.19                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.19                                               
						corresponding to amino acids 61 - 123 of Q8N2M6, which also  	                        Gaps:       0                        
						corresponds to amino acids 61 - 123 of F05869_P20, and a     	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						polypeptide having the sequence VSGARRGASGRRADRGRLREAGRRRGARG	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 124 - 152 of F05869_P20, wherein	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						said first amino acid sequence, bridging amino acid, second  	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						contiguous and in a sequential order.2.An isolated           	         |||||||||:||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of F05869_P20, comprising a  	      51 HDAIKLFIGRIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .                                
						80%, preferably at least about 85%, more preferably at least 	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||||||||||||||||||                             
						to the sequence VSGARRGASGRRADRGRLREAGRRRGARG in F05869_P20. 	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          

						Comparison report between F05869_P20 and Q9BQ96unique head   	Sequence name: Q9BQ96                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F05869_P20, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 608 x Q9BQ96   ..                              
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIP corresponding	                                                            
						to amino acids 1 - 47 of F05869_P20, a second amino acid     	                     Quality:  749.00                      Escore:       0                                               
						MKDHDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERES 	             Matching length:      76                Total length:      76                                               
						ALKAQSALHEQKTLPG                                             	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 76 of Q9BQ96, which also corresponds to amino	                        Gaps:       0                        
						acids 48 - 123 of F05869_P20, and a third amino acid sequence	                                                            
						being at least 70%, optionally at least 80%, preferably at   	Alignment:                                                   
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	      48 MKDHDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGC 97                                                           
						VSGARRGASGRRADRGRLREAGRRRGARG corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						124 - 152 of F05869_P20, wherein said first amino acid       	       1 MKDHDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGC 50                                                           
						sequence, second amino acid sequence and third amino acid    	                  .         .                                
						sequence are contiguous and in a sequential order.2.An       	      98 AFLTYCERESALKAQSALHEQKTLPG                         123                                                          
						isolated polypeptide encoding for a head of F05869_P20,      	         ||||||||||||||||||||||||||                          
						comprising a polypeptide being at least 70%, optionally at   	      51 AFLTYCERESALKAQSALHEQKTLPG                         76                                                           
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIP of           	                                                            
						F05869_P20.3.An isolated polypeptide encoding for a tail of  	                                                            
						F05869_P20, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VSGARRGASGRRADRGRLREAGRRRGARG in F05869_P20.                 	                                                            

						Comparison report between F05869_P20 and AAH45711partial WT  	Sequence name: AAH45711                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05869_P20, comprising a first amino	Sequence documentation:                                      
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	                                                            
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	Alignment of: 608 x AAH45711   ..                            
						LPG                                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 123 of AAH45711, which also corresponds to	                                                            
						amino acids 1 - 123 of F05869_P20, and a second amino acid   	                     Quality: 1207.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     123                Total length:     123                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VSGARRGASGRRADRGRLREAGRRRGARG            	                        Gaps:       0                        
						corresponding to amino acids 124 - 152 of F05869_P20, wherein	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F05869_P20, comprising a  	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSGARRGASGRRADRGRLREAGRRRGARG in F05869_P20. 	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          

						Comparison report between F05869_P20 and Q9BZC1partial WT    	Sequence name: Q9BZC1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F05869_P20, comprising a first amino	Sequence documentation:                                      
						MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKDHDAIKLFIGQ 	                                                            
						IPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFLTYCERESALKAQSALHEQKT 	Alignment of: 608 x Q9BZC1   ..                              
						LPG                                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 123 of Q9BZC1, which also corresponds to  	                                                            
						amino acids 1 - 123 of F05869_P20, and a second amino acid   	                     Quality: 1207.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     123                Total length:     123                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence VSGARRGASGRRADRGRLREAGRRRGARG            	                        Gaps:       0                        
						corresponding to amino acids 124 - 152 of F05869_P20, wherein	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F05869_P20, comprising a  	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MYIKMATLANGQADNASLSTNGLGSSPGSAGHMNGLSHSPGNPSTIPMKD 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VSGARRGASGRRADRGRLREAGRRRGARG in F05869_P20. 	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 HDAIKLFIGQIPRNLDEKDLKPLFEEFGKIYELTVLKDRFTGMHKGCAFL 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     101 TYCERESALKAQSALHEQKTLPG                            123                                                          

18382	HMR136_F06003_12_tr0_r1_1_gPRT		Comparison report between F06003_P12 and UBL5_HUMAN_V1unique 	Sequence name: UBL5_HUMAN_V1                                 
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F06003_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18382 x UBL5_HUMAN_V1   ..                     
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSLGWLERPPALSRAAGDGARRLSGSRRGDVWLTSSAAGLLRSVAGGSWCGGQLRARGGS 	Alignment segment 1/1:                                       
						GRCVARA                                                      	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2728.00                      Escore:       0                                               
						to amino acids 1 - 67 of F06003_P12, a second amino acid     	             Matching length:     287                Total length:     329                                               
						MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GEEPAGSVVQDSRLDTIFFAKQ                                       	    Total Percent Similarity:   87.23      Total Percent Identity:   87.23                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 1 - 82 of UBL5_HUMAN_V1, which also corresponds  	                                                            
						to amino acids 68 - 149 of F06003_P12, and a third amino acid	Alignment:                                                   
						MKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREG 	                  .         .         .         .         .  
						PIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQRQLAE 	      68 MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVH 117                                                          
						EEPMDTDQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELLKTLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHQQLIPLVEKAKEKQNAKKAQETK                                    	       1 MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVH 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 125 - 329 of UBL5_HUMAN_V1, which also           	     118 GLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQ.................. 149                                                          
						corresponds to amino acids 150 - 354 of F06003_P12, wherein  	         ||||||||||||||||||||||||||||||||                    
						said first amino acid sequence, second amino acid sequence   	      51 GLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNACATQAIVSVLLNC 100                                                          
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     150 ........................MKGLALSNSDVIRQVHNSFARQQMFE 175                                                          
						head of F06003_P12, comprising a polypeptide being at least  	                                 ||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 THQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFE 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						MSLGWLERPPALSRAAGDGARRLSGSRRGDVWLTSSAAGLLRSVAGGSWCGGQLRARGGS 	     176 FDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAV 225                                                          
						GRCVARA                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence of             	     151 FDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAV 200                                                          
						F06003_P12.3.An isolated chimeric polypeptide encoding for an	                  .         .         .         .         .  
						edge portion of F06003_P12, comprising a polypeptide having a	     226 RPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQRQLAEEEPMDT 275                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     201 RPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQRQLAEEEPMDT 250                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     276 DQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELL 325                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise QM, having a structure as  	     251 DQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELL 300                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .                                
						149-x to 150; and ending at any of amino acid numbers 150+   	     326 KTLAEHQQLIPLVEKAKEKQNAKKAQETK                      354                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         |||||||||||||||||||||||||||||                       
						                                                            	     301 KTLAEHQQLIPLVEKAKEKQNAKKAQETK                      329                                                          

18384	HMR136_F06003_4_tr0_r1_1_gPRT		Comparison report between F06003_P4 and UBL5_HUMAN_V1unique  	Sequence name: UBL5_HUMAN_V1                                 
						head followed by partial WT sequence followed by a short     	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						F06003_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18384 x UBL5_HUMAN_V1   ..                     
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSLGWLERPPALSRAAGDGARRLSGSRRGDVWLTSSAAGLLRSVAGGSWCGGQLRARGGS 	Alignment segment 1/1:                                       
						GRCVARA                                                      	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 3097.00                      Escore:       0                                               
						to amino acids 1 - 67 of F06003_P4, a second amino acid      	             Matching length:     315                Total length:     315                                               
						MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GEEPAGSVVQDSRLDTIFFAKQVINNACATQAIVSVLLNCTHQDVHLGETLSEFKEFSQS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FDAAMKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDG 	                        Gaps:       0                        
						LREGPIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQR 	                                                            
						QLAEEEPMDTDQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELL 	Alignment:                                                   
						KTLAEHQQLIPLVEK                                              	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      68 MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVH 117                                                          
						amino acids 1 - 315 of UBL5_HUMAN_V1, which also corresponds 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 68 - 382 of F06003_P4, and a third amino acid 	       1 MTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVH 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     118 GLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNACATQAIVSVLLNC 167                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence IF corresponding to amino acids 383 - 384	      51 GLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNACATQAIVSVLLNC 100                                                          
						of F06003_P4, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     168 THQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFE 217                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F06003_P4, comprising a   	     101 THQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFE 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     218 FDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAV 267                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSLGWLERPPALSRAAGDGARRLSGSRRGDVWLTSSAAGLLRSVAGGSWCGGQLRARGGS 	     151 FDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAV 200                                                          
						GRCVARA                                                      	                  .         .         .         .         .  
						to the sequence of F06003_P4.                                	     268 RPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQRQLAEEEPMDT 317                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQRQLAEEEPMDT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     318 DQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELL 367                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DQGNSMLSAIQSEVAKNQMLIEEEVQKLKRYKIENIRRKHNYLPFIMELL 300                                                          
						                                                            	                  .                                          
						                                                            	     368 KTLAEHQQLIPLVEK                                    382                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     301 KTLAEHQQLIPLVEK                                    315                                                          

19195	HMR136_F07016_12_tr0_r1_1_gPRT		Comparison report between F07016_P12 and O75197partial WT    	Sequence name: O75197                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07016_P12, comprising a first amino	Sequence documentation:                                      
						MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVS 	                                                            
						GLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGK 	Alignment of: 19195 x O75197   ..                            
						KLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAG 	                                                            
						MDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHP 	Alignment segment 1/1:                                       
						FALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 	                                                            
						EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTP 	                     Quality: 5888.00                      Escore:       0                                               
						DFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDG 	             Matching length:     601                Total length:     601                                               
						IAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 	                        Gaps:       0                        
						G                                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 601 of O75197, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 601 of F07016_P12, and a second amino acid   	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence ESGGSQAMA corresponding to amino acids   	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						602 - 610 of F07016_P12, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F07016_P12, comprising a polypeptide being at least  	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						at least about 95% homologous to the sequence ESGGSQAMA in   	                  .         .         .         .         .  
						F07016_P12.                                                  	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	                                                             
						                                                            	     601 G                                                  601                                                          
						                                                            	         |                                                   
						                                                            	     601 G                                                  601                                                          

						Comparison report between F07016_P12 and Q9UP66partial WT    	Sequence name: Q9UP66                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07016_P12, comprising a first amino	Sequence documentation:                                      
						MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVS 	                                                            
						GLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGK 	Alignment of: 19195 x Q9UP66   ..                            
						KLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAG 	                                                            
						MDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHP 	Alignment segment 1/1:                                       
						FALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 	                                                            
						EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTP 	                     Quality: 5888.00                      Escore:       0                                               
						DFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDG 	             Matching length:     601                Total length:     601                                               
						IAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 	                        Gaps:       0                        
						G                                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 601 of Q9UP66, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 601 of F07016_P12, and a second amino acid   	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence ESGGSQAMA corresponding to amino acids   	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						602 - 610 of F07016_P12, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F07016_P12, comprising a polypeptide being at least  	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						at least about 95% homologous to the sequence ESGGSQAMA in   	                  .         .         .         .         .  
						F07016_P12.                                                  	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	                                                             
						                                                            	     601 G                                                  601                                                          
						                                                            	         |                                                   
						                                                            	     601 G                                                  601                                                          

						Comparison report between F07016_P12 and Q9UES7partial WT    	Sequence name: Q9UES7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07016_P12, comprising a first amino	Sequence documentation:                                      
						MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVS 	                                                            
						GLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGK 	Alignment of: 19195 x Q9UES7   ..                            
						KLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAG 	                                                            
						MDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHP 	Alignment segment 1/1:                                       
						FALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 	                                                            
						EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTP 	                     Quality: 5888.00                      Escore:       0                                               
						DFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDG 	             Matching length:     601                Total length:     601                                               
						IAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 	                        Gaps:       0                        
						G                                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 601 of Q9UES7, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 601 of F07016_P12, and a second amino acid   	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence ESGGSQAMA corresponding to amino acids   	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						602 - 610 of F07016_P12, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F07016_P12, comprising a polypeptide being at least  	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						at least about 95% homologous to the sequence ESGGSQAMA in   	                  .         .         .         .         .  
						F07016_P12.                                                  	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	                                                             
						                                                            	     601 G                                                  601                                                          
						                                                            	         |                                                   
						                                                            	     601 G                                                  601                                                          

19197	HMR136_F07016_6_tr0_r1_1_gPRT		Comparison report between F07016_P6 and O75197partial WT     	Sequence name: O75197                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07016_P6, comprising a first amino 	Sequence documentation:                                      
						MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVS 	                                                            
						GLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGK 	Alignment of: 19197 x O75197   ..                            
						KLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAG 	                                                            
						MDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHP 	Alignment segment 1/1:                                       
						FALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 	                                                            
						EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTP 	                     Quality: 9310.00                      Escore:       0                                               
						DFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDG 	             Matching length:     942                Total length:     942                                               
						IAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 	                        Gaps:       0                        
						GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFTSRAAIHRISL 	                                                            
						ETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTISRAFMNGSSVEHVVEFGLDYP 	Alignment:                                                   
						EGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDLDNPRSLALDPTKGYIYWTEW 	                  .         .         .         .         .  
						GGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVV 	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						IADDLPHPFGLTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS                   	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 942 of O75197, which also corresponds to  	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						amino acids 1 - 942 of F07016_P6, and a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						having the sequence QICHQSDDPGRPAQPGSHPAPAWTEERQSHRL         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 943 - 974 of F07016_P6, wherein 	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						polypeptide encoding for a tail of F07016_P6, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						to the sequence QICHQSDDPGRPAQPGSHPAPAWTEERQSHRL in          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07016_P6.                                                   	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFT 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFT 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 SRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTIS 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTIS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQ 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQ 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 FRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLV 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 900                                                          
						                                                            	                  .         .         .         .            
						                                                            	     901 DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS         942                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     901 DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS         942                                                          

						Comparison report between F07016_P6 and Q9UP66partial WT     	Sequence name: Q9UP66                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07016_P6, comprising a first amino 	Sequence documentation:                                      
						MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVS 	                                                            
						GLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGK 	Alignment of: 19197 x Q9UP66   ..                            
						KLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAG 	                                                            
						MDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHP 	Alignment segment 1/1:                                       
						FALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 	                                                            
						EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTP 	                     Quality: 9310.00                      Escore:       0                                               
						DFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDG 	             Matching length:     942                Total length:     942                                               
						IAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 	                        Gaps:       0                        
						GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFTSRAAIHRISL 	                                                            
						ETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTISRAFMNGSSVEHVVEFGLDYP 	Alignment:                                                   
						EGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDLDNPRSLALDPTKGYIYWTEW 	                  .         .         .         .         .  
						GGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVV 	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						IADDLPHPFGLTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS                   	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 942 of Q9UP66, which also corresponds to  	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						amino acids 1 - 942 of F07016_P6, and a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						having the sequence QICHQSDDPGRPAQPGSHPAPAWTEERQSHRL         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 943 - 974 of F07016_P6, wherein 	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						polypeptide encoding for a tail of F07016_P6, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						to the sequence QICHQSDDPGRPAQPGSHPAPAWTEERQSHRL in          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07016_P6.                                                   	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFT 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFT 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 SRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTIS 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTIS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQ 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQ 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 FRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLV 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 900                                                          
						                                                            	                  .         .         .         .            
						                                                            	     901 DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS         942                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     901 DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS         942                                                          

						Comparison report between F07016_P6 and Q9UES7partial WT     	Sequence name: Q9UES7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07016_P6, comprising a first amino 	Sequence documentation:                                      
						MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVS 	                                                            
						GLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGK 	Alignment of: 19197 x Q9UES7   ..                            
						KLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAG 	                                                            
						MDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHP 	Alignment segment 1/1:                                       
						FALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 	                                                            
						EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTP 	                     Quality: 9310.00                      Escore:       0                                               
						DFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDG 	             Matching length:     942                Total length:     942                                               
						IAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 	                        Gaps:       0                        
						GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFTSRAAIHRISL 	                                                            
						ETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTISRAFMNGSSVEHVVEFGLDYP 	Alignment:                                                   
						EGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDLDNPRSLALDPTKGYIYWTEW 	                  .         .         .         .         .  
						GGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVV 	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						IADDLPHPFGLTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS                   	       1 MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGG 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 942 of Q9UES7, which also corresponds to  	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						amino acids 1 - 942 of F07016_P6, and a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 VKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQ 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						having the sequence QICHQSDDPGRPAQPGSHPAPAWTEERQSHRL         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 943 - 974 of F07016_P6, wherein 	     101 NVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDL 150                                                          
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						polypeptide encoding for a tail of F07016_P6, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     151 DQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGL 200                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						to the sequence QICHQSDDPGRPAQPGSHPAPAWTEERQSHRL in          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07016_P6.                                                   	     201 TIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCE 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 FTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFT 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 GTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFT 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 SRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTIS 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 SRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTIS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQ 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQ 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 FRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLV 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 FRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 DKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 DKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQ 900                                                          
						                                                            	                  .         .         .         .            
						                                                            	     901 DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS         942                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     901 DGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCS         942                                                          

19318	HMR136_F07041_1_tr0_r1_1_gPRT		Comparison report between F07041_P1 and NEUS_HUMANpartial WT 	Sequence name: NEUS_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F07041_P1, comprising a first amino acid        	                                                            
						MYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQEVPLATLEPLVKAQLV 	Alignment of: 19318 x NEUS_HUMAN   ..                        
						EEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIKDANLTGLSDNKEIFLSKA 	                                                            
						IHKSFLEVNEEGSEAAAVSGMIAISRMAVLYPQVIVDHPFFFLIRNRRTGTILFMGRVMH 	Alignment segment 1/1:                                       
						PETMNTSGHDFEEL                                               	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1874.00                      Escore:       0                                               
						amino acids 217 - 410 of NEUS_HUMAN, which also corresponds  	             Matching length:     194                Total length:     194                                               
						to amino acids 1 - 194 of F07041_P1.                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQEVPLAT 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     217 MYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQEVPLAT 266                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LEPLVKAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 LEPLVKAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IKDANLTGLSDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 IKDANLTGLSDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVL 366                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMNTSGHDFEEL       194                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     367 YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMNTSGHDFEEL       410                                                          

19417	HMR136_F07103_10_tr0_r1_1_gPRT		Comparison report between F07103_P10 and CLC6_HUMANunique    	Sequence name: CLC6_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F07103_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 19417 x CLC6_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence PAEGIPGSIWFLCN corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 14 of F07103_P10, and a second amino acid sequence 	                                                            
						RYTPYPNLYPDQSPSEDWTMEERFRPLTFHGLILRSQLVTLLVRGVCYSESQSSASQPRL 	                     Quality: 1565.00                      Escore:       0                                               
						SYAEMAEDYPRYPDIHDLDLTLLNPRMIVDVTPYMNPSPFTVSPNTHVSQVFNLFRTMGL 	             Matching length:     157                Total length:     157                                               
						RHLPVVNAVGEIVGIITRHNLTYEFLQARLRQHYQTI                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 713 - 869 of CLC6_HUMAN, which also corresponds to     	                        Gaps:       0                        
						amino acids 15 - 171 of F07103_P10, wherein said first amino 	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of F07103_P10, comprising a polypeptide being at  	      15 RYTPYPNLYPDQSPSEDWTMEERFRPLTFHGLILRSQLVTLLVRGVCYSE 64                                                           
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     713 RYTPYPNLYPDQSPSEDWTMEERFRPLTFHGLILRSQLVTLLVRGVCYSE 762                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						PAEGIPGSIWFLCN of F07103_P10.                                	      65 SQSSASQPRLSYAEMAEDYPRYPDIHDLDLTLLNPRMIVDVTPYMNPSPF 114                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     763 SQSSASQPRLSYAEMAEDYPRYPDIHDLDLTLLNPRMIVDVTPYMNPSPF 812                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     115 TVSPNTHVSQVFNLFRTMGLRHLPVVNAVGEIVGIITRHNLTYEFLQARL 164                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     813 TVSPNTHVSQVFNLFRTMGLRHLPVVNAVGEIVGIITRHNLTYEFLQARL 862                                                          
						                                                            	                                                             
						                                                            	     165 RQHYQTI                                            171                                                          
						                                                            	         |||||||                                             
						                                                            	     863 RQHYQTI                                            869                                                          

20430	HMR136_F07341_4_tr0_r1_1_gPRT		Comparison report between F07341_P4 and Q8WTV9partial WT     	Sequence name: Q8WTV9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07341_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLG corresponding  	Alignment of: 20430 x Q8WTV9   ..                            
						to amino acids 1 - 45 of Q8WTV9, which also corresponds to   	                                                            
						amino acids 1 - 45 of F07341_P4, and a second amino acid     	Alignment segment 1/1:                                       
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                     Quality:  459.00                      Escore:       0                                               
						most preferably at least 95% homologous to a polypeptide     	             Matching length:      45                Total length:      45                                               
						ITKEPSFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKG 	                        Gaps:       0                        
						NSVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKD 	                                                            
						LHQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAE 	Alignment:                                                   
						VKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGD 	                  .         .         .         .            
						PTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQK 	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLG      45                                                           
						QPGEKEEEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPT 	         |||||||||||||||||||||||||||||||||||||||||||||       
						PKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKE 	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLG      45                                                           
						SRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHV 	                                                            
						PSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLR 	                                                            
						AFQTLARAKKRKENFWGKT                                          	                                                            
						having the sequence corresponding to amino acids 46 - 724 of 	                                                            
						F07341_P4, wherein said first amino acid sequence and second 	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						F07341_P4, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						ITKEPSFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQE 	                                                            
						RVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDN 	                                                            
						GLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKG 	                                                            
						NSVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKD 	                                                            
						LHQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAE 	                                                            
						VKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGD 	                                                            
						PTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQK 	                                                            
						QPGEKEEEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPT 	                                                            
						PKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKE 	                                                            
						SRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHV 	                                                            
						PSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLR 	                                                            
						AFQTLARAKKRKENFWGKT                                          	                                                            
						least about 95% homologous to the sequence in F07341_P4.     	                                                            

						Comparison report between F07341_P4 and O43406unique head    	Sequence name: O43406                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F07341_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 20430 x O43406   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEPSFISKRRVPY 	Alignment segment 1/1:                                       
						HDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQERVHSLEASRVPKRTR 	                                                            
						SHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDNGLDRLLRKKAGLTVV 	                     Quality: 2498.00                      Escore:       0                                               
						PSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKGNSVIHETEYKRNFKG 	             Matching length:     253                Total length:     253                                               
						LSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDLHQPKRKLTPWKHQR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAEVKELREKAEFYRKRV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGDPTSHKTLQKCPSTEP 	                        Gaps:       0                        
						EEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQKQPGEKE          	                                                            
						having the sequence corresponding to amino acids 1 - 471 of  	Alignment:                                                   
						F07341_P4, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						EEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLREL 	     472 EEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGG 521                                                          
						GGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAVSL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHVPSYWHP 	       1 EEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGG 50                                                           
						SRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLA 	                  .         .         .         .         .  
						RAKKRKENFWGKT                                                	     522 RLPTPKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQ 571                                                          
						% homologous to corresponding to amino acids 1 - 253 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						O43406, which also corresponds to amino acids 472 - 724 of   	      51 RLPTPKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQ 100                                                          
						F07341_P4, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     572 DCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEA 621                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07341_P4, comprising a polypeptide being at least 70%,      	     101 DCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEA 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     622 TLPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKA 671                                                          
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEPSFISKRRVPY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQERVHSLEASRVPKRTR 	     151 TLPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKA 200                                                          
						SHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDNGLDRLLRKKAGLTVV 	                  .         .         .         .         .  
						PSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKGNSVIHETEYKRNFKG 	     672 RMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFW 721                                                          
						LSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDLHQPKRKLTPWKHQR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAEVKELREKAEFYRKRV 	     201 RMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFW 250                                                          
						QGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGDPTSHKTLQKCPSTEP 	                                                             
						EEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQKQPGEKE          	     722 GKT                                                724                                                          
						least about 95% homologous to the sequence of F07341_P4.     	         |||                                                 
						                                                            	     251 GKT                                                253                                                          

						Comparison report between F07341_P4 and Q9NR04partial WT     	Sequence name: Q9NR04                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07341_P4, comprising a first amino 	Sequence documentation:                                      
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEPSFISKRRVPY 	                                                            
						HDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQERVHSLEASRVPKRTR 	Alignment of: 20430 x Q9NR04   ..                            
						SHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDNG               	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 166 of Q9NR04, which also corresponds to  	                                                            
						amino acids 1 - 166 of F07341_P4, and a second amino acid    	                     Quality: 1642.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     166                Total length:     166                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKGN 	                        Gaps:       0                        
						SVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDL 	                                                            
						HQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAEV 	Alignment:                                                   
						KELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGDP 	                  .         .         .         .         .  
						TSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQKQ 	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEP 50                                                           
						PGEKEEEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKES 	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEP 50                                                           
						RAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHVP 	                  .         .         .         .         .  
						SYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRA 	      51 SFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQK 100                                                          
						FQTLARAKKRKENFWGKT                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 167 - 724 of	      51 SFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQK 100                                                          
						F07341_P4, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     101 DVTQERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENV 150                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07341_P4, comprising a polypeptide being at least 70%,      	     101 DVTQERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENV 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .                                          
						more preferably at least about 90% and most preferably at    	     151 ELEHSTKVLSENVDNG                                   166                                                          
						LDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKGN 	         ||||||||||||||||                                    
						SVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDL 	     151 ELEHSTKVLSENVDNG                                   166                                                          
						HQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAEV 	                                                            
						KELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGDP 	                                                            
						TSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQKQ 	                                                            
						PGEKEEEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTP 	                                                            
						KLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKES 	                                                            
						RAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHVP 	                                                            
						SYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRA 	                                                            
						FQTLARAKKRKENFWGKT                                           	                                                            
						least about 95% homologous to the sequence in F07341_P4.     	                                                            

20436	HMR136_F07341_5_tr0_r1_1_gPRT		Comparison report between F07341_P5 and Q8WTV9partial WT     	Sequence name: Q8WTV9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07341_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLG corresponding  	Alignment of: 20436 x Q8WTV9   ..                            
						to amino acids 1 - 45 of Q8WTV9, which also corresponds to   	                                                            
						amino acids 1 - 45 of F07341_P5, and a second amino acid     	Alignment segment 1/1:                                       
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                     Quality:  459.00                      Escore:       0                                               
						most preferably at least 95% homologous to a polypeptide     	             Matching length:      45                Total length:      45                                               
						ITKEPSFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKG 	                        Gaps:       0                        
						NSVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKD 	                                                            
						LHQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAE 	Alignment:                                                   
						VGCF                                                         	                  .         .         .         .            
						having the sequence corresponding to amino acids 46 - 349 of 	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLG      45                                                           
						F07341_P5, wherein said first amino acid sequence and second 	         |||||||||||||||||||||||||||||||||||||||||||||       
						amino acid sequence are contiguous and in a sequential       	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLG      45                                                           
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						F07341_P5, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						ITKEPSFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQE 	                                                            
						RVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDN 	                                                            
						GLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKG 	                                                            
						NSVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKD 	                                                            
						LHQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAE 	                                                            
						VGCF                                                         	                                                            
						least about 95% homologous to the sequence in F07341_P5.     	                                                            

						Comparison report between F07341_P5 and Q9NR04partial WT     	Sequence name: Q9NR04                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F07341_P5, comprising a first amino 	Sequence documentation:                                      
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEPSFISKRRVPY 	                                                            
						HDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDVTQERVHSLEASRVPKRTR 	Alignment of: 20436 x Q9NR04   ..                            
						SHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENVDNG               	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 166 of Q9NR04, which also corresponds to  	                                                            
						amino acids 1 - 166 of F07341_P5, and a second amino acid    	                     Quality: 1642.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     166                Total length:     166                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKGN 	                        Gaps:       0                        
						SVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDL 	                                                            
						HQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAEV 	Alignment:                                                   
						GCF                                                          	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 167 - 349 of	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEP 50                                                           
						F07341_P5, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEP 50                                                           
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F07341_P5, comprising a polypeptide being at least 70%,      	      51 SFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQK 100                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 SFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQK 100                                                          
						LDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPFKGN 	                  .         .         .         .         .  
						SVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDL 	     101 DVTQERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENV 150                                                          
						HQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQGSLNAMWYAEV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GCF                                                          	     101 DVTQERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENV 150                                                          
						least about 95% homologous to the sequence in F07341_P5.     	                  .                                          
						                                                            	     151 ELEHSTKVLSENVDNG                                   166                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     151 ELEHSTKVLSENVDNG                                   166                                                          

						Comparison report between F07341_P5 and Q8TC05partial WT     	Sequence name: Q8TC05                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F07341_P5, comprising a first amino acid sequence being at   	                                                            
						MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEPSFISKRRVPY 	Alignment of: 20436 x Q8TC05   ..                            
						HDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQKDV                   	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 102	Alignment segment 1/1:                                       
						of Q8TC05, which also corresponds to amino acids 1 - 102 of  	                                                            
						F07341_P5, a bridging amino acid T corresponding to amino    	                     Quality: 3319.00                      Escore:       0                                               
						acid 103 of F07341_P5, a second amino acid sequence being at 	             Matching length:     335                Total length:     335                                               
						QERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENVELEHSTKVLSENV 	 Matching Percent Similarity:   99.70   Matching Percent Identity:   99.70                                               
						DNGLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQFVPPF 	    Total Percent Similarity:   99.70      Total Percent Identity:   99.70                                               
						KGNSVIHETEYKRNFKGLSPVKEPKLRNDLRENRNLETVSPERKSNKIDDRLKLEAEMEL 	                        Gaps:       0                        
						KDLHQPKRKLTPWKHQRLGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQ         	                                                            
						least 90 % homologous to corresponding to amino acids 104 -  	Alignment:                                                   
						335 of Q8TC05, which also corresponds to amino acids 104 -   	                  .         .         .         .         .  
						335 of F07341_P5, and a third amino acid sequence being at   	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEP 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MPVRFKGLSEYQRNFLWKKSYLSESCNSSVGRKYPWAGLRSDQLGITKEP 50                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						GSLNAMWYAEVGCF corresponding to amino acids 336 - 349 of     	      51 SFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQK 100                                                          
						F07341_P5, wherein said first amino acid sequence, bridging  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid, second amino acid sequence and third amino acid  	      51 SFISKRRVPYHDPQISKSLEWNGAISESNVVASPEPEAPETPKSQEAEQK 100                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of F07341_P5,       	     101 DVTQERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENV 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     101 DVIQERVHSLEASRVPKRTRSHSADSRAEGASDVENNEGVTNHTPVNENV 150                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence GSLNAMWYAEVGCF in       	     151 ELEHSTKVLSENVDNGLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTS 200                                                          
						F07341_P5.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ELEHSTKVLSENVDNGLDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KETAPAFAANQVFHNKSQFVPPFKGNSVIHETEYKRNFKGLSPVKEPKLR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KETAPAFAANQVFHNKSQFVPPFKGNSVIHETEYKRNFKGLSPVKEPKLR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDLHQPKRKLTPWKHQR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 NDLRENRNLETVSPERKSNKIDDRLKLEAEMELKDLHQPKRKLTPWKHQR 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 LGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQ                335                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     301 LGKVNSEYRAKFLSPAQYLYKAGAWTHVKGNMPNQ                335                                                          

20434	HMR136_F07341_8_tr0_r1_1_gPRT		Comparison report between F07341_P8 and O43406unique head    	Sequence name: O43406                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F07341_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 20434 x O43406   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MWYAEVKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRAL 	Alignment segment 1/1:                                       
						DLAGDPTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTS 	                                                            
						EDVQKQPGEKE                                                  	                     Quality: 2498.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 131 of  	             Matching length:     253                Total length:     253                                               
						F07341_P8, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLREL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAVSL 	                        Gaps:       0                        
						LTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHVPSYWHP 	                                                            
						SRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLA 	Alignment:                                                   
						RAKKRKENFWGKT                                                	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 253 of      	     132 EEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGG 181                                                          
						O43406, which also corresponds to amino acids 132 - 384 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07341_P8, wherein said first amino acid sequence and second 	       1 EEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGG 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     182 RLPTPKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQ 231                                                          
						F07341_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 RLPTPKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQ 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MWYAEVKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRAL 	     232 DCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEA 281                                                          
						DLAGDPTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EDVQKQPGEKE                                                  	     101 DCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEA 150                                                          
						least about 95% homologous to the sequence of F07341_P8.     	                  .         .         .         .         .  
						                                                            	     282 TLPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKA 331                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 TLPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     332 RMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFW 381                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFW 250                                                          
						                                                            	                                                             
						                                                            	     382 GKT                                                384                                                          
						                                                            	         |||                                                 
						                                                            	     251 GKT                                                253                                                          

						Comparison report between F07341_P8 and Q8TC05unique head    	Sequence name: Q8TC05                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F07341_P8, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 20434 x Q8TC05   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MWYAE corresponding to amino 	Alignment segment 1/1:                                       
						acids 1 - 5 of F07341_P8, a second amino acid sequence being 	                                                            
						VKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVSSNIRALDLAGD 	                     Quality: 3726.00                      Escore:       0                                               
						PTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAPTIPVRRRLAWDTENTSEDVQK 	             Matching length:     380                Total length:     380                                               
						QPGEKEEEDDNEEEGDRKTGKQAFMGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPT 	 Matching Percent Similarity:   99.74   Matching Percent Identity:   99.47                                               
						PKLRELGGIQRTHHDLTTPAVGGAVLVSPSKMKPPA                         	    Total Percent Similarity:   99.74      Total Percent Identity:   99.47                                               
						at least 90 % homologous to corresponding to amino acids 336 	                        Gaps:       0                        
						- 551 of Q8TC05, which also corresponds to amino acids 6 -   	                                                            
						221 of F07341_P8, a bridging amino acid P corresponding to   	Alignment:                                                   
						amino acid 222 of F07341_P8, and a third amino acid sequence 	                  .         .         .         .         .  
						EQRKRMTSQDCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEAT 	       5 EVKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVS 54                                                           
						LPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHE 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						AFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFWGKT                   	     335 QVKELREKAEFYRKRVQGTHFSRDHLNQILSDSNCCWDVSSTTSSEGTVS 384                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 553 - 714 of Q8TC05, which also corresponds to amino   	      55 SNIRALDLAGDPTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAP 104                                                          
						acids 223 - 384 of F07341_P8, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid and	     385 SNIRALDLAGDPTSHKTLQKCPSTEPEEKGNIVEEQPQKNTTEKLGVSAP 434                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     105 TIPVRRRLAWDTENTSEDVQKQPGEKEEEDDNEEEGDRKTGKQAFMGEQE 154                                                          
						F07341_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     435 TIPVRRRLAWDTENTSEDVQKQPGEKEEEDDNEEEGDRKTGKQAFMGEQE 484                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence MWYAE of          	     155 KLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHHDLTTP 204                                                          
						F07341_P8.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     485 KLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHHDLTTP 534                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     205 AVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAVSLLTS 254                                                          
						                                                            	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						                                                            	     535 AVGGAVLVSPSKMKPPALEQRKRMTSQDCLETSKNDFTKKESRAVSLLTS 584                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     255 PAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPH 304                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     585 PAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPH 634                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     305 VPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSE 354                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     635 VPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDEDRLSE 684                                                          
						                                                            	                  .         .         .                      
						                                                            	     355 ISARSAASSLRAFQTLARAKKRKENFWGKT                     384                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     685 ISARSAASSLRAFQTLARAKKRKENFWGKT                     714                                                          

20432	HMR136_F07341_9_tr0_r1_1_gPRT		Comparison report between F07341_P9 and O43406partial WT     	Sequence name: O43406                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F07341_P9, comprising a first amino acid        	                                                            
						MGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHHDLTTPAVGGA 	Alignment of: 20432 x O43406   ..                            
						VLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLRE 	                                                            
						DSEDNIHKFAEATLPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVG 	Alignment segment 1/1:                                       
						KARMNNLQLPQHEAFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFWGKT      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2320.00                      Escore:       0                                               
						amino acids 19 - 253 of O43406, which also corresponds to    	             Matching length:     235                Total length:     235                                               
						amino acids 1 - 235 of F07341_P9.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      19 MGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHH 68                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      69 DLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAV 118                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     119 SLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQL 168                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     169 PSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDE 218                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 DRLSEISARSAASSLRAFQTLARAKKRKENFWGKT                235                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     219 DRLSEISARSAASSLRAFQTLARAKKRKENFWGKT                253                                                          

						Comparison report between F07341_P9 and Q8TC05partial WT     	Sequence name: Q8TC05                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F07341_P9, comprising a first amino 	Sequence documentation:                                      
						MGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHHDLTTPAVGGA 	                                                            
						VLVSPSKMKPPA                                                 	Alignment of: 20432 x Q8TC05   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 480 - 551 of Q8TC05, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 72 of F07341_P9, a bridging amino acid P     	                                                            
						corresponding to amino acid 73 of F07341_P9, and a second    	                     Quality: 2301.00                      Escore:       0                                               
						EQRKRMTSQDCLETSKNDFTKKESRAVSLLTSPAAGIKTVDPLPLREDSEDNIHKFAEAT 	             Matching length:     235                Total length:     235                                               
						LPVSKIPKYPTNPPGQLPSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHE 	 Matching Percent Similarity:   99.57   Matching Percent Identity:   99.57                                               
						AFNDEDEDRLSEISARSAASSLRAFQTLARAKKRKENFWGKT                   	    Total Percent Similarity:   99.57      Total Percent Identity:   99.57                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 553 - 714 of Q8TC05, which also 	                                                            
						corresponds to amino acids 74 - 235 of F07341_P9, wherein    	Alignment:                                                   
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHH 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     480 MGEQEKLDVHEKSKADKMKEGSDSSVSSEKGGRLPTPKLRELGGIQRTHH 529                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DLTTPAVGGAVLVSPSKMKPPAPEQRKRMTSQDCLETSKNDFTKKESRAV 100                                                          
						                                                            	         |||||||||||||||||||||| |||||||||||||||||||||||||||  
						                                                            	     530 DLTTPAVGGAVLVSPSKMKPPALEQRKRMTSQDCLETSKNDFTKKESRAV 579                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     580 SLLTSPAAGIKTVDPLPLREDSEDNIHKFAEATLPVSKIPKYPTNPPGQL 629                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     630 PSPPHVPSYWHPSRRIQGSLRDPEFQHNVGKARMNNLQLPQHEAFNDEDE 679                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 DRLSEISARSAASSLRAFQTLARAKKRKENFWGKT                235                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     680 DRLSEISARSAASSLRAFQTLARAKKRKENFWGKT                714                                                          

21191	HMR136_F07420_8_tr0_r1_1_gPRT		Comparison report between F07420_P8 and FAK2_HUMANpartial WT 	Sequence name: FAK2_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						insertion with extra amino acids.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for F07420_P8, comprising a first amino 	                                                            
						MSGVSEPLSRVKLGTLRRPEGPAEPMVVVPVDVEKEDVRILKVCFYSNSFNPGKNFKLVK 	Alignment of: 21191 x FAK2_HUMAN   ..                        
						CTVQTEIREIITSILLSGRIGPNIRLAECYGLRLKHMKSDEIHWLHPQMTVGEVQDKYEC 	                                                            
						LHVEAEWRYDLQIRYLPEDFMESLKEDRTTLLYFYQQLRNDYMQRYASKVSEGMALQLGC 	Alignment segment 1/1:                                       
						LELRRFFKDMPHNALDKKSNFELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYAS 	                                                            
						LREEECVMKFFNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDAKPTCLA 	                     Quality: 9358.00                      Escore:       0                                               
						EFKQIRSIRCLPLEEGQAVLQLGIEGAPQALSIKTSSLAEAENMADLIDGYCRLQGEHQG 	             Matching length:     967                Total length:    1018                                               
						SLIIHPRKDGEKRNSLPQIPMLNLEARRSHLSESCSIESDIYAEIPDETLRRPGGPQYGI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.90                                               
						AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 	    Total Percent Similarity:   94.99      Total Percent Identity:   94.89                                               
						LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 	                        Gaps:       2                        
						ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 	                                                            
						RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR 	Alignment:                                                   
						CWDYDPSDRPRFTELVCSLSDVYQMEKDIAMEQERNARYRTPKILEPTAFQEPPPKPSRP 	                  .         .         .         .         .  
						KYRPPPQTNLLAPKLQFQ                                           	       1 MSGVSEPLSRVKLGTLRRPEGPAEPMVVVPVDVEKEDVRILKVCFYSNSF 50                                                           
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 738 of FAK2_HUMAN, which also corresponds 	       1 MSGVSEPLSRVKLGTLRRPEGPAEPMVVVPVDVEKEDVRILKVCFYSNSF 50                                                           
						to amino acids 1 - 738 of F07420_P8, a second amino acid     	                  .         .         .         .         .  
						EEDFIQPSSREEAQQLWEAEKVKMRQILDKQQKQMVEDYQWLRQEEKSLDPMVYMNDKSP 	      51 NPGKNFKLVKCTVQTEIREIITSILLSGRIGPNIRLAECYGLRLKHMKSD 100                                                          
						LTPEKEVGY                                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 NPGKNFKLVKCTVQTEIREIITSILLSGRIGPNIRLAECYGLRLKHMKSD 100                                                          
						amino acids 781 - 849 of FAK2_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 739 - 807 of F07420_P8, a third amino acid    	     101 EIHWLHPQMTVGEVQDKYECLHVEAEWRYDLQIRYLPEDFMESLKEDRTT 150                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 EIHWLHPQMTVGEVQDKYECLHVEAEWRYDLQIRYLPEDFMESLKEDRTT 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence RECSRPSSGV corresponding to amino acids  	     151 LLYFYQQLRNDYMQRYASKVSEGMALQLGCLELRRFFKDMPHNALDKKSN 200                                                          
						808 - 817 of F07420_P8, and a fourth amino acid sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EFTGPPQKPPRLGAQSIQPTANLDRTDDLVYLNVMELVRAVLELKNELCQLPPEGYVVVV 	     151 LLYFYQQLRNDYMQRYASKVSEGMALQLGCLELRRFFKDMPHNALDKKSN 200                                                          
						KNVGLTLRKLIGSVDDLLPSLPSSSRTEIEGTQKLLNKDLAELINKMRLAQQNAVTSLSE 	                  .         .         .         .         .  
						ECKRQMLTASHTLAVDAKNLLDAVDQAKVLANLAHPPAE                      	     201 FELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYASLREEECVMKF 250                                                          
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 851 - 1009 of FAK2_HUMAN, which also corresponds to    	     201 FELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYASLREEECVMKF 250                                                          
						amino acids 818 - 976 of F07420_P8, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, second amino acid sequence, third amino acid  	     251 FNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDAKPTCLA 300                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated chimeric polypeptide        	     251 FNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDAKPTCLA 300                                                          
						encoding for an edge portion of F07420_P8, comprising a      	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	     301 EFKQIRSIRCLPLEEGQAVLQLGIEGAPQALSIKTSSLAEAENMADLIDG 350                                                          
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     301 EFKQIRSIRCLPLEEGQAVLQLGIEGAPQALSIKTSSLAEAENMADLIDG 350                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	     351 YCRLQGEHQGSLIIHPRKDGEKRNSLPQIPMLNLEARRSHLSESCSIESD 400                                                          
						length, wherein at least two amino acids comprise QE, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	     351 YCRLQGEHQGSLIIHPRKDGEKRNSLPQIPMLNLEARRSHLSESCSIESD 400                                                          
						acid numbers 738-x to 739; and ending at any of amino acid   	                  .         .         .         .         .  
						numbers 739+ ((n-2) - x), in which x varies from 0 to        	     401 IYAEIPDETLRRPGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGE 450                                                          
						n-2.3.An isolated polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F07420_P8, comprising an amino acid sequence being at least  	     401 IYAEIPDETLRRPGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGE 450                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     451 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 500                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RECSRPSSGV, corresponding to F07420_P8.4.A bridge portion of 	     451 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 500                                                          
						F07420_P8, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     501 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 550                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     501 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 550                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     551 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 600                                                          
						at least two amino acids comprise Y, having a structure as   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows (numbering according to F07420_P8): a sequence       	     551 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 600                                                          
						starting from any of amino acid numbers 849-x to 849; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 808 + ((n-2) - x), in    	     601 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 650                                                          
						which x varies from 0 to n-2.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAMEQERNARYR 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAMEQERNARYR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 TPKILEPTAFQEPPPKPSRPKYRPPPQTNLLAPKLQFQ............ 738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     701 TPKILEPTAFQEPPPKPSRPKYRPPPQTNLLAPKLQFQVPEGLCASSPTL 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     739 ..............................EEDFIQPSSREEAQQLWEAE 758                                                          
						                                                            	                                       ||||||||||||||||||||  
						                                                            	     751 TSPMEYPSPVNSLHTPPLHRHNVFKRHSMREEDFIQPSSREEAQQLWEAE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     759 KVKMRQILDKQQKQMVEDYQWLRQEEKSLDPMVYMNDKSPLTPEKEVGYR 808                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     801 KVKMRQILDKQQKQMVEDYQWLRQEEKSLDPMVYMNDKSPLTPEKEVGY. 849                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     809 ECSRPSSGVEFTGPPQKPPRLGAQSIQPTANLDRTDDLVYLNVMELVRAV 858                                                          
						                                                            	                 :|||||||||||||||||||||||||||||||||||||||||  
						                                                            	     850 ........LEFTGPPQKPPRLGAQSIQPTANLDRTDDLVYLNVMELVRAV 891                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     859 LELKNELCQLPPEGYVVVVKNVGLTLRKLIGSVDDLLPSLPSSSRTEIEG 908                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     892 LELKNELCQLPPEGYVVVVKNVGLTLRKLIGSVDDLLPSLPSSSRTEIEG 941                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     909 TQKLLNKDLAELINKMRLAQQNAVTSLSEECKRQMLTASHTLAVDAKNLL 958                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     942 TQKLLNKDLAELINKMRLAQQNAVTSLSEECKRQMLTASHTLAVDAKNLL 991                                                          
						                                                            	                  .                                          
						                                                            	     959 DAVDQAKVLANLAHPPAE                                 976                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     992 DAVDQAKVLANLAHPPAE                                 1009                                                         

1556	HMR136_F07698_4_tr0_r1_1_gPRT		Comparison report between F07698_P4 and Q96AB9partial WT     	Sequence name: Q96AB9                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F07698_P4, comprising a first amino 	Sequence documentation:                                      
						MTTFTEPEVVFLQSRGNEVCRKIWLGLFDARTSLVPDSRDPQKVKEFLQEKYEKKRWYVP 	                                                            
						PDQVKGPTYTKGSASTPVQGSIPEGKPLRTLLGDPAPSLSVAASTSSQPVSQSHARTSQA 	Alignment of: 1556 x Q96AB9   ..                             
						RSTQPPPHSSVKKASTDLLADIGGDPFAAPQMAPAFAAFPAFGGQTPSQGGFANFDAFSS 	                                                            
						GPSSSVFGSLPPAGQASFQAQPTPAGSSQGTPFGATPLAPASQPNSLADVGSFLGPGVPA 	Alignment segment 1/1:                                       
						AGVPSSLFGMAGQVPPLQSVT                                        	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 3845.00                      Escore:       0                                               
						to amino acids 88 - 348 of Q96AB9, which also corresponds to 	             Matching length:     394                Total length:     394                                               
						amino acids 1 - 261 of F07698_P4, a bridging amino acid M    	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						corresponding to amino acid 262 of F07698_P4, and a second   	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						GGGGGSSTGLAFGAFTNPFTAPAAQSPLPSTNPFQPNGLAPGPGFGMSSAGPGFPQAVPP 	                        Gaps:       0                        
						TGAFASSFPAPLFPPQTPLVQQQNGSSFGDLGSAKLGQRPLSQPAGISTNPFMTGPSSSP 	                                                            
						FASKPPTTNPFL                                                 	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 350 - 481 of Q96AB9, which also 	       1 MTTFTEPEVVFLQSRGNEVCRKIWLGLFDARTSLVPDSRDPQKVKEFLQE 50                                                           
						corresponds to amino acids 263 - 394 of F07698_P4, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid and      	      88 MTTFTEPEVVFLQSRGNEVCRKIWLGLFDARTSLVPDSRDPQKVKEFLQE 137                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 KYEKKRWYVPPDQVKGPTYTKGSASTPVQGSIPEGKPLRTLLGDPAPSLS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     138 KYEKKRWYVPPDQVKGPTYTKGSASTPVQGSIPEGKPLRTLLGDPAPSLS 187                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VAASTSSQPVSQSHARTSQARSTQPPPHSSVKKASTDLLADIGGDPFAAP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     188 VAASTSSQPVSQSHARTSQARSTQPPPHSSVKKASTDLLADIGGDPFAAP 237                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QMAPAFAAFPAFGGQTPSQGGFANFDAFSSGPSSSVFGSLPPAGQASFQA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     238 QMAPAFAAFPAFGGQTPSQGGFANFDAFSSGPSSSVFGSLPPAGQASFQA 287                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QPTPAGSSQGTPFGATPLAPASQPNSLADVGSFLGPGVPAAGVPSSLFGM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     288 QPTPAGSSQGTPFGATPLAPASQPNSLADVGSFLGPGVPAAGVPSSLFGM 337                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AGQVPPLQSVTMGGGGGSSTGLAFGAFTNPFTAPAAQSPLPSTNPFQPNG 300                                                          
						                                                            	         ||||||||||| ||||||||||||||||||||||||||||||||||||||  
						                                                            	     338 AGQVPPLQSVTTGGGGGSSTGLAFGAFTNPFTAPAAQSPLPSTNPFQPNG 387                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LAPGPGFGMSSAGPGFPQAVPPTGAFASSFPAPLFPPQTPLVQQQNGSSF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     388 LAPGPGFGMSSAGPGFPQAVPPTGAFASSFPAPLFPPQTPLVQQQNGSSF 437                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 GDLGSAKLGQRPLSQPAGISTNPFMTGPSSSPFASKPPTTNPFL       394                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     438 GDLGSAKLGQRPLSQPAGISTNPFMTGPSSSPFASKPPTTNPFL       481                                                          

22195	HMR136_F07904_2_tr0_r1_1_gPRT		Comparison report between F07904_P2 and VP26_HUMANpartial WT 	Sequence name: VP26_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F07904_P2, comprising a first amino acid        	                                                            
						MAEMKTEDGKVEKHYLFYDGESVSGKVNLAFKQPGKRLEHQGIRIEFVGQIELFNDKSNT 	Alignment of: 22195 x VP26_HUMAN   ..                        
						HEFVNLVKELALPGELTQSRSYDFEFMQVEKPYESYIGANVRLRYFLKVTIVRRLTDLVK 	                                                            
						EYDLIVHQLATYPDVNNSIKMEVGIEDCLHIEFEYNKSKYHLKDVIVGKIYFLLVRIKIQ 	Alignment segment 1/1:                                       
						HMELQLIKKEITGIGPSTTTETETIAKYEIMDGAPVKGESIPIRLFLAGYDPTPTMRDVN 	                                                            
						KKFSVRYFLNLVLVDEEDRRYFKQQEIILWRKAPEKLRKQRTNFHQRFESPESQASAEQP 	                     Quality: 2958.00                      Escore:       0                                               
						EM                                                           	             Matching length:     302                Total length:     302                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 26 - 327 of VP26_HUMAN, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 302 of F07904_P2.                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAEMKTEDGKVEKHYLFYDGESVSGKVNLAFKQPGKRLEHQGIRIEFVGQ 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      26 MAEMKTEDGKVEKHYLFYDGESVSGKVNLAFKQPGKRLEHQGIRIEFVGQ 75                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IELFNDKSNTHEFVNLVKELALPGELTQSRSYDFEFMQVEKPYESYIGAN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      76 IELFNDKSNTHEFVNLVKELALPGELTQSRSYDFEFMQVEKPYESYIGAN 125                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VRLRYFLKVTIVRRLTDLVKEYDLIVHQLATYPDVNNSIKMEVGIEDCLH 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     126 VRLRYFLKVTIVRRLTDLVKEYDLIVHQLATYPDVNNSIKMEVGIEDCLH 175                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IEFEYNKSKYHLKDVIVGKIYFLLVRIKIQHMELQLIKKEITGIGPSTTT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     176 IEFEYNKSKYHLKDVIVGKIYFLLVRIKIQHMELQLIKKEITGIGPSTTT 225                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ETETIAKYEIMDGAPVKGESIPIRLFLAGYDPTPTMRDVNKKFSVRYFLN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     226 ETETIAKYEIMDGAPVKGESIPIRLFLAGYDPTPTMRDVNKKFSVRYFLN 275                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LVLVDEEDRRYFKQQEIILWRKAPEKLRKQRTNFHQRFESPESQASAEQP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     276 LVLVDEEDRRYFKQQEIILWRKAPEKLRKQRTNFHQRFESPESQASAEQP 325                                                          
						                                                            	                                                             
						                                                            	     301 EM                                                 302                                                          
						                                                            	         ||                                                  
						                                                            	     326 EM                                                 327                                                          

22193	HMR136_F07904_7_tr0_r1_1_gPRT		Comparison report between F07904_P7 and VP26_HUMANpartial WT 	Sequence name: VP26_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F07904_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MQVEKPYESYIGANVRLR corresponding to amino acids 112 - 129 of 	Alignment of: 22193 x VP26_HUMAN   ..                        
						VP26_HUMAN, which also corresponds to amino acids 1 - 18 of  	                                                            
						F07904_P7, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						YHLKDVIVGKIYFLLVRIKIQHMELQLIKKEITGIGPSTTTETETIAKYEIMDGAPVKGE 	                                                            
						SIPIRLFLAGYDPTPTMRDVNKKFSVRYFLNLVLVDEEDRRYFKQQEIILWRKAPEKLRK 	                     Quality: 1479.00                      Escore:       0                                               
						QRTNFHQRFESPESQASAEQPEM                                      	             Matching length:     161                Total length:     216                                               
						% homologous to corresponding to amino acids 185 - 327 of    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VP26_HUMAN, which also corresponds to amino acids 19 - 161 of	    Total Percent Similarity:   74.54      Total Percent Identity:   74.54                                               
						F07904_P7, wherein said first amino acid sequence and second 	                        Gaps:       1                        
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated chimeric polypeptide encoding for an edge	Alignment:                                                   
						portion of F07904_P7, comprising a polypeptide having a      	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	       1 MQVEKPYESYIGANVRLR................................ 18                                                           
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||                                  
						preferably at least about 30 amino acids in length, more     	     112 MQVEKPYESYIGANVRLRYFLKVTIVRRLTDLVKEYDLIVHQLATYPDVN 161                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      19 .......................YHLKDVIVGKIYFLLVRIKIQHMELQL 45                                                           
						at least two amino acids comprise RY, having a structure as  	                                |||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     162 NSIKMEVGIEDCLHIEFEYNKSKYHLKDVIVGKIYFLLVRIKIQHMELQL 211                                                          
						18-x to 19; and ending at any of amino acid numbers 19+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      46 IKKEITGIGPSTTTETETIAKYEIMDGAPVKGESIPIRLFLAGYDPTPTM 95                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     212 IKKEITGIGPSTTTETETIAKYEIMDGAPVKGESIPIRLFLAGYDPTPTM 261                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      96 RDVNKKFSVRYFLNLVLVDEEDRRYFKQQEIILWRKAPEKLRKQRTNFHQ 145                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     262 RDVNKKFSVRYFLNLVLVDEEDRRYFKQQEIILWRKAPEKLRKQRTNFHQ 311                                                          
						                                                            	                  .                                          
						                                                            	     146 RFESPESQASAEQPEM                                   161                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     312 RFESPESQASAEQPEM                                   327                                                          

24320	HMR136_F08818_15_tr0_r1_1_gPRT		Comparison report between F08818_P15 and                     	Sequence name: AAKB_HUMAN_V1                                 
						AAKB_HUMAN_V1partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F08818_P15, comprising a first amino acid sequence being at  	                                                            
						MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSEEIKAPEKEEF 	Alignment of: 24320 x AAKB_HUMAN_V1   ..                     
						LAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNWSKLPLTRSHNNFVAILDLPE 	                                                            
						GEHQYKFFVDGQWTHDPSEPIVTSQLGTVNNIIQVKKTDFEVFDALMVDSQKCSDVS    	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 177	                                                            
						of AAKB_HUMAN_V1, which also corresponds to amino acids 1 -  	                     Quality: 1761.00                      Escore:       0                                               
						177 of F08818_P15, and a second amino acid sequence being at 	             Matching length:     177                Total length:     177                                               
						least 70%, optionally at least 80%, preferably at least 85%, 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						more preferably at least 90% and most preferably at least 95%	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence              	                        Gaps:       0                        
						GMNTVILYHMRAGGGCTV corresponding to amino acids 178 - 195 of 	                                                            
						F08818_P15, wherein said first amino acid sequence and second	Alignment:                                                   
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSE 50                                                           
						F08818_P15, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	       1 MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSE 50                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence GMNTVILYHMRAGGGCTV	      51 EIKAPEKEEFLAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNW 100                                                          
						in F08818_P15.                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EIKAPEKEEFLAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNW 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SKLPLTRSHNNFVAILDLPEGEHQYKFFVDGQWTHDPSEPIVTSQLGTVN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SKLPLTRSHNNFVAILDLPEGEHQYKFFVDGQWTHDPSEPIVTSQLGTVN 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 NIIQVKKTDFEVFDALMVDSQKCSDVS                        177                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     151 NIIQVKKTDFEVFDALMVDSQKCSDVS                        177                                                          

24322	HMR136_F08818_5_tr0_r1_1_gPRT		Comparison report between F08818_P5 and AAKB_HUMAN_V1partial 	Sequence name: AAKB_HUMAN_V1                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F08818_P5, comprising a first amino 	Sequence documentation:                                      
						MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSEEIKAPEKEEF 	                                                            
						LAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNWSKLPLTRSHNNFVAILDLPE 	Alignment of: 24322 x AAKB_HUMAN_V1   ..                     
						GEHQYKFFVDGQWTHDPSE                                          	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 139 of AAKB_HUMAN_V1, which also          	                                                            
						corresponds to amino acids 1 - 139 of F08818_P5, and a second	                     Quality: 1398.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     139                Total length:     139                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence SCPVLPQDPTIRSPTSANPKSAFGHPLFSPHISSRSS    	                        Gaps:       0                        
						corresponding to amino acids 140 - 176 of F08818_P5, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F08818_P5, comprising a   	       1 MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSE 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSE 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence SCPVLPQDPTIRSPTSANPKSAFGHPLFSPHISSRSS in     	      51 EIKAPEKEEFLAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNW 100                                                          
						F08818_P5.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EIKAPEKEEFLAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNW 100                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 SKLPLTRSHNNFVAILDLPEGEHQYKFFVDGQWTHDPSE            139                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     101 SKLPLTRSHNNFVAILDLPEGEHQYKFFVDGQWTHDPSE            139                                                          

24439	HMR136_F08824_14_tr0_r1_1_gPRT		Comparison report between F08824_P14 and Q8IZQ2partial WT    	Sequence name: Q8IZQ2                                        
						sequence with short unique insertion and a followed by a     	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						F08824_P14, comprising a first amino acid sequence being at  	                                                            
						least 90 % homologous to                                     	Alignment of: 24439 x Q8IZQ2   ..                            
						MSRVLVPCHVKGSVALQVGDVRTSQGRPGVLVIDVTFPSVAPFE corresponding to	                                                            
						amino acids 1 - 44 of Q8IZQ2, which also corresponds to amino	Alignment segment 1/1:                                       
						acids 1 - 44 of F08824_P14, a second amino acid sequence     	                                                            
						being at least 70%, optionally at least 80%, preferably at   	                     Quality:  902.00                      Escore:       0                                               
						least 85%, more preferably at least 90% and most preferably  	             Matching length:     101                Total length:     103                                               
						at least 95% homologous to a polypeptide having the sequence 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQ corresponding to amino acids 45 - 46 of F08824_P14, a     	    Total Percent Similarity:   98.06      Total Percent Identity:   98.06                                               
						third amino acid sequence being at least 90 % homologous to  	                        Gaps:       1                        
						EITFKNYYTAFLSIRVRQYTSAHTPAKWVTCLRDYCLMPDPHSEEGAQEYVSLFKHQ    	                                                            
						corresponding to amino acids 45 - 101 of Q8IZQ2, which also  	Alignment:                                                   
						corresponds to amino acids 47 - 103 of F08824_P14, and a     	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	       1 MSRVLVPCHVKGSVALQVGDVRTSQGRPGVLVIDVTFPSVAPFELQEITF 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||  ||||  
						90% and most preferably at least 95% homologous to a         	       1 MSRVLVPCHVKGSVALQVGDVRTSQGRPGVLVIDVTFPSVAPFE..EITF 48                                                           
						polypeptide having the sequence VSWASGWPG corresponding to   	                  .         .         .         .         .  
						amino acids 104 - 112 of F08824_P14, wherein said first amino	      51 KNYYTAFLSIRVRQYTSAHTPAKWVTCLRDYCLMPDPHSEEGAQEYVSLF 100                                                          
						acid sequence, second amino acid sequence, third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fourth amino acid sequence are contiguous and in	      49 KNYYTAFLSIRVRQYTSAHTPAKWVTCLRDYCLMPDPHSEEGAQEYVSLF 98                                                           
						a sequential order.2.An isolated polypeptide encoding for an 	                                                             
						edge portion of F08824_P14, comprising an amino acid sequence	     101 KHQ                                                103                                                          
						being at least 70%, optionally at least about 80%, preferably	         |||                                                 
						at least about 85%, more preferably at least about 90% and   	      99 KHQ                                                101                                                          
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for LQ, corresponding to F08824_P14.3.An isolated   	                                                            
						polypeptide encoding for a tail of F08824_P14, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VSWASGWPG in F08824_P14.                     	                                                            

						Comparison report between F08824_P14 and Q9BSH3partial WT    	Sequence name: Q9BSH3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F08824_P14, comprising a first amino	Sequence documentation:                                      
						MSRVLVPCHVKGSVALQVGDVRTSQGRPGVLVIDVTFPSVAPFELQEITFKNYYTAFLSI 	                                                            
						RVRQYTSAHTPAKWVTCLRDYCLMPDPHSEEGAQEYVSLFKHQ                  	Alignment of: 24439 x Q9BSH3   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 103 of Q9BSH3, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 103 of F08824_P14, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1021.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     103                Total length:     103                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence VSWASGWPG corresponding to amino acids   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						104 - 112 of F08824_P14, wherein said first amino acid       	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of F08824_P14, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MSRVLVPCHVKGSVALQVGDVRTSQGRPGVLVIDVTFPSVAPFELQEITF 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence VSWASGWPG in   	       1 MSRVLVPCHVKGSVALQVGDVRTSQGRPGVLVIDVTFPSVAPFELQEITF 50                                                           
						F08824_P14.                                                  	                  .         .         .         .         .  
						                                                            	      51 KNYYTAFLSIRVRQYTSAHTPAKWVTCLRDYCLMPDPHSEEGAQEYVSLF 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 KNYYTAFLSIRVRQYTSAHTPAKWVTCLRDYCLMPDPHSEEGAQEYVSLF 100                                                          
						                                                            	                                                             
						                                                            	     101 KHQ                                                103                                                          
						                                                            	         |||                                                 
						                                                            	     101 KHQ                                                103                                                          

25086	HMR136_F08841_4_tr0_r1_1_gPRT		Comparison report between F08841_P4 and Q8N4J3unique head    	Sequence name: Q8N4J3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F08841_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 25086 x Q8N4J3   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSSPGIDGDPKPPCLPRNGLVKLPGQPNGLGAASITKGTPATKNRPCQPPPPPTLPPPSL 	Alignment segment 1/1:                                       
						AAPLSRAALAGGPCTPAGGPASALAPGHPAERPPLATDEKILNGLFWYFSACEKCVLAQV 	                                                            
						CKAWRRVLYQPKFWAGLTPVLHAKELYNVLPGGEKEFVNLQGFAARGFEGFCLVGVSDLD 	                     Quality:  775.00                      Escore:       0                                               
						ICEFIDNYALSKKGVKAMSLKRSTITDAGLEVMLEQMQGVVRLELSGCNDFTEAGLWSSL 	             Matching length:      81                Total length:      81                                               
						SARITSLSVSDCINVADDAIAAISQLLPNLAELSLQAYHVTDTALAYFTARQGHSTHTLR 	 Matching Percent Similarity:   98.77   Matching Percent Identity:   98.77                                               
						LLSCWEITNHGVVNVVHSLPNLTALSLSGCSKVTDDGVELVAENLRKLRSLDLSWCPRIT 	    Total Percent Similarity:   98.77      Total Percent Identity:   98.77                                               
						DMALEYVACDLHRLEELVLD                                         	                        Gaps:       0                        
						having the sequence corresponding to amino acids 1 - 380 of  	                                                            
						F08841_P4, and a second amino acid sequence being at least 90	Alignment:                                                   
						SLYLRWCCQVQDFGLKHLLALGSLRLLSLAGCPLLTTTGLSGLVQLQELEELELTNCPGA 	                  .         .         .         .         .  
						TPELFKYFSQHLPRCLVIE                                          	     379 LDSLYLRWCCQVQDFGLKHLLALGSLRLLSLAGCPLLTTTGLSGLVQLQE 428                                                          
						% homologous to corresponding to amino acids 6 - 84 of       	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8N4J3, which also corresponds to amino acids 381 - 459 of   	       4 LRSLYLRWCCQVQDFGLKHLLALGSLRLLSLAGCPLLTTTGLSGLVQLQE 53                                                           
						F08841_P4, wherein said first amino acid sequence and second 	                  .         .         .                      
						amino acid sequence are contiguous and in a sequential       	     429 LEELELTNCPGATPELFKYFSQHLPRCLVIE                    459                                                          
						order.2.An isolated polypeptide encoding for a head of       	         |||||||||||||||||||||||||||||||                     
						F08841_P4, comprising a polypeptide being at least 70%,      	      54 LEELELTNCPGATPELFKYFSQHLPRCLVIE                    84                                                           
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						MSSPGIDGDPKPPCLPRNGLVKLPGQPNGLGAASITKGTPATKNRPCQPPPPPTLPPPSL 	                                                            
						AAPLSRAALAGGPCTPAGGPASALAPGHPAERPPLATDEKILNGLFWYFSACEKCVLAQV 	                                                            
						CKAWRRVLYQPKFWAGLTPVLHAKELYNVLPGGEKEFVNLQGFAARGFEGFCLVGVSDLD 	                                                            
						ICEFIDNYALSKKGVKAMSLKRSTITDAGLEVMLEQMQGVVRLELSGCNDFTEAGLWSSL 	                                                            
						SARITSLSVSDCINVADDAIAAISQLLPNLAELSLQAYHVTDTALAYFTARQGHSTHTLR 	                                                            
						LLSCWEITNHGVVNVVHSLPNLTALSLSGCSKVTDDGVELVAENLRKLRSLDLSWCPRIT 	                                                            
						DMALEYVACDLHRLEELVLD                                         	                                                            
						least about 95% homologous to the sequence of F08841_P4.     	                                                            

						Comparison report between F08841_P4 and Q8N461partial WT     	Sequence name: Q8N461                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for F08841_P4, comprising a    	Sequence documentation:                                      
						MSSPGIDGDPKPPCLPRNGLVKLPGQPNGLGAASITKGTPATKNRPCQPPPPPTLPPPSL 	                                                            
						AAPLSRAALAGGPCTPAGGPASALAPGHPAERPPLATDEKILNGLFWYFSACEKCVLAQV 	Alignment of: 25086 x Q8N461   ..                            
						CKAWRRVLYQPKFWAGLTPVLHAKELYNVLPGGEKEFVNLQGFAARGFEGFCLVGVSDLD 	                                                            
						ICEFIDNYALSKKGVKAMSLKRSTITDAGLEVMLEQMQGVVRLELSGCNDFTEAGLWSSL 	Alignment segment 1/1:                                       
						SARITSLSVSDCINVADDAIAAISQLLPNLAELSLQAYHVTDTALAYFTARQGHSTHTLR 	                                                            
						LLSCWEITNHGVVNVVHSLPNLTALSLSGCSKVTDDGVELVAENLRKLRSLDLSWCPRIT 	                     Quality: 4364.00                      Escore:       0                                               
						DMALEYVACDLHRLEELVLD                                         	             Matching length:     459                Total length:     479                                               
						first amino acid sequence being at least 90 % homologous to  	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						corresponding to amino acids 1 - 380 of Q8N461, which also   	    Total Percent Similarity:   95.62      Total Percent Identity:   95.62                                               
						corresponds to amino acids 1 - 380 of F08841_P4, a second    	                        Gaps:       1                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						SLYLRWCCQVQDFGLKHLLALGSLRLLS corresponding to amino acids 401	Alignment:                                                   
						- 428 of Q8N461, which also corresponds to amino acids 381 - 	                  .         .         .         .         .  
						408 of F08841_P4, a bridging amino acid L corresponding to   	       1 MSSPGIDGDPKPPCLPRNGLVKLPGQPNGLGAASITKGTPATKNRPCQPP 50                                                           
						amino acid 409 of F08841_P4, and a third amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to                            	       1 MSSPGIDGDPKPPCLPRNGLVKLPGQPNGLGAASITKGTPATKNRPCQPP 50                                                           
						AGCPLLTTTGLSGLVQLQELEELELTNCPGATPELFKYFSQHLPRCLVIE           	                  .         .         .         .         .  
						corresponding to amino acids 430 - 479 of Q8N461, which also 	      51 PPPTLPPPSLAAPLSRAALAGGPCTPAGGPASALAPGHPAERPPLATDEK 100                                                          
						corresponds to amino acids 410 - 459 of F08841_P4, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	      51 PPPTLPPPSLAAPLSRAALAGGPCTPAGGPASALAPGHPAERPPLATDEK 100                                                          
						bridging amino acid and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     101 ILNGLFWYFSACEKCVLAQVCKAWRRVLYQPKFWAGLTPVLHAKELYNVL 150                                                          
						polypeptide encoding for an edge portion of F08841_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     101 ILNGLFWYFSACEKCVLAQVCKAWRRVLYQPKFWAGLTPVLHAKELYNVL 150                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     151 PGGEKEFVNLQGFAARGFEGFCLVGVSDLDICEFIDNYALSKKGVKAMSL 200                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     151 PGGEKEFVNLQGFAARGFEGFCLVGVSDLDICEFIDNYALSKKGVKAMSL 200                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise DS, having a structure as follows: a sequence       	     201 KRSTITDAGLEVMLEQMQGVVRLELSGCNDFTEAGLWSSLSARITSLSVS 250                                                          
						starting from any of amino acid numbers 380-x to 381; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 381+ ((n-2) - x), in     	     201 KRSTITDAGLEVMLEQMQGVVRLELSGCNDFTEAGLWSSLSARITSLSVS 250                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     251 DCINVADDAIAAISQLLPNLAELSLQAYHVTDTALAYFTARQGHSTHTLR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DCINVADDAIAAISQLLPNLAELSLQAYHVTDTALAYFTARQGHSTHTLR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LLSCWEITNHGVVNVVHSLPNLTALSLSGCSKVTDDGVELVAENLRKLRS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LLSCWEITNHGVVNVVHSLPNLTALSLSGCSKVTDDGVELVAENLRKLRS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LDLSWCPRITDMALEYVACDLHRLEELVLD.................... 380                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     351 LDLSWCPRITDMALEYVACDLHRLEELVLDRCVRITDTGLSYLSTMSSLR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     381 SLYLRWCCQVQDFGLKHLLALGSLRLLSLAGCPLLTTTGLSGLVQLQELE 430                                                          
						                                                            	         |||||||||||||||||||||||||||| |||||||||||||||||||||  
						                                                            	     401 SLYLRWCCQVQDFGLKHLLALGSLRLLSPAGCPLLTTTGLSGLVQLQELE 450                                                          
						                                                            	                  .         .                                
						                                                            	     431 ELELTNCPGATPELFKYFSQHLPRCLVIE                      459                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     451 ELELTNCPGATPELFKYFSQHLPRCLVIE                      479                                                          

25419	HMR136_F08852_10_tr0_r1_1_gPRT		Comparison report between F08852_P10 and Q8NBX0partial WT    	Sequence name: Q8NBX0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F08852_P10, comprising a first amino	Sequence documentation:                                      
						MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSREKLQRVLEKAA 	                                                            
						LKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVGPYRFYGEPVIKACIENGASC 	Alignment of: 25419 x Q8NBX0   ..                            
						IDISGEPQFLELMQLKYHEKAADKGVYIIGSSGFDSIPADLGVIYTRNKMNGTLTAVESF 	                                                            
						LTIHSGPEGLSIHDGTWKSAIYGFGDQSNLRKLRNVSNLKPVPLIGP              	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 227 of Q8NBX0, which also corresponds to  	                     Quality: 2194.00                      Escore:       0                                               
						amino acids 1 - 227 of F08852_P10, and a second amino acid   	             Matching length:     229                Total length:     229                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:   99.56   Matching Percent Identity:   99.56                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:   99.56      Total Percent Identity:   99.56                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence FLLWDLMCLL corresponding to amino acids  	                                                            
						228 - 237 of F08852_P10, wherein said first amino acid       	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSRE 50                                                           
						tail of F08852_P10, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSRE 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence FLLWDLMCLL in  	      51 KLQRVLEKAALKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVG 100                                                          
						F08852_P10.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 KLQRVLEKAALKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVG 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PYRFYGEPVIKACIENGASCIDISGEPQFLELMQLKYHEKAADKGVYIIG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 PYRFYGEPVIKACIENGASCIDISGEPQFLELMQLKYHEKAADKGVYIIG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SSGFDSIPADLGVIYTRNKMNGTLTAVESFLTIHSGPEGLSIHDGTWKSA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SSGFDSIPADLGVIYTRNKMNGTLTAVESFLTIHSGPEGLSIHDGTWKSA 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 IYGFGDQSNLRKLRNVSNLKPVPLIGPFL                      229                                                          
						                                                            	         ||||||||||||||||||||||||||| |                       
						                                                            	     201 IYGFGDQSNLRKLRNVSNLKPVPLIGPKL                      229                                                          

						Comparison report between F08852_P10 and Q8TAR0partial WT    	Sequence name: Q8TAR0                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F08852_P10, comprising a first amino acid sequence being at  	                                                            
						MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSREKLQRVLEKAA 	Alignment of: 25419 x Q8TAR0   ..                            
						LKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVGPYRFYGEPVIKACIENGASC 	                                                            
						IDISGEPQFLELMQLKYHEKAADKGVYIIGSSGFDSIPADLGVIYTRNKMNGTLTAVESF 	Alignment segment 1/1:                                       
						LTIHSG                                                       	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 186	                     Quality: 2177.00                      Escore:       0                                               
						of Q8TAR0, which also corresponds to amino acids 1 - 186 of  	             Matching length:     229                Total length:     229                                               
						F08852_P10, a bridging amino acid P corresponding to amino   	 Matching Percent Similarity:   99.13   Matching Percent Identity:   99.13                                               
						acid 187 of F08852_P10, a second amino acid sequence being at	    Total Percent Similarity:   99.13      Total Percent Identity:   99.13                                               
						least 90 % homologous to                                     	                        Gaps:       0                        
						EGLSIHDGTWKSAIYGFGDQSNLRKLRNVSNLKPVPLIGP corresponding to    	                                                            
						amino acids 188 - 227 of Q8TAR0, which also corresponds to   	Alignment:                                                   
						amino acids 188 - 227 of F08852_P10, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSRE 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSRE 50                                                           
						having the sequence FLLWDLMCLL corresponding to amino acids  	                  .         .         .         .         .  
						228 - 237 of F08852_P10, wherein said first amino acid       	      51 KLQRVLEKAALKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVG 100                                                          
						sequence, bridging amino acid, second amino acid sequence and	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence are contiguous and in a sequential 	      51 KLQRVLEKAALKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVG 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F08852_P10, comprising a polypeptide being at least 70%,     	     101 PYRFYGEPVIKACIENGASCIDISGEPQFLELMQLKYHEKAADKGVYIIG 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 PYRFYGEPVIKACIENGASCIDISGEPQFLELMQLKYHEKAADKGVYIIG 150                                                          
						least about 95% homologous to the sequence FLLWDLMCLL in     	                  .         .         .         .         .  
						F08852_P10.                                                  	     151 SSGFDSIPADLGVIYTRNKMNGTLTAVESFLTIHSGPEGLSIHDGTWKSA 200                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||| |||||||||||||  
						                                                            	     151 SSGFDSIPADLGVIYTRNKMNGTLTAVESFLTIHSGHEGLSIHDGTWKSA 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 IYGFGDQSNLRKLRNVSNLKPVPLIGPFL                      229                                                          
						                                                            	         ||||||||||||||||||||||||||| |                       
						                                                            	     201 IYGFGDQSNLRKLRNVSNLKPVPLIGPKL                      229                                                          

27440	HMR136_F09012_13_tr0_r1_1_gPRT		Comparison report between F09012_P13 and MTR2_HUMANpartial   	Sequence name: MTR2_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F09012_P13, comprising a first amino	                                                            
						MLMLDGYYRTIRGFEVLVEKEWLSFGHRFQLRVGHGDKNHADADRSPVFLQFIDCVWQMT 	Alignment of: 27440 x MTR2_HUMAN   ..                        
						RQFPTAFEFNEYFLITILDHLYSCLFGTFLCNSEQQRGKENLPKRTVSLWSYINSQLEDF 	                                                            
						TNPLYGSYSNHVLYPVASMRHLELWVGYYIRWNPRMKPQEPIHNRYKELLAKRAELQKKV 	Alignment segment 1/1:                                       
						EELQREISNRSTSSSERASSPAQCVTPVQTVV                             	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2138.00                      Escore:       0                                               
						to amino acids 432 - 643 of MTR2_HUMAN, which also           	             Matching length:     212                Total length:     212                                               
						corresponds to amino acids 1 - 212 of F09012_P13.            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLMLDGYYRTIRGFEVLVEKEWLSFGHRFQLRVGHGDKNHADADRSPVFL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     432 MLMLDGYYRTIRGFEVLVEKEWLSFGHRFQLRVGHGDKNHADADRSPVFL 481                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QFIDCVWQMTRQFPTAFEFNEYFLITILDHLYSCLFGTFLCNSEQQRGKE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     482 QFIDCVWQMTRQFPTAFEFNEYFLITILDHLYSCLFGTFLCNSEQQRGKE 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NLPKRTVSLWSYINSQLEDFTNPLYGSYSNHVLYPVASMRHLELWVGYYI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     532 NLPKRTVSLWSYINSQLEDFTNPLYGSYSNHVLYPVASMRHLELWVGYYI 581                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RWNPRMKPQEPIHNRYKELLAKRAELQKKVEELQREISNRSTSSSERASS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     582 RWNPRMKPQEPIHNRYKELLAKRAELQKKVEELQREISNRSTSSSERASS 631                                                          
						                                                            	                  .                                          
						                                                            	     201 PAQCVTPVQTVV                                       212                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     632 PAQCVTPVQTVV                                       643                                                          

27888	HMR136_F09033_6_tr0_r1_1_gPRT		Comparison report between F09033_P6 and Q8WVJ2partial WT     	Sequence name: Q8WVJ2                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F09033_P6, comprising a first amino 	Sequence documentation:                                      
						MSAPFEERSGVVPCGTPWGQWYQTLEEVFIEVQVPPGTRAQDIQCGLQSRHVALSVGGRE 	                                                            
						ILKGKLFDSTIADEGTWT                                           	Alignment of: 27888 x Q8WVJ2   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 78 of Q8WVJ2, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 78 of F09033_P6, and a second amino acid     	                                                            
						sequence being at least 90 % homologous to                   	                     Quality: 1216.00                      Escore:       0                                               
						LESEYAADPWVQDQMQRKLTLERFQKENPGFDFSGAEISGNYTKGGPDFSNLEK       	             Matching length:     132                Total length:     157                                               
						corresponding to amino acids 104 - 157 of Q8WVJ2, which also 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 79 - 132 of F09033_P6, wherein    	    Total Percent Similarity:   84.08      Total Percent Identity:   84.08                                               
						said first amino acid sequence and second amino acid sequence	                        Gaps:       1                        
						are contiguous and in a sequential order.2.An isolated       	                                                            
						chimeric polypeptide encoding for an edge portion of         	Alignment:                                                   
						F09033_P6, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	       1 MSAPFEERSGVVPCGTPWGQWYQTLEEVFIEVQVPPGTRAQDIQCGLQSR 50                                                           
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	       1 MSAPFEERSGVVPCGTPWGQWYQTLEEVFIEVQVPPGTRAQDIQCGLQSR 50                                                           
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      51 HVALSVGGREILKGKLFDSTIADEGTWT...................... 78                                                           
						at least two amino acids comprise TL, having a structure as  	         ||||||||||||||||||||||||||||                        
						follows: a sequence starting from any of amino acid numbers  	      51 HVALSVGGREILKGKLFDSTIADEGTWTLEDRKMVRIVLTKTKRDAANCW 100                                                          
						78-x to 79; and ending at any of amino acid numbers 79+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      79 ...LESEYAADPWVQDQMQRKLTLERFQKENPGFDFSGAEISGNYTKGGP 125                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TSLLESEYAADPWVQDQMQRKLTLERFQKENPGFDFSGAEISGNYTKGGP 150                                                          
						                                                            	                                                             
						                                                            	     126 DFSNLEK                                            132                                                          
						                                                            	         |||||||                                             
						                                                            	     151 DFSNLEK                                            157                                                          

27890	HMR136_F09033_7_tr0_r1_1_gPRT		Comparison report between F09033_P7 and Q8WVJ2partial WT     	Sequence name: Q8WVJ2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09033_P7, comprising a first amino 	Sequence documentation:                                      
						MSAPFEERSGVVPCGTPWGQWYQTLEEVFIEVQVPPGTRAQDIQCGLQSRHVALSVGGRE 	                                                            
						ILKGKLFDSTIADEGTWTL                                          	Alignment of: 27890 x Q8WVJ2   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 79 of Q8WVJ2, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 79 of F09033_P7, and a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  783.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      79                Total length:      79                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence GKGNYYNSSN corresponding to amino acids  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						80 - 89 of F09033_P7, wherein said first amino acid sequence 	                        Gaps:       0                        
						and second amino acid sequence are contiguous and in a       	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	Alignment:                                                   
						tail of F09033_P7, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MSAPFEERSGVVPCGTPWGQWYQTLEEVFIEVQVPPGTRAQDIQCGLQSR 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence GKGNYYNSSN in  	       1 MSAPFEERSGVVPCGTPWGQWYQTLEEVFIEVQVPPGTRAQDIQCGLQSR 50                                                           
						F09033_P7.                                                   	                  .         .                                
						                                                            	      51 HVALSVGGREILKGKLFDSTIADEGTWTL                      79                                                           
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	      51 HVALSVGGREILKGKLFDSTIADEGTWTL                      79                                                           

28018	HMR136_F09045_1_tr0_r1_1_gPRT		Comparison report between F09045_P1 and OCTC_HUMAN_V1partial 	Sequence name: OCTC_HUMAN_V1                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F09045_P1, comprising a first amino 	Sequence documentation:                                      
						MENQLAKSTEERTFQYQDSLPSLPVPSLEESLKKYLESVKPFANQEEYKKTEEIVQKFQS 	                                                            
						GIGEKLHQKLLERAKGKRNWLEEWWLNVAYLDVRIPSQLNVNFAGPAAHFEHYWPPKEGT 	Alignment of: 28018 x OCTC_HUMAN_V1   ..                     
						QLERGSITLWHNLNYWQLLRKEKVPVHKVGNTPLDMNQFRMLFSTCKVPGITRDSIMNYF 	                                                            
						RTESEGRSPNHIVVLCRGRAFVFDVIHEGCLVTPPELLRQLTYIHKKCHSEPDGPGIAAL 	Alignment segment 1/1:                                       
						TSEERTRWAKAREYLIGLDPENLAL                                    	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2662.00                      Escore:       0                                               
						to amino acids 1 - 265 of OCTC_HUMAN_V1, which also          	             Matching length:     268                Total length:     268                                               
						corresponds to amino acids 1 - 265 of F09045_P1, and a second	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.88                                               
						amino acid sequence being at least 70%, optionally at least  	    Total Percent Similarity:  100.00      Total Percent Identity:   98.88                                               
						80%, preferably at least 85%, more preferably at least 90%   	                        Gaps:       0                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence VQRRYEIYHFQKSSFSLWMRKF corresponding to  	Alignment:                                                   
						amino acids 266 - 287 of F09045_P1, wherein said first amino 	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	       1 MENQLAKSTEERTFQYQDSLPSLPVPSLEESLKKYLESVKPFANQEEYKK 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a tail of F09045_P1, comprising a polypeptide being at   	       1 MENQLAKSTEERTFQYQDSLPSLPVPSLEESLKKYLESVKPFANQEEYKK 50                                                           
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      51 TEEIVQKFQSGIGEKLHQKLLERAKGKRNWLEEWWLNVAYLDVRIPSQLN 100                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VQRRYEIYHFQKSSFSLWMRKF in F09045_P1.                         	      51 TEEIVQKFQSGIGEKLHQKLLERAKGKRNWLEEWWLNVAYLDVRIPSQLN 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VNFAGPAAHFEHYWPPKEGTQLERGSITLWHNLNYWQLLRKEKVPVHKVG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VNFAGPAAHFEHYWPPKEGTQLERGSITLWHNLNYWQLLRKEKVPVHKVG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NTPLDMNQFRMLFSTCKVPGITRDSIMNYFRTESEGRSPNHIVVLCRGRA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NTPLDMNQFRMLFSTCKVPGITRDSIMNYFRTESEGRSPNHIVVLCRGRA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FVFDVIHEGCLVTPPELLRQLTYIHKKCHSEPDGPGIAALTSEERTRWAK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FVFDVIHEGCLVTPPELLRQLTYIHKKCHSEPDGPGIAALTSEERTRWAK 250                                                          
						                                                            	                  .                                          
						                                                            	     251 AREYLIGLDPENLALVQR                                 268                                                          
						                                                            	         |||||||||||||||:::                                  
						                                                            	     251 AREYLIGLDPENLALLEK                                 268                                                          

3893	HMR136_F09066_10_tr0_r1_1_gPRT		Comparison report between F09066_P10 and Q96B94partial WT    	Sequence name: Q96B94                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09066_P10, comprising a first amino acid sequence being at  	                                                            
						MKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCAT 	Alignment of: 3893 x Q96B94   ..                             
						LLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK  	                                                            
						least 90 % homologous to corresponding to amino acids 131 -  	Alignment segment 1/1:                                       
						249 of Q96B94, which also corresponds to amino acids 1 - 119 	                                                            
						of F09066_P10, a bridging amino acid I corresponding to amino	                     Quality: 5399.00                      Escore:       0                                               
						acid 120 of F09066_P10, a second amino acid sequence being at	             Matching length:     551                Total length:     551                                               
						GLMSLTTNLYEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						VGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						KQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVSEDGCLEI 	                        Gaps:       0                        
						RQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGLKGRDRSWVIG 	                                                            
						SPEILRKRLSVSESSHTESDSSPPMTVRRRCSGLLDAPRFPEGPEEASSTLRRQPQEGIW 	Alignment:                                                   
						VLTPPSGEGVSGPVTEHSGEQRPKLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAIS 	                  .         .         .         .         .  
						DLAVRRARHRLLSGDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQ 	       1 MKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVM 50                                                           
						SSNPSSRDSSP                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 251 -  	     131 MKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVM 180                                                          
						681 of Q96B94, which also corresponds to amino acids 121 -   	                  .         .         .         .         .  
						551 of F09066_P10, and a third amino acid sequence being at  	      51 EYVEGGDCATLLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPD 100                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     181 EYVEGGDCATLLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPD 230                                                          
						SRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYTVHHMVWHVEDGGPASEAG 	                  .         .         .         .         .  
						LRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLENTSIKVGPARKGSYKAKM 	     101 NLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDAREFLDKQVCGTP 150                                                          
						ARRSKRSRGKDGQESRKRSSLFRKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHS 	         |||||||||||||||||||:||||||||||||||||||||||||||||||  
						LSPRSPTQGYRVTPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQY 	     231 NLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHIEKDAREFLDKQVCGTP 280                                                          
						RSPRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSPPLGRQLSR 	                  .         .         .         .         .  
						PKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDLPHSELKKELPPREVSPLE 	     151 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 200                                                          
						VVGARSVLSGKGALPGKGVLQPAPSRALGTLRQDRAERRESLQKQEAIREVDSSEDDTEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPENSQGAQELSLAPHPEVSQSVAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGP 	     281 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 330                                                          
						PRMESPSGPHRRLGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTAL 	                  .         .         .         .         .  
						SPSTSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLANLQDLENTT 	     201 DEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLD 250                                                          
						PAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECAQAVKEDPALSITQVPDAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQKHRDLALVPDELLKQT             	     331 DEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLD 380                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 552 - 1259 of F09066_P10, wherein said first  	     251 WTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVSEDGCLEI 300                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     381 WTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVSEDGCLEI 430                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F09066_P10, comprising a polypeptide being at least  	     301 RQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGL 350                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     431 RQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGL 480                                                          
						SRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYTVHHMVWHVEDGGPASEAG 	                  .         .         .         .         .  
						LRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLENTSIKVGPARKGSYKAKM 	     351 KGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSGLLDAPRF 400                                                          
						ARRSKRSRGKDGQESRKRSSLFRKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSPRSPTQGYRVTPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQY 	     481 KGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSGLLDAPRF 530                                                          
						RSPRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSPPLGRQLSR 	                  .         .         .         .         .  
						PKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDLPHSELKKELPPREVSPLE 	     401 PEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVTEHSGEQRPKLDEEAV 450                                                          
						VVGARSVLSGKGALPGKGVLQPAPSRALGTLRQDRAERRESLQKQEAIREVDSSEDDTEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPENSQGAQELSLAPHPEVSQSVAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGP 	     531 PEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVTEHSGEQRPKLDEEAV 580                                                          
						PRMESPSGPHRRLGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTAL 	                  .         .         .         .         .  
						SPSTSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLANLQDLENTT 	     451 GRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVRRARHRLLSGDSTEKR 500                                                          
						PAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECAQAVKEDPALSITQVPDAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQKHRDLALVPDELLKQT             	     581 GRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVRRARHRLLSGDSTEKR 630                                                          
						at least about 95% homologous to the sequence in F09066_P10. 	                  .         .         .         .         .  
						                                                            	     501 TARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQSSNPSSRDSS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     631 TARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQSSNPSSRDSS 680                                                          
						                                                            	                                                             
						                                                            	     551 P                                                  551                                                          
						                                                            	         |                                                   
						                                                            	     681 P                                                  681                                                          

						Comparison report between F09066_P10 and Q8NDG1unique head   	Sequence name: Q8NDG1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09066_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 3893 x Q8NDG1   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCAT 	Alignment segment 1/1:                                       
						LLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 	                                                            
						GLMSLTTNLYEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 	                     Quality: 9424.00                      Escore:       0                                               
						VGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEV 	             Matching length:     966                Total length:     966                                               
						KQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVS        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 293 of  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						F09066_P10, and a second amino acid sequence being at least  	                        Gaps:       0                        
						EDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGLKGR 	                                                            
						DRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSGLLDAPRFPEGPEEASSTLRR 	Alignment:                                                   
						QPQEGIWVLTPPSGEGVSGPVTEHSGEQRPKLDEEAVGRSSGSSPAMETRGRGTSQLAEG 	                  .         .         .         .         .  
						ATAKAISDLAVRRARHRLLSGDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLAS 	     294 EDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDH 343                                                          
						PMSPHSQSSNPSSRDSSPSRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLE 	       1 EDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDH 50                                                           
						NTSIKVGPARKGSYKAKMARRSKRSRGKDGQESRKRSSLFRKITKQASLLHTSRSLSSLN 	                  .         .         .         .         .  
						RSLSSGESGPGSPTHSHSLSPRSPTQGYRVTPDAVHSVGGNSSQSSSPSSSVPSSPAGSG 	     344 SDGLAGLKGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSG 393                                                          
						HTRPSSLHGLAPKLQRQYRSPRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AFPTKLHLSPPLGRQLSRPKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDL 	      51 SDGLAGLKGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSG 100                                                          
						PHSELKKELPPREVSPLEVVGARSVLSGKGALPGKGVLQPAPSRALGTLRQDRAERRESL 	                  .         .         .         .         .  
						QKQEAIREVDSSEDDTEEGPENSQGAQELSLAPHPEVSQSVAPKGAGESGEEDPFPSRDP 	     394 LLDAPRFPEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVTEHSGEQRP 443                                                          
						RSLGPMVPSLLTGITLGPPRMESPSGPHRRLGSPQAIEEAASSSSAGPNLGQSGATDPIP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEGCWKAQHLHTQALTALSPSTSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSR 	     101 LLDAPRFPEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVTEHSGEQRP 150                                                          
						KATMAGGLANLQDLENTTPAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECA 	                  .         .         .         .         .  
						QAVKEDPALSITQVPDASGDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQKHRDLALVPD 	     444 KLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVRRARHRLLS 493                                                          
						ELLKQT                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 966 of   	     151 KLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVRRARHRLLS 200                                                          
						Q8NDG1, which also corresponds to amino acids 294 - 1259 of  	                  .         .         .         .         .  
						F09066_P10, wherein said first amino acid sequence and second	     494 GDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQSSN 543                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     201 GDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQSSN 250                                                          
						F09066_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     544 PSSRDSSPSRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYT 593                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCAT 	     251 PSSRDSSPSRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYT 300                                                          
						LLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 	                  .         .         .         .         .  
						GLMSLTTNLYEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 	     594 VHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGN 643                                                          
						VGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVS        	     301 VHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGN 350                                                          
						least about 95% homologous to the sequence of F09066_P10.    	                  .         .         .         .         .  
						                                                            	     644 KVAISTTPLENTSIKVGPARKGSYKAKMARRSKRSRGKDGQESRKRSSLF 693                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KVAISTTPLENTSIKVGPARKGSYKAKMARRSKRSRGKDGQESRKRSSLF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     694 RKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHSLSPRSPTQGYRV 743                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHSLSPRSPTQGYRV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     744 TPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQYRS 793                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQYRS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     794 PRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSP 843                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 PRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     844 PLGRQLSRPKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDL 893                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 PLGRQLSRPKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     894 PHSELKKELPPREVSPLEVVGARSVLSGKGALPGKGVLQPAPSRALGTLR 943                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PHSELKKELPPREVSPLEVVGARSVLSGKGALPGKGVLQPAPSRALGTLR 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     944 QDRAERRESLQKQEAIREVDSSEDDTEEGPENSQGAQELSLAPHPEVSQS 993                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QDRAERRESLQKQEAIREVDSSEDDTEEGPENSQGAQELSLAPHPEVSQS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     994 VAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGPPRMESPSGPHRR 1043                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGPPRMESPSGPHRR 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1044 LGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTALSP 1093                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTALSP 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1094 STSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLAN 1143                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 STSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLAN 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1144 LQDLENTTPAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECA 1193                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LQDLENTTPAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECA 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1194 QAVKEDPALSITQVPDASGDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQ 1243                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 QAVKEDPALSITQVPDASGDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQ 950                                                          
						                                                            	                  .                                          
						                                                            	    1244 KHRDLALVPDELLKQT                                   1259                                                         
						                                                            	         ||||||||||||||||                                    
						                                                            	     951 KHRDLALVPDELLKQT                                   966                                                          

3895	HMR136_F09066_11_tr0_r1_1_gPRT		Comparison report between F09066_P11 and Q96B94unique head   	Sequence name: Q96B94                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F09066_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 3895 x Q96B94   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GMGRTLFPR    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 9 of F09066_P11, a second   	                                                            
						AVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRH 	                     Quality: 5543.00                      Escore:       0                                               
						LCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLIT 	             Matching length:     566                Total length:     566                                               
						SMGHIKLTDFGLSK                                               	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						corresponding to amino acids 116 - 249 of Q96B94, which also 	                        Gaps:       0                        
						corresponds to amino acids 10 - 143 of F09066_P11, a bridging	                                                            
						amino acid I corresponding to amino acid 144 of F09066_P11, a	Alignment:                                                   
						GLMSLTTNLYEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 	                  .         .         .         .         .  
						VGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEV 	      10 AVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVS 59                                                           
						KQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMDSEDEEEVSEDGCLEI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGLKGRDRSWVIG 	     116 AVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVS 165                                                          
						SPEILRKRLSVSESSHTESDSSPPMTVRRRCSGLLDAPRFPEGPEEASSTLRRQPQEGIW 	                  .         .         .         .         .  
						VLTPPSGEGVSGPVTEHSGEQRPKLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAIS 	      60 MFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLALE 109                                                          
						DLAVRRARHRLLSGDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSNPSSRDSSP                                                  	     166 MFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLALE 215                                                          
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 251 - 681 of Q96B94, which also 	     110 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 159                                                          
						corresponds to amino acids 145 - 575 of F09066_P11, and a    	         ||||||||||||||||||||||||||||||||||:|||||||||||||||  
						fourth amino acid sequence being at least 70%, optionally at 	     216 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHIE 265                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     160 KDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 209                                                          
						SRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYTVHHMVWHVEDGGPASEAG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLENTSIKVGPARKGSYKAKM 	     266 KDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 315                                                          
						ARRSKRSRGKDGQESRKRSSLFRKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHS 	                  .         .         .         .         .  
						LSPRSPTQGYRVTPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQY 	     210 FFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTG 259                                                          
						RSPRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSPPLGRQLSR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDLPHSELKKELPPREVSPLE 	     316 FFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTG 365                                                          
						VVGARSVLSGKGALPGKGVLQPAPSRALGTLRQDRAERRESLQKQEAIREVDSSEDDTEE 	                  .         .         .         .         .  
						GPENSQGAQELSLAPHPEVSQSVAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGP 	     260 SAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMD 309                                                          
						PRMESPSGPHRRLGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPSTSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLANLQDLENTT 	     366 SAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTRSERYHHMD 415                                                          
						PAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECAQAVKEDPALSITQVPDAS 	                  .         .         .         .         .  
						GDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQKHRDLALVPDELLKQT             	     310 SEDEEEVSEDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRS 359                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						576 - 1283 of F09066_P11, wherein said first amino acid      	     416 SEDEEEVSEDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRS 465                                                          
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     360 LSEEKEDHSDGLAGLKGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPM 409                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F09066_P11, comprising a  	     466 LSEEKEDHSDGLAGLKGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPM 515                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     410 TVRRRCSGLLDAPRFPEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVT 459                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence GMGRTLFPR of F09066_P11.3.An isolated        	     516 TVRRRCSGLLDAPRFPEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVT 565                                                          
						polypeptide encoding for a tail of F09066_P11, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     460 EHSGEQRPKLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVR 509                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     566 EHSGEQRPKLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVR 615                                                          
						SRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYTVHHMVWHVEDGGPASEAG 	                  .         .         .         .         .  
						LRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLENTSIKVGPARKGSYKAKM 	     510 RARHRLLSGDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPM 559                                                          
						ARRSKRSRGKDGQESRKRSSLFRKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSPRSPTQGYRVTPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQY 	     616 RARHRLLSGDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPM 665                                                          
						RSPRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSPPLGRQLSR 	                  .                                          
						PKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDLPHSELKKELPPREVSPLE 	     560 SPHSQSSNPSSRDSSP                                   575                                                          
						VVGARSVLSGKGALPGKGVLQPAPSRALGTLRQDRAERRESLQKQEAIREVDSSEDDTEE 	         ||||||||||||||||                                    
						GPENSQGAQELSLAPHPEVSQSVAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGP 	     666 SPHSQSSNPSSRDSSP                                   681                                                          
						PRMESPSGPHRRLGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTAL 	                                                            
						SPSTSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLANLQDLENTT 	                                                            
						PAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECAQAVKEDPALSITQVPDAS 	                                                            
						GDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQKHRDLALVPDELLKQT             	                                                            
						to the sequence in F09066_P11.                               	                                                            

						Comparison report between F09066_P11 and Q8NDG1unique head   	Sequence name: Q8NDG1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09066_P11, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 3895 x Q8NDG1   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						GMGRTLFPRAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSM 	Alignment segment 1/1:                                       
						FCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRD 	                                                            
						LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDAREFLDKQVCGTPEYIAPE 	                     Quality: 9424.00                      Escore:       0                                               
						VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDA 	             Matching length:     966                Total length:     966                                               
						QDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSERYHHMDSEDEEEVS                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 317 of  	                        Gaps:       0                        
						F09066_P11, and a second amino acid sequence being at least  	                                                            
						EDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDHSDGLAGLKGR 	Alignment:                                                   
						DRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSGLLDAPRFPEGPEEASSTLRR 	                  .         .         .         .         .  
						QPQEGIWVLTPPSGEGVSGPVTEHSGEQRPKLDEEAVGRSSGSSPAMETRGRGTSQLAEG 	     318 EDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDH 367                                                          
						ATAKAISDLAVRRARHRLLSGDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PMSPHSQSSNPSSRDSSPSRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYT 	       1 EDGCLEIRQFSSCSPRFNKVYSSMERLSLLEERRTPPPTKRSLSEEKEDH 50                                                           
						VHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLE 	                  .         .         .         .         .  
						NTSIKVGPARKGSYKAKMARRSKRSRGKDGQESRKRSSLFRKITKQASLLHTSRSLSSLN 	     368 SDGLAGLKGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSG 417                                                          
						RSLSSGESGPGSPTHSHSLSPRSPTQGYRVTPDAVHSVGGNSSQSSSPSSSVPSSPAGSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HTRPSSLHGLAPKLQRQYRSPRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQ 	      51 SDGLAGLKGRDRSWVIGSPEILRKRLSVSESSHTESDSSPPMTVRRRCSG 100                                                          
						AFPTKLHLSPPLGRQLSRPKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDL 	                  .         .         .         .         .  
						PHSELKKELPPREVSPLEVVGARSVLSGKGALPGKGVLQPAPSRALGTLRQDRAERRESL 	     418 LLDAPRFPEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVTEHSGEQRP 467                                                          
						QKQEAIREVDSSEDDTEEGPENSQGAQELSLAPHPEVSQSVAPKGAGESGEEDPFPSRDP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSLGPMVPSLLTGITLGPPRMESPSGPHRRLGSPQAIEEAASSSSAGPNLGQSGATDPIP 	     101 LLDAPRFPEGPEEASSTLRRQPQEGIWVLTPPSGEGVSGPVTEHSGEQRP 150                                                          
						PEGCWKAQHLHTQALTALSPSTSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSR 	                  .         .         .         .         .  
						KATMAGGLANLQDLENTTPAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECA 	     468 KLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVRRARHRLLS 517                                                          
						QAVKEDPALSITQVPDASGDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQKHRDLALVPD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELLKQT                                                       	     151 KLDEEAVGRSSGSSPAMETRGRGTSQLAEGATAKAISDLAVRRARHRLLS 200                                                          
						90 % homologous to corresponding to amino acids 1 - 966 of   	                  .         .         .         .         .  
						Q8NDG1, which also corresponds to amino acids 318 - 1283 of  	     518 GDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQSSN 567                                                          
						F09066_P11, wherein said first amino acid sequence and second	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 GDSTEKRTARPVNKVIKSASATALSLLIPSEHHTCSPLASPMSPHSQSSN 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F09066_P11, comprising a polypeptide being at least 70%,     	     568 PSSRDSSPSRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYT 617                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 PSSRDSSPSRDFLPALGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYT 300                                                          
						GMGRTLFPRAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSM 	                  .         .         .         .         .  
						FCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLALEYLHNYGIVHRD 	     618 VHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGN 667                                                          
						LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDAREFLDKQVCGTPEYIAPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDA 	     301 VHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGN 350                                                          
						QDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDT 	                  .         .         .         .         .  
						RSERYHHMDSEDEEEVS                                            	     668 KVAISTTPLENTSIKVGPARKGSYKAKMARRSKRSRGKDGQESRKRSSLF 717                                                          
						least about 95% homologous to the sequence of F09066_P11.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KVAISTTPLENTSIKVGPARKGSYKAKMARRSKRSRGKDGQESRKRSSLF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     718 RKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHSLSPRSPTQGYRV 767                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RKITKQASLLHTSRSLSSLNRSLSSGESGPGSPTHSHSLSPRSPTQGYRV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     768 TPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQYRS 817                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TPDAVHSVGGNSSQSSSPSSSVPSSPAGSGHTRPSSLHGLAPKLQRQYRS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     818 PRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSP 867                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 PRRKSAGSIPLSPLAHTPSPPPPTASPQRSPSPLSGHVAQAFPTKLHLSP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     868 PLGRQLSRPKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDL 917                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 PLGRQLSRPKSAEPPRSPLLKRVQSAEKLAAALAASEKKLATSRKHSLDL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     918 PHSELKKELPPREVSPLEVVGARSVLSGKGALPGKGVLQPAPSRALGTLR 967                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PHSELKKELPPREVSPLEVVGARSVLSGKGALPGKGVLQPAPSRALGTLR 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     968 QDRAERRESLQKQEAIREVDSSEDDTEEGPENSQGAQELSLAPHPEVSQS 1017                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QDRAERRESLQKQEAIREVDSSEDDTEEGPENSQGAQELSLAPHPEVSQS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1018 VAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGPPRMESPSGPHRR 1067                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VAPKGAGESGEEDPFPSRDPRSLGPMVPSLLTGITLGPPRMESPSGPHRR 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1068 LGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTALSP 1117                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LGSPQAIEEAASSSSAGPNLGQSGATDPIPPEGCWKAQHLHTQALTALSP 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1118 STSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLAN 1167                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 STSGLTPTSSCSPPSSTSGKLSMWSWKSLIEGPDRASPSRKATMAGGLAN 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1168 LQDLENTTPAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECA 1217                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LQDLENTTPAQPKNLSPREQGKTQPPSAPRLAHPSYEDPSQGWLWESECA 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1218 QAVKEDPALSITQVPDASGDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQ 1267                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 QAVKEDPALSITQVPDASGDRRQDVPCRGCPLTQKSEPSLRRGQEPGGHQ 950                                                          
						                                                            	                  .                                          
						                                                            	    1268 KHRDLALVPDELLKQT                                   1283                                                         
						                                                            	         ||||||||||||||||                                    
						                                                            	     951 KHRDLALVPDELLKQT                                   966                                                          

3897	HMR136_F09066_29_tr0_r1_1_gPRT		Comparison report between F09066_P29 and Q9BYE8partial WT    	Sequence name: Q9BYE8                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09066_P29, comprising a first amino	Sequence documentation:                                      
						MKRSRCRDRPQPPPPDRREDGVQRAAELSQSLPPRRRAPPGRQRLEERTGPAGPEGKEQD 	                                                            
						VVTGVSPLLFRKLSNPDIFSSTGKVKLQRQLSQDDCKLWRGNLASSLSGKQLLPLSSSVH 	Alignment of: 3897 x Q9BYE8   ..                             
						SSVGQVTWQSSGEASNLVRMRNQSLGQSAPSLTAGLKELSLPRRGSFCRTSNRKSLIVTS 	                                                            
						STSPTLPRPHSPLHGHTGNSPLDSPRNFSPNAPAHFSFVPAR                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 222 of Q9BYE8, which also corresponds to  	                     Quality: 2186.00                      Escore:       0                                               
						amino acids 1 - 222 of F09066_P29, and a second amino acid   	             Matching length:     222                Total length:     222                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence SHSHRADR corresponding to amino acids 223	                                                            
						- 230 of F09066_P29, wherein said first amino acid sequence  	Alignment:                                                   
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	       1 MKRSRCRDRPQPPPPDRREDGVQRAAELSQSLPPRRRAPPGRQRLEERTG 50                                                           
						tail of F09066_P29, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MKRSRCRDRPQPPPPDRREDGVQRAAELSQSLPPRRRAPPGRQRLEERTG 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence SHSHRADR in    	      51 PAGPEGKEQDVVTGVSPLLFRKLSNPDIFSSTGKVKLQRQLSQDDCKLWR 100                                                          
						F09066_P29.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PAGPEGKEQDVVTGVSPLLFRKLSNPDIFSSTGKVKLQRQLSQDDCKLWR 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GNLASSLSGKQLLPLSSSVHSSVGQVTWQSSGEASNLVRMRNQSLGQSAP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GNLASSLSGKQLLPLSSSVHSSVGQVTWQSSGEASNLVRMRNQSLGQSAP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLTAGLKELSLPRRGSFCRTSNRKSLIVTSSTSPTLPRPHSPLHGHTGNS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLTAGLKELSLPRRGSFCRTSNRKSLIVTSSTSPTLPRPHSPLHGHTGNS 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 PLDSPRNFSPNAPAHFSFVPAR                             222                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     201 PLDSPRNFSPNAPAHFSFVPAR                             222                                                          

28782	HMR136_F09127_1_tr0_r1_1_gPRT		Comparison report between F09127_P1 and Q96NM7unique head    	Sequence name: Q96NM7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09127_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28782 x Q96NM7   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MIEDTMTLLSLLGRIMRYFLLRPETLFLLCISLALWSYFFHTDEVKTIVKSSRDAVKMVK 	Alignment segment 1/1:                                       
						GKVAEIMQNDRLGGLDVLEAEFSKTWEFKNHNVAVYSIQGRRDHMEDRFEVLTDLANKTH 	                                                            
						PSIFGIFDGHGGETAAEYVKSRLPEALKQHLQDYEKDKENSVLSYQTILEQQILSIDRE  	                     Quality: 1760.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 179 of  	             Matching length:     181                Total length:     181                                               
						F09127_P1, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLEKLTVSYDEAGTTCLIALLSDKDLTVANVGDSRGVLCDKDGNAIPLSHDHKPYQLKER 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KRIKRAGGFISFNGSWRVQGILAMSRSLGDYPLKNLNVVIPDPDILTFDLDKLQPEFMIL 	                        Gaps:       0                        
						ASDGLWDAFSNEEAVRFIKERLDEPHFGAKSIVLQSFYRGCPDNITVMVVKFRNSSKTEE 	                                                            
						Q                                                            	Alignment:                                                   
						% homologous to corresponding to amino acids 1 - 181 of      	                  .         .         .         .         .  
						Q96NM7, which also corresponds to amino acids 180 - 360 of   	     180 MLEKLTVSYDEAGTTCLIALLSDKDLTVANVGDSRGVLCDKDGNAIPLSH 229                                                          
						F09127_P1, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	       1 MLEKLTVSYDEAGTTCLIALLSDKDLTVANVGDSRGVLCDKDGNAIPLSH 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F09127_P1, comprising a polypeptide being at least 70%,      	     230 DHKPYQLKERKRIKRAGGFISFNGSWRVQGILAMSRSLGDYPLKNLNVVI 279                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 DHKPYQLKERKRIKRAGGFISFNGSWRVQGILAMSRSLGDYPLKNLNVVI 100                                                          
						MIEDTMTLLSLLGRIMRYFLLRPETLFLLCISLALWSYFFHTDEVKTIVKSSRDAVKMVK 	                  .         .         .         .         .  
						GKVAEIMQNDRLGGLDVLEAEFSKTWEFKNHNVAVYSIQGRRDHMEDRFEVLTDLANKTH 	     280 PDPDILTFDLDKLQPEFMILASDGLWDAFSNEEAVRFIKERLDEPHFGAK 329                                                          
						PSIFGIFDGHGGETAAEYVKSRLPEALKQHLQDYEKDKENSVLSYQTILEQQILSIDRE  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F09127_P1.     	     101 PDPDILTFDLDKLQPEFMILASDGLWDAFSNEEAVRFIKERLDEPHFGAK 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     330 SIVLQSFYRGCPDNITVMVVKFRNSSKTEEQ                    360                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     151 SIVLQSFYRGCPDNITVMVVKFRNSSKTEEQ                    181                                                          

5038	HMR136_F09184_0_tr0_r1_1_gPRT		Comparison report between F09184_P0 and Q9Y5P6partial WT     	Sequence name: Q9Y5P6                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F09184_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						DTGRIHRFVEKPQVFVSNKINAGMYILSPAVL corresponding to amino acids	Alignment of: 5038 x Q9Y5P6   ..                             
						152 - 183 of Q9Y5P6, which also corresponds to amino acids 1 	                                                            
						- 32 of F09184_P0, a bridging amino acid Q corresponding to  	Alignment segment 1/1:                                       
						amino acid 33 of F09184_P0, and a second amino acid sequence 	                                                            
						RIQLQPTSIEKEVFPIMAKEGQLYAMELQGFWMDIGQPKDFLTGMCLFLQSLRQKQPERL 	                     Quality: 2048.00                      Escore:       0                                               
						CSGPGIVGNVLVDPSARIGQNCSIGPNVSLGPGVVVEDGVCIRRCTVLRDARIRSHSWLE 	             Matching length:     209                Total length:     209                                               
						SCIVGWRCRVGQWVRMENVTVLGEDVIVNDELYLNGASVLPHKSIGESVPEPRIIM     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.52                                               
						acids 185 - 360 of Q9Y5P6, which also corresponds to amino   	                        Gaps:       0                        
						acids 34 - 209 of F09184_P0, wherein said first amino acid   	                                                            
						sequence, bridging amino acid and second amino acid sequence 	Alignment:                                                   
						are contiguous and in a sequential order.                    	                  .         .         .         .         .  
						                                                            	       1 DTGRIHRFVEKPQVFVSNKINAGMYILSPAVLQRIQLQPTSIEKEVFPIM 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||:|||||||||||||||||  
						                                                            	     152 DTGRIHRFVEKPQVFVSNKINAGMYILSPAVLRRIQLQPTSIEKEVFPIM 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AKEGQLYAMELQGFWMDIGQPKDFLTGMCLFLQSLRQKQPERLCSGPGIV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 AKEGQLYAMELQGFWMDIGQPKDFLTGMCLFLQSLRQKQPERLCSGPGIV 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GNVLVDPSARIGQNCSIGPNVSLGPGVVVEDGVCIRRCTVLRDARIRSHS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 GNVLVDPSARIGQNCSIGPNVSLGPGVVVEDGVCIRRCTVLRDARIRSHS 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WLESCIVGWRCRVGQWVRMENVTVLGEDVIVNDELYLNGASVLPHKSIGE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 WLESCIVGWRCRVGQWVRMENVTVLGEDVIVNDELYLNGASVLPHKSIGE 351                                                          
						                                                            	                                                             
						                                                            	     201 SVPEPRIIM                                          209                                                          
						                                                            	         |||||||||                                           
						                                                            	     352 SVPEPRIIM                                          360                                                          

						Comparison report between F09184_P0 and Q9H7U3partial WT     	Sequence name: Q9H7U3                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09184_P0, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to DTGRIHRFVEKPQVFVSNKINAGMYILSPAVL    	Alignment of: 5038 x Q9H7U3   ..                             
						corresponding to amino acids 152 - 183 of Q9H7U3, which also 	                                                            
						corresponds to amino acids 1 - 32 of F09184_P0, a bridging   	Alignment segment 1/1:                                       
						amino acid Q corresponding to amino acid 33 of F09184_P0, a  	                                                            
						RIQLQPTSIEKEVFPIMAKEGQLYAMELQGFWMDIGQPKDFLTGMCLFLQSLRQKQPERL 	                     Quality: 1948.00                      Escore:       0                                               
						CSGPGIVGNVLVDPSARIGQNCSIGPNVSLGPGVVVEDGVCIRRCTVLRDARIRSHSWLE 	             Matching length:     209                Total length:     236                                               
						SCIVGWRCRVGQW                                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:   88.56      Total Percent Identity:   88.14                                               
						corresponding to amino acids 185 - 317 of Q9H7U3, which also 	                        Gaps:       1                        
						corresponds to amino acids 34 - 166 of F09184_P0, and a third	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						VRMENVTVLGEDVIVNDELYLNGASVLPHKSIGESVPEPRIIM corresponding to 	                  .         .         .         .         .  
						amino acids 345 - 387 of Q9H7U3, which also corresponds to   	       1 DTGRIHRFVEKPQVFVSNKINAGMYILSPAVLQRIQLQPTSIEKEVFPIM 50                                                           
						amino acids 167 - 209 of F09184_P0, wherein said first amino 	         ||||||||||||||||||||||||||||||||:|||||||||||||||||  
						acid sequence, bridging amino acid, second amino acid        	     152 DTGRIHRFVEKPQVFVSNKINAGMYILSPAVLRRIQLQPTSIEKEVFPIM 201                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated chimeric polypeptide        	      51 AKEGQLYAMELQGFWMDIGQPKDFLTGMCLFLQSLRQKQPERLCSGPGIV 100                                                          
						encoding for an edge portion of F09184_P0, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     202 AKEGQLYAMELQGFWMDIGQPKDFLTGMCLFLQSLRQKQPERLCSGPGIV 251                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     101 GNVLVDPSARIGQNCSIGPNVSLGPGVVVEDGVCIRRCTVLRDARIRSHS 150                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     252 GNVLVDPSARIGQNCSIGPNVSLGPGVVVEDGVCIRRCTVLRDARIRSHS 301                                                          
						length, wherein at least two amino acids comprise WV, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     151 WLESCIVGWRCRVGQW...........................VRMENVT 173                                                          
						acid numbers 166-x to 167; and ending at any of amino acid   	         ||||||||||||||||                           |||||||  
						numbers 167+ ((n-2) - x), in which x varies from 0 to n-2.   	     302 WLESCIVGWRCRVGQWVSLWAGLGGERGGECACLPDKAYPLLEVRMENVT 351                                                          
						                                                            	                  .         .         .                      
						                                                            	     174 VLGEDVIVNDELYLNGASVLPHKSIGESVPEPRIIM               209                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     352 VLGEDVIVNDELYLNGASVLPHKSIGESVPEPRIIM               387                                                          

9291	HMR136_F09280_2_tr0_r1_1_gPRT		Comparison report between F09280_P2 and AOC3_HUMANpartial WT 	Sequence name: AOC3_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F09280_P2, comprising a first amino 	Sequence documentation:                                      
						MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLF 	                                                            
						ADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPP 	Alignment of: 9291 x AOC3_HUMAN   ..                         
						AREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDID 	                                                            
						QMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFL 	Alignment segment 1/1:                                       
						HHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGT     	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 5130.00                      Escore:       0                                               
						to amino acids 1 - 296 of AOC3_HUMAN, which also corresponds 	             Matching length:     526                Total length:     763                                               
						to amino acids 1 - 296 of F09280_P2, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNH 	    Total Percent Similarity:   68.94      Total Percent Identity:   68.94                                               
						SNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDP 	                        Gaps:       1                        
						WAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDE 	                                                            
						DPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN           	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 534 - 763 of AOC3_HUMAN, which also corresponds  	       1 MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQP 50                                                           
						to amino acids 297 - 526 of F09280_P2, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	       1 MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQP 50                                                           
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of F09280_P2,       	      51 WTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVE 100                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	      51 WTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVE 100                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     101 LQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPS 150                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     101 LQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPS 150                                                          
						comprise TG, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 296-x to 297; and    	     151 YMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCF 200                                                          
						ending at any of amino acid numbers 297+ ((n-2) - x), in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.                                	     151 YMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCF 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 YKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGT.... 296                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     251 HKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSW 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     296 .................................................. 296                                                          
						                                                            	                                                            
						                                                            	     301 SLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIF 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     296 .................................................. 296                                                          
						                                                            	                                                            
						                                                            	     351 DVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     296 .................................................. 296                                                          
						                                                            	                                                            
						                                                            	     401 GVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSH 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     296 .................................................. 296                                                          
						                                                            	                                                            
						                                                            	     451 YFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     297 .................................GLENWVWAEDMVFVPMA 313                                                          
						                                                            	                                          |||||||||||||||||  
						                                                            	     501 FGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 VPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHP 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     364 RGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQ 413                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQ 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     414 NDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNG 463                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 NDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     464 VGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAP 513                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAP 750                                                          
						                                                            	                  .                                          
						                                                            	     514 DLPAFSHGGFSHN                                      526                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     751 DLPAFSHGGFSHN                                      763                                                          

9673	HMR136_F09306_12_tr0_r1_1_gPRT		Comparison report between F09306_P12 and ATX7_HUMANpartial   	Sequence name: ATX7_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for F09306_P12, comprising a first amino	Sequence documentation:                                      
						MSERAADDVRGEPRRAAAAAGGAAAAAARQQQQQQQQQQPPPPQPQRQQHPPPPPRRTRP 	                                                            
						EDGGPGAASTSAAAMATVGERRPLPSPEVMLGQSWNLWVEASKLPGKDGTELDESFKEFG 	Alignment of: 9673 x ATX7_HUMAN   ..                         
						KNREVMGLCRE                                                  	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 131 of ATX7_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 131 of F09306_P12, and a second amino acid	                     Quality: 1307.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     131                Total length:     131                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence GESSPPDGVCTNPWEV corresponding to amino  	                        Gaps:       0                        
						acids 132 - 147 of F09306_P12, wherein said first amino acid 	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F09306_P12, comprising a polypeptide being at least  	       1 MSERAADDVRGEPRRAAAAAGGAAAAAARQQQQQQQQQQPPPPQPQRQQH 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MSERAADDVRGEPRRAAAAAGGAAAAAARQQQQQQQQQQPPPPQPQRQQH 50                                                           
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						GESSPPDGVCTNPWEV in F09306_P12.                              	      51 PPPPPRRTRPEDGGPGAASTSAAAMATVGERRPLPSPEVMLGQSWNLWVE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PPPPPRRTRPEDGGPGAASTSAAAMATVGERRPLPSPEVMLGQSWNLWVE 100                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 ASKLPGKDGTELDESFKEFGKNREVMGLCRE                    131                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     101 ASKLPGKDGTELDESFKEFGKNREVMGLCRE                    131                                                          

10162	HMR136_F09329_10_tr0_r1_1_gPRT		Comparison report between F09329_P10 and Q8NDN3unique head   	Sequence name: Q8NDN3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09329_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10162 x Q8NDN3   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	Alignment segment 1/1:                                       
						VILASTVVA                                                    	                                                            
						having the sequence corresponding to amino acids 1 - 69 of   	                     Quality: 4573.00                      Escore:       0                                               
						F09329_P10, and a second amino acid sequence being at least  	             Matching length:     467                Total length:     467                                               
						MSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERTSSQVTILCT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LQADITISLDGVPFLMHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTD 	                        Gaps:       0                        
						PFWTASSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFINVTLE 	                                                            
						AVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSR 	Alignment:                                                   
						QELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPLWIMPPDEYCL 	                  .         .         .         .         .  
						MWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEI 	      70 MSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAER 119                                                          
						SDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSHTKTLIERSGR              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 467 of   	       1 MSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAER 50                                                           
						Q8NDN3, which also corresponds to amino acids 70 - 536 of    	                  .         .         .         .         .  
						F09329_P10, wherein said first amino acid sequence and second	     120 TSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPM 169                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 TSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPM 100                                                          
						F09329_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     170 LAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLMHDTTLRRTTNVEEE 219                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	     101 LAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLMHDTTLRRTTNVEEE 150                                                          
						VILASTVVA                                                    	                  .         .         .         .         .  
						least about 95% homologous to the sequence of F09329_P10.    	     220 FPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTASSLSPSDHREAQNQS 269                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTASSLSPSDHREAQNQS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     270 ICSLAELLELAKGNATLLLNLRDPPREHPYRSSFINVTLEAVLHSGFPQH 319                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ICSLAELLELAKGNATLLLNLRDPPREHPYRSSFINVTLEAVLHSGFPQH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     320 QVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSR 369                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     370 QELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPL 419                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     420 WIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAA 469                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 WIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     470 VRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDTYANSTATPVG 519                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDTYANSTATPVG 450                                                          
						                                                            	                  .                                          
						                                                            	     520 PRGGGSHTKTLIERSGR                                  536                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     451 PRGGGSHTKTLIERSGR                                  467                                                          

						Comparison report between F09329_P10 and Q8NCB7unique head   	Sequence name: Q8NCB7                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09329_P10, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 10162 x Q8NCB7   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	Alignment segment 1/1:                                       
						VILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVT                 	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 4229.00                      Escore:       0                                               
						1 - 104 of F09329_P10, a second amino acid sequence being at 	             Matching length:     432                Total length:     432                                               
						MLSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGH 	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.77                                               
						RGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLMHDTTLRRTTNVEEEFPELA 	    Total Percent Similarity:   99.77      Total Percent Identity:   99.77                                               
						RRPASMLNWTTLQRLNAGQWFLKTDPFWTASSLSPSDHREAQNQSICSLAELLELAKGNA 	                        Gaps:       0                        
						TLLLNLRDPPREHPYRSSFINVTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSG 	                                                            
						SKEAVASLRRGHIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSV 	Alignment:                                                   
						TSDNSH                                                       	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 306	     105 MLSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKD 154                                                          
						of Q8NCB7, which also corresponds to amino acids 105 - 410 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09329_P10, a bridging amino acid T corresponding to amino   	       1 MLSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKD 50                                                           
						acid 411 of F09329_P10, and a third amino acid sequence being	                  .         .         .         .         .  
						LSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVR 	     155 LGPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFL 204                                                          
						RTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSHTKTLI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERSGR                                                        	      51 LGPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFL 100                                                          
						at least 90 % homologous to corresponding to amino acids 308 	                  .         .         .         .         .  
						- 432 of Q8NCB7, which also corresponds to amino acids 412 - 	     205 MHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTA 254                                                          
						536 of F09329_P10, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, bridging amino acid and third    	     101 MHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTA 150                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     255 SSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFI 304                                                          
						F09329_P10, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 SSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFI 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	     305 NVTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRR 354                                                          
						VILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVT                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F09329_P10.    	     201 NVTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     355 GHIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSV 404                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GHIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     405 TSDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLG 454                                                          
						                                                            	         |||||| |||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 TSDNSHALSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     455 GIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSD 504                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 GIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSD 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     505 NSYDTYANSTATPVGPRGGGSHTKTLIERSGR                   536                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     401 NSYDTYANSTATPVGPRGGGSHTKTLIERSGR                   432                                                          

						Comparison report between F09329_P10 and Q8TB77unique head   	Sequence name: Q8TB77                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09329_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10162 x Q8TB77   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	Alignment segment 1/1:                                       
						VILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERT 	                                                            
						SSQVTILCTFFTVVFALYLAPLTISSPCI                                	                     Quality: 3807.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 149 of  	             Matching length:     387                Total length:     387                                               
						F09329_P10, and a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MEKKDLGPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLMHDTT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTASSLSPSDHREAQNQS 	                        Gaps:       0                        
						ICSLAELLELAKGNATLLLNLRDPPREHPYRSSFINVTLEAVLHSGFPQHQVMWLPSRQR 	                                                            
						PLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNA 	Alignment:                                                   
						PWLFSLLWCAGVPSVTSDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQ 	                  .         .         .         .         .  
						KWRLGGIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDT 	     150 MEKKDLGPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLD 199                                                          
						YANSTATPVGPRGGGSHTKTLIERSGR                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 387 of   	       1 MEKKDLGPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLD 50                                                           
						Q8TB77, which also corresponds to amino acids 150 - 536 of   	                  .         .         .         .         .  
						F09329_P10, wherein said first amino acid sequence and second	     200 GVPFLMHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTD 249                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 GVPFLMHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTD 100                                                          
						F09329_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     250 PFWTASSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPY 299                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	     101 PFWTASSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPY 150                                                          
						VILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERT 	                  .         .         .         .         .  
						SSQVTILCTFFTVVFALYLAPLTISSPCI                                	     300 RSSFINVTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAV 349                                                          
						least about 95% homologous to the sequence of F09329_P10.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RSSFINVTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     350 ASLRRGHIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCA 399                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ASLRRGHIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     400 GVPSVTSDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQ 449                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GVPSVTSDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     450 KWRLGGIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVL 499                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 KWRLGGIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVL 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     500 SVCSDNSYDTYANSTATPVGPRGGGSHTKTLIERSGR              536                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     351 SVCSDNSYDTYANSTATPVGPRGGGSHTKTLIERSGR              387                                                          

						Comparison report between F09329_P10 and Q8WTR4unique head   	Sequence name: Q8WTR4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09329_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10162 x Q8WTR4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MIPHR corresponding to amino acids 1 - 5 	Alignment segment 1/1:                                       
						of F09329_P10, and a second amino acid sequence being at     	                                                            
						YLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLVVILAS 	                     Quality: 5195.00                      Escore:       0                                               
						TVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERTSSQVT 	             Matching length:     531                Total length:     531                                               
						ILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPMLAPEHTLMSFRKALEQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLYGLQADITISLDGVPFLMHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKTDPFWTASSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFIN 	                        Gaps:       0                        
						VTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYT 	                                                            
						QVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPLWIMPPD 	Alignment:                                                   
						EYCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVRRTSRDVSIMKEKLI 	                  .         .         .         .         .  
						FSEISDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSHTKTLIERSGR          	       6 YLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLH 55                                                           
						least 90 % homologous to corresponding to amino acids 75 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						605 of Q8WTR4, which also corresponds to amino acids 6 - 536 	      75 YLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLH 124                                                          
						of F09329_P10, wherein said first amino acid sequence and    	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      56 KIGLVVILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTM 105                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09329_P10, comprising a polypeptide being at least 70%,     	     125 KIGLVVILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTM 174                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     106 LSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDL 155                                                          
						least about 95% homologous to the sequence MIPHR of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09329_P10.                                                  	     175 LSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDL 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     156 GPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLM 205                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 GPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLM 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 HDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTAS 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 HDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTAS 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 SLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFIN 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 SLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFIN 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 VTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRG 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 VTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRG 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 HIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVT 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 HIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVT 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 SDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGG 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 SDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGG 524                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 IRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDN 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     525 IRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDN 574                                                          
						                                                            	                  .         .         .                      
						                                                            	     506 SYDTYANSTATPVGPRGGGSHTKTLIERSGR                    536                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     575 SYDTYANSTATPVGPRGGGSHTKTLIERSGR                    605                                                          

						Comparison report between F09329_P10 and Q8NEM9unique head   	Sequence name: Q8NEM9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09329_P10, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 10162 x Q8NEM9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MIPHR corresponding to amino 	Alignment segment 1/1:                                       
						acids 1 - 5 of F09329_P10, a second amino acid sequence being	                                                            
						YLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLVVILAS 	                     Quality: 5177.00                      Escore:       0                                               
						TVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERTSSQVT 	             Matching length:     531                Total length:     531                                               
						ILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPMLAPEHTLMSFRKALEQ 	 Matching Percent Similarity:   99.81   Matching Percent Identity:   99.81                                               
						KLYGLQADITISLDGVPFLMHDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWF 	    Total Percent Similarity:   99.81      Total Percent Identity:   99.81                                               
						LKT                                                          	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 75 -	                                                            
						317 of Q8NEM9, which also corresponds to amino acids 6 - 248 	Alignment:                                                   
						of F09329_P10, a bridging amino acid D corresponding to amino	                  .         .         .         .         .  
						acid 249 of F09329_P10, and a third amino acid sequence being	       6 YLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLH 55                                                           
						PFWTASSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFINVTLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSR 	      75 YLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLH 124                                                          
						QELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPLWIMPPDEYCL 	                  .         .         .         .         .  
						MWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEI 	      56 KIGLVVILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTM 105                                                          
						SDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSHTKTLIERSGR              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 319 	     125 KIGLVVILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTM 174                                                          
						- 605 of Q8NEM9, which also corresponds to amino acids 250 - 	                  .         .         .         .         .  
						536 of F09329_P10, wherein said first amino acid sequence,   	     106 LSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDL 155                                                          
						second amino acid sequence, bridging amino acid and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     175 LSWIVAGQFARAERTSSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDL 224                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F09329_P10, comprising a polypeptide being at least 70%,     	     156 GPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLM 205                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     225 GPKPALIGHRGAPMLAPEHTLMSFRKALEQKLYGLQADITISLDGVPFLM 274                                                          
						least about 95% homologous to the sequence MIPHR of          	                  .         .         .         .         .  
						F09329_P10.                                                  	     206 HDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTDPFWTAS 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||| ||||||  
						                                                            	     275 HDTTLRRTTNVEEEFPELARRPASMLNWTTLQRLNAGQWFLKTVPFWTAS 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 SLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFIN 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 SLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPREHPYRSSFIN 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 VTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRG 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 VTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRG 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 HIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVT 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 HIQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVT 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 SDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGG 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 SDNSHTLSQVPSPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGG 524                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 IRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDN 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     525 IRSYNPEQIMLSAAVRRTSRDVSIMKEKLIFSEISDGVEVSDVLSVCSDN 574                                                          
						                                                            	                  .         .         .                      
						                                                            	     506 SYDTYANSTATPVGPRGGGSHTKTLIERSGR                    536                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     575 SYDTYANSTATPVGPRGGGSHTKTLIERSGR                    605                                                          

						Comparison report between F09329_P10 and Q8N781unique head   	Sequence name: Q8N781                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09329_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10162 x Q8N781   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	Alignment segment 1/1:                                       
						VILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERT 	                                                            
						SSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPMLAPEHTL     	                     Quality: 3539.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 176 of  	             Matching length:     360                Total length:     360                                               
						F09329_P10, and a second amino acid sequence being at least  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MSFRKALEQKLYGLQADITISLDGVPFLMHDTTLRRTTNVEEEFPELARRPASMLNWTTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QRLNAGQWFLKTDPFWTASSLSPSDHREAQNQSICSLAELLELAKGNATLLLNLRDPPRE 	                        Gaps:       0                        
						HPYRSSFINVTLEAVLHSGFPQHQVMWLPSRQRPLVRKVAPGFQQTSGSKEAVASLRRGH 	                                                            
						IQRLNLRYTQVSRQELRDYASWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVP 	Alignment:                                                   
						SPLWIMPPDEYCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVRRTSRD 	                  .         .         .         .         .  
						VSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSHTKTLIERSGR 	     177 MSFRKALEQKLYGLQADITISLDGVPFLMHDTTLRRTTNVEEEFPELARR 226                                                          
						90 % homologous to corresponding to amino acids 1 - 360 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8N781, which also corresponds to amino acids 177 - 536 of   	       1 MSFRKALEQKLYGLQADITISLDGVPFLMHDTTLRRTTNVEEEFPELARR 50                                                           
						F09329_P10, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     227 PASMLNWTTLQRLNAGQWFLKTDPFWTASSLSPSDHREAQNQSICSLAEL 276                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09329_P10, comprising a polypeptide being at least 70%,     	      51 PASMLNWTTLQRLNAGQWFLKTDPFWTASSLSPSDHREAQNQSICSLAEL 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     277 LELAKGNATLLLNLRDPPREHPYRSSFINVTLEAVLHSGFPQHQVMWLPS 326                                                          
						MIPHRYLYNRMGYWSDWPVPILVTTAAAFAYIAGLLVLALCHIAVGQQMNLHWLHKIGLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VILASTVVAMSAVAQLWEDEWEVLLISLQGTAPFLHVGAVAAVTMLSWIVAGQFARAERT 	     101 LELAKGNATLLLNLRDPPREHPYRSSFINVTLEAVLHSGFPQHQVMWLPS 150                                                          
						SSQVTILCTFFTVVFALYLAPLTISSPCIMEKKDLGPKPALIGHRGAPMLAPEHTL     	                  .         .         .         .         .  
						least about 95% homologous to the sequence of F09329_P10.    	     327 RQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSRQELRDYA 376                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RQRPLVRKVAPGFQQTSGSKEAVASLRRGHIQRLNLRYTQVSRQELRDYA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 SWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPLWIMPPDE 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SWNLSVNLYTVNAPWLFSLLWCAGVPSVTSDNSHTLSQVPSPLWIMPPDE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 YCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVRRTSRD 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YCLMWVTADLVSFTLIVGIFVLQKWRLGGIRSYNPEQIMLSAAVRRTSRD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 VSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSH 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VSIMKEKLIFSEISDGVEVSDVLSVCSDNSYDTYANSTATPVGPRGGGSH 350                                                          
						                                                            	                  .                                          
						                                                            	     527 TKTLIERSGR                                         536                                                          
						                                                            	         ||||||||||                                          
						                                                            	     351 TKTLIERSGR                                         360                                                          

10294	HMR136_F09335_14_tr0_r1_1_gPRT		Comparison report between F09335_P14 and                     	Sequence name: ATC1_HUMAN_V1                                 
						ATC1_HUMAN_V1partial WT sequence followed by short unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09335_P14, comprising a first amino acid sequence being at  	                                                            
						MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEVSHRRAFHGW 	Alignment of: 10294 x ATC1_HUMAN_V1   ..                     
						NEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFDDAVSITVAILIVVTVAFVQ 	                                                            
						EYRSEKSLEELSKLVPPECHCVREGKLEHTLARDLVPGDTVCLSVGDRVPADLRLFEAVD 	Alignment segment 1/1:                                       
						LSIDESSLTGETTPCSKVTAPQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSE 	                                                            
						FGEVFKMMQAEEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 	                     Quality: 8808.00                      Escore:       0                                               
						LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDKTGTLTKNEM 	             Matching length:     918                Total length:     918                                               
						TVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LMGKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEICFMK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLG 	                        Gaps:       0                        
						LVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 	                                                            
						AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVALKAADIGVA 	Alignment:                                                   
						MGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLA 	                  .         .         .         .         .  
						TLMNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLILKIL 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						VSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						SREKIQKHVSSTSSSFLE                                           	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 918	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						of ATC1_HUMAN_V1, which also corresponds to amino acids 1 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						918 of F09335_P14, and a second amino acid sequence being at 	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						homologous to a polypeptide having the sequence LSL          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 919 - 921 of F09335_P14, wherein	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.                    	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	                  .                                          
						                                                            	     901 SREKIQKHVSSTSSSFLE                                 918                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     901 SREKIQKHVSSTSSSFLE                                 918                                                          

						Comparison report between F09335_P14 and Q8N6V1partial WT    	Sequence name: Q8N6V1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09335_P14, comprising a first amino	Sequence documentation:                                      
						MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEVSHRRAFHGW 	                                                            
						NEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFDDAVSITVAILIVVTVAFVQ 	Alignment of: 10294 x Q8N6V1   ..                            
						EYRSEKSLEELSKLVPPECHCVREGKLEHTLARDLVPGDTVCLSVGDRVPADLRLFEAVD 	                                                            
						LSIDESSLTGETTPCSKVTAPQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSE 	Alignment segment 1/1:                                       
						FGEVFKMMQAEEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 	                                                            
						LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDKTGTLTKNEM 	                     Quality: 8423.00                      Escore:       0                                               
						TVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNT 	             Matching length:     878                Total length:     878                                               
						LMGKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEICFMK 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.89                                               
						GAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLG 	    Total Percent Similarity:   99.89      Total Percent Identity:   99.89                                               
						LVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 	                        Gaps:       0                        
						AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVALKAADIGVA 	                                                            
						MGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLA 	Alignment:                                                   
						TLMNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLILKIL 	                  .         .         .         .         .  
						VSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCS 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						NRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSIL                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						to amino acids 1 - 876 of Q8N6V1, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 876 of F09335_P14, and a second amino acid   	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						DLLFLLGLTSSVCIVAEIIKKVERSREKIQKHVSSTSSSFLELSL corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 877 - 921 of F09335_P14, wherein said first   	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						polypeptide encoding for a tail of F09335_P14, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						to the sequence DLLFLLGLTSSVCIVAEIIKKVERSREKIQKHVSSTSSSFLELSL	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in F09335_P14.                                               	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	                  .         .                                
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDL                       878                                                          
						                                                            	         |||||||||||||||||||||||||| |                        
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILGL                       878                                                          

						Comparison report between F09335_P14 and AAP30008partial WT  	Sequence name: AAP30008                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09335_P14, comprising a first amino	Sequence documentation:                                      
						MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEVSHRRAFHGW 	                                                            
						NEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFDDAVSITVAILIVVTVAFVQ 	Alignment of: 10294 x AAP30008   ..                          
						EYRSEKSLEELSKLVPPECHCVREGKLEHTLARDLVPGDTVCLSVGDRVPADLRLFEAVD 	                                                            
						LSIDESSLTGETTPCSKVTAPQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSE 	Alignment segment 1/1:                                       
						FGEVFKMMQAEEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 	                                                            
						LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDKTGTLTKNEM 	                     Quality: 8725.00                      Escore:       0                                               
						TVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNT 	             Matching length:     909                Total length:     909                                               
						LMGKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEICFMK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 	                        Gaps:       0                        
						AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVALKAADIGVA 	                                                            
						MGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLA 	Alignment:                                                   
						TLMNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLILKIL 	                  .         .         .         .         .  
						VSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCS 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						NRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SREKIQKHV                                                    	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 909 of AAP30008, which also corresponds to	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						amino acids 1 - 909 of F09335_P14, and a second amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						having the sequence SSTSSSFLELSL corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						910 - 921 of F09335_P14, wherein said first amino acid       	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						tail of F09335_P14, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence SSTSSSFLELSL in	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						F09335_P14.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	                                                             
						                                                            	     901 SREKIQKHV                                          909                                                          
						                                                            	         |||||||||                                           
						                                                            	     901 SREKIQKHV                                          909                                                          

						Comparison report between F09335_P14 and AAP30009partial WT  	Sequence name: AAP30009                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09335_P14, comprising a first amino	Sequence documentation:                                      
						MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEVSHRRAFHGW 	                                                            
						NEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFDDAVSITVAILIVVTVAFVQ 	Alignment of: 10294 x AAP30009   ..                          
						EYRSEKSLEELSKLVPPECHCVREGKLEHTLARDLVPGDTVCLSVGDRVPADLRLFEAVD 	                                                            
						LSIDESSLTGETTPCSKVTAPQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSE 	Alignment segment 1/1:                                       
						FGEVFKMMQAEEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 	                                                            
						LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDKTGTLTKNEM 	                     Quality: 8809.00                      Escore:       0                                               
						TVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNT 	             Matching length:     921                Total length:     921                                               
						LMGKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEICFMK 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.78                                               
						GAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLG 	    Total Percent Similarity:   99.89      Total Percent Identity:   99.78                                               
						LVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 	                        Gaps:       0                        
						AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVALKAADIGVA 	                                                            
						MGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLA 	Alignment:                                                   
						TLMNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLILKIL 	                  .         .         .         .         .  
						VSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCS 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						NRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SREKIQKHVSSTSSSFLE                                           	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 918 of AAP30009, which also corresponds to	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						amino acids 1 - 918 of F09335_P14, and a second amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						having the sequence LSL corresponding to amino acids 919 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						921 of F09335_P14, wherein said first amino acid sequence and	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						F09335_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence LSL in F09335_P14.	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	                  .         .                                
						                                                            	     901 SREKIQKHVSSTSSSFLELSL                              921                                                          
						                                                            	         ||||||||||||||||||: |                               
						                                                            	     901 SREKIQKHVSSTSSSFLEVWL                              921                                                          

10290	HMR136_F09335_24_tr0_r1_1_gPRT		Comparison report between F09335_P24 and ATC1_HUMANpartial   	Sequence name: ATC1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F09335_P24, comprising a first amino	                                                            
						MTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLGSIMGQLLVIYFPPLQKVFQ 	Alignment of: 10290 x ATC1_HUMAN   ..                        
						TESLSILDLLFLLGLTSSVCIVAEIIKKVERSREKIQKHVSSTSSSFLEV           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 810 - 919 of ATC1_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 110 of F09335_P24.            	                     Quality: 1057.00                      Escore:       0                                               
						                                                            	             Matching length:     110                Total length:     110                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLGSIMGQLLVI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     810 MTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLGSIMGQLLVI 859                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVERSREKIQKHV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     860 YFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVERSREKIQKHV 909                                                          
						                                                            	                  .                                          
						                                                            	     101 SSTSSSFLEV                                         110                                                          
						                                                            	         ||||||||||                                          
						                                                            	     910 SSTSSSFLEV                                         919                                                          

10292	HMR136_F09335_4_tr0_r1_1_gPRT		Comparison report between F09335_P4 and ATC1_HUMAN_V1unique  	Sequence name: ATC1_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F09335_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10292 x ATC1_HUMAN_V1   ..                     
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MDSLLPPSRFSYFKKYPLHAIRRYLSTLRNQRAEEQ     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 36 of F09335_P4, and a      	                                                            
						VARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEVSHRRAFHGWNE 	                     Quality: 8796.00                      Escore:       0                                               
						FDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFDDAVSITVAILIVVTVAFVQEY 	             Matching length:     918                Total length:     918                                               
						RSEKSLEELSKLVPPECHCVREGKLEHTLARDLVPGDTVCLSVGDRVPADLRLFEAVDLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.89                                               
						IDESSLTGETTPCSKVTAPQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFG 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.89                                               
						EVFKMMQAEEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVSLA 	                        Gaps:       0                        
						VAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDKTGTLTKNEMTV 	                                                            
						THIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNTLM 	Alignment:                                                   
						GKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEICFMKGA 	                  .         .         .         .         .  
						YEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLV 	      36 QVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEV 85                                                           
						GIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEIDAM 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						DVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVALKAADIGVAMG 	       2 KVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEV 51                                                           
						QTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLATL 	                  .         .         .         .         .  
						MNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLILKILVS 	      86 SHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFD 135                                                          
						SIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVERSR 	      52 SHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFD 101                                                          
						EKIQKHVSSTSSSFLEV                                            	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	     136 DAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHTL 185                                                          
						corresponding to amino acids 3 - 919 of ATC1_HUMAN_V1, which 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 37 - 953 of F09335_P4,       	     102 DAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHTL 151                                                          
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     186 ARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTAP 235                                                          
						isolated polypeptide encoding for a head of F09335_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     152 ARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTAP 201                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     236 QPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQAE 285                                                          
						about 95% homologous to the sequence                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MDSLLPPSRFSYFKKYPLHAIRRYLSTLRNQRAEEQ of F09335_P4.           	     202 QPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQAE 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     286 EAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVSL 335                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 EAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVSL 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     336 AVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDK 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 AVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDK 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 TGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAV 435                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 TGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAV 401                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     436 SRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKAE 485                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 SRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKAE 451                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     486 YPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTLT 535                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     452 YPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTLT 501                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     536 LTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRTG 585                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     502 LTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRTG 551                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     586 VKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEIDA 635                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 VKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEIDA 601                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     636 MDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVA 685                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     602 MDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVA 651                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     686 LKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKN 735                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     652 LKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKN 701                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     736 FVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLGV 785                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     702 FVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLGV 751                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     786 EPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRDN 835                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     752 EPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRDN 801                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     836 VITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLGS 885                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     802 VITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLGS 851                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     886 IMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVERS 935                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     852 IMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVERS 901                                                          
						                                                            	                  .                                          
						                                                            	     936 REKIQKHVSSTSSSFLEV                                 953                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     902 REKIQKHVSSTSSSFLEV                                 919                                                          

10296	HMR136_F09335_6_tr0_r1_1_gPRT		Comparison report between F09335_P6 and ATC1_HUMANunique     	Sequence name: ATC1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F09335_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 10296 x ATC1_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MWQSK corresponding to amino acids 1 - 5 	Alignment segment 1/1:                                       
						of F09335_P6, and a second amino acid sequence being at least	                                                            
						GIIMLVGWLLGKDILEMFTISVSLAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPI 	                     Quality: 6146.00                      Escore:       0                                               
						VETLGCCNVICSDKTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFY 	             Matching length:     642                Total length:     642                                               
						NPAVSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GSAGLRVLALASGPELGQLTFLGLVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETA 	                        Gaps:       0                        
						VAIASRLGLYSKTSQSVSGEEIDAMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGS 	                                                            
						VVAMTGDGVNDAVALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYN 	Alignment:                                                   
						NIKNFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKD 	                  .         .         .         .         .  
						VIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVF 	       6 GIIMLVGWLLGKDILEMFTISVSLAVAAIPEGLPIVVTVTLALGVMRMVK 55                                                           
						FDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLFLLGLTSSVCIVAEIIKKVERSREKIQKHVSSTSSSFLEV                   	     278 GIIMLVGWLLGKDILEMFTISVSLAVAAIPEGLPIVVTVTLALGVMRMVK 327                                                          
						90 % homologous to corresponding to amino acids 278 - 919 of 	                  .         .         .         .         .  
						ATC1_HUMAN, which also corresponds to amino acids 6 - 647 of 	      56 KRAIVKKLPIVETLGCCNVICSDKTGTLTKNEMTVTHIFTSDGLHAEVTG 105                                                          
						F09335_P6, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     328 KRAIVKKLPIVETLGCCNVICSDKTGTLTKNEMTVTHIFTSDGLHAEVTG 377                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F09335_P6, comprising a polypeptide being at least 70%,      	     106 VGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNTLMGKPTE 155                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     378 VGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNTLMGKPTE 427                                                          
						least about 95% homologous to the sequence MWQSK of          	                  .         .         .         .         .  
						F09335_P6.                                                   	     156 GALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEIC 205                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     428 GALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEIC 477                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 FMKGAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLAL 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     478 FMKGAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLAL 527                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 ASGPELGQLTFLGLVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETA 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     528 ASGPELGQLTFLGLVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETA 577                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 VAIASRLGLYSKTSQSVSGEEIDAMDVQQLSQIVPKVAVFYRASPRHKMK 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     578 VAIASRLGLYSKTSQSVSGEEIDAMDVQQLSQIVPKVAVFYRASPRHKMK 627                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 IIKSLQKNGSVVAMTGDGVNDAVALKAADIGVAMGQTGTDVCKEAADMIL 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     628 IIKSLQKNGSVVAMTGDGVNDAVALKAADIGVAMGQTGTDVCKEAADMIL 677                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 VDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLATLMNFPN 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     678 VDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLATLMNFPN 727                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 PLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLIL 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     728 PLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLIL 777                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     506 KILVSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSR 555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     778 KILVSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSR 827                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     556 SQTKSVFEIGLCSNRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILD 605                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     828 SQTKSVFEIGLCSNRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILD 877                                                          
						                                                            	                  .         .         .         .            
						                                                            	     606 LLFLLGLTSSVCIVAEIIKKVERSREKIQKHVSSTSSSFLEV         647                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     878 LLFLLGLTSSVCIVAEIIKKVERSREKIQKHVSSTSSSFLEV         919                                                          

10298	HMR136_F09335_7_tr0_r1_1_gPRT		Comparison report between F09335_P7 and ATC1_HUMAN_V1partial 	Sequence name: ATC1_HUMAN_V1                                 
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09335_P7, comprising a first amino 	Sequence documentation:                                      
						MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCEVSHRRAFHGW 	                                                            
						NEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQFDDAVSITV             	Alignment of: 10298 x ATC1_HUMAN_V1   ..                     
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 108 of ATC1_HUMAN_V1, which also          	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 108 of F09335_P7, and a second	                                                            
						EYRSEKSLEELSKLVPPECHCVREGKLEHTLARDLVPGDTVCLSVGDRVPADLRLFEAVD 	                     Quality: 8613.00                      Escore:       0                                               
						LSIDESSLTGETTPCSKVTAPQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSE 	             Matching length:     907                Total length:     919                                               
						FGEVFKMMQAEEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSDKTGTLTKNEM 	    Total Percent Similarity:   98.69      Total Percent Identity:   98.69                                               
						TVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPAVSRIVEAGCVCNDAVIRNNT 	                        Gaps:       1                        
						LMGKPTEGALIALAMKMGLDGLQQDYIRKAEYPFSSEQKWMAVKCVHRTQQDRPEICFMK 	                                                            
						GAYEQVIKYCTTYQSKGQTLTLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLG 	Alignment:                                                   
						LVGIIDPPRTGVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 	                  .         .         .         .         .  
						AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAVALKAADIGVA 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						MGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIKNFVRFQLSTSIAALTLISLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLMNFPNPLNAMQILWINIIMDGPPAQSLGVEPVDKDVIRKPPRNWKDSILTKNLILKIL 	       1 MKVARFQKIPNGENETMIPVLTSKKASELPVSEVASILQADLQNGLNKCE 50                                                           
						VSSIIIVCGTLFVFWRELRDNVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCS 	                  .         .         .         .         .  
						NRMFCYAVLGSIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						SREKIQKHVSSTSSSFLEV                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	      51 VSHRRAFHGWNEFDISEDEPLWKKYISQFKNPLIMLLLASAVISVLMHQF 100                                                          
						corresponding to amino acids 121 - 919 of ATC1_HUMAN_V1,     	                  .         .         .         .         .  
						which also corresponds to amino acids 109 - 907 of F09335_P7,	     101 DDAVSITV............EYRSEKSLEELSKLVPPECHCVREGKLEHT 138                                                          
						wherein said first amino acid sequence and second amino acid 	         ||||||||            ||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     101 DDAVSITVAILIVVTVAFVQEYRSEKSLEELSKLVPPECHCVREGKLEHT 150                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						F09335_P7, comprising a polypeptide having a length "n",     	     139 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 188                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     151 LARDLVPGDTVCLSVGDRVPADLRLFEAVDLSIDESSLTGETTPCSKVTA 200                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     189 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 238                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise VE, having a structure as  	     201 PQPAATNGDLASRSNIAFMGTLVRCGKAKGVVIGTGENSEFGEVFKMMQA 250                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						108-x to 109; and ending at any of amino acid numbers 109+   	     239 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 288                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEAPKTPLQKSMDLLGKQLSFYSFGIIGIIMLVGWLLGKDILEMFTISVS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     289 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 338                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LAVAAIPEGLPIVVTVTLALGVMRMVKKRAIVKKLPIVETLGCCNVICSD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     339 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 388                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KTGTLTKNEMTVTHIFTSDGLHAEVTGVGYNQFGEVIVDGDVVHGFYNPA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     389 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 438                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VSRIVEAGCVCNDAVIRNNTLMGKPTEGALIALAMKMGLDGLQQDYIRKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     439 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 488                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EYPFSSEQKWMAVKCVHRTQQDRPEICFMKGAYEQVIKYCTTYQSKGQTL 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     489 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 538                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TLTQQQRDVYQQEKARMGSAGLRVLALASGPELGQLTFLGLVGIIDPPRT 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     539 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 588                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GVKEAVTTLIASGVSIKMITGDSQETAVAIASRLGLYSKTSQSVSGEEID 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     589 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 638                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AMDVQQLSQIVPKVAVFYRASPRHKMKIIKSLQKNGSVVAMTGDGVNDAV 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     639 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 688                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ALKAADIGVAMGQTGTDVCKEAADMILVDDDFQTIMSAIEEGKGIYNNIK 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     689 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NFVRFQLSTSIAALTLISLATLMNFPNPLNAMQILWINIIMDGPPAQSLG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     739 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 788                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 VEPVDKDVIRKPPRNWKDSILTKNLILKILVSSIIIVCGTLFVFWRELRD 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     789 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 838                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NVITPRDTTMTFTCFVFFDMFNALSSRSQTKSVFEIGLCSNRMFCYAVLG 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     839 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 888                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 SIMGQLLVIYFPPLQKVFQTESLSILDLLFLLGLTSSVCIVAEIIKKVER 900                                                          
						                                                            	                  .                                          
						                                                            	     889 SREKIQKHVSSTSSSFLEV                                907                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     901 SREKIQKHVSSTSSSFLEV                                919                                                          

5472	HMR136_F09351_3_tr0_r1_1_gPRT		Comparison report between F09351_P3 and Q9BS46partial WT     	Sequence name: Q9BS46                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09351_P3, comprising a first amino 	Sequence documentation:                                      
						MAAAAWLQVLPVILLLLGAHPSPLSFFSAGPATVAAADRSKWHIPIPSGKNYFSFGKILF 	                                                            
						RNTTIFLKFDGEPCDLSLNITWYLKSADCYNEIYNFKAEEVELYLEKLKEKRGLSGKYQT 	Alignment of: 5472 x Q9BS46   ..                             
						SSKLFQNCSELFKTQTFSGDFMHRLPLLGEKQEAKENGTNLTFIGDKT             	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 168 of Q9BS46, which also corresponds to  	                                                            
						amino acids 1 - 168 of F09351_P3, and a second amino acid    	                     Quality: 1652.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     168                Total length:     168                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AMHEPLQTWQDAPYIFIVHIGISSSKESSKENSLSNLFTMTVEVKGPYEYLTLEDYPLMI 	                        Gaps:       0                        
						FFMVMCIVYVLFGVLWLAWSACYWRDLLRIQFWIGAVIFLGMLEKAVFYAEFQNIRYKGE 	                                                            
						SVQGALILAELLSAVKRSLARTLVIIVSLGYGIVKPRLGVTLHKVVVAGALYLLFSGMEG 	Alignment:                                                   
						VLRVTGYFSYPLTLIVNLALSAIDACVILWIFISLTQTMKLLKLRRNIVKLSLYRHFTNT 	                  .         .         .         .         .  
						LILAVAASIVFIIWTTMKFRIVTCQSDWRELWVDDAIWRLLFSMILFVIMVLWRPSANNQ 	       1 MAAAAWLQVLPVILLLLGAHPSPLSFFSAGPATVAAADRSKWHIPIPSGK 50                                                           
						RRNENEKYQTRTQWK                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 169 - 483 of	       1 MAAAAWLQVLPVILLLLGAHPSPLSFFSAGPATVAAADRSKWHIPIPSGK 50                                                           
						F09351_P3, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      51 NYFSFGKILFRNTTIFLKFDGEPCDLSLNITWYLKSADCYNEIYNFKAEE 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09351_P3, comprising a polypeptide being at least 70%,      	      51 NYFSFGKILFRNTTIFLKFDGEPCDLSLNITWYLKSADCYNEIYNFKAEE 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 VELYLEKLKEKRGLSGKYQTSSKLFQNCSELFKTQTFSGDFMHRLPLLGE 150                                                          
						AMHEPLQTWQDAPYIFIVHIGISSSKESSKENSLSNLFTMTVEVKGPYEYLTLEDYPLMI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FFMVMCIVYVLFGVLWLAWSACYWRDLLRIQFWIGAVIFLGMLEKAVFYAEFQNIRYKGE 	     101 VELYLEKLKEKRGLSGKYQTSSKLFQNCSELFKTQTFSGDFMHRLPLLGE 150                                                          
						SVQGALILAELLSAVKRSLARTLVIIVSLGYGIVKPRLGVTLHKVVVAGALYLLFSGMEG 	                  .                                          
						VLRVTGYFSYPLTLIVNLALSAIDACVILWIFISLTQTMKLLKLRRNIVKLSLYRHFTNT 	     151 KQEAKENGTNLTFIGDKT                                 168                                                          
						LILAVAASIVFIIWTTMKFRIVTCQSDWRELWVDDAIWRLLFSMILFVIMVLWRPSANNQ 	         ||||||||||||||||||                                  
						RRNENEKYQTRTQWK                                              	     151 KQEAKENGTNLTFIGDKT                                 168                                                          
						least about 95% homologous to the sequence in F09351_P3.     	                                                            

11053	HMR136_F09357_1_tr0_r1_1_gPRT		Comparison report between F09357_P1 and Q8N0U8unique head    	Sequence name: Q8N0U8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09357_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11053 x Q8N0U8   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						GGGGGGGGGGGGGGGGGGGWVGPRRAAAAEVEAEGGGGGGGGKMAAPVLLRVSVPRWERV 	Alignment segment 1/1:                                       
						ARYAVCAAGILLSIYAYHVEREKERDPEHRALCDLGPWVKCSAALASR             	                                                            
						having the sequence corresponding to amino acids 1 - 108 of  	                     Quality: 1098.00                      Escore:       0                                               
						F09357_P1, and a second amino acid sequence being at least 90	             Matching length:     112                Total length:     112                                               
						HDSKRCGGFDPHDVLHHVGRGVPVPGLHSVLCAEGVLHHLHRHVRAELPSSHYQLQTTSL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LERGLEAAAATQAGLTPDRLHPNSLKPLSIQFILQQVFIIIIIIIIHNRHFP         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						% homologous to corresponding to amino acids 38 - 149 of     	                        Gaps:       0                        
						Q8N0U8, which also corresponds to amino acids 109 - 220 of   	                                                            
						F09357_P1, wherein said first amino acid sequence and second 	Alignment:                                                   
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     109 HDSKRCGGFDPHDVLHHVGRGVPVPGLHSVLCAEGVLHHLHRHVRAELPS 158                                                          
						F09357_P1, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      38 HDSKRCGGFDPHDVLHHVGRGVPVPGLHSVLCAEGVLHHLHRHVRAELPS 87                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						GGGGGGGGGGGGGGGGGGGWVGPRRAAAAEVEAEGGGGGGGGKMAAPVLLRVSVPRWERV 	     159 SHYQLQTTSLLERGLEAAAATQAGLTPDRLHPNSLKPLSIQFILQQVFII 208                                                          
						ARYAVCAAGILLSIYAYHVEREKERDPEHRALCDLGPWVKCSAALASR             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F09357_P1.     	      88 SHYQLQTTSLLERGLEAAAATQAGLTPDRLHPNSLKPLSIQFILQQVFII 137                                                          
						                                                            	                  .                                          
						                                                            	     209 IIIIIIHNRHFP                                       220                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     138 IIIIIIHNRHFP                                       149                                                          

5640	HMR136_F09359_9_tr0_r1_1_gPRT		Comparison report between F09359_P9 and Q9Y369unique head    	Sequence name: Q9Y369                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a mismatch.1.An isolated chimeric polypeptide encoding for   	Sequence documentation:                                      
						F09359_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 5640 x Q9Y369   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AGAPPGRASARKTHALAACAALSAAPARGGPVGLSAGFEISPGACAAAA            	                                                            
						corresponding to amino acids 1 - 49 of F09359_P9, a second   	                     Quality: 1824.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     196                Total length:     349                                               
						MAAEEEEVDSADTGE corresponding to amino acids 1 - 15 of       	 Matching Percent Similarity:   99.49   Matching Percent Identity:   99.49                                               
						Q9Y369, which also corresponds to amino acids 50 - 64 of     	    Total Percent Similarity:   55.87      Total Percent Identity:   55.87                                               
						F09359_P9, a third amino acid sequence being at least 90 %   	                        Gaps:       1                        
						RVNHLILVEPWGFPERPDLADQDRPIPVWIRALGAALTPFNPLAGLRIAGPFGLSLVQRL 	                                                            
						RPDFKRKYSSMFEDDTVTEYIYHCNVQTPSGETA                           	Alignment:                                                   
						homologous to corresponding to amino acids 169 - 262 of      	                  .         .         .         .         .  
						Q9Y369, which also corresponds to amino acids 65 - 158 of    	      50 MAAEEEEVDSADTGE................................... 64                                                           
						F09359_P9, a bridging amino acid F corresponding to amino    	         |||||||||||||||                                     
						acid 159 of F09359_P9, and a fourth amino acid sequence being	       1 MAAEEEEVDSADTGERSGWLTGWLPTWCPTSISHLKEAEEKMLKCVPCTY 50                                                           
						KNMTIPYGWAKRPMLQRIGKMHPDIPVSVIFGARSCIDGNSGTSIQSLRPHSYVKTIAIL 	                  .         .         .         .         .  
						GAGHYVYADQPEEFNQKVKEICDTVD                                   	      64 .................................................. 64                                                           
						at least 90 % homologous to corresponding to amino acids 264 	                                                            
						- 349 of Q9Y369, which also corresponds to amino acids 160 - 	      51 KKEPVRISNGNKIWTLKFSHNISNKTPLVLLHGFGGGLGLWALNFGDLCT 100                                                          
						245 of F09359_P9, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence,       	      64 .................................................. 64                                                           
						bridging amino acid and fourth amino acid sequence are       	                                                            
						contiguous and in a sequential order.2.An isolated           	     101 NRPVYAFDLLGFGRSSRPRFDSDAEEVENQFVESIEEWRCALGLDKMILL 150                                                          
						polypeptide encoding for a head of F09359_P9, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      65 ..................RVNHLILVEPWGFPERPDLADQDRPIPVWIRA 96                                                           
						80%, preferably at least about 85%, more preferably at least 	                           ||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 GHNLGGFLAAAYSLKYPSRVNHLILVEPWGFPERPDLADQDRPIPVWIRA 200                                                          
						to the sequence                                              	                  .         .         .         .         .  
						AGAPPGRASARKTHALAACAALSAAPARGGPVGLSAGFEISPGACAAAA of         	      97 LGAALTPFNPLAGLRIAGPFGLSLVQRLRPDFKRKYSSMFEDDTVTEYIY 146                                                          
						F09359_P9.3.An isolated chimeric polypeptide encoding for an 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of F09359_P9, comprising a polypeptide having a 	     201 LGAALTPFNPLAGLRIAGPFGLSLVQRLRPDFKRKYSSMFEDDTVTEYIY 250                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     147 HCNVQTPSGETAFKNMTIPYGWAKRPMLQRIGKMHPDIPVSVIFGARSCI 196                                                          
						preferably at least about 30 amino acids in length, more     	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     251 HCNVQTPSGETASKNMTIPYGWAKRPMLQRIGKMHPDIPVSVIFGARSCI 300                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .            
						at least two amino acids comprise ER, having a structure as  	     197 DGNSGTSIQSLRPHSYVKTIAILGAGHYVYADQPEEFNQKVKEICDTVD  245                                                          
						follows: a sequence starting from any of amino acid numbers  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						64-x to 65; and ending at any of amino acid numbers 65+      	     301 DGNSGTSIQSLRPHSYVKTIAILGAGHYVYADQPEEFNQKVKEICDTVD  349                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between F09359_P9 and Q8WTS1unique head    	Sequence name: Q8WTS1                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F09359_P9,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 5640 x Q8WTS1   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AGAPPGRASARKTHALAACAALSAAPARGGPVGLSAGFEISPGACAAAA            	                                                            
						corresponding to amino acids 1 - 49 of F09359_P9, a second   	                     Quality: 1840.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     196                Total length:     349                                               
						MAAEEEEVDSADTGE corresponding to amino acids 1 - 15 of       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						Q8WTS1, which also corresponds to amino acids 50 - 64 of     	    Total Percent Similarity:   56.16      Total Percent Identity:   56.16                                               
						F09359_P9, and a third amino acid sequence being at least 90 	                        Gaps:       1                        
						RVNHLILVEPWGFPERPDLADQDRPIPVWIRALGAALTPFNPLAGLRIAGPFGLSLVQRL 	                                                            
						RPDFKRKYSSMFEDDTVTEYIYHCNVQTPSGETAFKNMTIPYGWAKRPMLQRIGKMHPDI 	Alignment:                                                   
						PVSVIFGARSCIDGNSGTSIQSLRPHSYVKTIAILGAGHYVYADQPEEFNQKVKEICDTV 	                  .         .         .         .         .  
						D                                                            	      50 MAAEEEEVDSADTGE................................... 64                                                           
						% homologous to corresponding to amino acids 169 - 349 of    	         |||||||||||||||                                     
						Q8WTS1, which also corresponds to amino acids 65 - 245 of    	       1 MAAEEEEVDSADTGERSGWLTGWLPTWCPTSISHLKEAEEKMLKCVPCTY 50                                                           
						F09359_P9, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	      64 .................................................. 64                                                           
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of F09359_P9, comprising a   	      51 KKEPVRISNGNKIWTLKFSHNISNKTPLVLLHGFGGGLGLWALNFGDLCT 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      64 .................................................. 64                                                           
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence                                              	     101 NRPVYAFDLLGFGRSSRPRFDSDAEEVENQFVESIEEWRCALGLDKMILL 150                                                          
						AGAPPGRASARKTHALAACAALSAAPARGGPVGLSAGFEISPGACAAAA of         	                  .         .         .         .         .  
						F09359_P9.3.An isolated chimeric polypeptide encoding for an 	      65 ..................RVNHLILVEPWGFPERPDLADQDRPIPVWIRA 96                                                           
						edge portion of F09359_P9, comprising a polypeptide having a 	                           ||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     151 GHNLGGFLAAAYSLKYPSRVNHLILVEPWGFPERPDLADQDRPIPVWIRA 200                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      97 LGAALTPFNPLAGLRIAGPFGLSLVQRLRPDFKRKYSSMFEDDTVTEYIY 146                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     201 LGAALTPFNPLAGLRIAGPFGLSLVQRLRPDFKRKYSSMFEDDTVTEYIY 250                                                          
						at least two amino acids comprise ER, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     147 HCNVQTPSGETAFKNMTIPYGWAKRPMLQRIGKMHPDIPVSVIFGARSCI 196                                                          
						64-x to 65; and ending at any of amino acid numbers 65+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     251 HCNVQTPSGETAFKNMTIPYGWAKRPMLQRIGKMHPDIPVSVIFGARSCI 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     197 DGNSGTSIQSLRPHSYVKTIAILGAGHYVYADQPEEFNQKVKEICDTVD  245                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     301 DGNSGTSIQSLRPHSYVKTIAILGAGHYVYADQPEEFNQKVKEICDTVD  349                                                          

11590	HMR136_F09377_3_tr0_r1_1_gPRT		Comparison report between F09377_P3 and ARH6_HUMANpartial WT 	Sequence name: ARH6_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F09377_P3, comprising a first amino 	Sequence documentation:                                      
						MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMPGSVEKFCLDP 	                                                            
						QTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVLSTLLAVNKATEDQLSERPCG 	Alignment of: 11590 x ARH6_HUMAN   ..                        
						RSSSLSAANTSQTNPQGAVSSTVSGLQRQSKTVEMTENGSHQLIVKARFNFKQTNEDELS 	                                                            
						VCKGDIIYVTRVEEGGWWEGTLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKN 	Alignment segment 1/1:                                       
						YYTVVLQNILDTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLC 	                                                            
						QALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSDELEQFMENQG 	                     Quality: 7447.00                      Escore:       0                                               
						ASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPDHQDILKAIVAFKTLMGQCQD 	             Matching length:     769                Total length:     776                                               
						LRKRKQLELQILSEPIQAWEGEDIKNLGNVIFMSQVMVQYGACEEKEERYLMLFSNVLIM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LSASPRMSGFIYQGKIPIAGTVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWL 	    Total Percent Similarity:   99.10      Total Percent Identity:   99.10                                               
						EQLNRLIRGPASCSSLSKTSSSSCSAHSSFSSTGQPRGPLEPPQIIKPWSLSCLRPAPPL 	                        Gaps:       1                        
						RPSAALGYKE                                                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 1 - 610 of ARH6_HUMAN, which also corresponds 	                  .         .         .         .         .  
						to amino acids 1 - 610 of F09377_P3, and a second amino acid 	       1 MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMP 50                                                           
						ESSKSPKTMKKFLHKRKTERKPSEEEYVIRKSTAALEEDAQILKVIEAYCTSANFQQGHG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSTRKDSIPQVLLPEEEKLIIEETRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQ 	       1 MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMP 50                                                           
						CLEEELKSRRDLEKLVRRLLKQTDECIRGESSSKTSILP                      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      51 GSVEKFCLDPQTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVL 100                                                          
						amino acids 618 - 776 of ARH6_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 611 - 769 of F09377_P3, wherein said first    	      51 GSVEKFCLDPQTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVL 100                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     101 STLLAVNKATEDQLSERPCGRSSSLSAANTSQTNPQGAVSSTVSGLQRQS 150                                                          
						polypeptide encoding for an edge portion of F09377_P3,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     101 STLLAVNKATEDQLSERPCGRSSSLSAANTSQTNPQGAVSSTVSGLQRQS 150                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     151 KTVEMTENGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVEEGGWWEG 200                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     151 KTVEMTENGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVEEGGWWEG 200                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise EE, having a structure as follows: a sequence       	     201 TLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKNYYTVVLQNIL 250                                                          
						starting from any of amino acid numbers 610-x to 611; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 611+ ((n-2) - x), in     	     201 TLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKNYYTVVLQNIL 250                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     251 DTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ELEQFMENQGASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPD 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ELEQFMENQGASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 HQDILKAIVAFKTLMGQCQDLRKRKQLELQILSEPIQAWEGEDIKNLGNV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 HQDILKAIVAFKTLMGQCQDLRKRKQLELQILSEPIQAWEGEDIKNLGNV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IFMSQVMVQYGACEEKEERYLMLFSNVLIMLSASPRMSGFIYQGKIPIAG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IFMSQVMVQYGACEEKEERYLMLFSNVLIMLSASPRMSGFIYQGKIPIAG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWLEQLNRLIRGP 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWLEQLNRLIRGP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 ASCSSLSKTSSSSCSAHSSFSSTGQPRGPLEPPQIIKPWSLSCLRPAPPL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 ASCSSLSKTSSSSCSAHSSFSSTGQPRGPLEPPQIIKPWSLSCLRPAPPL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RPSAALGYKE.......ESSKSPKTMKKFLHKRKTERKPSEEEYVIRKST 643                                                          
						                                                            	         ||||||||||       |||||||||||||||||||||||||||||||||  
						                                                            	     601 RPSAALGYKERMSYILKESSKSPKTMKKFLHKRKTERKPSEEEYVIRKST 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     644 AALEEDAQILKVIEAYCTSANFQQGHGSSTRKDSIPQVLLPEEEKLIIEE 693                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 AALEEDAQILKVIEAYCTSANFQQGHGSSTRKDSIPQVLLPEEEKLIIEE 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     694 TRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQCLEEELKSRRDLE 743                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 TRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQCLEEELKSRRDLE 750                                                          
						                                                            	                  .         .                                
						                                                            	     744 KLVRRLLKQTDECIRGESSSKTSILP                         769                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     751 KLVRRLLKQTDECIRGESSSKTSILP                         776                                                          

11592	HMR136_F09377_4_tr0_r1_1_gPRT		Comparison report between F09377_P4 and ARH6_HUMANpartial WT 	Sequence name: ARH6_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F09377_P4, comprising a first amino 	Sequence documentation:                                      
						MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMPGSVEKFCLDP 	                                                            
						QTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVLSTLLAVNKATEDQLSERPCG 	Alignment of: 11592 x ARH6_HUMAN   ..                        
						RSSSLSAANTSQTNPQGAVSSTVSGLQRQSKTVEMTENGSHQLIVKARFNFKQTNEDELS 	                                                            
						VCKGDIIYVTRVEEGGWWEGTLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKN 	Alignment segment 1/1:                                       
						YYTVVLQNILDTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLC 	                                                            
						QALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSDELEQFMENQG 	                     Quality: 6883.00                      Escore:       0                                               
						ASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPDHQDILKAIVAFKTLMGQCQD 	             Matching length:     723                Total length:     776                                               
						LRKRKQLELQILSEPIQAWEGEDIKNLGNVIFMSQVMVQYGACEEKEERYLMLFSNVLIM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LSASPRMSGFIYQGKIPIAGTVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWL 	    Total Percent Similarity:   93.17      Total Percent Identity:   93.17                                               
						EQLNRLIRGPASCSSLSKTSSSSCSAHS                                 	                        Gaps:       2                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 568 of ARH6_HUMAN, which also corresponds 	Alignment:                                                   
						to amino acids 1 - 568 of F09377_P4, a second amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	       1 MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMP 50                                                           
						ESSKSPKTMKKFLHKRKTERKPSEEEYVIRKSTAALEEDAQILKVIEAYCTSANFQQG   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 618 - 675 of ARH6_HUMAN, which  	       1 MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMP 50                                                           
						also corresponds to amino acids 569 - 626 of F09377_P4, and a	                  .         .         .         .         .  
						TRKDSIPQVLLPEEEKLIIEETRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQCL 	      51 GSVEKFCLDPQTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVL 100                                                          
						EEELKSRRDLEKLVRRLLKQTDECIRGESSSKTSILP                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	      51 GSVEKFCLDPQTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVL 100                                                          
						corresponding to amino acids 680 - 776 of ARH6_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 627 - 723 of F09377_P4,      	     101 STLLAVNKATEDQLSERPCGRSSSLSAANTSQTNPQGAVSSTVSGLQRQS 150                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 STLLAVNKATEDQLSERPCGRSSSLSAANTSQTNPQGAVSSTVSGLQRQS 150                                                          
						a sequential order.2.An isolated chimeric polypeptide        	                  .         .         .         .         .  
						encoding for an edge portion of F09377_P4, comprising a      	     151 KTVEMTENGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVEEGGWWEG 200                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     151 KTVEMTENGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVEEGGWWEG 200                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     201 TLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKNYYTVVLQNIL 250                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise SE, having 	     201 TLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKNYYTVVLQNIL 250                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 568-x to 569; and ending at any of amino acid   	     251 DTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLC 300                                                          
						numbers 569+ ((n-2) - x), in which x varies from 0 to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						n-2.3.An isolated chimeric polypeptide encoding for an edge  	     251 DTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLC 300                                                          
						portion of F09377_P4, comprising a polypeptide having a      	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     301 QALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSD 350                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     301 QALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSD 350                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     351 ELEQFMENQGASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPD 400                                                          
						at least two amino acids comprise GT, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     351 ELEQFMENQGASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPD 400                                                          
						626-x to 627; and ending at any of amino acid numbers 627+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     401 HQDILKAIVAFKTLMGQCQDLRKRKQLELQILSEPIQAWEGEDIKNLGNV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 HQDILKAIVAFKTLMGQCQDLRKRKQLELQILSEPIQAWEGEDIKNLGNV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IFMSQVMVQYGACEEKEERYLMLFSNVLIMLSASPRMSGFIYQGKIPIAG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 IFMSQVMVQYGACEEKEERYLMLFSNVLIMLSASPRMSGFIYQGKIPIAG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWLEQLNRLIRGP 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 TVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWLEQLNRLIRGP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 ASCSSLSKTSSSSCSAHS................................ 568                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     551 ASCSSLSKTSSSSCSAHSSFSSTGQPRGPLEPPQIIKPWSLSCLRPAPPL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     569 .................ESSKSPKTMKKFLHKRKTERKPSEEEYVIRKST 601                                                          
						                                                            	                          |||||||||||||||||||||||||||||||||  
						                                                            	     601 RPSAALGYKERMSYILKESSKSPKTMKKFLHKRKTERKPSEEEYVIRKST 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     602 AALEEDAQILKVIEAYCTSANFQQG....TRKDSIPQVLLPEEEKLIIEE 647                                                          
						                                                            	         |||||||||||||||||||||||||    |||||||||||||||||||||  
						                                                            	     651 AALEEDAQILKVIEAYCTSANFQQGHGSSTRKDSIPQVLLPEEEKLIIEE 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     648 TRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQCLEEELKSRRDLE 697                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 TRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQCLEEELKSRRDLE 750                                                          
						                                                            	                  .         .                                
						                                                            	     698 KLVRRLLKQTDECIRGESSSKTSILP                         723                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     751 KLVRRLLKQTDECIRGESSSKTSILP                         776                                                          

11694	HMR136_F09380_10_tr0_r1_1_gPRT		Comparison report between F09380_P10 and Q9Y2F7unique head   	Sequence name: Q9Y2F7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09380_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11694 x Q9Y2F7   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence KPIFPLPQ corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F09380_P10, and a second amino acid sequence being at   	                                                            
						VPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQ 	                     Quality:  652.00                      Escore:       0                                               
						LFGTNRE                                                      	             Matching length:      73                Total length:      73                                               
						least 90 % homologous to corresponding to amino acids 277 -  	 Matching Percent Similarity:   97.26   Matching Percent Identity:   93.15                                               
						343 of Q9Y2F7, which also corresponds to amino acids 9 - 75  	    Total Percent Similarity:   97.26      Total Percent Identity:   93.15                                               
						of F09380_P10, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a head of       	Alignment:                                                   
						F09380_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	       3 IFPLPQVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGA 52                                                           
						more preferably at least about 90% and most preferably at    	         ::|:  ||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence KPIFPLPQ of       	     271 LLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGA 320                                                          
						F09380_P10.                                                  	                  .         .                                
						                                                            	      53 LNIYLDIIYIFTFFLQLFGTNRE                            75                                                           
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     321 LNIYLDIIYIFTFFLQLFGTNRE                            343                                                          

						Comparison report between F09380_P10 and Q9UJY9unique head   	Sequence name: Q9UJY9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09380_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11694 x Q9UJY9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence KPIFPLPQ corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F09380_P10, and a second amino acid sequence being at   	                                                            
						VPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQ 	                     Quality:  652.00                      Escore:       0                                               
						LFGTNRE                                                      	             Matching length:      73                Total length:      73                                               
						least 90 % homologous to corresponding to amino acids 250 -  	 Matching Percent Similarity:   97.26   Matching Percent Identity:   93.15                                               
						316 of Q9UJY9, which also corresponds to amino acids 9 - 75  	    Total Percent Similarity:   97.26      Total Percent Identity:   93.15                                               
						of F09380_P10, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a head of       	Alignment:                                                   
						F09380_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	       3 IFPLPQVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGA 52                                                           
						more preferably at least about 90% and most preferably at    	         ::|:  ||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence KPIFPLPQ of       	     244 LLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGA 293                                                          
						F09380_P10.                                                  	                  .         .                                
						                                                            	      53 LNIYLDIIYIFTFFLQLFGTNRE                            75                                                           
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     294 LNIYLDIIYIFTFFLQLFGTNRE                            316                                                          

						Comparison report between F09380_P10 and Q9BWQ8unique head   	Sequence name: Q9BWQ8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09380_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11694 x Q9BWQ8   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence KPIFPLPQ corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of F09380_P10, and a second amino acid sequence being at   	                                                            
						VPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQ 	                     Quality:  652.00                      Escore:       0                                               
						LFGTNRE                                                      	             Matching length:      73                Total length:      73                                               
						least 90 % homologous to corresponding to amino acids 250 -  	 Matching Percent Similarity:   97.26   Matching Percent Identity:   93.15                                               
						316 of Q9BWQ8, which also corresponds to amino acids 9 - 75  	    Total Percent Similarity:   97.26      Total Percent Identity:   93.15                                               
						of F09380_P10, wherein said first amino acid sequence and    	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a head of       	Alignment:                                                   
						F09380_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	       3 IFPLPQVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGA 52                                                           
						more preferably at least about 90% and most preferably at    	         ::|:  ||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence KPIFPLPQ of       	     244 LLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGA 293                                                          
						F09380_P10.                                                  	                  .         .                                
						                                                            	      53 LNIYLDIIYIFTFFLQLFGTNRE                            75                                                           
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     294 LNIYLDIIYIFTFFLQLFGTNRE                            316                                                          

11696	HMR136_F09380_8_tr0_r1_1_gPRT		Comparison report between F09380_P8 and Q9Y2F7unique head    	Sequence name: Q9Y2F7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09380_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11696 x Q9Y2F7   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MARRRRLQQCPQPHPLSLLCS corresponding to   	Alignment segment 1/1:                                       
						amino acids 1 - 21 of F09380_P8, and a second amino acid     	                                                            
						DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTLSMAYLTGMLS 	                     Quality: 1847.00                      Escore:       0                                               
						SYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVLFVLLMTLFFSGLILAILLPF 	             Matching length:     189                Total length:     189                                               
						QYVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGALNIYLDIIYIFTFF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQLFGTNRE                                                    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 155 - 343 of Q9Y2F7, which also corresponds to   	                                                            
						amino acids 22 - 210 of F09380_P8, wherein said first amino  	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	      22 DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTL 71                                                           
						for a head of F09380_P8, comprising a polypeptide being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     155 DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTL 204                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	      72 SMAYLTGMLSSYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVL 121                                                          
						MARRRRLQQCPQPHPLSLLCS of F09380_P8.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 SMAYLTGMLSSYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVL 254                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     122 FVLLMTLFFSGLILAILLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLM 171                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     255 FVLLMTLFFSGLILAILLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLM 304                                                          
						                                                            	                  .         .         .                      
						                                                            	     172 GNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE            210                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     305 GNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE            343                                                          

						Comparison report between F09380_P8 and Q9UJY9unique head    	Sequence name: Q9UJY9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09380_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11696 x Q9UJY9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MARRRRLQQCPQPHPLSLLCSDPVKDYVQAN          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 31 of F09380_P8, and a      	                                                            
						PGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTLSMAYLTGMLSSYYNTTSVLL 	                     Quality: 1753.00                      Escore:       0                                               
						CLGITALVCLSVTVFSFQTKFDFTSCQGVLFVLLMTLFFSGLILAILLPFQYVPWLHAVY 	             Matching length:     189                Total length:     189                                               
						AALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE  	 Matching Percent Similarity:   96.30   Matching Percent Identity:   95.77                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:   96.30      Total Percent Identity:   95.77                                               
						corresponding to amino acids 138 - 316 of Q9UJY9, which also 	                        Gaps:       0                        
						corresponds to amino acids 32 - 210 of F09380_P8, wherein    	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of F09380_P8, comprising a   	      22 DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTL 71                                                           
						polypeptide being at least 70%, optionally at least about    	         || :      ||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     128 DPCQGLCSGQPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTL 177                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MARRRRLQQCPQPHPLSLLCSDPVKDYVQAN of F09380_P8.	      72 SMAYLTGMLSSYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVL 121                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 SMAYLTGMLSSYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVL 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     122 FVLLMTLFFSGLILAILLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLM 171                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 FVLLMTLFFSGLILAILLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLM 277                                                          
						                                                            	                  .         .         .                      
						                                                            	     172 GNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE            210                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     278 GNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE            316                                                          

						Comparison report between F09380_P8 and Q9BWQ8unique head    	Sequence name: Q9BWQ8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09380_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11696 x Q9BWQ8   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MARRRRLQQCPQPHPLSLLCS corresponding to   	Alignment segment 1/1:                                       
						amino acids 1 - 21 of F09380_P8, and a second amino acid     	                                                            
						DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTLSMAYLTGMLS 	                     Quality: 1847.00                      Escore:       0                                               
						SYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVLFVLLMTLFFSGLILAILLPF 	             Matching length:     189                Total length:     189                                               
						QYVPWLHAVYAALGAGVFTLFLALDTQLLMGNRRHSLSPEEYIFGALNIYLDIIYIFTFF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQLFGTNRE                                                    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 128 - 316 of Q9BWQ8, which also corresponds to   	                                                            
						amino acids 22 - 210 of F09380_P8, wherein said first amino  	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	      22 DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTL 71                                                           
						for a head of F09380_P8, comprising a polypeptide being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     128 DPVKDYVQANPGWYWASYAVFFATYLTLACCSGPRRHFPWNLILLTVFTL 177                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	      72 SMAYLTGMLSSYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVL 121                                                          
						MARRRRLQQCPQPHPLSLLCS of F09380_P8.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 SMAYLTGMLSSYYNTTSVLLCLGITALVCLSVTVFSFQTKFDFTSCQGVL 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     122 FVLLMTLFFSGLILAILLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLM 171                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 FVLLMTLFFSGLILAILLPFQYVPWLHAVYAALGAGVFTLFLALDTQLLM 277                                                          
						                                                            	                  .         .         .                      
						                                                            	     172 GNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE            210                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     278 GNRRHSLSPEEYIFGALNIYLDIIYIFTFFLQLFGTNRE            316                                                          

11862	HMR136_F09391_6_tr0_r1_1_gPRT		Comparison report between F09391_P6 and Q9BQ72partial WT     	Sequence name: Q9BQ72                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09391_P6, comprising a first amino 	Sequence documentation:                                      
						MGERKGVNKYYPPDFNPEKHGSLNRYHNSHPLRERARKLSQGILIIRFEMPYNIWCDGCK 	                                                            
						NHIGMGVRYNAEKKKVGNYYTTPIYRFRMKCHLCVNYIEMQTDPANCDYVIVSGAQRKEE 	Alignment of: 11862 x Q9BQ72   ..                            
						RWDMADNEQVLTTEHEKKQKLETDAMFRLEHGEADRSTLKKALPTLSHIQEAQSAWKDDF 	                                                            
						ALNSMLRRRFR                                                  	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 191 of Q9BQ72, which also corresponds to  	                     Quality: 1946.00                      Escore:       0                                               
						amino acids 1 - 191 of F09391_P6, and a second amino acid    	             Matching length:     191                Total length:     191                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence PTRTSRNSSGPRSSAAPGSPLPPDPPPAARSAAS       	                                                            
						corresponding to amino acids 192 - 225 of F09391_P6, wherein 	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	       1 MGERKGVNKYYPPDFNPEKHGSLNRYHNSHPLRERARKLSQGILIIRFEM 50                                                           
						polypeptide encoding for a tail of F09391_P6, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       1 MGERKGVNKYYPPDFNPEKHGSLNRYHNSHPLRERARKLSQGILIIRFEM 50                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      51 PYNIWCDGCKNHIGMGVRYNAEKKKVGNYYTTPIYRFRMKCHLCVNYIEM 100                                                          
						to the sequence PTRTSRNSSGPRSSAAPGSPLPPDPPPAARSAAS in        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09391_P6.                                                   	      51 PYNIWCDGCKNHIGMGVRYNAEKKKVGNYYTTPIYRFRMKCHLCVNYIEM 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QTDPANCDYVIVSGAQRKEERWDMADNEQVLTTEHEKKQKLETDAMFRLE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QTDPANCDYVIVSGAQRKEERWDMADNEQVLTTEHEKKQKLETDAMFRLE 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 HGEADRSTLKKALPTLSHIQEAQSAWKDDFALNSMLRRRFR          191                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     151 HGEADRSTLKKALPTLSHIQEAQSAWKDDFALNSMLRRRFR          191                                                          

6074	HMR136_F09425_1_tr0_r1_1_gPRT		Comparison report between F09425_P1 and Q8ND89unique head    	Sequence name: Q8ND89                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09425_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6074 x Q8ND89   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MKSSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTW 	Alignment segment 1/1:                                       
						RRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAIL 	                                                            
						WRKTGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVN 	                     Quality: 2304.00                      Escore:       0                                               
						FKFGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGI 	             Matching length:     243                Total length:     243                                               
						HSVYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLING 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEA 	                        Gaps:       0                        
						RQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQAL 	                                                            
						LVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQ 	Alignment:                                                   
						KGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPS 	                  .         .         .         .         .  
						GVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVN 	     749 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 798                                                          
						ESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDFQFCWNQAPYAIVCAFPYLLAFTTDS                                 	       1 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 50                                                           
						having the sequence corresponding to amino acids 1 - 748 of  	                  .         .         .         .         .  
						F09425_P1, and a second amino acid sequence being at least 90	     799 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 848                                                          
						MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAIP 	      51 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 100                                                          
						VTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAV 	                  .         .         .         .         .  
						RSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDII 	     849 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 898                                                          
						DLK                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 243 of      	     101 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 150                                                          
						Q8ND89, which also corresponds to amino acids 749 - 991 of   	                  .         .         .         .         .  
						F09425_P1, wherein said first amino acid sequence and second 	     899 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 948                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 200                                                          
						F09425_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .            
						optionally at least about 80%, preferably at least about 85%,	     949 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        991                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||||||||||||||||||||||||||||||||||         
						MKSSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTW 	     201 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        243                                                          
						RRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAIL 	                                                            
						WRKTGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVN 	                                                            
						FKFGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGI 	                                                            
						HSVYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMI 	                                                            
						RSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLING 	                                                            
						EKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEA 	                                                            
						RQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQAL 	                                                            
						LVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQ 	                                                            
						KGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPS 	                                                            
						GVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVN 	                                                            
						ESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSA 	                                                            
						SDFQFCWNQAPYAIVCAFPYLLAFTTDS                                 	                                                            
						least about 95% homologous to the sequence of F09425_P1.     	                                                            

						Comparison report between F09425_P1 and Q9BQH6short unique   	Sequence name: Q9BQH6                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09425_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6074 x Q9BQH6   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MK           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 2 of F09425_P1, a second    	                                                            
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	                     Quality: 7588.00                      Escore:       0                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	             Matching length:     772                Total length:     772                                               
						KTGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 	                        Gaps:       0                        
						HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEK 	                                                            
						ATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQ 	Alignment:                                                   
						AEFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLV 	                  .         .         .         .         .  
						STDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKG 	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						LEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNES 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						TGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASD 	                  .         .         .         .         .  
						FQFCWNQAPYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASR         	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 7 - 778 of Q9BQH6, which also   	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 106                                                          
						corresponds to amino acids 3 - 774 of F09425_P1, and a third 	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	                  .         .         .         .         .  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						having the sequence corresponding to amino acids 775 - 991 of	                  .         .         .         .         .  
						F09425_P1, wherein said first amino acid sequence, second    	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						polypeptide encoding for a tail of F09425_P1, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	                  .         .         .         .         .  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						to the sequence in F09425_P1.                                	                  .         .         .         .         .  
						                                                            	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     453 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 502                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     503 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 552                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     553 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 602                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     603 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 652                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 656                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     653 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 702                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     657 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 706                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     703 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 752                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     707 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 756                                                          
						                                                            	                  .         .                                
						                                                            	     753 LVVNGNLVHTAVVPQLQLVASR                             774                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     757 LVVNGNLVHTAVVPQLQLVASR                             778                                                          

						Comparison report between F09425_P1 and Q8N951short unique   	Sequence name: Q8N951                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for F09425_P1, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6074 x Q8N951   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MK corresponding to amino    	                                                            
						acids 1 - 2 of F09425_P1, a second amino acid sequence being 	                     Quality: 3727.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     387                Total length:     428                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KTGTQKICLPYSPTKTLSVKSILS                                     	    Total Percent Similarity:   90.42      Total Percent Identity:   90.42                                               
						at least 90 % homologous to corresponding to amino acids 25 -	                        Gaps:       1                        
						168 of Q8N951, which also corresponds to amino acids 3 - 146 	                                                            
						of F09425_P1, a third amino acid sequence being at least 70%,	Alignment:                                                   
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF corresponding to   	      25 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 74                                                           
						amino acids 147 - 187 of F09425_P1, a fourth amino acid      	                  .         .         .         .         .  
						AKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLET 	      75 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 124                                                          
						PTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVR 	                  .         .         .         .         .  
						IGQ                                                          	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||        
						amino acids 169 - 411 of Q8N951, which also corresponds to   	     125 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS...... 168                                                          
						amino acids 188 - 430 of F09425_P1, and a fifth amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						preferably at least 85%, more preferably at least 90% and    	                                            |||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     169 ...................................AKDGQLTDDEMFSNE 183                                                          
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                  .         .         .         .         .  
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	     184 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 233                                                          
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	                  .         .         .         .         .  
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	     234 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 283                                                          
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	                  .         .         .         .         .  
						VSGSSPFQLTAFSDEDIIDLK                                        	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						having the sequence corresponding to amino acids 431 - 991 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P1, wherein said first amino acid sequence, second    	     284 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 333                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .         .         .         .  
						acid sequence and fifth amino acid sequence are contiguous   	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of F09425_P1, comprising an amino acid   	     334 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 383                                                          
						sequence being at least 70%, optionally at least about 80%,  	                  .         .                                
						preferably at least about 85%, more preferably at least about	     403 FSDVLPESPKSARKKEEARQAEFVRIGQ                       430                                                          
						90% and most preferably at least about 95% homologous to the 	         ||||||||||||||||||||||||||||                        
						sequence encoding for                                        	     384 FSDVLPESPKSARKKEEARQAEFVRIGQ                       411                                                          
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF, corresponding to  	                                                            
						F09425_P1.3.An isolated polypeptide encoding for a tail of   	                                                            
						F09425_P1, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                                                            
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	                                                            
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                                                            
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	                                                            
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	                                                            
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	                                                            
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	                                                            
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	                                                            
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	                                                            
						VSGSSPFQLTAFSDEDIIDLK                                        	                                                            
						least about 95% homologous to the sequence in F09425_P1.     	                                                            

						Comparison report between F09425_P1 and Q8IYU1short unique   	Sequence name: Q8IYU1                                        
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for F09425_P1, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 6074 x Q8IYU1   ..                             
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MK corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 2 of F09425_P1, a second amino acid sequence being 	                                                            
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	                     Quality: 9636.00                      Escore:       0                                               
						TDVHLENPEYHTRWYFKYFLGQV                                      	             Matching length:     989                Total length:     989                                               
						at least 90 % homologous to corresponding to amino acids 7 - 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.90                                               
						89 of Q8IYU1, which also corresponds to amino acids 3 - 85 of	    Total Percent Similarity:   99.90      Total Percent Identity:   99.90                                               
						F09425_P1, a bridging amino acid H corresponding to amino    	                        Gaps:       0                        
						acid 86 of F09425_P1, and a third amino acid sequence being  	                                                            
						QNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS 	Alignment:                                                   
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSE 	                  .         .         .         .         .  
						PFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKEN 	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						KQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLH 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						QDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 	                  .         .         .         .         .  
						AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLP 	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						VKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGC 	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						HLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREIC 	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVRQNYIGNDAEKSPFFLS 106                                                          
						LSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVY 	                  .         .         .         .         .  
						EDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						DSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAA 	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						IPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPG 	                  .         .         .         .         .  
						AVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDED 	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						IIDLK                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 91 -	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						995 of Q8IYU1, which also corresponds to amino acids 87 - 991	                  .         .         .         .         .  
						of F09425_P1, wherein said first amino acid sequence, second 	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						amino acid sequence, bridging amino acid and third amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.           	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     453 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 502                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     503 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 552                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     553 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 602                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     603 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 652                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 656                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     653 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 702                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     657 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 706                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     703 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 752                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     707 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 756                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     753 LVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNS 802                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     757 LVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNS 806                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     803 PQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSK 852                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     807 PQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSK 856                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     853 VITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKS 902                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     857 VITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKS 906                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     903 EGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPE 952                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     907 EGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPE 956                                                          
						                                                            	                  .         .         .                      
						                                                            	     953 GHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK            991                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     957 GHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK            995                                                          

6072	HMR136_F09425_10_tr0_r1_1_gPRT		Comparison report between F09425_P10 and Q9BQH6short unique  	Sequence name: Q9BQH6                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09425_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6072 x Q9BQH6   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MK           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 2 of F09425_P10, a second   	                                                            
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	                     Quality: 6099.00                      Escore:       0                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	             Matching length:     621                Total length:     621                                               
						KTGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 	                        Gaps:       0                        
						HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEK 	                                                            
						ATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQ 	Alignment:                                                   
						AEFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLV 	                  .         .         .         .         .  
						STDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKG 	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						LEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSTSLLSPLSESPVEEFQYIR                                        	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 7 - 627 of Q9BQH6, which also   	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						corresponds to amino acids 3 - 623 of F09425_P10, and a third	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 106                                                          
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						having the sequence TRVH corresponding to amino acids 624 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						627 of F09425_P10, wherein said first amino acid sequence,   	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						polypeptide encoding for a tail of F09425_P10, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						to the sequence TRVH in F09425_P10.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     453 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 502                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     503 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 552                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     553 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 602                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .                                
						                                                            	     603 TSTSLLSPLSESPVEEFQYIR                              623                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     607 TSTSLLSPLSESPVEEFQYIR                              627                                                          

						Comparison report between F09425_P10 and Q8N951short unique  	Sequence name: Q8N951                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for F09425_P10, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6072 x Q8N951   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MK corresponding to amino    	                                                            
						acids 1 - 2 of F09425_P10, a second amino acid sequence being	                     Quality: 3727.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     387                Total length:     428                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KTGTQKICLPYSPTKTLSVKSILS                                     	    Total Percent Similarity:   90.42      Total Percent Identity:   90.42                                               
						at least 90 % homologous to corresponding to amino acids 25 -	                        Gaps:       1                        
						168 of Q8N951, which also corresponds to amino acids 3 - 146 	                                                            
						of F09425_P10, a third amino acid sequence being at least    	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF corresponding to   	      25 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 74                                                           
						amino acids 147 - 187 of F09425_P10, a fourth amino acid     	                  .         .         .         .         .  
						AKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLET 	      75 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 124                                                          
						PTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVR 	                  .         .         .         .         .  
						IGQ                                                          	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||        
						amino acids 169 - 411 of Q8N951, which also corresponds to   	     125 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS...... 168                                                          
						amino acids 188 - 430 of F09425_P10, and a fifth amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						preferably at least 85%, more preferably at least 90% and    	                                            |||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     169 ...................................AKDGQLTDDEMFSNE 183                                                          
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                  .         .         .         .         .  
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSESPVEEFQYIRTRVH                                            	     184 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 233                                                          
						having the sequence corresponding to amino acids 431 - 627 of	                  .         .         .         .         .  
						F09425_P10, wherein said first amino acid sequence, second   	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and fifth amino acid sequence are contiguous   	     234 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 283                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of F09425_P10, comprising an amino acid  	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     284 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 333                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for                                        	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF, corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P10.3.An isolated polypeptide encoding for a tail of  	     334 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 383                                                          
						F09425_P10, comprising a polypeptide being at least 70%,     	                  .         .                                
						optionally at least about 80%, preferably at least about 85%,	     403 FSDVLPESPKSARKKEEARQAEFVRIGQ                       430                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||                        
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	     384 FSDVLPESPKSARKKEEARQAEFVRIGQ                       411                                                          
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	                                                            
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                                                            
						LSESPVEEFQYIRTRVH                                            	                                                            
						least about 95% homologous to the sequence in F09425_P10.    	                                                            

						Comparison report between F09425_P10 and Q8IYU1short unique  	Sequence name: Q8IYU1                                        
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for F09425_P10, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6072 x Q8IYU1   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MK corresponding to amino acids 1 - 2 of 	                                                            
						F09425_P10, a second amino acid sequence being at least 90 % 	                     Quality: 6085.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     621                Total length:     621                                               
						TDVHLENPEYHTRWYFKYFLGQV                                      	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						homologous to corresponding to amino acids 7 - 89 of Q8IYU1, 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						which also corresponds to amino acids 3 - 85 of F09425_P10, a	                        Gaps:       0                        
						bridging amino acid H corresponding to amino acid 86 of      	                                                            
						F09425_P10, a third amino acid sequence being at least 90 %  	Alignment:                                                   
						QNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS 	                  .         .         .         .         .  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSE 	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						PFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFS 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						EESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLH 	                  .         .         .         .         .  
						QDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLP 	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						VKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGC 	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVRQNYIGNDAEKSPFFLS 106                                                          
						HLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIR    	                  .         .         .         .         .  
						homologous to corresponding to amino acids 91 - 627 of       	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						Q8IYU1, which also corresponds to amino acids 87 - 623 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P10, and a fourth amino acid sequence being at least  	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						homologous to a polypeptide having the sequence TRVH         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 624 - 627 of F09425_P10, wherein	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						bridging amino acid, third amino acid sequence and fourth    	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						F09425_P10, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence TRVH in           	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						F09425_P10.                                                  	                  .         .         .         .         .  
						                                                            	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     453 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 502                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     503 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 552                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     553 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 602                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .                                
						                                                            	     603 TSTSLLSPLSESPVEEFQYIR                              623                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     607 TSTSLLSPLSESPVEEFQYIR                              627                                                          

6082	HMR136_F09425_14_tr0_r1_1_gPRT		Comparison report between F09425_P14 and Q9BQH6short unique  	Sequence name: Q9BQH6                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09425_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6082 x Q9BQH6   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MK           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 2 of F09425_P14, a second   	                                                            
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	                     Quality: 6835.00                      Escore:       0                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	             Matching length:     698                Total length:     698                                               
						KTGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFK 	 Matching Percent Similarity:   99.86   Matching Percent Identity:   99.86                                               
						FGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHS 	    Total Percent Similarity:   99.86      Total Percent Identity:   99.86                                               
						VYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 	                        Gaps:       0                        
						HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEK 	                                                            
						ATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQ 	Alignment:                                                   
						AEFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLV 	                  .         .         .         .         .  
						STDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKG 	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						LEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNES 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						TGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYN                         	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						corresponding to amino acids 7 - 702 of Q9BQH6, which also   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 3 - 698 of F09425_P14, and a third	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 106                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence SSQQQAPAFHGNTVSSCSFPVYTTAFLLNGVQ         	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						corresponding to amino acids 699 - 730 of F09425_P14, wherein	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						and third amino acid sequence are contiguous and in a        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						tail of F09425_P14, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						SSQQQAPAFHGNTVSSCSFPVYTTAFLLNGVQ in F09425_P14.              	                  .         .         .         .         .  
						                                                            	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     453 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 502                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     503 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 552                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     553 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 602                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     603 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 652                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 656                                                          
						                                                            	                  .         .         .         .            
						                                                            	     653 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNSS   700                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||| |    
						                                                            	     657 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYS   704                                                          

						Comparison report between F09425_P14 and Q8N951short unique  	Sequence name: Q8N951                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for F09425_P14, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6082 x Q8N951   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MK corresponding to amino    	                                                            
						acids 1 - 2 of F09425_P14, a second amino acid sequence being	                     Quality: 3727.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     387                Total length:     428                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KTGTQKICLPYSPTKTLSVKSILS                                     	    Total Percent Similarity:   90.42      Total Percent Identity:   90.42                                               
						at least 90 % homologous to corresponding to amino acids 25 -	                        Gaps:       1                        
						168 of Q8N951, which also corresponds to amino acids 3 - 146 	                                                            
						of F09425_P14, a third amino acid sequence being at least    	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF corresponding to   	      25 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 74                                                           
						amino acids 147 - 187 of F09425_P14, a fourth amino acid     	                  .         .         .         .         .  
						AKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLET 	      75 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 124                                                          
						PTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVR 	                  .         .         .         .         .  
						IGQ                                                          	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||        
						amino acids 169 - 411 of Q8N951, which also corresponds to   	     125 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS...... 168                                                          
						amino acids 188 - 430 of F09425_P14, and a fifth amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						preferably at least 85%, more preferably at least 90% and    	                                            |||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     169 ...................................AKDGQLTDDEMFSNE 183                                                          
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                  .         .         .         .         .  
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	     184 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 233                                                          
						HVEANRVNFVAAIDVYEDGEAGLLLCYNSSQQQAPAFHGNTVSSCSFPVYTTAFLLNGVQ 	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 431 - 730 of	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						F09425_P14, wherein said first amino acid sequence, second   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, third amino acid sequence, fourth amino 	     234 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 283                                                          
						acid sequence and fifth amino acid sequence are contiguous   	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						for an edge portion of F09425_P14, comprising an amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least about 80%,  	     284 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 333                                                          
						preferably at least about 85%, more preferably at least about	                  .         .         .         .         .  
						90% and most preferably at least about 95% homologous to the 	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						sequence encoding for                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF, corresponding to  	     334 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 383                                                          
						F09425_P14.3.An isolated polypeptide encoding for a tail of  	                  .         .                                
						F09425_P14, comprising a polypeptide being at least 70%,     	     403 FSDVLPESPKSARKKEEARQAEFVRIGQ                       430                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||                        
						more preferably at least about 90% and most preferably at    	     384 FSDVLPESPKSARKKEEARQAEFVRIGQ                       411                                                          
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                                                            
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	                                                            
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                                                            
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	                                                            
						HVEANRVNFVAAIDVYEDGEAGLLLCYNSSQQQAPAFHGNTVSSCSFPVYTTAFLLNGVQ 	                                                            
						least about 95% homologous to the sequence in F09425_P14.    	                                                            

						Comparison report between F09425_P14 and Q8IYU1short unique  	Sequence name: Q8IYU1                                        
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for F09425_P14, comprising a first amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 6082 x Q8IYU1   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence MK corresponding to amino acids 1 - 2 of 	                                                            
						F09425_P14, a second amino acid sequence being at least 90 % 	                     Quality: 6821.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     698                Total length:     698                                               
						TDVHLENPEYHTRWYFKYFLGQV                                      	 Matching Percent Similarity:   99.71   Matching Percent Identity:   99.71                                               
						homologous to corresponding to amino acids 7 - 89 of Q8IYU1, 	    Total Percent Similarity:   99.71      Total Percent Identity:   99.71                                               
						which also corresponds to amino acids 3 - 85 of F09425_P14, a	                        Gaps:       0                        
						bridging amino acid H corresponding to amino acid 86 of      	                                                            
						F09425_P14, a third amino acid sequence being at least 90 %  	Alignment:                                                   
						QNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS 	                  .         .         .         .         .  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSE 	       3 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 52                                                           
						PFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFS 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						EESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLH 	                  .         .         .         .         .  
						QDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 	      53 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 102                                                          
						AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLP 	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						VKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGC 	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVRQNYIGNDAEKSPFFLS 106                                                          
						HLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREIC 	                  .         .         .         .         .  
						LSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVY 	     103 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 152                                                          
						EDGEAGLLLCYN                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 91 - 702 of       	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						Q8IYU1, which also corresponds to amino acids 87 - 698 of    	                  .         .         .         .         .  
						F09425_P14, and a fourth amino acid sequence being at least  	     153 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 202                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						SSQQQAPAFHGNTVSSCSFPVYTTAFLLNGVQ corresponding to amino acids	     203 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 252                                                          
						699 - 730 of F09425_P14, wherein said first amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid,   	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     253 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 302                                                          
						polypeptide encoding for a tail of F09425_P14, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     303 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 352                                                          
						to the sequence SSQQQAPAFHGNTVSSCSFPVYTTAFLLNGVQ in          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P14.                                                  	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     453 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 502                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     503 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 552                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     553 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 602                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     603 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 652                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 656                                                          
						                                                            	                  .         .         .         .            
						                                                            	     653 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNSS   700                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||| |    
						                                                            	     657 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYS   704                                                          

6080	HMR136_F09425_3_tr0_r1_1_gPRT		Comparison report between F09425_P3 and Q8ND89unique head    	Sequence name: Q8ND89                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09425_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6080 x Q8ND89   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	Alignment segment 1/1:                                       
						AKSSLSFGIQPLQTWPTKDPELESQVNLSVSEDLGCRRGDFSRKHYGSVELLISSDADGA 	                                                            
						IQRAGRFRVENGSSDENATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAE 	                     Quality: 2304.00                      Escore:       0                                               
						KSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKFEK 	             Matching length:     243                Total length:     243                                               
						GPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENKQQVERKRH 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						IGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGP 	                        Gaps:       0                        
						PLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHK 	                                                            
						NMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKE 	Alignment:                                                   
						PWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLET 	                  .         .         .         .         .  
						LDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHH 	     834 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 883                                                          
						SRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLL 	       1 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 50                                                           
						CYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDS        	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 833 of  	     884 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 933                                                          
						F09425_P3, and a second amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPPG 	      51 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 100                                                          
						RDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAIP 	                  .         .         .         .         .  
						VTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAV 	     934 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 983                                                          
						RSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDII 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLK                                                          	     101 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 150                                                          
						% homologous to corresponding to amino acids 1 - 243 of      	                  .         .         .         .         .  
						Q8ND89, which also corresponds to amino acids 834 - 1076 of  	     984 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 1033                                                         
						F09425_P3, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     151 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 200                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .            
						F09425_P3, comprising a polypeptide being at least 70%,      	    1034 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        1076                                                         
						optionally at least about 80%, preferably at least about 85%,	         |||||||||||||||||||||||||||||||||||||||||||         
						more preferably at least about 90% and most preferably at    	     201 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        243                                                          
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	                                                            
						AKSSLSFGIQPLQTWPTKDPELESQVNLSVSEDLGCRRGDFSRKHYGSVELLISSDADGA 	                                                            
						IQRAGRFRVENGSSDENATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAE 	                                                            
						KSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKFEK 	                                                            
						GPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLL 	                                                            
						GDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENKQQVERKRH 	                                                            
						IGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGP 	                                                            
						PLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHK 	                                                            
						NMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKE 	                                                            
						PWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLET 	                                                            
						LDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHH 	                                                            
						SRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMT 	                                                            
						LVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLL 	                                                            
						CYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDS        	                                                            
						least about 95% homologous to the sequence of F09425_P3.     	                                                            

						Comparison report between F09425_P3 and Q9BQH6unique head    	Sequence name: Q9BQH6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09425_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6080 x Q9BQH6   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	Alignment segment 1/1:                                       
						AKSSLSFGIQPLQTWPTKDPELESQVNL                                 	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 7579.00                      Escore:       0                                               
						to amino acids 1 - 88 of F09425_P3, a second amino acid      	             Matching length:     771                Total length:     771                                               
						SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRRT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKF 	                        Gaps:       0                        
						GVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSV 	                                                            
						YTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 	Alignment:                                                   
						FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKA 	                  .         .         .         .         .  
						TLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQA 	      89 SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENA 138                                                          
						EFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGL 	       8 SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENA 57                                                           
						EGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVT 	                  .         .         .         .         .  
						STSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNEST 	     139 TALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSV 188                                                          
						GEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QFCWNQAPYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASR          	      58 TALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSV 107                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 8 - 778 of Q9BQH6, which also corresponds to     	     189 TLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKF 238                                                          
						amino acids 89 - 859 of F09425_P3, and a third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     108 TLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKF 157                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     239 EKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEI 288                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     158 EKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEI 207                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	                  .         .         .         .         .  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     289 GSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIM 338                                                          
						having the sequence corresponding to amino acids 860 - 1076  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F09425_P3, wherein said first amino acid sequence, second 	     208 GSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIM 257                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     339 FHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 388                                                          
						polypeptide encoding for a head of F09425_P3, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     258 FHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 307                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     389 FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFL 438                                                          
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKSSLSFGIQPLQTWPTKDPELESQVNL                                 	     308 FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFL 357                                                          
						to the sequence of F09425_P3.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of F09425_P3, comprising a polypeptide   	     439 LVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSF 488                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     358 LVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSF 407                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	                  .         .         .         .         .  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     489 SDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICK 538                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     408 SDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICK 457                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						in F09425_P3.                                                	     539 KEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDR 588                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     458 KEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDR 507                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     589 TLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRS 638                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     508 TLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRS 557                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     639 DCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVT 688                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     558 DCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVT 607                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     689 STSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYR 738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     608 STSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYR 657                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     739 HQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIY 788                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     658 HQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIY 707                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     789 KKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIRL 838                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     708 KKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIRL 757                                                          
						                                                            	                  .         .                                
						                                                            	     839 VVNGNLVHTAVVPQLQLVASR                              859                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     758 VVNGNLVHTAVVPQLQLVASR                              778                                                          

						Comparison report between F09425_P3 and Q8N951unique head    	Sequence name: Q8N951                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for F09425_P3, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6080 x Q8N951   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	                                                            
						AKSSLSFGIQPLQTWPTKDPELESQVNL                                 	                     Quality: 3718.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     386                Total length:     427                                               
						1 - 88 of F09425_P3, a second amino acid sequence being at   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRRT 	    Total Percent Similarity:   90.40      Total Percent Identity:   90.40                                               
						DVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRK 	                        Gaps:       1                        
						TGTQKICLPYSPTKTLSVKSILS                                      	                                                            
						least 90 % homologous to corresponding to amino acids 26 -   	Alignment:                                                   
						168 of Q8N951, which also corresponds to amino acids 89 - 231	                  .         .         .         .         .  
						of F09425_P3, a third amino acid sequence being at least 70%,	      89 SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENA 138                                                          
						optionally at least 80%, preferably at least 85%, more       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      26 SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENA 75                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF corresponding to   	     139 TALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSV 188                                                          
						amino acids 232 - 272 of F09425_P3, a fourth amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 	      76 TALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSV 125                                                          
						QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHI 	                  .         .         .         .         .  
						FALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLET 	     189 TLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKF 238                                                          
						PTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVR 	         |||||||||||||||||||||||||||||||||||||||||||         
						IGQ                                                          	     126 TLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS....... 168                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 169 - 411 of Q8N951, which also corresponds to   	     239 EKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEI 288                                                          
						amino acids 273 - 515 of F09425_P3, and a fifth amino acid   	                                           ||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     169 ..................................AKDGQLTDDEMFSNEI 184                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     289 GSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIM 338                                                          
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	     185 GSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIM 234                                                          
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                  .         .         .         .         .  
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	     339 FHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 388                                                          
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	     235 FHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 284                                                          
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	                  .         .         .         .         .  
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	     389 FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFL 438                                                          
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSGSSPFQLTAFSDEDIIDLK                                        	     285 FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFL 334                                                          
						having the sequence corresponding to amino acids 516 - 1076  	                  .         .         .         .         .  
						of F09425_P3, wherein said first amino acid sequence, second 	     439 LVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSF 488                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and fifth amino acid sequence are contiguous   	     335 LVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSF 384                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .                                
						for a head of F09425_P3, comprising a polypeptide being at   	     489 SDVLPESPKSARKKEEARQAEFVRIGQ                        515                                                          
						least 70%, optionally at least about 80%, preferably at least	         |||||||||||||||||||||||||||                         
						about 85%, more preferably at least about 90% and most       	     385 SDVLPESPKSARKKEEARQAEFVRIGQ                        411                                                          
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	                                                            
						AKSSLSFGIQPLQTWPTKDPELESQVNL                                 	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						F09425_P3.3.An isolated polypeptide encoding for an edge     	                                                            
						portion of F09425_P3, comprising an amino acid sequence being	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF,      	                                                            
						corresponding to F09425_P3.4.An isolated polypeptide encoding	                                                            
						for a tail of F09425_P3, comprising a polypeptide being at   	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                                                            
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	                                                            
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                                                            
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	                                                            
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	                                                            
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	                                                            
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	                                                            
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	                                                            
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	                                                            
						VSGSSPFQLTAFSDEDIIDLK                                        	                                                            
						preferably at least about 95% homologous to the sequence in  	                                                            
						F09425_P3.                                                   	                                                            

						Comparison report between F09425_P3 and Q8IYU1unique head    	Sequence name: Q8IYU1                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09425_P3, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 6080 x Q8IYU1   ..                             
						90% and most preferably at least 95% homologous to a         	                                                            
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	Alignment segment 1/1:                                       
						AKSSLSFGIQPLQTWPTKDPELESQVNL                                 	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 9627.00                      Escore:       0                                               
						1 - 88 of F09425_P3, a second amino acid sequence being at   	             Matching length:     988                Total length:     988                                               
						SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRRT 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.90                                               
						DVHLENPEYHTRWYFKYFLGQV                                       	    Total Percent Similarity:   99.90      Total Percent Identity:   99.90                                               
						least 90 % homologous to corresponding to amino acids 8 - 89 	                        Gaps:       0                        
						of Q8IYU1, which also corresponds to amino acids 89 - 170 of 	                                                            
						F09425_P3, a bridging amino acid H corresponding to amino    	Alignment:                                                   
						acid 171 of F09425_P3, and a third amino acid sequence being 	                  .         .         .         .         .  
						QNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS 	      89 SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENA 138                                                          
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKEN 	       8 SVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENA 57                                                           
						KQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFS 	                  .         .         .         .         .  
						EESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLH 	     139 TALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSV 188                                                          
						QDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 	         |||||||||||||||||||||||||||||||| |||||||||||||||||  
						AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLP 	      58 TALPGTWRRTDVHLENPEYHTRWYFKYFLGQVRQNYIGNDAEKSPFFLSV 107                                                          
						VKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGC 	                  .         .         .         .         .  
						HLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREIC 	     189 TLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKF 238                                                          
						LSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 	     108 TLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDKF 157                                                          
						DSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTP 	                  .         .         .         .         .  
						PGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAA 	     239 EKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEI 288                                                          
						IPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDED 	     158 EKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEI 207                                                          
						IIDLK                                                        	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 91 -	     289 GSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIM 338                                                          
						995 of Q8IYU1, which also corresponds to amino acids 172 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1076 of F09425_P3, wherein said first amino acid sequence,   	     208 GSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIM 257                                                          
						second amino acid sequence, bridging amino acid and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     339 FHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 388                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P3, comprising a polypeptide being at least 70%,      	     258 FHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSH 307                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     389 FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFL 438                                                          
						MEPEPGGVAAALLRQKRAALRRRGCSFESPRTAAQPPGPLMDPLTKVPCGSQIAQTILWK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKSSLSFGIQPLQTWPTKDPELESQVNL                                 	     308 FTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFL 357                                                          
						least about 95% homologous to the sequence of F09425_P3.     	                  .         .         .         .         .  
						                                                            	     439 LVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSF 488                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     358 LVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSF 407                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     489 SDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICK 538                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 SDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICK 457                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     539 KEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDR 588                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     458 KEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDR 507                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     589 TLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRS 638                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     508 TLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRS 557                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     639 DCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVT 688                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     558 DCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVT 607                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     689 STSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYR 738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     608 STSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYR 657                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     739 HQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIY 788                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     658 HQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIY 707                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     789 KKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIRL 838                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     708 KKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIRL 757                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     839 VVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSP 888                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     758 VVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSP 807                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     889 QTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKV 938                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     808 QTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKV 857                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     939 ITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSE 988                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     858 ITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSE 907                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     989 GAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEG 1038                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     908 GAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEG 957                                                          
						                                                            	                  .         .         .                      
						                                                            	    1039 HSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK             1076                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     958 HSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK             995                                                          

6070	HMR136_F09425_5_tr0_r1_1_gPRT		Comparison report between F09425_P5 and Q8ND89unique head    	Sequence name: Q8ND89                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09425_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6070 x Q8ND89   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MEPEPGGVAAALLRQKRAALRRRGCSFESPSSVSEDLGCRRGDFSRKHYGSVELLISSDA 	Alignment segment 1/1:                                       
						DGAIQRAGRFRVENGSSDENATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGN 	                                                            
						DAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 	                     Quality: 2304.00                      Escore:       0                                               
						FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEPFQKFL 	             Matching length:     243                Total length:     243                                               
						NLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENKQQVER 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPD 	                        Gaps:       0                        
						LHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 	                                                            
						KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHV 	Alignment:                                                   
						LETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAIN 	                  .         .         .         .         .  
						THHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPM 	     777 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 826                                                          
						VMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDS     	       1 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 50                                                           
						having the sequence corresponding to amino acids 1 - 776 of  	                  .         .         .         .         .  
						F09425_P5, and a second amino acid sequence being at least 90	     827 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 876                                                          
						MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAIP 	      51 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 100                                                          
						VTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAV 	                  .         .         .         .         .  
						RSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDII 	     877 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 926                                                          
						DLK                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 243 of      	     101 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 150                                                          
						Q8ND89, which also corresponds to amino acids 777 - 1019 of  	                  .         .         .         .         .  
						F09425_P5, wherein said first amino acid sequence and second 	     927 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 976                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 200                                                          
						F09425_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .            
						optionally at least about 80%, preferably at least about 85%,	     977 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        1019                                                         
						more preferably at least about 90% and most preferably at    	         |||||||||||||||||||||||||||||||||||||||||||         
						MEPEPGGVAAALLRQKRAALRRRGCSFESPSSVSEDLGCRRGDFSRKHYGSVELLISSDA 	     201 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        243                                                          
						DGAIQRAGRFRVENGSSDENATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGN 	                                                            
						DAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 	                                                            
						FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEPFQKFL 	                                                            
						NLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENKQQVER 	                                                            
						KRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPL 	                                                            
						FGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPD 	                                                            
						LHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 	                                                            
						KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHV 	                                                            
						LETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAIN 	                                                            
						THHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPM 	                                                            
						VMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAG 	                                                            
						LLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDS     	                                                            
						least about 95% homologous to the sequence of F09425_P5.     	                                                            

						Comparison report between F09425_P5 and Q9BQH6unique head    	Sequence name: Q9BQH6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09425_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6070 x Q9BQH6   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MEPEPGGVAAALLRQKRAALRRRGCSFESP corresponding to amino acids 1	                                                            
						- 30 of F09425_P5, a second amino acid sequence being at     	                     Quality: 7588.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     772                Total length:     772                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KTGTQKICLPYSPTKTLSVKSILSAMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FGVLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHS 	                        Gaps:       0                        
						VYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 	                                                            
						HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEK 	Alignment:                                                   
						ATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQ 	                  .         .         .         .         .  
						AEFVRIGQALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLV 	      31 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 80                                                           
						STDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNES 	                  .         .         .         .         .  
						TGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASD 	      81 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 130                                                          
						FQFCWNQAPYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASR         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 7 - 778	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 106                                                          
						of Q9BQH6, which also corresponds to amino acids 31 - 802 of 	                  .         .         .         .         .  
						F09425_P5, and a third amino acid sequence being at least    	     131 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 180                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	                  .         .         .         .         .  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     181 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 230                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 803 - 1019 of F09425_P5, wherein said first   	     231 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 280                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F09425_P5, comprising a polypeptide being at least 70%,      	     281 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 330                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						MEPEPGGVAAALLRQKRAALRRRGCSFESP of F09425_P5.3.An isolated    	     331 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 380                                                          
						polypeptide encoding for a tail of F09425_P5, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     381 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 430                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	                  .         .         .         .         .  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     431 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 480                                                          
						to the sequence in F09425_P5.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     481 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 530                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     531 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 580                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     581 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 630                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     631 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 680                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 656                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     681 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 730                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     657 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 706                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     731 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 780                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     707 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 756                                                          
						                                                            	                  .         .                                
						                                                            	     781 LVVNGNLVHTAVVPQLQLVASR                             802                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     757 LVVNGNLVHTAVVPQLQLVASR                             778                                                          

						Comparison report between F09425_P5 and Q8N951unique head    	Sequence name: Q8N951                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for F09425_P5, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 6070 x Q8N951   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						MEPEPGGVAAALLRQKRAALRRRGCSFESP corresponding to amino acids 1	                     Quality: 3727.00                      Escore:       0                                               
						- 30 of F09425_P5, a second amino acid sequence being at     	             Matching length:     387                Total length:     428                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWR 	    Total Percent Similarity:   90.42      Total Percent Identity:   90.42                                               
						KTGTQKICLPYSPTKTLSVKSILS                                     	                        Gaps:       1                        
						least 90 % homologous to corresponding to amino acids 25 -   	                                                            
						168 of Q8N951, which also corresponds to amino acids 31 - 174	Alignment:                                                   
						of F09425_P5, a third amino acid sequence being at least 70%,	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	      31 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 80                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	      25 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 74                                                           
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF corresponding to   	                  .         .         .         .         .  
						amino acids 175 - 215 of F09425_P5, a fourth amino acid      	      81 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 130                                                          
						AKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHI 	      75 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 124                                                          
						FALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLET 	                  .         .         .         .         .  
						PTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVR 	     131 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 180                                                          
						IGQ                                                          	         ||||||||||||||||||||||||||||||||||||||||||||        
						sequence being at least 90 % homologous to corresponding to  	     125 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS...... 168                                                          
						amino acids 169 - 411 of Q8N951, which also corresponds to   	                  .         .         .         .         .  
						amino acids 216 - 458 of F09425_P5, and a fifth amino acid   	     181 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 230                                                          
						sequence being at least 70%, optionally at least 80%,        	                                            |||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     169 ...................................AKDGQLTDDEMFSNE 183                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	     231 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 280                                                          
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	     184 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 233                                                          
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	                  .         .         .         .         .  
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	     281 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 330                                                          
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	     234 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 283                                                          
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	                  .         .         .         .         .  
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	     331 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 380                                                          
						VSGSSPFQLTAFSDEDIIDLK                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 459 - 1019  	     284 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 333                                                          
						of F09425_P5, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, fourth amino 	     381 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 430                                                          
						acid sequence and fifth amino acid sequence are contiguous   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     334 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 383                                                          
						for a head of F09425_P5, comprising a polypeptide being at   	                  .         .                                
						least 70%, optionally at least about 80%, preferably at least	     431 FSDVLPESPKSARKKEEARQAEFVRIGQ                       458                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||                        
						preferably at least about 95% homologous to the sequence     	     384 FSDVLPESPKSARKKEEARQAEFVRIGQ                       411                                                          
						MEPEPGGVAAALLRQKRAALRRRGCSFESP of F09425_P5.3.An isolated    	                                                            
						polypeptide encoding for an edge portion of F09425_P5,       	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF, corresponding to  	                                                            
						F09425_P5.4.An isolated polypeptide encoding for a tail of   	                                                            
						F09425_P5, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                                                            
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	                                                            
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                                                            
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	                                                            
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	                                                            
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	                                                            
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	                                                            
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	                                                            
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	                                                            
						VSGSSPFQLTAFSDEDIIDLK                                        	                                                            
						least about 95% homologous to the sequence in F09425_P5.     	                                                            

						Comparison report between F09425_P5 and Q8IYU1unique head    	Sequence name: Q8IYU1                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09425_P5, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 6070 x Q8IYU1   ..                             
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment segment 1/1:                                       
						MEPEPGGVAAALLRQKRAALRRRGCSFESP corresponding to amino acids 1	                                                            
						- 30 of F09425_P5, a second amino acid sequence being at     	                     Quality: 9636.00                      Escore:       0                                               
						SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDENATALPGTWRR 	             Matching length:     989                Total length:     989                                               
						TDVHLENPEYHTRWYFKYFLGQV                                      	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.90                                               
						least 90 % homologous to corresponding to amino acids 7 - 89 	    Total Percent Similarity:   99.90      Total Percent Identity:   99.90                                               
						of Q8IYU1, which also corresponds to amino acids 31 - 113 of 	                        Gaps:       0                        
						F09425_P5, a bridging amino acid H corresponding to amino    	                                                            
						acid 114 of F09425_P5, and a third amino acid sequence being 	Alignment:                                                   
						QNYIGNDAEKSPFFLSVTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILS 	                  .         .         .         .         .  
						AMNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSE 	      31 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 80                                                           
						PFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFS 	       7 SSVSEDLGCRRGDFSRKHYGSVELLISSDADGAIQRAGRFRVENGSSDEN 56                                                           
						EESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLH 	                  .         .         .         .         .  
						QDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 	      81 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVHQNYIGNDAEKSPFFLS 130                                                          
						AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLP 	         ||||||||||||||||||||||||||||||||| ||||||||||||||||  
						VKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGC 	      57 ATALPGTWRRTDVHLENPEYHTRWYFKYFLGQVRQNYIGNDAEKSPFFLS 106                                                          
						HLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREIC 	                  .         .         .         .         .  
						LSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVY 	     131 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 180                                                          
						EDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTP 	     107 VTLSDQNNQRVPQYRAILWRKTGTQKICLPYSPTKTLSVKSILSAMNLDK 156                                                          
						PGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAA 	                  .         .         .         .         .  
						IPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPG 	     181 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 230                                                          
						AVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IIDLK                                                        	     157 FEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNE 206                                                          
						at least 90 % homologous to corresponding to amino acids 91 -	                  .         .         .         .         .  
						995 of Q8IYU1, which also corresponds to amino acids 115 -   	     231 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 280                                                          
						1019 of F09425_P5, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, bridging amino acid and third    	     207 IGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEI 256                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     281 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 330                                                          
						F09425_P5, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     257 MFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRS 306                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     331 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 380                                                          
						MEPEPGGVAAALLRQKRAALRRRGCSFESP of F09425_P5.                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 HFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDF 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     381 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 430                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 LLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRS 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     431 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 480                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 FSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGIC 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     481 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 530                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 KKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFD 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     531 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 580                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 RTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSR 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     581 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 630                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 SDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGV 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     631 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 680                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 TSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAY 656                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     681 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 730                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     657 RHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCYNYSCI 706                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     731 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 780                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     707 YKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIR 756                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     781 LVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNS 830                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     757 LVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNS 806                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     831 PQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSK 880                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     807 PQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSK 856                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     881 VITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKS 930                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     857 VITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKS 906                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     931 EGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPE 980                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     907 EGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPE 956                                                          
						                                                            	                  .         .         .                      
						                                                            	     981 GHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK            1019                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     957 GHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK            995                                                          

6076	HMR136_F09425_6_tr0_r1_1_gPRT		Comparison report between F09425_P6 and Q8ND89unique head    	Sequence name: Q8ND89                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09425_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6076 x Q8ND89   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEP 	Alignment segment 1/1:                                       
						FQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENK 	                                                            
						QQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSE 	                     Quality: 2304.00                      Escore:       0                                               
						ESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQ 	             Matching length:     243                Total length:     243                                               
						DLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCH 	                        Gaps:       0                        
						LYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICL 	                                                            
						SDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYE 	Alignment:                                                   
						DGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 	                  .         .         .         .         .  
						S                                                            	     602 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 651                                                          
						having the sequence corresponding to amino acids 1 - 601 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P6, and a second amino acid sequence being at least 90	       1 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 50                                                           
						MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPPG 	                  .         .         .         .         .  
						RDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAIP 	     652 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 701                                                          
						VTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDII 	      51 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 100                                                          
						DLK                                                          	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 243 of      	     702 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 751                                                          
						Q8ND89, which also corresponds to amino acids 602 - 844 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09425_P6, wherein said first amino acid sequence and second 	     101 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 150                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     752 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 801                                                          
						F09425_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEP 	     802 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        844                                                          
						FQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENK 	         |||||||||||||||||||||||||||||||||||||||||||         
						QQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSE 	     201 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        243                                                          
						ESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQ 	                                                            
						DLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 	                                                            
						ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPV 	                                                            
						KQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCH 	                                                            
						LYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICL 	                                                            
						SDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYE 	                                                            
						DGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 	                                                            
						S                                                            	                                                            
						least about 95% homologous to the sequence of F09425_P6.     	                                                            

						Comparison report between F09425_P6 and Q9BQH6partial WT     	Sequence name: Q9BQH6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09425_P6, comprising a first amino 	Sequence documentation:                                      
						MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEP 	                                                            
						FQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENK 	Alignment of: 6076 x Q9BQH6   ..                             
						QQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSE 	                                                            
						ESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQ 	Alignment segment 1/1:                                       
						DLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 	                                                            
						ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPV 	                     Quality: 6154.00                      Escore:       0                                               
						KQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCH 	             Matching length:     627                Total length:     627                                               
						LYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 	                        Gaps:       0                        
						SMEIRLVVNGNLVHTAVVPQLQLVASR                                  	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 152 - 778 of Q9BQH6, which also corresponds to	                  .         .         .         .         .  
						amino acids 1 - 627 of F09425_P6, and a second amino acid    	       1 MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDE 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     152 MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDE 201                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	      51 MFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 100                                                          
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	     202 MFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 251                                                          
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 628 - 844 of	     101 QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKP 150                                                          
						F09425_P6, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     252 QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKP 301                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F09425_P6, comprising a polypeptide being at least 70%,      	     151 SMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQ 200                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     302 SMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQ 351                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	                  .         .         .         .         .  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     201 EFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNM 250                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     352 EFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNM 401                                                          
						least about 95% homologous to the sequence in F09425_P6.     	                  .         .         .         .         .  
						                                                            	     251 LNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 LNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 451                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     452 ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPS 501                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     502 VPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQ 551                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 AGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHN 601                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     602 KPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNL 651                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCY 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     652 ICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCY 701                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 NYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     702 NYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 751                                                          
						                                                            	                  .         .                                
						                                                            	     601 SMEIRLVVNGNLVHTAVVPQLQLVASR                        627                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     752 SMEIRLVVNGNLVHTAVVPQLQLVASR                        778                                                          

						Comparison report between F09425_P6 and Q8N951unique head    	Sequence name: Q8N951                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09425_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6076 x Q8N951   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF corresponding to    	                                                            
						amino acids 1 - 40 of F09425_P6, a second amino acid sequence	                     Quality: 2408.00                      Escore:       0                                               
						AKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 	             Matching length:     246                Total length:     246                                               
						QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHI 	 Matching Percent Similarity:   99.59   Matching Percent Identity:   99.19                                               
						FALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLET 	    Total Percent Similarity:   99.59      Total Percent Identity:   99.19                                               
						PTFAQKRRRTLDMLIRSLHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVR 	                        Gaps:       0                        
						IGQ                                                          	                                                            
						being at least 90 % homologous to corresponding to amino     	Alignment:                                                   
						acids 169 - 411 of Q8N951, which also corresponds to amino   	                  .         .         .         .         .  
						acids 41 - 283 of F09425_P6, and a third amino acid sequence 	      38 VLFAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTK 87                                                           
						being at least 70%, optionally at least 80%, preferably at   	         :| |||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     166 ILSAKDGQLTDDEMFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTK 215                                                          
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                  .         .         .         .         .  
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	      88 NDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIV 137                                                          
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	     216 NDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIV 265                                                          
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	                  .         .         .         .         .  
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	     138 FQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFG 187                                                          
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	     266 FQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFG 315                                                          
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	                  .         .         .         .         .  
						VSGSSPFQLTAFSDEDIIDLK                                        	     188 PPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRS 237                                                          
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 284 - 844 of F09425_P6, wherein 	     316 PPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRS 365                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .            
						and third amino acid sequence are contiguous and in a        	     238 LHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQ     283                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||      
						head of F09425_P6, comprising a polypeptide being at least   	     366 LHQDLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQ     411                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLF of F09425_P6.3.An   	                                                            
						isolated polypeptide encoding for a tail of F09425_P6,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						ALKLKSIVRGDAPSSLAASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLL 	                                                            
						VDDDLPSVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGK 	                                                            
						SRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSP 	                                                            
						LSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLH 	                                                            
						HVEANRVNFVAAIDVYEDGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQA 	                                                            
						PYAIVCAFPYLLAFTTDSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSS 	                                                            
						GGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLV 	                                                            
						SKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKS 	                                                            
						KPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSP 	                                                            
						VSGSSPFQLTAFSDEDIIDLK                                        	                                                            
						about 95% homologous to the sequence in F09425_P6.           	                                                            

						Comparison report between F09425_P6 and Q8IYU1partial WT     	Sequence name: Q8IYU1                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F09425_P6, comprising a first amino acid        	                                                            
						MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDEMFSNEIGSEP 	Alignment of: 6076 x Q8IYU1   ..                             
						FQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVYQGHEIMFHVSTMLPYSKENK 	                                                            
						QQVERKRHIGNDIVTIVFQEGEESSPAFKPSMIRSHFTHIFALVRYNQQNDNYRLKIFSE 	Alignment segment 1/1:                                       
						ESVPLFGPPLPTPPVFTDHQEFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQ 	                                                            
						DLMPDLHKNMLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 	                     Quality: 8216.00                      Escore:       0                                               
						ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPV 	             Matching length:     844                Total length:     844                                               
						KQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LYAINTHHSRELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SDSPMVMTLVDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYE 	                        Gaps:       0                        
						DGEAGLLLCYNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 	                                                            
						SMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPP 	Alignment:                                                   
						GRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAI 	                  .         .         .         .         .  
						PVTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGA 	       1 MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDE 50                                                           
						VRSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IDLK                                                         	     152 MNLDKFEKGPREIFHPEIQKDLLVLEEQEGSVNFKFGVLFAKDGQLTDDE 201                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 152 - 995 of Q8IYU1, which also corresponds to   	      51 MFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 100                                                          
						amino acids 1 - 844 of F09425_P6.                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 MFSNEIGSEPFQKFLNLLGDTITLKGWTGYRGGLDTKNDTTGIHSVYTVY 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 QGHEIMFHVSTMLPYSKENKQQVERKRHIGNDIVTIVFQEGEESSPAFKP 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 SMIRSHFTHIFALVRYNQQNDNYRLKIFSEESVPLFGPPLPTPPVFTDHQ 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 EFRDFLLVKLINGEKATLETPTFAQKRRRTLDMLIRSLHQDLMPDLHKNM 401                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 LNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLA 451                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     452 ASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPS 501                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     502 VPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGKQ 551                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 AGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKHN 601                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     602 KPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDNL 651                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCY 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     652 ICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLCY 701                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 NYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     702 NYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTD 751                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 SMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     752 SMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGA 801                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 SARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKS 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     802 SARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKS 851                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 PLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     852 PLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDE 901                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTS 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     902 GGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTS 951                                                          
						                                                            	                  .         .         .         .            
						                                                            	     801 EANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK       844                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     952 EANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK       995                                                          

6078	HMR136_F09425_8_tr0_r1_1_gPRT		Comparison report between F09425_P8 and Q8ND89unique head    	Sequence name: Q8ND89                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09425_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6078 x Q8ND89   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKEP 	Alignment segment 1/1:                                       
						WEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETL 	                                                            
						DLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHS 	                     Quality: 2304.00                      Escore:       0                                               
						RELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTL 	             Matching length:     243                Total length:     243                                               
						VDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDS         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 352 of  	                        Gaps:       0                        
						F09425_P8, and a second amino acid sequence being at least 90	                                                            
						MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPPG 	Alignment:                                                   
						RDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAIP 	                  .         .         .         .         .  
						VTHSLSLSRMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAV 	     353 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 402                                                          
						RSSSSDRIPSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDII 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLK                                                          	       1 MEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGAS 50                                                           
						% homologous to corresponding to amino acids 1 - 243 of      	                  .         .         .         .         .  
						Q8ND89, which also corresponds to amino acids 353 - 595 of   	     403 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 452                                                          
						F09425_P8, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 ARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLKSP 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						F09425_P8, comprising a polypeptide being at least 70%,      	     453 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 502                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 LVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSDEG 150                                                          
						MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKEP 	                  .         .         .         .         .  
						WEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETL 	     503 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 552                                                          
						DLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTL 	     151 GPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSE 200                                                          
						VDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 	                  .         .         .         .            
						YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDS         	     553 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        595                                                          
						least about 95% homologous to the sequence of F09425_P8.     	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     201 ANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK        243                                                          

						Comparison report between F09425_P8 and Q9BQH6partial WT     	Sequence name: Q9BQH6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09425_P8, comprising a first amino 	Sequence documentation:                                      
						MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKEP 	                                                            
						WEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETL 	Alignment of: 6078 x Q9BQH6   ..                             
						DLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHS 	                                                            
						RELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTL 	Alignment segment 1/1:                                       
						VDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 	                                                            
						YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIRLVVN 	                     Quality: 3689.00                      Escore:       0                                               
						GNLVHTAVVPQLQLVASR                                           	             Matching length:     378                Total length:     378                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 401 - 778 of Q9BQH6, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 378 of F09425_P8, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	       1 MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 50                                                           
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	     401 MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 450                                                          
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 379 - 595 of	      51 AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLP 100                                                          
						F09425_P8, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     451 AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLP 500                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F09425_P8, comprising a polypeptide being at least 70%,      	     101 SVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGK 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     501 SVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGK 550                                                          
						SDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLR 	                  .         .         .         .         .  
						NLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGL 	     151 QAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKH 200                                                          
						SDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESASTSEANPEGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK                        	     551 QAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKH 600                                                          
						least about 95% homologous to the sequence in F09425_P8.     	                  .         .         .         .         .  
						                                                            	     201 NKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDN 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 750                                                          
						                                                            	                  .         .                                
						                                                            	     351 DSMEIRLVVNGNLVHTAVVPQLQLVASR                       378                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     751 DSMEIRLVVNGNLVHTAVVPQLQLVASR                       778                                                          

						Comparison report between F09425_P8 and Q8IYU1partial WT     	Sequence name: Q8IYU1                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F09425_P8, comprising a first amino acid        	                                                            
						MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSLAASGICKKEP 	Alignment of: 6078 x Q8IYU1   ..                             
						WEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLPSVPVFDRTLPVKQMHVLETL 	                                                            
						DLLVLRADKGKDARLFVFRLSALQKGLEGKQAGKSRSDCRENKLEKTKGCHLYAINTHHS 	Alignment segment 1/1:                                       
						RELRIVVAIRNKLLLITRKHNKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTL 	                                                            
						VDGPAEESDNLICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 	                     Quality: 5751.00                      Escore:       0                                               
						YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTTDSMEIRLVVN 	             Matching length:     595                Total length:     595                                               
						GNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKGASARNSPQTPPGRDTPVFPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SLGEGEIQSKNLYKIPLRNLVGRSIERPLKSPLVSKVITPPTPISVGLAAIPVTHSLSLS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RMEIKEIASRTRRELLGLSDEGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRI 	                        Gaps:       0                        
						PSGSLESASTSEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK      	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 401 - 995 of Q8IYU1, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1 - 595 of F09425_P8.                            	       1 MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 MLNRRSFSDVLPESPKSARKKEEARQAEFVRIGQALKLKSIVRGDAPSSL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AASGICKKEPWEPQCFCSNFPHEAVCADPWGQALLVSTDAGVLLVDDDLP 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SVPVFDRTLPVKQMHVLETLDLLVLRADKGKDARLFVFRLSALQKGLEGK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 QAGKSRSDCRENKLEKTKGCHLYAINTHHSRELRIVVAIRNKLLLITRKH 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 NKPSGVTSTSLLSPLSESPVEEFQYIREICLSDSPMVMTLVDGPAEESDN 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LICVAYRHQFDVVNESTGEAFRLHHVEANRVNFVAAIDVYEDGEAGLLLC 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 YNYSCIYKKVCPFNGGSFLVQPSASDFQFCWNQAPYAIVCAFPYLLAFTT 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 DSMEIRLVVNGNLVHTAVVPQLQLVASRSDIYFTATAAVNEVSSGGSSKG 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ASARNSPQTPPGRDTPVFPSSLGEGEIQSKNLYKIPLRNLVGRSIERPLK 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSD 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 SPLVSKVITPPTPISVGLAAIPVTHSLSLSRMEIKEIASRTRRELLGLSD 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 EGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESAST 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 EGGPKSEGAPKAKSKPRKRLEESQGGPKPGAVRSSSSDRIPSGSLESAST 950                                                          
						                                                            	                  .         .         .         .            
						                                                            	     551 SEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK      595                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     951 SEANPEGHSASSDQDPVADREGSPVSGSSPFQLTAFSDEDIIDLK      995                                                          

13606	HMR136_F09497_4_tr0_r1_1_gPRT		Comparison report between F09497_P4 and Q8N9K9partial WT     	Sequence name: Q8N9K9                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						F09497_P4, comprising a first amino acid sequence being at   	                                                            
						MSHPDYRMNLRPLGTPRGVSAVAGPHDIGASPGDKKSKNRSTRGKKKSIFETYMSKEDVS 	Alignment of: 13606 x Q8N9K9   ..                            
						EGLKRGTLIQGVLRINPKKFHEAFIPSPDGDRDIFIDGVVARNRALNGDLVVVKLLPEEH 	                                                            
						WK                                                           	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 122	                                                            
						of Q8N9K9, which also corresponds to amino acids 1 - 122 of  	                     Quality: 5059.00                      Escore:       0                                               
						F09497_P4, a second amino acid sequence being at least 70%,  	             Matching length:     527                Total length:     542                                               
						optionally at least 80%, preferably at least 85%, more       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 90% and most preferably at least 95%     	    Total Percent Similarity:   97.23      Total Percent Identity:   97.23                                               
						homologous to a polypeptide having the sequence              	                        Gaps:       1                        
						LVIRLPQPPKMLGLQ corresponding to amino acids 123 - 137 of    	                                                            
						F09497_P4, a third amino acid sequence being at least 90 %   	Alignment:                                                   
						VVKPESNDKETEAAYESDIPEELCGHHLPQQSLKSYNDSPDVIVEAQFDGSDSEDGHGIT 	                  .         .         .         .         .  
						QNVLVDGVKKLSVCVSEKGREDGDAPVTKDETTCISQDTRALSEKSLQRSAKVVYILEKK 	       1 MSHPDYRMNLRPLGTPRGVSAVAGPHDIGASPGDKKSKNRSTRGKKKSIF 50                                                           
						HSRAATGFLKLLADKNSELFRKYALFSPSDHRVPRIYVPLKDCPQDFVARPKDYANTLFI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CRIVDWKEDCNFALGQLAKSLGQAGEIEPETEGILTEYGVDFSDFSSEVLECLPQGLPWT 	       1 MSHPDYRMNLRPLGTPRGVSAVAGPHDIGASPGDKKSKNRSTRGKKKSIF 50                                                           
						IPPEEFSKRRDLRKDCIFTIDPSTARDLDDALSCKPLADGNFKVGVHIADVSYFVPEGSD 	                  .         .         .         .         .  
						LDKVAAERATSVYLVQKVVPMLPRLLCEELCSLNPMSDKLTFSVIWTLTPEGKILDEWFG 	      51 ETYMSKEDVSEGLKRGTLIQGVLRINPKKFHEAFIPSPDGDRDIFIDGVV 100                                                          
						RTIIRSCTKLSYEHAQSMIESPTEKIPAKELPPISPEHSSEEVHQ                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 123 - 527 of      	      51 ETYMSKEDVSEGLKRGTLIQGVLRINPKKFHEAFIPSPDGDRDIFIDGVV 100                                                          
						Q8N9K9, which also corresponds to amino acids 138 - 542 of   	                  .         .         .         .         .  
						F09497_P4, and a fourth amino acid sequence being at least   	     101 ARNRALNGDLVVVKLLPEEHWKLVIRLPQPPKMLGLQVVKPESNDKETEA 150                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||               |||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     101 ARNRALNGDLVVVKLLPEEHWK...............VVKPESNDKETEA 135                                                          
						AVLNLHGIAKQLRQQRFVDGALRLDQLKLAFTLDHETGLPQGCHIYEYRESNKLVEEFML 	                  .         .         .         .         .  
						LANMAVAHKIHRAFPEQALLRRHPPPQTRMLSDLVEFCDQMGLPVDFSSAGALNKSLTQT 	     151 AYESDIPEELCGHHLPQQSLKSYNDSPDVIVEAQFDGSDSEDGHGITQNV 200                                                          
						FGDDKYSLARKEVLTNMCSRPMQMALYFCSGLLQDPAQFRHYALNVPLYTHFTSPIRRFA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DVLVHRLLAAALGYRERLDMAPDTLQKQADHCNDRRMASKRVQELSTSLFFAVLVKESGP 	     136 AYESDIPEELCGHHLPQQSLKSYNDSPDVIVEAQFDGSDSEDGHGITQNV 185                                                          
						LESEAMVMGILKQAFDVLVLRYGVQKRIYCNALALRSHHFQKVGKKPELTLVWEPEDMEQ 	                  .         .         .         .         .  
						EPAQQVITIFSLVEVVLQAESTALKYSAILKRPGTQGHLGPEKEEEESDGEPEDSSTS   	     201 LVDGVKKLSVCVSEKGREDGDAPVTKDETTCISQDTRALSEKSLQRSAKV 250                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 543 - 900 of F09497_P4, wherein said first    	     186 LVDGVKKLSVCVSEKGREDGDAPVTKDETTCISQDTRALSEKSLQRSAKV 235                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence and fourth amino acid sequence are contiguous  	     251 VYILEKKHSRAATGFLKLLADKNSELFRKYALFSPSDHRVPRIYVPLKDC 300                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of F09497_P4, comprising an amino acid   	     236 VYILEKKHSRAATGFLKLLADKNSELFRKYALFSPSDHRVPRIYVPLKDC 285                                                          
						sequence being at least 70%, optionally at least about 80%,  	                  .         .         .         .         .  
						preferably at least about 85%, more preferably at least about	     301 PQDFVARPKDYANTLFICRIVDWKEDCNFALGQLAKSLGQAGEIEPETEG 350                                                          
						90% and most preferably at least about 95% homologous to the 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence encoding for LVIRLPQPPKMLGLQ, corresponding to      	     286 PQDFVARPKDYANTLFICRIVDWKEDCNFALGQLAKSLGQAGEIEPETEG 335                                                          
						F09497_P4.3.An isolated polypeptide encoding for a tail of   	                  .         .         .         .         .  
						F09497_P4, comprising a polypeptide being at least 70%,      	     351 ILTEYGVDFSDFSSEVLECLPQGLPWTIPPEEFSKRRDLRKDCIFTIDPS 400                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     336 ILTEYGVDFSDFSSEVLECLPQGLPWTIPPEEFSKRRDLRKDCIFTIDPS 385                                                          
						AVLNLHGIAKQLRQQRFVDGALRLDQLKLAFTLDHETGLPQGCHIYEYRESNKLVEEFML 	                  .         .         .         .         .  
						LANMAVAHKIHRAFPEQALLRRHPPPQTRMLSDLVEFCDQMGLPVDFSSAGALNKSLTQT 	     401 TARDLDDALSCKPLADGNFKVGVHIADVSYFVPEGSDLDKVAAERATSVY 450                                                          
						FGDDKYSLARKEVLTNMCSRPMQMALYFCSGLLQDPAQFRHYALNVPLYTHFTSPIRRFA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DVLVHRLLAAALGYRERLDMAPDTLQKQADHCNDRRMASKRVQELSTSLFFAVLVKESGP 	     386 TARDLDDALSCKPLADGNFKVGVHIADVSYFVPEGSDLDKVAAERATSVY 435                                                          
						LESEAMVMGILKQAFDVLVLRYGVQKRIYCNALALRSHHFQKVGKKPELTLVWEPEDMEQ 	                  .         .         .         .         .  
						EPAQQVITIFSLVEVVLQAESTALKYSAILKRPGTQGHLGPEKEEEESDGEPEDSSTS   	     451 LVQKVVPMLPRLLCEELCSLNPMSDKLTFSVIWTLTPEGKILDEWFGRTI 500                                                          
						least about 95% homologous to the sequence in F09497_P4.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     436 LVQKVVPMLPRLLCEELCSLNPMSDKLTFSVIWTLTPEGKILDEWFGRTI 485                                                          
						                                                            	                  .         .         .         .            
						                                                            	     501 IRSCTKLSYEHAQSMIESPTEKIPAKELPPISPEHSSEEVHQ         542                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     486 IRSCTKLSYEHAQSMIESPTEKIPAKELPPISPEHSSEEVHQ         527                                                          

						Comparison report between F09497_P4 and Q8NF60unique head    	Sequence name: Q8NF60                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09497_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13606 x Q8NF60   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSHPDYRMNLRPLGTPRGVSAVAGPHDIGASPGDKKSKNRSTRGKKKSIFETYMSKEDVS 	Alignment segment 1/1:                                       
						EGLKRGTLIQGVLRINPKKFHEAFIPSPDGDRDIFIDGVVARNRALNGDLVVVKLLPEEH 	                                                            
						WKLVIRLPQPPKMLGLQVVKPESNDKETEAAYESDIPEELCGHHLPQQSLKSYNDSPDVI 	                     Quality: 1814.00                      Escore:       0                                               
						VEAQFDGSDSEDGHGITQNVLVDGVKKLSVCVSEKGREDGDAPVTKDETTCISQDTRALS 	             Matching length:     188                Total length:     188                                               
						EKSLQRSAKVVYILEKKHSRAATGFLKLLADKNSELFRKYALFSPSDHRVPRIYVPLKDC 	 Matching Percent Similarity:   98.94   Matching Percent Identity:   98.40                                               
						PQDFVARPKDYANTLFICRIVDWKEDCNFALGQLAKSLGQAGEIEPETEGILTEYGVDFS 	    Total Percent Similarity:   98.94      Total Percent Identity:   98.40                                               
						DFSSEVLECLPQGLPWTIPPEEFSKRRDLRKDCIFTIDPSTARDLDDALSCKPLADGNFK 	                        Gaps:       0                        
						VGVHIADVSYFVPEGSDLDKVAAERATSVYLVQKVVPMLPRLLCEELCSLNPMSDKLTFS 	                                                            
						VIWTLTPEGKILDEWFGRTIIRSCTKLSYEHAQSMIESPTEKIPAKELPPISPEHSSEEV 	Alignment:                                                   
						HQAVLNLHGIAKQLRQQRFVDGALRLDQLKLAFTLDHETGLPQGCHIYEYRESNK      	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     595 KLVEEFMLLANMAVAHKIHRAFPEQALLRRHPPPQTRMLSDLVEFCDQMG 644                                                          
						to amino acids 1 - 595 of F09497_P4, a second amino acid     	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						LVEEFMLLANMAVAHKIHRAFPEQALLRRHPPPQTRMLSDLVEFCDQMGLPVDFSSAGAL 	      29 RLVEEFMLLANMAVAHKIHRAFPEQALLRRHPPPQTRMLSDLVEFCDQMG 78                                                           
						NKSLTQTFGDDKYSLARKEVLTNMCSRPMQMALYFCSGLLQDPAQFRHYALNVPLYTHFT 	                  .         .         .         .         .  
						SPIRRFADVLVHRLLAAALGYRERLDMAPDTLQKQADHCNDRRMASKRVQELSTSLFFAV 	     645 LPVDFSSAGALNKSLTQTFGDDKYSLARKEVLTNMCSRPMQMALYFCSGL 694                                                          
						LVK                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      79 LPVDFSSAGALNKSLTQTFGDDKYSLARKEVLTNMCSRPMQMALYFCSGL 128                                                          
						amino acids 30 - 212 of Q8NF60, which also corresponds to    	                  .         .         .         .         .  
						amino acids 596 - 778 of F09497_P4, and a third amino acid   	     695 LQDPAQFRHYALNVPLYTHFTSPIRRFADVLVHRLLAAALGYRERLDMAP 744                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     129 LQDPAQFRHYALNVPLYTHFTSPIRRFADVLVHRLLAAALGYRERLDMAP 178                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .                      
						ESGPLESEAMVMGILKQAFDVLVLRYGVQKRIYCNALALRSHHFQKVGKKPELTLVWEPE 	     745 DTLQKQADHCNDRRMASKRVQELSTSLFFAVLVKESGP             782                                                          
						DMEQEPAQQVITIFSLVEVVLQAESTALKYSAILKRPGTQGHLGPEKEEEESDGEPEDSS 	         |||||||||||||||||||||||||||||||||| | |              
						TS                                                           	     179 DTLQKQADHCNDRRMASKRVQELSTSLFFAVLVKVSPP             216                                                          
						having the sequence corresponding to amino acids 779 - 900 of	                                                            
						F09497_P4, wherein said first amino acid sequence, second    	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of F09497_P4, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MSHPDYRMNLRPLGTPRGVSAVAGPHDIGASPGDKKSKNRSTRGKKKSIFETYMSKEDVS 	                                                            
						EGLKRGTLIQGVLRINPKKFHEAFIPSPDGDRDIFIDGVVARNRALNGDLVVVKLLPEEH 	                                                            
						WKLVIRLPQPPKMLGLQVVKPESNDKETEAAYESDIPEELCGHHLPQQSLKSYNDSPDVI 	                                                            
						VEAQFDGSDSEDGHGITQNVLVDGVKKLSVCVSEKGREDGDAPVTKDETTCISQDTRALS 	                                                            
						EKSLQRSAKVVYILEKKHSRAATGFLKLLADKNSELFRKYALFSPSDHRVPRIYVPLKDC 	                                                            
						PQDFVARPKDYANTLFICRIVDWKEDCNFALGQLAKSLGQAGEIEPETEGILTEYGVDFS 	                                                            
						DFSSEVLECLPQGLPWTIPPEEFSKRRDLRKDCIFTIDPSTARDLDDALSCKPLADGNFK 	                                                            
						VGVHIADVSYFVPEGSDLDKVAAERATSVYLVQKVVPMLPRLLCEELCSLNPMSDKLTFS 	                                                            
						VIWTLTPEGKILDEWFGRTIIRSCTKLSYEHAQSMIESPTEKIPAKELPPISPEHSSEEV 	                                                            
						HQAVLNLHGIAKQLRQQRFVDGALRLDQLKLAFTLDHETGLPQGCHIYEYRESNK      	                                                            
						to the sequence of F09497_P4.3.An isolated polypeptide       	                                                            
						encoding for a tail of F09497_P4, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						ESGPLESEAMVMGILKQAFDVLVLRYGVQKRIYCNALALRSHHFQKVGKKPELTLVWEPE 	                                                            
						DMEQEPAQQVITIFSLVEVVLQAESTALKYSAILKRPGTQGHLGPEKEEEESDGEPEDSS 	                                                            
						TS                                                           	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F09497_P4.                                                	                                                            

14641	HMR136_F09531_14_tr0_r1_1_gPRT		Comparison report between F09531_P14 and Q96AL9partial WT    	Sequence name: Q96AL9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09531_P14, comprising a first amino	Sequence documentation:                                      
						MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQEVQEDHYGAE 	                                                            
						IRPSLESLGTMQLFFFFF                                           	Alignment of: 14641 x Q96AL9   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 148 - 225 of Q96AL9, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 78 of F09531_P14, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  798.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      80                Total length:      80                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:   98.75   Matching Percent Identity:   98.75                                               
						having the sequence SFLRQGLTLSPNWSAVAQSWLTTASTYWAQVILSFRLPE  	    Total Percent Similarity:   98.75      Total Percent Identity:   98.75                                               
						corresponding to amino acids 79 - 117 of F09531_P14, wherein 	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a tail of F09531_P14, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	       1 MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQ 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     148 MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQ 197                                                          
						to the sequence SFLRQGLTLSPNWSAVAQSWLTTASTYWAQVILSFRLPE in   	                  .         .         .                      
						F09531_P14.                                                  	      51 EVQEDHYGAEIRPSLESLGTMQLFFFFFSF                     80                                                           
						                                                            	         |||||||||||||||||||||||||||| |                      
						                                                            	     198 EVQEDHYGAEIRPSLESLGTMQLFFFFFFF                     227                                                          

						Comparison report between F09531_P14 and AAH47469partial WT  	Sequence name: AAH47469                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09531_P14, comprising a first amino	Sequence documentation:                                      
						MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQEVQEDHYGAE 	                                                            
						IRPSLESLG                                                    	Alignment of: 14641 x AAH47469   ..                          
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 69 of AAH47469, which also corresponds to 	Alignment segment 1/1:                                       
						amino acids 1 - 69 of F09531_P14, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  697.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      69                Total length:      69                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence                                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TMQLFFFFFSFLRQGLTLSPNWSAVAQSWLTTASTYWAQVILSFRLPE             	                        Gaps:       0                        
						corresponding to amino acids 70 - 117 of F09531_P14, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F09531_P14, comprising a  	       1 MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQ 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQ 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .                                          
						to the sequence                                              	      51 EVQEDHYGAEIRPSLESLG                                69                                                           
						TMQLFFFFFSFLRQGLTLSPNWSAVAQSWLTTASTYWAQVILSFRLPE in          	         |||||||||||||||||||                                 
						F09531_P14.                                                  	      51 EVQEDHYGAEIRPSLESLG                                69                                                           

						Comparison report between F09531_P14 and Q8NHH3partial WT    	Sequence name: Q8NHH3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09531_P14, comprising a first amino	Sequence documentation:                                      
						MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQEVQEDHYGAE 	                                                            
						IRPSLESLG                                                    	Alignment of: 14641 x Q8NHH3   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 69 of Q8NHH3, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 69 of F09531_P14, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  697.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      69                Total length:      69                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence                                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TMQLFFFFFSFLRQGLTLSPNWSAVAQSWLTTASTYWAQVILSFRLPE             	                        Gaps:       0                        
						corresponding to amino acids 70 - 117 of F09531_P14, wherein 	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F09531_P14, comprising a  	       1 MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQ 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQ 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .                                          
						to the sequence                                              	      51 EVQEDHYGAEIRPSLESLG                                69                                                           
						TMQLFFFFFSFLRQGLTLSPNWSAVAQSWLTTASTYWAQVILSFRLPE in          	         |||||||||||||||||||                                 
						F09531_P14.                                                  	      51 EVQEDHYGAEIRPSLESLG                                69                                                           

15037	HMR136_F09577_4_tr0_r1_1_gPRT		Comparison report between F09577_P4 and Q14865unique head    	Sequence name: Q14865                                        
						followed by partial WT sequence featuring a skipped exon, a  	                                                            
						mismatch and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for F09577_P4, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 15037 x Q14865   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MEPNSLQWVGSPCGLHGPYIFYKAFQFHLEGKPRILSLGDFFFVRCTPKDPICIAELQLL 	                                                            
						WEERTSRQLLSSSKLYFLPEDTPQGRNSDHGEDEVIAVSEKVIVKLEDLVKWVHSDFSKW 	                     Quality: 2239.00                      Escore:       0                                               
						RCGFHAGPVKTEALGRNGQKEALLKYRQSTLNSGLNFKDVLKEKADLGEDEEETNVIVLS 	             Matching length:     238                Total length:     246                                               
						YPQYCRYRSMLKRIQDKPSSILTDQFALALGGIAVVSRNPQILYCRDTFDHPTLIENESI 	 Matching Percent Similarity:   99.58   Matching Percent Identity:   99.58                                               
						CDEFAPNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKPKNNHNC 	    Total Percent Similarity:   96.34      Total Percent Identity:   96.34                                               
						K                                                            	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 301 of F09577_P4, a second amino acid sequence being at  	Alignment:                                                   
						least 90 % homologous to                                     	                  .         .         .         .         .  
						KVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPYLGFK corresponding	     302 KVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPYLGFK... 348                                                          
						to amino acids 1 - 47 of Q14865, which also corresponds to   	         |||||||||||||||||||||||||||||||||||||||||||||||     
						amino acids 302 - 348 of F09577_P4, a third amino acid       	       1 KVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPYLGFKQIN 50                                                           
						sequence being at least 90 % homologous to Q corresponding to	                  .         .         .         .         .  
						amino acids 56 - 56 of Q14865, which also corresponds to     	     349 .....QTAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRHYERL 393                                                          
						amino acids 349 - 349 of F09577_P4, a bridging amino acid T  	              | |||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 350 of F09577_P4, a fourth amino 	      51 LWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRHYERL 100                                                          
						AQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRHYERLILPYERFIKGEEDKPLP 	                  .         .         .         .         .  
						PIKPRKQENSSQENENKTKVSGTKRIKHEIPKSKKEKENAPKPQDAAEVSSEQEKEQETL 	     394 ILPYERFIKGEEDKPLPPIKPRKQENSSQENENKTKVSGTKRIKHEIPKS 443                                                          
						ISQKSIPEPLPAADMKKKIEGYQEFSAKPLASRVDPEKDNETDQGSNSEKVAEEAGEKGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TPPLPSAPL                                                    	     101 ILPYERFIKGEEDKPLPPIKPRKQENSSQENENKTKVSGTKRIKHEIPKS 150                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 58 - 246 of Q14865, which also corresponds to 	     444 KKEKENAPKPQDAAEVSSEQEKEQETLISQKSIPEPLPAADMKKKIEGYQ 493                                                          
						amino acids 351 - 539 of F09577_P4, and a fifth amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 KKEKENAPKPQDAAEVSSEQEKEQETLISQKSIPEPLPAADMKKKIEGYQ 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .            
						most preferably at least 95% homologous to a polypeptide     	     494 EFSAKPLASRVDPEKDNETDQGSNSEKVAEEAGEKGPTPPLPSAPL     539                                                          
						APEKDSALVPGASKQPLTSPSALVDSKQESKLCCFTESPESEPQEASFPSFPTTQPPLAN 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						QNETEDDKLPAMADYIANCTVKVDQLGSDDIHNALKQTPKVLVVQSFDMFKDKDLTGPMN 	     201 EFSAKPLASRVDPEKDNETDQGSNSEKVAEEAGEKGPTPPLPSAPL     246                                                          
						ENHGLNYTPLLYSRGNPGIMSPLAKKKLLSQVSGASLSSSYPYGSPPPLISKKKLIARDD 	                                                            
						LCSSLSQTHHGQSTDHMAVSRPSVIQHVQSFRSKPSEERKTINDIFKHEKLSRSDPHRCS 	                                                            
						FSKHHLNPLADSYVLKQEIQEGKDKLLEKRALPHSHMPSFLADFYSSPHLHSLYRHTEHH 	                                                            
						LHNEQTSKYPSRDMYRESENSSFPSHRHQEKLHVNYLTSLHLQDKKSAAAEAPTDDQPTD 	                                                            
						LSLPKNPHKPTGKVLGLAHSTTGPQESKGISQFQVLGSQSRDCHPKACRVSPMTMSGPKK 	                                                            
						YPESLSRSGKPHHVRLENFRKMEGMVHPILHRKMSPQNIGAARPIKRSLEDLDLVIAGKK 	                                                            
						ARAVSPLDPSKEVSGKEKASEQESEGSKAAHGGHSGGGSEGHKLPLSSPIFPGLYSGSLC 	                                                            
						NSGLNSRLPAGYSHSLQYLKNQTVLSPLMQPLAFHSLVMQRGIFTSPTNSQQLYRHLAAA 	                                                            
						TPVGSSYGDLLHNSIYPLAAINPQAAFPSSQLSSVHPSTKL                    	                                                            
						having the sequence corresponding to amino acids 540 - 1180  	                                                            
						of F09577_P4, wherein said first amino acid sequence, second 	                                                            
						amino acid sequence, third amino acid sequence, bridging     	                                                            
						amino acid, fourth amino acid sequence and fifth amino acid  	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of F09577_P4,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MEPNSLQWVGSPCGLHGPYIFYKAFQFHLEGKPRILSLGDFFFVRCTPKDPICIAELQLL 	                                                            
						WEERTSRQLLSSSKLYFLPEDTPQGRNSDHGEDEVIAVSEKVIVKLEDLVKWVHSDFSKW 	                                                            
						RCGFHAGPVKTEALGRNGQKEALLKYRQSTLNSGLNFKDVLKEKADLGEDEEETNVIVLS 	                                                            
						YPQYCRYRSMLKRIQDKPSSILTDQFALALGGIAVVSRNPQILYCRDTFDHPTLIENESI 	                                                            
						CDEFAPNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKPKNNHNC 	                                                            
						K                                                            	                                                            
						about 95% homologous to the sequence of F09577_P4.3.An       	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						F09577_P4, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KQ, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						348-x to 349; and ending at any of amino acid numbers 349+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						polypeptide encoding for a tail of F09577_P4, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						APEKDSALVPGASKQPLTSPSALVDSKQESKLCCFTESPESEPQEASFPSFPTTQPPLAN 	                                                            
						QNETEDDKLPAMADYIANCTVKVDQLGSDDIHNALKQTPKVLVVQSFDMFKDKDLTGPMN 	                                                            
						ENHGLNYTPLLYSRGNPGIMSPLAKKKLLSQVSGASLSSSYPYGSPPPLISKKKLIARDD 	                                                            
						LCSSLSQTHHGQSTDHMAVSRPSVIQHVQSFRSKPSEERKTINDIFKHEKLSRSDPHRCS 	                                                            
						FSKHHLNPLADSYVLKQEIQEGKDKLLEKRALPHSHMPSFLADFYSSPHLHSLYRHTEHH 	                                                            
						LHNEQTSKYPSRDMYRESENSSFPSHRHQEKLHVNYLTSLHLQDKKSAAAEAPTDDQPTD 	                                                            
						LSLPKNPHKPTGKVLGLAHSTTGPQESKGISQFQVLGSQSRDCHPKACRVSPMTMSGPKK 	                                                            
						YPESLSRSGKPHHVRLENFRKMEGMVHPILHRKMSPQNIGAARPIKRSLEDLDLVIAGKK 	                                                            
						ARAVSPLDPSKEVSGKEKASEQESEGSKAAHGGHSGGGSEGHKLPLSSPIFPGLYSGSLC 	                                                            
						NSGLNSRLPAGYSHSLQYLKNQTVLSPLMQPLAFHSLVMQRGIFTSPTNSQQLYRHLAAA 	                                                            
						TPVGSSYGDLLHNSIYPLAAINPQAAFPSSQLSSVHPSTKL                    	                                                            
						to the sequence in F09577_P4.                                	                                                            

						Comparison report between F09577_P4 and Q8N421unique head    	Sequence name: Q8N421                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09577_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15037 x Q8N421   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MEPNSLQWVGSPCGLHGPYIFYKAFQFHLEGKPRILSLGDFFFVRCTPKDPICIAELQLL 	Alignment segment 1/1:                                       
						WEERTSRQLLSSSKLYFLPEDTPQGRNSDHGEDEVIAVSEKVIVKLEDLVKWVHSDFSKW 	                                                            
						RCGFHAGPVKTEALGRNGQKEALLKYRQSTLNSGLNFKDVLKEKADLGEDEEETNVIVLS 	                     Quality: 7044.00                      Escore:       0                                               
						YPQYCRYRSMLKRIQDKPSSILTDQFALALGGIAVVSRNPQILYCRDTFDHPTLIENESI 	             Matching length:     712                Total length:     712                                               
						CDEFAPNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKPKNNHNC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KKVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPYLGFKQTAQKLGGYETI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TARRQWKHIYDELGGNPGSTSAATCTRRHYERLILPYERFIKGEEDKPLPPIKPRKQENS 	                        Gaps:       0                        
						SQENENKTKVSGTKRIKHEIPKSKKEKENAPKPQDAAEVSSEQEKEQE             	                                                            
						having the sequence corresponding to amino acids 1 - 468 of  	Alignment:                                                   
						F09577_P4, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						TLISQKSIPEPLPAADMKKKIEGYQEFSAKPLASRVDPEKDNETDQGSNSEKVAEEAGEK 	     469 TLISQKSIPEPLPAADMKKKIEGYQEFSAKPLASRVDPEKDNETDQGSNS 518                                                          
						GPTPPLPSAPLAPEKDSALVPGASKQPLTSPSALVDSKQESKLCCFTESPESEPQEASFP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SFPTTQPPLANQNETEDDKLPAMADYIANCTVKVDQLGSDDIHNALKQTPKVLVVQSFDM 	       5 TLISQKSIPEPLPAADMKKKIEGYQEFSAKPLASRVDPEKDNETDQGSNS 54                                                           
						FKDKDLTGPMNENHGLNYTPLLYSRGNPGIMSPLAKKKLLSQVSGASLSSSYPYGSPPPL 	                  .         .         .         .         .  
						ISKKKLIARDDLCSSLSQTHHGQSTDHMAVSRPSVIQHVQSFRSKPSEERKTINDIFKHE 	     519 EKVAEEAGEKGPTPPLPSAPLAPEKDSALVPGASKQPLTSPSALVDSKQE 568                                                          
						KLSRSDPHRCSFSKHHLNPLADSYVLKQEIQEGKDKLLEKRALPHSHMPSFLADFYSSPH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHSLYRHTEHHLHNEQTSKYPSRDMYRESENSSFPSHRHQEKLHVNYLTSLHLQDKKSAA 	      55 EKVAEEAGEKGPTPPLPSAPLAPEKDSALVPGASKQPLTSPSALVDSKQE 104                                                          
						AEAPTDDQPTDLSLPKNPHKPTGKVLGLAHSTTGPQESKGISQFQVLGSQSRDCHPKACR 	                  .         .         .         .         .  
						VSPMTMSGPKKYPESLSRSGKPHHVRLENFRKMEGMVHPILHRKMSPQNIGAARPIKRSL 	     569 SKLCCFTESPESEPQEASFPSFPTTQPPLANQNETEDDKLPAMADYIANC 618                                                          
						EDLDLVIAGKKARAVSPLDPSKEVSGKEKASEQESEGSKAAHGGHSGGGSEGHKLPLSSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IFPGLYSGSLCNSGLNSRLPAGYSHSLQYLKNQTVLSPLMQPLAFHSLVMQRGIFTSPTN 	     105 SKLCCFTESPESEPQEASFPSFPTTQPPLANQNETEDDKLPAMADYIANC 154                                                          
						SQQLYRHLAAATPVGSSYGDLLHNSIYPLAAINPQAAFPSSQLSSVHPSTKL         	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 5 - 716 of      	     619 TVKVDQLGSDDIHNALKQTPKVLVVQSFDMFKDKDLTGPMNENHGLNYTP 668                                                          
						Q8N421, which also corresponds to amino acids 469 - 1180 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09577_P4, wherein said first amino acid sequence and second 	     155 TVKVDQLGSDDIHNALKQTPKVLVVQSFDMFKDKDLTGPMNENHGLNYTP 204                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     669 LLYSRGNPGIMSPLAKKKLLSQVSGASLSSSYPYGSPPPLISKKKLIARD 718                                                          
						F09577_P4, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     205 LLYSRGNPGIMSPLAKKKLLSQVSGASLSSSYPYGSPPPLISKKKLIARD 254                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MEPNSLQWVGSPCGLHGPYIFYKAFQFHLEGKPRILSLGDFFFVRCTPKDPICIAELQLL 	     719 DLCSSLSQTHHGQSTDHMAVSRPSVIQHVQSFRSKPSEERKTINDIFKHE 768                                                          
						WEERTSRQLLSSSKLYFLPEDTPQGRNSDHGEDEVIAVSEKVIVKLEDLVKWVHSDFSKW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RCGFHAGPVKTEALGRNGQKEALLKYRQSTLNSGLNFKDVLKEKADLGEDEEETNVIVLS 	     255 DLCSSLSQTHHGQSTDHMAVSRPSVIQHVQSFRSKPSEERKTINDIFKHE 304                                                          
						YPQYCRYRSMLKRIQDKPSSILTDQFALALGGIAVVSRNPQILYCRDTFDHPTLIENESI 	                  .         .         .         .         .  
						CDEFAPNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKPKNNHNC 	     769 KLSRSDPHRCSFSKHHLNPLADSYVLKQEIQEGKDKLLEKRALPHSHMPS 818                                                          
						KKVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPYLGFKQTAQKLGGYETI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TARRQWKHIYDELGGNPGSTSAATCTRRHYERLILPYERFIKGEEDKPLPPIKPRKQENS 	     305 KLSRSDPHRCSFSKHHLNPLADSYVLKQEIQEGKDKLLEKRALPHSHMPS 354                                                          
						SQENENKTKVSGTKRIKHEIPKSKKEKENAPKPQDAAEVSSEQEKEQE             	                  .         .         .         .         .  
						least about 95% homologous to the sequence of F09577_P4.     	     819 FLADFYSSPHLHSLYRHTEHHLHNEQTSKYPSRDMYRESENSSFPSHRHQ 868                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 FLADFYSSPHLHSLYRHTEHHLHNEQTSKYPSRDMYRESENSSFPSHRHQ 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     869 EKLHVNYLTSLHLQDKKSAAAEAPTDDQPTDLSLPKNPHKPTGKVLGLAH 918                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     405 EKLHVNYLTSLHLQDKKSAAAEAPTDDQPTDLSLPKNPHKPTGKVLGLAH 454                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     919 STTGPQESKGISQFQVLGSQSRDCHPKACRVSPMTMSGPKKYPESLSRSG 968                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     455 STTGPQESKGISQFQVLGSQSRDCHPKACRVSPMTMSGPKKYPESLSRSG 504                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     969 KPHHVRLENFRKMEGMVHPILHRKMSPQNIGAARPIKRSLEDLDLVIAGK 1018                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     505 KPHHVRLENFRKMEGMVHPILHRKMSPQNIGAARPIKRSLEDLDLVIAGK 554                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1019 KARAVSPLDPSKEVSGKEKASEQESEGSKAAHGGHSGGGSEGHKLPLSSP 1068                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     555 KARAVSPLDPSKEVSGKEKASEQESEGSKAAHGGHSGGGSEGHKLPLSSP 604                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1069 IFPGLYSGSLCNSGLNSRLPAGYSHSLQYLKNQTVLSPLMQPLAFHSLVM 1118                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     605 IFPGLYSGSLCNSGLNSRLPAGYSHSLQYLKNQTVLSPLMQPLAFHSLVM 654                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1119 QRGIFTSPTNSQQLYRHLAAATPVGSSYGDLLHNSIYPLAAINPQAAFPS 1168                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     655 QRGIFTSPTNSQQLYRHLAAATPVGSSYGDLLHNSIYPLAAINPQAAFPS 704                                                          
						                                                            	                  .                                          
						                                                            	    1169 SQLSSVHPSTKL                                       1180                                                         
						                                                            	         ||||||||||||                                        
						                                                            	     705 SQLSSVHPSTKL                                       716                                                          

						Comparison report between F09577_P4 and Q9H786unique head    	Sequence name: Q9H786                                        
						followed by partial WT sequence featuring a skipped exon, a  	                                                            
						mismatch and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for F09577_P4, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 15037 x Q9H786   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MEPNSLQWVGSPCGLHGPYIFYKAFQFHLEGKPRILSLGDFFFVRCTPKDPICIAELQLL 	                                                            
						WEERTSRQLLSSSKLYFLPEDTPQGRNSDHGEDEVIAVSEKVIVKLEDLVKWVHSDFSKW 	                     Quality: 1904.00                      Escore:       0                                               
						RCGFHAGPVKTEALGRNGQKEALLKYRQSTLNSGLNFKDVLKEKADLGEDEEETNVIVLS 	             Matching length:     203                Total length:     211                                               
						YPQYCRYRSMLKRIQDKPSSILTDQFALALGGIAVVSRNPQILYCRDTFDHPTLIENESI 	 Matching Percent Similarity:   99.51   Matching Percent Identity:   99.01                                               
						CDEF                                                         	    Total Percent Similarity:   95.73      Total Percent Identity:   95.26                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       1                        
						1 - 244 of F09577_P4, a second amino acid sequence being at  	                                                            
						APNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKPKNNHNCKKVS 	Alignment:                                                   
						NEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPYLGFK                 	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 2 - 105	     245 APNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKP 294                                                          
						of Q9H786, which also corresponds to amino acids 245 - 348 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09577_P4, a third amino acid sequence being at least 90 %   	       2 APNLKGRPRKKKPCPQRRDSFSGVKDSNNNSDGKAVAKVKCEARSALTKP 51                                                           
						homologous to Q corresponding to amino acids 114 - 114 of    	                  .         .         .         .         .  
						Q9H786, which also corresponds to amino acids 349 - 349 of   	     295 KNNHNCKKVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPY 344                                                          
						F09577_P4, a bridging amino acid T corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 350 of F09577_P4, a fourth amino acid sequence being at 	      52 KNNHNCKKVSNEEKPKVAIGEECRADEQAFLVALYKYMKERKTPIERIPY 101                                                          
						AQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRHYERLILPYERFIKGEEDKPLP 	                  .         .         .         .         .  
						PIKPRKQENSSQENENKTKVSGTKRIKHEIPKSKK                          	     345 LGFK........QTAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCT 386                                                          
						least 90 % homologous to corresponding to amino acids 116 -  	         ||||        | ||||||||||||||||||||||||||||||||||||  
						210 of Q9H786, which also corresponds to amino acids 351 -   	     102 LGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCT 151                                                          
						445 of F09577_P4, and a fifth amino acid sequence being at   	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     387 RRHYERLILPYERFIKGEEDKPLPPIKPRKQENSSQENENKTKVSGTKRI 436                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKENAPKPQDAAEVSSEQEKEQETLISQKSIPEPLPAADMKKKIEGYQEFSAKPLASRVD 	     152 RRHYERLILPYERFIKGEEDKPLPPIKPRKQENSSQENENKTKVSGTKRI 201                                                          
						PEKDNETDQGSNSEKVAEEAGEKGPTPPLPSAPLAPEKDSALVPGASKQPLTSPSALVDS 	                  .                                          
						KQESKLCCFTESPESEPQEASFPSFPTTQPPLANQNETEDDKLPAMADYIANCTVKVDQL 	     437 KHEIPKSKKEK                                        447                                                          
						GSDDIHNALKQTPKVLVVQSFDMFKDKDLTGPMNENHGLNYTPLLYSRGNPGIMSPLAKK 	         |||||||||:|                                         
						KLLSQVSGASLSSSYPYGSPPPLISKKKLIARDDLCSSLSQTHHGQSTDHMAVSRPSVIQ 	     202 KHEIPKSKKKK                                        212                                                          
						HVQSFRSKPSEERKTINDIFKHEKLSRSDPHRCSFSKHHLNPLADSYVLKQEIQEGKDKL 	                                                            
						LEKRALPHSHMPSFLADFYSSPHLHSLYRHTEHHLHNEQTSKYPSRDMYRESENSSFPSH 	                                                            
						RHQEKLHVNYLTSLHLQDKKSAAAEAPTDDQPTDLSLPKNPHKPTGKVLGLAHSTTGPQE 	                                                            
						SKGISQFQVLGSQSRDCHPKACRVSPMTMSGPKKYPESLSRSGKPHHVRLENFRKMEGMV 	                                                            
						HPILHRKMSPQNIGAARPIKRSLEDLDLVIAGKKARAVSPLDPSKEVSGKEKASEQESEG 	                                                            
						SKAAHGGHSGGGSEGHKLPLSSPIFPGLYSGSLCNSGLNSRLPAGYSHSLQYLKNQTVLS 	                                                            
						PLMQPLAFHSLVMQRGIFTSPTNSQQLYRHLAAATPVGSSYGDLLHNSIYPLAAINPQAA 	                                                            
						FPSSQLSSVHPSTKL                                              	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 446 - 1180 of F09577_P4, wherein said first   	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence, bridging amino acid, fourth amino acid        	                                                            
						sequence and fifth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of F09577_P4, comprising a polypeptide being at least   	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MEPNSLQWVGSPCGLHGPYIFYKAFQFHLEGKPRILSLGDFFFVRCTPKDPICIAELQLL 	                                                            
						WEERTSRQLLSSSKLYFLPEDTPQGRNSDHGEDEVIAVSEKVIVKLEDLVKWVHSDFSKW 	                                                            
						RCGFHAGPVKTEALGRNGQKEALLKYRQSTLNSGLNFKDVLKEKADLGEDEEETNVIVLS 	                                                            
						YPQYCRYRSMLKRIQDKPSSILTDQFALALGGIAVVSRNPQILYCRDTFDHPTLIENESI 	                                                            
						CDEF                                                         	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F09577_P4.3.An isolated chimeric polypeptide encoding for an 	                                                            
						edge portion of F09577_P4, comprising a polypeptide having a 	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KQ, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						348-x to 349; and ending at any of amino acid numbers 349+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						polypeptide encoding for a tail of F09577_P4, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						EKENAPKPQDAAEVSSEQEKEQETLISQKSIPEPLPAADMKKKIEGYQEFSAKPLASRVD 	                                                            
						PEKDNETDQGSNSEKVAEEAGEKGPTPPLPSAPLAPEKDSALVPGASKQPLTSPSALVDS 	                                                            
						KQESKLCCFTESPESEPQEASFPSFPTTQPPLANQNETEDDKLPAMADYIANCTVKVDQL 	                                                            
						GSDDIHNALKQTPKVLVVQSFDMFKDKDLTGPMNENHGLNYTPLLYSRGNPGIMSPLAKK 	                                                            
						KLLSQVSGASLSSSYPYGSPPPLISKKKLIARDDLCSSLSQTHHGQSTDHMAVSRPSVIQ 	                                                            
						HVQSFRSKPSEERKTINDIFKHEKLSRSDPHRCSFSKHHLNPLADSYVLKQEIQEGKDKL 	                                                            
						LEKRALPHSHMPSFLADFYSSPHLHSLYRHTEHHLHNEQTSKYPSRDMYRESENSSFPSH 	                                                            
						RHQEKLHVNYLTSLHLQDKKSAAAEAPTDDQPTDLSLPKNPHKPTGKVLGLAHSTTGPQE 	                                                            
						SKGISQFQVLGSQSRDCHPKACRVSPMTMSGPKKYPESLSRSGKPHHVRLENFRKMEGMV 	                                                            
						HPILHRKMSPQNIGAARPIKRSLEDLDLVIAGKKARAVSPLDPSKEVSGKEKASEQESEG 	                                                            
						SKAAHGGHSGGGSEGHKLPLSSPIFPGLYSGSLCNSGLNSRLPAGYSHSLQYLKNQTVLS 	                                                            
						PLMQPLAFHSLVMQRGIFTSPTNSQQLYRHLAAATPVGSSYGDLLHNSIYPLAAINPQAA 	                                                            
						FPSSQLSSVHPSTKL                                              	                                                            
						to the sequence in F09577_P4.                                	                                                            

15521	HMR136_F09582_2_tr0_r1_1_gPRT		Comparison report between F09582_P2 and O75165unique head    	Sequence name: O75165                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09582_P2, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15521 x O75165   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQAFKSEETKGQDIFQRSILG 	Alignment segment 1/1:                                       
						HILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRLMIEKIAAHLADF        	                                                            
						polypeptide having the sequence corresponding to amino acids 	                     Quality: 9952.00                      Escore:       0                                               
						1 - 113 of F09582_P2, a second amino acid sequence being at  	             Matching length:    1021                Total length:    1021                                               
						TPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPIKDPVKLLKDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.90                                               
						LDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQKYHPDKNPEGRDM 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.90                                               
						FEKVNKAYEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTI 	                        Gaps:       0                        
						TMETSDDLLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTR 	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 240	Alignment:                                                   
						of O75165, which also corresponds to amino acids 114 - 353 of	                  .         .         .         .         .  
						F09582_P2, a bridging amino acid A corresponding to amino    	     114 TPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPI 163                                                          
						acid 354 of F09582_P2, and a third amino acid sequence being 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVE 	       1 TPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPI 50                                                           
						CVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSV 	                  .         .         .         .         .  
						HALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLI 	     164 KDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRK 213                                                          
						WNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYN 	      51 KDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRK 100                                                          
						PGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALL 	                  .         .         .         .         .  
						HSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMT 	     214 AYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILI 263                                                          
						ADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFL 	     101 AYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILI 150                                                          
						IALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNN 	                  .         .         .         .         .  
						AIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQSE 	     264 LKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPLLPAA 313                                                          
						LVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNEILCRS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT 	     151 LKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPLLPAA 200                                                          
						at least 90 % homologous to corresponding to amino acids 242 	                  .         .         .         .         .  
						- 1021 of O75165, which also corresponds to amino acids 355 -	     314 TELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDMSVQ 363                                                          
						1134 of F09582_P2, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||:|||||||||  
						second amino acid sequence, bridging amino acid and third    	     201 TELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRSSKPSDMSVQ 250                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     364 VCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGV 413                                                          
						F09582_P2, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 VCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGV 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQAFKSEETKGQDIFQRSILG 	     414 ECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQ 463                                                          
						HILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRLMIEKIAAHLADF        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F09582_P2.     	     301 ECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     464 EVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLA 513                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     514 VASVTEILKMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKT 563                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VASVTEILKMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     564 YGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYIGSQA 613                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 YGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYIGSQA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     614 QYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIG 663                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 QYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIG 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     664 HFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLAL 713                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 HFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLAL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     714 LHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVR 763                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVR 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     764 AQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGT 813                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 AQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGT 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     814 HENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVFG 863                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 HENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVFG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     864 EAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGE 913                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     914 TLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRV 963                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     964 IHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQS 1013                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 IHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQS 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1014 ELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQY 1063                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 ELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQY 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1064 GEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTST 1113                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 GEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTST 1000                                                         
						                                                            	                  .         .                                
						                                                            	    1114 SVMSNLPPPVDHEAGDLGYQT                              1134                                                         
						                                                            	         |||||||||||||||||||||                               
						                                                            	    1001 SVMSNLPPPVDHEAGDLGYQT                              1021                                                         

						Comparison report between F09582_P2 and Q9BWK9unique head    	Sequence name: Q9BWK9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15521 x Q9BWK9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQAFKSEETKGQDIFQRSILG 	Alignment segment 1/1:                                       
						HILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRLMIEKIAAHLADFTPRLQSN 	                                                            
						TRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPIKDPVKLLKDTLDAWKKE 	                     Quality: 3815.00                      Escore:       0                                               
						VEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKA 	             Matching length:     394                Total length:     394                                               
						YEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDD 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						LLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDM 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						SVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFA 	                        Gaps:       0                        
						VDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRL 	                                                            
						GGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTR 	Alignment:                                                   
						AELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKA 	                  .         .         .         .         .  
						FAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESE 	     741 AMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 790                                                          
						CIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSS 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						RQLVLETLYALTSSTKIIKEAM                                       	       6 ASAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 55                                                           
						having the sequence corresponding to amino acids 1 - 742 of  	                  .         .         .         .         .  
						F09582_P2, and a second amino acid sequence being at least 90	     791 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 840                                                          
						AKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVF 	      56 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 105                                                          
						GEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGETLETLTMAT 	                  .         .         .         .         .  
						VCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLET 	     841 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 890                                                          
						IGPLMNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPG 	     106 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 155                                                          
						VAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT                             	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 8 - 399 of      	     891 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 940                                                          
						Q9BWK9, which also corresponds to amino acids 743 - 1134 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09582_P2, wherein said first amino acid sequence and second 	     156 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 205                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     941 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 990                                                          
						F09582_P2, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     206 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 255                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQAFKSEETKGQDIFQRSILG 	     991 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 1040                                                         
						HILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRLMIEKIAAHLADFTPRLQSN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPIKDPVKLLKDTLDAWKKE 	     256 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 305                                                          
						VEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKA 	                  .         .         .         .         .  
						YEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDD 	    1041 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 1090                                                         
						LLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFA 	     306 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 355                                                          
						VDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRL 	                  .         .         .         .            
						GGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTR 	    1091 ESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT       1134                                                         
						AELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKA 	         ||||||||||||||||||||||||||||||||||||||||||||        
						FAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESE 	     356 ESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT       399                                                          
						CIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSS 	                                                            
						RQLVLETLYALTSSTKIIKEAM                                       	                                                            
						least about 95% homologous to the sequence of F09582_P2.     	                                                            

						Comparison report between F09582_P2 and Q96DC1unique head    	Sequence name: Q96DC1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15521 x Q96DC1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQAFKSEETKGQDIFQRSILG 	Alignment segment 1/1:                                       
						HILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRLMIEKIAAHLADFTPRLQSN 	                                                            
						TRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPIKDPVKLLKDTLDAWKKE 	                     Quality: 4113.00                      Escore:       0                                               
						VEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKA 	             Matching length:     425                Total length:     425                                               
						YEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFA 	                        Gaps:       0                        
						VDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRL 	                                                            
						GGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTR 	Alignment:                                                   
						AELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKA 	                  .         .         .         .         .  
						FAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESE 	     710 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 759                                                          
						CIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSS            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 709 of  	       1 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 50                                                           
						F09582_P2, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAEL 	     760 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 809                                                          
						FAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						STTVREMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRK 	      51 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 100                                                          
						PREFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAM 	                  .         .         .         .         .  
						NHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 	     810 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 859                                                          
						KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGD 	     101 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 150                                                          
						LGYQT                                                        	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 425 of      	     860 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 909                                                          
						Q96DC1, which also corresponds to amino acids 710 - 1134 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09582_P2, wherein said first amino acid sequence and second 	     151 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     910 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 959                                                          
						F09582_P2, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQAFKSEETKGQDIFQRSILG 	     960 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 1009                                                         
						HILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRLMIEKIAAHLADFTPRLQSN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPIKDPVKLLKDTLDAWKKE 	     251 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 300                                                          
						VEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKA 	                  .         .         .         .         .  
						YEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDD 	    1010 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 1059                                                         
						LLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFA 	     301 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 350                                                          
						VDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRL 	                  .         .         .         .         .  
						GGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTR 	    1060 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTA 1109                                                         
						AELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESE 	     351 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTA 400                                                          
						CIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSS            	                  .         .                                
						least about 95% homologous to the sequence of F09582_P2.     	    1110 GTSTSVMSNLPPPVDHEAGDLGYQT                          1134                                                         
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     401 GTSTSVMSNLPPPVDHEAGDLGYQT                          425                                                          

15526	HMR136_F09582_3_tr0_r1_1_gPRT		Comparison report between F09582_P3 and O75165unique head    	Sequence name: O75165                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09582_P3, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15526 x O75165   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence FLVPYYTHKTIFLFNR             	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 16 of F09582_P3, a second   	                                                            
						HDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILILK 	                     Quality: 9011.00                      Escore:       0                                               
						TQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPLLPAATELAFHTVNCSA 	             Matching length:     929                Total length:     929                                               
						LNAEELRRENGLEVLQEAFSRCVAVLTR                                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.89                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.89                                               
						corresponding to amino acids 93 - 240 of O75165, which also  	                        Gaps:       0                        
						corresponds to amino acids 17 - 164 of F09582_P3, a bridging 	                                                            
						amino acid A corresponding to amino acid 165 of F09582_P3,   	Alignment:                                                   
						and a third amino acid sequence being at least 90 %          	                  .         .         .         .         .  
						SKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVE 	      17 HDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGP 66                                                           
						CVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLI 	      93 HDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGP 142                                                          
						WNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQ 	                  .         .         .         .         .  
						LEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYN 	      67 DPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSK 116                                                          
						PGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMT 	     143 DPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSK 192                                                          
						ADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVR 	                  .         .         .         .         .  
						EMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFL 	     117 ESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRAS 166                                                          
						IALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNN 	         ||||||||||||||||||||||||||||||||||||||||||||||||:|  
						AIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQSE 	     193 ESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRSS 242                                                          
						LVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNEILCRS 	                  .         .         .         .         .  
						SVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT 	     167 KPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSI 216                                                          
						homologous to corresponding to amino acids 242 - 1021 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						O75165, which also corresponds to amino acids 166 - 945 of   	     243 KPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSI 292                                                          
						F09582_P3, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and third amino acid	     217 PRVAALGVECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQ 266                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F09582_P3,       	     293 PRVAALGVECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQ 342                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     267 KSEETNQQEVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLT 316                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence FLVPYYTHKTIFLFNR of     	     343 KSEETNQQEVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLT 392                                                          
						F09582_P3.                                                   	                  .         .         .         .         .  
						                                                            	     317 PYVARKLAVASVTEILKMLNSNTESPYLIWNNSTRAELLEFLESQQENMI 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 PYVARKLAVASVTEILKMLNSNTESPYLIWNNSTRAELLEFLESQQENMI 442                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     367 KKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASL 416                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     443 KKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASL 492                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     417 LDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNP 466                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     493 LDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNP 542                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     467 GSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESM 516                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     543 GSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESM 592                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     517 VLSSLLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFC 566                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     593 VLSSLLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFC 642                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     567 NSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEA 616                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     643 NSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEA 692                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     617 AVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLP 666                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     693 AVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLP 742                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     667 EDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELL 716                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     743 EDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELL 792                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     717 EKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNA 766                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     793 EKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNA 842                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     767 IPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAIN 816                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     843 IPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAIN 892                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     817 RMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALK 866                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     893 RMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALK 942                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     867 AMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAG 916                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     943 AMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAG 992                                                          
						                                                            	                  .         .                                
						                                                            	     917 YLTAGTSTSVMSNLPPPVDHEAGDLGYQT                      945                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     993 YLTAGTSTSVMSNLPPPVDHEAGDLGYQT                      1021                                                         

						Comparison report between F09582_P3 and Q9BWK9unique head    	Sequence name: Q9BWK9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15526 x Q9BWK9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						FLVPYYTHKTIFLFNRHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSA 	Alignment segment 1/1:                                       
						KIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPL 	                                                            
						LPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDMSVQVCGYIS 	                     Quality: 3815.00                      Escore:       0                                               
						KCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFAVDFWLQTHL 	             Matching length:     394                Total length:     394                                               
						FQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRLGGYLAEEQA 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						TPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTRAELLEFLES 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						QQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYI 	                        Gaps:       0                        
						GSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIGHFKLIF 	                                                            
						SLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLY 	Alignment:                                                   
						ALTSSTKIIKEAM                                                	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 553 of  	     552 AMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 601                                                          
						F09582_P3, and a second amino acid sequence being at least 90	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						AKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDN 	       6 ASAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 55                                                           
						PEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVF 	                  .         .         .         .         .  
						GEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGETLETLTMAT 	     602 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 651                                                          
						VCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLET 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IGPLMNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDS 	      56 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 105                                                          
						PAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPG 	                  .         .         .         .         .  
						VAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT                             	     652 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 701                                                          
						% homologous to corresponding to amino acids 8 - 399 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9BWK9, which also corresponds to amino acids 554 - 945 of   	     106 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 155                                                          
						F09582_P3, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     702 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 751                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09582_P3, comprising a polypeptide being at least 70%,      	     156 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 205                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     752 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 801                                                          
						FLVPYYTHKTIFLFNRHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPL 	     206 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 255                                                          
						LPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDMSVQVCGYIS 	                  .         .         .         .         .  
						KCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFAVDFWLQTHL 	     802 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 851                                                          
						FQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRLGGYLAEEQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTRAELLEFLES 	     256 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 305                                                          
						QQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYI 	                  .         .         .         .         .  
						GSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIGHFKLIF 	     852 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 901                                                          
						SLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALTSSTKIIKEAM                                                	     306 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 355                                                          
						least about 95% homologous to the sequence of F09582_P3.     	                  .         .         .         .            
						                                                            	     902 ESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT       945                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     356 ESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT       399                                                          

						Comparison report between F09582_P3 and Q96DC1unique head    	Sequence name: Q96DC1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15526 x Q96DC1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						FLVPYYTHKTIFLFNRHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSA 	Alignment segment 1/1:                                       
						KIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPL 	                                                            
						LPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDMSVQVCGYIS 	                     Quality: 4113.00                      Escore:       0                                               
						KCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFAVDFWLQTHL 	             Matching length:     425                Total length:     425                                               
						FQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRLGGYLAEEQA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTRAELLEFLES 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYI 	                        Gaps:       0                        
						GSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIGHFKLIF 	                                                            
						SLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSS                     	Alignment:                                                   
						having the sequence corresponding to amino acids 1 - 520 of  	                  .         .         .         .         .  
						F09582_P3, and a second amino acid sequence being at least 90	     521 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 570                                                          
						LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKV 	       1 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 50                                                           
						STTVREMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRK 	                  .         .         .         .         .  
						PREFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAM 	     571 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 620                                                          
						NHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNE 	      51 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 100                                                          
						ILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGD 	                  .         .         .         .         .  
						LGYQT                                                        	     621 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 670                                                          
						% homologous to corresponding to amino acids 1 - 425 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q96DC1, which also corresponds to amino acids 521 - 945 of   	     101 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 150                                                          
						F09582_P3, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     671 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 720                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09582_P3, comprising a polypeptide being at least 70%,      	     151 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     721 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 770                                                          
						FLVPYYTHKTIFLFNRHDESKIRKAYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPL 	     201 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 250                                                          
						LPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDMSVQVCGYIS 	                  .         .         .         .         .  
						KCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVECVSSFAVDFWLQTHL 	     771 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 820                                                          
						FQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSVHALSRLGGYLAEEQA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLIWNNSTRAELLEFLES 	     251 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 300                                                          
						QQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYI 	                  .         .         .         .         .  
						GSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIGHFKLIF 	     821 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 870                                                          
						SLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSS                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of F09582_P3.     	     301 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     871 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTA 920                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTA 400                                                          
						                                                            	                  .         .                                
						                                                            	     921 GTSTSVMSNLPPPVDHEAGDLGYQT                          945                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     401 GTSTSVMSNLPPPVDHEAGDLGYQT                          425                                                          

15524	HMR136_F09582_4_tr0_r1_1_gPRT		Comparison report between F09582_P4 and O75165unique head    	Sequence name: O75165                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15524 x O75165   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence FTILLINFQ corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of F09582_P4, and a second amino acid sequence being at  	                                                            
						VVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGA 	                     Quality: 4333.00                      Escore:       0                                               
						LIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAA 	             Matching length:     449                Total length:     449                                               
						VHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVFGEAE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						GELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGETLETLTMATVCLF 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.78                                               
						SAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPL 	                        Gaps:       0                        
						MNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAAT 	                                                            
						KAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGY 	Alignment:                                                   
						LTAGTSTSVMSNLPPPVDHEAGDLGYQT                                 	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 574 -  	       9 QVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLYALTSST 58                                                           
						1021 of O75165, which also corresponds to amino acids 10 -   	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						457 of F09582_P4, wherein said first amino acid sequence and 	     573 EVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLYALTSST 622                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      59 KIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRI 108                                                          
						F09582_P4, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     623 KIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRI 672                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence FTILLINFQ of      	     109 TLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVRE 158                                                          
						F09582_P4.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     673 TLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVRE 722                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 MMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAW 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     723 MMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAW 772                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 VLRKPREFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQ 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     773 VLRKPREFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQ 822                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 VPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGP 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     823 VPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGP 872                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 LMNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGI 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     873 LMNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGI 922                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 GLENLDSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKH 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     923 GLENLDSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKH 972                                                          
						                                                            	                  .         .         .         .            
						                                                            	     409 DLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT  457                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     973 DLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT  1021                                                         

						Comparison report between F09582_P4 and Q9BWK9unique head    	Sequence name: Q9BWK9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15524 x Q9BWK9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						FTILLINFQVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLYALTSSTKI 	Alignment segment 1/1:                                       
						IKEAM                                                        	                                                            
						having the sequence corresponding to amino acids 1 - 65 of   	                     Quality: 3815.00                      Escore:       0                                               
						F09582_P4, and a second amino acid sequence being at least 90	             Matching length:     394                Total length:     394                                               
						AKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDN 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						PEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVF 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						GEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGETLETLTMAT 	                        Gaps:       0                        
						VCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLET 	                                                            
						IGPLMNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDS 	Alignment:                                                   
						PAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPG 	                  .         .         .         .         .  
						VAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT                             	      64 AMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 113                                                          
						% homologous to corresponding to amino acids 8 - 399 of      	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9BWK9, which also corresponds to amino acids 66 - 457 of    	       6 ASAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 55                                                           
						F09582_P4, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     114 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 163                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09582_P4, comprising a polypeptide being at least 70%,      	      56 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 105                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     164 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 213                                                          
						FTILLINFQVVNIVTSNQDCVNNIAESMVLSSLLALLHSLPSSRQLVLETLYALTSSTKI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IKEAM                                                        	     106 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 155                                                          
						least about 95% homologous to the sequence of F09582_P4.     	                  .         .         .         .         .  
						                                                            	     214 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     156 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 305                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     364 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 413                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     306 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 355                                                          
						                                                            	                  .         .         .         .            
						                                                            	     414 ESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT       457                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     356 ESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGDLGYQT       399                                                          

						Comparison report between F09582_P4 and Q96DC1unique head    	Sequence name: Q96DC1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09582_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15524 x Q96DC1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence FTILLINFQVVNIVTSNQDCVNNIAESMVLSS         	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 32 of F09582_P4, and a      	                                                            
						LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAEL 	                     Quality: 4113.00                      Escore:       0                                               
						FAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKV 	             Matching length:     425                Total length:     425                                               
						STTVREMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PREFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						NHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 	                        Gaps:       0                        
						KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNE 	                                                            
						ILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTAGTSTSVMSNLPPPVDHEAGD 	Alignment:                                                   
						LGYQT                                                        	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	      33 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 82                                                           
						corresponding to amino acids 1 - 425 of Q96DC1, which also   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 33 - 457 of F09582_P4, wherein    	       1 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 50                                                           
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      83 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 132                                                          
						polypeptide encoding for a head of F09582_P4, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	      51 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 100                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     133 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 182                                                          
						to the sequence FTILLINFQVVNIVTSNQDCVNNIAESMVLSS of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09582_P4.                                                   	     101 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     183 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 232                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     233 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 282                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     283 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 332                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     333 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 382                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     383 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTA 432                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTGPGVAGYLTA 400                                                          
						                                                            	                  .         .                                
						                                                            	     433 GTSTSVMSNLPPPVDHEAGDLGYQT                          457                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     401 GTSTSVMSNLPPPVDHEAGDLGYQT                          425                                                          

15528	HMR136_F09582_5_tr0_r1_1_gPRT		Comparison report between F09582_P5 and O75165unique head    	Sequence name: O75165                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F09582_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15528 x O75165   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						YEFFNELYHRFLLTPKVNMKCLCLQALAIVYGRCHEEIGPFTDTRYIIGMLERCTDKLER 	Alignment segment 1/1:                                       
						DRLILFLNKLILNKKNVKDLMDSNGIRILVDLLTLAHLHVSRATVPLQSNVIEAAPDMKR 	                                                            
						ESEKEWYFGNADKERSGPYGFHEMQELWTKGMLNAKTRCWAQGMDGWRPLQSIPQLKWCL 	                     Quality: 9623.00                      Escore:       0                                               
						LASGQAVLNETDLATLILNMLITMCGYFPSRDQDNAIIRPLPKVKRLLSDSTCLPHIIQL 	             Matching length:     987                Total length:     987                                               
						LLTFDPILVEKVAILLYHIMQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.90                                               
						AFKSEETKGQDIFQRSILGHILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.90                                               
						MIEKIAAHLADF                                                 	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 372 of F09582_P5, a second amino acid     	Alignment:                                                   
						TPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPIKDPVKLLKDT 	                  .         .         .         .         .  
						LDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQKYHPDKNPEGRDM 	     373 TPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPI 422                                                          
						FEKVNKAYEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPYKYAGYPMLIRTI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TMETSDDLLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTR 	       1 TPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDWPI 50                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 240 of O75165, which also corresponds to     	     423 KDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRK 472                                                          
						amino acids 373 - 612 of F09582_P5, a bridging amino acid A  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 613 of F09582_P5, a third amino  	      51 KDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRK 100                                                          
						SKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGVE 	                  .         .         .         .         .  
						CVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQEVANSLAKLSV 	     473 AYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILI 522                                                          
						HALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEILKMLNSNTESPYLI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGEIFVRVYNEVPTFQ 	     101 AYFRLAQKYHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILI 150                                                          
						LEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYN 	                  .         .         .         .         .  
						PGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLALL 	     523 LKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPLLPAA 572                                                          
						HSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVR 	     151 LKTQSILFNRHKEDLQPYKYAGYPMLIRTITMETSDDLLFSKESPLLPAA 200                                                          
						EMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFL 	                  .         .         .         .         .  
						IALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNN 	     573 TELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRASKPSDMSVQ 622                                                          
						AIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQSE 	         ||||||||||||||||||||||||||||||||||||||||:|||||||||  
						LVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNEILCRS 	     201 TELAFHTVNCSALNAEELRRENGLEVLQEAFSRCVAVLTRSSKPSDMSVQ 250                                                          
						SVWSAFKDQKHDLFISESQTAGYLTG                                   	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     623 VCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGV 672                                                          
						to amino acids 242 - 987 of O75165, which also corresponds to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 614 - 1359 of F09582_P5, and a fourth amino acid 	     251 VCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYFGKSIPRVAALGV 300                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     673 ECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQ 722                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VSPSLLTGSSPLHLRSGL corresponding to amino	     301 ECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETNQQ 350                                                          
						acids 1360 - 1377 of F09582_P5, wherein said first amino acid	                  .         .         .         .         .  
						sequence, second amino acid sequence, bridging amino acid,   	     723 EVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLA 772                                                          
						third amino acid sequence and fourth amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     351 EVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLA 400                                                          
						polypeptide encoding for a head of F09582_P5, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     773 VASVTEILKMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKT 822                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     401 VASVTEILKMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKT 450                                                          
						YEFFNELYHRFLLTPKVNMKCLCLQALAIVYGRCHEEIGPFTDTRYIIGMLERCTDKLER 	                  .         .         .         .         .  
						DRLILFLNKLILNKKNVKDLMDSNGIRILVDLLTLAHLHVSRATVPLQSNVIEAAPDMKR 	     823 YGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYIGSQA 872                                                          
						ESEKEWYFGNADKERSGPYGFHEMQELWTKGMLNAKTRCWAQGMDGWRPLQSIPQLKWCL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LASGQAVLNETDLATLILNMLITMCGYFPSRDQDNAIIRPLPKVKRLLSDSTCLPHIIQL 	     451 YGSEFVYSDHAKELIVGEIFVRVYNEVPTFQLEVPKAFAASLLDYIGSQA 500                                                          
						LLTFDPILVEKVAILLYHIMQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQ 	                  .         .         .         .         .  
						AFKSEETKGQDIFQRSILGHILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRL 	     873 QYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIG 922                                                          
						MIEKIAAHLADF                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of F09582_P5.3.An isolated polypeptide       	     501 QYLHTFMAITHAAKVESEQHGDRLPRVEMALEALRNVIKYNPGSESECIG 550                                                          
						encoding for a tail of F09582_P5, comprising a polypeptide   	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     923 HFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLAL 972                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     551 HFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNIAESMVLSSLLAL 600                                                          
						VSPSLLTGSSPLHLRSGL in F09582_P5.                             	                  .         .         .         .         .  
						                                                            	     973 LHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVR 1022                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVR 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 AQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 AQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGT 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 HENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVFG 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 HENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVFG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 EAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGE 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 TLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRV 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 TLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 IHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQS 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 IHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQKEQS 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 ELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQY 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 ELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQY 950                                                          
						                                                            	                  .         .         .                      
						                                                            	    1323 GEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTG              1359                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     951 GEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTG              987                                                          

						Comparison report between F09582_P5 and Q9BWK9unique head    	Sequence name: Q9BWK9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09582_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15528 x Q9BWK9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						YEFFNELYHRFLLTPKVNMKCLCLQALAIVYGRCHEEIGPFTDTRYIIGMLERCTDKLER 	Alignment segment 1/1:                                       
						DRLILFLNKLILNKKNVKDLMDSNGIRILVDLLTLAHLHVSRATVPLQSNVIEAAPDMKR 	                                                            
						ESEKEWYFGNADKERSGPYGFHEMQELWTKGMLNAKTRCWAQGMDGWRPLQSIPQLKWCL 	                     Quality: 3486.00                      Escore:       0                                               
						LASGQAVLNETDLATLILNMLITMCGYFPSRDQDNAIIRPLPKVKRLLSDSTCLPHIIQL 	             Matching length:     360                Total length:     360                                               
						LLTFDPILVEKVAILLYHIMQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQ 	 Matching Percent Similarity:   99.72   Matching Percent Identity:   99.72                                               
						AFKSEETKGQDIFQRSILGHILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRL 	    Total Percent Similarity:   99.72      Total Percent Identity:   99.72                                               
						MIEKIAAHLADFTPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDW 	                        Gaps:       0                        
						PIKDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQK 	                                                            
						YHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPY 	Alignment:                                                   
						KYAGYPMLIRTITMETSDDLLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQ 	                  .         .         .         .         .  
						EAFSRCVAVLTRASKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYF 	    1000 AMAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 1049                                                         
						GKSIPRVAALGVECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETN 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						QQEVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEIL 	       6 ASAKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKF 55                                                           
						KMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGE 	                  .         .         .         .         .  
						IFVRVYNEVPTFQLEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVE 	    1050 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 1099                                                         
						MALEALRNVIKYNPGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AESMVLSSLLALLHSLPSSRQLVLETLYALTSSTKIIKEAM                    	      56 LPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEH 105                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 1001 of F09582_P5, a second amino acid    	    1100 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 1149                                                         
						AKGALIYLLDMFCNSTHPQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEAAVHIFEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFAVVF 	     106 FKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRKP 155                                                          
						GEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNNPHGETLETLTMAT 	                  .         .         .         .         .  
						VCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLET 	    1150 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 1199                                                         
						IGPLMNGMKKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENLDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTG   	     156 REFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLG 205                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 8 - 365 of Q9BWK9, which also corresponds to     	    1200 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 1249                                                         
						amino acids 1002 - 1359 of F09582_P5, and a third amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     206 HLPKVIQAMNHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGM 255                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	    1250 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 1299                                                         
						having the sequence VSPSLLTGSSPLHLRSGL corresponding to amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 1360 - 1377 of F09582_P5, wherein said first amino acid	     256 KKRADTVGLACEAINRMFQKEQSELVAQALKADLVPYLLKLLEGIGLENL 305                                                          
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	    1300 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 1349                                                         
						isolated polypeptide encoding for a head of F09582_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     306 DSPAATKAQIVKALKAMTRSLQYGEQVNEILCRSSVWSAFKDQKHDLFIS 355                                                          
						least about 80%, preferably at least about 85%, more         	                  .                                          
						preferably at least about 90% and most preferably at least   	    1350 ESQTAGYLTG                                         1359                                                         
						YEFFNELYHRFLLTPKVNMKCLCLQALAIVYGRCHEEIGPFTDTRYIIGMLERCTDKLER 	         ||||||||||                                          
						DRLILFLNKLILNKKNVKDLMDSNGIRILVDLLTLAHLHVSRATVPLQSNVIEAAPDMKR 	     356 ESQTAGYLTG                                         365                                                          
						ESEKEWYFGNADKERSGPYGFHEMQELWTKGMLNAKTRCWAQGMDGWRPLQSIPQLKWCL 	                                                            
						LASGQAVLNETDLATLILNMLITMCGYFPSRDQDNAIIRPLPKVKRLLSDSTCLPHIIQL 	                                                            
						LLTFDPILVEKVAILLYHIMQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQ 	                                                            
						AFKSEETKGQDIFQRSILGHILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRL 	                                                            
						MIEKIAAHLADFTPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDW 	                                                            
						PIKDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQK 	                                                            
						YHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPY 	                                                            
						KYAGYPMLIRTITMETSDDLLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQ 	                                                            
						EAFSRCVAVLTRASKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYF 	                                                            
						GKSIPRVAALGVECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETN 	                                                            
						QQEVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEIL 	                                                            
						KMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGE 	                                                            
						IFVRVYNEVPTFQLEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVE 	                                                            
						MALEALRNVIKYNPGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNI 	                                                            
						AESMVLSSLLALLHSLPSSRQLVLETLYALTSSTKIIKEAM                    	                                                            
						about 95% homologous to the sequence of F09582_P5.3.An       	                                                            
						isolated polypeptide encoding for a tail of F09582_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VSPSLLTGSSPLHLRSGL in   	                                                            
						F09582_P5.                                                   	                                                            

						Comparison report between F09582_P5 and Q96DC1unique head    	Sequence name: Q96DC1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09582_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15528 x Q96DC1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						YEFFNELYHRFLLTPKVNMKCLCLQALAIVYGRCHEEIGPFTDTRYIIGMLERCTDKLER 	Alignment segment 1/1:                                       
						DRLILFLNKLILNKKNVKDLMDSNGIRILVDLLTLAHLHVSRATVPLQSNVIEAAPDMKR 	                                                            
						ESEKEWYFGNADKERSGPYGFHEMQELWTKGMLNAKTRCWAQGMDGWRPLQSIPQLKWCL 	                     Quality: 3784.00                      Escore:       0                                               
						LASGQAVLNETDLATLILNMLITMCGYFPSRDQDNAIIRPLPKVKRLLSDSTCLPHIIQL 	             Matching length:     391                Total length:     391                                               
						LLTFDPILVEKVAILLYHIMQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AFKSEETKGQDIFQRSILGHILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MIEKIAAHLADFTPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDW 	                        Gaps:       0                        
						PIKDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQK 	                                                            
						YHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPY 	Alignment:                                                   
						KYAGYPMLIRTITMETSDDLLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQ 	                  .         .         .         .         .  
						EAFSRCVAVLTRASKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYF 	     969 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 1018                                                         
						GKSIPRVAALGVECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQEVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEIL 	       1 LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTH 50                                                           
						KMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGE 	                  .         .         .         .         .  
						IFVRVYNEVPTFQLEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVE 	    1019 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 1068                                                         
						MALEALRNVIKYNPGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AESMVLSS                                                     	      51 PQVRAQTAELFAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHI 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 968 of F09582_P5, a second amino acid     	    1069 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 1118                                                         
						LLALLHSLPSSRQLVLETLYALTSSTKIIKEAMAKGALIYLLDMFCNSTHPQVRAQTAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FAKMTADKLIGPKVRITLMKFLPSVFMDAMRDNPEAAVHIFEGTHENPELIWNDNSRDKV 	     101 FEGTHENPELIWNDNSRDKVSTTVREMMLEHFKNQQDNPEANWKLPEDFA 150                                                          
						STTVREMMLEHFKNQQDNPEANWKLPEDFAVVFGEAEGELAVGGVFLRIFIAQPAWVLRK 	                  .         .         .         .         .  
						PREFLIALLEKLTELLEKNNPHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAM 	    1119 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 1168                                                         
						NHRNNAIPKSAIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTRSLQYGEQVNE 	     151 VVFGEAEGELAVGGVFLRIFIAQPAWVLRKPREFLIALLEKLTELLEKNN 200                                                          
						ILCRSSVWSAFKDQKHDLFISESQTAGYLTG                              	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	    1169 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 1218                                                         
						amino acids 1 - 391 of Q96DC1, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 969 - 1359 of F09582_P5, and a third amino acid  	     201 PHGETLETLTMATVCLFSAQPQLADQVPPLGHLPKVIQAMNHRNNAIPKS 250                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	    1219 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 1268                                                         
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence VSPSLLTGSSPLHLRSGL corresponding to amino	     251 AIRVIHALSENELCVRAMASLETIGPLMNGMKKRADTVGLACEAINRMFQ 300                                                          
						acids 1360 - 1377 of F09582_P5, wherein said first amino acid	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	    1269 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 1318                                                         
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F09582_P5,       	     301 KEQSELVAQALKADLVPYLLKLLEGIGLENLDSPAATKAQIVKALKAMTR 350                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .            
						least about 80%, preferably at least about 85%, more         	    1319 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTG          1359                                                         
						preferably at least about 90% and most preferably at least   	         |||||||||||||||||||||||||||||||||||||||||           
						YEFFNELYHRFLLTPKVNMKCLCLQALAIVYGRCHEEIGPFTDTRYIIGMLERCTDKLER 	     351 SLQYGEQVNEILCRSSVWSAFKDQKHDLFISESQTAGYLTG          391                                                          
						DRLILFLNKLILNKKNVKDLMDSNGIRILVDLLTLAHLHVSRATVPLQSNVIEAAPDMKR 	                                                            
						ESEKEWYFGNADKERSGPYGFHEMQELWTKGMLNAKTRCWAQGMDGWRPLQSIPQLKWCL 	                                                            
						LASGQAVLNETDLATLILNMLITMCGYFPSRDQDNAIIRPLPKVKRLLSDSTCLPHIIQL 	                                                            
						LLTFDPILVEKVAILLYHIMQDNPQLPRLYLSGVFFFIMMYTGSNVLPVARFLKYTHTKQ 	                                                            
						AFKSEETKGQDIFQRSILGHILPEAMVCYLENYEPEKFSEIFLGEFDTPEAIWSSEMRRL 	                                                            
						MIEKIAAHLADFTPRLQSNTRALYQYCPIPIINYPQLENELFCNIYYLKQLCDTLRFPDW 	                                                            
						PIKDPVKLLKDTLDAWKKEVEKKPPMMSIDDAYEVLNLPQGQGPHDESKIRKAYFRLAQK 	                                                            
						YHPDKNPEGRDMFEKVNKAYEFLCTKSAKIVDGPDPENIILILKTQSILFNRHKEDLQPY 	                                                            
						KYAGYPMLIRTITMETSDDLLFSKESPLLPAATELAFHTVNCSALNAEELRRENGLEVLQ 	                                                            
						EAFSRCVAVLTRASKPSDMSVQVCGYISKCYSVAAQFEECREKITEMPSIIKDLCRVLYF 	                                                            
						GKSIPRVAALGVECVSSFAVDFWLQTHLFQAGILWYLLGFLFNYDYTLEESGIQKSEETN 	                                                            
						QQEVANSLAKLSVHALSRLGGYLAEEQATPENPTIRKSLAGMLTPYVARKLAVASVTEIL 	                                                            
						KMLNSNTESPYLIWNNSTRAELLEFLESQQENMIKKGDCDKTYGSEFVYSDHAKELIVGE 	                                                            
						IFVRVYNEVPTFQLEVPKAFAASLLDYIGSQAQYLHTFMAITHAAKVESEQHGDRLPRVE 	                                                            
						MALEALRNVIKYNPGSESECIGHFKLIFSLLRVHGAGQVQQLALEVVNIVTSNQDCVNNI 	                                                            
						AESMVLSS                                                     	                                                            
						about 95% homologous to the sequence of F09582_P5.3.An       	                                                            
						isolated polypeptide encoding for a tail of F09582_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VSPSLLTGSSPLHLRSGL in   	                                                            
						F09582_P5.                                                   	                                                            

15628	HMR136_F09586_4_tr0_r1_1_gPRT		Comparison report between F09586_P4 and Q96MD2partial WT     	Sequence name: Q96MD2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F09586_P4, comprising a first amino acid        	                                                            
						MEIADFYEKMYTLSTQKFINAEELVGLLDAIMKKYSSRFHHPILSPLESSFQLEVDVLCH 	Alignment of: 15628 x Q96MD2   ..                            
						LLKAQAQVSEWKFLPSLVNLHSAHTKLQTWGQIFEKQRETKKHLFGGQSQKAVQPPHLFL 	                                                            
						WLMKLKNMLLAKFSFYFHEALSRQTTASEMKTLTAKANPDFFGKISSFIRKYDAANVSLI 	Alignment segment 1/1:                                       
						FDNRGSESFQGHGYHHPHSYREAPKGVDQYPAVVSLPSDRPVMHWPNVIMIMTDRTSDLN 	                                                            
						SLEKVVHFYDDKVQSTYFLTRPEPHFTIVIIFESKKSERDSHFISFLNEVSLALKNPKVF 	                     Quality: 3067.00                      Escore:       0                                               
						ASLKPGSKG                                                    	             Matching length:     309                Total length:     309                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 137 - 445 of Q96MD2, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 309 of F09586_P4.                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEIADFYEKMYTLSTQKFINAEELVGLLDAIMKKYSSRFHHPILSPLESS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     137 MEIADFYEKMYTLSTQKFINAEELVGLLDAIMKKYSSRFHHPILSPLESS 186                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FQLEVDVLCHLLKAQAQVSEWKFLPSLVNLHSAHTKLQTWGQIFEKQRET 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     187 FQLEVDVLCHLLKAQAQVSEWKFLPSLVNLHSAHTKLQTWGQIFEKQRET 236                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KKHLFGGQSQKAVQPPHLFLWLMKLKNMLLAKFSFYFHEALSRQTTASEM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     237 KKHLFGGQSQKAVQPPHLFLWLMKLKNMLLAKFSFYFHEALSRQTTASEM 286                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KTLTAKANPDFFGKISSFIRKYDAANVSLIFDNRGSESFQGHGYHHPHSY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 KTLTAKANPDFFGKISSFIRKYDAANVSLIFDNRGSESFQGHGYHHPHSY 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 REAPKGVDQYPAVVSLPSDRPVMHWPNVIMIMTDRTSDLNSLEKVVHFYD 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 REAPKGVDQYPAVVSLPSDRPVMHWPNVIMIMTDRTSDLNSLEKVVHFYD 386                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DKVQSTYFLTRPEPHFTIVIIFESKKSERDSHFISFLNEVSLALKNPKVF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     387 DKVQSTYFLTRPEPHFTIVIIFESKKSERDSHFISFLNEVSLALKNPKVF 436                                                          
						                                                            	                                                             
						                                                            	     301 ASLKPGSKG                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     437 ASLKPGSKG                                          445                                                          

						Comparison report between F09586_P4 and Q8IYA0partial WT     	Sequence name: Q8IYA0                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F09586_P4, comprising a first amino 	Sequence documentation:                                      
						MEIADFYEKMYTLSTQKFINAEELVGLLDAIMKKYSSRFHHPILSPLESSFQLEVDVLCH 	                                                            
						LLKAQAQVSEWKFLPSLVNLHSAHTKLQTWGQIFEKQRETKKHLFGGQSQKAVQPPHLFL 	Alignment of: 15628 x Q8IYA0   ..                            
						WLMKLKNMLLAKFSFYFHEALSRQTTASEMKTLTAKANPDFFGKISSFIRKYDAANVSLI 	                                                            
						FDNRGSES                                                     	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 137 - 324 of Q8IYA0, which also corresponds to	                     Quality: 3051.00                      Escore:       0                                               
						amino acids 1 - 188 of F09586_P4, a bridging amino acid F    	             Matching length:     309                Total length:     309                                               
						corresponding to amino acid 189 of F09586_P4, and a second   	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						QGHGYHHPHSYREAPKGVDQYPAVVSLPSDRPVMHWPNVIMIMTDRTSDLNSLEKVVHFY 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						DDKVQSTYFLTRPEPHFTIVIIFESKKSERDSHFISFLNEVSLALKNPKVFASLKPGSKG 	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 326 - 445 of Q8IYA0, which also 	Alignment:                                                   
						corresponds to amino acids 190 - 309 of F09586_P4, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	       1 MEIADFYEKMYTLSTQKFINAEELVGLLDAIMKKYSSRFHHPILSPLESS 50                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	     137 MEIADFYEKMYTLSTQKFINAEELVGLLDAIMKKYSSRFHHPILSPLESS 186                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FQLEVDVLCHLLKAQAQVSEWKFLPSLVNLHSAHTKLQTWGQIFEKQRET 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     187 FQLEVDVLCHLLKAQAQVSEWKFLPSLVNLHSAHTKLQTWGQIFEKQRET 236                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KKHLFGGQSQKAVQPPHLFLWLMKLKNMLLAKFSFYFHEALSRQTTASEM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     237 KKHLFGGQSQKAVQPPHLFLWLMKLKNMLLAKFSFYFHEALSRQTTASEM 286                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KTLTAKANPDFFGKISSFIRKYDAANVSLIFDNRGSESFQGHGYHHPHSY 200                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||| |||||||||||  
						                                                            	     287 KTLTAKANPDFFGKISSFIRKYDAANVSLIFDNRGSESSQGHGYHHPHSY 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 REAPKGVDQYPAVVSLPSDRPVMHWPNVIMIMTDRTSDLNSLEKVVHFYD 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 REAPKGVDQYPAVVSLPSDRPVMHWPNVIMIMTDRTSDLNSLEKVVHFYD 386                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DKVQSTYFLTRPEPHFTIVIIFESKKSERDSHFISFLNEVSLALKNPKVF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     387 DKVQSTYFLTRPEPHFTIVIIFESKKSERDSHFISFLNEVSLALKNPKVF 436                                                          
						                                                            	                                                             
						                                                            	     301 ASLKPGSKG                                          309                                                          
						                                                            	         |||||||||                                           
						                                                            	     437 ASLKPGSKG                                          445                                                          

15720	HMR136_F09597_5_tr0_r1_1_gPRT		Comparison report between F09597_P5 and DBP_HUMANpartial WT  	Sequence name: DBP_HUMAN                                     
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F09597_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MARPVSDRTPAPLLLGGPAGTPPGGGALLGLRSLLQGTSKPKEPASC corresponding	Alignment of: 15720 x DBP_HUMAN   ..                         
						to amino acids 1 - 47 of DBP_HUMAN, which also corresponds to	                                                            
						amino acids 1 - 47 of F09597_P5, and a second amino acid     	Alignment segment 1/1:                                       
						LTSRDTPSPVDPDTVEVLMTFEPDPADLALSSIPGHETFDPRRHRFSEEELKPQPIMKKA 	                                                            
						RKIQVPEEQKDEKYWSRRYKNNEAAKRSRDARRLKENQISVRAAFLEKENALLRQEVVAV 	                     Quality: 1734.00                      Escore:       0                                               
						RQELSHYRAVLSRYQAQHGAL                                        	             Matching length:     188                Total length:     325                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 185 - 325 of DBP_HUMAN, which also corresponds to	    Total Percent Similarity:   57.85      Total Percent Identity:   57.85                                               
						amino acids 48 - 188 of F09597_P5, wherein said first amino  	                        Gaps:       1                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated chimeric polypeptide 	Alignment:                                                   
						encoding for an edge portion of F09597_P5, comprising a      	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	       1 MARPVSDRTPAPLLLGGPAGTPPGGGALLGLRSLLQGTSKPKEPASC... 47                                                           
						10 amino acids in length, optionally at least about 20 amino 	         |||||||||||||||||||||||||||||||||||||||||||||||     
						acids in length, preferably at least about 30 amino acids in 	       1 MARPVSDRTPAPLLLGGPAGTPPGGGALLGLRSLLQGTSKPKEPASCLLK 50                                                           
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      47 .................................................. 47                                                           
						length, wherein at least two amino acids comprise CL, having 	                                                            
						a structure as follows: a sequence starting from any of amino	      51 EKERKAALPAATTPGPGLETAGPADAPAGAVVGGGSPRGRPGPVPAPGLL 100                                                          
						acid numbers 47-x to 48; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 48+ ((n-2) - x), in which x varies from 0 to n-2.    	      47 .................................................. 47                                                           
						                                                            	                                                            
						                                                            	     101 APLLWERTLPFGDVEYVDLDAFLLEHGLPPSPPPPGGPSPEPSPARTPAP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      48 ..................................LTSRDTPSPVDPDTVE 63                                                           
						                                                            	                                           ||||||||||||||||  
						                                                            	     151 SPGPGSCGSASPRSSPGHAPARAALGTASGHRAGLTSRDTPSPVDPDTVE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      64 VLMTFEPDPADLALSSIPGHETFDPRRHRFSEEELKPQPIMKKARKIQVP 113                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VLMTFEPDPADLALSSIPGHETFDPRRHRFSEEELKPQPIMKKARKIQVP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     114 EEQKDEKYWSRRYKNNEAAKRSRDARRLKENQISVRAAFLEKENALLRQE 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEQKDEKYWSRRYKNNEAAKRSRDARRLKENQISVRAAFLEKENALLRQE 300                                                          
						                                                            	                  .         .                                
						                                                            	     164 VVAVRQELSHYRAVLSRYQAQHGAL                          188                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     301 VVAVRQELSHYRAVLSRYQAQHGAL                          325                                                          

15913	HMR136_F09598_4_tr0_r1_1_gPRT		Comparison report between F09598_P4 and Q9BVG9partial WT     	Sequence name: Q9BVG9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09598_P4, comprising a first amino 	Sequence documentation:                                      
						MRRGERRDAGGPRPESPVPAGRASLEEPPDGPSAGQATGPGEGRRSTESEVYDDGTNTFF 	                                                            
						WRAHTLTVLFILTCTLGYVTLLEETPQDTAYNTKRGIVASILVFLCFGVTQAKDGPFSRP 	Alignment of: 15913 x Q9BVG9   ..                            
						HPAYWRFWLCVSVVYELFLIFILFQTVQDGRQFLKYVDPKLGVPLPERDYGGNCLIYDPD 	                                                            
						NETDPFHNIWDKLDGFVPAHFLGWYLKTLMIRDWWMCMIISVMFEFLEYSLEHQLPNFSE 	Alignment segment 1/1:                                       
						CWWDHWIMDVLVCNGLGIYCGMKTLEWLSLKTYKWQGLWNIPTYKGKMKRIAFQFTPYSW 	                                                            
						VRFEWKPASSLRRWLAVCGIILVFLLAELNTFYLKFVLWMPPEHYLVLLRLVFFVNVGGV 	                     Quality: 3781.00                      Escore:       0                                               
						AMREIYDFMDDP                                                 	             Matching length:     372                Total length:     372                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 372 of Q9BVG9, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 372 of F09598_P4, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence AGPSAPSWRSPGPSGASSCGTSH corresponding to 	       1 MRRGERRDAGGPRPESPVPAGRASLEEPPDGPSAGQATGPGEGRRSTESE 50                                                           
						amino acids 373 - 395 of F09598_P4, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	       1 MRRGERRDAGGPRPESPVPAGRASLEEPPDGPSAGQATGPGEGRRSTESE 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a tail of F09598_P4, comprising a polypeptide being at   	      51 VYDDGTNTFFWRAHTLTVLFILTCTLGYVTLLEETPQDTAYNTKRGIVAS 100                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      51 VYDDGTNTFFWRAHTLTVLFILTCTLGYVTLLEETPQDTAYNTKRGIVAS 100                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						AGPSAPSWRSPGPSGASSCGTSH in F09598_P4.                        	     101 ILVFLCFGVTQAKDGPFSRPHPAYWRFWLCVSVVYELFLIFILFQTVQDG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ILVFLCFGVTQAKDGPFSRPHPAYWRFWLCVSVVYELFLIFILFQTVQDG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RQFLKYVDPKLGVPLPERDYGGNCLIYDPDNETDPFHNIWDKLDGFVPAH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RQFLKYVDPKLGVPLPERDYGGNCLIYDPDNETDPFHNIWDKLDGFVPAH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FLGWYLKTLMIRDWWMCMIISVMFEFLEYSLEHQLPNFSECWWDHWIMDV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FLGWYLKTLMIRDWWMCMIISVMFEFLEYSLEHQLPNFSECWWDHWIMDV 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LVCNGLGIYCGMKTLEWLSLKTYKWQGLWNIPTYKGKMKRIAFQFTPYSW 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LVCNGLGIYCGMKTLEWLSLKTYKWQGLWNIPTYKGKMKRIAFQFTPYSW 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VRFEWKPASSLRRWLAVCGIILVFLLAELNTFYLKFVLWMPPEHYLVLLR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VRFEWKPASSLRRWLAVCGIILVFLLAELNTFYLKFVLWMPPEHYLVLLR 350                                                          
						                                                            	                  .         .                                
						                                                            	     351 LVFFVNVGGVAMREIYDFMDDP                             372                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     351 LVFFVNVGGVAMREIYDFMDDP                             372                                                          

16210	HMR136_F09621_6_tr0_r1_1_gPRT		Comparison report between F09621_P6 and Q9UJ93partial WT     	Sequence name: Q9UJ93                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09621_P6, comprising a first amino 	Sequence documentation:                                      
						MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSP 	                                                            
						GLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCE 	Alignment of: 16210 x Q9UJ93   ..                            
						QRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGG 	                                                            
						IPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQ 	Alignment segment 1/1:                                       
						SRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 	                                                            
						APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDV 	                     Quality: 6676.00                      Escore:       0                                               
						NSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAF 	             Matching length:     676                Total length:     676                                               
						LGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PANISREETREVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 	                        Gaps:       0                        
						RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWGCNWCVWQHLC 	                                                            
						THKASCDAGPMVASHQ                                             	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 676 of Q9UJ93, which also corresponds to  	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						amino acids 1 - 676 of F09621_P6, and a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						SPLVSPDPPARGGPSPSPPTAPKALATPAPDTLPVEPGAPSTATASDISPGASPSLLSPW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GPWAGSGSISSPGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSE 	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						VAAVPPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELPEADEWT 	                  .         .         .         .         .  
						GGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGLWELEEATLGASSCPCV 	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						ESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAM 	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						PQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLG 	                  .         .         .         .         .  
						QHVQDVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHD 	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						FAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CETSPRPTPATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQN 	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						LDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETFEEPCHVNSSQLITCRTPALPGLPED 	                  .         .         .         .         .  
						PWVRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLD 	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						LAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYRWVQPDVAGLGQVVGSG 	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						WTGKGQTGPGVRKHSL                                             	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 677 - 1532  	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						of F09621_P6, wherein said first amino acid sequence and     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						F09621_P6, comprising a polypeptide being at least 70%,      	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						SPLVSPDPPARGGPSPSPPTAPKALATPAPDTLPVEPGAPSTATASDISPGASPSLLSPW 	                  .         .         .         .         .  
						GPWAGSGSISSPGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSE 	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						VAAVPPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELPEADEWT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGLWELEEATLGASSCPCV 	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						ESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQ 	                  .         .         .         .         .  
						CHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAM 	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						PQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QHVQDVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHD 	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						FAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLR 	                  .         .         .         .         .  
						CETSPRPTPATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQN 	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						LDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETFEEPCHVNSSQLITCRTPALPGLPED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PWVRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLD 	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						LAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNL 	                  .         .         .         .         .  
						RFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYRWVQPDVAGLGQVVGSG 	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						WTGKGQTGPGVRKHSL                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in F09621_P6.     	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						                                                            	                  .         .                                
						                                                            	     651 CNWCVWQHLCTHKASCDAGPMVASHQ                         676                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     651 CNWCVWQHLCTHKASCDAGPMVASHQ                         676                                                          

						Comparison report between F09621_P6 and Q9UIV7partial WT     	Sequence name: Q9UIV7                                        
						sequence followed by mismatch, featuring a skipped exon and a	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for F09621_P6, comprising a first amino acid        	                                                            
						MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSP 	Alignment of: 16210 x Q9UIV7   ..                            
						GLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCE 	                                                            
						QRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGG 	Alignment segment 1/1:                                       
						IPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQ 	                                                            
						SRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 	                     Quality: 14661.00                      Escore:       0                                              
						APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDV 	             Matching length:    1500                Total length:    1512                                               
						NSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.93                                               
						LGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVA 	    Total Percent Similarity:   99.21      Total Percent Identity:   99.14                                               
						SCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMS 	                        Gaps:       1                        
						PANISREETREVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 	                                                            
						RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWGCNWCVWQHLC 	Alignment:                                                   
						THKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKALATPAPDTLPVEPGAPSTAT 	                  .         .         .         .         .  
						ASDISPGASPSLLSPWGPWAGSGSISSPGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRP 	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						SATPEDLLASPLSPSEVAAVPPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WLTREGGELPEADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLE 	                  .         .         .         .         .  
						VVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLY 	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						DCSVGHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGA 	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						TAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 	                  .         .         .         .         .  
						DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPT 	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						KSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQP                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						amino acids 1 - 1296 of Q9UIV7, which also corresponds to    	                  .         .         .         .         .  
						amino acids 1 - 1296 of F09621_P6, a bridging amino acid S   	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						corresponding to amino acid 1297 of F09621_P6, a second amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to QGLGRRRRVVPET	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						corresponding to amino acids 1298 - 1310 of Q9UIV7, which    	                  .         .         .         .         .  
						also corresponds to amino acids 1298 - 1310 of F09621_P6, a  	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						FEEPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVE 	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						QPLPRHHALREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLAL 	                  .         .         .         .         .  
						GVIIIVLMYR                                                   	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1323 - 1512 of Q9UIV7, which    	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						also corresponds to amino acids 1311 - 1500 of F09621_P6, and	                  .         .         .         .         .  
						a fourth amino acid sequence being at least 70%, optionally  	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						at least 80%, preferably at least 85%, more preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90% and most preferably at least 95% homologous to a   	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						polypeptide having the sequence                              	                  .         .         .         .         .  
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL corresponding to amino acids	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						1501 - 1532 of F09621_P6, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid, second amino acid sequence,   	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated chimeric  	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						polypeptide encoding for an edge portion of F09621_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise TF, having a structure as follows: a sequence       	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						starting from any of amino acid numbers 1310-x to 1311; and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 1311+ ((n-2) - x), in    	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						which x varies from 0 to n-2.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of F09621_P6, comprising a polypeptide   	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL in F09621_P6.               	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 CNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKA 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 CNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAV 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 PPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELP 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 PPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 EADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 EADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 ECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLF 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 ECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLF 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 LRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 LRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQ 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 DVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGR 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 DVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGR 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 GVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 GVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTL 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTL 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 DPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGL 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||:|||  
						                                                            	    1251 DPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPNQGL 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 GRRRRVVPET............FEEPCHVNSSQLITCRTPALPGLPEDPW 1338                                                         
						                                                            	         ||||||||||            ||||||||||||||||||||||||||||  
						                                                            	    1301 GRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPGLPEDPW 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1339 VRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVF 1388                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 VRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVF 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1389 SVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHA 1438                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 SVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1439 LREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLL 1488                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 LREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLL 1500                                                         
						                                                            	                  .                                          
						                                                            	    1489 ALGVIIIVLMYR                                       1500                                                         
						                                                            	         ||||||||||||                                        
						                                                            	    1501 ALGVIIIVLMYR                                       1512                                                         

						Comparison report between F09621_P6 and O43157partial WT     	Sequence name: O43157                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09621_P6, comprising a first amino acid sequence being at   	                                                            
						MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSP 	Alignment of: 16210 x O43157   ..                            
						GLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCE 	                                                            
						QRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGG 	Alignment segment 1/1:                                       
						IPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQ 	                                                            
						SRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 	                     Quality: 14670.00                      Escore:       0                                              
						APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDV 	             Matching length:    1500                Total length:    1512                                               
						NSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVA 	    Total Percent Similarity:   99.21      Total Percent Identity:   99.21                                               
						SCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMS 	                        Gaps:       1                        
						PANISREETREVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 	                                                            
						RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWGCNWCVWQHLC 	Alignment:                                                   
						THKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKALATPAPDTLPVEPGAPSTAT 	                  .         .         .         .         .  
						ASDISPGASPSLLSPWGPWAGSGSISSPGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRP 	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						SATPEDLLASPLSPSEVAAVPPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WLTREGGELPEADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLE 	                  .         .         .         .         .  
						VVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLY 	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						DCSVGHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGA 	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						TAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 	                  .         .         .         .         .  
						DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPT 	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						KSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPET           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 -    	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						1310 of O43157, which also corresponds to amino acids 1 -    	                  .         .         .         .         .  
						1310 of F09621_P6, a second amino acid sequence being at     	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						FEEPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVE 	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						QPLPRHHALREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLAL 	                  .         .         .         .         .  
						GVIIIVLMYR                                                   	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						least 90 % homologous to corresponding to amino acids 1323 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1512 of O43157, which also corresponds to amino acids 1311 - 	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						1500 of F09621_P6, and a third amino acid sequence being at  	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL corresponding to amino acids	                  .         .         .         .         .  
						1501 - 1532 of F09621_P6, wherein said first amino acid      	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						F09621_P6, comprising a polypeptide having a length "n",     	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TF, having a structure as  	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						1310-x to 1311; and ending at any of amino acid numbers 1311+	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of F09621_P6, comprising a   	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL in          	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						F09621_P6.                                                   	                  .         .         .         .         .  
						                                                            	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 CNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKA 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 CNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKA 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 TGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAV 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 TGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 PPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELP 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 PPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 EADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 EADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 ECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLF 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 ECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLF 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 LRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 LRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQ 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 DVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGR 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 DVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGR 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 GVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 GVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTL 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTL 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 DPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGL 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 DPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGL 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 GRRRRVVPET............FEEPCHVNSSQLITCRTPALPGLPEDPW 1338                                                         
						                                                            	         ||||||||||            ||||||||||||||||||||||||||||  
						                                                            	    1301 GRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPGLPEDPW 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1339 VRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVF 1388                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 VRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVF 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1389 SVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHA 1438                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 SVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1439 LREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLL 1488                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 LREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLL 1500                                                         
						                                                            	                  .                                          
						                                                            	    1489 ALGVIIIVLMYR                                       1500                                                         
						                                                            	         ||||||||||||                                        
						                                                            	    1501 ALGVIIIVLMYR                                       1512                                                         

						Comparison report between F09621_P6 and Q9UJ92partial WT     	Sequence name: Q9UJ92                                        
						sequence followed by unique insertion, featuring a skipped   	                                                            
						exon and a followed by a unique tail.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for F09621_P6, comprising a first amino 	                                                            
						MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSP 	Alignment of: 16210 x Q9UJ92   ..                            
						GLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCE 	                                                            
						QRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGG 	Alignment segment 1/1:                                       
						IPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQ 	                                                            
						SRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 	                     Quality: 12776.00                      Escore:       0                                              
						APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDV 	             Matching length:    1317                Total length:    1512                                               
						NSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVA 	    Total Percent Similarity:   87.10      Total Percent Identity:   87.10                                               
						SCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMS 	                        Gaps:       2                        
						PANISREETREVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 	                                                            
						RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWGCNWCVWQHLC 	Alignment:                                                   
						THKASCDAGPMVASHQSPLVSPDPPAR                                  	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						to amino acids 1 - 687 of Q9UJ92, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 687 of F09621_P6, a second amino acid        	       1 MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLG 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGPSPSPPTAPKALATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISS 	      51 ATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQL 100                                                          
						PGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAVPPADPGP 	                  .         .         .         .         .  
						EALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELPEADEWTGGDAPAFSTST 	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						LLS                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 688 - 870 of	     101 LLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAV 150                                                          
						F09621_P6, a third amino acid sequence being at least 90 %   	                  .         .         .         .         .  
						GDGDSAELEGPPAPLILPSSLDYQYDTPGLWELEEATLGASSCPCVESVQGSTLMPVHVE 	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						REIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 	     151 STVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSY 200                                                          
						CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAG 	                  .         .         .         .         .  
						VPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPA 	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						RGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPTPATLPV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVV 	     201 EETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSR 250                                                          
						SRMLQPSQGLGRRRRVVPET                                         	                  .         .         .         .         .  
						homologous to corresponding to amino acids 688 - 1127 of     	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						Q9UJ92, which also corresponds to amino acids 871 - 1310 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09621_P6, a fourth amino acid sequence being at least 90 %  	     251 VCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSA 300                                                          
						FEEPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQP 	                  .         .         .         .         .  
						LNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVE 	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						QPLPRHHALREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVIIIVLMYR                                                   	     301 APPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDG 350                                                          
						homologous to corresponding to amino acids 1140 - 1329 of    	                  .         .         .         .         .  
						Q9UJ92, which also corresponds to amino acids 1311 - 1500 of 	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						F09621_P6, and a fifth amino acid sequence being at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     351 TEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEW 400                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1501 - 1532 of F09621_P6, wherein said first amino acid      	     401 PGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQG 450                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .         .         .         .  
						sequence, fourth amino acid sequence and fifth amino acid    	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     451 SAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCG 500                                                          
						F09621_P6, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGPSPSPPTAPKALATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISS 	     501 WCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETR 550                                                          
						PGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAVPPADPGP 	                  .         .         .         .         .  
						EALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELPEADEWTGGDAPAFSTST 	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						LLS,                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     551 EVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLP 600                                                          
						corresponding to F09621_P6.3.An isolated chimeric polypeptide	                  .         .         .         .         .  
						encoding for an edge portion of F09621_P6, comprising a      	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     601 RGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWG 650                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     651 CNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKA 700                                                          
						length and most preferably at least about 50 amino acids in  	         |||||||||||||||||||||||||||||||||||||               
						length, wherein at least two amino acids comprise TF, having 	     651 CNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPAR............. 687                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 1310-x to 1311; and ending at any of amino acid 	     701 LATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGS 750                                                          
						numbers 1311+ ((n-2) - x), in which x varies from 0 to       	                                                            
						n-2.4.An isolated polypeptide encoding for a tail of         	     687 .................................................. 687                                                          
						F09621_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     751 TGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAV 800                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	     687 .................................................. 687                                                          
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL in F09621_P6.               	                  .         .         .         .         .  
						                                                            	     801 PPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELP 850                                                          
						                                                            	                                                            
						                                                            	     687 .................................................. 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 EADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGL 900                                                          
						                                                            	                             ||||||||||||||||||||||||||||||  
						                                                            	     688 ....................GDGDSAELEGPPAPLILPSSLDYQYDTPGL 717                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     718 WELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDN 767                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 ECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLF 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     768 ECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLF 817                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 LRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     818 LRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPR 867                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQ 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     868 CVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQ 917                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 DVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGR 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     918 DVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGR 967                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 GVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     968 GVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVG 1017                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTL 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1018 DQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTL 1067                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 DPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGL 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1068 DPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGL 1117                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 GRRRRVVPET............FEEPCHVNSSQLITCRTPALPGLPEDPW 1338                                                         
						                                                            	         ||||||||||            ||||||||||||||||||||||||||||  
						                                                            	    1118 GRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPGLPEDPW 1167                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1339 VRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVF 1388                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1168 VRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVF 1217                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1389 SVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHA 1438                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1218 SVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHA 1267                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1439 LREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLL 1488                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1268 LREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLL 1317                                                         
						                                                            	                  .                                          
						                                                            	    1489 ALGVIIIVLMYR                                       1500                                                         
						                                                            	         ||||||||||||                                        
						                                                            	    1318 ALGVIIIVLMYR                                       1329                                                         

16212	HMR136_F09621_7_tr0_r1_1_gPRT		Comparison report between F09621_P7 and Q9UIV7partial WT     	Sequence name: Q9UIV7                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09621_P7, comprising a first amino acid sequence being at   	                                                            
						MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQCHVTCQQH 	Alignment of: 16212 x Q9UIV7   ..                            
						QLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWC 	                                                            
						EGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQDVLG 	Alignment segment 1/1:                                       
						MVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKV 	                                                            
						HSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 	                     Quality: 5777.00                      Escore:       0                                               
						PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQNLDVVQTPR 	             Matching length:     588                Total length:     588                                               
						IRVTVVSRMLQP                                                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						least 90 % homologous to corresponding to amino acids 925 -  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						1296 of Q9UIV7, which also corresponds to amino acids 1 - 372	                        Gaps:       0                        
						of F09621_P7, a bridging amino acid S corresponding to amino 	                                                            
						acid 373 of F09621_P7, a second amino acid sequence being at 	Alignment:                                                   
						QGLGRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPGLPEDPWVRVEFIL 	                  .         .         .         .         .  
						DNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVV 	       1 MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPD 50                                                           
						AMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGHVQY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR                          	     925 MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPD 974                                                          
						least 90 % homologous to corresponding to amino acids 1298 - 	                  .         .         .         .         .  
						1512 of Q9UIV7, which also corresponds to amino acids 374 -  	      51 TQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSV 100                                                          
						588 of F09621_P7, and a third amino acid sequence being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	     975 TQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSV 1024                                                         
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     101 GHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHS 150                                                          
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL corresponding to amino acids	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						589 - 620 of F09621_P7, wherein said first amino acid        	    1025 GHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHS 1074                                                         
						sequence, bridging amino acid, second amino acid sequence and	                  .         .         .         .         .  
						third amino acid sequence are contiguous and in a sequential 	     151 VEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSS 200                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09621_P7, comprising a polypeptide being at least 70%,      	    1075 VEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSS 1124                                                         
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     201 SLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPR 250                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL in F09621_P7.               	    1125 SLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPR 1174                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1175 AGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 1224                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1225 PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRG 1274                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFE 400                                                          
						                                                            	         ||||||||||||||||||||||:|||||||||||||||||||||||||||  
						                                                            	    1275 QNLDVVQTPRIRVTVVSRMLQPNQGLGRRRRVVPETACSLGPSCSSQQFE 1324                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSY 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1325 EPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSY 1374                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1375 EADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGP 1424                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 CVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGH 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1425 CVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGH 1474                                                         
						                                                            	                  .         .         .                      
						                                                            	     551 VQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             588                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1475 VQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             1512                                                         

						Comparison report between F09621_P7 and O43157partial WT     	Sequence name: O43157                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09621_P7, comprising a first amino 	Sequence documentation:                                      
						MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQCHVTCQQH 	                                                            
						QLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWC 	Alignment of: 16212 x O43157   ..                            
						EGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQDVLG 	                                                            
						MVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKV 	Alignment segment 1/1:                                       
						HSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 	                                                            
						PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQNLDVVQTPR 	                     Quality: 5786.00                      Escore:       0                                               
						IRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPG 	             Matching length:     588                Total length:     588                                               
						LPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 925 - 1512 of O43157, which also corresponds  	Alignment:                                                   
						to amino acids 1 - 588 of F09621_P7, and a second amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPD 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     925 MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPD 974                                                          
						having the sequence WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL         	                  .         .         .         .         .  
						corresponding to amino acids 589 - 620 of F09621_P7, wherein 	      51 TQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSV 100                                                          
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	     975 TQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSV 1024                                                         
						polypeptide encoding for a tail of F09621_P7, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     101 GHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHS 150                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	    1025 GHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHS 1074                                                         
						to the sequence WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL in          	                  .         .         .         .         .  
						F09621_P7.                                                   	     151 VEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1075 VEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSS 1124                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1125 SLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPR 1174                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1175 AGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 1224                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1225 PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRG 1274                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1275 QNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFE 1324                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSY 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1325 EPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSY 1374                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1375 EADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGP 1424                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 CVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGH 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1425 CVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGH 1474                                                         
						                                                            	                  .         .         .                      
						                                                            	     551 VQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             588                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1475 VQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             1512                                                         

						Comparison report between F09621_P7 and Q9UJ92partial WT     	Sequence name: Q9UJ92                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09621_P7, comprising a first amino 	Sequence documentation:                                      
						MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQCHVTCQQH 	                                                            
						QLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWC 	Alignment of: 16212 x Q9UJ92   ..                            
						EGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQDVLG 	                                                            
						MVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKV 	Alignment segment 1/1:                                       
						HSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 	                                                            
						PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQNLDVVQTPR 	                     Quality: 5786.00                      Escore:       0                                               
						IRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPG 	             Matching length:     588                Total length:     588                                               
						LPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 742 - 1329 of Q9UJ92, which also corresponds  	Alignment:                                                   
						to amino acids 1 - 588 of F09621_P7, and a second amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	       1 MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPD 50                                                           
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     742 MPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPD 791                                                          
						having the sequence WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL         	                  .         .         .         .         .  
						corresponding to amino acids 589 - 620 of F09621_P7, wherein 	      51 TQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSV 100                                                          
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	     792 TQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSV 841                                                          
						polypeptide encoding for a tail of F09621_P7, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     101 GHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHS 150                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     842 GHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHS 891                                                          
						to the sequence WVQPDVAGLGQVVGSGWTGKGQTGPGVRKHSL in          	                  .         .         .         .         .  
						F09621_P7.                                                   	     151 VEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     892 VEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSS 941                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     942 SLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPR 991                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     992 AGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPT 1041                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1042 PATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRG 1091                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1092 QNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFE 1141                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSY 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1142 EPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSY 1191                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1192 EADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGP 1241                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 CVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGH 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1242 CVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGH 1291                                                         
						                                                            	                  .         .         .                      
						                                                            	     551 VQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             588                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1292 VQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYR             1329                                                         

20321	HMR136_F09690_6_tr0_r1_1_gPRT		Comparison report between F09690_P6 and AAH51790partial WT   	Sequence name: AAH51790                                      
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09690_P6, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to                                     	Alignment of: 20321 x AAH51790   ..                          
						MSEDEEKVKLRRLEPAIQKFIKIVIPTDLERLRKHQINIEK corresponding to   	                                                            
						amino acids 1 - 41 of AAH51790, which also corresponds to    	Alignment segment 1/1:                                       
						amino acids 1 - 41 of F09690_P6, a second amino acid sequence	                                                            
						QLRSNIREIEKLCLKVRKDDLVLLKRMIDPVKEEASAATAEFLQLHLESVEELKKQFNDE 	                     Quality: 1020.00                      Escore:       0                                               
						ETLLQPPLTRSMTVGG                                             	             Matching length:     117                Total length:     139                                               
						being at least 90 % homologous to corresponding to amino     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acids 64 - 139 of AAH51790, which also corresponds to amino  	    Total Percent Similarity:   84.17      Total Percent Identity:   84.17                                               
						acids 42 - 117 of F09690_P6, and a third amino acid sequence 	                        Gaps:       1                        
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	Alignment:                                                   
						AFHTTEAEASSQSLTQIYALPEIPQDQNAAESWETLEADLIELSQLVTDFSLLVNSQQEK 	                  .         .         .         .         .  
						IDSIADHVNSAAVNVEEGTKNLGKAAKYKLAALPVAGALIGGMVGGPIGLLAGFKVAGIA 	       1 MSEDEEKVKLRRLEPAIQKFIKIVIPTDLERLRKHQINIEK......... 41                                                           
						AALGGGVLGFTGGKLIQRKKQKMMEKLTSSCPDLPSQTDKKCS                  	         |||||||||||||||||||||||||||||||||||||||||           
						at least 95% homologous to a polypeptide having the sequence 	       1 MSEDEEKVKLRRLEPAIQKFIKIVIPTDLERLRKHQINIEKYQRCRIWDK 50                                                           
						corresponding to amino acids 118 - 280 of F09690_P6, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence   	      42 .............QLRSNIREIEKLCLKVRKDDLVLLKRMIDPVKEEASA 78                                                           
						and third amino acid sequence are contiguous and in a        	                      |||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated chimeric polypeptide encoding 	      51 LHEEHINAGRTVQQLRSNIREIEKLCLKVRKDDLVLLKRMIDPVKEEASA 100                                                          
						for an edge portion of F09690_P6, comprising a polypeptide   	                  .         .         .                      
						having a length "n", wherein n is at least about 10 amino    	      79 ATAEFLQLHLESVEELKKQFNDEETLLQPPLTRSMTVGG            117                                                          
						acids in length, optionally at least about 20 amino acids in 	         |||||||||||||||||||||||||||||||||||||||             
						length, preferably at least about 30 amino acids in length,  	     101 ATAEFLQLHLESVEELKKQFNDEETLLQPPLTRSMTVGG            139                                                          
						more preferably at least about 40 amino acids in length and  	                                                            
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise KQ, having a       	                                                            
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 41-x to 42; and ending at any of amino acid     	                                                            
						numbers 42+ ((n-2) - x), in which x varies from 0 to n-2.3.An	                                                            
						isolated polypeptide encoding for a tail of F09690_P6,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						AFHTTEAEASSQSLTQIYALPEIPQDQNAAESWETLEADLIELSQLVTDFSLLVNSQQEK 	                                                            
						IDSIADHVNSAAVNVEEGTKNLGKAAKYKLAALPVAGALIGGMVGGPIGLLAGFKVAGIA 	                                                            
						AALGGGVLGFTGGKLIQRKKQKMMEKLTSSCPDLPSQTDKKCS                  	                                                            
						about 95% homologous to the sequence in F09690_P6.           	                                                            

						Comparison report between F09690_P6 and Q8N3G0unique head    	Sequence name: Q8N3G0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09690_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 20321 x Q8N3G0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSEDEEKVKLRRLEPAIQKFIKIVIPTDLERLRKHQINIEKQLRSNIREIEKLCLKVRKD 	Alignment segment 1/1:                                       
						DLVLLKRMIDPVKEEASAATAEFLQLHLESVEELKKQFNDEETLLQPPLTRSMTVGGAFH 	                                                            
						TTEAE                                                        	                     Quality: 1473.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 125 of  	             Matching length:     158                Total length:     158                                               
						F09690_P6, and a second amino acid sequence being at least 90	 Matching Percent Similarity:   99.37   Matching Percent Identity:   99.37                                               
						ASSQSLTQIYALPEIPQDQNAAESWETLEADLIELSQLVTDFSLLVNSQQEKIDSIADHV 	    Total Percent Similarity:   99.37      Total Percent Identity:   99.37                                               
						NSAAVNVEEGTKNLGKAAKYKLAALPVAGALIGGMVGGPIGLLAGFKVAGIAAALGGGVL 	                        Gaps:       0                        
						GFTGGKLIQRKKQKMMEKLTSSCPDLPSQTDKKCS                          	                                                            
						% homologous to corresponding to amino acids 5 - 159 of      	Alignment:                                                   
						Q8N3G0, which also corresponds to amino acids 126 - 280 of   	                  .         .         .         .         .  
						F09690_P6, wherein said first amino acid sequence and second 	     123 EAEASSQSLTQIYALPEIPQDQNAAESWETLEADLIELSQLVTDFSLLVN 172                                                          
						amino acid sequence are contiguous and in a sequential       	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       2 EAVASSQSLTQIYALPEIPQDQNAAESWETLEADLIELSQLVTDFSLLVN 51                                                           
						F09690_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     173 SQQEKIDSIADHVNSAAVNVEEGTKNLGKAAKYKLAALPVAGALIGGMVG 222                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSEDEEKVKLRRLEPAIQKFIKIVIPTDLERLRKHQINIEKQLRSNIREIEKLCLKVRKD 	      52 SQQEKIDSIADHVNSAAVNVEEGTKNLGKAAKYKLAALPVAGALIGGMVG 101                                                          
						DLVLLKRMIDPVKEEASAATAEFLQLHLESVEELKKQFNDEETLLQPPLTRSMTVGGAFH 	                  .         .         .         .         .  
						TTEAE                                                        	     223 GPIGLLAGFKVAGIAAALGGGVLGFTGGKLIQRKKQKMMEKLTSSCPDLP 272                                                          
						least about 95% homologous to the sequence of F09690_P6.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     102 GPIGLLAGFKVAGIAAALGGGVLGFTGGKLIQRKKQKMMEKLTSSCPDLP 151                                                          
						                                                            	                                                             
						                                                            	     273 SQTDKKCS                                           280                                                          
						                                                            	         ||||||||                                            
						                                                            	     152 SQTDKKCS                                           159                                                          

24831	HMR136_F09709_6_tr0_r1_1_gPRT		Comparison report between F09709_P6 and Q8NHV5unique head    	Sequence name: Q8NHV5                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09709_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24831 x Q8NHV5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MDKLTIISGCLFLAADIFAIASIANPDWINTGESAG corresponding to amino  	                                                            
						acids 1 - 36 of F09709_P6, a second amino acid sequence being	                     Quality:  692.00                      Escore:       0                                               
						ALTVGLVRQCQTIHGRDRTCIPPRLPPEWVTTLFFIIMGIISLTVTCGLLVASHWRREAT 	             Matching length:      70                Total length:      70                                               
						KYARWIAFTG                                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						at least 90 % homologous to corresponding to amino acids 14 -	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						83 of Q8NHV5, which also corresponds to amino acids 37 - 106 	                        Gaps:       0                        
						of F09709_P6, and a third amino acid sequence being at least 	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence SK           	      37 ALTVGLVRQCQTIHGRDRTCIPPRLPPEWVTTLFFIIMGIISLTVTCGLL 86                                                           
						corresponding to amino acids 107 - 108 of F09709_P6, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	      14 ALTVGLVRQCQTIHGRDRTCIPPRLPPEWVTTLFFIIMGIISLTVTCGLL 63                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .                                
						sequential order.2.An isolated polypeptide encoding for a    	      87 VASHWRREATKYARWIAFTG                               106                                                          
						head of F09709_P6, comprising a polypeptide being at least   	         ||||||||||||||||||||                                
						70%, optionally at least about 80%, preferably at least about	      64 VASHWRREATKYARWIAFTG                               83                                                           
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MDKLTIISGCLFLAADIFAIASIANPDWINTGESAG of F09709_P6.           	                                                            

7752	HMR136_F09734_2_tr0_r1_1_gPRT		Comparison report between F09734_P2 and Q9Y2E8unique head    	Sequence name: Q9Y2E8                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for F09734_P2,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 7752 x Q9Y2E8   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence MTIFFSLLV    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 9 of F09734_P2, a second    	                                                            
						LGILMGAVIKIIEFKKLANWKEEEMFRPNMFFLLLLPPIIFESGYSLHKGNFFQNIGSIT 	                     Quality: 4542.00                      Escore:       0                                               
						LFAVFGTAISAFVVGGGIYFLGQADVISKLNMTDSFAFGSLISAVDPVATIAIFNALHVD 	             Matching length:     480                Total length:     486                                               
						PVLNMLVFGESILNDAVSIVLTNTAEGLTRKNMSDVSGWQTFLQALDYFLKMFFGSAALG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TLTGLISAL                                                    	    Total Percent Similarity:   98.77      Total Percent Identity:   98.77                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       1                        
						corresponding to amino acids 110 - 298 of Q9Y2E8, which also 	                                                            
						corresponds to amino acids 10 - 198 of F09734_P2, and a third	Alignment:                                                   
						LRKTPSLEFGMMIIFAYLPYGLAEGISLSGIMAILFSGIVMSHYTHHNLSPVTQILMQQT 	                  .         .         .         .         .  
						LRTVAFLCETCVFAFLGLSIFSFPHKFEISFVIWCIVLVLFGRAVNIFPLSYLLNFFRDH 	      10 LGILMGAVIKIIEFKKLANWKEEEMFRPNMFFLLLLPPIIFESGYSLHKG 59                                                           
						KITPKMMFIMWFSGLRGAIPYALSLHLDLEPMEKRQLIGTTTIVIVLFTILLLGGSTMPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IRLMDIEDAKAHRRNKKDVNLSKTEKMGNTVESEHLSELTEEEYEAHYIRRQDLKGFVWL 	     110 LGILMGAVIKIIEFKKLANWKEEEMFRPNMFFLLLLPPIIFESGYSLHKG 159                                                          
						DAKYLNPFFTRRLTQEDLHHGRIQMKTLTNKWYEEVRQGPSGSEDDEQELL          	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      60 NFFQNIGSITLFAVFGTAISAFVVGGGIYFLGQADVISKLNMTDSFAFGS 109                                                          
						corresponding to amino acids 305 - 595 of Q9Y2E8, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 199 - 489 of F09734_P2, wherein   	     160 NFFQNIGSITLFAVFGTAISAFVVGGGIYFLGQADVISKLNMTDSFAFGS 209                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	     110 LISAVDPVATIAIFNALHVDPVLNMLVFGESILNDAVSIVLTNTAEGLTR 159                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of F09734_P2, comprising a polypeptide being at least   	     210 LISAVDPVATIAIFNALHVDPVLNMLVFGESILNDAVSIVLTNTAEGLTR 259                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     160 KNMSDVSGWQTFLQALDYFLKMFFGSAALGTLTGLISAL......LRKTP 203                                                          
						at least about 95% homologous to the sequence MTIFFSLLV of   	         |||||||||||||||||||||||||||||||||||||||      |||||  
						F09734_P2.3.An isolated chimeric polypeptide encoding for an 	     260 KNMSDVSGWQTFLQALDYFLKMFFGSAALGTLTGLISALVLKHIDLRKTP 309                                                          
						edge portion of F09734_P2, comprising a polypeptide having a 	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	     204 SLEFGMMIIFAYLPYGLAEGISLSGIMAILFSGIVMSHYTHHNLSPVTQI 253                                                          
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     310 SLEFGMMIIFAYLPYGLAEGISLSGIMAILFSGIVMSHYTHHNLSPVTQI 359                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     254 LMQQTLRTVAFLCETCVFAFLGLSIFSFPHKFEISFVIWCIVLVLFGRAV 303                                                          
						at least two amino acids comprise LL, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     360 LMQQTLRTVAFLCETCVFAFLGLSIFSFPHKFEISFVIWCIVLVLFGRAV 409                                                          
						198-x to 199; and ending at any of amino acid numbers 199+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     304 NIFPLSYLLNFFRDHKITPKMMFIMWFSGLRGAIPYALSLHLDLEPMEKR 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     410 NIFPLSYLLNFFRDHKITPKMMFIMWFSGLRGAIPYALSLHLDLEPMEKR 459                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     354 QLIGTTTIVIVLFTILLLGGSTMPLIRLMDIEDAKAHRRNKKDVNLSKTE 403                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     460 QLIGTTTIVIVLFTILLLGGSTMPLIRLMDIEDAKAHRRNKKDVNLSKTE 509                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     404 KMGNTVESEHLSELTEEEYEAHYIRRQDLKGFVWLDAKYLNPFFTRRLTQ 453                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     510 KMGNTVESEHLSELTEEEYEAHYIRRQDLKGFVWLDAKYLNPFFTRRLTQ 559                                                          
						                                                            	                  .         .         .                      
						                                                            	     454 EDLHHGRIQMKTLTNKWYEEVRQGPSGSEDDEQELL               489                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     560 EDLHHGRIQMKTLTNKWYEEVRQGPSGSEDDEQELL               595                                                          

7754	HMR136_F09734_4_tr0_r1_1_gPRT		Comparison report between F09734_P4 and Q9Y2E8partial WT     	Sequence name: Q9Y2E8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F09734_P4, comprising a first amino acid        	                                                            
						MLVFGESILNDAVSIVLTNTAEGLTRKNMSDVSGWQTFLQALDYFLKMFFGSAALGTLTG 	Alignment of: 7754 x Q9Y2E8   ..                             
						LISALVLKHIDLRKTPSLEFGMMIIFAYLPYGLAEGISLSGIMAILFSGIVMSHYTHHNL 	                                                            
						SPVTQILMQQTLRTVAFLCETCVFAFLGLSIFSFPHKFEISFVIWCIVLVLFGRAVNIFP 	Alignment segment 1/1:                                       
						LSYLLNFFRDHKITPKMMFIMWFSGLRGAIPYALSLHLDLEPMEKRQLIGTTTIVIVLFT 	                                                            
						ILLLGGSTMPLIRLMDIEDAKAHRRNKKDVNLSKTEKMGNTVESEHLSELTEEEYEAHYI 	                     Quality: 3520.00                      Escore:       0                                               
						RRQDLKGFVWLDAKYLNPFFTRRLTQEDLHHGRIQMKTLTNKWYEEVRQGPSGSEDDEQE 	             Matching length:     362                Total length:     362                                               
						LL                                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 234 - 595 of Q9Y2E8, which also corresponds to   	                        Gaps:       0                        
						amino acids 1 - 362 of F09734_P4.                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLVFGESILNDAVSIVLTNTAEGLTRKNMSDVSGWQTFLQALDYFLKMFF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 MLVFGESILNDAVSIVLTNTAEGLTRKNMSDVSGWQTFLQALDYFLKMFF 283                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GSAALGTLTGLISALVLKHIDLRKTPSLEFGMMIIFAYLPYGLAEGISLS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     284 GSAALGTLTGLISALVLKHIDLRKTPSLEFGMMIIFAYLPYGLAEGISLS 333                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GIMAILFSGIVMSHYTHHNLSPVTQILMQQTLRTVAFLCETCVFAFLGLS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     334 GIMAILFSGIVMSHYTHHNLSPVTQILMQQTLRTVAFLCETCVFAFLGLS 383                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IFSFPHKFEISFVIWCIVLVLFGRAVNIFPLSYLLNFFRDHKITPKMMFI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     384 IFSFPHKFEISFVIWCIVLVLFGRAVNIFPLSYLLNFFRDHKITPKMMFI 433                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 MWFSGLRGAIPYALSLHLDLEPMEKRQLIGTTTIVIVLFTILLLGGSTMP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     434 MWFSGLRGAIPYALSLHLDLEPMEKRQLIGTTTIVIVLFTILLLGGSTMP 483                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LIRLMDIEDAKAHRRNKKDVNLSKTEKMGNTVESEHLSELTEEEYEAHYI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     484 LIRLMDIEDAKAHRRNKKDVNLSKTEKMGNTVESEHLSELTEEEYEAHYI 533                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RRQDLKGFVWLDAKYLNPFFTRRLTQEDLHHGRIQMKTLTNKWYEEVRQG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     534 RRQDLKGFVWLDAKYLNPFFTRRLTQEDLHHGRIQMKTLTNKWYEEVRQG 583                                                          
						                                                            	                  .                                          
						                                                            	     351 PSGSEDDEQELL                                       362                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     584 PSGSEDDEQELL                                       595                                                          

7750	HMR136_F09734_5_tr0_r1_1_gPRT		Comparison report between F09734_P5 and Q9Y2E8partial WT     	Sequence name: Q9Y2E8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F09734_P5, comprising a first amino acid        	                                                            
						MAILFSGIVMSHYTHHNLSPVTQILMQQTLRTVAFLCETCVFAFLGLSIFSFPHKFEISF 	Alignment of: 7750 x Q9Y2E8   ..                             
						VIWCIVLVLFGRAVNIFPLSYLLNFFRDHKITPKMMFIMWFSGLRGAIPYALSLHLDLEP 	                                                            
						MEKRQLIGTTTIVIVLFTILLLGGSTMPLIRLMDIEDAKAHRRNKKDVNLSKTEKMGNTV 	Alignment segment 1/1:                                       
						ESEHLSELTEEEYEAHYIRRQDLKGFVWLDAKYLNPFFTRRLTQEDLHHGRIQMKTLTNK 	                                                            
						WYEEVRQGPSGSEDDEQELL                                         	                     Quality: 2560.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     260                Total length:     260                                               
						amino acids 336 - 595 of Q9Y2E8, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 260 of F09734_P5.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAILFSGIVMSHYTHHNLSPVTQILMQQTLRTVAFLCETCVFAFLGLSIF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     336 MAILFSGIVMSHYTHHNLSPVTQILMQQTLRTVAFLCETCVFAFLGLSIF 385                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 SFPHKFEISFVIWCIVLVLFGRAVNIFPLSYLLNFFRDHKITPKMMFIMW 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     386 SFPHKFEISFVIWCIVLVLFGRAVNIFPLSYLLNFFRDHKITPKMMFIMW 435                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FSGLRGAIPYALSLHLDLEPMEKRQLIGTTTIVIVLFTILLLGGSTMPLI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     436 FSGLRGAIPYALSLHLDLEPMEKRQLIGTTTIVIVLFTILLLGGSTMPLI 485                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RLMDIEDAKAHRRNKKDVNLSKTEKMGNTVESEHLSELTEEEYEAHYIRR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     486 RLMDIEDAKAHRRNKKDVNLSKTEKMGNTVESEHLSELTEEEYEAHYIRR 535                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QDLKGFVWLDAKYLNPFFTRRLTQEDLHHGRIQMKTLTNKWYEEVRQGPS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     536 QDLKGFVWLDAKYLNPFFTRRLTQEDLHHGRIQMKTLTNKWYEEVRQGPS 585                                                          
						                                                            	                  .                                          
						                                                            	     251 GSEDDEQELL                                         260                                                          
						                                                            	         ||||||||||                                          
						                                                            	     586 GSEDDEQELL                                         595                                                          

7748	HMR136_F09734_9_tr0_r1_1_gPRT		Comparison report between F09734_P9 and Q9Y2E8unique head    	Sequence name: Q9Y2E8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09734_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7748 x Q9Y2E8   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MTIFFSLLV    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 9 of F09734_P9, a second    	                                                            
						LGILMGAVIKIIEFKKLANWKEEEMFRPNMFFLLLLPPIIFESGYSLHKGNFFQNIGSIT 	                     Quality:  799.00                      Escore:       0                                               
						LFAVFGTAISAFVVGGGIYFLGQ                                      	             Matching length:      83                Total length:      83                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 110 - 192 of Q9Y2E8, which also 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 10 - 92 of F09734_P9, and a third 	                        Gaps:       0                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence                                          	      10 LGILMGAVIKIIEFKKLANWKEEEMFRPNMFFLLLLPPIIFESGYSLHKG 59                                                           
						FCVWLPNICCRSSGHYCHFQCTSCGPRAQHAGLWRKYSQRCSLHCSDQASWPSFSQAS   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 93 - 150 of F09734_P9, wherein  	     110 LGILMGAVIKIIEFKKLANWKEEEMFRPNMFFLLLLPPIIFESGYSLHKG 159                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .                      
						and third amino acid sequence are contiguous and in a        	      60 NFFQNIGSITLFAVFGTAISAFVVGGGIYFLGQ                  92                                                           
						sequential order.2.An isolated polypeptide encoding for a    	         |||||||||||||||||||||||||||||||||                   
						head of F09734_P9, comprising a polypeptide being at least   	     160 NFFQNIGSITLFAVFGTAISAFVVGGGIYFLGQ                  192                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence MTIFFSLLV of   	                                                            
						F09734_P9.3.An isolated polypeptide encoding for a tail of   	                                                            
						F09734_P9, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						FCVWLPNICCRSSGHYCHFQCTSCGPRAQHAGLWRKYSQRCSLHCSDQASWPSFSQAS in	                                                            
						F09734_P9.                                                   	                                                            

10680	HMR136_F09771_11_tr0_r1_1_gPRT		Comparison report between F09771_P11 and Q96SU8partial WT    	Sequence name: Q96SU8                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F09771_P11, comprising a first amino	Sequence documentation:                                      
						MNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEAAEQSYRTAIK 	                                                            
						HRRKYPDCYYNLGRLYADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAE 	Alignment of: 10680 x Q96SU8   ..                            
						AVGREALELIPNDHSLMFSLANVLGKSQ                                 	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 257 - 404 of Q96SU8, which also corresponds to	                                                            
						amino acids 1 - 148 of F09771_P11, a bridging amino acid K   	                     Quality: 2169.00                      Escore:       0                                               
						corresponding to amino acid 149 of F09771_P11, and a second  	             Matching length:     223                Total length:     223                                               
						YKESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISLQLDPTASGTKENYG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.55                                               
						LLRRKLELMQKKAV                                               	    Total Percent Similarity:  100.00      Total Percent Identity:   99.55                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 406 - 479 of Q96SU8, which also 	                                                            
						corresponds to amino acids 150 - 223 of F09771_P11, wherein  	Alignment:                                                   
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEA 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 MNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEA 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AEQSYRTAIKHRRKYPDCYYNLGRLYADLNRHVDALNAWRNATVLKPEHS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 AEQSYRTAIKHRRKYPDCYYNLGRLYADLNRHVDALNAWRNATVLKPEHS 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LAWNNMIILLDNTGNLAQAEAVGREALELIPNDHSLMFSLANVLGKSQKY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||:|  
						                                                            	     357 LAWNNMIILLDNTGNLAQAEAVGREALELIPNDHSLMFSLANVLGKSQEY 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISLQLDPT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 KESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISLQLDPT 456                                                          
						                                                            	                  .         .                                
						                                                            	     201 ASGTKENYGLLRRKLELMQKKAV                            223                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     457 ASGTKENYGLLRRKLELMQKKAV                            479                                                          

10676	HMR136_F09771_17_tr0_r1_1_gPRT		Comparison report between F09771_P17 and Q8WV63partial WT    	Sequence name: Q8WV63                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09771_P17, comprising a first amino	Sequence documentation:                                      
						MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNGGLLFRMTLLT 	                                                            
						SGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVNYNYYYSLNAWLLLCPWWLCF 	Alignment of: 10676 x Q8WV63   ..                            
						DWSMGCIPLIKSISDWRVIALAALWFCLIGLICQALCSEDGHKRRILTLGLGFLVIPFLP 	                                                            
						ASNLFFRVGFVVAERVLYLPSVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRC 	Alignment segment 1/1:                                       
						VLRSGEWRSEEQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 	                                                            
						AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEAAEQSYRTAI 	                     Quality: 3676.00                      Escore:       0                                               
						KHRRKYPDCYYNLGRL                                             	             Matching length:     376                Total length:     376                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 376 of Q8WV63, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 376 of F09771_P17, and a second amino acid   	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						YADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAEAVGREALELIPNDHS 	       1 MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNG 50                                                           
						LMFSLANVLGKSQKYKVRKPQAVSSCS                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 377 - 463 of	       1 MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNG 50                                                           
						F09771_P17, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      51 GLLFRMTLLTSGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVN 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09771_P17, comprising a polypeptide being at least 70%,     	      51 GLLFRMTLLTSGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVN 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 YNYYYSLNAWLLLCPWWLCFDWSMGCIPLIKSISDWRVIALAALWFCLIG 150                                                          
						YADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAEAVGREALELIPNDHS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LMFSLANVLGKSQKYKVRKPQAVSSCS                                  	     101 YNYYYSLNAWLLLCPWWLCFDWSMGCIPLIKSISDWRVIALAALWFCLIG 150                                                          
						least about 95% homologous to the sequence in F09771_P17.    	                  .         .         .         .         .  
						                                                            	     151 LICQALCSEDGHKRRILTLGLGFLVIPFLPASNLFFRVGFVVAERVLYLP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LICQALCSEDGHKRRILTLGLGFLVIPFLPASNLFFRVGFVVAERVLYLP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRCVLRSGEWRSE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRCVLRSGEWRSE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFE 350                                                          
						                                                            	                  .         .                                
						                                                            	     351 AAEQSYRTAIKHRRKYPDCYYNLGRL                         376                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     351 AAEQSYRTAIKHRRKYPDCYYNLGRL                         376                                                          

10678	HMR136_F09771_18_tr0_r1_1_gPRT		Comparison report between F09771_P18 and Q96SU8partial WT    	Sequence name: Q96SU8                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F09771_P18, comprising a first amino	Sequence documentation:                                      
						MNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEAAEQSYRTAIK 	                                                            
						HRRKYPDCYYNLGRLYADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAE 	Alignment of: 10678 x Q96SU8   ..                            
						AVGREALELIPNDHSLMFSLANVLGKSQ                                 	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 257 - 404 of Q96SU8, which also corresponds to	                                                            
						amino acids 1 - 148 of F09771_P18, a bridging amino acid K   	                     Quality: 2169.00                      Escore:       0                                               
						corresponding to amino acid 149 of F09771_P18, and a second  	             Matching length:     223                Total length:     223                                               
						YKESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISLQLDPTASGTKENYG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.55                                               
						LLRRKLELMQKKAV                                               	    Total Percent Similarity:  100.00      Total Percent Identity:   99.55                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 406 - 479 of Q96SU8, which also 	                                                            
						corresponds to amino acids 150 - 223 of F09771_P18, wherein  	Alignment:                                                   
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEA 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 MNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEA 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AEQSYRTAIKHRRKYPDCYYNLGRLYADLNRHVDALNAWRNATVLKPEHS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 AEQSYRTAIKHRRKYPDCYYNLGRLYADLNRHVDALNAWRNATVLKPEHS 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LAWNNMIILLDNTGNLAQAEAVGREALELIPNDHSLMFSLANVLGKSQKY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||:|  
						                                                            	     357 LAWNNMIILLDNTGNLAQAEAVGREALELIPNDHSLMFSLANVLGKSQEY 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISLQLDPT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 KESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISLQLDPT 456                                                          
						                                                            	                  .         .                                
						                                                            	     201 ASGTKENYGLLRRKLELMQKKAV                            223                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     457 ASGTKENYGLLRRKLELMQKKAV                            479                                                          

10682	HMR136_F09771_6_tr0_r1_1_gPRT		Comparison report between F09771_P6 and Q8WV63partial WT     	Sequence name: Q8WV63                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09771_P6, comprising a first amino 	Sequence documentation:                                      
						MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNGGLLFRMTLLT 	                                                            
						SGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVNYNYYYSLNAWLLLCPWWLCF 	Alignment of: 10682 x Q8WV63   ..                            
						DWSMGCIPLIKSISDWRVIALAALWFCLIGLICQALCSEDGHKRRILTLGLGFLVIPFLP 	                                                            
						ASNLFFRVGFVVAERVLYLPSVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRC 	Alignment segment 1/1:                                       
						VLRSGEWRSEEQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 	                                                            
						AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEAAEQSYRTAI 	                     Quality: 3676.00                      Escore:       0                                               
						KHRRKYPDCYYNLGRL                                             	             Matching length:     376                Total length:     376                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 376 of Q8WV63, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 376 of F09771_P6, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						YADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAEAVGREALELIPNDHS 	       1 MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNG 50                                                           
						LMFSLANVLGKSQKYKESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLDPTASGTKENYGLLRRKLELMQKKAV                                 	       1 MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNG 50                                                           
						having the sequence corresponding to amino acids 377 - 524 of	                  .         .         .         .         .  
						F09771_P6, wherein said first amino acid sequence and second 	      51 GLLFRMTLLTSGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVN 100                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	      51 GLLFRMTLLTSGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVN 100                                                          
						F09771_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     101 YNYYYSLNAWLLLCPWWLCFDWSMGCIPLIKSISDWRVIALAALWFCLIG 150                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAEAVGREALELIPNDHS 	     101 YNYYYSLNAWLLLCPWWLCFDWSMGCIPLIKSISDWRVIALAALWFCLIG 150                                                          
						LMFSLANVLGKSQKYKESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISL 	                  .         .         .         .         .  
						QLDPTASGTKENYGLLRRKLELMQKKAV                                 	     151 LICQALCSEDGHKRRILTLGLGFLVIPFLPASNLFFRVGFVVAERVLYLP 200                                                          
						least about 95% homologous to the sequence in F09771_P6.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LICQALCSEDGHKRRILTLGLGFLVIPFLPASNLFFRVGFVVAERVLYLP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRCVLRSGEWRSE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRCVLRSGEWRSE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFE 350                                                          
						                                                            	                  .         .                                
						                                                            	     351 AAEQSYRTAIKHRRKYPDCYYNLGRL                         376                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     351 AAEQSYRTAIKHRRKYPDCYYNLGRL                         376                                                          

10674	HMR136_F09771_7_tr0_r1_1_gPRT		Comparison report between F09771_P7 and Q8WV63unique head    	Sequence name: Q8WV63                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09771_P7, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10674 x Q8WV63   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MVDVFSVLFGGLQYTSKGRRLHLAPRASLLAALLFAVHPVHTECGNKEGAHSSTFWVLLS 	Alignment segment 1/1:                                       
						IFLGAVA                                                      	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 3676.00                      Escore:       0                                               
						to amino acids 1 - 67 of F09771_P7, a second amino acid      	             Matching length:     376                Total length:     376                                               
						MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNGGLLFRMTLLT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVNYNYYYSLNAWLLLCPWWLCF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DWSMGCIPLIKSISDWRVIALAALWFCLIGLICQALCSEDGHKRRILTLGLGFLVIPFLP 	                        Gaps:       0                        
						ASNLFFRVGFVVAERVLYLPSVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRC 	                                                            
						VLRSGEWRSEEQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 	Alignment:                                                   
						AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFEAAEQSYRTAI 	                  .         .         .         .         .  
						KHRRKYPDCYYNLGRL                                             	      68 MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNG 117                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 376 of Q8WV63, which also corresponds to     	       1 MLCKEQGITVLGLNAVFDILVIGKFNVLEIVQKVLHKDKSLENLGMLRNG 50                                                           
						amino acids 68 - 443 of F09771_P7, and a third amino acid    	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     118 GLLFRMTLLTSGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVN 167                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 GLLFRMTLLTSGGAGMLYVRWRIMGTGPPAFTEVDNPASFADSMLVRAVN 100                                                          
						YADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAEAVGREALELIPNDHS 	                  .         .         .         .         .  
						LMFSLANVLGKSQKYKESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISL 	     168 YNYYYSLNAWLLLCPWWLCFDWSMGCIPLIKSISDWRVIALAALWFCLIG 217                                                          
						QLDPTASGTKENYGLLRRKLELMQKKAV                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 444 - 591 of	     101 YNYYYSLNAWLLLCPWWLCFDWSMGCIPLIKSISDWRVIALAALWFCLIG 150                                                          
						F09771_P7, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     218 LICQALCSEDGHKRRILTLGLGFLVIPFLPASNLFFRVGFVVAERVLYLP 267                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of F09771_P7, comprising a   	     151 LICQALCSEDGHKRRILTLGLGFLVIPFLPASNLFFRVGFVVAERVLYLP 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     268 SVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRCVLRSGEWRSE 317                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MVDVFSVLFGGLQYTSKGRRLHLAPRASLLAALLFAVHPVHTECGNKEGAHSSTFWVLLS 	     201 SVGYCVLLTFGFGALSKHTKKKKLIAAVVLGILFINTLRCVLRSGEWRSE 250                                                          
						IFLGAVA                                                      	                  .         .         .         .         .  
						to the sequence of F09771_P7.3.An isolated polypeptide       	     318 EQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 367                                                          
						encoding for a tail of F09771_P7, comprising a polypeptide   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     251 EQLFRSALSVCPLNAKVHYNIGKNLADKGNQTAAIRYYREAVRLNPKYVH 300                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						YADLNRHVDALNAWRNATVLKPEHSLAWNNMIILLDNTGNLAQAEAVGREALELIPNDHS 	     368 AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFE 417                                                          
						LMFSLANVLGKSQKYKESEALFLKAIKANPNAASYHGNLAVLYHRWGHLDLAKKHYEISL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLDPTASGTKENYGLLRRKLELMQKKAV                                 	     301 AMNNLGNILKERNELQEAEELLSLAVQIQPDFAAAWMNLGIVQNSLKRFE 350                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .                                
						in F09771_P7.                                                	     418 AAEQSYRTAIKHRRKYPDCYYNLGRL                         443                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     351 AAEQSYRTAIKHRRKYPDCYYNLGRL                         376                                                          

13746	HMR136_F09786_13_tr0_r1_1_gPRT		Comparison report between F09786_P13 and SKB1_HUMANpartial   	Sequence name: SKB1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F09786_P13, comprising a first amino	                                                            
						MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVPLVAPEDLRDD 	Alignment of: 13746 x SKB1_HUMAN   ..                        
						IIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVALEIGADLPSNHVIDRWLGEPI 	                                                            
						KAAILPTSIFLTNKKGFPVLSKMHQRLIFRLLKLEVQFIITGTNHHSEKEFCSYLQYLEY 	Alignment segment 1/1:                                       
						LSQNRPPPNAYELFAKGYEDYLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLL 	                                                            
						DRVPEEEKDTNVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 	                     Quality: 5320.00                      Escore:       0                                               
						EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHFLKDDGVSIPG 	             Matching length:     531                Total length:     531                                               
						EYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRLHNFHQLSAPQPCFTFSHPNR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DPMIDNNRYCTLEFPVEVNTVLHGFAGYFETVLYQDITLSIRPETHSPGMFSWFPILFPI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KQPITVREGQTICVRFWRCSNSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL          	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 107 - 637 of SKB1_HUMAN, which also           	Alignment:                                                   
						corresponds to amino acids 1 - 531 of F09786_P13.            	                  .         .         .         .         .  
						                                                            	       1 MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     107 MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVP 156                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LVAPEDLRDDIIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVAL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 LVAPEDLRDDIIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVAL 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EIGADLPSNHVIDRWLGEPIKAAILPTSIFLTNKKGFPVLSKMHQRLIFR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 EIGADLPSNHVIDRWLGEPIKAAILPTSIFLTNKKGFPVLSKMHQRLIFR 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLKLEVQFIITGTNHHSEKEFCSYLQYLEYLSQNRPPPNAYELFAKGYED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 LLKLEVQFIITGTNHHSEKEFCSYLQYLEYLSQNRPPPNAYELFAKGYED 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLLDRVPEEEKDT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 YLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLLDRVPEEEKDT 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 NVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHF 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LKDDGVSIPGEYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 LKDDGVSIPGEYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRL 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 HNFHQLSAPQPCFTFSHPNRDPMIDNNRYCTLEFPVEVNTVLHGFAGYFE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 HNFHQLSAPQPCFTFSHPNRDPMIDNNRYCTLEFPVEVNTVLHGFAGYFE 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TVLYQDITLSIRPETHSPGMFSWFPILFPIKQPITVREGQTICVRFWRCS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 TVLYQDITLSIRPETHSPGMFSWFPILFPIKQPITVREGQTICVRFWRCS 606                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 NSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL                    531                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     607 NSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL                    637                                                          

13750	HMR136_F09786_17_tr0_r1_1_gPRT		Comparison report between F09786_P17 and SKB1_HUMANpartial   	Sequence name: SKB1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F09786_P17, comprising a first amino	                                                            
						MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVPLVAPEDLRDD 	Alignment of: 13750 x SKB1_HUMAN   ..                        
						IIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVALEIGADLPSNHVIDRWLGEPI 	                                                            
						KAAILPTSIFLTNKKGFPVLSKMHQRLIFRLLKLEVQFIITGTNHHSEKEFCSYLQYLEY 	Alignment segment 1/1:                                       
						LSQNRPPPNAYELFAKGYEDYLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLL 	                                                            
						DRVPEEEKDTNVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 	                     Quality: 5320.00                      Escore:       0                                               
						EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHFLKDDGVSIPG 	             Matching length:     531                Total length:     531                                               
						EYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRLHNFHQLSAPQPCFTFSHPNR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DPMIDNNRYCTLEFPVEVNTVLHGFAGYFETVLYQDITLSIRPETHSPGMFSWFPILFPI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KQPITVREGQTICVRFWRCSNSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL          	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 107 - 637 of SKB1_HUMAN, which also           	Alignment:                                                   
						corresponds to amino acids 1 - 531 of F09786_P17.            	                  .         .         .         .         .  
						                                                            	       1 MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     107 MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVP 156                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LVAPEDLRDDIIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVAL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 LVAPEDLRDDIIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVAL 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EIGADLPSNHVIDRWLGEPIKAAILPTSIFLTNKKGFPVLSKMHQRLIFR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 EIGADLPSNHVIDRWLGEPIKAAILPTSIFLTNKKGFPVLSKMHQRLIFR 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLKLEVQFIITGTNHHSEKEFCSYLQYLEYLSQNRPPPNAYELFAKGYED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 LLKLEVQFIITGTNHHSEKEFCSYLQYLEYLSQNRPPPNAYELFAKGYED 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLLDRVPEEEKDT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 YLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLLDRVPEEEKDT 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 NVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHF 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LKDDGVSIPGEYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 LKDDGVSIPGEYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRL 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 HNFHQLSAPQPCFTFSHPNRDPMIDNNRYCTLEFPVEVNTVLHGFAGYFE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 HNFHQLSAPQPCFTFSHPNRDPMIDNNRYCTLEFPVEVNTVLHGFAGYFE 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TVLYQDITLSIRPETHSPGMFSWFPILFPIKQPITVREGQTICVRFWRCS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 TVLYQDITLSIRPETHSPGMFSWFPILFPIKQPITVREGQTICVRFWRCS 606                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 NSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL                    531                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     607 NSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL                    637                                                          

13744	HMR136_F09786_18_tr0_r1_1_gPRT		Comparison report between F09786_P18 and SKB1_HUMANpartial   	Sequence name: SKB1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for F09786_P18, comprising a first amino	                                                            
						MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVPLVAPEDLRDD 	Alignment of: 13744 x SKB1_HUMAN   ..                        
						IIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVALEIGADLPSNHVIDRWLGEPI 	                                                            
						KAAILPTSIFLTNKKGFPVLSKMHQRLIFRLLKLEVQFIITGTNHHSEKEFCSYLQYLEY 	Alignment segment 1/1:                                       
						LSQNRPPPNAYELFAKGYEDYLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLL 	                                                            
						DRVPEEEKDTNVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 	                     Quality: 5320.00                      Escore:       0                                               
						EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHFLKDDGVSIPG 	             Matching length:     531                Total length:     531                                               
						EYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRLHNFHQLSAPQPCFTFSHPNR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DPMIDNNRYCTLEFPVEVNTVLHGFAGYFETVLYQDITLSIRPETHSPGMFSWFPILFPI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KQPITVREGQTICVRFWRCSNSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL          	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 107 - 637 of SKB1_HUMAN, which also           	Alignment:                                                   
						corresponds to amino acids 1 - 531 of F09786_P18.            	                  .         .         .         .         .  
						                                                            	       1 MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     107 MLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSMFWMRVP 156                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LVAPEDLRDDIIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVAL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 LVAPEDLRDDIIENAPTTHTEEYSGEEKTWMWWHNFRTLCDYSKRIAVAL 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EIGADLPSNHVIDRWLGEPIKAAILPTSIFLTNKKGFPVLSKMHQRLIFR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 EIGADLPSNHVIDRWLGEPIKAAILPTSIFLTNKKGFPVLSKMHQRLIFR 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLKLEVQFIITGTNHHSEKEFCSYLQYLEYLSQNRPPPNAYELFAKGYED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 LLKLEVQFIITGTNHHSEKEFCSYLQYLEYLSQNRPPPNAYELFAKGYED 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLLDRVPEEEKDT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 YLQSPLQPLMDNLESQTYEVFEKDPIKYSQYQQAIYKCLLDRVPEEEKDT 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 NVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 NVQVLMVLGAGRGPLVNASLRAAKQADRRIKLYAVEKNPNAVVTLENWQF 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 EEWGSQVTVVSSDMREWVAPEKADIIVSELLGSFADNELSPECLDGAQHF 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LKDDGVSIPGEYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 LKDDGVSIPGEYTSFLAPISSSKLYNEVRACREKDRDPEAQFEMPYVVRL 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 HNFHQLSAPQPCFTFSHPNRDPMIDNNRYCTLEFPVEVNTVLHGFAGYFE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 HNFHQLSAPQPCFTFSHPNRDPMIDNNRYCTLEFPVEVNTVLHGFAGYFE 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 TVLYQDITLSIRPETHSPGMFSWFPILFPIKQPITVREGQTICVRFWRCS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 TVLYQDITLSIRPETHSPGMFSWFPILFPIKQPITVREGQTICVRFWRCS 606                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 NSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL                    531                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     607 NSKKVWYEWAVTAPVCSAIHNPTGRSYTIGL                    637                                                          

13748	HMR136_F09786_28_tr0_r1_1_gPRT		Comparison report between F09786_P28 and SKB1_HUMANpartial   	Sequence name: SKB1_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for F09786_P28, comprising a   	Sequence documentation:                                      
						MAAMAVGGAGGSRVSSGRDLNCVPEIADTLGAVAKQGFDFLCMPVFHPRFKREFIQEPAK 	                                                            
						NRPGPQTRSDLLLSGRDWNTLIVGKLSPWIRPDSKVEKIRRNSEAAMLQELNFGAYLGLP 	Alignment of: 13748 x SKB1_HUMAN   ..                        
						AFLLPLNQEDNTNLARVLTNHIHTGHHSSM                               	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 150 of SKB1_HUMAN, which    	                                                            
						also corresponds to amino acids 1 - 150 of F09786_P28, and a 	                     Quality: 1473.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     150                Total length:     150                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence V corresponding to amino     	                        Gaps:       0                        
						acids 151 - 151 of F09786_P28, wherein said first amino acid 	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.                                          	                  .         .         .         .         .  
						                                                            	       1 MAAMAVGGAGGSRVSSGRDLNCVPEIADTLGAVAKQGFDFLCMPVFHPRF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAAMAVGGAGGSRVSSGRDLNCVPEIADTLGAVAKQGFDFLCMPVFHPRF 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KREFIQEPAKNRPGPQTRSDLLLSGRDWNTLIVGKLSPWIRPDSKVEKIR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 KREFIQEPAKNRPGPQTRSDLLLSGRDWNTLIVGKLSPWIRPDSKVEKIR 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RNSEAAMLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSM 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RNSEAAMLQELNFGAYLGLPAFLLPLNQEDNTNLARVLTNHIHTGHHSSM 150                                                          

16604	HMR136_F09800_11_tr0_r1_1_gPRT		Comparison report between F09800_P11 and Q9HBY5unique head   	Sequence name: Q9HBY5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09800_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16604 x Q9HBY5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						LLPARARPFLPGVQSSGSRPPEPGAERAGRGRPAAAAKPGVRQRPWFPRRRRAPEPRDAS 	Alignment segment 1/1:                                       
						AGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDL 	                                                            
						CHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQP 	                     Quality: 3859.00                      Escore:       0                                               
						KYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYE 	             Matching length:     390                Total length:     390                                               
						AEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDES 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGN 	                        Gaps:       0                        
						INLTELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKL 	                                                            
						KSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELE 	Alignment:                                                   
						QEIEKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKF 	                  .         .         .         .         .  
						GDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSP 	    1645 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 1694                                                         
						SEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKQLDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCR 	       1 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 50                                                           
						HEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVR 	                  .         .         .         .         .  
						GLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEA 	    1695 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 1744                                                         
						QFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQ 	      51 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 100                                                          
						ILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKA 	                  .         .         .         .         .  
						TCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQG 	    1745 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 1794                                                         
						EQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEAS 	     101 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 150                                                          
						VEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLK 	                  .         .         .         .         .  
						MLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKK 	    1795 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 1844                                                         
						MEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTI 	     151 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 200                                                          
						QTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILV 	                  .         .         .         .         .  
						KQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEE 	    1845 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 1894                                                         
						DSISNLKLGTLNGSQEEMWQKTET                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     201 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 250                                                          
						to amino acids 1 - 1644 of F09800_P11, a second amino acid   	                  .         .         .         .         .  
						VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQRLTEMLCQ 	    1895 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 1944                                                         
						KEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAELSEVKIQTHIVQQENHLLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSLLEHRI 	     251 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 300                                                          
						ATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALK 	                  .         .         .         .         .  
						QEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 	    1945 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 1994                                                         
						TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKRECDQFQKEQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PANRKVSQMNSLEQELETIHLENEGLKKKQ                               	     301 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 350                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .            
						amino acids 1 - 390 of Q9HBY5, which also corresponds to     	    1995 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQ           2034                                                         
						amino acids 1645 - 2034 of F09800_P11, and a third amino acid	         ||||||||||||||||||||||||||||||||||||||||            
						sequence being at least 70%, optionally at least 80%,        	     351 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQ           390                                                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence NSVVGSSREGCSSLPEIVCEDAAPEVHCDA           	                                                            
						corresponding to amino acids 2035 - 2064 of F09800_P11,      	                                                            
						wherein said first amino acid sequence, second amino acid    	                                                            
						sequence and third amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of F09800_P11, comprising a polypeptide being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						LLPARARPFLPGVQSSGSRPPEPGAERAGRGRPAAAAKPGVRQRPWFPRRRRAPEPRDAS 	                                                            
						AGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDL 	                                                            
						CHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQP 	                                                            
						KYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYE 	                                                            
						AEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGL 	                                                            
						QNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDES 	                                                            
						GRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGN 	                                                            
						INLTELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKL 	                                                            
						KSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELE 	                                                            
						QEIEKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKF 	                                                            
						GDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSP 	                                                            
						SEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHY 	                                                            
						EKQLDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCR 	                                                            
						HEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVR 	                                                            
						GLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEA 	                                                            
						QFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELL 	                                                            
						KETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQ 	                                                            
						ILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKA 	                                                            
						TCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQG 	                                                            
						EQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFF 	                                                            
						GNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEAS 	                                                            
						VEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLK 	                                                            
						MLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKK 	                                                            
						MEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLE 	                                                            
						IEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTI 	                                                            
						QTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILV 	                                                            
						KQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEE 	                                                            
						DSISNLKLGTLNGSQEEMWQKTET                                     	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F09800_P11.3.An isolated polypeptide encoding for a tail of  	                                                            
						F09800_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						NSVVGSSREGCSSLPEIVCEDAAPEVHCDA in F09800_P11.                	                                                            

						Comparison report between F09800_P11 and Q9HCK7unique head   	Sequence name: Q9HCK7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion, with a short unique insertion and a featuring a   	Sequence documentation:                                      
						skipped exon.1.An isolated chimeric polypeptide encoding for 	                                                            
						F09800_P11, comprising a first amino acid sequence being at  	Alignment of: 16604 x Q9HCK7   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						LLPARARPFLPGVQSSGSRPPEPGAERAGRGRPAAAAKPGVRQRPW corresponding 	                     Quality: 12498.00                      Escore:       0                                              
						to amino acids 1 - 46 of F09800_P11, a second amino acid     	             Matching length:    1304                Total length:    2027                                               
						FPRRRRAPEPRDASAGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEARLKELFDSFDT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TGTGSLGQEELTDLCHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNE 	    Total Percent Similarity:   64.33      Total Percent Identity:   64.33                                               
						EHFQEPDCSLEAQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGD 	                        Gaps:       3                        
						CSEHWKTQRSEEYEAEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHL 	                                                            
						NRKKLVSICEQYGLQNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYR 	Alignment:                                                   
						QLKRHLSMQSFDESGRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENS 	                  .         .         .         .         .  
						QEILKALDFSLDGNINLTELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVRE 	      47 FPRRRRAPEPRDASAGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEAR 96                                                           
						KEKLRSDLDKAEKLKSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKERE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QILQQAGKQRLELEQEIEKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTN 	       1 FPRRRRAPEPRDASAGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEAR 50                                                           
						KLQRNLENVLAEKFGDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYR 	                  .         .         .         .         .  
						AQGRVLRLPLKNSPSEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDI 	      97 LKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQQTLLQDNLLGRV 146                                                          
						CCLRLELEDKVRHYEKQLDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAVLKEAHHEATCRHEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFERER 	      51 LKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQQTLLQDNLLGRV 100                                                          
						EGLQSSAWTEEKVRGLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEG    	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     147 HFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVRGGKRYGRRSLPE 196                                                          
						amino acids 1 - 837 of Q9HCK7, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 47 - 883 of F09800_P11, a third amino acid       	     101 HFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVRGGKRYGRRSLPE 150                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     197 FQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEGQLR 246                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REKMETECNRRTSQIEAQFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWE 	     151 FQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEGQLR 200                                                          
						FEKDELTQECAEAQELLKETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDL 	                  .         .         .         .         .  
						EDLRNVSETQQSLLSDQILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQE 	     247 FWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICE 296                                                          
						RQEMMSKLLAMENIHKATCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GEEEVEGDGALSLLQQGEQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLE 	     201 FWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICE 250                                                          
						PGLVMSSCLDEPATEFFGNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTG 	                  .         .         .         .         .  
						TSSVQRQEVKIEESEASVEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASE 	     297 QYGLQNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYR 346                                                          
						KKQDLLFDVSVLKKKLKMLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NKELTAEVFRLQDELKKMEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESV 	     251 QYGLQNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYR 300                                                          
						VQRCDCCLWEASLENLEIEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQ 	                  .         .         .         .         .  
						LLEKVKAHEIAWLHGTIQTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKT 	     347 QLKRHLSMQSFDESGRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILD 396                                                          
						KLQELTRKLKERVTILVKQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELL        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 884 - 1596  	     301 QLKRHLSMQSFDESGRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILD 350                                                          
						of F09800_P11, a fourth amino acid sequence being at least 90	                  .         .         .         .         .  
						% homologous to RYESEKLQQENSILRNEITTLNEEDSISNLKLGTLNGSQEEM   	     397 TWQEEGIENSQEILKALDFSLDGNINLTELTLALENELLVTKNSIHQAAL 446                                                          
						corresponding to amino acids 838 - 879 of Q9HCK7, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 1597 - 1638 of F09800_P11, a fifth	     351 TWQEEGIENSQEILKALDFSLDGNINLTELTLALENELLVTKNSIHQAAL 400                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     447 ASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSLMASEVDDHHAAIE 496                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence W corresponding to amino acids 1639 -    	     401 ASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSLMASEVDDHHAAIE 450                                                          
						1639 of F09800_P11, a sixth amino acid sequence being at     	                  .         .         .         .         .  
						QKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQRLT 	     497 RRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEIEKA 546                                                          
						EMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAELSEVKIQTHIVQQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSL 	     451 RRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEIEKA 500                                                          
						LEHRIATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQE 	                  .         .         .         .         .  
						KEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQE 	     547 KTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVL 596                                                          
						NERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKRECDQF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQ                          	     501 KTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVL 550                                                          
						least 90 % homologous to corresponding to amino acids 880 -  	                  .         .         .         .         .  
						1274 of Q9HCK7, which also corresponds to amino acids 1640 - 	     597 AEKFGDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYR 646                                                          
						2034 of F09800_P11, and a seventh amino acid sequence being  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to NSVVGSSREGCSSLPEIVCEDAAPEVHCDA   	     551 AEKFGDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYR 600                                                          
						corresponding to amino acids 1284 - 1313 of Q9HCK7, which    	                  .         .         .         .         .  
						also corresponds to amino acids 2035 - 2064 of F09800_P11,   	     647 AQGRVLRLPLKNSPSEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIE 696                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, fourth amino acid       	     601 AQGRVLRLPLKNSPSEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIE 650                                                          
						sequence, fifth amino acid sequence, sixth amino acid        	                  .         .         .         .         .  
						sequence and seventh amino acid sequence are contiguous and  	     697 QMKEQHHRDICCLRLELEDKVRHYEKQLDETVVSCKKAQENMKQRHENET 746                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a head of F09800_P11, comprising a polypeptide being at least	     651 QMKEQHHRDICCLRLELEDKVRHYEKQLDETVVSCKKAQENMKQRHENET 700                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     747 HTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEEEKKQLQVKLEEEK 796                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLPARARPFLPGVQSSGSRPPEPGAERAGRGRPAAAAKPGVRQRPW of            	     701 HTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEEEKKQLQVKLEEEK 750                                                          
						F09800_P11.3.An isolated polypeptide encoding for an edge    	                  .         .         .         .         .  
						portion of F09800_P11, comprising an amino acid sequence     	     797 THLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLTQEL 846                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     751 THLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLTQEL 800                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						REKMETECNRRTSQIEAQFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWE 	     847 EQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTS 896                                                          
						FEKDELTQECAEAQELLKETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDL 	         |||||||||||||||||||||||||||||||||||||               
						EDLRNVSETQQSLLSDQILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQE 	     801 EQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEG............. 837                                                          
						RQEMMSKLLAMENIHKATCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVI 	                  .         .         .         .         .  
						GEEEVEGDGALSLLQQGEQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLE 	     897 QIEAQFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEK 946                                                          
						PGLVMSSCLDEPATEFFGNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTG 	                                                            
						TSSVQRQEVKIEESEASVEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASE 	     837 .................................................. 837                                                          
						KKQDLLFDVSVLKKKLKMLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALEN 	                  .         .         .         .         .  
						NKELTAEVFRLQDELKKMEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESV 	     947 DELTQECAEAQELLKETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVER 996                                                          
						VQRCDCCLWEASLENLEIEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQ 	                                                            
						LLEKVKAHEIAWLHGTIQTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKT 	     837 .................................................. 837                                                          
						KLQELTRKLKERVTILVKQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELL,       	                  .         .         .         .         .  
						encoding for corresponding to F09800_P11.4.An isolated       	     997 QQLLQDLEDLRNVSETQQSLLSDQILELKSSHKRELREREEVLCQAGASE 1046                                                         
						polypeptide encoding for an edge portion of F09800_P11,      	                                                            
						comprising an amino acid sequence being at least 70%,        	     837 .................................................. 837                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	    1047 QLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCETADRERAEMSTEI 1096                                                         
						least about 95% homologous to the sequence encoding for W,   	                                                            
						corresponding to F09800_P11.5.An isolated chimeric           	     837 .................................................. 837                                                          
						polypeptide encoding for an edge portion of F09800_P11,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	    1097 SRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQLLEE 1146                                                         
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	     837 .................................................. 837                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	    1147 NGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPA 1196                                                         
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise QN, having a structure as follows: a sequence       	     837 .................................................. 837                                                          
						starting from any of amino acid numbers 2034-x to 2035; and  	                  .         .         .         .         .  
						ending at any of amino acid numbers 2035+ ((n-2) - x), in    	    1197 TEFFGNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSS 1246                                                         
						which x varies from 0 to n-2.                                	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1247 VQRQEVKIEESEASVEGFSELENSEETRTESWELKNQISQLQEQLMMLCA 1296                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1297 DCDRASEKKQDLLFDVSVLKKKLKMLERIPEASPKYKLLYEDVSRENDCL 1346                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1347 QEELRMMETRYDEALENNKELTAEVFRLQDELKKMEEVTETFLSLEKSYD 1396                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1397 EVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEPDGN 1446                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1447 ILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWL 1496                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1497 HGTIQTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQ 1546                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1547 ELTRKLKERVTILVKQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELL 1596                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1597 RYESEKLQQENSILRNEITTLNEEDSISNLKLGTLNGSQEEMWQKTETVK 1646                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||| |||||||  
						                                                            	     838 RYESEKLQQENSILRNEITTLNEEDSISNLKLGTLNGSQEEM.QKTETVK 886                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1647 QENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQ 1696                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     887 QENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQ 936                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1697 RLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAEL 1746                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     937 RLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAEL 986                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1747 SEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKL 1796                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     987 SEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKL 1036                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1797 LKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQLV 1846                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1037 LKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQLV 1086                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1847 ASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQLQN 1896                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1087 ASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQLQN 1136                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1897 AGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQTM 1946                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1137 AGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQTM 1186                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1947 VQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKREC 1996                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1187 VQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKREC 1236                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1997 DQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQ.........NSV 2037                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||         |||  
						                                                            	    1237 DQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMENSV 1286                                                         
						                                                            	                  .         .                                
						                                                            	    2038 VGSSREGCSSLPEIVCEDAAPEVHCDA                        2064                                                         
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1287 VGSSREGCSSLPEIVCEDAAPEVHCDA                        1313                                                         

						Comparison report between F09800_P11 and Q9BWU6unique head   	Sequence name: Q9BWU6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09800_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16604 x Q9BWU6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						LLPARARPFLPGVQSSGSRPPEPGAERAGRGRPAAAAKPGVRQRPWFPRRRRAPEPRDAS 	Alignment segment 1/1:                                       
						AGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDL 	                                                            
						CHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQP 	                     Quality: 3859.00                      Escore:       0                                               
						KYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYE 	             Matching length:     390                Total length:     390                                               
						AEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDES 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGN 	                        Gaps:       0                        
						INLTELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKL 	                                                            
						KSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELE 	Alignment:                                                   
						QEIEKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKF 	                  .         .         .         .         .  
						GDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSP 	    1645 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 1694                                                         
						SEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKQLDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCR 	       1 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 50                                                           
						HEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVR 	                  .         .         .         .         .  
						GLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEA 	    1695 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 1744                                                         
						QFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQ 	      51 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 100                                                          
						ILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKA 	                  .         .         .         .         .  
						TCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQG 	    1745 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 1794                                                         
						EQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEAS 	     101 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 150                                                          
						VEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLK 	                  .         .         .         .         .  
						MLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKK 	    1795 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 1844                                                         
						MEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTI 	     151 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 200                                                          
						QTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILV 	                  .         .         .         .         .  
						KQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEE 	    1845 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 1894                                                         
						DSISNLKLGTLNGSQEEMWQKTET                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     201 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 250                                                          
						to amino acids 1 - 1644 of F09800_P11, a second amino acid   	                  .         .         .         .         .  
						VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQRLTEMLCQ 	    1895 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 1944                                                         
						KEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAELSEVKIQTHIVQQENHLLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSLLEHRI 	     251 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 300                                                          
						ATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALK 	                  .         .         .         .         .  
						QEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 	    1945 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 1994                                                         
						TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKRECDQFQKEQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PANRKVSQMNSLEQELETIHLENEGLKKKQ                               	     301 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 350                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .            
						amino acids 1 - 390 of Q9BWU6, which also corresponds to     	    1995 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQ           2034                                                         
						amino acids 1645 - 2034 of F09800_P11, and a third amino acid	         ||||||||||||||||||||||||||||||||||||||||            
						sequence being at least 70%, optionally at least 80%,        	     351 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQ           390                                                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence NSVVGSSREGCSSLPEIVCEDAAPEVHCDA           	                                                            
						corresponding to amino acids 2035 - 2064 of F09800_P11,      	                                                            
						wherein said first amino acid sequence, second amino acid    	                                                            
						sequence and third amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of F09800_P11, comprising a polypeptide being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						LLPARARPFLPGVQSSGSRPPEPGAERAGRGRPAAAAKPGVRQRPWFPRRRRAPEPRDAS 	                                                            
						AGGGLPAVRALRRDRQKVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDL 	                                                            
						CHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQP 	                                                            
						KYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYE 	                                                            
						AEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGL 	                                                            
						QNVDGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDES 	                                                            
						GRRTTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGN 	                                                            
						INLTELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKL 	                                                            
						KSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELE 	                                                            
						QEIEKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKF 	                                                            
						GDLDPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSP 	                                                            
						SEEVEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHY 	                                                            
						EKQLDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCR 	                                                            
						HEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVR 	                                                            
						GLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEA 	                                                            
						QFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELL 	                                                            
						KETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQ 	                                                            
						ILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKA 	                                                            
						TCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQG 	                                                            
						EQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFF 	                                                            
						GNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEAS 	                                                            
						VEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLK 	                                                            
						MLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKK 	                                                            
						MEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLE 	                                                            
						IEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTI 	                                                            
						QTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILV 	                                                            
						KQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEE 	                                                            
						DSISNLKLGTLNGSQEEMWQKTET                                     	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						F09800_P11.3.An isolated polypeptide encoding for a tail of  	                                                            
						F09800_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						NSVVGSSREGCSSLPEIVCEDAAPEVHCDA in F09800_P11.                	                                                            

16602	HMR136_F09800_24_tr0_r1_1_gPRT		Comparison report between F09800_P24 and Q9UH61unique head   	Sequence name: Q9UH61                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F09800_P24, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16602 x Q9UH61   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTD     	                                                            
						corresponding to amino acids 1 - 56 of F09800_P24, a second  	                     Quality: 1072.00                      Escore:       0                                               
						LCHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQ 	             Matching length:     111                Total length:     111                                               
						PKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPS                    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.20                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:   98.20                                               
						corresponding to amino acids 42 - 142 of Q9UH61, which also  	                        Gaps:       0                        
						corresponds to amino acids 57 - 157 of F09800_P24, a bridging	                                                            
						amino acid H corresponding to amino acid 158 of F09800_P24, a	Alignment:                                                   
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						IPAGDCSE corresponding to amino acids 144 - 151 of Q9UH61,   	      56 DLCHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEH 105                                                          
						which also corresponds to amino acids 159 - 166 of           	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						F09800_P24, and a fourth amino acid sequence being at least  	      41 ELCHMLSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEH 90                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     106 FQEPDCSLEAQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEAR 155                                                          
						homologous to a polypeptide having the sequence LLES         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 167 - 170 of F09800_P24, wherein	      91 FQEPDCSLEAQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEAR 140                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .                                          
						bridging amino acid, third amino acid sequence and fourth    	     156 PSHIPAGDCSE                                        166                                                          
						amino acid sequence are contiguous and in a sequential       	         ||:||||||||                                         
						order.2.An isolated polypeptide encoding for a head of       	     141 PSYIPAGDCSE                                        151                                                          
						F09800_P24, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTD of  	                                                            
						F09800_P24.3.An isolated polypeptide encoding for a tail of  	                                                            
						F09800_P24, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence LLES in           	                                                            
						F09800_P24.                                                  	                                                            

						Comparison report between F09800_P24 and Q9HCK7unique head   	Sequence name: Q9HCK7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09800_P24, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16602 x Q9HCK7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AESCLEPGKWRFLE corresponding to amino acids 1 - 14 of        	                                                            
						F09800_P24, a second amino acid sequence being at least 90 % 	                     Quality: 1485.00                      Escore:       0                                               
						VSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQQTL 	             Matching length:     152                Total length:     152                                               
						LQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVRGGKRYGRRSLPEF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QESVEEFPEVTVIEPLDEEARPSHIPAGDCSE                             	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to corresponding to amino acids 32 - 183 of       	                        Gaps:       0                        
						Q9HCK7, which also corresponds to amino acids 15 - 166 of    	                                                            
						F09800_P24, and a third amino acid sequence being at least   	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	      15 VSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLE 64                                                           
						homologous to a polypeptide having the sequence LLES         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 167 - 170 of F09800_P24, wherein	      32 VSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLE 81                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      65 EVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLE 114                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of F09800_P24, comprising a polypeptide being at least  	      82 EVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLE 131                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     115 AQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDC 164                                                          
						at least about 95% homologous to the sequence AESCLEPGKWRFLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of F09800_P24.3.An isolated polypeptide encoding for a tail  	     132 AQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDC 181                                                          
						of F09800_P24, comprising a polypeptide being at least 70%,  	                                                             
						optionally at least about 80%, preferably at least about 85%,	     165 SE                                                 166                                                          
						more preferably at least about 90% and most preferably at    	         ||                                                  
						least about 95% homologous to the sequence LLES in           	     182 SE                                                 183                                                          
						F09800_P24.                                                  	                                                            

						Comparison report between F09800_P24 and Q9HAT7unique head   	Sequence name: Q9HAT7                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						F09800_P24, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16602 x Q9HAT7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AESCLEPGKWRFLEVSTVGYG corresponding to amino acids 1 - 21 of 	                                                            
						F09800_P24, a second amino acid sequence being at least 90 % 	                     Quality: 1409.00                      Escore:       0                                               
						MDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQQTLLQDNLLG 	             Matching length:     145                Total length:     145                                               
						RVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVRGGKRYGRRSLPEFQESVEEF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.31                                               
						PEVTVIEPLDEEARPS                                             	    Total Percent Similarity:  100.00      Total Percent Identity:   99.31                                               
						homologous to corresponding to amino acids 1 - 136 of Q9HAT7,	                        Gaps:       0                        
						which also corresponds to amino acids 22 - 157 of F09800_P24,	                                                            
						a bridging amino acid H corresponding to amino acid 158 of   	Alignment:                                                   
						F09800_P24, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						homologous to IPAGDCSE corresponding to amino acids 138 - 145	      22 MDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQ 71                                                           
						of Q9HAT7, which also corresponds to amino acids 159 - 166 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09800_P24, and a fourth amino acid sequence being at least  	       1 MDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQ 50                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	      72 QTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVR 121                                                          
						homologous to a polypeptide having the sequence LLES         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 167 - 170 of F09800_P24, wherein	      51 QTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVR 100                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .            
						bridging amino acid, third amino acid sequence and fourth    	     122 GGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSE      166                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||:||||||||       
						order.2.An isolated polypeptide encoding for a head of       	     101 GGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSYIPAGDCSE      145                                                          
						F09800_P24, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						AESCLEPGKWRFLEVSTVGYG of F09800_P24.3.An isolated polypeptide	                                                            
						encoding for a tail of F09800_P24, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						LLES in F09800_P24.                                          	                                                            

16599	HMR136_F09800_5_tr0_r1_1_gPRT		Comparison report between F09800_P5 and Q9HBY5unique head    	Sequence name: Q9HBY5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09800_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 16599 x Q9HBY5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	Alignment segment 1/1:                                       
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                     Quality: 5652.00                      Escore:       0                                               
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	             Matching length:     573                Total length:     573                                               
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                        Gaps:       0                        
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	Alignment:                                                   
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                  .         .         .         .         .  
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	    1582 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 1631                                                         
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	       1 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 50                                                           
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                  .         .         .         .         .  
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	    1632 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 1681                                                         
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	      51 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 100                                                          
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                  .         .         .         .         .  
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	    1682 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 1731                                                         
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	     101 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 150                                                          
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                  .         .         .         .         .  
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	    1732 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 1781                                                         
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	     151 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 200                                                          
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                  .         .         .         .         .  
						SNLKLGTLNGSQEEMWQKTET                                        	    1782 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 1831                                                         
						having the sequence corresponding to amino acids 1 - 1581 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09800_P5, and a second amino acid sequence being at least 90	     201 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 250                                                          
						VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQRLTEMLCQ 	                  .         .         .         .         .  
						KEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAELSEVKIQTHIVQQENHLLK 	    1832 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 1881                                                         
						DELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSLLEHRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALK 	     251 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 300                                                          
						QEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 	                  .         .         .         .         .  
						TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKRECDQFQKEQS 	    1882 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 1931                                                         
						PANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDLQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQGNQEQLVTVMEERM 	     301 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 350                                                          
						IEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDLYVENAQLLKALEVTEQRQKTAE 	                  .         .         .         .         .  
						KKNYLLEEKIASLSNIVRNLTPAPLTSTPPLRS                            	    1932 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMEM 1981                                                         
						% homologous to corresponding to amino acids 1 - 573 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9HBY5, which also corresponds to amino acids 1582 - 2154 of 	     351 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMEM 400                                                          
						F09800_P5, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	    1982 QHLRSTATPSPSPHAWDLQLLQQQACPMVPREQFLQLQRQLLQAERINQH 2031                                                         
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09800_P5, comprising a polypeptide being at least 70%,      	     401 QHLRSTATPSPSPHAWDLQLLQQQACPMVPREQFLQLQRQLLQAERINQH 450                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	    2032 LQEELENRTSETNTPQGNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQ 2081                                                         
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	     451 LQEELENRTSETNTPQGNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQ 500                                                          
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                  .         .         .         .         .  
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	    2082 LKEQLCKNTKADAMVKDLYVENAQLLKALEVTEQRQKTAEKKNYLLEEKI 2131                                                         
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	     501 LKEQLCKNTKADAMVKDLYVENAQLLKALEVTEQRQKTAEKKNYLLEEKI 550                                                          
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                  .         .                                
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	    2132 ASLSNIVRNLTPAPLTSTPPLRS                            2154                                                         
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	         |||||||||||||||||||||||                             
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	     551 ASLSNIVRNLTPAPLTSTPPLRS                            573                                                          
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	                                                            
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	                                                            
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	                                                            
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                                                            
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	                                                            
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	                                                            
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	                                                            
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                                                            
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	                                                            
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	                                                            
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	                                                            
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                                                            
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	                                                            
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	                                                            
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	                                                            
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                                                            
						SNLKLGTLNGSQEEMWQKTET                                        	                                                            
						least about 95% homologous to the sequence of F09800_P5.     	                                                            

						Comparison report between F09800_P5 and Q8N4C6unique head    	Sequence name: Q8N4C6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09800_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16599 x Q8N4C6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	Alignment segment 1/1:                                       
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                     Quality:  985.00                      Escore:       0                                               
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	             Matching length:      98                Total length:      98                                               
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                        Gaps:       0                        
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	Alignment:                                                   
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                  .         .         .         .         .  
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	    1950 MNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDL 1999                                                         
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	       1 MNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDL 50                                                           
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                  .         .         .         .            
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	    2000 QLLQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQ   2047                                                         
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	      51 QLLQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQ   98                                                           
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                                                            
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	                                                            
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	                                                            
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	                                                            
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                                                            
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	                                                            
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	                                                            
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	                                                            
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                                                            
						SNLKLGTLNGSQEEMWQKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQK 	                                                            
						NSQNQEKLQELNQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLE 	                                                            
						AELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEAL 	                                                            
						SEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVN 	                                                            
						LQMSRMKSDLRVTQQEKEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWD 	                                                            
						KLDHLMNEEQQLLWQENERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMN 	                                                            
						PTEQEKLSLKRECDQFQKEQSPANRKVSQ                                	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 1949 of F09800_P5, a second amino acid    	                                                            
						MNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDLQLLQQQACPM 	                                                            
						VPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQ                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 98 of Q8N4C6, which also corresponds to amino	                                                            
						acids 1950 - 2047 of F09800_P5, and a third amino acid       	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						GNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDLYVENAQLL 	                                                            
						KALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTSTPPLRS              	                                                            
						having the sequence corresponding to amino acids 2048 - 2154 	                                                            
						of F09800_P5, wherein said first amino acid sequence, second 	                                                            
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of F09800_P5, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	                                                            
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                                                            
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	                                                            
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	                                                            
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	                                                            
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                                                            
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	                                                            
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                                                            
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	                                                            
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	                                                            
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	                                                            
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                                                            
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	                                                            
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	                                                            
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	                                                            
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                                                            
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	                                                            
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	                                                            
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	                                                            
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                                                            
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	                                                            
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	                                                            
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	                                                            
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                                                            
						SNLKLGTLNGSQEEMWQKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQK 	                                                            
						NSQNQEKLQELNQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLE 	                                                            
						AELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEAL 	                                                            
						SEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVN 	                                                            
						LQMSRMKSDLRVTQQEKEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWD 	                                                            
						KLDHLMNEEQQLLWQENERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMN 	                                                            
						PTEQEKLSLKRECDQFQKEQSPANRKVSQ                                	                                                            
						to the sequence of F09800_P5.3.An isolated polypeptide       	                                                            
						encoding for a tail of F09800_P5, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						GNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDLYVENAQLL 	                                                            
						KALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTSTPPLRS              	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F09800_P5.                                                	                                                            

						Comparison report between F09800_P5 and Q9HCK7unique head    	Sequence name: Q9HCK7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion, with a short unique insertion and a followed by a 	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						F09800_P5, comprising a first amino acid sequence being at   	Alignment of: 16599 x Q9HCK7   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						AESCLEPGKWRFLE corresponding to amino acids 1 - 14 of        	                     Quality: 12090.00                      Escore:       0                                              
						F09800_P5, a second amino acid sequence being at least 90 %  	             Matching length:    1252                Total length:    1966                                               
						VSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLEEVAPVLQQTL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYVRGGKRYGRRSLPEF 	    Total Percent Similarity:   63.68      Total Percent Identity:   63.68                                               
						QESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEGQLRFWNPDDLNASQ 	                        Gaps:       2                        
						SGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNVDGEMLEEVFHNLDP 	                                                            
						DGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRRTTTSSAMTSTIGFR 	Alignment:                                                   
						VFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINLTELTLALENELLVT 	                  .         .         .         .         .  
						KNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSLMASEVDDHHAAIER 	      15 VSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLE 64                                                           
						RNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEIEKAKTEENYIRDRL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDLDPSSAEFFLQEERL 	      32 VSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHMLSLE 81                                                           
						TQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEEVEANSGGIEPEHGL 	                  .         .         .         .         .  
						GSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQLDETVVSCKKAQEN 	      65 EVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLE 114                                                          
						MKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEEEKKQLQVKLEEEKT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLTQELEQFHQEQLTSL 	      82 EVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLE 131                                                          
						VEKHTLEKEELRKELLEKHQRELQEG                                   	                  .         .         .         .         .  
						homologous to corresponding to amino acids 32 - 837 of       	     115 AQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDC 164                                                          
						Q9HCK7, which also corresponds to amino acids 15 - 820 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09800_P5, a third amino acid sequence being at least 70%,   	     132 AQPKYVRGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDC 181                                                          
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     165 SEHWKTQRSEEYEAEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCED 214                                                          
						REKMETECNRRTSQIEAQFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FEKDELTQECAEAQELLKETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDL 	     182 SEHWKTQRSEEYEAEGQLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCED 231                                                          
						EDLRNVSETQQSLLSDQILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQE 	                  .         .         .         .         .  
						RQEMMSKLLAMENIHKATCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVI 	     215 LGITRDGHLNRKKLVSICEQYGLQNVDGEMLEEVFHNLDPDGTMSVEDFF 264                                                          
						GEEEVEGDGALSLLQQGEQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGLVMSSCLDEPATEFFGNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTG 	     232 LGITRDGHLNRKKLVSICEQYGLQNVDGEMLEEVFHNLDPDGTMSVEDFF 281                                                          
						TSSVQRQEVKIEESEASVEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASE 	                  .         .         .         .         .  
						KKQDLLFDVSVLKKKLKMLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALEN 	     265 YGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRRTTTSSAMTSTIGFR 314                                                          
						NKELTAEVFRLQDELKKMEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VQRCDCCLWEASLENLEIEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQ 	     282 YGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRRTTTSSAMTSTIGFR 331                                                          
						LLEKVKAHEIAWLHGTIQTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKT 	                  .         .         .         .         .  
						KLQELTRKLKERVTILVKQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELL        	     315 VFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINLTELT 364                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 821 - 1533 of F09800_P5, a fourth amino acid  	     332 VFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINLTELT 381                                                          
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						RYESEKLQQENSILRNEITTLNEEDSISNLKLGTLNGSQEEM corresponding to  	     365 LALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKA 414                                                          
						amino acids 838 - 879 of Q9HCK7, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1534 - 1575 of F09800_P5, a fifth amino acid     	     382 LALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKA 431                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     415 EKLKSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQ 464                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence W corresponding to amino acids 1576 -    	     432 EKLKSLMASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQ 481                                                          
						1576 of F09800_P5, a sixth amino acid sequence being at least	                  .         .         .         .         .  
						QKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQRLT 	     465 ILQQAGKQRLELEQEIEKAKTEENYIRDRLALSLKENSRLENELLENAEK 514                                                          
						EMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAELSEVKIQTHIVQQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSL 	     482 ILQQAGKQRLELEQEIEKAKTEENYIRDRLALSLKENSRLENELLENAEK 531                                                          
						LEHRIATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQE 	                  .         .         .         .         .  
						KEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQE 	     515 LAEYENLTNKLQRNLENVLAEKFGDLDPSSAEFFLQEERLTQMRNEYERQ 564                                                          
						NERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKRECDQF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLME                 	     532 LAEYENLTNKLQRNLENVLAEKFGDLDPSSAEFFLQEERLTQMRNEYERQ 581                                                          
						90 % homologous to corresponding to amino acids 880 - 1283 of	                  .         .         .         .         .  
						Q9HCK7, which also corresponds to amino acids 1577 - 1980 of 	     565 CRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEEVEANSGGIEPEHGL 614                                                          
						F09800_P5, and a seventh amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     582 CRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEEVEANSGGIEPEHGL 631                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						MQHLRSTATPSPSPHAWDLQLLQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRT 	     615 GSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQLDET 664                                                          
						SETNTPQGNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTSTPPLRS       	     632 GSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQLDET 681                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1981 - 2154 of F09800_P5, wherein said first  	     665 VVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEA 714                                                          
						amino acid sequence, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, fourth amino acid sequence, fifth amino acid  	     682 VVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEA 731                                                          
						sequence, sixth amino acid sequence and seventh amino acid   	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     715 TCRHEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFERERE 764                                                          
						isolated polypeptide encoding for a head of F09800_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     732 TCRHEEEKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFERERE 781                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     765 GLQSSAWTEEKVRGLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQ 814                                                          
						about 95% homologous to the sequence AESCLEPGKWRFLE of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F09800_P5.3.An isolated polypeptide encoding for an edge     	     782 GLQSSAWTEEKVRGLTQELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQ 831                                                          
						portion of F09800_P5, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     815 RELQEGREKMETECNRRTSQIEAQFQSDCQKVTERCESALQSLEGRYRQE 864                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||                                              
						preferably at least about 95% homologous to the sequence     	     832 RELQEG............................................ 837                                                          
						REKMETECNRRTSQIEAQFQSDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWE 	                  .         .         .         .         .  
						FEKDELTQECAEAQELLKETLKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDL 	     865 LKDLQEQQREEKSQWEFEKDELTQECAEAQELLKETLKREKTTSLVLTQE 914                                                          
						EDLRNVSETQQSLLSDQILELKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQE 	                                                            
						RQEMMSKLLAMENIHKATCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVI 	     837 .................................................. 837                                                          
						GEEEVEGDGALSLLQQGEQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLE 	                  .         .         .         .         .  
						PGLVMSSCLDEPATEFFGNTAEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTG 	     915 REMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILELKSS 964                                                          
						TSSVQRQEVKIEESEASVEGFSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASE 	                                                            
						KKQDLLFDVSVLKKKLKMLERIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALEN 	     837 .................................................. 837                                                          
						NKELTAEVFRLQDELKKMEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESV 	                  .         .         .         .         .  
						VQRCDCCLWEASLENLEIEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQ 	     965 HKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENI 1014                                                         
						LLEKVKAHEIAWLHGTIQTHQERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKT 	                                                            
						KLQELTRKLKERVTILVKQKDVLSHGEKEEELKAMMHDLQITCSEMQQKVELL,       	     837 .................................................. 837                                                          
						encoding for corresponding to F09800_P5.4.An isolated        	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of F09800_P5,       	    1015 HKATCETADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEE 1064                                                         
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	     837 .................................................. 837                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for W,   	    1065 VEGDGALSLLQQGEQLLEENGDVLLSLQRAHEQAVKENVKMATEISRLQQ 1114                                                         
						corresponding to F09800_P5.5.An isolated polypeptide encoding	                                                            
						for a tail of F09800_P5, comprising a polypeptide being at   	     837 .................................................. 837                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	    1115 RLQKLEPGLVMSSCLDEPATEFFGNTAEQTEPFLQQNRTKQVEGVTRRHV 1164                                                         
						MQHLRSTATPSPSPHAWDLQLLQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRT 	                                                            
						SETNTPQGNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDLY 	     837 .................................................. 837                                                          
						VENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTSTPPLRS       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence in  	    1165 LSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEGFSELENSEETRTES 1214                                                         
						F09800_P5.                                                   	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1215 WELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLERIPE 1264                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1265 ASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDE 1314                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1315 LKKMEEVTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRC 1364                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1365 DCCLWEASLENLEIEPDGNILQLNQTLEECVPRVRSVHHVIEECKQENQY 1414                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1415 LEGNTQLLEKVKAHEIAWLHGTIQTHQERPRVQNQVILEENTTLLGFQDK 1464                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1465 HFQHQATIAELELEKTKLQELTRKLKERVTILVKQKDVLSHGEKEEELKA 1514                                                         
						                                                            	                                                            
						                                                            	     837 .................................................. 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1515 MMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSISNLK 1564                                                         
						                                                            	                            |||||||||||||||||||||||||||||||  
						                                                            	     838 ...................RYESEKLQQENSILRNEITTLNEEDSISNLK 868                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1565 LGTLNGSQEEMWQKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLEN 1614                                                         
						                                                            	         ||||||||||| ||||||||||||||||||||||||||||||||||||||  
						                                                            	     869 LGTLNGSQEEM.QKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLEN 917                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1615 TELSQKNSQNQEKLQELNQRLTEMLCQKEKEPGNSALEEREQEKFNLKEE 1664                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     918 TELSQKNSQNQEKLQELNQRLTEMLCQKEKEPGNSALEEREQEKFNLKEE 967                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1665 LERCKVQSSTLVSSLEAELSEVKIQTHIVQQENHLLKDELEKMKQLHRCP 1714                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     968 LERCKVQSSTLVSSLEAELSEVKIQTHIVQQENHLLKDELEKMKQLHRCP 1017                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1715 DLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSLLEHRIATM 1764                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1018 DLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSLLEHRIATM 1067                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1765 KQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQ 1814                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1068 KQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQ 1117                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1815 QEKEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDH 1864                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1118 QEKEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDH 1167                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1865 LMNEEQQLLWQENERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLN 1914                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1168 LMNEEQQLLWQENERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLN 1217                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1915 PSGTMNPTEQEKLSLKRECDQFQKEQSPANRKVSQMNSLEQELETIHLEN 1964                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1218 PSGTMNPTEQEKLSLKRECDQFQKEQSPANRKVSQMNSLEQELETIHLEN 1267                                                         
						                                                            	                  .                                          
						                                                            	    1965 EGLKKKQVKLDEQLME                                   1980                                                         
						                                                            	         ||||||||||||||||                                    
						                                                            	    1268 EGLKKKQVKLDEQLME                                   1283                                                         

						Comparison report between F09800_P5 and Q9H5I6unique head    	Sequence name: Q9H5I6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09800_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 16599 x Q9H5I6   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	Alignment segment 1/1:                                       
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                     Quality: 2009.00                      Escore:       0                                               
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	             Matching length:     205                Total length:     205                                               
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                        Gaps:       0                        
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	Alignment:                                                   
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                  .         .         .         .         .  
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	    1950 MNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDL 1999                                                         
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	       1 MNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDL 50                                                           
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                  .         .         .         .         .  
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	    2000 QLLQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQGN 2049                                                         
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	      51 QLLQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQGN 100                                                          
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                  .         .         .         .         .  
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	    2050 QEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDL 2099                                                         
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	     101 QEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQLKEQLCKNTKADAMVKDL 150                                                          
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                  .         .         .         .         .  
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	    2100 YVENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTST 2149                                                         
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	     151 YVENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTST 200                                                          
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                                                             
						SNLKLGTLNGSQEEMWQKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQK 	    2150 PPLRS                                              2154                                                         
						NSQNQEKLQELNQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLE 	         |||||                                               
						AELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEAL 	     201 PPLRS                                              205                                                          
						SEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVN 	                                                            
						LQMSRMKSDLRVTQQEKEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWD 	                                                            
						KLDHLMNEEQQLLWQENERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMN 	                                                            
						PTEQEKLSLKRECDQFQKEQSPANRKVSQ                                	                                                            
						having the sequence corresponding to amino acids 1 - 1949 of 	                                                            
						F09800_P5, and a second amino acid sequence being at least 90	                                                            
						MNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDLQLLQQQACPM 	                                                            
						VPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQGNQEQLVTVMEERMIEVEQKLK 	                                                            
						LVKRLLQEKVNQLKEQLCKNTKADAMVKDLYVENAQLLKALEVTEQRQKTAEKKNYLLEE 	                                                            
						KIASLSNIVRNLTPAPLTSTPPLRS                                    	                                                            
						% homologous to corresponding to amino acids 1 - 205 of      	                                                            
						Q9H5I6, which also corresponds to amino acids 1950 - 2154 of 	                                                            
						F09800_P5, wherein said first amino acid sequence and second 	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						F09800_P5, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	                                                            
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                                                            
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	                                                            
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	                                                            
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	                                                            
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                                                            
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	                                                            
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                                                            
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	                                                            
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	                                                            
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	                                                            
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                                                            
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	                                                            
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	                                                            
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	                                                            
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                                                            
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	                                                            
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	                                                            
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	                                                            
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                                                            
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	                                                            
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	                                                            
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	                                                            
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                                                            
						SNLKLGTLNGSQEEMWQKTETVKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQK 	                                                            
						NSQNQEKLQELNQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLE 	                                                            
						AELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEAL 	                                                            
						SEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVN 	                                                            
						LQMSRMKSDLRVTQQEKEALKQEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWD 	                                                            
						KLDHLMNEEQQLLWQENERLQTMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMN 	                                                            
						PTEQEKLSLKRECDQFQKEQSPANRKVSQ                                	                                                            
						least about 95% homologous to the sequence of F09800_P5.     	                                                            

						Comparison report between F09800_P5 and Q9BWU6unique head    	Sequence name: Q9BWU6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09800_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16599 x Q9BWU6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	Alignment segment 1/1:                                       
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                     Quality: 4994.00                      Escore:       0                                               
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	             Matching length:     504                Total length:     504                                               
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                        Gaps:       0                        
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	Alignment:                                                   
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                  .         .         .         .         .  
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	    1582 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 1631                                                         
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	       1 VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQEL 50                                                           
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                  .         .         .         .         .  
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	    1632 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 1681                                                         
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	      51 NQRLTEMLCQKEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEA 100                                                          
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                  .         .         .         .         .  
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	    1682 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 1731                                                         
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	     101 ELSEVKIQTHIVQQENHLLKDELEKMKQLHRCPDLSDFQQKISSVLSYNE 150                                                          
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                  .         .         .         .         .  
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	    1732 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 1781                                                         
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	     151 KLLKEKEALSEELNSCVDKLAKSSLLEHRIATMKQEQKSWEHQSASLKSQ 200                                                          
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                  .         .         .         .         .  
						SNLKLGTLNGSQEEMWQKTET                                        	    1782 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 1831                                                         
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 1581 of F09800_P5, a second amino acid    	     201 LVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALKQEVMSLHKQL 250                                                          
						VKQENAAVQKMVENLKKQISELKIKNQQLDLENTELSQKNSQNQEKLQELNQRLTEMLCQ 	                  .         .         .         .         .  
						KEKEPGNSALEEREQEKFNLKEELERCKVQSSTLVSSLEAELSEVKIQTHIVQQENHLLK 	    1832 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 1881                                                         
						DELEKMKQLHRCPDLSDFQQKISSVLSYNEKLLKEKEALSEELNSCVDKLAKSSLLEHRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATMKQEQKSWEHQSASLKSQLVASQEKVQNLEDTVQNVNLQMSRMKSDLRVTQQEKEALK 	     251 QNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 300                                                          
						QEVMSLHKQLQNAGGKSWAPEIATHPSGLHNQQKRLSWDKLDHLMNEEQQLLWQENERLQ 	                  .         .         .         .         .  
						TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKRECDQFQKEQS 	    1882 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 1931                                                         
						PANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMEMQHLRSTATPSPSPHAWDLQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQQQACPMVPREQFLQLQRQLLQAERINQHLQEELENRTSETNTPQGNQEQLVTVMEERM 	     301 TMVQNTKAELTHSREKVRQLESNLLPKHQKHLNPSGTMNPTEQEKLSLKR 350                                                          
						IEVEQKLKLVKRLLQEKVNQLKEQ                                     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	    1932 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMEM 1981                                                         
						amino acids 1 - 504 of Q9BWU6, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1582 - 2085 of F09800_P5, and a third amino acid 	     351 ECDQFQKEQSPANRKVSQMNSLEQELETIHLENEGLKKKQVKLDEQLMEM 400                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	    1982 QHLRSTATPSPSPHAWDLQLLQQQACPMVPREQFLQLQRQLLQAERINQH 2031                                                         
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LCKNTKADAMVKDLYVENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAP 	     401 QHLRSTATPSPSPHAWDLQLLQQQACPMVPREQFLQLQRQLLQAERINQH 450                                                          
						LTSTPPLRS                                                    	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 2086 - 2154 	    2032 LQEELENRTSETNTPQGNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQ 2081                                                         
						of F09800_P5, wherein said first amino acid sequence, second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     451 LQEELENRTSETNTPQGNQEQLVTVMEERMIEVEQKLKLVKRLLQEKVNQ 500                                                          
						contiguous and in a sequential order.2.An isolated           	                                                             
						polypeptide encoding for a head of F09800_P5, comprising a   	    2082 LKEQ                                               2085                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||                                                
						80%, preferably at least about 85%, more preferably at least 	     501 LKEQ                                               504                                                          
						about 90% and most preferably at least about 95% homologous  	                                                            
						AESCLEPGKWRFLEVSTVGYGMDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTDLCHM 	                                                            
						LSLEEVAPVLQQTLLQDNLLGRVHFDQFKEALILILSRTLSNEEHFQEPDCSLEAQPKYV 	                                                            
						RGGKRYGRRSLPEFQESVEEFPEVTVIEPLDEEARPSHIPAGDCSEHWKTQRSEEYEAEG 	                                                            
						QLRFWNPDDLNASQSGSSPPQDWIEEKLQEVCEDLGITRDGHLNRKKLVSICEQYGLQNV 	                                                            
						DGEMLEEVFHNLDPDGTMSVEDFFYGLFKNGKSLTPSASTPYRQLKRHLSMQSFDESGRR 	                                                            
						TTTSSAMTSTIGFRVFSCLDDGMGHASVERILDTWQEEGIENSQEILKALDFSLDGNINL 	                                                            
						TELTLALENELLVTKNSIHQAALASFKAEIRHLLERVDQVVREKEKLRSDLDKAEKLKSL 	                                                            
						MASEVDDHHAAIERRNEYNLRKLDEEYKERIAALKNELRKEREQILQQAGKQRLELEQEI 	                                                            
						EKAKTEENYIRDRLALSLKENSRLENELLENAEKLAEYENLTNKLQRNLENVLAEKFGDL 	                                                            
						DPSSAEFFLQEERLTQMRNEYERQCRVLQDQVDELQSELEEYRAQGRVLRLPLKNSPSEE 	                                                            
						VEANSGGIEPEHGLGSEECNPLNMSIEAELVIEQMKEQHHRDICCLRLELEDKVRHYEKQ 	                                                            
						LDETVVSCKKAQENMKQRHENETHTLEKQISDLKNEIAELQGQAAVLKEAHHEATCRHEE 	                                                            
						EKKQLQVKLEEEKTHLQEKLRLQHEMELKARLTQAQASFEREREGLQSSAWTEEKVRGLT 	                                                            
						QELEQFHQEQLTSLVEKHTLEKEELRKELLEKHQRELQEGREKMETECNRRTSQIEAQFQ 	                                                            
						SDCQKVTERCESALQSLEGRYRQELKDLQEQQREEKSQWEFEKDELTQECAEAQELLKET 	                                                            
						LKREKTTSLVLTQEREMLEKTYKEHLNSMVVERQQLLQDLEDLRNVSETQQSLLSDQILE 	                                                            
						LKSSHKRELREREEVLCQAGASEQLASQRLERLEMEHDQERQEMMSKLLAMENIHKATCE 	                                                            
						TADRERAEMSTEISRLQSKIKEMQQATSPLSMLQSGCQVIGEEEVEGDGALSLLQQGEQL 	                                                            
						LEENGDVLLSLQRAHEQAVKENVKMATEISRLQQRLQKLEPGLVMSSCLDEPATEFFGNT 	                                                            
						AEQTEPFLQQNRTKQVEGVTRRHVLSDLEDDEVRDLGSTGTSSVQRQEVKIEESEASVEG 	                                                            
						FSELENSEETRTESWELKNQISQLQEQLMMLCADCDRASEKKQDLLFDVSVLKKKLKMLE 	                                                            
						RIPEASPKYKLLYEDVSRENDCLQEELRMMETRYDEALENNKELTAEVFRLQDELKKMEE 	                                                            
						VTETFLSLEKSYDEVKIENEELNVLVLRLQGKIEKLQESVVQRCDCCLWEASLENLEIEP 	                                                            
						DGNILQLNQTLEECVPRVRSVHHVIEECKQENQYLEGNTQLLEKVKAHEIAWLHGTIQTH 	                                                            
						QERPRVQNQVILEENTTLLGFQDKHFQHQATIAELELEKTKLQELTRKLKERVTILVKQK 	                                                            
						DVLSHGEKEEELKAMMHDLQITCSEMQQKVELLRYESEKLQQENSILRNEITTLNEEDSI 	                                                            
						SNLKLGTLNGSQEEMWQKTET                                        	                                                            
						to the sequence of F09800_P5.3.An isolated polypeptide       	                                                            
						encoding for a tail of F09800_P5, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						LCKNTKADAMVKDLYVENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAP 	                                                            
						LTSTPPLRS                                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in F09800_P5.                                                	                                                            

16952	HMR136_F09831_7_tr0_r1_1_gPRT		Comparison report between F09831_P7 and Q96BT2partial WT     	Sequence name: Q96BT2                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F09831_P7, comprising a first amino acid sequence being at   	                                                            
						MAGSLPPCVVDCGTGYTKLGYAGNTEPQFIIPSCIAIRESAKVVDQAQRRVLRGVDDLDF 	Alignment of: 16952 x Q96BT2   ..                            
						FIGDEAIDKPTYATKWPIRHGIIEDWDLMERFMEQVVFKYLRAEPEDHYFLM         	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 112	Alignment segment 1/1:                                       
						of Q96BT2, which also corresponds to amino acids 1 - 112 of  	                                                            
						F09831_P7, a second amino acid sequence being at least 90 %  	                     Quality: 2604.00                      Escore:       0                                               
						AEGYVIGSCIKHIPIAGRDITYFIQQLLREREVGIPPEQSLETAKAIKEKYCYICPDIVK 	             Matching length:     280                Total length:     418                                               
						EFAKYDVDPRKWIKQYTGINAINQKKFVIDVGYERFLGPEIFFHPEFANPDFMESISDVV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DEVIQNCPIDVRRPLYK                                            	    Total Percent Similarity:   66.99      Total Percent Identity:   66.99                                               
						homologous to corresponding to amino acids 181 - 317 of      	                        Gaps:       2                        
						Q96BT2, which also corresponds to amino acids 113 - 249 of   	                                                            
						F09831_P7, a third amino acid sequence being at least 70%,   	Alignment:                                                   
						optionally at least 80%, preferably at least 85%, more       	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       1 MAGSLPPCVVDCGTGYTKLGYAGNTEPQFIIPSCIAIRESAKVVDQAQRR 50                                                           
						NVVLSGGSTMFRDFGRRLQRDLKRVVDARLRLSEELSGGRIKPKPVEVQVVTHHMQRYAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WFGGSMLAST                                                   	       1 MAGSLPPCVVDCGTGYTKLGYAGNTEPQFIIPSCIAIRESAKVVDQAQRR 50                                                           
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 250 - 319 of F09831_P7, and a fourth amino    	      51 VLRGVDDLDFFIGDEAIDKPTYATKWPIRHGIIEDWDLMERFMEQVVFKY 100                                                          
						acid sequence being at least 90 % homologous to              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PEFFQVCHTKKDYEEYGPSICRHNPVFGVMS corresponding to amino acids 	      51 VLRGVDDLDFFIGDEAIDKPTYATKWPIRHGIIEDWDLMERFMEQVVFKY 100                                                          
						318 - 348 of Q96BT2, which also corresponds to amino acids   	                  .         .         .         .         .  
						320 - 350 of F09831_P7, wherein said first amino acid        	     101 LRAEPEDHYFLM...................................... 112                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||                                        
						sequence and fourth amino acid sequence are contiguous and in	     101 LRAEPEDHYFLMTEPPLNTPENREYLAEIMFESFNVPGLYIAVQAVLALA 150                                                          
						a sequential order.2.An isolated chimeric polypeptide        	                  .         .         .         .         .  
						encoding for an edge portion of F09831_P7, comprising a      	     113 ..............................AEGYVIGSCIKHIPIAGRDI 132                                                          
						polypeptide having a length "n", wherein n is at least about 	                                       ||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     151 ASWTSRQVGERTLTGIVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDI 200                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     133 TYFIQQLLREREVGIPPEQSLETAKAIKEKYCYICPDIVKEFAKYDVDPR 182                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise MA, having 	     201 TYFIQQLLREREVGIPPEQSLETAKAIKEKYCYICPDIVKEFAKYDVDPR 250                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 112-x to 113; and ending at any of amino acid   	     183 KWIKQYTGINAINQKKFVIDVGYERFLGPEIFFHPEFANPDFMESISDVV 232                                                          
						numbers 113+ ((n-2) - x), in which x varies from 0 to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						n-2.3.An isolated polypeptide encoding for an edge portion of	     251 KWIKQYTGINAINQKKFVIDVGYERFLGPEIFFHPEFANPDFMESISDVV 300                                                          
						F09831_P7, comprising an amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     233 DEVIQNCPIDVRRPLYKNVVLSGGSTMFRDFGRRLQRDLKRVVDARLRLS 282                                                          
						85%, more preferably at least about 90% and most preferably  	         |||||||||||||||||                                   
						NVVLSGGSTMFRDFGRRLQRDLKRVVDARLRLSEELSGGRIKPKPVEVQVVTHHMQRYAV 	     301 DEVIQNCPIDVRRPLYK................................. 317                                                          
						WFGGSMLAST,                                                  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     283 EELSGGRIKPKPVEVQVVTHHMQRYAVWFGGSMLASTPEFFQVCHTKKDY 332                                                          
						corresponding to F09831_P7.                                  	                                              |||||||||||||  
						                                                            	     318 .....................................PEFFQVCHTKKDY 330                                                          
						                                                            	                  .                                          
						                                                            	     333 EEYGPSICRHNPVFGVMS                                 350                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     331 EEYGPSICRHNPVFGVMS                                 348                                                          

						Comparison report between F09831_P7 and Q9P1U1partial WT     	Sequence name: Q9P1U1                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for F09831_P7, comprising a first amino 	Sequence documentation:                                      
						MAGSLPPCVVDCGTGYTKLGYAGNTEPQFIIPSCIAIRESAKVVDQAQRRVLRGVDDLDF 	                                                            
						FIGDEAIDKPTYATKWPIRHGIIEDWDLMERFMEQVVFKYLRAEPEDHYFLM         	Alignment of: 16952 x Q9P1U1   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 112 of Q9P1U1, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 112 of F09831_P7, and a second amino acid    	                                                            
						AEGYVIGSCIKHIPIAGRDITYFIQQLLREREVGIPPEQSLETAKAIKEKYCYICPDIVK 	                     Quality: 3380.00                      Escore:       0                                               
						EFAKYDVDPRKWIKQYTGINAINQKKFVIDVGYERFLGPEIFFHPEFANPDFMESISDVV 	             Matching length:     350                Total length:     418                                               
						DEVIQNCPIDVRRPLYKNVVLSGGSTMFRDFGRRLQRDLKRVVDARLRLSEELSGGRIKP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KPVEVQVVTHHMQRYAVWFGGSMLASTPEFFQVCHTKKDYEEYGPSICRHNPVFGVMS   	    Total Percent Similarity:   83.73      Total Percent Identity:   83.73                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       1                        
						amino acids 181 - 418 of Q9P1U1, which also corresponds to   	                                                            
						amino acids 113 - 350 of F09831_P7, wherein said first amino 	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	       1 MAGSLPPCVVDCGTGYTKLGYAGNTEPQFIIPSCIAIRESAKVVDQAQRR 50                                                           
						encoding for an edge portion of F09831_P7, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	       1 MAGSLPPCVVDCGTGYTKLGYAGNTEPQFIIPSCIAIRESAKVVDQAQRR 50                                                           
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	      51 VLRGVDDLDFFIGDEAIDKPTYATKWPIRHGIIEDWDLMERFMEQVVFKY 100                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	      51 VLRGVDDLDFFIGDEAIDKPTYATKWPIRHGIIEDWDLMERFMEQVVFKY 100                                                          
						length, wherein at least two amino acids comprise MA, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     101 LRAEPEDHYFLM...................................... 112                                                          
						acid numbers 112-x to 113; and ending at any of amino acid   	         ||||||||||||                                        
						numbers 113+ ((n-2) - x), in which x varies from 0 to n-2.   	     101 LRAEPEDHYFLMTEPPLNTPENREYLAEIMFESFNVPGLYIAVQAVLALA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     113 ..............................AEGYVIGSCIKHIPIAGRDI 132                                                          
						                                                            	                                       ||||||||||||||||||||  
						                                                            	     151 ASWTSRQVGERTLTGIVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     133 TYFIQQLLREREVGIPPEQSLETAKAIKEKYCYICPDIVKEFAKYDVDPR 182                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TYFIQQLLREREVGIPPEQSLETAKAIKEKYCYICPDIVKEFAKYDVDPR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     183 KWIKQYTGINAINQKKFVIDVGYERFLGPEIFFHPEFANPDFMESISDVV 232                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KWIKQYTGINAINQKKFVIDVGYERFLGPEIFFHPEFANPDFMESISDVV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     233 DEVIQNCPIDVRRPLYKNVVLSGGSTMFRDFGRRLQRDLKRVVDARLRLS 282                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DEVIQNCPIDVRRPLYKNVVLSGGSTMFRDFGRRLQRDLKRVVDARLRLS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     283 EELSGGRIKPKPVEVQVVTHHMQRYAVWFGGSMLASTPEFFQVCHTKKDY 332                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EELSGGRIKPKPVEVQVVTHHMQRYAVWFGGSMLASTPEFFQVCHTKKDY 400                                                          
						                                                            	                  .                                          
						                                                            	     333 EEYGPSICRHNPVFGVMS                                 350                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     401 EEYGPSICRHNPVFGVMS                                 418                                                          

17062	HMR136_F09849_0_tr0_r1_1_gPRT		Comparison report between F09849_P0 and AAH44948unique head  	Sequence name: AAH44948                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09849_P0, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17062 x AAH44948   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MSGVWGAGGPRCQEALAVLASLCRARPPPLGLDVETCRSFELQPPERSPSAAGAGTSVSL 	Alignment segment 1/1:                                       
						LAVVVIVCGVALVAVFLFLFWKLCW                                    	                                                            
						having the sequence corresponding to amino acids 1 - 85 of   	                     Quality: 4196.00                      Escore:       0                                               
						F09849_P0, and a second amino acid sequence being at least 90	             Matching length:     425                Total length:     425                                               
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	                        Gaps:       0                        
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	                                                            
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	Alignment:                                                   
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIPPENMDQVS 	                  .         .         .         .         .  
						LLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAYPRKPIAHWHSLVEVKKSFKE 	      86 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 135                                                          
						GNPRL                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 425 of      	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						AAH44948, which also corresponds to amino acids 86 - 510 of  	                  .         .         .         .         .  
						F09849_P0, wherein said first amino acid sequence and second 	     136 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 185                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						F09849_P0, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     186 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 235                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSGVWGAGGPRCQEALAVLASLCRARPPPLGLDVETCRSFELQPPERSPSAAGAGTSVSL 	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						LAVVVIVCGVALVAVFLFLFWKLCW                                    	                  .         .         .         .         .  
						least about 95% homologous to the sequence of F09849_P0.     	     236 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 285                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     286 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 335                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     336 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 435                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     436 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 485                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	                  .         .                                
						                                                            	     486 PRKPIAHWHSLVEVKKSFKEGNPRL                          510                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     401 PRKPIAHWHSLVEVKKSFKEGNPRL                          425                                                          

17058	HMR136_F09849_10_tr0_r1_1_gPRT		Comparison report between F09849_P10 and AAH44948partial WT  	Sequence name: AAH44948                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09849_P10, comprising a first amino	Sequence documentation:                                      
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	                                                            
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	Alignment of: 17058 x AAH44948   ..                          
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	                                                            
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	Alignment segment 1/1:                                       
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	                                                            
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIPPENMDQVS 	                     Quality: 4146.00                      Escore:       0                                               
						LLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAYPRKPIAHWHSLVEVKKSFKE 	             Matching length:     420                Total length:     420                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 420 of AAH44948, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 420 of F09849_P10, and a second amino acid   	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VGEVTWPLACLLHGSVGWRMAVSCSDTLGLLWKGGH     	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						corresponding to amino acids 421 - 456 of F09849_P10, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a tail of F09849_P10, comprising a  	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VGEVTWPLACLLHGSVGWRMAVSCSDTLGLLWKGGH in      	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						F09849_P10.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          

17056	HMR136_F09849_3_tr0_r1_1_gPRT		Comparison report between F09849_P3 and AAH44948partial WT   	Sequence name: AAH44948                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09849_P3, comprising a first amino 	Sequence documentation:                                      
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	                                                            
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	Alignment of: 17056 x AAH44948   ..                          
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	                                                            
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	Alignment segment 1/1:                                       
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	                                                            
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIPPENMDQVS 	                     Quality: 4146.00                      Escore:       0                                               
						LLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAYPRKPIAHWHSLVEVKKSFKE 	             Matching length:     420                Total length:     420                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 420 of AAH44948, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 420 of F09849_P3, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence WQGRAASFDSESSCPSPKPPPTP corresponding to 	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						amino acids 421 - 443 of F09849_P3, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a tail of F09849_P3, comprising a polypeptide being at   	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						WQGRAASFDSESSCPSPKPPPTP in F09849_P3.                        	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          

17054	HMR136_F09849_5_tr0_r1_1_gPRT		Comparison report between F09849_P5 and AAH44948partial WT   	Sequence name: AAH44948                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09849_P5, comprising a first amino 	Sequence documentation:                                      
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	                                                            
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	Alignment of: 17054 x AAH44948   ..                          
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	                                                            
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	Alignment segment 1/1:                                       
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	                                                            
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIPPENMDQVS 	                     Quality: 4146.00                      Escore:       0                                               
						LLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAYPRKPIAHWHSLVEVKKSFKE 	             Matching length:     420                Total length:     420                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 420 of AAH44948, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 420 of F09849_P5, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence WQGRAASFDSESSCPSPKPPPTP corresponding to 	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						amino acids 421 - 443 of F09849_P5, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a tail of F09849_P5, comprising a polypeptide being at   	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						WQGRAASFDSESSCPSPKPPPTP in F09849_P5.                        	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          

17050	HMR136_F09849_7_tr0_r1_1_gPRT		Comparison report between F09849_P7 and AAH44948partial WT   	Sequence name: AAH44948                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09849_P7, comprising a first amino 	Sequence documentation:                                      
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	                                                            
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	Alignment of: 17050 x AAH44948   ..                          
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	                                                            
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	Alignment segment 1/1:                                       
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	                                                            
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIPPENMDQVS 	                     Quality: 4146.00                      Escore:       0                                               
						LLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAYPRKPIAHWHSLVEVKKSFKE 	             Matching length:     420                Total length:     420                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 420 of AAH44948, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 420 of F09849_P7, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence WQGRAASFDSESSCPSPKPPPTP corresponding to 	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						amino acids 421 - 443 of F09849_P7, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a tail of F09849_P7, comprising a polypeptide being at   	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						WQGRAASFDSESSCPSPKPPPTP in F09849_P7.                        	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          

17052	HMR136_F09849_8_tr0_r1_1_gPRT		Comparison report between F09849_P8 and AAH44948unique head  	Sequence name: AAH44948                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09849_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17052 x AAH44948   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MACRALAAGAAGGSATWRPAQGTSVSLLAVVVIVCGVALVAVFLFLFWKLCW         	                                                            
						corresponding to amino acids 1 - 52 of F09849_P8, a second   	                     Quality: 4146.00                      Escore:       0                                               
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	             Matching length:     420                Total length:     420                                               
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	                        Gaps:       0                        
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	                                                            
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIPPENMDQVS 	Alignment:                                                   
						LLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAYPRKPIAHWHSLVEVKKSFKE 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      53 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 102                                                          
						corresponding to amino acids 1 - 420 of AAH44948, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 53 - 472 of F09849_P8, and a third	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     103 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 152                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence WQGRAASFDSESSCPSPKPPPTP corresponding to 	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						amino acids 473 - 495 of F09849_P8, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, second amino acid sequence and third amino    	     153 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 202                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F09849_P8,       	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     203 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 252                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						MACRALAAGAAGGSATWRPAQGTSVSLLAVVVIVCGVALVAVFLFLFWKLCW of      	                  .         .         .         .         .  
						F09849_P8.3.An isolated polypeptide encoding for a tail of   	     253 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 302                                                          
						F09849_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     303 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 352                                                          
						WQGRAASFDSESSCPSPKPPPTP in F09849_P8.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     403 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 452                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IPPENMDQVSLLISVMDYDRVGHNEIIGVCRVGITAEGLGRDHWNEMLAY 400                                                          
						                                                            	                  .         .                                
						                                                            	     453 PRKPIAHWHSLVEVKKSFKE                               472                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     401 PRKPIAHWHSLVEVKKSFKE                               420                                                          

17060	HMR136_F09849_9_tr0_r1_1_gPRT		Comparison report between F09849_P9 and AAH44948partial WT   	Sequence name: AAH44948                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09849_P9, comprising a first amino 	Sequence documentation:                                      
						MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKISHTSPDIPAEV 	                                                            
						QMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHVSSVDYGNELPPAAEQPTSIG 	Alignment of: 17060 x AAH44948   ..                          
						RIKPELYKQKSVDGEDAKSEATKSCGKINFSLRYDYETETLIVRILKAFDLPAKDFCGSS 	                                                            
						DPYVKIYLLPDRKCKLQTRVHRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRH 	Alignment segment 1/1:                                       
						DMIGEVILDNLFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 	                                                            
						RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFDIP         	                     Quality: 3465.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     352                Total length:     352                                               
						to amino acids 1 - 352 of AAH44948, which also corresponds to	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 352 of F09849_P9, and a second amino acid    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence QWATMRS corresponding to amino acids 353 	                  .         .         .         .         .  
						- 359 of F09849_P9, wherein said first amino acid sequence   	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	       1 MPWRNKEASSPSSANPPLEALQSPSFRGNMADKLKDPSTLGFLEAAVKIS 50                                                           
						tail of F09849_P9, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence QWATMRS in     	      51 HTSPDIPAEVQMSVKEHIMRHTRLQRQTTEPASSTRHTSFKRHLPRQMHV 100                                                          
						F09849_P9.                                                   	                  .         .         .         .         .  
						                                                            	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSVDYGNELPPAAEQPTSIGRIKPELYKQKSVDGEDAKSEATKSCGKINF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLRYDYETETLIVRILKAFDLPAKDFCGSSDPYVKIYLLPDRKCKLQTRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HRKTLNPTFDENFHFPVPYEELADRKLHLSVFDFDRFSRHDMIGEVILDN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LFEASDLSRETSIWKDIQYATSESVDLGEIMFSLCYLPTAGRLTLTVIKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RNLKAMDITGYSDPYVKVSLLCDGRRLKKKKTTIKKNTLNPVYNEAIIFD 350                                                          
						                                                            	                                                             
						                                                            	     351 IP                                                 352                                                          
						                                                            	         ||                                                  
						                                                            	     351 IP                                                 352                                                          

19199	HMR136_F09963_1_tr0_r1_1_gPRT		Comparison report between F09963_P1 and S127_HUMAN_V1unique  	Sequence name: S127_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for F09963_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 19199 x S127_HUMAN_V1   ..                     
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LPILLYCREPGRY corresponding to amino     	Alignment segment 1/1:                                       
						acids 1 - 13 of F09963_P1, and a second amino acid sequence  	                                                            
						GDGNPRENSPFLNNVEVEQESFFEGKNMALFEEEMDSNPMVSSLLNKLANYTNLSQGVVE 	                     Quality: 10140.00                      Escore:       0                                              
						HEEDEESRRREAKAPRMGTFIGVYLPCLQNILGVILFLRLTWIVGVAGVLESFLIVAMCC 	             Matching length:    1042                Total length:    1042                                               
						TCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EIFLTYISPGAAIFQAEAAGGEAAAMLHNMRVYGTCTLVLMALVVFVGVKYVNKLALVFL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ACVVLSILAIYAGVIKSAFDPPDIPVCLLGNRTLSRRSFDACVKAYGIHNNSATSALWGL 	                        Gaps:       0                        
						FCNGSQPSAACDEYFIQNNVTEIQGIPGAASGVFLENLWSTYAHAGAFVEKKGVPSVPVA 	                                                            
						EESRASALPYVLTDIAASFTLLVGIYFPSVTGIMAGSNRSGDLKDAQKSIPTGTILAIVT 	Alignment:                                                   
						TSFIYLSCIVLFGACIEGVVLRDKFGEALQGNLVIGMLAWPSPWVIVIGSFFSTCGAGLQ 	                  .         .         .         .         .  
						SLTGAPRLLQAIARDGIVPFLQVFGHGKANGEPTWALLLTVLICETGILIASLDSVAPIL 	      14 GDGNPRENSPFLNNVEVEQESFFEGKNMALFEEEMDSNPMVSSLLNKLAN 63                                                           
						SMFFLMCYLFVNLACAVQTLLRTPNWRPRFKFYHWTLSFLGMSLCLALMFICSWYYALSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MLIAGCIYKYIEYRGAEKEWGDGIRGLSLNAARYALLRVEHGPPHTKNWRPQVLVMLNLD 	      42 GDGNPRENSPFLNNVEVEQESFFEGKNMALFEEEMDSNPMVSSLLNKLAN 91                                                           
						AEQAVKHPRLLSFTSQLKAGKGLTIVGSVLEGTYLDKHMEAQRAEENIRSLMSTEKTKGF 	                  .         .         .         .         .  
						CQLVVSSSLRDGMSHLIQSAGLGGLKHNTVLMAWPASWKQEDNPFSWKNFVDTVRDTTAA 	      64 YTNLSQGVVEHEEDEESRRREAKAPRMGTFIGVYLPCLQNILGVILFLRL 113                                                          
						HQALLVAKNVDSFPQNQERFGGGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AQVDDNSIQMKKDLQMFLYHLRISAEVEVVEMVENDISAFTYERTLMMEQRSQMLKQMQL 	      92 YTNLSQGVVEHEEDEESRRREAKAPRMGTFIGVYLPCLQNILGVILFLRL 141                                                          
						SKNEQEREAQLIHDRNTASHTAAAARTQAPPTPDKVQMTWTREKLIAEKYRSRDTSLSGF 	                  .         .         .         .         .  
						KDLFSMKPDQSNVRRMHTAVKLNGVVLNKSQDAQLVLLNMPGPPKNRQGDENYMEFLEVL 	     114 TWIVGVAGVLESFLIVAMCCTCTMLTAISMSAIATNGVVPAGGSYYMISR 163                                                          
						TEGLNRVLLVRGGGREVITIYS                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     142 TWIVGVAGVLESFLIVAMCCTCTMLTAISMSAIATNGVVPAGGSYYMISR 191                                                          
						acids 42 - 1083 of S127_HUMAN_V1, which also corresponds to  	                  .         .         .         .         .  
						amino acids 14 - 1055 of F09963_P1, wherein said first amino 	     164 SLGPEFGGAVGLCFYLGTTFAGAMYILGTIEIFLTYISPGAAIFQAEAAG 213                                                          
						acid sequence and second amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     192 SLGPEFGGAVGLCFYLGTTFAGAMYILGTIEIFLTYISPGAAIFQAEAAG 241                                                          
						for a head of F09963_P1, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     214 GEAAAMLHNMRVYGTCTLVLMALVVFVGVKYVNKLALVFLACVVLSILAI 263                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     242 GEAAAMLHNMRVYGTCTLVLMALVVFVGVKYVNKLALVFLACVVLSILAI 291                                                          
						LPILLYCREPGRY of F09963_P1.                                  	                  .         .         .         .         .  
						                                                            	     264 YAGVIKSAFDPPDIPVCLLGNRTLSRRSFDACVKAYGIHNNSATSALWGL 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 YAGVIKSAFDPPDIPVCLLGNRTLSRRSFDACVKAYGIHNNSATSALWGL 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 FCNGSQPSAACDEYFIQNNVTEIQGIPGAASGVFLENLWSTYAHAGAFVE 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 FCNGSQPSAACDEYFIQNNVTEIQGIPGAASGVFLENLWSTYAHAGAFVE 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     364 KKGVPSVPVAEESRASALPYVLTDIAASFTLLVGIYFPSVTGIMAGSNRS 413                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 KKGVPSVPVAEESRASALPYVLTDIAASFTLLVGIYFPSVTGIMAGSNRS 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     414 GDLKDAQKSIPTGTILAIVTTSFIYLSCIVLFGACIEGVVLRDKFGEALQ 463                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 GDLKDAQKSIPTGTILAIVTTSFIYLSCIVLFGACIEGVVLRDKFGEALQ 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     464 GNLVIGMLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIARDGIVPF 513                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 GNLVIGMLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIARDGIVPF 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     514 LQVFGHGKANGEPTWALLLTVLICETGILIASLDSVAPILSMFFLMCYLF 563                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 LQVFGHGKANGEPTWALLLTVLICETGILIASLDSVAPILSMFFLMCYLF 591                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     564 VNLACAVQTLLRTPNWRPRFKFYHWTLSFLGMSLCLALMFICSWYYALSA 613                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     592 VNLACAVQTLLRTPNWRPRFKFYHWTLSFLGMSLCLALMFICSWYYALSA 641                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     614 MLIAGCIYKYIEYRGAEKEWGDGIRGLSLNAARYALLRVEHGPPHTKNWR 663                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     642 MLIAGCIYKYIEYRGAEKEWGDGIRGLSLNAARYALLRVEHGPPHTKNWR 691                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     664 PQVLVMLNLDAEQAVKHPRLLSFTSQLKAGKGLTIVGSVLEGTYLDKHME 713                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     692 PQVLVMLNLDAEQAVKHPRLLSFTSQLKAGKGLTIVGSVLEGTYLDKHME 741                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     714 AQRAEENIRSLMSTEKTKGFCQLVVSSSLRDGMSHLIQSAGLGGLKHNTV 763                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     742 AQRAEENIRSLMSTEKTKGFCQLVVSSSLRDGMSHLIQSAGLGGLKHNTV 791                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     764 LMAWPASWKQEDNPFSWKNFVDTVRDTTAAHQALLVAKNVDSFPQNQERF 813                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     792 LMAWPASWKQEDNPFSWKNFVDTVRDTTAAHQALLVAKNVDSFPQNQERF 841                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     814 GGGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQVDDNSIQM 863                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     842 GGGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQVDDNSIQM 891                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     864 KKDLQMFLYHLRISAEVEVVEMVENDISAFTYERTLMMEQRSQMLKQMQL 913                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     892 KKDLQMFLYHLRISAEVEVVEMVENDISAFTYERTLMMEQRSQMLKQMQL 941                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     914 SKNEQEREAQLIHDRNTASHTAAAARTQAPPTPDKVQMTWTREKLIAEKY 963                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     942 SKNEQEREAQLIHDRNTASHTAAAARTQAPPTPDKVQMTWTREKLIAEKY 991                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     964 RSRDTSLSGFKDLFSMKPDQSNVRRMHTAVKLNGVVLNKSQDAQLVLLNM 1013                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     992 RSRDTSLSGFKDLFSMKPDQSNVRRMHTAVKLNGVVLNKSQDAQLVLLNM 1041                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1014 PGPPKNRQGDENYMEFLEVLTEGLNRVLLVRGGGREVITIYS         1055                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	    1042 PGPPKNRQGDENYMEFLEVLTEGLNRVLLVRGGGREVITIYS         1083                                                         

19322	HMR136_F09967_0_tr0_r1_1_gPRT		Comparison report between F09967_P0 and Q9UKV9unique head    	Sequence name: Q9UKV9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09967_P0, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19322 x Q9UKV9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	Alignment segment 1/1:                                       
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	                                                            
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	                     Quality: 6100.00                      Escore:       0                                               
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	             Matching length:     626                Total length:     626                                               
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	                        Gaps:       0                        
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	                                                            
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	Alignment:                                                   
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	                  .         .         .         .         .  
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	    1100 MEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 1149                                                         
						LSVVSDPKNRKAIENQIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPS 	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						KLALGRLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKE 	       1 MEGPRENQDPPPRPLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 50                                                           
						KRPSITQIFDSSGSHGFSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHF 	                  .         .         .         .         .  
						QDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQ 	    1150 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 1199                                                         
						VYDEIEVFPLNVYDVQLTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KGNEIMTLNGEAVSDLDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQK 	      51 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 100                                                          
						SLLPPPNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFR 	                  .         .         .         .         .  
						SAEQITALCRSFNDSQANG                                          	    1200 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 1249                                                         
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1 - 1099 of F09967_P0, a second amino acid sequence being at 	     101 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 150                                                          
						least 90 % homologous to MEGPRENQDPPPR corresponding to amino	                  .         .         .         .         .  
						acids 1 - 13 of Q9UKV9, which also corresponds to amino acids	    1250 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 1299                                                         
						1100 - 1112 of F09967_P0, a bridging amino acid S            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 1113 of F09967_P0, and a third   	     151 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 200                                                          
						LARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPE 	                  .         .         .         .         .  
						MLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHI 	    1300 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 1349                                                         
						KVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGELLMH 	     201 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 250                                                          
						STVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPF 	                  .         .         .         .         .  
						KFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKV 	    1350 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 1399                                                         
						IRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILS 	     251 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 300                                                          
						DEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQPKLVR 	                  .         .         .         .         .  
						GHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSE 	    1400 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 1449                                                         
						ECFYETESHGKS                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     301 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 350                                                          
						corresponding to amino acids 15 - 626 of Q9UKV9, which also  	                  .         .         .         .         .  
						corresponds to amino acids 1114 - 1725 of F09967_P0, wherein 	    1450 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 1499                                                         
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid and third amino acid sequence are        	     351 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 400                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of F09967_P0, comprising a   	    1500 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 1549                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     401 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 450                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	    1550 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 1599                                                         
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	     451 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 500                                                          
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	                  .         .         .         .         .  
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	    1600 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 1649                                                         
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	     501 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 550                                                          
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	                  .         .         .         .         .  
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	    1650 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 1699                                                         
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	     551 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 600                                                          
						LSVVSDPKNRKAIENQIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPS 	                  .         .                                
						KLALGRLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKE 	    1700 REFSVQSLTSVVSEECFYETESHGKS                         1725                                                         
						KRPSITQIFDSSGSHGFSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHF 	         ||||||||||||||||||||||||||                          
						QDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQ 	     601 REFSVQSLTSVVSEECFYETESHGKS                         626                                                          
						VYDEIEVFPLNVYDVQLTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLR 	                                                            
						KGNEIMTLNGEAVSDLDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQK 	                                                            
						SLLPPPNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFR 	                                                            
						SAEQITALCRSFNDSQANG                                          	                                                            
						to the sequence of F09967_P0.                                	                                                            

						Comparison report between F09967_P0 and Q9UFG6unique head    	Sequence name: Q9UFG6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a mismatch.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for F09967_P0, comprising a first amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 19322 x Q9UFG6   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	                                                            
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	                     Quality: 9895.00                      Escore:       0                                               
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	             Matching length:    1026                Total length:    1050                                               
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.81                                               
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	    Total Percent Similarity:   97.62      Total Percent Identity:   97.52                                               
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	                        Gaps:       1                        
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	                                                            
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	Alignment:                                                   
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	                  .         .         .         .         .  
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	     676 QIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALG 725                                                          
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						LSVVSDPKNRKAIENQ                                             	      21 EIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALG 70                                                           
						having the sequence corresponding to amino acids 1 - 676 of  	                  .         .         .         .         .  
						F09967_P0, a second amino acid sequence being at least 90 %  	     726 RLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLA 775                                                          
						IQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVSSFH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQ          	      71 RLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLA 120                                                          
						homologous to corresponding to amino acids 22 - 132 of       	                  .         .         .         .         .  
						Q9UFG6, which also corresponds to amino acids 677 - 787 of   	     776 RKGKEKRPSITQIFDSSGSHGFSGTQLPQNSSNSSEVDELLHIYGSTVDG 825                                                          
						F09967_P0, a third amino acid sequence being at least 70%,   	         ||||||||||||                        ||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     121 RKGKEKRPSITQ........................VDELLHIYGSTVDG 146                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     826 VPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYG 875                                                          
						IFDSSGSHGFSGTQLPQNSSNSSE corresponding to amino acids 788 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						811 of F09967_P0, a fourth amino acid sequence being at least	     147 VPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYG 196                                                          
						VDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEP 	                  .         .         .         .         .  
						SHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCDFGFAVT 	     876 LQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCD 925                                                          
						AQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDLDLKQMEALFSEKSVG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFLDNFKKNTANDFSNVP 	     197 LQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCD 246                                                          
						DITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQANGMEGPRENQDPPP 	                  .         .         .         .         .  
						R                                                            	     926 FGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSD 975                                                          
						90 % homologous to corresponding to amino acids 133 - 433 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9UFG6, which also corresponds to amino acids 812 - 1112 of  	     247 FGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSD 296                                                          
						F09967_P0, a bridging amino acid S corresponding to amino    	                  .         .         .         .         .  
						acid 1113 of F09967_P0, and a fifth amino acid sequence being	     976 LDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPP 1025                                                         
						LARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHI 	     297 LDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPP 346                                                          
						KVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQE 	                  .         .         .         .         .  
						SEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGELLMH 	    1026 PNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKM 1075                                                         
						STVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKV 	     347 PNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKM 396                                                          
						IRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGE 	                  .         .         .         .         .  
						TGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILS 	    1076 EQTFRSAEQITALCRSFNDSQANGMEGPRENQDPPPRSLARHLSDADRLR 1125                                                         
						DEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQPKLVR 	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						GHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSE 	     397 EQTFRSAEQITALCRSFNDSQANGMEGPRENQDPPPRPLARHLSDADRLR 446                                                          
						ECFYETESHGKS                                                 	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 435 	    1126 KVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPEML 1175                                                         
						- 1046 of Q9UFG6, which also corresponds to amino acids 1114 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 1725 of F09967_P0, wherein said first amino acid sequence, 	     447 KVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPEML 496                                                          
						second amino acid sequence, third amino acid sequence, fourth	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and fifth amino acid	    1176 EFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLY 1225                                                         
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F09967_P0,       	     497 EFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLY 546                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	    1226 SGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQR 1275                                                         
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	     547 SGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQR 596                                                          
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	                  .         .         .         .         .  
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	    1276 VLKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYG 1325                                                         
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	     597 VLKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYG 646                                                          
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	                  .         .         .         .         .  
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	    1326 TVFDQLVAEQSGTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELT 1375                                                         
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	     647 TVFDQLVAEQSGTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELT 696                                                          
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	                  .         .         .         .         .  
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	    1376 VFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPFKFRWLIPISALQ 1425                                                         
						LSVVSDPKNRKAIENQ                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of F09967_P0.3.An       	     697 VFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPFKFRWLIPISALQ 746                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						F09967_P0, comprising an amino acid sequence being at least  	    1426 VRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKVIR 1475                                                         
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     747 VRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKVIR 796                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						IFDSSGSHGFSGTQLPQNSSNSSE, corresponding to F09967_P0.        	    1476 SILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNS 1525                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     797 SILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNS 846                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1526 SSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPH 1575                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     847 SSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPH 896                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1576 PGLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDP 1625                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     897 PGLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDP 946                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1626 DVHPEAEQQPGPESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLK 1675                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     947 DVHPEAEQQPGPESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLK 996                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1676 AQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSEECFYETESHGKS 1725                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     997 AQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSEECFYETESHGKS 1046                                                         

						Comparison report between F09967_P0 and Q8IVF5partial WT     	Sequence name: Q8IVF5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09967_P0, comprising a first amino 	Sequence documentation:                                      
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	                                                            
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	Alignment of: 19322 x Q8IVF5   ..                            
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	                                                            
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	Alignment segment 1/1:                                       
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	                                                            
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	                     Quality: 6650.00                      Escore:       0                                               
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	             Matching length:     677                Total length:     677                                               
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.85                                               
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	                        Gaps:       0                        
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	                                                            
						LSVVSDPKNRKAIENQ                                             	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 15 - 690 of Q8IVF5, which also corresponds to 	       1 MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGS 50                                                           
						amino acids 1 - 676 of F09967_P0, and a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      15 MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGS 64                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 NGAGYKSRSLARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPG 100                                                          
						IQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVSSFH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQIFDSSGSHG 	      65 NGAGYKSRSLARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPG 114                                                          
						FSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRV 	                  .         .         .         .         .  
						EDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQ 	     101 KDFQGISAAFSTENGFHSVGHELADNHITSRDCNGHLLNCYGRNESIAST 150                                                          
						LTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFL 	     115 KDFQGISAAFSTENGFHSVGHELADNHITSRDCNGHLLNCYGRNESIAST 164                                                          
						DNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQ 	                  .         .         .         .         .  
						ANGMEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNE 	     151 PPGEDRKSPRVLIKTLGKLDGCLRVEFHNGGNPSKVPAEDCSEPVQLLRY 200                                                          
						TFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YYADHFKLYSGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRV 	     165 PPGEDRKSPRVLIKTLGKLDGCLRVEFHNGGNPSKVPAEDCSEPVQLLRY 214                                                          
						LKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQS 	                  .         .         .         .         .  
						GTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKK 	     201 SPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKGSSLSSESSWY 250                                                          
						LPSNSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASS 	     215 SPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKGSSLSSESSWY 264                                                          
						RSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHP 	                  .         .         .         .         .  
						GLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPG 	     251 DSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 300                                                          
						PESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLEREFSVQSLTSVVSEECFYETESHGKS                                	     265 DSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 314                                                          
						having the sequence corresponding to amino acids 677 - 1725  	                  .         .         .         .         .  
						of F09967_P0, wherein said first amino acid sequence and     	     301 ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDP 350                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     315 ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDP 364                                                          
						F09967_P0, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     351 IQYSSFTLPCRKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEP 400                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVSSFH 	     365 IQYSSFTLPCRKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEP 414                                                          
						ALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQIFDSSGSHG 	                  .         .         .         .         .  
						FSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRV 	     401 RSKEGSDYFDSRSDGLNTDVQGSSQASAFLWSGGSTQILSQRSESTHAIG 450                                                          
						EDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDL 	     415 RSKEGSDYFDSRSDGLNTDVQGSSQASAFLWSGGSTQILSQRSESTHAIG 464                                                          
						DLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFL 	                  .         .         .         .         .  
						DNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQ 	     451 SDPLRQNIYENFMRELEMSRTNTENIETSTETAESSSESLSSLEQLDLLF 500                                                          
						ANGMEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFL 	     465 SDPLRQNIYENFMRELEMSRTNTENIETSTETAESSSESLSSLEQLDLLF 514                                                          
						YYADHFKLYSGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRV 	                  .         .         .         .         .  
						LKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQS 	     501 EKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWVTLKGCTLLFY 550                                                          
						GTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPSNSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETI 	     515 EKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWVTLKGCTLLFY 564                                                          
						FQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASS 	                  .         .         .         .         .  
						RSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHP 	     551 ETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 600                                                          
						GLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNS 	     565 ETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 614                                                          
						VLEREFSVQSLTSVVSEECFYETESHGKS                                	                  .         .         .         .         .  
						least about 95% homologous to the sequence in F09967_P0.     	     601 QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMD 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     615 QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMD 664                                                          
						                                                            	                  .         .                                
						                                                            	     651 SKMKKMAELQLSVVSDPKNRKAIENQI                        677                                                          
						                                                            	         ||||||||||||||||||||||||||:                         
						                                                            	     665 SKMKKMAELQLSVVSDPKNRKAIENQV                        691                                                          

19324	HMR136_F09967_2_tr0_r1_1_gPRT		Comparison report between F09967_P2 and Q9UKV9unique head    	Sequence name: Q9UKV9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09967_P2, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19324 x Q9UKV9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	Alignment segment 1/1:                                       
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	                                                            
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	                     Quality: 6100.00                      Escore:       0                                               
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	             Matching length:     626                Total length:     626                                               
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	                        Gaps:       0                        
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	                                                            
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	Alignment:                                                   
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	                  .         .         .         .         .  
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	    1100 MEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 1149                                                         
						LSVVSDPKNRKAIENQIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPS 	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						KLALGRLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKE 	       1 MEGPRENQDPPPRPLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 50                                                           
						KRPSITQIFDSSGSHGFSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHF 	                  .         .         .         .         .  
						QDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQ 	    1150 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 1199                                                         
						VYDEIEVFPLNVYDVQLTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KGNEIMTLNGEAVSDLDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQK 	      51 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 100                                                          
						SLLPPPNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFR 	                  .         .         .         .         .  
						SAEQITALCRSFNDSQANG                                          	    1200 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 1249                                                         
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1 - 1099 of F09967_P2, a second amino acid sequence being at 	     101 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 150                                                          
						least 90 % homologous to MEGPRENQDPPPR corresponding to amino	                  .         .         .         .         .  
						acids 1 - 13 of Q9UKV9, which also corresponds to amino acids	    1250 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 1299                                                         
						1100 - 1112 of F09967_P2, a bridging amino acid S            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 1113 of F09967_P2, and a third   	     151 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 200                                                          
						LARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPE 	                  .         .         .         .         .  
						MLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHI 	    1300 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 1349                                                         
						KVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGELLMH 	     201 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 250                                                          
						STVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPF 	                  .         .         .         .         .  
						KFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKV 	    1350 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 1399                                                         
						IRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILS 	     251 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 300                                                          
						DEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQPKLVR 	                  .         .         .         .         .  
						GHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSE 	    1400 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 1449                                                         
						ECFYETESHGKS                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     301 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 350                                                          
						corresponding to amino acids 15 - 626 of Q9UKV9, which also  	                  .         .         .         .         .  
						corresponds to amino acids 1114 - 1725 of F09967_P2, wherein 	    1450 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 1499                                                         
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid and third amino acid sequence are        	     351 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 400                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of F09967_P2, comprising a   	    1500 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 1549                                                         
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     401 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 450                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	    1550 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 1599                                                         
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	     451 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 500                                                          
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	                  .         .         .         .         .  
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	    1600 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 1649                                                         
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	     501 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 550                                                          
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	                  .         .         .         .         .  
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	    1650 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 1699                                                         
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	     551 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 600                                                          
						LSVVSDPKNRKAIENQIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPS 	                  .         .                                
						KLALGRLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKE 	    1700 REFSVQSLTSVVSEECFYETESHGKS                         1725                                                         
						KRPSITQIFDSSGSHGFSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHF 	         ||||||||||||||||||||||||||                          
						QDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQ 	     601 REFSVQSLTSVVSEECFYETESHGKS                         626                                                          
						VYDEIEVFPLNVYDVQLTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLR 	                                                            
						KGNEIMTLNGEAVSDLDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQK 	                                                            
						SLLPPPNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFR 	                                                            
						SAEQITALCRSFNDSQANG                                          	                                                            
						to the sequence of F09967_P2.                                	                                                            

						Comparison report between F09967_P2 and Q9UFG6unique head    	Sequence name: Q9UFG6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a mismatch.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for F09967_P2, comprising a first amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 19324 x Q9UFG6   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	                                                            
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	                     Quality: 9895.00                      Escore:       0                                               
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	             Matching length:    1026                Total length:    1050                                               
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.81                                               
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	    Total Percent Similarity:   97.62      Total Percent Identity:   97.52                                               
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	                        Gaps:       1                        
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	                                                            
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	Alignment:                                                   
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	                  .         .         .         .         .  
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	     676 QIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALG 725                                                          
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						LSVVSDPKNRKAIENQ                                             	      21 EIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALG 70                                                           
						having the sequence corresponding to amino acids 1 - 676 of  	                  .         .         .         .         .  
						F09967_P2, a second amino acid sequence being at least 90 %  	     726 RLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLA 775                                                          
						IQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVSSFH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQ          	      71 RLGILSVSSFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLA 120                                                          
						homologous to corresponding to amino acids 22 - 132 of       	                  .         .         .         .         .  
						Q9UFG6, which also corresponds to amino acids 677 - 787 of   	     776 RKGKEKRPSITQIFDSSGSHGFSGTQLPQNSSNSSEVDELLHIYGSTVDG 825                                                          
						F09967_P2, a third amino acid sequence being at least 70%,   	         ||||||||||||                        ||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     121 RKGKEKRPSITQ........................VDELLHIYGSTVDG 146                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     826 VPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYG 875                                                          
						IFDSSGSHGFSGTQLPQNSSNSSE corresponding to amino acids 788 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						811 of F09967_P2, a fourth amino acid sequence being at least	     147 VPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYG 196                                                          
						VDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEP 	                  .         .         .         .         .  
						SHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCDFGFAVT 	     876 LQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCD 925                                                          
						AQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDLDLKQMEALFSEKSVG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFLDNFKKNTANDFSNVP 	     197 LQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCD 246                                                          
						DITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQANGMEGPRENQDPPP 	                  .         .         .         .         .  
						R                                                            	     926 FGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSD 975                                                          
						90 % homologous to corresponding to amino acids 133 - 433 of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9UFG6, which also corresponds to amino acids 812 - 1112 of  	     247 FGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSD 296                                                          
						F09967_P2, a bridging amino acid S corresponding to amino    	                  .         .         .         .         .  
						acid 1113 of F09967_P2, and a fifth amino acid sequence being	     976 LDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPP 1025                                                         
						LARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHI 	     297 LDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPP 346                                                          
						KVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQE 	                  .         .         .         .         .  
						SEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGELLMH 	    1026 PNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKM 1075                                                         
						STVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKV 	     347 PNQSQLLEEFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKM 396                                                          
						IRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGE 	                  .         .         .         .         .  
						TGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILS 	    1076 EQTFRSAEQITALCRSFNDSQANGMEGPRENQDPPPRSLARHLSDADRLR 1125                                                         
						DEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQPKLVR 	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						GHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSE 	     397 EQTFRSAEQITALCRSFNDSQANGMEGPRENQDPPPRPLARHLSDADRLR 446                                                          
						ECFYETESHGKS                                                 	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 435 	    1126 KVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPEML 1175                                                         
						- 1046 of Q9UFG6, which also corresponds to amino acids 1114 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 1725 of F09967_P2, wherein said first amino acid sequence, 	     447 KVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPEML 496                                                          
						second amino acid sequence, third amino acid sequence, fourth	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and fifth amino acid	    1176 EFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLY 1225                                                         
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of F09967_P2,       	     497 EFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLY 546                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	    1226 SGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQR 1275                                                         
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	     547 SGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQR 596                                                          
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	                  .         .         .         .         .  
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	    1276 VLKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYG 1325                                                         
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	     597 VLKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYG 646                                                          
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	                  .         .         .         .         .  
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	    1326 TVFDQLVAEQSGTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELT 1375                                                         
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	     647 TVFDQLVAEQSGTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELT 696                                                          
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	                  .         .         .         .         .  
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	    1376 VFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPFKFRWLIPISALQ 1425                                                         
						LSVVSDPKNRKAIENQ                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of F09967_P2.3.An       	     697 VFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPFKFRWLIPISALQ 746                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						F09967_P2, comprising an amino acid sequence being at least  	    1426 VRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKVIR 1475                                                         
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     747 VRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKVIR 796                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						IFDSSGSHGFSGTQLPQNSSNSSE, corresponding to F09967_P2.        	    1476 SILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNS 1525                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     797 SILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNS 846                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1526 SSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPH 1575                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     847 SSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPH 896                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1576 PGLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDP 1625                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     897 PGLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDP 946                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1626 DVHPEAEQQPGPESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLK 1675                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     947 DVHPEAEQQPGPESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLK 996                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1676 AQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSEECFYETESHGKS 1725                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     997 AQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSEECFYETESHGKS 1046                                                         

						Comparison report between F09967_P2 and Q8IVF5partial WT     	Sequence name: Q8IVF5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09967_P2, comprising a first amino 	Sequence documentation:                                      
						MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGSNGAGYKSRSL 	                                                            
						ARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPGKDFQGISAAFSTENGFHSVG 	Alignment of: 19324 x Q8IVF5   ..                            
						HELADNHITSRDCNGHLLNCYGRNESIASTPPGEDRKSPRVLIKTLGKLDGCLRVEFHNG 	                                                            
						GNPSKVPAEDCSEPVQLLRYSPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKG 	Alignment segment 1/1:                                       
						SSLSSESSWYDSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 	                                                            
						ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDPIQYSSFTLPC 	                     Quality: 6650.00                      Escore:       0                                               
						RKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEPRSKEGSDYFDSRSDGLNTDV 	             Matching length:     677                Total length:     677                                               
						QGSSQASAFLWSGGSTQILSQRSESTHAIGSDPLRQNIYENFMRELEMSRTNTENIETST 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						ETAESSSESLSSLEQLDLLFEKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.85                                               
						TLKGCTLLFYETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 	                        Gaps:       0                        
						QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMDSKMKKMAELQ 	                                                            
						LSVVSDPKNRKAIENQ                                             	Alignment:                                                   
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 15 - 690 of Q8IVF5, which also corresponds to 	       1 MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGS 50                                                           
						amino acids 1 - 676 of F09967_P2, and a second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      15 MGNSDSQYTLQGSKNHSNTITGAKQIPCSLKIRGIHAKEEKSLHGWGHGS 64                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 NGAGYKSRSLARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPG 100                                                          
						IQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVSSFH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQIFDSSGSHG 	      65 NGAGYKSRSLARSCLSHFKSNQPYASRLGGPTCKVSRGVAYSTHRTNAPG 114                                                          
						FSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRV 	                  .         .         .         .         .  
						EDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQ 	     101 KDFQGISAAFSTENGFHSVGHELADNHITSRDCNGHLLNCYGRNESIAST 150                                                          
						LTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFL 	     115 KDFQGISAAFSTENGFHSVGHELADNHITSRDCNGHLLNCYGRNESIAST 164                                                          
						DNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQ 	                  .         .         .         .         .  
						ANGMEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNE 	     151 PPGEDRKSPRVLIKTLGKLDGCLRVEFHNGGNPSKVPAEDCSEPVQLLRY 200                                                          
						TFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YYADHFKLYSGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRV 	     165 PPGEDRKSPRVLIKTLGKLDGCLRVEFHNGGNPSKVPAEDCSEPVQLLRY 214                                                          
						LKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQS 	                  .         .         .         .         .  
						GTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKK 	     201 SPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKGSSLSSESSWY 250                                                          
						LPSNSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASS 	     215 SPTLASETSPVPEARRGSSADSLPSHRPSPTDSRLRSSKGSSLSSESSWY 264                                                          
						RSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHP 	                  .         .         .         .         .  
						GLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPG 	     251 DSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 300                                                          
						PESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLEREFSVQSLTSVVSEECFYETESHGKS                                	     265 DSPWGNAGELSEAEGSFLAPGMPDPSLHASFPPGDAKKPFNQSSSLSSLR 314                                                          
						having the sequence corresponding to amino acids 677 - 1725  	                  .         .         .         .         .  
						of F09967_P2, wherein said first amino acid sequence and     	     301 ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDP 350                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     315 ELYKDANLGSLSPSGIRLSDEYMGTHASLSNRVSFASDIDVPSRVAHGDP 364                                                          
						F09967_P2, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     351 IQYSSFTLPCRKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEP 400                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVSSFH 	     365 IQYSSFTLPCRKPKAFVEDTAKKDSLKARMRRISDWTGSLSRKKRKLQEP 414                                                          
						ALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQIFDSSGSHG 	                  .         .         .         .         .  
						FSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRV 	     401 RSKEGSDYFDSRSDGLNTDVQGSSQASAFLWSGGSTQILSQRSESTHAIG 450                                                          
						EDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDL 	     415 RSKEGSDYFDSRSDGLNTDVQGSSQASAFLWSGGSTQILSQRSESTHAIG 464                                                          
						DLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFL 	                  .         .         .         .         .  
						DNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQ 	     451 SDPLRQNIYENFMRELEMSRTNTENIETSTETAESSSESLSSLEQLDLLF 500                                                          
						ANGMEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFL 	     465 SDPLRQNIYENFMRELEMSRTNTENIETSTETAESSSESLSSLEQLDLLF 514                                                          
						YYADHFKLYSGFCANHIKVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRV 	                  .         .         .         .         .  
						LKYPLLLKELVSLTDQESEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQS 	     501 EKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWVTLKGCTLLFY 550                                                          
						GTEKEVTELSMGELLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPSNSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETI 	     515 EKEQGVVRKAGWLFFKPLVTVQKERKLELVARRKWKQYWVTLKGCTLLFY 564                                                          
						FQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASS 	                  .         .         .         .         .  
						RSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHP 	     551 ETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 600                                                          
						GLADFADNLIKESDILSDEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PESGEGQKGGEQPKLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNS 	     565 ETYGKNSMDQSSAPRCALFAEDSIVQSVPEHPKKENVFCLSNSFGDVYLF 614                                                          
						VLEREFSVQSLTSVVSEECFYETESHGKS                                	                  .         .         .         .         .  
						least about 95% homologous to the sequence in F09967_P2.     	     601 QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMD 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     615 QATSQTDLENWVTAVHSACASLFAKKHGKEDTLRLLKNQTKNLLQKIDMD 664                                                          
						                                                            	                  .         .                                
						                                                            	     651 SKMKKMAELQLSVVSDPKNRKAIENQI                        677                                                          
						                                                            	         ||||||||||||||||||||||||||:                         
						                                                            	     665 SKMKKMAELQLSVVSDPKNRKAIENQV                        691                                                          

19320	HMR136_F09967_3_tr0_r1_1_gPRT		Comparison report between F09967_P3 and Q9UKV9unique head    	Sequence name: Q9UKV9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09967_P3, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19320 x Q9UKV9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MLSGTTPAWSEGAGSGRDKLHCDAACPTASCGAGRAIQSSAWRQGGRPSSPQASRARQLP 	Alignment segment 1/1:                                       
						SIEIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVS 	                                                            
						SFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQVDELLH 	                     Quality: 6100.00                      Escore:       0                                               
						IYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYGLQ 	             Matching length:     626                Total length:     626                                               
						LRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCDFGFAVTAQVDER 	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						QHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDLDLKQMEALFSEKSVGLTLIAR 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						PPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFLDNFKKNTANDFSNVPDITTGL 	                        Gaps:       0                        
						KRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQANG                   	                                                            
						polypeptide having the sequence corresponding to amino acids 	Alignment:                                                   
						1 - 462 of F09967_P3, a second amino acid sequence being at  	                  .         .         .         .         .  
						least 90 % homologous to MEGPRENQDPPPR corresponding to amino	     463 MEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 512                                                          
						acids 1 - 13 of Q9UKV9, which also corresponds to amino acids	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						463 - 475 of F09967_P3, a bridging amino acid S corresponding	       1 MEGPRENQDPPPRPLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 50                                                           
						to amino acid 476 of F09967_P3, and a third amino acid       	                  .         .         .         .         .  
						LARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPE 	     513 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 562                                                          
						MLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQE 	      51 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 100                                                          
						SEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGELLMH 	                  .         .         .         .         .  
						STVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPF 	     563 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 612                                                          
						KFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGE 	     101 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 150                                                          
						TGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILS 	                  .         .         .         .         .  
						DEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQPKLVR 	     613 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 662                                                          
						GHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ECFYETESHGKS                                                 	     151 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 200                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 15 - 626 of Q9UKV9, which also corresponds to    	     663 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 712                                                          
						amino acids 477 - 1088 of F09967_P3, wherein said first amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, bridging amino    	     201 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 250                                                          
						acid and third amino acid sequence are contiguous and in a   	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     713 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 762                                                          
						head of F09967_P3, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     251 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 300                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						MLSGTTPAWSEGAGSGRDKLHCDAACPTASCGAGRAIQSSAWRQGGRPSSPQASRARQLP 	     763 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 812                                                          
						SIEIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQVDELLH 	     301 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 350                                                          
						IYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPEHRVEDILTLACKMRQLEPSHYGLQ 	                  .         .         .         .         .  
						LRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVYDVQLTKTGSVCDFGFAVTAQVDER 	     813 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 862                                                          
						QHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAVSDLDLKQMEALFSEKSVGLTLIAR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLEEFLDNFKKNTANDFSNVPDITTGL 	     351 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 400                                                          
						KRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFNDSQANG                   	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of F09967_P3.  	     863 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 912                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     913 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 962                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     963 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 1012                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1013 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 1062                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 600                                                          
						                                                            	                  .         .                                
						                                                            	    1063 REFSVQSLTSVVSEECFYETESHGKS                         1088                                                         
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     601 REFSVQSLTSVVSEECFYETESHGKS                         626                                                          

19326	HMR136_F09967_4_tr0_r1_1_gPRT		Comparison report between F09967_P4 and Q9UKV9unique head    	Sequence name: Q9UKV9                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for F09967_P4, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19326 x Q9UKV9   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MLSGTTPAWSEGAGSGRDKLHCDAACPTASCGAGRAIQSSAWRQGGRPSSPQASRARQLP 	Alignment segment 1/1:                                       
						SIEIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVS 	                                                            
						SFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQIFDSSG 	                     Quality: 6100.00                      Escore:       0                                               
						SHGFSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPE 	             Matching length:     626                Total length:     626                                               
						HRVEDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVY 	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						DVQLTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAV 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						SDLDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLE 	                        Gaps:       0                        
						EFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFN 	                                                            
						DSQANG                                                       	Alignment:                                                   
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						1 - 486 of F09967_P4, a second amino acid sequence being at  	     487 MEGPRENQDPPPRSLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 536                                                          
						least 90 % homologous to MEGPRENQDPPPR corresponding to amino	         ||||||||||||| ||||||||||||||||||||||||||||||||||||  
						acids 1 - 13 of Q9UKV9, which also corresponds to amino acids	       1 MEGPRENQDPPPRPLARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELY 50                                                           
						487 - 499 of F09967_P4, a bridging amino acid S corresponding	                  .         .         .         .         .  
						to amino acid 500 of F09967_P4, and a third amino acid       	     537 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 586                                                          
						LARHLSDADRLRKVIQELVDTEKSYVKDLSCLFELYLEPLQNETFLTQDEMESLFGSLPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MLEFQKVFLETLEDGISASSDFNTLETPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHI 	      51 LEPLQNETFLTQDEMESLFGSLPEMLEFQKVFLETLEDGISASSDFNTLE 100                                                          
						KVQKVLERAKTDKAFKAFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQE 	                  .         .         .         .         .  
						SEEHYHLTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGELLMH 	     587 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 636                                                          
						STVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPSNSRPAHNSTDLDPF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEIEGRPETIFQLCCSDSESKTNIVKV 	     101 TPSQFRKLLFSLGGSFLYYADHFKLYSGFCANHIKVQKVLERAKTDKAFK 150                                                          
						IRSILRENFRRHIKCELPLEKTCKDRLVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGE 	                  .         .         .         .         .  
						TGKGTLLDSDEGSLSSGTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILS 	     637 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 686                                                          
						DEDDDHRQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQPKLVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLEREFSVQSLTSVVSE 	     151 AFLDARNPTKQHSSTLESYLIKPVQRVLKYPLLLKELVSLTDQESEEHYH 200                                                          
						ECFYETESHGKS                                                 	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     687 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 736                                                          
						amino acids 15 - 626 of Q9UKV9, which also corresponds to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 501 - 1112 of F09967_P4, wherein said first amino	     201 LTEALKAMEKVASHINEMQKIYEDYGTVFDQLVAEQSGTEKEVTELSMGE 250                                                          
						acid sequence, second amino acid sequence, bridging amino    	                  .         .         .         .         .  
						acid and third amino acid sequence are contiguous and in a   	     737 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 786                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of F09967_P4, comprising a polypeptide being at least   	     251 LLMHSTVSWLNPFLSLGKARKDLELTVFVFKRAVILVYKENCKLKKKLPS 300                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     787 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 836                                                          
						MLSGTTPAWSEGAGSGRDKLHCDAACPTASCGAGRAIQSSAWRQGGRPSSPQASRARQLP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIEIQQWEQNLEKFHMDLFRMRCYLASLQGGELPNPKSLLAAASRPSKLALGRLGILSVS 	     301 NSRPAHNSTDLDPFKFRWLIPISALQVRLGNPAGTENNSIWELIHTKSEI 350                                                          
						SFHALVCSRDDSALRKRTLSLTQRGRNKKGIFSSLKGLDTLARKGKEKRPSITQIFDSSG 	                  .         .         .         .         .  
						SHGFSGTQLPQNSSNSSEVDELLHIYGSTVDGVPRDNAWEIQTYVHFQDNHGVTVGIKPE 	     837 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 886                                                          
						HRVEDILTLACKMRQLEPSHYGLQLRKLVDDNVEYCIPAPYEYMQQQVYDEIEVFPLNVY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DVQLTKTGSVCDFGFAVTAQVDERQHLSRIFISDVLPDGLAYGEGLRKGNEIMTLNGEAV 	     351 EGRPETIFQLCCSDSESKTNIVKVIRSILRENFRRHIKCELPLEKTCKDR 400                                                          
						SDLDLKQMEALFSEKSVGLTLIARPPDTKATLCTSWSDSDLFSRDQKSLLPPPNQSQLLE 	                  .         .         .         .         .  
						EFLDNFKKNTANDFSNVPDITTGLKRSQTDGTLDQVSHREKMEQTFRSAEQITALCRSFN 	     887 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 936                                                          
						DSQANG                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence of F09967_P4.  	     401 LVPLKNRVPVSAKLASSRSLKVLKNSSSNEWTGETGKGTLLDSDEGSLSS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     937 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 986                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GTQSSGCPTAEGRQDSKSTSPGKYPHPGLADFADNLIKESDILSDEDDDH 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     987 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 1036                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RQTVKQGSPTKDIEIQFQRLRISEDPDVHPEAEQQPGPESGEGQKGGEQP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1037 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 1086                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 KLVRGHFCPIKRKANSTKRDRGTLLKAQIRHQSLDSQSENATIDLNSVLE 600                                                          
						                                                            	                  .         .                                
						                                                            	    1087 REFSVQSLTSVVSEECFYETESHGKS                         1112                                                         
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     601 REFSVQSLTSVVSEECFYETESHGKS                         626                                                          

1040	HMR136_F09972_3_tr0_r1_1_gPRT		Comparison report between F09972_P3 and Q9NTI5partial WT     	Sequence name: Q9NTI5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09972_P3, comprising a first amino 	Sequence documentation:                                      
						MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGCVREITKKLGN 	                                                            
						PKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSIDGTADDEDEGVPTDQAIRAG 	Alignment of: 1040 x Q9NTI5   ..                             
						LELLKVLSFTHPISFHSAETFESLLACLKMDDEKVAEAALQIFKNTGSKIEEDFPHIRSA 	                                                            
						LLPVLHHKSKKGPPRQAKYAIHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVT 	Alignment segment 1/1:                                       
						IGHIALLAPDQFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 	                                                            
						KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLRLAAGSAIVKL 	                     Quality: 8457.00                      Escore:       0                                               
						AQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKGLSRLRLPLEYMAICALCAKD 	             Matching length:     861                Total length:     861                                               
						PVKERRAHARQCLVKNINVRREYLKQHAAVSEKLLSLLPEYVVPYTIHLLAHDPDYVKVQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DIEQLKDVKECLWFVLEILMAKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DVAMNIIMSKSTTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 	                        Gaps:       0                        
						VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEMDHSENEDYTM 	                                                            
						SSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKLGMDDLTKLVQEQKPKGSQRS 	Alignment:                                                   
						RKRGHTASESDEQQWPEEKRLKEDILENEDEQNSPPKKGKRGRPPKPLGGGTPKEEPTMK 	                  .         .         .         .         .  
						TSKKGSKKKSGPPAPEEEEEEERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQS 	       1 MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGC 50                                                           
						TPQKGRGRPSKTPSPSQPKKN                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     530 MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGC 579                                                          
						to amino acids 530 - 1390 of Q9NTI5, which also corresponds  	                  .         .         .         .         .  
						to amino acids 1 - 861 of F09972_P3, and a second amino acid 	      51 VREITKKLGNPKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSI 100                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     580 VREITKKLGNPKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSI 629                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PCRTLQTSSY corresponding to amino acids  	     101 DGTADDEDEGVPTDQAIRAGLELLKVLSFTHPISFHSAETFESLLACLKM 150                                                          
						862 - 871 of F09972_P3, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	     630 DGTADDEDEGVPTDQAIRAGLELLKVLSFTHPISFHSAETFESLLACLKM 679                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F09972_P3, comprising a polypeptide being at least   	     151 DDEKVAEAALQIFKNTGSKIEEDFPHIRSALLPVLHHKSKKGPPRQAKYA 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     680 DDEKVAEAALQIFKNTGSKIEEDFPHIRSALLPVLHHKSKKGPPRQAKYA 729                                                          
						at least about 95% homologous to the sequence PCRTLQTSSY in  	                  .         .         .         .         .  
						F09972_P3.                                                   	     201 IHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVTIGHIALLAPD 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     730 IHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVTIGHIALLAPD 779                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     780 QFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 829                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     830 KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLR 879                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LAAGSAIVKLAQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     880 LAAGSAIVKLAQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKG 929                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LSRLRLPLEYMAICALCAKDPVKERRAHARQCLVKNINVRREYLKQHAAV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     930 LSRLRLPLEYMAICALCAKDPVKERRAHARQCLVKNINVRREYLKQHAAV 979                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SEKLLSLLPEYVVPYTIHLLAHDPDYVKVQDIEQLKDVKECLWFVLEILM 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     980 SEKLLSLLPEYVVPYTIHLLAHDPDYVKVQDIEQLKDVKECLWFVLEILM 1029                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 AKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVCDVAMNIIMSK 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1030 AKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVCDVAMNIIMSK 1079                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 STTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1080 STTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 1129                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1130 VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEM 1179                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DHSENEDYTMSSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1180 DHSENEDYTMSSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKL 1229                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GMDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENED 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1230 GMDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENED 1279                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EQNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1280 EQNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEE 1329                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 EERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQSTPQKGRGRPS 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1330 EERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQSTPQKGRGRPS 1379                                                         
						                                                            	                  .                                          
						                                                            	     851 KTPSPSQPKKN                                        861                                                          
						                                                            	         |||||||||||                                         
						                                                            	    1380 KTPSPSQPKKN                                        1390                                                         

						Comparison report between F09972_P3 and Q9H5N8unique head    	Sequence name: Q9H5N8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						F09972_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 1040 x Q9H5N8   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGCVREITKKLGN 	Alignment segment 1/1:                                       
						PKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSIDGTADDEDEGVPTDQAIRAG 	                                                            
						LELLKVLSFTHPISFHSAETFESLLACLKMDDEKVAEAALQIFKNTGSKIEEDFPHIRSA 	                     Quality: 1255.00                      Escore:       0                                               
						LLPVLHHKSKKGPPRQAKYAIHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVT 	             Matching length:     125                Total length:     125                                               
						IGHIALLAPDQFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLRLAAGSAIVKL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKGLSRLRLPLEYMAICALCAKD 	                        Gaps:       0                        
						PVKERRAHARQCLVKNINVRREYLKQHAAVSEKLLSLLPEYVVPYTIHLLAHDPDYVKVQ 	                                                            
						DIEQLKDVKECLWFVLEILMAKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVC 	Alignment:                                                   
						DVAMNIIMSKSTTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 	                  .         .         .         .         .  
						VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEMDHSENEDYTM 	     702 MDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENEDE 751                                                          
						SSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKLG                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	       1 MDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENEDE 50                                                           
						to amino acids 1 - 701 of F09972_P3, a second amino acid     	                  .         .         .         .         .  
						MDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENEDEQNSPPKKGKR 	     752 QNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEEE 801                                                          
						GRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEEEERQSGNTEQKSKSKQHRVSR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RAQQR                                                        	      51 QNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEEE 100                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .                                
						amino acids 1 - 125 of Q9H5N8, which also corresponds to     	     802 ERQSGNTEQKSKSKQHRVSRRAQQR                          826                                                          
						amino acids 702 - 826 of F09972_P3, and a third amino acid   	         |||||||||||||||||||||||||                           
						sequence being at least 70%, optionally at least 80%,        	     101 ERQSGNTEQKSKSKQHRVSRRAQQR                          125                                                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	                                                            
						AESPESSAIESTQSTPQKGRGRPSKTPSPSQPKKNPCRTLQTSSY corresponding  	                                                            
						to amino acids 827 - 871 of F09972_P3, wherein said first    	                                                            
						amino acid sequence, second amino acid sequence and third    	                                                            
						amino acid sequence are contiguous and in a sequential       	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						F09972_P3, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGCVREITKKLGN 	                                                            
						PKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSIDGTADDEDEGVPTDQAIRAG 	                                                            
						LELLKVLSFTHPISFHSAETFESLLACLKMDDEKVAEAALQIFKNTGSKIEEDFPHIRSA 	                                                            
						LLPVLHHKSKKGPPRQAKYAIHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVT 	                                                            
						IGHIALLAPDQFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 	                                                            
						KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLRLAAGSAIVKL 	                                                            
						AQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKGLSRLRLPLEYMAICALCAKD 	                                                            
						PVKERRAHARQCLVKNINVRREYLKQHAAVSEKLLSLLPEYVVPYTIHLLAHDPDYVKVQ 	                                                            
						DIEQLKDVKECLWFVLEILMAKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVC 	                                                            
						DVAMNIIMSKSTTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 	                                                            
						VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEMDHSENEDYTM 	                                                            
						SSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKLG                    	                                                            
						least about 95% homologous to the sequence of F09972_P3.3.An 	                                                            
						isolated polypeptide encoding for a tail of F09972_P3,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						AESPESSAIESTQSTPQKGRGRPSKTPSPSQPKKNPCRTLQTSSY in F09972_P3.  	                                                            

						Comparison report between F09972_P3 and Q9Y2I5partial WT     	Sequence name: Q9Y2I5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09972_P3, comprising a first amino 	Sequence documentation:                                      
						MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGCVREITKKLGN 	                                                            
						PKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSIDGTADDEDEGVPTDQAIRAG 	Alignment of: 1040 x Q9Y2I5   ..                             
						LELLKVLSFTHPISFHSAETFESLLACLKMDDEKVAEAALQIFKNTGSKIEEDFPHIRSA 	                                                            
						LLPVLHHKSKKGPPRQAKYAIHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVT 	Alignment segment 1/1:                                       
						IGHIALLAPDQFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 	                                                            
						KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLRLAAGSAIVKL 	                     Quality: 8457.00                      Escore:       0                                               
						AQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKGLSRLRLPLEYMAICALCAKD 	             Matching length:     861                Total length:     861                                               
						PVKERRAHARQCLVKNINVRREYLKQHAAVSEKLLSLLPEYVVPYTIHLLAHDPDYVKVQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DIEQLKDVKECLWFVLEILMAKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DVAMNIIMSKSTTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 	                        Gaps:       0                        
						VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEMDHSENEDYTM 	                                                            
						SSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKLGMDDLTKLVQEQKPKGSQRS 	Alignment:                                                   
						RKRGHTASESDEQQWPEEKRLKEDILENEDEQNSPPKKGKRGRPPKPLGGGTPKEEPTMK 	                  .         .         .         .         .  
						TSKKGSKKKSGPPAPEEEEEEERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQS 	       1 MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGC 50                                                           
						TPQKGRGRPSKTPSPSQPKKN                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     566 MVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGC 615                                                          
						to amino acids 566 - 1426 of Q9Y2I5, which also corresponds  	                  .         .         .         .         .  
						to amino acids 1 - 861 of F09972_P3, and a second amino acid 	      51 VREITKKLGNPKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSI 100                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     616 VREITKKLGNPKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSI 665                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PCRTLQTSSY corresponding to amino acids  	     101 DGTADDEDEGVPTDQAIRAGLELLKVLSFTHPISFHSAETFESLLACLKM 150                                                          
						862 - 871 of F09972_P3, wherein said first amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	     666 DGTADDEDEGVPTDQAIRAGLELLKVLSFTHPISFHSAETFESLLACLKM 715                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of F09972_P3, comprising a polypeptide being at least   	     151 DDEKVAEAALQIFKNTGSKIEEDFPHIRSALLPVLHHKSKKGPPRQAKYA 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     716 DDEKVAEAALQIFKNTGSKIEEDFPHIRSALLPVLHHKSKKGPPRQAKYA 765                                                          
						at least about 95% homologous to the sequence PCRTLQTSSY in  	                  .         .         .         .         .  
						F09972_P3.                                                   	     201 IHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVTIGHIALLAPD 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     766 IHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVTIGHIALLAPD 815                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     816 QFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAI 865                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     866 KMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLR 915                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LAAGSAIVKLAQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     916 LAAGSAIVKLAQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKG 965                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LSRLRLPLEYMAICALCAKDPVKERRAHARQCLVKNINVRREYLKQHAAV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     966 LSRLRLPLEYMAICALCAKDPVKERRAHARQCLVKNINVRREYLKQHAAV 1015                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SEKLLSLLPEYVVPYTIHLLAHDPDYVKVQDIEQLKDVKECLWFVLEILM 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1016 SEKLLSLLPEYVVPYTIHLLAHDPDYVKVQDIEQLKDVKECLWFVLEILM 1065                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 AKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVCDVAMNIIMSK 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1066 AKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVCDVAMNIIMSK 1115                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 STTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1116 STTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTN 1165                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1166 VLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEM 1215                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DHSENEDYTMSSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1216 DHSENEDYTMSSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKL 1265                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GMDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENED 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1266 GMDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENED 1315                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EQNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1316 EQNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEE 1365                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 EERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQSTPQKGRGRPS 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1366 EERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQSTPQKGRGRPS 1415                                                         
						                                                            	                  .                                          
						                                                            	     851 KTPSPSQPKKN                                        861                                                          
						                                                            	         |||||||||||                                         
						                                                            	    1416 KTPSPSQPKKN                                        1426                                                         

1042	HMR136_F09972_6_tr0_r1_1_gPRT		Comparison report between F09972_P6 and Q9NTI5unique head    	Sequence name: Q9NTI5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09972_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 1042 x Q9NTI5   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence HCVLHVFYSS corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of F09972_P6, and a second amino acid sequence being at 	                                                            
						least 90 % homologous to                                     	                     Quality:  536.00                      Escore:       0                                               
						RVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRSAKRERR     	             Matching length:      56                Total length:      56                                               
						corresponding to amino acids 1392 - 1447 of Q9NTI5, which    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 11 - 66 of F09972_P6, wherein	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						said first amino acid sequence and second amino acid sequence	                        Gaps:       0                        
						are contiguous and in a sequential order.2.An isolated       	                                                            
						polypeptide encoding for a head of F09972_P6, comprising a   	Alignment:                                                   
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      11 RVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRS 60                                                           
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence HCVLHVFYSS of F09972_P6.                     	    1392 RVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRS 1441                                                         
						                                                            	                                                             
						                                                            	      61 AKRERR                                             66                                                           
						                                                            	         ||||||                                              
						                                                            	    1442 AKRERR                                             1447                                                         

						Comparison report between F09972_P6 and Q9Y2I5unique head    	Sequence name: Q9Y2I5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for F09972_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 1042 x Q9Y2I5   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence HCVLHVFYSS corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of F09972_P6, and a second amino acid sequence being at 	                                                            
						least 90 % homologous to                                     	                     Quality:  536.00                      Escore:       0                                               
						RVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRSAKRERR     	             Matching length:      56                Total length:      56                                               
						corresponding to amino acids 1428 - 1483 of Q9Y2I5, which    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 11 - 66 of F09972_P6, wherein	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						said first amino acid sequence and second amino acid sequence	                        Gaps:       0                        
						are contiguous and in a sequential order.2.An isolated       	                                                            
						polypeptide encoding for a head of F09972_P6, comprising a   	Alignment:                                                   
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      11 RVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRS 60                                                           
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence HCVLHVFYSS of F09972_P6.                     	    1428 RVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRS 1477                                                         
						                                                            	                                                             
						                                                            	      61 AKRERR                                             66                                                           
						                                                            	         ||||||                                              
						                                                            	    1478 AKRERR                                             1483                                                         

19779	HMR136_F09983_1_tr0_r1_1_gPRT		Comparison report between F09983_P1 and Q9H5P6partial WT     	Sequence name: Q9H5P6                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F09983_P1, comprising a first amino 	Sequence documentation:                                      
						MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDLTTSSSSSGPR 	                                                            
						VSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEVLGESDHGNCITSLQLHPKGW 	Alignment of: 19779 x Q9H5P6   ..                            
						ATLLRCSSNSDDEECTCVYEFQEGAPVRPVSPR                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 3 - 155 of Q9H5P6, which also corresponds to  	                                                            
						amino acids 1 - 153 of F09983_P1, a bridging amino acid C    	                     Quality: 2503.00                      Escore:       0                                               
						corresponding to amino acid 154 of F09983_P1, and a second   	             Matching length:     256                Total length:     256                                               
						SLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQCSELVDCLPKEASP 	 Matching Percent Similarity:   99.61   Matching Percent Identity:   99.61                                               
						LRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVSLYQPKF                   	    Total Percent Similarity:   99.61      Total Percent Identity:   99.61                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 157 - 258 of Q9H5P6, which also 	                                                            
						corresponds to amino acids 155 - 256 of F09983_P1, wherein   	Alignment:                                                   
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 50                                                           
						order.                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       3 MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 52                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      53 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 102                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 200                                                          
						                                                            	         ||| ||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 SPRWSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 202                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 252                                                          
						                                                            	                                                             
						                                                            	     251 LYQPKF                                             256                                                          
						                                                            	         ||||||                                              
						                                                            	     253 LYQPKF                                             258                                                          

						Comparison report between F09983_P1 and Q96ET5partial WT     	Sequence name: Q96ET5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for F09983_P1, comprising a first amino acid        	                                                            
						MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDLTTSSSSSGPR 	Alignment of: 19779 x Q96ET5   ..                            
						VSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEVLGESDHGNCITSLQLHPKGW 	                                                            
						ATLLRCSSNSDDEECTCVYEFQEGAPVRPVSPRCSLRLTHYIEEANVGRGYIKELCFSPD 	Alignment segment 1/1:                                       
						GRMISSPHGYGIRLLGFDKQCSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQI 	                                                            
						ASGCLSGRVSLYQPKF                                             	                     Quality: 2524.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     256                Total length:     256                                               
						amino acids 3 - 258 of Q96ET5, which also corresponds to     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 256 of F09983_P1.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       3 MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 52                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      53 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 102                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 202                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 252                                                          
						                                                            	                                                             
						                                                            	     251 LYQPKF                                             256                                                          
						                                                            	         ||||||                                              
						                                                            	     253 LYQPKF                                             258                                                          

						Comparison report between F09983_P1 and Q8N2Q5partial WT     	Sequence name: Q8N2Q5                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for F09983_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MRLTP        	                                                            
						corresponding to amino acids 157 - 161 of Q8N2Q5, which also 	Alignment of: 19779 x Q8N2Q5   ..                            
						corresponds to amino acids 1 - 5 of F09983_P1, a bridging    	                                                            
						amino acid D corresponding to amino acid 6 of F09983_P1, and 	Alignment segment 1/1:                                       
						a second amino acid sequence being at least 90 % homologous  	                                                            
						CSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDLTTSSSSSGPRVSGSPC 	                     Quality: 2510.00                      Escore:       0                                               
						HHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEVLGESDHGNCITSLQLHPKGWATLLRC 	             Matching length:     256                Total length:     256                                               
						SSNSDDEECTCVYEFQEGAPVRPVSPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISS 	 Matching Percent Similarity:   99.61   Matching Percent Identity:   99.61                                               
						PHGYGIRLLGFDKQCSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLS 	    Total Percent Similarity:   99.61      Total Percent Identity:   99.61                                               
						GRVSLYQPKF                                                   	                        Gaps:       0                        
						to corresponding to amino acids 163 - 412 of Q8N2Q5, which   	                                                            
						also corresponds to amino acids 7 - 256 of F09983_P1, wherein	Alignment:                                                   
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 50                                                           
						order.                                                       	         ||||| ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 MRLTPGCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 406                                                          
						                                                            	                                                             
						                                                            	     251 LYQPKF                                             256                                                          
						                                                            	         ||||||                                              
						                                                            	     407 LYQPKF                                             412                                                          

						Comparison report between F09983_P1 and Q9BTQ5partial WT     	Sequence name: Q9BTQ5                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						F09983_P1, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MRLTPDCSKMLISTSSGYLLILHDLDLT        	Alignment of: 19779 x Q9BTQ5   ..                            
						corresponding to amino acids 3 - 30 of Q9BTQ5, which also    	                                                            
						corresponds to amino acids 1 - 28 of F09983_P1, a bridging   	Alignment segment 1/1:                                       
						amino acid K corresponding to amino acid 29 of F09983_P1, a  	                                                            
						second amino acid sequence being at least 90 % homologous to 	                     Quality: 2045.00                      Escore:       0                                               
						SLEVGSYPILRARRTTSSS corresponding to amino acids 32 - 50 of  	             Matching length:     219                Total length:     256                                               
						Q9BTQ5, which also corresponds to amino acids 30 - 48 of     	 Matching Percent Similarity:   99.54   Matching Percent Identity:   99.54                                               
						F09983_P1, a third amino acid sequence being at least 70%,   	    Total Percent Similarity:   85.16      Total Percent Identity:   85.16                                               
						optionally at least 80%, preferably at least 85%, more       	                        Gaps:       1                        
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment:                                                   
						DLTTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQRE corresponding to amino 	                  .         .         .         .         .  
						acids 49 - 85 of F09983_P1, and a fourth amino acid sequence 	       1 MRLTPDCSKMLISTSSGYLLILHDLDLTKSLEVGSYPILRARRTTSSSDL 50                                                           
						GVSPRNSLEVVTPEVLGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGA 	         |||||||||||||||||||||||||||| |||||||||||||||||||    
						PVRPVSPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQCSELV 	       3 MRLTPDCSKMLISTSSGYLLILHDLDLTNSLEVGSYPILRARRTTSSS.. 50                                                           
						DCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVSLYQPKF          	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	      51 TTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQREGVSPRNSLEVVTPEV 100                                                          
						acids 51 - 221 of Q9BTQ5, which also corresponds to amino    	                                            |||||||||||||||  
						acids 86 - 256 of F09983_P1, wherein said first amino acid   	      51 ...................................GVSPRNSLEVVTPEV 65                                                           
						sequence, bridging amino acid, second amino acid sequence,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     101 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 150                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of F09983_P1,       	      66 LGESDHGNCITSLQLHPKGWATLLRCSSNSDDEECTCVYEFQEGAPVRPV 115                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     151 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 200                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence encoding for      	     116 SPRCSLRLTHYIEEANVGRGYIKELCFSPDGRMISSPHGYGIRLLGFDKQ 165                                                          
						DLTTSSSSSGPRVSGSPCHHSDSNSSEKHMSRASQRE, corresponding to      	                  .         .         .         .         .  
						F09983_P1.                                                   	     201 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     166 CSELVDCLPKEASPLRVIRSLYSHNDVVLTTKFSPTHCQIASGCLSGRVS 215                                                          
						                                                            	                                                             
						                                                            	     251 LYQPKF                                             256                                                          
						                                                            	         ||||||                                              
						                                                            	     216 LYQPKF                                             221                                                          

20195	HMR136_F09992_9_tr0_r1_1_gPRT		Comparison report between F09992_P9 and S15B_HUMANpartial WT 	Sequence name: S15B_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F09992_P9, comprising a first amino 	Sequence documentation:                                      
						MERGKMAEAESLETAAEHERILREIESTDTACIGPTLRSVYDGEEHGRFMEKLETRIRNH 	                                                            
						DREIEKMCNFHYQGFVDSITELLKVRGEAQKLKNQVTDTNRKLQHEGKE            	Alignment of: 20195 x S15B_HUMAN   ..                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 109 of S15B_HUMAN, which also corresponds 	Alignment segment 1/1:                                       
						to amino acids 1 - 109 of F09992_P9, and a second amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1071.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     109                Total length:     109                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence VRPVYLLKKSFLFH corresponding to amino    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 110 - 123 of F09992_P9, wherein said first amino acid  	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of F09992_P9, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MERGKMAEAESLETAAEHERILREIESTDTACIGPTLRSVYDGEEHGRFM 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence VRPVYLLKKSFLFH 	       1 MERGKMAEAESLETAAEHERILREIESTDTACIGPTLRSVYDGEEHGRFM 50                                                           
						in F09992_P9.                                                	                  .         .         .         .         .  
						                                                            	      51 EKLETRIRNHDREIEKMCNFHYQGFVDSITELLKVRGEAQKLKNQVTDTN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EKLETRIRNHDREIEKMCNFHYQGFVDSITELLKVRGEAQKLKNQVTDTN 100                                                          
						                                                            	                                                             
						                                                            	     101 RKLQHEGKE                                          109                                                          
						                                                            	         |||||||||                                           
						                                                            	     101 RKLQHEGKE                                          109                                                          

20855	HMR136_F10023_11_tr0_r1_1_gPRT		Comparison report between F10023_P11 and Q8WV90partial WT    	Sequence name: Q8WV90                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for F10023_P11, comprising a first amino	Sequence documentation:                                      
						MLLRAAWRRAAVAVTAAPGPKPAAPTRGLRLRVGDRAPQSAVPADTAAAPEVGPVLRPLY 	                                                            
						MDVQATTPLDPRVLDAMLPYLINYYGNPHSRTHAYGWESEAAMERARQQVASLIGADPRE 	Alignment of: 20855 x Q8WV90   ..                            
						IIFTSGATESNNIAIK                                             	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 136 of Q8WV90, which also corresponds to  	                                                            
						amino acids 1 - 136 of F10023_P11, and a second amino acid   	                     Quality: 1311.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     136                Total length:     136                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ELEAAIQPDTSLVSVMTVNNEIGVKQPIAEIGRICSSRKVYFHTDAAQAVGKIPLDVNDM 	                        Gaps:       0                        
						KIDLMSISGHKIYGPKGVGAIYIRRRPRVRVEALQSGGGQERGMRSGTVPTPLVVGLGAA 	                                                            
						CEVAQQEMEYDHKRISKLSERLIQNIMKSLPDVVMNGDPKHHYPGCINLSFAYVEGESLL 	Alignment:                                                   
						MALKDVALSSGSACTSASLEPSYVLRAIGTDEDLAHSSIRFGIGRFTTEEEVDYTVEKCI 	                  .         .         .         .         .  
						QHVKRLREMSPLWEMVQDGIDLKSIKWTQH                               	       1 MLLRAAWRRAAVAVTAAPGPKPAAPTRGLRLRVGDRAPQSAVPADTAAAP 50                                                           
						having the sequence corresponding to amino acids 137 - 406 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						F10023_P11, wherein said first amino acid sequence and second	       1 MLLRAAWRRAAVAVTAAPGPKPAAPTRGLRLRVGDRAPQSAVPADTAAAP 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 EVGPVLRPLYMDVQATTPLDPRVLDAMLPYLINYYGNPHSRTHAYGWESE 100                                                          
						F10023_P11, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 EVGPVLRPLYMDVQATTPLDPRVLDAMLPYLINYYGNPHSRTHAYGWESE 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .                      
						ELEAAIQPDTSLVSVMTVNNEIGVKQPIAEIGRICSSRKVYFHTDAAQAVGKIPLDVNDM 	     101 AAMERARQQVASLIGADPREIIFTSGATESNNIAIK               136                                                          
						KIDLMSISGHKIYGPKGVGAIYIRRRPRVRVEALQSGGGQERGMRSGTVPTPLVVGLGAA 	         ||||||||||||||||||||||||||||||||||||                
						CEVAQQEMEYDHKRISKLSERLIQNIMKSLPDVVMNGDPKHHYPGCINLSFAYVEGESLL 	     101 AAMERARQQVASLIGADPREIIFTSGATESNNIAIK               136                                                          
						MALKDVALSSGSACTSASLEPSYVLRAIGTDEDLAHSSIRFGIGRFTTEEEVDYTVEKCI 	                                                            
						QHVKRLREMSPLWEMVQDGIDLKSIKWTQH                               	                                                            
						least about 95% homologous to the sequence in F10023_P11.    	                                                            

